Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
KRTAP19-3	KAP19.3	ENSG00000244025	"Keratin associated protein 19-3"	Q7Z4W3	21	30491464-30491985	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	279	"skeletal muscle: 39.3;skin 1: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.3	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IDI2	IPPI2	ENSG00000148377	"Isopentenyl-diphosphate delta isomerase 2"	Q9BXS1	10	1018907-1025859	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	125	"skeletal muscle: 141.6"	"Cell line enhanced"	"Detected in some"		"HEL: 1.3;NB-4: 2.6;NTERA-2: 1.5;SK-MEL-30: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"																														"unprognostic (6.69e-3)"	"unprognostic (4.05e-2)"				"unprognostic (1.64e-1)"				1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	141.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.7	0.5	0.1	0.0	0.7	0.0	0.8	0.1	0.0	1.0	0.0	0.0	0.4	0.4	0.8	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.7	0.0	0.5	0.0	0.3	0.9	1.3	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	2.6	1.5	0.0	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	3.4	1.0	0.1	0.0	0.1	0.1	0.4	0.0	0.2	0.4	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	1.0	0.1	0.1	0.1	0.0	0.7	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD1	"ALRP, C-193, CARP, CVARP, MCARP"	ENSG00000148677	"Ankyrin repeat domain 1"	Q15327	10	90912096-90921276	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	81	"heart muscle: 398.9;skeletal muscle: 333.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 37.6;EFO-21: 103.9;HUVEC TERT2: 35.4;LHCN-M2: 127.6;TIME: 177.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA038736	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA038736: AB_2676184"	"unprognostic (2.45e-1)"	"unprognostic (6.14e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.39e-1)"	"unprognostic (9.14e-3)"	"prognostic unfavourable (1.95e-4)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.72e-5)"	"unprognostic (3.40e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.16e-3)"	1.5	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	2.1	1.5	0.1	0.1	398.9	0.0	0.0	0.1	0.1	4.5	0.2	0.0	0.0	0.1	0.4	0.1	0.1	0.7	0.1	0.9	0.1	0.0	0.8	0.1	333.3	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	2.9	1.6	0.5	0.3	0.0	0.4	0.5	1.9	0.6	0.9	0.4	0.2	2.9	0.8	0.5	0.0	0.4	0.5	0.0	1.7	0.1	0.4	0.9	37.6	1.4	0.0	103.9	0.1	1.0	0.1	0.2	1.3	0.1	0.1	0.0	0.2	11.6	2.3	0.0	0.0	3.7	0.0	0.7	1.8	35.4	0.0	0.0	127.6	0.0	0.0	0.0	0.1	0.0	0.0	8.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	177.6	0.3	13.6	0.2	13.9	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.2	0.5	0.2	0.3	0.3	0.3	0.2	0.2	0.2	0.4	0.4	0.3	0.7	0.9	0.6	0.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
LBX1	"HPX6, LBX1H"	ENSG00000138136	"Ladybird homeobox 1"	P52954	10	101226195-101229794	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	76	"brain: 11.8;skeletal muscle: 25.0"	"Group enriched"	"Detected in some"	5	"HEK 293: 4.9;RH-30: 6.2;SCLC-21H: 13.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	7	"cerebellum: 11.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"cerebellum: 1.8;pons and medulla: 3.2"	"Group enriched"	"Detected in some"	20	"cerebellum: 2.9;pons and medulla: 2.8"	"HPA002016, HPA002086"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA002016: AB_2666518, HPA002086: "		"unprognostic (4.13e-1)"			"unprognostic (3.86e-2)"	"unprognostic (2.25e-2)"		"unprognostic (2.29e-1)"	"unprognostic (7.28e-3)"	"unprognostic (3.31e-1)"				"unprognostic (9.76e-2)"	"unprognostic (1.45e-1)"			0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	25.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	6.2	0.0	0.0	0.0	13.3	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.8	0.8	0.0	0.0	0.0	0.0	1.7	0.0
DUPD1	DUSP27	ENSG00000188716	"Dual specificity phosphatase and pro isomerase domain containing 1"	Q68J44	10	75037836-75058514	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	71	"skeletal muscle: 38.9"	"Cell line enhanced"	"Detected in single"		"NB-4: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042964	Uncertain									"HPA042964: AB_10795764"						"unprognostic (1.05e-2)"				"unprognostic (1.77e-1)"					"unprognostic (2.34e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.5	0.0	38.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0										
AL022312.1		ENSG00000285025	"MIEF1 upstream open reading frame protein "	L0R8F8	22	39504231-39504443	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	66	"blood: 3.3;skeletal muscle: 9.7"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.8;MOLT-4: 11.3;REH: 2.0;U-698: 2.4"									"Cell type enhanced"	"Detected in some"		"eosinophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"																																			0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	9.7	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.4	0.6	3.3	0.9	2.4	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.9	3.3	1.0	0.7	0.0	0.0	0.0	0.4	0.0	0.4	0.5	0.1	0.0	2.4	0.0	0.6	1.9	0.1										
LMOD2		ENSG00000170807	"Leiomodin 2"	Q6P5Q4	7	123655807-123664290	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	44	"heart muscle: 117.3;skeletal muscle: 297.2;tongue: 100.1"	"Cell line enriched"	"Detected in single"	9	"HSkMC: 5.7"	"Group enriched"	"Detected in some"	20	"head and neck cancer: 3.5;prostate cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA051039	Enhanced									"HPA051039: AB_2681321"	"unprognostic (2.55e-1)"			"unprognostic (1.14e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.50e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.98e-2)"		"unprognostic (2.13e-2)"	"unprognostic (1.43e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.82e-3)"	3.3	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.2	3.8	0.0	0.0	117.3	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.5	0.0	0.0	2.6	0.0	297.2	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.4	100.1	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
RTP2	"MGC78665, Z3CXXC2"	ENSG00000198471	"Receptor transporter protein 2"	Q5QGT7	3	187698259-187702557	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	42	"skeletal muscle: 5.7;testis: 3.1"	"Cell line enriched"	"Detected in single"	11	"SK-BR-3: 6.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	15	"olfactory region: 0.3"																						"unprognostic (5.86e-2)"		"unprognostic (1.12e-2)"					0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	3.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TNNT3	"AMCD2B, DA2B, DKFZp779M2348, FSSV"	ENSG00000130595	"Troponin T3, fast skeletal type"	P45378	11	1919562-1938706	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	38	"skeletal muscle: 834.7;tongue: 355.7"	"Cell line enriched"	"Detected in some"	21	"HSkMC: 32.9"	"Group enriched"	"Detected in many"	9	"head and neck cancer: 28.8;urothelial cancer: 19.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	10	"basophil: 9.5"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 9.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002451, HPA037810, HPA056909"	Enhanced									"CAB002451: AB_564151, HPA037810: AB_10966217, HPA056909: AB_2683273"	"unprognostic (1.01e-2)"	"prognostic favourable (7.37e-4)"	"unprognostic (2.17e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.53e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.42e-5)"	"unprognostic (2.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.90e-2)"	15.6	0.1	0.0	0.1	0.0	0.1	0.9	0.0	0.1	0.5	0.2	0.0	0.0	0.1	0.3	4.4	7.5	0.6	0.2	4.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	2.9	0.0	1.4	0.1	0.0	12.1	0.3	834.7	0.3	0.1	0.3	0.1	0.1	0.1	0.4	0.0	0.0	4.1	355.7	10.1	1.2	0.6	0.0	0.9	9.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	32.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PYGM		ENSG00000068976	"Glycogen phosphorylase, muscle associated"	P11217	11	64746389-64760297	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	37	"skeletal muscle: 572.6;tongue: 172.6"	"Cell line enhanced"	"Detected in some"		"HSkMC: 8.2;NB-4: 4.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 9.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056003	Enhanced					12000000	12000000			"HPA056003: AB_2683006"	"unprognostic (3.33e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.87e-4)"	"unprognostic (1.95e-3)"	"unprognostic (8.71e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.33e-6)"	"unprognostic (3.37e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.68e-2)"	6.4	0.8	2.2	0.7	3.0	0.7	0.8	1.1	3.1	0.9	2.1	1.8	0.7	0.7	1.1	4.6	7.1	1.5	0.9	5.5	2.9	1.0	0.7	0.6	0.7	0.7	1.5	1.1	0.7	0.7	0.6	0.3	0.7	6.6	2.5	0.9	1.6	7.9	2.8	572.6	0.6	0.8	2.5	4.1	0.7	0.8	0.9	1.8	0.0	1.2	172.6	6.4	1.5	0.6	1.9	0.3	9.9	0.0	1.6	0.3	0.2	0.2	0.1	1.7	0.2	1.2	1.7	0.3	0.2	0.1	0.3	0.0	0.7	0.7	1.3	0.5	0.0	0.3	0.5	0.1	0.1	1.4	0.3	0.8	0.3	0.0	0.7	0.8	0.3	8.2	0.6	0.6	0.2	0.0	1.5	1.5	0.0	2.1	1.4	4.7	1.7	0.2	0.9	1.5	0.3	0.0	0.2	0.5	0.1	0.6	0.7	0.9	0.7	0.9	0.6	0.0	0.9	0.3	0.1	2.3	2.8	1.0	0.0	0.2	0.0	9.9	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.2	0.0	1.9	0.0	0.1	0.2	1.6	0.0	0.3	0.3	0.2	2.2	3.0	1.1	3.1	2.9	1.0	1.5	1.1	6.6	1.8
MYH2	"IBM3, MYH2A, MYHas8, MyHC-2A, MyHC-IIa, MYHSA2"	ENSG00000125414	"Myosin heavy chain 2"	Q9UKX2	17	10521148-10549957	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	34	"skeletal muscle: 559.4;tongue: 232.5"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 6.0;HSkMC: 2.9;NTERA-2: 12.8"	"Cancer enriched"	"Detected in single"	60	"head and neck cancer: 27.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001349, CAB010760"	Enhanced					42000000	42000000			"CAB010760: AB_477190, HPA001349: AB_1079437"	"unprognostic (6.50e-2)"					"unprognostic (1.86e-2)"		"unprognostic (4.76e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.05e-4)"	"unprognostic (2.89e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"			10.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	11.6	0.1	559.4	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.1	232.5	11.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.1	12.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYL1		ENSG00000168530	"Myosin light chain 1"	P05976	2	210290150-210315190	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	34	"skeletal muscle: 743.1;tongue: 350.7"	"Cell line enriched"	"Detected in some"	5	"HSkMC: 33.8"	"Group enriched"	"Detected in some"	18	"head and neck cancer: 36.0;prostate cancer: 12.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA046859, HPA063034, HPA073827"	Enhanced				"Intracellular and membrane"	20000000	20000000			"HPA046859: AB_2679842, HPA063034: AB_2684927, HPA073827: "						"prognostic unfavourable (6.59e-4)"									"unprognostic (1.88e-1)"			12.9	0.1	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	16.1	9.9	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	6.1	0.0	0.0	13.4	0.0	743.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	2.4	350.7	9.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.3	0.0	0.0	7.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
TCAP	"CMD1N, LGMD2G, T-cap, TELE, telethonin"	ENSG00000173991	Titin-cap	O15273	17	39664187-39666555	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	34	"heart muscle: 298.7;skeletal muscle: 708.2;tongue: 249.2"	"Cell line enhanced"	"Detected in many"		"NB-4: 6.8;SK-BR-3: 11.8"	"Group enriched"	"Detected in many"	8	"head and neck cancer: 20.2;prostate cancer: 11.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"naive CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 15.0"	"Low region specificity"	"Detected in many"			"CAB004591, HPA026477"	Enhanced					68000	68000			"CAB004591: AB_628340, HPA026477: AB_1857888"	"unprognostic (5.29e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.40e-3)"	"unprognostic (4.32e-3)"	"unprognostic (8.79e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-4)"	"unprognostic (2.62e-1)"	"unprognostic (4.51e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"prognostic favourable (4.55e-4)"	3.2	0.2	0.2	0.1	0.5	0.2	0.2	0.4	0.2	0.1	0.1	0.0	0.1	0.1	0.1	11.1	8.6	0.1	0.1	298.7	0.2	0.2	0.1	0.1	0.2	0.2	0.6	0.0	0.1	0.2	0.1	0.2	0.1	0.0	4.1	0.1	0.0	12.3	0.1	708.2	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0.0	0.0	5.8	249.2	11.5	0.2	0.1	0.3	0.0	0.0	0.2	0.3	2.4	0.1	0.2	3.1	2.4	3.6	0.5	0.5	0.8	0.5	0.1	0.5	0.8	1.2	2.1	1.3	2.5	0.3	1.3	1.1	0.1	0.2	1.1	3.1	1.3	1.6	0.3	0.7	0.7	0.4	1.0	0.6	1.0	0.3	0.2	2.4	0.8	0.2	1.3	1.0	6.8	1.6	0.8	1.0	2.5	0.8	0.5	0.4	1.5	2.4	1.7	11.8	1.4	0.8	1.4	1.2	1.0	1.7	2.2	0.7	5.2	2.9	0.7	1.1	1.8	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.4	2.4	0.0	0.3	0.2	0.0	0.0	0.1	0.2	0.5	0.4	0.2	0.2	0.2	0.6	0.0	0.0	0.0
MYH1	"MGC133384, MYHa, MyHC-2X/D, MYHSA1"	ENSG00000109061	"Myosin heavy chain 1"	P12882	17	10492307-10518543	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"skeletal muscle: 428.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;U-2 OS: 2.2"	"Cancer enriched"	"Detected in single"	45	"head and neck cancer: 8.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA001349, CAB010759"	Enhanced					49000000	49000000			"CAB010759: AB_477248, HPA001349: AB_1079437"	"unprognostic (2.87e-2)"					"unprognostic (3.27e-3)"		"unprognostic (1.91e-1)"	"unprognostic (8.95e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.31e-2)"		"unprognostic (5.63e-3)"	"unprognostic (9.85e-4)"	"unprognostic (1.92e-1)"		"unprognostic (4.58e-2)"	5.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	428.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC30		ENSG00000206422	"Leucine rich repeat containing 30"	A6NM36	18	7231125-7232047	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	30	"skeletal muscle: 18.7"	"Cell line enriched"	"Detected in single"	12	"SH-SY5Y: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041039	Uncertain									"HPA041039: AB_2677270"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.1	0.0		0.2	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MYOT	"LGMD1, LGMD1A, TTID"	ENSG00000120729	Myotilin	Q9UBF9	5	137867791-137887851	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	30	"skeletal muscle: 297.3;tongue: 85.1"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.5;HeLa: 2.4;U-266/70: 1.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.7"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037733, HPA037734"	Enhanced									"HPA037733: AB_10697082, HPA037734: AB_2675638"	"unprognostic (5.85e-2)"	"unprognostic (2.38e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (8.85e-4)"	"unprognostic (8.03e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.56e-4)"	"unprognostic (1.72e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.40e-1)"	2.8	0.3	0.6	0.2	1.4	0.1	0.1	0.1	0.4	0.3	1.0	0.0	0.0	0.3	0.1	6.0	6.2	0.1	0.2	6.2	0.7	0.4	0.2	0.1	0.1	0.1	0.9	0.0	0.1	0.1	0.1	0.0	0.1	0.1	2.4	0.3	0.0	3.6	0.6	297.3	0.1	0.4	0.2	0.7	0.1	0.2	0.1	0.6	0.0	2.2	85.1	6.0	0.2	0.4	0.8	1.0	0.0	0.1	0.4	0.6	0.0	0.5	0.3	0.0	0.0	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	1.2	1.1	1.1	0.0	0.1	0.0	0.3	0.0	0.5	1.5	0.4	2.4	0.0	0.0	0.0	0.3	1.4	0.4	0.0	0.0	0.0	0.2	1.1	1.2	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.7	0.0	0.8	0.0	0.2	0.6	0.1	0.5	0.0	0.0	1.7	0.7	0.0	0.6	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.1	0.0	0.8	0.5	0.2	0.0	0.4	0.1	1.0	0.0	0.0	0.6	1.4	0.1	0.4	0.7	0.4	0.9	0.0	0.1	0.6
CALML6	CAGLP	ENSG00000169885	"Calmodulin like 6"	Q8TD86	1	1914827-1917296	"Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	29	"skeletal muscle: 51.4;tongue: 73.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"														"unprognostic (3.85e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.59e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.33e-3)"	"unprognostic (9.72e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.03e-2)"	"unprognostic (9.76e-2)"	"unprognostic (5.21e-10)"	"unprognostic (5.06e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.23e-2)"	"unprognostic (6.48e-2)"	0.2	0.0	0.1	0.1	0.6	0.1	0.2	0.7	0.3	0.1	0.1	0.1	0.1	0.1	0.2	0.3	2.1	0.0	0.1	0.1	0.1	0.0	0.2	0.9	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.3	0.1	0.1	0.7	0.1	0.1	1.8	0.2	51.4	0.8	0.1	0.1	0.1	0.2	0.1	0.6	0.1	0.1	0.1	73.7	0.7	0.1	0.5	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	4.9	1.5	0.9	2.9	1.0	0.0	0.4	0.5	0.0	2.9	0.9	0.1	1.2	1.5	0.3	0.5	0.0	0.7	0.3	0.0	1.1	0.0	0.4	0.1	0.6	2.1	2.9	0.4	0.3	0.2	0.0	1.7	0.1	1.0	0.0	0.1	0.9	0.8	1.5	0.1	2.5	0.5	0.2	0.2	0.5	0.0	0.3	0.1	0.8	0.3	0.0	0.1	0.0	2.7	0.1	1.5	0.3	2.9	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.6	0.7	0.3	0.1	0.0	0.1	0.1	0.1	0.1
MYH4	"MYH2B, MyHC-2B, MyHC-IIb"	ENSG00000264424	"Myosin heavy chain 4"	Q9Y623	17	10443290-10469559	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	29	"skeletal muscle: 15.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.5;U-2 OS: 1.4"	"Cancer enriched"	"Detected in single"	115	"liver cancer: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"amygdala: 0.9"	HPA001349	Supported					34000000	34000000			"HPA001349: AB_1079437"	"unprognostic (3.27e-2)"		"unprognostic (2.94e-2)"			"unprognostic (4.94e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.72e-1)"			"unprognostic (1.37e-1)"		"unprognostic (3.32e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.52e-4)"		"unprognostic (9.97e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
COX6A2		ENSG00000156885	"Cytochrome c oxidase subunit 6A2"	Q02221	16	31427731-31428428	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	28	"heart muscle: 398.6;skeletal muscle: 421.1;tongue: 230.8"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 14.3"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 9.3;liver cancer: 2.9;prostate cancer: 3.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	125	"NK-cell: 12.5"	"Lineage enriched"	"Detected in single"	125	"NK-cells: 12.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.66e-1)"	"unprognostic (1.73e-3)"			"unprognostic (2.09e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.68e-2)"		"unprognostic (3.88e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.65e-1)"			3.0	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	9.3	5.6	0.1	0.1	398.6	0.1	0.3	0.2	0.9	0.1	0.1	0.2	0.0	0.1	0.2	0.2	0.8	0.1	0.0	2.3	0.1	0.9	8.4	0.1	421.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	5.5	230.8	11.4	0.1	0.1	0.0	0.0	0.0	0.0	12.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.0	0.0	0.0
SMTNL1	CHASM	ENSG00000214872	"Smoothelin like 1"	A8MU46	11	57542641-57550274	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"skeletal muscle: 118.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.5;HDLM-2: 2.8;U-266/70: 5.0;U-266/84: 2.8"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"																		"unprognostic (1.35e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.53e-3)"	"unprognostic (4.04e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.44e-2)"	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.1	0.0		1.4	0.0	118.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	1.2	0.8	4.3	1.7	0.7	2.4	0.5	0.1	0.2	1.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.5	1.3	1.3	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.9	0.0	0.1	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.4	1.9	1.1	0.7	0.1	1.6	0.4	0.8	0.0	0.0	0.0	0.9	0.6	0.1	0.5	0.3	0.0	0.0	0.2	0.4	0.5	0.0	5.0	2.8	0.1	0.5	1.3	0.0	2.5	1.2	2.7	1.8	1.4	1.9	1.1	1.2	1.9	0.8	1.2	2.4	1.8	4.3	0.7	1.7	0.8	0.7	0.5										
MYLPF	"HUMMLC2B, MRLC2, MYL11"	ENSG00000180209	"Myosin light chain, phosphorylatable, fast skeletal muscle"	Q96A32	16	30370934-30377991	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	27	"skeletal muscle: 689.9;tongue: 215.7"	"Group enriched"	"Detected in some"	18	"BEWO: 25.5;HSkMC: 57.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 15.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	71	"plasmacytoid DC: 16.5"	"Lineage enriched"	"Detected in single"	71	"dendritic cells: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039262, HPA055059"	Enhanced					28000	28000			"HPA039262: AB_2676418, HPA055059: AB_2732591"	"unprognostic (8.81e-3)"	"unprognostic (7.55e-3)"	"unprognostic (1.05e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.37e-3)"	"unprognostic (8.26e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.14e-4)"	"unprognostic (1.84e-1)"	"unprognostic (3.88e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.44e-2)"	16.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	2.1	5.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	10.4	0.0	689.9	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.6	215.7	5.8	0.0	0.0	0.1	16.5	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	57.3	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	16.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
ATP2A1	"ATP2A, SERCA1"	ENSG00000196296	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1"	O14983	16	28878405-28904509	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"skeletal muscle: 456.3;tongue: 209.0"	"Cell line enhanced"	"Detected in many"		"HEK 293: 19.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"NK-cell: 4.7"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	8	"thalamus: 14.3"	"Low region specificity"	"Detected in all"			"CAB002310, CAB032706"	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB002310: AB_564139, CAB032706: AB_2061286"	"unprognostic (2.37e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.23e-5)"	"unprognostic (5.35e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-2)"	7.6	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.1	1.1	5.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.6	0.1	12.6	7.0	0.3	456.3	0.2	0.2	0.1	0.1	0.1	0.1	0.9	0.0	0.0	4.2	209.0	6.5	0.2	0.1	1.6	3.1	0.7	0.2	4.7	1.5	0.6	4.8	5.2	9.6	5.7	0.4	1.6	8.9	2.3	1.3	0.4	0.4	2.9	4.4	7.6	2.7	0.4	5.1	2.4	0.1	0.7	3.8	19.8	2.7	11.8	9.0	0.2	1.1	2.5	4.1	1.1	0.6	0.5	0.2	5.1	6.5	0.3	9.7	10.9	6.1	9.6	7.4	16.8	6.8	5.7	0.0	0.6	6.1	4.9	3.3	4.5	3.4	3.4	2.7	2.0	3.0	6.3	5.6	2.8	9.5	5.7	7.4	5.9	15.0	2.9	0.0	0.1	0.7	1.0	0.0	1.3	1.6	1.1	1.0	0.0	0.8	1.4	1.3	0.0	4.7	0.2	3.1	1.5	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0
MB	PVALB	ENSG00000198125	Myoglobin	P02144	22	35606764-35637951	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"heart muscle: 366.6;skeletal muscle: 871.2;tongue: 310.7"	"Cell line enriched"	"Detected in some"	4	"SK-BR-3: 61.5"	"Group enriched"	"Detected in many"	7	"breast cancer: 13.6;head and neck cancer: 31.1;prostate cancer: 30.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 4.4"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 4.4"	"Not detected"	"Not detected"							"CAB000060, HPA003123"	Enhanced					190000000	190000000			"CAB000060: , HPA003123: AB_1079442"	"unprognostic (7.51e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.07e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.66e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.19e-2)"	3.6	0.1	0.2	0.1	0.2	0.0	1.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	13.0	19.6	0.4	0.0	366.6	0.2	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.1	0.7	0.0	0.3	0.1	0.0	5.0	0.3	0.0	13.0	0.0	871.2	0.3	0.3	0.0	0.2	0.1	0.1	0.1	0.0	0.0	4.6	310.7	14.4	0.3	0.1	0.1	0.4	0.1	0.0	4.4	0.7	0.0	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.2	0.0	0.1	0.3	0.0	0.0	0.0	1.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	6.3	0.0	0.2	0.0	0.8	0.3	0.1	2.6	0.0	2.2	0.5	0.0	6.5	61.5	0.0	13.7	0.0	0.1	0.2	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.4	0.0	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.0
ODF3L2	"C19orf19, FLJ40059"	ENSG00000181781	"Outer dense fiber of sperm tails 3 like 2"	Q3SX64	19	463346-474983	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"skeletal muscle: 12.5;testis: 16.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.5;BEWO: 2.2;EFO-21: 3.0;HMC-1: 2.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067973	Uncertain									"HPA067973: AB_2685937"	"unprognostic (3.75e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.83e-3)"	"unprognostic (9.69e-3)"	"unprognostic (5.88e-2)"	"unprognostic (5.65e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.02e-5)"	"unprognostic (3.13e-3)"	"unprognostic (8.99e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.99e-1)"	0.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.2		0.0	0.0	0.0	0.0	0.3		0.1	0.0		0.0	0.0	12.5	0.0	0.0	0.0	0.3	0.5	0.0	16.7			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.5	0.0	0.0	2.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	3.0	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.3	0.0	0.2	0.0	0.5	0.1	0.6	0.9	0.1	0.0	0.8	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.9	0.0	0.5	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3										
ACTN3		ENSG00000248746	"Actinin alpha 3 (gene/pseudogene)"	Q08043	11	66546395-66563329	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"skeletal muscle: 185.5"	"Cell line enriched"	"Detected in some"	11	"HDLM-2: 16.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"					"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA006035	Uncertain		Uncertain	"Actin filaments"		29000000	29000000	"Actin filaments"	"Actin filaments"	"HPA006035: AB_1078095"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.35e-4)"	"unprognostic (1.40e-3)"	"unprognostic (5.37e-3)"	"unprognostic (5.09e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.71e-9)"	"unprognostic (2.06e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.48e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	1.0	0.0	0.0	0.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.0	185.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	7.7	1.9	0.1	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1										
MYOZ1	"CS-2, FATZ, MYOZ"	ENSG00000177791	"Myozenin 1"	Q9NP98	10	73631654-73641757	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"skeletal muscle: 387.8;tongue: 133.0"	"Cell line enriched"	"Detected in some"	18	"BEWO: 29.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	17	"olfactory region: 4.9"	"Low region specificity"	"Detected in all"			"HPA037848, HPA038437"	Enhanced									"HPA037848: AB_10670156, HPA038437: AB_2676009"	"unprognostic (4.55e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.22e-4)"	"unprognostic (1.18e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.64e-2)"	"unprognostic (6.78e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.09e-1)"	8.1	0.1	0.2	0.1	0.2	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	10.9	4.2	0.1	0.1	4.1	0.2	0.2	0.2	0.1	0.4	0.1	0.2	0.0	0.2	0.1	0.1	0.2	0.4	0.0	1.3	0.1	0.0	5.6	0.3	387.8	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	1.4	133.0	5.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	29.9	0.2	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.3	0.7	0.2	0.0	0.8	0.8	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.0
SMPX	"DFN6, DFNX4"	ENSG00000091482	"Small muscle protein, X-linked"	Q9UHP9	X	21705972-21758163	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	23	"heart muscle: 108.8;skeletal muscle: 155.8;tongue: 74.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.6;Hep G2: 6.7;HSkMC: 7.3;Karpas-707: 5.0;U-266/70: 7.4;U-266/84: 2.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA077360			Approved	"Plasma membrane"		45000	45000	"Plasma membrane"	"Plasma membrane"	"HPA077360: AB_2732342"	"unprognostic (7.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (3.04e-5)"	"unprognostic (1.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.27e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.58e-2)"		"unprognostic (2.67e-2)"	"unprognostic (2.82e-1)"		"unprognostic (8.38e-2)"	1.4	0.0	0.1	0.6	0.1	0.0	0.2	0.6	0.9	0.1	4.0	0.0	0.0	0.1	0.1	4.7	4.0	0.1	0.1	108.8	0.1	0.2	0.0	0.2	0.0	0.1	0.7	0.3	0.2	0.1	0.0	0.0	0.0	0.0	1.6	0.5	0.0	3.6	0.1	155.8	0.0	0.9	1.8	0.1	0.0	1.5	0.1	0.0	0.0	1.0	74.5	4.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.7	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	5.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	7.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.9	0.1	0.2	0.7	0.3	0.0	0.0
PPP1R27	"DYSFIP1, toonin"	ENSG00000182676	"Protein phosphatase 1 regulatory subunit 27"	Q86WC6	17	81833492-81835050	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"skeletal muscle: 211.0"	"Group enriched"	"Detected in some"	23	"HL-60: 62.4;THP-1: 121.0"	"Cancer enriched"	"Detected in single"	10	"head and neck cancer: 3.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048632	Uncertain									"HPA048632: AB_2680469"	"unprognostic (3.35e-2)"	"unprognostic (1.12e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.21e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.38e-2)"	"unprognostic (8.70e-2)"	"unprognostic (4.98e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.19e-3)"	"unprognostic (1.30e-1)"	1.8	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.7	0.0	0.0	1.7	0.0	211.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	9.6	1.2	0.0	0.0	0.8	0.4	3.2	0.4	0.7	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	121.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	0.4	0.3	0.3	0.2	0.3	0.4	0.2	0.2	0.3	0.8	0.3	0.4	3.2	0.7	0.3	0.4	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMCO1	"C3orf43, DKFZp313B0440, FLJ41923"	ENSG00000214097	"Single-pass membrane protein with coiled-coil domains 1"	Q147U7	3	196506877-196515366	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	22	"heart muscle: 48.6;skeletal muscle: 57.8;tongue: 66.9"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.5;NTERA-2: 1.4;U-251 MG: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"NK-cell: 2.1"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (4.86e-2)"	"unprognostic (1.62e-1)"		"unprognostic (1.51e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.72e-2)"		"unprognostic (1.73e-1)"		"unprognostic (3.25e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.94e-2)"		"unprognostic (2.95e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.88e-3)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.0	0.0	48.6	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	2.1	0.0	57.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	66.9	2.5	0.0	0.0	0.0	0.0	0.4	0.0	2.1	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.4	0.6	0.3	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.7	0.1	0.0	0.2	0.2	0.0	0.2	0.2	0.8	0.2	1.5	0.7	0.1	1.4	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.3	0.3	0.4	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.2	0.5	0.5	0.4	0.0	0.7	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
CAMK2A	"CAMKA, CaMKIINalpha, KIAA0968"	ENSG00000070808	"Calcium/calmodulin dependent protein kinase II alpha"	Q9UQM7	5	150219491-150290291	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"brain: 105.7;skeletal muscle: 50.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.6;SCLC-21H: 9.5;U-87 MG: 8.0"	"Cancer enriched"	"Detected in single"	13	"glioma: 6.0"	"Group enriched"	"Detected in all"	6	"amygdala: 60.7;basal ganglia: 50.6;cerebral cortex: 99.6;hippocampal formation: 74.6;olfactory region: 39.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	4	"amygdala: 1311.6;basal ganglia: 698.1;cerebral cortex: 1576.4;hippocampal formation: 1569.1"	"Low region specificity"	"Detected in all"			"CAB004330, HPA051783, HPA051785, HPA053973"	Supported		Approved	"Plasma membrane,Cell Junctions,Cytosol"		21000	21000	"Plasma membrane"	"Plasma membrane"	"CAB004330: AB_626788, HPA051783: AB_2681608, HPA051785: , HPA053973: AB_2682328"	"unprognostic (7.20e-3)"	"unprognostic (6.47e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.85e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.00e-8)"	"unprognostic (2.71e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.36e-3)"	1.3	1.7	60.7	1.3	50.6	1.3	1.1	1.4	105.7	1.8	1.3	3.7	0.0	1.2	2.1	1.4	1.9	1.7	1.3	3.7	74.6	10.5	1.6	1.2	1.5	1.2	5.1	39.8	1.3	1.1	1.1	0.4	1.3	2.4	1.6	1.3	0.0	1.2	1.4	50.1	1.6	1.3	2.5	1.7	1.2	1.3	1.2	2.3	0.0	1.2	0.0	1.1	1.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.6	0.0	0.5	1.3	0.8	0.7	0.0	0.1	0.0	0.2	0.6	2.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.2	0.5	0.2	1.7	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.2	0.0	0.0	9.5	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	8.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	60.7	50.6	1.4	99.6	74.6	10.5	5.1	39.8	2.4	2.3
DHRS7C	SDR32C2	ENSG00000184544	"Dehydrogenase/reductase 7C"	A6NNS2	17	9771434-9791297	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"heart muscle: 44.0;skeletal muscle: 87.4;tongue: 40.1"	"Group enriched"	"Detected in some"	28	"BJ hTERT+: 4.4;HeLa: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"										"unprognostic (6.83e-2)"													0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	2.7	0.0	87.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	40.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0
LDB3	"CMD1C, KIAA0613, PDLIM6, ZASP"	ENSG00000122367	"LIM domain binding 3"	O75112	10	86668449-86736068	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"heart muscle: 213.9;skeletal muscle: 329.7;tongue: 110.3"	"Cell line enhanced"	"Detected in some"		"HSkMC: 6.0;SCLC-21H: 9.7;SK-MEL-30: 4.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							HPA048955	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		450000	450000	"Focal adhesion sites, Cytosol"	"Focal adhesion sites, Cytosol"	"HPA048955: AB_2680568"	"unprognostic (1.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.72e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-1)"	6.4	0.4	0.9	1.3	1.6	0.2	0.5	0.1	1.3	2.8	2.3	0.0	4.9	0.4	4.2	9.9	9.9	1.3	1.0	213.9	1.7	1.0	0.3	0.2	0.4	0.2	2.6	0.0	1.5	0.3	0.3	0.1	0.5	0.0	4.4	0.8	4.7	7.6	3.1	329.7	0.3	1.2	3.6	6.7	0.2	0.7	0.5	0.0	0.0	2.8	110.3	10.2	1.9	0.9	0.9	0.6	1.8	0.4	0.6	0.6	0.0	0.3	0.3	0.4	3.2	0.4	0.1	0.3	0.4	0.3	0.1	0.2	0.3	0.3	0.3	0.6	0.0	0.4	0.2	0.0	0.1	0.9	0.8	0.7	0.9	0.1	0.1	0.1	1.7	6.0	0.5	0.1	0.0	0.0	0.3	1.9	0.3	1.6	0.4	0.2	0.4	0.3	0.0	2.0	0.1	0.0	1.1	9.7	1.8	0.3	0.2	4.7	0.3	0.2	0.0	0.3	0.5	0.4	0.1	0.2	0.6	0.4	0.8	0.3	0.5	1.8	0.4	0.4	0.4	0.3	0.4	0.3	0.3	0.3	0.2	0.9	0.5	0.6	1.4	0.6	0.4	0.6	0.3	0.0	0.9	1.6	0.1	0.6	1.7	1.0	2.6	0.0	0.0	0.0
ART1	"ART2, CD296"	ENSG00000129744	"ADP-ribosyltransferase 1"	P52961	11	3645128-3664416	"CD markers, Enzymes, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	20	"skeletal muscle: 50.9;tongue: 13.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051148	Uncertain									"HPA051148: AB_2681363"	"unprognostic (3.73e-1)"							"unprognostic (4.58e-2)"		"unprognostic (3.12e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.06e-1)"		"unprognostic (1.73e-1)"		1.5	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.3	0.2	0.1	50.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	13.7	0.5	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.2	0.4	0.0
DUSP27		ENSG00000198842	"Dual specificity phosphatase 27, atypical"	Q5VZP5	1	167094045-167129165	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"heart muscle: 46.8;skeletal muscle: 64.8;tongue: 18.2"	"Cell line enriched"	"Detected in some"	10	"RH-30: 17.7"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 12.8;stomach cancer: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA012912			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA012912: AB_2668767"	"unprognostic (1.26e-2)"		"unprognostic (1.74e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.39e-1)"	2.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.1	46.8	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.8	0.0	0.0	0.9	0.0	64.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.5	18.2	0.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.0	0.1	0.1
KLHL41	"KBTBD10, Krp1, SARCOSIN"	ENSG00000239474	"Kelch like family member 41"	O60662	2	169509702-169526262	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"skeletal muscle: 564.4;tongue: 157.3"	"Group enriched"	"Detected in some"	9	"HSkMC: 12.5;LHCN-M2: 19.8;RH-30: 31.8"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 10.8;prostate cancer: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021165, HPA021753, HPA021760"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA021165: AB_1852087, HPA021753: AB_1852089, HPA021760: AB_1852091"	"unprognostic (2.44e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.65e-4)"	"unprognostic (9.64e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.52e-1)"	12.0	0.1	0.2	0.1	0.2	0.1	0.2	0.3	0.2	0.1	0.2	0.0	0.0	0.1	0.1	17.8	9.8	0.2	0.6	10.2	0.2	0.3	0.1	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.1	0.5	0.1	0.0	3.9	0.1	0.0	6.6	0.1	564.4	0.2	0.1	2.3	0.2	0.1	0.2	0.5	0.0	0.0	2.0	157.3	5.0	2.1	0.1	0.2	0.5	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.2	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.1	0.0	12.5	0.2	0.1	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.1	0.0	31.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.2	0.3	0.2	0.2	0.3	0.2	0.0	0.0	0.0
MYADML2	LOC255275	ENSG00000185105	"Myeloid associated differentiation marker like 2"	A6NDP7	17	81939645-81947233	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	20	"skeletal muscle: 44.5"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 8.2"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA041856, HPA048476"	Uncertain									"HPA041856: AB_2677709, HPA048476: AB_2680410"	"unprognostic (1.83e-1)"	"unprognostic (1.71e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.90e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.62e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.16e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.91e-1)"		"unprognostic (8.68e-2)"	0.0	0.0	0.7	0.0	2.0	0.0	0.0	0.4	2.2	0.0	0.0			0.2	0.0	0.0	0.5	0.0	0.0	1.5	0.6	1.5	0.0	0.0	0.0	0.0	1.1		0.0	0.1	0.0	0.0	0.0		0.3	0.0		0.3	0.0	44.5	0.0	0.2	0.0	0.1	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.3	1.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.6	0.0	0.1	0.6	0.5	0.0	0.4	0.1	0.0	0.2	8.2	0.6	0.2	0.2	0.6	0.2	0.0	0.0	0.3	0.7	0.2	0.0	1.5	1.1	0.3	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PPP1R3A	"GM, PPP1R3"	ENSG00000154415	"Protein phosphatase 1 regulatory subunit 3A"	Q16821	7	113876777-114075920	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"heart muscle: 24.1;skeletal muscle: 69.4;tongue: 75.4"	"Cell line enriched"	"Detected in single"	64	"THP-1: 17.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	19	"thalamus: 1.2"	"Low region specificity"	"Detected in some"			"HPA070440, HPA073138"	Enhanced									"HPA070440: , HPA073138: "						"unprognostic (8.96e-3)"												1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.7	0.0	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	1.4	0.0	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	75.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYOZ3	"CS-3, CS3, FRP3"	ENSG00000164591	"Myozenin 3"	Q8TDC0	5	150660874-150679365	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"skeletal muscle: 81.2;tongue: 79.7"	"Group enriched"	"Detected in some"	4	"HAP1: 5.8;NTERA-2: 10.3;REH: 15.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 2.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039166	Enhanced									"HPA039166: AB_10671871"	"unprognostic (2.74e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.57e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.59e-2)"	"unprognostic (8.77e-2)"	"unprognostic (9.19e-4)"	"unprognostic (6.99e-2)"	"unprognostic (5.19e-2)"	"unprognostic (7.21e-3)"	"unprognostic (7.31e-9)"	"unprognostic (2.19e-2)"	"unprognostic (2.79e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.20e-2)"	0.7	0.3	0.3	0.1	1.4	0.4	0.2	0.2	0.9	0.8	0.2	0.1	0.0	0.2	0.6	3.4	2.3	0.4	0.6	2.0	0.3	2.1	0.2	0.1	0.4	0.1	1.1	0.7	0.4	0.1	0.1	0.7	0.1	0.8	1.7	0.1	1.3	3.8	0.5	81.2	0.1	0.4	0.4	1.9	0.1	0.3	1.8	0.1	0.0	0.3	79.7	4.3	0.2	0.2	0.0	2.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.5	0.0	0.1	0.0	0.1	0.0	0.0	5.8	0.0	0.2	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.0	0.6	1.5	10.3	0.0	15.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.3	1.4	0.2	0.9	0.3	2.1	1.1	0.7	0.8	0.1
PERM1	"C1orf170, MGC13275, Perm1, RP11-54O7.8"	ENSG00000187642	"PPARGC1 and ESRR induced regulator, muscle 1"	Q5SV97	1	975204-982093	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"heart muscle: 23.8;skeletal muscle: 68.1;tongue: 24.7"	"Cell line enhanced"	"Detected in some"		"A-431: 2.4;HaCaT: 4.4;MCF7: 3.0;SK-BR-3: 4.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA031711, HPA031712"	Enhanced									"HPA031711: AB_10669636, HPA031712: AB_2674005"	"unprognostic (3.67e-2)"	"unprognostic (5.72e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.58e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavourable (1.95e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.96e-2)"	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.0	1.1	0.0	0.0	23.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.9	0.0	68.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	24.7	0.9	0.1	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.4	0.1	0.0	0.2	0.0	0.0	0.3	1.6	0.0	0.0	0.0	1.4	1.5	0.0	0.5	0.0	4.4	0.0	0.0	0.0	1.4	0.5	0.0	1.4	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	3.0	0.0	0.0	0.0	1.1	0.0	0.0	1.7	0.0	0.9	0.0	0.1	1.3	4.6	1.0	0.4	0.0	0.9	0.7	0.9	0.0	0.7	0.5	0.0	0.0	1.8	0.4	0.4	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
ABRA	STARS	ENSG00000174429	"Actin binding Rho activating protein"	Q8N0Z2	8	106759483-106770245	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"heart muscle: 21.6;skeletal muscle: 77.6;tongue: 35.0"	"Cell line enhanced"	"Detected in some"		"U-266/70: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (9.08e-3)"	"unprognostic (1.61e-2)"	"unprognostic (3.26e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.64e-2)"		"unprognostic (1.35e-2)"		"unprognostic (6.84e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.15e-2)"		"unprognostic (4.34e-1)"	"unprognostic (6.21e-3)"	1.2	0.2	0.1	0.1	0.1	0.1	0.4	0.3	0.1	0.3	0.1	0.0	0.8	0.1	0.6	1.7	2.1	0.2	0.1	21.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.6	0.7	0.1	0.0	2.6	1.6	77.6	0.1	0.1	0.5	0.1	0.1	0.1	0.9	0.0	0.0	2.6	35.0	1.2	0.6	2.2	0.7	0.5	2.6	0.6	0.6	0.5	0.0	0.2	0.0	0.2	0.1	0.3	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.6	0.3	0.2	0.0	0.2	0.0	0.5	0.1	0.4	0.0	0.0	0.7	0.4	0.4	0.1	0.2	0.2	0.1	0.0	1.0	0.1	0.0	0.9	0.0	0.0	0.2	0.4	0.6	0.5	0.3	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.8	0.2	0.0	1.2	0.2	0.6	0.1	0.1	0.1	0.2	0.6	1.3	0.1	0.4	0.0	0.2	0.4	0.1	0.2	0.7	0.5	0.5	2.6	0.6	0.5	0.5	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.6	0.0
CASQ1	"CASQ, PDIB1"	ENSG00000143318	"Calsequestrin 1"	P31415	1	160190556-160201886	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"skeletal muscle: 320.9;tongue: 83.5"	"Group enriched"	"Detected in some"	9	"BEWO: 10.4;HDLM-2: 19.8;RT4: 35.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA007845, CAB015170, HPA026823"	Enhanced		Uncertain	Nucleoplasm,Mitochondria	"Intracellular and membrane"			"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"CAB015170: AB_2071451, HPA007845: AB_1078388, HPA026823: AB_10603557"	"unprognostic (1.87e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.65e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.04e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-1)"	"prognostic favourable (8.93e-5)"	6.1	0.1	0.5	0.0	0.3	0.1	0.2	0.3	2.0	0.1	0.1	0.0	0.1	0.0	0.1	11.9	3.9	0.2	0.1	4.0	0.4	0.3	0.1	0.1	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.5	0.0	1.3	0.0	0.2	4.5	0.4	320.9	0.1	0.1	0.6	0.2	0.1	0.1	0.3	0.0	0.0	0.9	83.5	4.7	0.4	0.1	0.9	0.0	0.9	0.7	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	10.4	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	19.8	0.2	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.1	0.0	35.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.4	0.1	0.1	0.0	0.0	0.9	0.7	0.2	0.0	0.1	0.0	0.5	0.1	0.1	0.0	0.9	0.1	0.1	0.9	0.2	0.1	0.0	0.3	0.0	0.5	0.3	0.3	2.0	0.4	0.3	0.2	0.0	0.0	0.0
MYLK4	SgK085	ENSG00000145949	"Myosin light chain kinase family member 4"	Q86YV6	6	2663629-2750966	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	17	"skeletal muscle: 23.6;tongue: 63.6"	"Cell line enriched"	"Detected in some"	6	"HEL: 12.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA015860	Uncertain		Approved	"Nucleoli,Golgi apparatus,Vesicles"				"Golgi apparatus"	"Golgi apparatus"	"HPA015860: AB_2147922"	"unprognostic (1.75e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.63e-2)"	0.5	0.3	0.3	0.3	0.4	0.4	0.8	1.4	0.7	0.3	0.3	0.3	0.3	0.1	0.3	0.5	1.0	0.2	0.3	1.0	0.5	0.5	2.6	0.3	0.5	0.3	0.4	0.3	0.3	1.1	0.7	0.7	0.4	0.4	0.4	0.1	0.4	2.4	0.4	23.6	0.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.0	63.6	1.5	0.5	0.3	0.1	0.8	0.3	0.3	0.9	1.4	0.1	0.3	0.1	0.6	1.1	1.0	1.2	0.6	0.7	1.5	0.5	0.4	0.5	1.0	1.0	1.6	0.8	1.9	0.2	0.4	0.7	0.2	0.6	12.4	0.6	0.1	0.3	0.3	0.6	1.5	0.5	0.1	1.2	0.5	0.1	0.1	0.3	0.5	0.1	1.3	0.2	0.0	0.9	0.0	0.0	0.8	0.3	1.0	0.6	0.3	0.2	0.5	0.4	0.8	0.7	0.5	0.1	0.2	0.4	0.4	0.2	0.1	0.2	0.3	1.2	0.1	0.1	0.1	0.5	0.0	0.3	0.1	0.2	1.4	0.2	0.1	0.6	0.1	0.3	0.9	0.3	0.8	0.1	0.1	0.3	0.4	1.4	0.7	0.5	0.5	0.4	0.3	0.4	0.3
SRL		ENSG00000185739	Sarcalumenin	Q86TD4	16	4189374-4242080	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"heart muscle: 70.9;skeletal muscle: 104.1;tongue: 48.3"	"Cell line enriched"	"Detected in single"	13	"HSkMC: 9.6"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.5;thyroid cancer: 5.9"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in many"			"HPA041535, HPA045520"	Enhanced				"Intracellular and membrane"	26000	26000			"HPA041535: AB_2677538, HPA045520: AB_2679358"	"unprognostic (1.24e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.04e-7)"	"unprognostic (1.41e-1)"	"unprognostic (8.28e-2)"	"unprognostic (7.40e-4)"	"unprognostic (4.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (7.78e-4)"	"unprognostic (3.33e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.68e-4)"	3.1	0.1	0.2	0.2	0.2	0.0	0.4	0.1	1.0	0.8	0.3	0.0	1.2	0.1	0.9	4.2	2.9	0.8	0.4	70.9	0.2	0.2	0.5	0.1	0.3	0.1	0.3	0.2	0.4	0.1	0.1	0.1	0.3	0.4	1.3	0.2	0.1	2.1	0.6	104.1	0.2	0.4	0.8	0.2	0.4	0.3	0.5	0.1	0.2	0.9	48.3	3.4	0.9	0.7	0.6	0.3	2.4	0.5	0.8	0.5	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.1	0.0	0.2	0.2	9.6	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.4	0.0	2.4	0.2	0.8	0.5	0.5	0.2	0.3	0.3	0.3	0.1	0.6	0.4	0.4	1.3	0.8	0.3	0.3	0.3	0.9	0.2	0.2	0.1	1.0	0.2	0.2	0.3	0.2	0.4	0.1
STAC3	MGC2793	ENSG00000185482	"SH3 and cysteine rich domain 3"	Q96MF2	12	57243453-57251193	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"skeletal muscle: 222.7;tongue: 107.8"	"Cell line enriched"	"Detected in some"	23	"RH-30: 224.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 8.0"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.9;monocytes: 8.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA039285, HPA039527"			Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA039285: AB_2676427, HPA039527: "	"unprognostic (6.16e-2)"	"prognostic favourable (2.01e-4)"	"prognostic unfavourable (7.10e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (7.11e-6)"	"unprognostic (4.58e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-3)"	3.7	0.2	0.1	0.6	0.1	1.6	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.1	10.3	3.2	0.2	0.1	0.1	0.1	0.1	0.2	0.4	0.6	0.7	0.2	0.0	0.1	0.1	0.4	0.2	0.2	0.0	2.3	0.2	0.1	5.4	0.0	222.7	0.2	0.3	0.1	0.3	1.1	0.1	1.2	0.0	0.1	1.2	107.8	3.8	0.1	0.1	1.1	4.9	0.5	8.0	0.0	0.3	1.8	0.0	0.0	0.2	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	2.6	0.0	0.0	0.0	1.6	9.6	1.0	0.1	0.0	0.0	0.0	0.2	0.2	0.7	0.5	0.1	3.4	0.0	0.1	1.2	224.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	4.6	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.9	0.1	3.1	0.0	0.0	6.1	0.5	0.0	8.0	0.1	1.1	0.0	0.3	4.9	0.5	0.0	0.1	0.3	0.0	4.0	1.4	0.3	1.8	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0
ANKRD23	"DARP, FLJ32449, MARP3"	ENSG00000163126	"Ankyrin repeat domain 23"	Q86SG2	2	96824526-96857934	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"skeletal muscle: 184.5"	"Cell line enriched"	"Detected in some"	8	"Karpas-707: 29.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"gdTCR: 1.2"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"			HPA036201	Approved		Supported	"Nucleoplasm,Actin filaments"				Nucleoplasm	Nucleoplasm	"HPA036201: AB_10673347"	"unprognostic (2.48e-1)"	"unprognostic (7.83e-4)"	"unprognostic (4.93e-4)"	"unprognostic (1.21e-2)"	"unprognostic (4.28e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.27e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.81e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-6)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.70e-4)"	0.4	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.8	0.1	0.1	2.6	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.1	0.1	0.1	0.7	0.0	0.1	2.2	0.1	184.5	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	12.2	0.9	0.1	0.1	0.4	0.2	0.5	0.0	0.9	1.2	0.4	0.3	0.5	0.3	0.6	0.0	0.2	0.8	0.2	0.0	0.2	0.1	0.0	0.1	0.3	0.1	0.0	0.2	0.2	0.2	0.1	0.8	0.7	0.3	0.4	0.1	0.1	0.5	1.3	0.2	0.2	0.4	0.0	0.1	0.6	29.0	0.2	0.7	0.3	0.6	0.3	0.2	1.0	0.0	3.6	0.1	0.6	1.0	0.1	0.2	0.5	0.0	0.8	0.0	0.2	0.3	0.4	0.5	0.0	1.3	0.4	0.2	0.3	0.8	0.3	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.0	0.9	0.0	0.2	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CHRNA10		ENSG00000129749	"Cholinergic receptor nicotinic alpha 10 subunit"	Q9GZZ6	11	3665587-3671384	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"skeletal muscle: 33.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"olfactory region: 8.9"	"Not detected"	"Not detected"														"unprognostic (3.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.11e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.90e-5)"	"unprognostic (4.35e-2)"	"unprognostic (1.06e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.39e-3)"	0.2	0.2	0.2	0.4	0.3	0.2	0.1	1.1	0.1	0.2	0.2			0.4	0.2	0.2	0.4	0.3	0.1	0.2	0.2	0.2	0.3	0.6	0.4	0.3	0.1		0.3	0.1	0.0	0.7	0.1		0.7	0.1		0.3	0.1	33.6	0.4	0.2	0.1	0.0	1.0	0.2	0.3			0.5		0.1	0.1	0.0	0.3	0.3	2.2	0.6	0.2	1.0	0.2	1.4	1.5	2.1	2.8	0.9	0.3	1.4	1.7	0.4	1.3	1.3	1.1	2.5	2.5	1.0	0.8	3.1	1.6	0.9	1.1	1.6	5.2	0.7	3.9	0.5	1.2	0.6	2.7	0.9	1.0	0.9	0.3	0.8	2.0	0.6	1.0	0.4	1.5	4.1	2.9	2.0	2.7	0.9	0.4	1.0	2.0	1.9	0.8	0.9	0.9	1.5	0.6	3.2	0.7	1.8	2.3	1.3	2.1	0.7	1.7	1.3	0.9	1.3	1.2	0.0	0.4	0.4	1.0	0.0	0.3	0.0	0.8	0.2	0.1	0.3	0.4	0.5	2.2	0.2	0.6	0.3	0.6	0.2										
MYOZ2	"C4orf5, CS-1"	ENSG00000172399	"Myozenin 2"	Q9NPC6	4	119135784-119187789	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 219.1;skeletal muscle: 188.6"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 3.2;HSkMC: 3.7;SK-MEL-30: 9.3;U-87 MG: 9.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035763, HPA035764"	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA035763: AB_2674770, HPA035764: AB_10696509"	"unprognostic (2.53e-1)"	"unprognostic (9.20e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.34e-2)"	"unprognostic (5.71e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.07e-2)"	"unprognostic (6.19e-7)"	"unprognostic (6.66e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.83e-2)"	3.7	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.4	2.4	2.6	0.2	0.1	219.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	1.9	0.1	188.6	0.0	0.1	0.2	0.0	0.1	0.1	0.6	0.0	0.0	2.0	13.9	3.2	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.2	3.2	0.0	0.4	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	3.7	0.0	0.6	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	9.3	0.0	0.0	0.2	0.1	0.2	0.5	0.0	0.0	0.0	0.0	9.7	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0
NRAP		ENSG00000197893	"Nebulin related anchoring protein"	Q86VF7	10	113588716-113664127	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 74.1;skeletal muscle: 268.1;tongue: 82.3"	"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.1"	"Group enriched"	"Detected in some"	7	"head and neck cancer: 8.2;prostate cancer: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA037953, HPA037954"	Enhanced									"HPA037953: AB_2675755, HPA037954: AB_10672394"	"unprognostic (1.13e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.03e-3)"	"unprognostic (3.72e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.39e-4)"	"unprognostic (8.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.16e-1)"		5.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	9.4	5.8	0.0	0.0	74.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.3	0.1	0.0	4.2	0.0	268.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.8	82.3	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.8	0.0	0.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SYNPO2L	FLJ12921	ENSG00000166317	"Synaptopodin 2 like"	Q9H987	10	73644881-73663803	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 69.3;skeletal muscle: 72.8;tongue: 29.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 7.5;HSkMC: 6.0;RH-30: 5.8;SK-BR-3: 6.1"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA055192, HPA057142"	Enhanced		Supported	"Nuclear speckles,Cell Junctions,Cytosol"				"Nuclear speckles"	"Nuclear speckles"	"HPA055192: AB_2682732, HPA057142: AB_2683348"	"unprognostic (2.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.34e-1)"	3.8	0.1	0.0	0.0	0.1	0.1	1.1	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	3.2	3.3	0.0	0.0	69.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.8	0.0	0.0	1.6	0.0	72.8	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.3	29.3	3.4	0.0	0.3	0.7	1.0	3.0	0.7	0.7	0.7	0.1	0.5	0.1	0.8	0.2	0.1	0.0	1.1	0.9	1.2	0.2	0.0	7.5	0.7	0.3	0.5	0.9	0.1	0.1	0.0	0.4	0.1	0.2	0.3	0.6	0.4	0.6	0.2	0.2	6.0	0.1	1.2	0.1	0.0	0.3	0.3	0.3	0.3	0.2	1.8	0.2	0.7	0.2	5.8	0.2	0.0	0.6	0.3	0.4	0.1	6.1	0.1	0.4	0.7	0.0	0.6	1.0	0.2	0.3	1.0	0.3	0.3	0.2	0.6	0.0	2.9	0.7	0.7	0.7	0.4	0.3	0.5	0.3	0.3	0.2	0.7	0.4	0.4	3.0	0.7	0.4	1.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0
UCP3	SLC25A9	ENSG00000175564	"Uncoupling protein 3"	P55916	11	74000281-74009435	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"skeletal muscle: 99.6"	"Cell line enriched"	"Detected in many"	4	"HDLM-2: 17.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"cerebellum: 1.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010771, HPA072225"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	Nucleoplasm	"CAB010771: AB_261839, HPA072225: AB_2686498"	"unprognostic (3.76e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.25e-6)"	"unprognostic (2.68e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.50e-4)"	0.9	0.2	0.2	0.3	0.2	0.6	0.2	1.1	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.5	0.9	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	1.0	0.2	99.6	0.3	0.2	0.2	0.2	0.5	0.1	0.6	0.2	0.2	0.6	6.4	0.8	0.2	0.2	0.8	0.1	0.7	0.3	0.2	2.1	0.4	0.2	2.0	2.0	1.7	0.8	0.4	0.4	0.5	0.5	0.5	0.3	0.5	0.4	1.0	0.3	0.4	2.2	0.8	0.4	0.8	17.8	0.7	0.4	2.4	0.2	0.6	1.2	1.7	0.5	1.4	1.3	0.1	0.6	0.5	1.4	0.7	1.2	0.8	1.6	1.0	1.4	1.6	4.2	0.6	1.1	0.6	1.2	1.2	0.5	0.9	0.7	0.2	1.1	0.4	0.3	1.4	0.6	1.2	1.6	1.7	0.8	0.3	1.1	0.6	0.0	0.3	0.7	2.1	0.1	0.9	0.0	1.5	1.8	0.0	0.8	0.6	1.2	0.1	0.2	0.0	0.1	0.4	0.4	0.2	0.2	1.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2
CARNS1	"ATPGD1, KIAA1394"	ENSG00000172508	"Carnosine synthase 1"	A5YM72	11	67414968-67425607	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"brain: 88.7;skeletal muscle: 64.8"	"Cell line enriched"	"Detected in some"	12	"RPMI-8226: 12.8"	"Group enriched"	"Detected in many"	5	"glioma: 4.1;thyroid cancer: 10.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	20	"B-cells: 1.9;NK-cells: 1.3;T-cells: 3.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA038569	Enhanced				"Intracellular and membrane"					"HPA038569: AB_2676089"	"unprognostic (1.07e-4)"	"unprognostic (4.33e-3)"	"unprognostic (2.00e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.28e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.14e-6)"	"unprognostic (3.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.83e-3)"	"unprognostic (8.33e-2)"	2.9	1.3	9.2	1.5	24.3	1.5	1.2	3.0	23.9	1.3	1.4	88.7	0.0	1.5	1.2	2.5	2.0	1.5	1.6	5.3	19.7	10.2	1.2	1.3	1.5	2.1	36.9	14.5	1.4	1.6	2.0	0.4	1.1	30.6	1.8	1.3	0.0	1.3	1.3	64.8	1.3	1.9	1.3	51.1	1.8	2.1	1.1	28.1	0.0	2.3	0.9	1.6	1.1	0.3	1.9	0.1	0.0	0.0	1.3	3.2	0.9	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.2	0.3	0.5	0.7	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.8	0.0	0.2	0.0	0.0	0.1	0.4	0.1	0.1	1.0	0.6	0.2	0.0	0.1	0.1	12.8	0.0	0.0	0.1	0.2	0.1	0.8	0.1	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.9	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	2.9	0.0	1.4	1.7	1.0	3.1	0.1	1.9	1.3	3.2	0.0	1.3	0.0	0.0	0.7	0.9	9.2	24.3	3.0	22.2	19.7	10.2	36.9	14.5	30.6	28.1
MYOM2		ENSG00000036448	"Myomesin 2"	P54296	8	2045040-2165552	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"heart muscle: 170.7;skeletal muscle: 75.9"	"Group enriched"	"Detected in some"	8	"HEK 293: 9.9;SCLC-21H: 4.2;U-266/84: 5.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"							"HPA001765, HPA005953"	Enhanced		Approved	Mitochondria		120000	120000	Mitochondria	Mitochondria	"HPA001765: AB_1079443, HPA005953: AB_1854258"	"unprognostic (2.81e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.19e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.30e-5)"	"unprognostic (1.10e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.71e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.14e-1)"	2.0	0.0	0.3	0.1	0.4	0.0	1.7	0.9	0.9	0.2	0.2	0.0	0.2	0.0	0.5	2.7	1.2	0.1	0.1	170.7	0.3	0.1	0.7	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.2	1.2	1.0	75.9	0.2	0.1	0.3	0.1	0.4	0.0	0.2	0.0	0.0	0.6	8.9	1.2	0.3	0.1	1.9	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	9.9	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.4	0.2	0.0	1.9	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.4	0.9	0.9	0.3	0.1	0.2	0.0	0.1	0.0
TXLNB	"C6orf198, dJ522B19.2, DKFZp451A175, MDP77"	ENSG00000164440	"Taxilin beta"	Q8N3L3	6	139240061-139292139	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"heart muscle: 37.9;skeletal muscle: 131.5;tongue: 49.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.2;HSkMC: 4.6;REH: 3.8;RPMI-8226: 5.3;U-698: 10.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.3"	"Group enriched"	"Detected in many"	4	"B-cells: 5.3;granulocytes: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA030401, HPA030402, HPA030403"	Enhanced									"HPA030401: AB_2673459, HPA030402: AB_10602486, HPA030403: AB_2673461"	"unprognostic (1.54e-1)"	"unprognostic (7.01e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.10e-3)"	"unprognostic (4.79e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.16e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.05e-4)"	4.5	0.9	0.4	1.1	0.6	0.1	0.7	0.2	0.5	1.0	0.7	0.6	0.0	0.2	1.3	5.1	3.4	0.6	0.7	37.9	0.5	0.5	0.3	0.3	0.6	0.9	0.5	0.4	3.8	0.2	2.3	0.7	0.2	0.8	0.9	0.3	0.1	2.1	0.1	131.5	0.3	0.8	1.1	1.5	1.0	0.4	1.2	0.1	3.4	0.9	49.7	2.7	1.0	0.5	5.3	0.3	2.1	0.3	0.3	0.8	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.0	7.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.8	1.0	0.1	0.0	0.0	2.0	0.3	4.6	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.3	0.7	0.8	0.2	0.5	3.8	1.7	5.3	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.9	2.2	1.4	0.1	0.1	0.0	0.1	1.2	2.0	10.1	0.3	2.0	0.0	0.0	0.2	0.0	0.4	0.2	0.6	5.3	0.4	0.8	0.1	1.9	0.4	0.2	2.1	0.3	0.3	0.3	0.3	0.3	0.4	0.6	0.2	0.5	0.5	0.5	0.5	0.4	0.8	0.1
APOBEC2	"ARCD1, ARP1"	ENSG00000124701	"Apolipoprotein B mRNA editing enzyme catalytic subunit 2"	Q9Y235	6	41053304-41064511	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"heart muscle: 58.4;skeletal muscle: 163.0;tongue: 53.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;CACO-2: 8.9;HSkMC: 3.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 4.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA014252, HPA017957"	Enhanced									"HPA014252: AB_1844932, HPA017957: AB_1844933"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.01e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.19e-2)"	1.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	6.1	2.8	0.0	0.0	58.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.1	0.0	1.6	0.0	0.1	3.2	0.0	163.0	0.2	0.2	0.4	0.0	0.0	2.2	0.5	0.0	1.3	0.5	53.9	4.2	0.1	0.0	5.5	5.5	3.6	2.4	1.5	4.8	0.4	0.1	0.0	0.5	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	8.9	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.1	0.0	0.6	0.0	1.0	0.1	3.1	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.2	1.0	0.1	0.1	0.5	0.5	0.1	0.1	0.0	1.2	0.3	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.4	0.1	1.7	0.3	0.8	0.2	0.5	0.0	1.3	2.0	3.6	4.4	1.3	3.5	4.3	4.0	4.8	1.1	5.5	4.2	4.6	1.6	1.5	2.4	5.5	3.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CKMT2	SMTCK	ENSG00000131730	"Creatine kinase, mitochondrial 2"	P17540	5	81233285-81266397	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"heart muscle: 153.2;skeletal muscle: 182.4;tongue: 103.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.6;BEWO: 5.9;Hep G2: 5.1;HHSteC: 3.9;T-47d: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	9	"NK-cell: 3.8"	"Lineage enriched"	"Detected in single"	9	"NK-cells: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051880	Enhanced					3200000	3200000			"HPA051880: AB_2681650"	"unprognostic (3.64e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.75e-3)"	2.5	5.0	1.3	0.3	1.9	0.2	0.8	0.4	1.2	1.2	0.5	1.2	2.5	0.3	1.3	11.5	3.0	1.2	1.5	153.2	1.5	0.9	2.7	0.3	0.4	0.3	2.3	1.4	1.6	1.3	1.1	0.7	0.3	4.1	2.0	0.3	2.5	9.1	2.1	182.4	0.5	0.6	1.4	2.8	0.4	2.1	0.9	1.5	0.0	3.3	103.6	2.9	1.0	0.6	0.4	0.1	0.0	0.4	3.8	0.3	0.0	0.1	0.9	0.0	0.9	3.6	0.7	5.9	0.1	0.0	0.0	0.0	0.3	0.3	0.6	0.4	0.0	0.1	0.0	0.0	0.0	0.5	3.1	0.0	0.7	5.1	3.9	0.4	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.2	0.1	0.7	0.4	0.8	0.9	0.0	0.0	0.1	0.7	0.7	0.5	0.4	0.8	9.5	0.4	0.8	0.5	0.9	0.5	0.3	0.1	0.1	0.8	0.4	0.5	0.9	0.0	0.2	0.0	0.1	0.4	0.0	0.1	0.3	0.0	0.0	0.4	0.1	0.2	0.0	3.8	0.0	0.1	0.2	0.0	1.3	1.9	0.4	1.2	1.5	0.9	2.3	1.4	4.1	1.5
FSD2	"RP11-127F21, SPRYD1"	ENSG00000186628	"Fibronectin type III and SPRY domain containing 2"	A1L4K1	15	82755362-82806070	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"heart muscle: 20.8;skeletal muscle: 54.0;tongue: 18.1"	"Cell line enhanced"	"Detected in many"		"U-266/70: 8.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA046263			Approved	Cytosol				Cytosol	Cytosol	"HPA046263: AB_2679604"	"unprognostic (2.80e-1)"	"unprognostic (3.54e-1)"	"unprognostic (6.63e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.37e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.59e-2)"	1.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.6	0.7	0.1	0.0	20.8	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.3	0.0	0.4	1.0	0.0	54.0	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	18.1	1.4	0.0	0.1	1.4	0.8	2.3	0.9	0.8	2.2	0.5	1.3	1.3	2.0	2.3	0.0	0.0	1.1	1.3	0.0	0.0	0.0	1.1	2.1	4.0	0.9	0.0	4.8	0.0	0.0	0.4	0.7	5.3	2.2	5.6	1.8	0.0	1.3	0.9	0.1	0.2	0.0	0.6	0.0	2.0	3.6	0.0	1.2	0.7	2.3	1.8	1.0	1.3	1.5	1.0	0.2	2.2	1.9	1.6	1.0	1.0	1.5	1.6	1.7	0.8	2.9	1.5	1.0	1.8	8.3	3.5	1.4	1.8	4.8	0.7	2.3	0.8	0.8	1.0	0.7	0.8	1.4	1.1	0.9	0.8	1.1	2.2	1.1	1.1	0.8	0.9	0.8	1.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
MSS51	"FLJ39565, ZMYND17"	ENSG00000166343	"MSS51 mitochondrial translational activator"	Q4VC12	10	73423579-73433561	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	13	"parathyroid gland: 34.4;skeletal muscle: 66.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"cerebellum: 2.7"	"Cell type enhanced"	"Detected in some"		"gdTCR: 1.7;naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA038564			Uncertain	Vesicles,Cytosol				Vesicles	Vesicles	"HPA038564: AB_10674687"	"unprognostic (2.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.62e-3)"	"unprognostic (3.05e-3)"	"unprognostic (7.88e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.50e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.78e-7)"	"unprognostic (1.51e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.55e-2)"	2.8	0.3	0.4	0.4	0.4	0.3	0.4	2.7	0.4	0.5	0.5	0.4	0.4	0.2	0.6	0.4	0.9	0.6	0.4	3.9	0.4	0.1	0.4	0.4	0.6	0.4	0.4	0.4	1.1	0.5	34.4	0.7	0.4	0.4	0.8	0.3	0.4	2.3	0.4	66.9	0.8	0.8	0.4	0.4	1.4	0.4	0.4	0.4	0.6	0.4	1.2	0.4	0.5	0.6	0.1	0.0	0.0	0.5	0.0	1.7	0.4	1.2	1.3	3.0	4.7	4.2	6.0	2.6	1.4	1.1	0.6	1.3	0.7	1.5	3.8	0.5	1.5	2.3	1.9	0.4	1.7	1.8	1.5	3.3	2.0	1.1	1.5	2.2	3.1	4.7	1.5	1.3	3.5	0.6	1.1	2.0	2.5	0.5	1.8	3.0	0.9	1.6	1.1	7.7	0.2	1.8	1.9	0.6	1.2	1.0	2.2	1.7	1.9	1.8	2.6	2.3	1.4	0.9	3.0	1.2	3.4	2.0	1.0	3.8	0.6	0.0	0.4	0.0	1.7	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.3	1.2	0.0	0.0	0.5	0.0	0.0	0.4	0.4	0.4	2.7	0.4	0.4	0.1	0.4	0.4	0.4	0.4
TNNI2	"AMCD2B, DA2B, FSSV"	ENSG00000130598	"Troponin I2, fast skeletal type"	P48788	11	1838989-1841680	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"skeletal muscle: 635.0;tongue: 527.7"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 22.7;hTCEpi: 65.2"	"Group enriched"	"Detected in many"	10	"cervical cancer: 12.7;head and neck cancer: 33.6;pancreatic cancer: 12.9;urothelial cancer: 39.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 46.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 46.4;granulocytes: 26.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB018697, HPA055938"	Enhanced		Approved	"Plasma membrane,Intermediate filaments"		29000	29000	"Plasma membrane"	"Plasma membrane"	"CAB018697: AB_628400, HPA055938: AB_2682976"	"unprognostic (2.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.92e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.79e-2)"	13.9	0.1	0.1	0.1	0.1	0.5	0.6	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	16.5	11.6	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.5	0.2	0.1	0.0	0.1	0.5	0.0	0.1	0.3	0.0	1.2	0.1	0.0	15.7	0.4	635.0	4.8	0.2	0.1	0.2	0.4	0.1	0.1	0.0	0.0	3.0	527.7	11.5	2.1	0.1	2.3	46.4	26.7	8.6	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.5	22.7	0.6	0.1	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	5.4	65.2	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.8	1.4	0.0	0.6	0.0	0.6	0.0	0.4	0.0	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	6.1	3.1	26.7	0.0	6.5	0.0	1.9	0.0	0.0	4.3	2.3	0.0	0.0	21.1	0.2	8.6	46.4	0.0	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
UNC45B	"CMYA4, UNC45"	ENSG00000141161	"Unc-45 myosin chaperone B"	Q8IWX7	17	35147817-35189345	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"heart muscle: 48.8;skeletal muscle: 62.5;tongue: 23.2"	"Group enriched"	"Detected in some"	11	"BEWO: 4.6;HSkMC: 6.9"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 0.9;testis cancer: 1.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"gdTCR: 3.5"	"Lineage enriched"	"Detected in single"	10	"T-cells: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017861			Supported	Cytosol				Cytosol	Cytosol	"HPA017861: AB_1847012"	"unprognostic (7.17e-2)"	"unprognostic (6.47e-3)"	"unprognostic (9.36e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.49e-3)"	"unprognostic (5.30e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.13e-6)"	"unprognostic (6.77e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.21e-1)"	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.9	0.0	0.3	48.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.2	62.5	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.2	23.2	1.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	3.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.5	0.2	2.9	0.0	0.7	1.8	0.0	0.0	0.4	2.0	0.2	0.3	0.3	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ART3		ENSG00000156219	"ADP-ribosyltransferase 3"	Q13508	4	76011184-76112802	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"brain: 29.1;heart muscle: 55.1;skeletal muscle: 85.2;testis: 42.6;tongue: 27.2"	"Group enriched"	"Detected in some"	8	"NB-4: 6.1;NTERA-2: 16.5;SK-MEL-30: 7.3"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Region enhanced"	"Detected in many"		"cerebellum: 29.1"	"Cell type enriched"	"Detected in single"	5	"gdTCR: 1.9"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.2"	HPA011268	Enhanced				"Intracellular and membrane"	45000000	45000000			"HPA011268: AB_1845059"	"unprognostic (2.45e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.85e-4)"	"unprognostic (2.35e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.61e-3)"	3.5	0.6	4.9	0.9	1.9	0.4	0.7	29.1	9.0	1.0	1.3	6.0	0.0	0.6	0.5	1.1	2.5	0.5	0.5	55.1	3.0	0.9	0.5	0.5	0.6	0.5	3.9	2.0	0.5	3.8	0.4	1.1	0.5	2.7	1.0	1.4	0.4	1.3	1.0	85.2	0.5	0.8	0.6	3.0	1.5	0.9	42.6	7.2	0.0	0.5	27.2	0.5	0.6	0.7	0.0	0.0	0.1	0.0	0.0	1.9	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.1	16.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.9	1.9	29.1	9.0	3.0	0.9	3.9	2.0	2.7	7.2
CA3	"CAIII, Car3"	ENSG00000164879	"Carbonic anhydrase 3"	P07451	8	85373436-85449040	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"skeletal muscle: 347.5"	"Group enriched"	"Detected in some"	32	"HEL: 23.3;RH-30: 39.2"	"Group enriched"	"Detected in many"	7	"glioma: 23.1;prostate cancer: 9.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB004967, HPA021775, HPA026700"	Enhanced					31000000	31000000			"CAB004967: AB_437014, HPA021775: AB_1845990, HPA026700: AB_1845991"	"prognostic favourable (4.24e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.22e-3)"	"unprognostic (4.71e-2)"	"unprognostic (8.43e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.54e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.19e-1)"	18.0	0.4	0.2	0.1	0.2	0.5	0.6	0.2	0.1	0.5	0.3	0.0	0.1	0.1	0.6	29.0	9.5	1.0	0.2	1.3	0.2	0.1	0.2	0.2	4.1	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	6.6	0.0	0.0	5.5	0.2	347.5	0.3	0.4	1.4	0.1	0.1	0.3	0.5	0.0	0.0	0.3	14.1	3.4	0.7	0.5	0.5	1.8	0.0	0.0	0.0	0.8	0.2	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	23.3	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	1.8	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0
DDN	KIAA0749	ENSG00000181418	Dendrin	O94850	12	48995149-48999309	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"brain: 40.8;skeletal muscle: 73.8"	"Cell line enhanced"	"Detected in some"		"HAP1: 10.3;RPMI-8226: 19.7;SCLC-21H: 10.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	33	"amygdala: 228.1;basal ganglia: 257.7;cerebral cortex: 232.0;hippocampal formation: 236.4;olfactory region: 128.1"	HPA060952	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA060952: AB_2684396"	"unprognostic (2.80e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.56e-2)"	"unprognostic (8.10e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.20e-5)"	"unprognostic (8.61e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.37e-6)"	"unprognostic (1.72e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.53e-2)"	0.7	0.7	40.5	0.8	40.8	1.3	0.7	0.0	38.5	0.7	0.7	0.2	0.0	0.7	0.7	3.8	1.0	0.7	0.7	0.9	30.5	2.0	4.8	0.7	0.7	0.9	2.9	9.3	0.7	0.8	0.8	0.0	0.7	0.0	1.6	0.7	0.0	0.7	0.7	73.8	0.8	0.8	0.7	0.0	0.8	0.8	0.8	1.2	0.0	0.7	0.0	0.8	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.3	0.3	0.2	0.6	0.0	0.0	0.1	0.1	0.1	0.1	0.2	4.4	0.4	0.0	0.2	0.0	1.5	10.3	0.0	0.1	0.5	4.7	2.3	0.5	1.0	0.0	5.3	0.2	0.0	0.1	0.1	0.0	0.1	0.0	3.5	0.2	0.1	5.2	5.8	0.1	1.4	4.8	0.3	19.7	0.0	0.1	10.3	1.0	0.2	0.5	0.2	0.2	0.7	0.1	0.2	0.5	0.2	0.0	1.2	2.3	4.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	40.5	40.8	0.0	31.9	30.5	2.0	2.9	9.3	0.0	1.2
ENO3		ENSG00000108515	"Enolase 3"	P13929	17	4948092-4957131	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"skeletal muscle: 638.2;tongue: 320.3"	"Group enriched"	"Detected in many"	4	"HDLM-2: 70.1;HeLa: 30.0;HMC-1: 29.6;RH-30: 48.2;RPMI-8226: 25.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA000793, HPA068284, HPA068721"	Enhanced		Supported	"Plasma membrane,Cytosol"		100000000	100000000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA000793: AB_1078742, HPA068284: , HPA068721: AB_2732119"	"unprognostic (7.35e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavourable (7.33e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.50e-2)"	7.6	0.3	0.2	0.6	0.2	0.7	0.5	0.6	0.2	0.2	0.4	0.0	0.1	0.8	0.4	8.5	8.6	0.4	0.1	38.3	0.2	0.1	0.5	5.0	0.4	0.5	0.2	0.0	0.4	0.3	0.3	0.5	0.2	0.1	2.1	0.1	1.2	11.8	0.1	638.2	0.3	0.7	0.4	0.2	0.8	0.4	0.5	0.0	0.6	4.8	320.3	10.5	0.3	0.3	13.3	21.0	27.1	24.8	18.5	23.3	36.0	2.8	6.2	2.8	2.6	2.4	0.6	6.8	5.0	0.6	0.3	0.3	3.0	1.9	5.2	6.8	0.4	3.6	1.0	0.4	0.2	70.1	5.7	5.1	30.0	4.4	0.9	1.5	29.6	4.1	1.0	0.5	1.0	0.3	2.3	9.7	1.5	1.5	1.8	6.2	3.6	2.6	8.3	48.2	25.2	0.7	1.9	1.8	6.8	3.2	2.8	3.6	2.5	1.6	1.5	3.0	5.5	1.3	3.7	6.9	3.8	4.3	1.7	5.0	2.9	13.5	15.6	27.1	21.8	22.5	14.7	13.3	18.7	20.3	21.0	11.1	12.3	19.7	19.7	18.5	24.8	16.6	23.3	36.0	0.2	0.2	0.6	0.2	0.2	0.1	0.2	0.0	0.1	0.0
FBXO40	"Fbx40, KIAA1195"	ENSG00000163833	"F-box protein 40"	Q9UH90	3	121593119-121630295	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"heart muscle: 48.3;skeletal muscle: 58.2;tongue: 38.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.4;U-266/70: 3.0;U-266/84: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"pons and medulla: 1.8"	"Low region specificity"	"Detected in many"														"unprognostic (1.67e-2)"	"unprognostic (1.23e-4)"			"unprognostic (9.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-1)"		"unprognostic (4.30e-2)"	1.0	0.1	0.2	0.0	0.1	0.3	0.1	0.1	1.0	0.1	0.1	0.0	0.0	0.1	0.1	0.6	1.1	0.1	0.1	48.3	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.5	0.1	0.1	0.0	0.1	0.0	0.2	0.4	0.0	1.3	2.3	0.0	58.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.9	38.0	3.9	0.1	0.1	0.5	0.6	2.8	0.8	0.2	0.9	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.4	0.1	0.0	0.4	0.6	0.1	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.6	0.1	0.3	0.0	0.1	0.2	0.2	0.0	0.1	0.3	0.5	0.4	0.0	0.0	0.0	3.0	1.9	0.8	0.2	0.1	0.0	0.2	0.8	0.8	0.9	0.6	0.3	0.2	0.8	0.2	0.2	0.5	0.4	0.6	2.8	0.2	0.4	0.6	0.9	0.1	0.2	0.1	0.1	1.0	0.1	0.1	0.2	0.5	0.2	0.0
HHATL	"C3orf3, GUP1, KIAA1173, MBOAT3, MSTP002, OACT3"	ENSG00000010282	"Hedgehog acyltransferase like"	Q9HCP6	3	42692663-42702827	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"brain: 57.1;heart muscle: 184.7;skeletal muscle: 93.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.1;HSkMC: 1.3;Karpas-707: 1.1;NTERA-2: 1.4;RPMI-8226: 4.1;THP-1: 1.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 25.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018174	Enhanced									"HPA018174: AB_2116671"	"unprognostic (1.72e-2)"	"unprognostic (1.56e-1)"		"unprognostic (5.20e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.94e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.14e-1)"	1.5	1.6	12.9	1.3	29.0	1.3	1.9	2.3	15.2	1.5	1.4	36.5	0.0	1.3	1.7	1.5	2.7	2.0	1.5	184.7	14.5	8.9	1.4	1.3	1.5	1.4	51.6	10.5	1.4	1.8	1.4	0.9	1.4	25.9	1.9	1.4	5.4	4.7	1.4	93.6	1.6	1.4	1.4	57.1	1.4	1.3	1.7	39.9	0.0	9.3	7.2	1.4	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.3	0.0	1.4	0.0	0.5	0.0	4.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.5	0.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	29.0	2.3	15.2	14.5	8.9	51.6	10.5	25.9	39.9
JSRP1	"FLJ32416, JP-45"	ENSG00000167476	"Junctional sarcoplasmic reticulum protein 1"	Q96MG2	19	2252252-2269759	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"skeletal muscle: 92.0;tongue: 33.9"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 35.0;RPMI-8226: 21.9;U-266/70: 95.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 11.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"naive B-cell: 4.8"	"Lineage enriched"	"Detected in single"	6	"B-cells: 4.8"	"Group enriched"	"Detected in many"	6	"amygdala: 8.6;basal ganglia: 11.5;cerebral cortex: 10.1;hippocampal formation: 4.9"					HPA044741	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA044741: AB_10794295"	"unprognostic (9.41e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.64e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.87e-2)"	"unprognostic (8.64e-5)"	"unprognostic (3.63e-1)"	"unprognostic (4.43e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.71e-1)"	1.1	0.1	0.0	0.9	0.1	0.2	0.1	0.0	0.1	0.4	3.0	0.0	0.0	0.9	0.1	4.5	1.7	0.1	0.1	0.1	0.0	0.1	0.6	0.1	0.2	1.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.6	0.1	0.0	2.7	0.0	92.0	0.0	0.6	0.0	0.0	1.4	0.6	0.3	0.0	0.0	1.8	33.9	5.0	0.6	0.1	4.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	35.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	5.7	21.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.5	11.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.5	0.3	0.8	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0
MYL3	"CMH8, MLC1SB, MLC1V, VLC1"	ENSG00000160808	"Myosin light chain 3"	P08590	3	46857872-46882169	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"heart muscle: 398.1;skeletal muscle: 319.8"	"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 27.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA016564, CAB018662, HPA046859, HPA063034"	Enhanced		Approved	Nucleoli,Mitochondria		15000000	15000000	"Nucleoli, Mitochondria"	"Nucleoli, Mitochondria"	"CAB018662: AB_627952, HPA016564: AB_1854244, HPA046859: AB_2679842, HPA063034: AB_2684927"	"unprognostic (3.11e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.67e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.88e-2)"	"prognostic favourable (1.22e-8)"	"unprognostic (1.16e-3)"	"unprognostic (9.45e-3)"	"unprognostic (7.18e-5)"	"unprognostic (2.53e-3)"	0.9	0.2	0.5	0.2	0.4	0.0	0.6	0.2	0.4	0.5	0.1	0.3	0.0	0.0	0.2	10.1	10.5	0.1	0.2	398.1	0.7	0.4	2.3	0.1	0.2	0.1	0.7	0.3	0.3	0.1	0.0	0.0	0.3	0.3	1.6	0.0	0.3	5.5	0.0	319.8	0.1	0.0	0.1	0.8	0.4	0.0	0.1	0.4	0.0	1.1	30.1	3.1	0.2	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.9	1.6	0.3	0.1	0.0	0.1	5.8	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.4	0.7	0.4	0.7	0.3	0.3	0.4
PGAM2	PGAM-M	ENSG00000164708	"Phosphoglycerate mutase 2"	P15259	7	44062727-44065587	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 111.6;skeletal muscle: 379.1;tongue: 119.0"	"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 38.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.2;neutrophil: 1.1;plasmacytoid DC: 1.3;T-reg: 1.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.3;granulocytes: 1.2;T-cells: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043801, HPA050314, HPA060173"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		60000000	60000000	Nucleoplasm	Nucleoplasm	"HPA043801: , HPA050314: AB_2732558, HPA060173: "																		1.4	0.8	2.0	0.4	2.2	0.4	0.5	6.9	2.1	0.5	0.5	3.6	0.0	0.6	0.5	9.1	6.1	0.6	0.7	111.6	2.1	3.2	0.8	0.4	0.4	0.4	4.2	1.6	0.5	0.6	0.6	1.3	0.4	2.0	1.9	0.4	2.3	7.6	0.5	379.1	0.4	0.4	0.4	3.2	0.5	0.5	16.7	1.1	4.8	1.5	119.0	4.8	0.4	0.0	0.3	1.3	1.2	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	38.1	4.2	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	1.3	1.7	0.2	2.0	2.2	6.9	2.1	2.1	3.2	4.2	1.6	2.0	1.1
ASB4	ASB-4	ENSG00000005981	"Ankyrin repeat and SOCS box containing 4"	Q9Y574	7	95478444-95540232	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"adrenal gland: 28.6;pituitary gland: 40.1;skeletal muscle: 20.7"	"Cell line enhanced"	"Detected in some"		"A549: 6.8;Hep G2: 11.1;SCLC-21H: 7.0"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.2"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basal ganglia: 10.0;hypothalamus: 37.1"	"Region enriched"	"Detected in single"	7	"midbrain: 3.7"	HPA055240	Uncertain									"HPA055240: AB_2682753"	"unprognostic (1.41e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.24e-1)"	"unprognostic (9.13e-7)"	"unprognostic (1.71e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.23e-2)"	0.3	28.6	0.7	0.1	1.1	0.3	0.2	0.1	1.3	0.1	0.1	1.3	0.1	0.2	0.1	0.3	0.1	0.2	0.4	2.6	0.7	0.6	0.1	1.0	0.4	0.1	1.7	0.5	0.1	0.4	0.0	40.1	1.3	0.2	0.2	0.0	0.1	0.3	0.1	20.7	0.2	0.2	0.1	1.6	0.1	0.4	0.2	0.1	0.2	0.2	2.5	0.4	0.1	0.1	1.0	0.6	1.3	0.3	0.9	0.7	0.0	0.3	6.8	0.3	2.5	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.8	1.3	0.2	0.1	0.2	0.3	0.0	0.0	0.0	0.2	0.2	0.1	0.5	11.1	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.1	0.1	0.6	0.0	0.2	0.2	0.3	0.2	1.5	0.1	0.2	0.0	0.2	0.2	7.0	0.0	0.1	0.3	0.7	0.1	0.3	0.3	0.4	0.4	0.1	0.1	0.8	0.2	0.4	0.2	0.4	0.2	0.3	0.3	0.5	0.6	0.1	0.7	1.0	0.6	0.5	0.2	1.0	0.7	0.7	1.3	0.9	0.3	0.6	0.3	0.0	0.7	1.1	0.1	1.3	0.7	0.6	1.7	0.5	0.2	0.1
CHRNG	ACHRG	ENSG00000196811	"Cholinergic receptor nicotinic gamma subunit"	P07510	2	232539727-232546403	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"epididymis: 16.7;skeletal muscle: 40.0"	"Group enriched"	"Detected in some"	18	"HSkMC: 4.9;RH-30: 13.7"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (2.26e-1)"	"unprognostic (8.97e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.38e-1)"	"unprognostic (4.86e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.19e-6)"	"unprognostic (6.13e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.24e-2)"	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.6	0.0	40.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	0.6	0.3	0.5	0.5	1.1	0.8	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.3	0.0	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.2	0.1	0.1	0.1	13.7	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.5	0.2	0.2	0.2	0.7	0.2	0.4	0.5	0.2	0.6	0.8	0.8	0.2	1.1	0.2	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGFN1	"DKFZp434B1231, EEF1A2BP1"	ENSG00000163395	"Immunoglobulin-like and fibronectin type III domain containing 1"	Q86VF2	1	201190825-201228952	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"skeletal muscle: 118.8"	"Cell line enriched"	"Detected in some"	9	"HeLa: 36.8"	"Group enriched"	"Detected in some"	11	"renal cancer: 1.8;thyroid cancer: 8.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA050415	Enhanced		Approved	"Midbody ring"				"Midbody ring"	"Midbody ring"	"HPA050415: AB_2681120"	"unprognostic (2.09e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavourable (1.27e-8)"	"unprognostic (3.55e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.42e-2)"	0.5	0.0	0.6	0.1	0.4	0.0	0.1	0.4	1.4	0.3	0.2	0.3	0.1	0.0	4.3	6.4	0.1	0.3	0.1	0.1	0.3	0.2	0.2	0.1	0.2	0.1	0.3	0.2	0.3	4.6	0.0	0.7	0.1	1.7	0.2	0.0	1.6	0.1	0.1	118.8	0.0	0.1	0.3	0.1	0.1	0.0	1.1	0.2	0.1	11.3	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	2.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.4	0.3	0.3	0.2	0.3	0.2	1.7	0.2
MYL2	CMH10	ENSG00000111245	"Myosin light chain 2"	P10916	12	110910819-110920722	"Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"heart muscle: 656.7;skeletal muscle: 672.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 4.2;HSkMC: 9.2;U-2 OS: 18.5"	"Group enriched"	"Detected in some"	46	"head and neck cancer: 31.5;prostate cancer: 25.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	31	"memory B-cell: 3.8;naive B-cell: 2.4"	"Lineage enriched"	"Detected in single"	38	"B-cells: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019763, HPA039262"	Supported		Uncertain	Microtubules		190000	190000	Microtubules	Microtubules	"HPA019763: AB_1854243, HPA039262: AB_2676418"	"unprognostic (2.07e-2)"	"unprognostic (1.37e-1)"		"unprognostic (1.39e-1)"		"prognostic unfavourable (2.60e-4)"		"unprognostic (1.32e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.20e-1)"		"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.55e-1)"		3.6	0.0	0.1	0.1	0.1	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	6.4	8.9	0.0	0.2	656.7	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	6.1	0.0	0.0	7.7	0.0	672.9	0.1	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	2.4	59.4	10.5	0.3	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	4.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.2	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.1	0.0	0.0	1.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0
RAPSN	"CMS1D, CMS1E, RNF205"	ENSG00000165917	"Receptor associated protein of the synapse"	Q13702	11	47437757-47449178	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"skeletal muscle: 45.3;tongue: 14.8"	"Cell line enriched"	"Detected in some"	4	"RH-30: 71.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"							HPA039475	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Centrosome, Cytosol"	"Plasma membrane, Centrosome, Cytosol"	"HPA039475: AB_10794196"	"unprognostic (5.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.35e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.64e-4)"	"unprognostic (3.83e-1)"	"unprognostic (4.73e-3)"	"unprognostic (4.48e-2)"	1.7	0.8	0.2	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	2.7	0.7	0.1	0.1	1.4	0.4	0.0	0.1	0.2	0.2	0.1	0.7	0.0	0.0	0.1	0.0	0.0	1.2	0.3	0.4	0.0	0.3	0.8	0.0	45.3	0.2	0.2	0.1	0.2	0.3	0.1	0.2	0.1	0.1	0.4	14.8	0.4	0.0	0.0	0.2	0.1	2.6	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.4	0.1	0.0	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	71.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.6	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.7	0.0	2.6	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.2	0.4	0.0	0.7	0.0	0.3	0.1
TAL2	bHLHa19	ENSG00000186051	"TAL bHLH transcription factor 2"	Q16559	9	105662457-105663112	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"blood: 8.8;kidney: 4.6;skeletal muscle: 17.3"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.8;K-562: 12.6"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.6"					"Group enriched"	"Detected in some"	21	"memory B-cell: 8.8;naive B-cell: 7.9;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	18	"B-cells: 8.8;dendritic cells: 2.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA030886	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA030886: AB_10601596"	"unprognostic (3.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.00e-4)"	"unprognostic (2.84e-2)"	"prognostic favourable (2.69e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.39e-2)"	0.1	0.3	0.5	0.1	0.7	0.0	0.0	0.3	0.6	0.2	0.0			0.0	0.2	0.9	0.1	0.2	0.0	0.3	0.4	0.5	4.6	0.3	0.0	0.2	0.7		0.3	0.1	0.0	0.8	0.1		0.1	0.1		0.0	0.2	17.3	0.1	0.1	0.0	0.8	0.3	0.0	0.6			0.1		0.4	0.1	0.0	8.8	2.2	0.0	0.0	0.3	0.0	0.1	0.0	0.6	2.5	0.7	0.3	0.0	0.3	0.1	0.3	0.1	0.4	3.3	0.2	0.1	0.2	0.0	0.1	4.8	0.0	0.1	0.6	0.5	1.1	0.0	0.0	0.2	0.5	1.8	0.2	0.5	0.1	0.2	0.0	12.6	0.3	0.4	0.3	0.8	0.7	0.2	0.2	0.1	0.1	0.0	0.0	0.0	2.8	1.1	0.2	0.2	0.2	0.2	2.0	0.5	0.3	0.8	0.7	1.0	0.9	1.9	0.1	0.2	2.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.1										
ACTA1	"ACTA, NEM3"	ENSG00000143632	"Actin, alpha 1, skeletal muscle"	P68133	1	229431245-229434098	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"skeletal muscle: 1935.3;tongue: 523.6"	"Cell line enriched"	"Detected in some"	22	"BEWO: 102.2"	"Group enriched"	"Detected in many"	18	"head and neck cancer: 133.1;prostate cancer: 34.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000045, HPA041264, HPA041271"	Enhanced					6100000000	6100000000			"CAB000045: AB_2242301, HPA041264: AB_2677383, HPA041271: "	"unprognostic (5.59e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.07e-4)"	"unprognostic (5.75e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.86e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.64e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.56e-3)"	"unprognostic (9.40e-4)"	"unprognostic (2.61e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.01e-1)"	29.6	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.3	0.2	0.2	0.0	0.8	0.2	0.2	48.6	30.0	0.2	0.2	122.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.1	0.2	0.0	2.7	0.2	0.0	40.4	0.2	1935.3	0.5	0.2	1.2	0.4	0.2	0.2	0.2	0.0	0.0	5.3	523.6	39.9	0.2	0.1	4.4	14.7	20.5	15.5	5.1	9.7	20.8	0.0	0.0	0.0	0.0	0.0	0.0	102.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.4	0.0	0.1	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	8.9	9.3	20.5	7.6	15.5	5.7	4.4	6.4	7.4	14.7	4.3	5.0	7.7	12.1	5.1	14.0	4.7	9.7	20.8	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.0	0.0	0.0
ANKRD2	ARPP	ENSG00000165887	"Ankyrin repeat domain 2"	Q9GZV1	10	97572499-97583884	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skeletal muscle: 472.2"	"Cell line enhanced"	"Detected in some"		"A-431: 14.5;BJ hTERT+ SV40 Large T+: 5.4;HaCaT: 11.5;RPTEC TERT1: 12.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	18	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 1.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040842, HPA040884"	Enhanced		Enhanced	Vesicles				Vesicles	Vesicles	"HPA040842: AB_10963794, HPA040884: AB_10969453"	"unprognostic (1.27e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.60e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.69e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	2.3	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	1.2	2.7	0.0	0.1	47.2	0.0	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.3	472.2	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	3.0	1.2	1.1	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	14.5	5.0	0.0	0.0	0.2	0.0	0.4	0.7	0.0	5.4	3.5	0.2	4.5	0.0	0.6	0.1	11.5	0.0	3.9	3.6	0.1	0.2	0.0	0.2	0.0	0.4	0.0	0.0	0.6	1.7	3.2	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.8	0.7	0.0	0.0	0.0	3.7	0.0	1.8	0.3	0.0	0.1	1.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0
ASB10	GLC1F	ENSG00000146926	"Ankyrin repeat and SOCS box containing 10"	Q8WXI3	7	151175698-151187832	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	10	"heart muscle: 12.3;skeletal muscle: 44.0;tongue: 15.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																			"unprognostic (6.72e-3)"				"unprognostic (1.96e-1)"								0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.2	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	15.3	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASB15	FLJ43370	ENSG00000146809	"Ankyrin repeat and SOCS box containing 15"	Q8WXK1	7	123567010-123639481	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	10	"heart muscle: 20.1;skeletal muscle: 52.0;tongue: 28.1"	"Cell line enhanced"	"Detected in single"		"A549: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.19e-1)"					"unprognostic (7.45e-2)"	"unprognostic (1.37e-1)"					"unprognostic (5.98e-1)"	"unprognostic (6.09e-6)"	"unprognostic (7.31e-2)"	"unprognostic (6.39e-2)"			0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	20.1	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	52.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	28.1	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GBX1		ENSG00000164900	"Gastrulation brain homeobox 1"	Q14549	7	151148589-151174745	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 6.0;skeletal muscle: 16.6;testis: 9.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.8;HEK 293: 1.9;HMC-1: 5.6;PC-3: 1.1"	"Cancer enhanced"	"Detected in single"		"cervical cancer: 1.0"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 3.4"	"Low region specificity"	"Detected in many"			HPA055783	Uncertain									"HPA055783: AB_2682919"		"unprognostic (4.24e-2)"			"unprognostic (3.87e-2)"			"unprognostic (3.58e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.95e-1)"				"unprognostic (1.87e-1)"	"unprognostic (1.91e-1)"		"unprognostic (3.14e-1)"	1.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.5	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	6.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.5	0.0	0.2	0.0	0.0	0.7	0.0
KLHL34	"FLJ34960, RP11-450P7.3"	ENSG00000185915	"Kelch like family member 34"	Q8N239	X	21654690-21658330	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"skeletal muscle: 31.1"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.1;PC-3: 1.1;SCLC-21H: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.0"	"Lineage enriched"	"Detected in single"	4	"T-cells: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA060287	Uncertain									"HPA060287: AB_2684243"	"unprognostic (2.00e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.68e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.74e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.29e-1)"	0.3	0.1	0.7	0.1	0.9	0.0	0.0	1.7	0.8	0.0	0.3	0.1	0.0	1.1	0.0	0.0	0.3	0.0	0.0	1.8	0.5	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	3.1	0.6	0.0	31.1	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	2.8	0.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.5	0.0	0.5	0.5	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.1	0.0	1.1	1.1	0.1	0.8	0.2	0.0	0.2	1.0	0.5	0.0	0.1	0.0	0.1	0.1	0.8	0.2	0.1	0.1	0.5	0.1	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.3	3.0	0.9	0.0	0.0	0.0	0.0	0.6	0.5	0.7	0.9	1.7	0.8	0.5	0.3	0.2	0.0	0.2	0.0
KRTAP5-4	KRTAP5.4	ENSG00000241598	"Keratin associated protein 5-4"		11	1620958-1622138	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	10	"skeletal muscle: 2.4;skin 1: 8.7"	"Cell line enhanced"	"Detected in single"		"HSkMC: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																								"unprognostic (6.52e-2)"	"unprognostic (4.04e-4)"						"unprognostic (1.80e-1)"	"unprognostic (7.83e-2)"			"unprognostic (2.00e-2)"				0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	2.4	8.7	0.0	0.0	0.0	0.1	0.1	0.0			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LSMEM1	"C7orf53, FLJ39575"	ENSG00000181016	"Leucine rich single-pass membrane protein 1"	Q8N8F7	7	112480853-112491062	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"skeletal muscle: 51.3;tongue: 19.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 12.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"cerebellum: 3.6"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 2.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA013753, HPA047988"	Uncertain		Enhanced	Cytosol				Cytosol	Cytosol	"HPA013753: AB_1848926, HPA047988: AB_2680229"	"unprognostic (6.87e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.47e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.42e-2)"	1.1	0.7	0.6	0.6	0.6	0.8	0.9	3.6	0.7	0.6	0.6	0.6	0.6	1.3	0.6	1.7	0.7	0.4	0.6	2.1	0.7	0.8	1.4	3.5	1.8	0.6	0.7	0.6	0.6	2.8	0.3	0.9	0.6	0.6	0.9	0.8	0.6	1.9	0.6	51.3	0.8	0.8	0.6	0.6	1.9	0.8	1.1	0.6	0.6	0.9	19.2	1.5	0.6	0.6	0.0	0.1	2.7	0.1	0.0	0.2	2.2	0.8	1.3	0.7	2.8	2.8	3.1	0.1	1.3	0.9	0.6	0.5	2.2	1.8	1.2	1.9	0.3	0.7	0.8	0.9	1.2	0.6	0.8	0.8	12.3	2.2	1.3	1.2	0.6	2.2	3.7	0.8	0.8	0.7	0.9	2.8	0.4	1.0	1.0	3.6	0.6	0.9	0.4	0.2	0.6	2.4	1.4	2.6	1.4	2.2	1.1	1.5	0.4	0.5	0.5	2.8	1.0	0.8	1.0	0.8	1.7	1.1	0.8	0.8	0.8	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.0	2.2	0.6	0.6	3.6	0.7	0.7	0.8	0.7	0.6	0.6	0.6
MAPK12	"ERK6, p38gamma, PRKM12, SAPK-3, SAPK3"	ENSG00000188130	"Mitogen-activated protein kinase 12"	P53778	22	50245450-50261825	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"skeletal muscle: 104.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	31	"NK-cell: 3.0"	"Lineage enriched"	"Detected in single"	31	"NK-cells: 3.0"	"Region enhanced"	"Detected in many"		"cerebellum: 35.4"	"Low region specificity"	"Detected in all"			"CAB025483, HPA054562"	Enhanced		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nuclear speckles"	"CAB025483: , HPA054562: AB_2682524"	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.90e-3)"	"unprognostic (3.16e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.70e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (5.00e-6)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.28e-3)"	3.0	1.6	4.5	2.1	4.5	1.0	1.8	9.0	7.0	2.1	1.4	2.1	1.6	2.0	5.4	5.1	3.3	2.9	2.4	5.1	3.9	3.6	2.5	1.0	2.1	2.0	3.5	5.7	3.0	1.4	1.2	7.0	2.3	2.6	2.9	1.1	2.2	1.4	3.7	104.2	0.9	1.5	4.2	2.6	1.6	1.5	1.6	2.4	0.0	1.3	10.8	1.1	2.4	1.9	0.0	0.0	0.0	0.0	3.0	0.0	0.0	10.3	6.4	2.4	7.4	5.6	6.2	3.5	7.9	6.9	13.3	8.5	9.2	3.2	19.4	10.8	8.7	6.9	11.0	1.6	2.5	5.6	15.4	12.7	19.3	11.4	17.9	11.9	25.2	13.4	2.9	3.0	0.0	15.0	11.2	18.1	6.1	5.7	0.0	15.9	7.5	10.4	18.1	6.7	19.7	7.9	1.4	8.5	2.9	6.1	0.2	9.8	3.3	13.8	7.8	13.7	12.4	2.9	4.9	4.2	3.2	10.4	3.5	11.2	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	4.5	4.5	9.0	7.0	3.9	3.6	3.5	5.7	2.6	2.4
MYF5	bHLHc2	ENSG00000111049	"Myogenic factor 5"	P13349	12	80716912-80719673	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	10	"skeletal muscle: 23.1;tongue: 13.0"	"Cell line enriched"	"Detected in some"	22	"LHCN-M2: 102.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA041691			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA041691: "						"unprognostic (2.65e-2)"												0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	13.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.4	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYF6	"bHLHc4, MRF4"	ENSG00000111046	"Myogenic factor 6"	P23409	12	80707498-80709474	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	10	"skeletal muscle: 175.1"	"Cell line enriched"	"Detected in some"	17	"LHCN-M2: 22.6"	"Group enriched"	"Detected in some"	11	"head and neck cancer: 3.0;prostate cancer: 0.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"gdTCR: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"																		"unprognostic (2.20e-2)"	"prognostic unfavourable (2.05e-4)"		"unprognostic (9.88e-2)"							"unprognostic (6.64e-1)"			3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.0	175.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	17.1	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYH8	"MyHC-peri, MyHC-pn"	ENSG00000133020	"Myosin heavy chain 8"	P13535	17	10390322-10421950	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"esophagus: 16.5;skeletal muscle: 18.3;tongue: 10.0"	"Cell line enriched"	"Detected in single"	14	"HSkMC: 12.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 0.7;renal cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA001349, CAB016527"	Enhanced									"CAB016527: AB_2147291, HPA001349: AB_1079437"	"unprognostic (5.87e-2)"					"unprognostic (5.13e-3)"		"unprognostic (4.12e-2)"	"unprognostic (1.25e-2)"		"unprognostic (2.29e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.02e-3)"	"unprognostic (7.87e-2)"	"unprognostic (1.61e-1)"		"unprognostic (3.56e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.4	0.0	18.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.8	0.0	10.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MYLK2	"KMLC, MLCK2, skMLCK"	ENSG00000101306	"Myosin light chain kinase 2"	Q9H1R3	20	31819308-31834689	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skeletal muscle: 176.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.2;RH-30: 13.2;RPMI-8226: 10.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA059704, HPA059890"	Enhanced		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA059704: AB_2684108, HPA059890: AB_2684153"	"unprognostic (1.74e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.84e-2)"	"unprognostic (5.27e-2)"	"prognostic favourable (4.00e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.38e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.25e-11)"	"unprognostic (2.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.70e-2)"	1.4	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.4	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.3	176.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.1	18.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.8	0.0	0.0	0.5	0.1	0.0	0.4	0.1	0.3	0.3	0.6	0.4	0.0	0.1	0.1	0.0	0.2	0.2	0.2	0.7	0.3	0.0	0.0	0.6	0.1	0.0	0.0	0.4	0.0	1.0	0.2	5.2	0.1	0.8	0.7	0.4	0.6	0.4	0.7	13.2	10.7	0.1	0.1	0.7	0.6	3.4	0.1	0.0	0.1	0.1	2.6	0.2	1.0	0.6	2.9	0.1	0.9	0.2	0.2	3.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0
NMRK2	"ITGB1BP3, MIBP, NRK2"	ENSG00000077009	"Nicotinamide riboside kinase 2"	Q9NPI5	19	3933103-3942416	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"heart muscle: 271.6;skeletal muscle: 103.2"	"Group enriched"	"Detected in some"	7	"BEWO: 22.4;NTERA-2: 18.5"	"Cancer enhanced"	"Detected in some"		"renal cancer: 32.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA049909, HPA054792, HPA072450"	Approved		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA049909: , HPA054792: AB_2682601, HPA072450: "				"unprognostic (3.61e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.18e-2)"		"unprognostic (2.54e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.61e-2)"		"unprognostic (3.30e-2)"	"prognostic favourable (1.19e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.38e-1)"		0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	1.0	0.0	0.0	271.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	1.0	1.9	0.1	103.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	18.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
PDE4DIP	"CMYA2, KIAA0454, KIAA0477, MMGL"	ENSG00000178104	"Phosphodiesterase 4D interacting protein"	Q5VU43	1	148808181-149048286	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	10	"heart muscle: 106.0;skeletal muscle: 276.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 62.3;ASC TERT1: 50.7;K-562: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA012678			Supported	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA012678: AB_1855123"	"unprognostic (2.14e-1)"	"unprognostic (3.27e-1)"	"unprognostic (5.31e-2)"	"unprognostic (6.73e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.14e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.28e-1)"	4.8	2.9	9.2	4.3	8.3	2.3	9.0	12.1	15.1	4.8	6.2	8.3	5.6	3.8	3.1	11.8	6.1	3.3	5.0	106.0	9.7	7.8	6.6	9.3	5.5	3.8	15.6	8.1	2.3	3.4	13.6	7.7	10.2	9.3	4.6	4.1	7.2	5.4	4.5	276.2	4.1	7.7	3.1	18.5	2.9	4.4	1.7	11.2	1.5	3.1	18.1	3.8	3.6	6.1	12.0	6.7	7.4	5.9	4.7	13.2	4.3	7.8	1.5	2.2	2.4	62.3	50.7	13.0	9.2	8.7	9.0	11.8	7.2	5.0	4.0	2.8	13.2	4.0	5.3	6.5	15.3	2.9	7.6	2.0	3.2	2.8	16.5	1.7	2.1	36.0	13.0	38.2	20.8	3.5	50.9	9.4	15.9	13.3	1.3	1.0	7.8	3.3	2.9	5.6	1.5	5.4	8.1	10.7	0.9	9.0	26.3	7.2	7.8	2.3	4.6	10.4	2.3	26.1	20.4	4.1	5.8	5.9	42.6	1.6	6.4	7.4	5.3	4.1	5.4	5.9	5.5	12.0	10.9	7.2	6.7	11.7	8.4	4.6	1.2	4.7	1.9	2.9	13.2	4.3	9.2	8.3	12.1	10.2	9.7	7.8	15.6	8.1	9.3	11.2
PPFIA4		ENSG00000143847	"PTPRF interacting protein alpha 4"	O75335	1	203026498-203078740	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 72.6;heart muscle: 26.2;skeletal muscle: 20.4"	"Cell line enhanced"	"Detected in many"		"A-431: 7.7;LHCN-M2: 6.5;RH-30: 13.7;U-266/70: 8.6;U-87 MG: 12.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"cerebellum: 72.6;cerebral cortex: 21.1"	"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053419, HPA054132"	Enhanced									"HPA053419: AB_2682143, HPA054132: AB_2682393"	"unprognostic (2.83e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.38e-5)"	"unprognostic (3.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.49e-8)"	"unprognostic (4.65e-1)"	"unprognostic (6.01e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.60e-2)"	"prognostic unfavourable (1.73e-8)"	"unprognostic (6.82e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.28e-2)"	0.6	1.3	9.2	1.0	10.9	1.6	0.9	72.6	21.1	1.8	1.0	1.4	0.0	1.1	1.7	3.5	1.3	1.2	2.6	26.2	6.6	5.0	1.9	0.6	1.2	0.8	3.0	10.8	0.9	0.6	1.3	0.7	3.9	11.4	1.5	0.8	0.6	1.4	1.3	20.4	2.9	1.3	2.0	2.0	2.2	0.8	3.3	2.3	0.0	0.9	0.4	0.8	0.9	0.9	0.0	1.4	1.3	0.9	0.0	0.6	0.0	7.7	0.0	0.1	1.9	0.0	0.3	0.4	0.4	0.9	0.7	3.3	0.4	0.3	0.4	1.6	1.7	0.9	0.6	1.5	1.5	0.0	0.6	0.1	0.0	0.0	0.1	0.0	1.0	2.5	0.1	0.4	0.0	0.0	0.1	0.3	6.5	1.1	0.5	1.0	0.9	0.3	1.3	13.7	2.2	0.0	0.0	2.6	3.3	0.8	0.2	1.1	0.2	0.6	0.0	4.9	3.0	0.1	0.0	8.6	0.2	0.1	12.6	0.7	0.5	0.0	0.9	1.3	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.6	0.0	9.2	10.9	72.6	21.1	6.6	5.0	3.0	10.8	11.4	2.3
SMYD1	"BOP, KMT3D, ZMYND22"	ENSG00000115593	"SET and MYND domain containing 1"	Q8NB12	2	88067780-88113387	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"heart muscle: 45.9;skeletal muscle: 103.7;tongue: 36.4"	"Cell line enriched"	"Detected in some"	5	"HSkMC: 5.5"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.6"	"Region enriched"	"Detected in single"	4	"cerebral cortex: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA062282	Enhanced									"HPA062282: AB_2684736"	"unprognostic (1.93e-2)"		"unprognostic (2.49e-1)"		"unprognostic (4.09e-2)"	"unprognostic (8.51e-3)"			"unprognostic (2.74e-1)"		"unprognostic (3.91e-1)"			"unprognostic (8.81e-3)"	"unprognostic (1.40e-1)"			2.7	0.0	0.1	0.1	0.3	0.0	1.2	0.0	1.4	0.0	4.6	0.0	0.0	0.4	0.0	3.4	2.5	0.0	0.2	45.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.9	0.4	0.0	1.5	0.0	103.7	0.0	4.4	6.3	0.1	0.0	2.6	0.1	0.0	0.0	0.2	36.4	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.4	0.1	0.0	0.1	0.1	0.0	0.0
TRIM72	MG53	ENSG00000177238	"Tripartite motif containing 72"	Q6ZMU5	16	31214021-31231537	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"skeletal muscle: 71.6;tongue: 37.7"	"Cell line enhanced"	"Detected in some"		"HL-60: 4.7;LHCN-M2: 8.7;RH-30: 22.6;U-266/70: 14.1"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	12	"cerebellum: 3.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA054909	Enhanced		Approved	Nucleoplasm,Vesicles				Vesicles	Vesicles	"HPA054909: AB_2682639"	"unprognostic (2.61e-1)"	"unprognostic (3.21e-3)"	"unprognostic (5.07e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.57e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.24e-10)"	"unprognostic (7.70e-2)"	"unprognostic (6.72e-2)"	"unprognostic (4.15e-1)"	"unprognostic (4.30e-4)"	2.3	0.1	0.1	0.1	0.2	0.3	0.1	3.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	5.5	1.8	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.8	0.0	0.0	1.0	0.0	71.6	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	1.2	37.7	1.9	0.0	0.0	2.0	1.9	4.9	1.3	2.1	1.3	0.4	0.1	0.1	0.2	0.3	0.1	0.1	0.3	0.2	0.1	0.0	0.0	0.1	0.4	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.2	0.6	0.3	0.2	4.7	0.2	1.0	0.1	0.0	0.1	0.0	0.3	0.5	8.7	0.2	0.1	0.4	0.2	0.3	0.3	22.6	3.0	0.0	0.3	1.9	0.2	0.2	0.3	0.1	0.2	1.9	0.1	0.2	0.3	0.2	0.1	14.1	1.2	0.2	0.2	0.3	0.2	4.5	1.3	1.5	1.1	1.2	1.0	1.3	1.0	0.9	0.8	2.0	1.3	1.3	4.9	2.1	1.2	1.9	0.8	0.4	0.1	0.2	3.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0
AC018554.3		ENSG00000278499	"Putative UPF0607 protein ENSP00000381418 "	A8MU76	16	60358455-60359480	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	9	"skeletal muscle: 1.9;testis: 7.1"	"Cell line enhanced"	"Detected in single"		"HaCaT: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	1.9	0.0	0.0	0.0		0.0	0.0	7.1			0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ASB11	DKFZp779E2460	ENSG00000165192	"Ankyrin repeat and SOCS box containing 11"	Q8WXH4	X	15281697-15315656	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"heart muscle: 51.8;skeletal muscle: 50.7;tongue: 29.8"	"Cell line enhanced"	"Detected in single"		"SK-MEL-30: 1.6"	"Cancer enriched"	"Detected in single"	20	"melanoma: 2.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"amygdala: 2.2;basal ganglia: 7.7;cerebral cortex: 5.7;hippocampal formation: 2.9;olfactory region: 5.0"	"Low region specificity"	"Detected in single"														"unprognostic (5.89e-3)"				"unprognostic (1.04e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.54e-2)"		"unprognostic (2.04e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"		"unprognostic (6.21e-2)"		2.2	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	1.2	1.3	0.1	0.0	51.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	5.0	2.2	0.0	50.7	0.5	0.1	0.0	0.1	0.1	2.8	0.1	0.0	0.0	0.3	29.8	2.3	0.1	0.1	0.6	0.6	0.8	0.3	1.4	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.2	0.4	0.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.2	0.4	0.4	0.3	0.1	0.3	0.1	0.2	0.3	0.2	0.2	0.1	0.6	0.3	0.3	0.8	1.4	0.1	0.6	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
ATP1B4		ENSG00000101892	"ATPase Na+/K+ transporting family member beta 4"	Q9UN42	X	120362085-120383249	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"skeletal muscle: 47.3;tongue: 26.1"	"Cell line enriched"	"Detected in single"	4	"HSkMC: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (2.59e-2)"	"unprognostic (6.02e-4)"						"unprognostic (5.78e-1)"		"unprognostic (5.29e-2)"				1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.2	1.7	0.1	0.0	2.4	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.4	0.0	47.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	26.1	2.5	0.0	0.0	0.7	0.2	1.4	0.3	0.7	0.3	1.0	0.1	0.1	0.1	0.4	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.7	0.3	0.3	0.5	0.1	0.2	0.3	3.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.4	0.2	0.1	0.2	0.0	0.2	0.2	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.0	0.6	0.0	0.6	0.5	0.4	0.3	0.2	0.0	0.0	0.3	0.4	0.4	0.1	1.3	0.3	0.3	0.3	0.1	0.2	0.3	0.1	0.2	0.1	0.7	0.3	0.3	1.4	0.7	0.3	0.2	0.2	1.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0
BIN1	"AMPH2, AMPHL, SH3P9"	ENSG00000136717	"Bridging integrator 1"	O00499	2	127048027-127107355	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"skeletal muscle: 399.9"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdTCR: 37.0;MAIT T-cell: 32.5;memory B-cell: 32.2;memory CD4 T-cell: 38.4;memory CD8 T-cell: 36.9;naive B-cell: 34.1;naive CD4 T-cell: 36.2;naive CD8 T-cell: 34.4;NK-cell: 31.2;T-reg: 45.0"	"Group enriched"	"Detected in many"	9	"B-cells: 34.1;NK-cells: 31.2;T-cells: 45.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001945, HPA003894, HPA005437"	Enhanced		Supported	Cytosol		1200000	1200000	Cytosol	Cytosol	"CAB001945: , HPA003894: AB_1845360, HPA005437: AB_1078284"	"unprognostic (2.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.41e-3)"	"unprognostic (3.22e-3)"	9.5	12.1	21.0	6.7	26.8	3.7	4.2	10.3	24.9	6.2	5.4	36.2	3.6	5.3	5.6	7.3	8.8	7.8	6.4	3.1	24.8	15.2	10.3	4.9	4.6	9.3	26.8	15.8	6.8	5.3	7.3	4.9	6.5	17.3	9.2	4.4	7.9	4.9	7.2	399.9	2.7	5.0	11.6	22.1	10.4	6.1	3.1	26.8	0.0	4.7	30.8	7.3	9.0	7.9	34.1	4.0	1.1	0.6	31.2	45.0	22.4	15.3	8.4	10.1	12.0	30.4	24.4	3.5	4.6	10.1	11.1	7.3	32.2	9.5	0.0	14.3	8.7	2.0	4.5	7.6	3.0	1.7	1.2	4.5	13.8	2.1	27.4	0.0	0.9	22.2	1.9	24.0	4.4	15.0	0.9	0.5	13.7	0.3	1.4	12.8	7.6	9.6	3.5	11.2	1.4	39.3	0.0	6.6	18.8	16.8	6.5	5.1	0.4	2.9	17.9	12.8	12.6	16.3	15.5	0.4	0.4	0.0	18.9	0.8	5.8	0.1	0.6	0.1	37.0	0.3	32.5	32.2	38.4	36.9	2.8	34.1	36.2	34.4	1.1	31.2	0.5	4.0	45.0	22.4	21.0	26.8	10.3	24.9	24.8	15.2	26.8	15.8	17.3	26.8
CHRND	ACHRD	ENSG00000135902	"Cholinergic receptor nicotinic delta subunit"	Q07001	2	232525993-232536667	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"skeletal muscle: 49.1"	"Cell line enriched"	"Detected in single"	72	"RH-30: 42.8"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"olfactory region: 1.4"	"HPA056404, HPA065404"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA056404: AB_2732603, HPA065404: AB_2732734"				"unprognostic (1.69e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.28e-3)"	"unprognostic (7.75e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.90e-1)"		"unprognostic (4.97e-8)"	"unprognostic (7.52e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.46e-1)"		2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	49.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	42.8	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FABP3	"FABP11, H-FABP, MDGI, O-FABP"	ENSG00000121769	"Fatty acid binding protein 3"	P05413	1	31365625-31376850	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"heart muscle: 420.9;skeletal muscle: 129.4"	"Cell line enriched"	"Detected in some"	5	"ASC TERT1: 117.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 92.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							"CAB017830, HPA055754"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Focal adhesion sites"		4400000	4400000	"Focal adhesion sites"	"Focal adhesion sites"	"CAB017830: , HPA055754: AB_2682909"	"unprognostic (2.07e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.67e-1)"	"prognostic favourable (1.54e-7)"	"unprognostic (5.80e-3)"	"unprognostic (3.45e-1)"	"unprognostic (7.38e-3)"	"unprognostic (9.76e-3)"	2.3	5.2	8.1	0.7	6.0	0.5	22.7	1.4	14.6	3.9	1.3	0.8	3.4	0.7	6.8	5.3	3.1	2.8	1.1	420.9	11.0	5.3	21.3	1.9	4.3	1.3	9.8	6.0	2.2	0.4	0.3	0.7	1.1	13.7	5.0	1.5	3.0	4.4	14.0	129.4	0.9	0.6	13.0	3.4	3.9	3.6	2.0	1.3	0.1	1.7	31.6	2.2	2.5	2.5	1.4	0.5	0.0	0.9	0.2	0.9	0.6	0.1	0.0	3.2	0.2	22.6	117.9	1.1	0.9	8.7	0.1	3.1	0.2	0.8	0.2	12.5	2.4	0.3	0.9	0.0	0.1	0.1	0.5	0.3	1.1	2.3	1.5	0.2	0.0	10.4	0.0	2.3	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.2	6.0	0.4	0.1	1.2	0.0	2.8	0.0	0.3	0.0	0.5	0.0	13.5	0.1	1.4	0.3	0.2	0.1	2.1	0.1	0.1	0.4	0.1	0.5	0.1	0.2	0.0	0.4	0.0	0.9	0.9	0.6	0.2	0.5	0.5	0.5	1.4	0.0	0.9	0.0	0.2	0.1	0.4	0.6	0.6	8.1	6.0	1.4	13.3	11.0	5.3	9.8	6.0	13.7	1.3
FHL3	SLIM2	ENSG00000183386	"Four and a half LIM domains 3"	Q13643	1	37996770-38005606	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"blood: 67.9;skeletal muscle: 247.1;tongue: 100.1"	"Cell line enhanced"	"Detected in many"		"HEL: 29.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	9	"eosinophil: 67.9"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 67.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045723			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA045723: AB_10966278"	"prognostic favourable (5.62e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.02e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavourable (8.59e-5)"	"unprognostic (1.02e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.05e-2)"	"unprognostic (5.05e-2)"	"prognostic unfavourable (4.20e-11)"	"unprognostic (8.88e-3)"	"unprognostic (2.38e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.77e-2)"	7.0	2.0	1.2	3.3	2.1	3.9	4.5	0.6	1.4	5.5	6.4	1.3	2.4	1.1	7.5	8.1	6.9	4.4	3.6	2.3	1.6	1.1	1.7	1.3	2.9	5.0	2.4	0.9	7.6	2.0	1.4	1.1	2.1	2.1	4.8	1.6	2.2	5.5	3.6	247.1	2.6	1.9	12.0	2.2	2.5	2.7	1.7	1.0	0.3	1.8	100.1	4.0	15.5	5.7	0.1	3.8	67.9	5.7	3.0	3.4	2.3	6.2	2.3	6.2	6.3	5.8	23.5	3.9	5.0	9.8	9.4	7.0	5.2	5.0	0.0	8.4	11.2	2.4	4.0	6.0	4.7	2.3	7.2	29.5	5.1	5.9	22.7	2.3	21.6	20.7	6.9	10.7	6.1	13.2	24.7	0.1	17.6	3.3	0.8	10.0	8.1	1.6	4.0	5.2	0.4	6.2	1.1	0.7	3.2	4.5	0.4	7.1	1.9	2.0	9.3	4.1	9.5	1.1	4.5	1.6	5.7	0.7	1.9	13.7	4.3	1.3	5.7	67.9	3.2	3.7	3.4	0.0	0.7	1.6	3.8	0.1	0.5	0.7	7.4	3.0	2.4	0.1	1.6	2.3	1.2	2.1	0.6	1.3	1.6	1.1	2.4	0.9	2.1	1.0
IL17D	"FLJ30846, IL-17D, IL-22, IL-27, IL27"	ENSG00000172458	"Interleukin 17D"	Q8TAD2	13	20702127-20723098	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 36.1;skeletal muscle: 65.7"	"Cell line enhanced"	"Detected in many"		"TIME: 18.2"	"Group enriched"	"Detected in many"	9	"glioma: 10.8;melanoma: 3.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD8 T-cell: 1.0;NK-cell: 1.9"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.9;T-cells: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (1.76e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.86e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.93e-2)"	"unprognostic (5.97e-2)"	2.5	3.2	22.4	1.3	24.6	0.6	2.1	9.5	36.1	3.6	1.9	16.1	0.2	5.6	2.9	1.1	5.5	1.4	3.2	3.9	16.5	13.9	0.8	0.5	3.5	1.0	16.7	9.4	5.3	3.7	0.7	0.6	1.4	11.0	3.1	0.7	2.2	1.8	1.4	65.7	2.0	3.5	1.2	14.6	0.7	1.4	1.9	10.9	0.0	2.5	1.1	0.6	2.6	1.6	0.3	0.0	0.1	0.1	1.9	1.0	0.1	10.7	1.5	2.4	5.2	5.7	3.2	12.5	3.0	0.8	0.3	0.6	5.0	5.9	7.3	0.6	0.3	5.7	1.0	0.1	0.1	2.6	8.3	0.5	0.5	6.0	0.7	7.9	1.6	4.4	0.1	0.4	0.0	3.4	2.9	0.0	2.0	10.4	8.8	6.5	7.3	1.8	11.6	5.9	0.8	0.1	9.4	14.2	4.6	1.7	2.6	11.8	6.5	6.8	18.2	1.2	2.1	0.9	3.7	1.3	1.1	1.9	2.8	3.8	5.3	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.2	1.0	0.0	0.2	0.1	0.0	0.1	1.9	0.0	0.0	0.0	0.1	22.4	24.6	9.5	15.2	16.5	13.9	16.7	9.4	11.0	10.9
KCNA7	"HAK6, Kv1.7"	ENSG00000104848	"Potassium voltage-gated channel subfamily A member 7"	Q96RP8	19	49067418-49072941	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	9	"skeletal muscle: 40.6"	"Cell line enhanced"	"Detected in some"		"HMC-1: 3.9;U-251 MG: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (2.00e-1)"	"unprognostic (2.10e-2)"		"unprognostic (1.19e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.68e-1)"		"unprognostic (4.31e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.21e-8)"	"unprognostic (1.70e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.29e-2)"	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	40.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.6	0.3	0.0	0.0	1.1	0.9	3.3	0.8	0.9	0.8	0.2	0.7	0.3	0.4	2.0	0.0	0.2	0.7	0.4	0.0	0.1	0.0	0.5	0.9	0.4	0.2	0.2	1.3	0.1	0.2	0.0	0.4	0.6	0.2	1.4	0.4	0.1	0.6	3.9	0.1	0.3	0.1	0.1	0.0	0.5	1.1	0.1	0.5	0.3	0.6	0.5	0.3	0.4	0.1	0.4	0.2	0.5	0.4	0.4	1.5	0.2	0.1	0.5	1.1	0.7	1.4	0.5	0.9	3.9	0.7	0.3	0.3	0.6	0.4	0.5	3.3	0.8	0.7	0.8	0.4	0.5	0.5	0.7	0.7	0.2	1.1	0.7	0.8	2.6	0.9	0.7	0.9	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MUSTN1	Mustang	ENSG00000272573	"Musculoskeletal, embryonic nuclear protein 1"	Q8IVN3	3	52833114-52835219	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"skeletal muscle: 252.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 9.4;HSkMC: 5.9;RH-30: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.1"																				"unprognostic (2.79e-2)"	"unprognostic (3.73e-2)"			"unprognostic (4.11e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.34e-2)"	"unprognostic (6.21e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-3)"	"unprognostic (6.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.88e-2)"	12.1	1.8	2.5	1.8	5.2	1.3	6.1	1.5	5.7	16.0	4.6	2.6	2.4	1.7	11.1	18.9	7.9	6.4	10.6	15.5	2.6	2.2	1.8	0.8	3.2	1.4	4.3	3.9	5.1	1.6	0.8	1.1	1.3	5.2	11.6	3.4	3.8	5.9	8.9	252.5	2.7	2.6	6.1	2.2	0.9	2.3	6.4	0.2	0.0	5.4	26.9	3.6	8.1	7.9	0.0	0.0	2.1	0.6	0.0	0.3	0.2	0.1	0.2	2.9	0.0	0.8	2.0	3.4	0.2	0.9	0.4	0.3	0.4	0.4	0.0	0.0	1.4	1.2	0.7	0.5	0.4	0.1	0.9	0.0	1.5	9.4	1.4	1.9	0.6	5.9	1.0	0.9	0.0	1.2	0.2	0.0	0.1	0.6	0.7	2.7	0.4	2.1	1.0	8.3	0.0	0.6	0.0	0.3	0.3	0.6	0.7	1.4	0.0	0.7	0.0	0.3	0.7	1.2	0.6	0.0	0.0	0.0	0.3	2.4	0.3	0.0	0.4	0.0	0.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.6	0.0	0.0	0.2	2.5	5.2	1.5	5.7	2.6	2.2	4.3	3.9	5.2	0.2
RTN2	"NSP2, NSPL1, SPG12"	ENSG00000125744	"Reticulon 2"	O75298	19	45485289-45497061	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"skeletal muscle: 155.7;tongue: 43.2"	"Cell line enhanced"	"Detected in many"		"RH-30: 23.2;RT4: 23.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 9.1;eosinophil: 3.5;plasmacytoid DC: 2.4"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.4;granulocytes: 9.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034941, HPA034948"	Approved		Approved	"Nuclear speckles"		16000	16000	"Nuclear speckles"	"Nuclear speckles"	"HPA034941: , HPA034948: AB_2674375"	"unprognostic (3.08e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.68e-3)"	"unprognostic (5.07e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.44e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.96e-2)"	"prognostic unfavourable (5.58e-6)"	"unprognostic (4.34e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.03e-1)"	3.4	3.1	6.9	1.9	9.0	1.3	3.4	5.9	10.4	2.5	4.2	1.0	3.7	1.8	3.4	6.7	5.4	2.0	3.5	5.4	7.4	4.8	1.4	1.7	2.6	2.2	4.8	3.7	1.0	2.5	2.2	1.6	11.4	4.6	5.1	1.6	2.6	6.5	4.8	155.7	2.6	1.8	3.3	1.4	2.6	1.9	1.2	1.0	0.0	1.8	43.2	3.5	4.2	1.5	0.1	2.4	9.1	0.5	0.3	0.0	0.5	1.9	2.6	4.5	3.5	7.8	9.6	8.9	4.4	10.5	2.7	5.3	5.3	1.7	1.7	6.1	4.7	3.7	2.9	2.1	0.8	4.0	4.3	11.6	1.9	3.9	3.4	0.7	13.2	10.5	1.1	1.2	2.2	5.0	6.3	3.2	8.1	1.5	0.0	2.1	3.3	3.4	2.0	23.2	9.3	1.5	23.0	12.7	12.2	0.9	21.4	6.7	16.8	4.6	4.4	7.8	2.4	0.2	0.9	1.8	4.3	3.8	2.1	2.7	3.9	9.1	0.2	3.5	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.3	0.5	2.4	0.0	0.5	6.9	9.0	5.9	10.4	7.4	4.8	4.8	3.7	4.6	1.0
SCN4A	"HYKPP, HYPP, Nav1.4, SkM1"	ENSG00000007314	"Sodium voltage-gated channel alpha subunit 4"	P35499	17	63938554-63972918	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"skeletal muscle: 53.7"	"Group enriched"	"Detected in some"	11	"REH: 9.8;RH-30: 30.9"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.2"					"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.9"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053992			Approved	"Nucleoplasm,Centriolar satellite"				Nucleoplasm	Nucleoplasm	"HPA053992: AB_2797249"	"unprognostic (2.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.87e-4)"	"unprognostic (3.84e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.59e-3)"	"unprognostic (3.15e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.38e-3)"	"unprognostic (3.46e-1)"	"unprognostic (4.15e-1)"	"unprognostic (6.45e-2)"	5.9	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.2			0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.3	0.3	0.0		0.1	0.0		0.5	0.0	53.7	0.0	0.0	0.0	0.0	0.1	0.0	0.4			1.6		0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	9.8	30.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0										
SLC36A2	"PAT2, TRAMD1, tramdorin"	ENSG00000186335	"Solute carrier family 36 member 2"	Q495M3	5	151314978-151347590	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"kidney: 60.3;skeletal muscle: 36.8;tongue: 16.1"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.0"	"Cancer enriched"	"Detected in single"	9	"renal cancer: 0.5"	"Region enhanced"	"Detected in single"		"midbrain: 1.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA044002, HPA062229"	Enhanced									"HPA044002: AB_10964214, HPA062229: AB_2684717"	"unprognostic (3.47e-1)"	"unprognostic (3.40e-1)"		"unprognostic (2.26e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.38e-3)"	"unprognostic (4.66e-3)"	"unprognostic (3.03e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.89e-2)"	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	2.6	0.5	0.1	0.0	0.2	0.1	0.1	60.3	0.1	0.1	0.0	1.2	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.0	1.1	2.0	0.0	36.8	0.1	0.1	0.0	0.2	0.1	0.1	0.7	0.0	0.0	0.1	16.1	1.4	0.1	0.1	2.1	1.5	4.3	0.8	1.5	0.9	0.3	0.1	0.3	0.4	0.7	0.3	0.1	1.0	0.4	0.0	0.1	0.0	0.6	0.3	0.8	0.3	0.2	0.4	0.0	0.7	0.0	1.4	1.5	0.3	0.8	0.3	0.0	1.8	0.5	0.1	0.1	0.0	0.0	0.5	0.1	1.4	0.2	0.3	0.4	2.0	1.1	0.2	0.5	0.3	0.2	0.2	0.1	0.4	0.4	0.1	1.2	0.0	0.3	0.3	0.5	0.2	0.2	1.2	0.2	0.5	0.2	0.4	0.3	0.3	0.1	3.2	0.8	0.9	0.7	0.6	0.6	1.1	0.6	0.6	0.2	2.1	0.7	0.9	4.3	1.5	0.6	1.5	0.5	0.3	0.1	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.4	0.0
SYPL2	Mg29	ENSG00000143028	"Synaptophysin like 2"	Q5VXT5	1	109466628-109482137	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"skeletal muscle: 102.5;tongue: 25.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 19.8;ASC TERT1: 8.3;BJ: 8.4;BJ hTERT+: 26.7;fHDF/TERT166: 13.8;HAP1: 7.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA076657			Approved	"Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA076657: "	"unprognostic (1.82e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.90e-4)"	"unprognostic (6.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.36e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-1)"	"prognostic favourable (3.05e-4)"	"unprognostic (2.54e-3)"	"unprognostic (3.40e-1)"	"unprognostic (9.46e-3)"	"unprognostic (6.39e-4)"	0.9	3.9	0.8	0.3	0.7	0.1	1.4	0.5	1.2	1.6	1.9	0.3	0.8	0.3	2.5	4.3	1.6	0.4	1.1	7.4	0.8	0.2	6.0	4.7	0.6	0.3	0.3	0.0	1.1	3.2	3.7	0.4	1.2	0.8	1.2	0.5	1.7	1.6	2.2	102.5	0.2	0.6	3.5	0.1	0.4	1.1	6.0	0.2	0.0	5.1	25.6	1.2	2.5	2.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	19.8	8.3	0.0	8.4	26.7	2.6	1.0	0.0	0.0	0.0	0.0	13.8	0.0	7.1	0.0	0.5	0.0	3.1	0.0	0.2	0.1	0.4	0.0	0.6	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.9	2.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.5	1.2	0.8	0.2	0.3	0.0	0.8	0.2
USP6	"HRP1, Tre-2, TRE17, Tre2, TRESMCR"	ENSG00000129204	"Ubiquitin specific peptidase 6"	P35125	17	5116438-5175034	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"skeletal muscle: 18.2;testis: 29.0"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	14	"testis cancer: 2.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA046969			Uncertain	Vesicles				Vesicles	Vesicles	"HPA046969: "	"unprognostic (3.89e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.32e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.91e-4)"	"unprognostic (6.28e-3)"	"unprognostic (3.24e-4)"	"unprognostic (3.75e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.71e-1)"	"unprognostic (7.09e-4)"	0.3	0.3	0.3	0.3	0.6	0.2	0.4	0.5	0.5	0.3	0.5	0.3	1.2	0.0	0.6	0.6	0.3	0.5	0.4	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.3	0.3	2.6	0.3	0.0	0.4	0.4	0.3	0.4	0.1	0.3	0.3	0.3	18.2	0.6	0.7	0.9	0.3	0.3	0.0	29.0	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.9	1.2	1.9	1.0	0.2	0.4	0.1	2.2	1.0	2.2	1.7	0.4	0.2	2.3	1.9	0.1	0.6	0.4	0.8	1.1	2.2	1.7	1.3	1.0	0.7	0.8	0.5	1.6	1.3	1.7	1.3	0.9	1.2	0.5	2.9	1.1	0.5	0.1	0.2	0.3	0.5	0.3	0.5	2.5	1.9	0.7	1.6	0.1	1.4	2.0	0.2	0.5	0.7	0.9	2.2	1.0	0.1	3.3	2.2	2.2	1.2	1.0	3.3	2.1	1.4	2.0	1.7	1.5	0.0	0.1	2.7	0.1	0.4	0.9	0.4	0.3	0.2	0.6	0.3	0.3	0.3	0.9	0.3	0.4	1.9	0.2	1.0	1.2	0.1	0.1	0.3	0.6	0.5	0.3	0.3	0.1	0.3	0.3	0.3	0.3
XIRP1	"CMYA1, DKFZp451D042, Xin"	ENSG00000168334	"Xin actin binding repeat containing 1"	Q702N8	3	39183210-39192596	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"heart muscle: 95.0;skeletal muscle: 219.0"	"Group enriched"	"Detected in some"	5	"HSkMC: 9.1;LHCN-M2: 2.3;RH-30: 6.1"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA016750, HPA018458, CAB026391"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"				"Plasma membrane, Actin filaments"	"Plasma membrane, Actin filaments"	"CAB026391: , HPA016750: AB_1858884, HPA018458: AB_1858885"	"unprognostic (2.19e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.30e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.02e-5)"	"unprognostic (2.08e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.86e-4)"	"unprognostic (4.12e-2)"	1.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	1.7	1.9	0.0	0.4	95.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.2	0.3	1.1	0.0	0.0	1.3	0.0	219.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	4.9	18.2	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	1.1	9.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0
YIPF7	"FinGER9, FLJ39576"	ENSG00000177752	"Yip1 domain family member 7"	Q8N8F6	4	44622065-44678556	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"skeletal muscle: 45.3;tongue: 14.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;fHDF/TERT166: 1.4;PC-3: 1.3;SCLC-21H: 2.8;WM-115: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.3"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"cerebellum: 0.7"	"Region enriched"	"Detected in single"	28	"cerebellum: 14.8"	HPA030642	Uncertain									"HPA030642: AB_10601027"	"unprognostic (9.41e-4)"	"unprognostic (2.27e-1)"		"unprognostic (2.90e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.63e-2)"		"unprognostic (1.34e-1)"	"unprognostic (9.46e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.98e-2)"	1.5	0.0	0.3	0.0	0.5	0.0	0.1	0.8	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.9	0.0	0.0	0.5	0.3	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.6	0.1	45.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	14.8	0.7	0.0	0.0	2.3	3.3	0.3	1.0	0.3	0.9	0.3	0.2	0.0	0.1	0.0	0.0	0.0	1.5	0.8	0.0	0.0	0.8	0.0	0.0	0.0	0.8	1.4	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.8	0.0	1.0	0.0	0.3	0.0	0.7	0.0	0.6	0.3	0.0	0.3	0.5	1.1	0.0	0.0	0.0	1.6	0.0	1.0	0.0	0.5	0.7	0.4	2.3	0.9	0.7	0.6	0.6	0.3	0.4	0.3	0.3	0.2	3.3	0.1	0.3	0.3	0.5	0.8	0.3	0.3	0.5	0.3	0.0	0.1	0.0
AMPD1	"MAD, MADA"	ENSG00000116748	"Adenosine monophosphate deaminase 1"	P23109	1	114673090-114695618	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 212.4"	"Cell line enriched"	"Detected in single"	32	"U-266/70: 13.9"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	31	"memory B-cell: 3.0"	"Lineage enriched"	"Detected in single"	31	"B-cells: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA026478, HPA028080"	Enhanced				"Intracellular and membrane"					"HPA026478: AB_10599969, HPA028080: AB_10600776"	"unprognostic (1.98e-3)"	"unprognostic (1.43e-3)"	"unprognostic (8.75e-3)"	"unprognostic (8.03e-2)"		"unprognostic (1.95e-2)"		"unprognostic (5.61e-3)"	"unprognostic (8.21e-2)"	"unprognostic (4.29e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.36e-5)"	"unprognostic (1.68e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.02e-1)"	2.9	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.2	3.3	0.0	0.0	3.5	0.1	3.3	1.4	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.6	1.2	0.0	2.1	1.5	212.4	0.1	1.4	0.0	0.1	0.5	0.7	0.1	0.0	0.0	0.2	25.3	2.8	0.2	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
ASB18		ENSG00000182177	"Ankyrin repeat and SOCS box containing 18"	Q6ZVZ8	2	236194872-236264409	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	8	"heart muscle: 9.8;skeletal muscle: 14.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.9;CACO-2: 1.7;HEK 293: 2.3;K-562: 2.7;MCF7: 3.1;RH-30: 2.4;SiHa: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"																		"unprognostic (1.12e-1)"	"unprognostic (7.33e-3)"				"unprognostic (3.07e-1)"			"unprognostic (1.78e-6)"	"unprognostic (4.75e-2)"	"unprognostic (3.22e-1)"			0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.2	0.0	0.0	1.9	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	3.1	0.0	0.0	0.0	1.4	0.0	2.4	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.1	0.0	1.4	0.6	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CACNA1S	"CACNL1A3, Cav1.1, HOKPP, hypoPP, MHS5"	ENSG00000081248	"Calcium voltage-gated channel subunit alpha1 S"	Q13698	1	201039512-201112566	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 83.1"	"Group enriched"	"Detected in some"	32	"BEWO: 5.4;HSkMC: 6.9"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	20	"olfactory region: 5.3"	"CAB009507, HPA048892, HPA056815"	Enhanced									"CAB009507: AB_2069576, HPA048892: AB_2680548, HPA056815: "	"unprognostic (2.14e-2)"		"unprognostic (1.38e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.52e-3)"	"unprognostic (4.53e-2)"	"unprognostic (2.84e-1)"		"unprognostic (2.23e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.57e-1)"	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.6	0.0	83.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.1	0.1	0.1	0.1	0.0
CDH15	"CDH14, CDH3"	ENSG00000129910	"Cadherin 15"	P55291	16	89171767-89195492	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 44.2;skeletal muscle: 60.3"	"Cell line enriched"	"Detected in some"	5	"RH-30: 56.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	24	"cerebellum: 44.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	7	"cerebellum: 17.6"	"Region enriched"	"Detected in many"	6	"cerebellum: 17.9"	"HPA009139, HPA070961"	Enhanced	Supported	Enhanced	"Golgi apparatus,Plasma membrane"		390000	390000	"Golgi apparatus, Plasma membrane"	"Golgi apparatus, Plasma membrane"	"HPA009139: AB_1078372, HPA070961: AB_2686328"	"unprognostic (1.26e-1)"	"unprognostic (7.70e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.70e-3)"	"unprognostic (2.84e-3)"	"unprognostic (4.37e-2)"	"unprognostic (2.30e-3)"	"unprognostic (7.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-7)"	"unprognostic (3.09e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.64e-2)"	0.8	0.2	0.0	0.1	0.0	0.1	0.1	44.2	0.2	0.7	0.1	0.0	0.0	0.2	0.1	2.8	0.6	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.2	0.1	0.0	0.0	0.1	0.9	0.1	0.0	0.8	1.8	0.5	0.1	0.0	0.3	0.2	60.3	0.1	0.1	0.1	0.3	0.6	0.1	0.3	0.0	0.0	0.1	6.5	0.3	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	12.0	0.0	0.0	0.0	0.0	0.1	0.0	56.6	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	44.2	0.1	0.0	0.0	0.0	0.0	1.8	0.0
CHRNA1	CHRNA	ENSG00000138435	"Cholinergic receptor nicotinic alpha 1 subunit"	P02708	2	174747592-174787935	"Disease related genes, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 96.7"	"Group enriched"	"Detected in some"	18	"LHCN-M2: 87.3;RH-30: 71.4"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.0"	"Cell type enriched"	"Detected in single"	27	"plasmacytoid DC: 2.6"	"Lineage enriched"	"Detected in single"	27	"dendritic cells: 2.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA071554	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA071554: AB_2686416"	"unprognostic (1.49e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.96e-1)"	"unprognostic (8.55e-3)"	"unprognostic (5.34e-2)"	"unprognostic (5.29e-3)"	"unprognostic (9.59e-2)"	"unprognostic (9.64e-2)"	"unprognostic (9.66e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.18e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.18e-2)"	4.5	0.0	0.5	0.5	0.1	0.0	0.6	0.0	0.4	0.7	1.7	0.0	0.1	0.2	0.0	4.6	1.2	0.0	0.0	0.3	2.0	0.1	0.0	0.2	0.7	0.9	0.1	0.0	0.0	0.0	0.0	12.1	0.2	0.0	2.4	1.0	0.0	1.5	0.0	96.7	0.0	0.0	0.0	0.8	0.1	0.0	0.3	0.0	0.5	0.0	4.5	1.3	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.2	0.0	0.0	87.3	0.0	0.0	0.0	0.0	0.0	0.0	71.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.5	0.1	0.0	0.4	2.0	0.1	0.1	0.0	0.0	0.0
CLCN1	"ClC-1, CLC1"	ENSG00000188037	"Chloride voltage-gated channel 1"	P35523	7	143316126-143352083	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"skeletal muscle: 38.9;tongue: 21.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.4;HSkMC: 5.4;NTERA-2: 1.2;PC-3: 3.6"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.4;intermediate monocyte: 2.6;myeloid DC: 1.8;non-classical monocyte: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.8;monocytes: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (5.16e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.56e-4)"	"unprognostic (8.71e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.12e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.55e-3)"	"unprognostic (3.57e-2)"	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	38.9	0.0	0.8	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.7	21.1	0.9	0.1	0.0	0.0	1.8	0.5	3.8	0.0	0.2	0.9	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	1.2	3.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	2.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	3.8	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0
FBP2		ENSG00000130957	"Fructose-bisphosphatase 2"	O00757	9	94558720-94593793	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 33.7;skeletal muscle: 134.7;tongue: 45.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.2;CACO-2: 3.7;HMC-1: 4.0;MCF7: 5.3;PC-3: 3.7;SiHa: 5.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	36	"pons and medulla: 33.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA012513, HPA055286, HPA077371"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"HPA012513: AB_1848446, HPA055286: AB_2682772, HPA077371: "	"unprognostic (3.88e-2)"	"unprognostic (3.54e-4)"	"unprognostic (2.38e-1)"	"unprognostic (6.03e-2)"		"unprognostic (2.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.40e-4)"	"unprognostic (3.95e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.48e-4)"	2.0	0.4	0.1	0.0	0.1	0.0	0.2	0.1	0.9	0.1	0.1	3.8	4.4	1.0	0.1	1.0	1.6	0.1	0.0	0.1	0.7	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	1.2	4.1	0.1	0.0	33.7	0.2	0.0	5.0	1.4	1.8	134.7	0.1	0.1	0.1	0.2	0.1	9.0	0.4	0.0	0.0	0.2	45.6	2.7	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.3	0.0	2.5	0.0	0.0	7.2	0.0	0.0	0.1	0.0	3.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	1.9	2.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.3	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	2.4	0.6	0.1	5.0	1.2	0.0	0.4	0.1	0.0	0.0	2.3	2.2	0.0	0.0	0.1	1.0	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.9	0.7	0.1	0.1	0.0	33.7	0.0
FGF6		ENSG00000111241	"Fibroblast growth factor 6"	P10767	12	4428155-4445614	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"skeletal muscle: 24.6;tongue: 6.9"	"Group enriched"	"Detected in some"	7	"NB-4: 1.7;NTERA-2: 6.0;REH: 6.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"																				"unprognostic (4.29e-2)"			0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.9	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	6.0	0.0	6.4	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FLNC	"ABP-280, ABPL, FLN2"	ENSG00000128591	"Filamin C"	Q14315	7	128830377-128859274	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 546.8"	"Cell line enhanced"	"Detected in many"		"BJ: 78.6;fHDF/TERT166: 35.8;hTEC/SVTERT24-B: 38.9;U-2 OS: 33.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA006135	Enhanced		Supported	"Plasma membrane,Cytosol"		54000000	54000000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA006135: AB_1848602"	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavourable (2.80e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavourable (2.17e-5)"	"unprognostic (1.03e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavourable (5.69e-4)"	"unprognostic (5.68e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavourable (3.73e-5)"	2.6	0.8	0.5	7.1	0.7	0.2	0.7	0.3	1.0	5.2	24.4	1.4	18.4	1.9	14.0	10.1	16.0	4.8	13.3	70.0	0.8	0.5	0.4	0.3	1.4	0.3	1.4	0.5	3.1	0.6	1.0	0.3	0.6	1.9	11.9	2.1	1.7	3.1	20.2	546.8	1.0	5.2	69.0	4.7	0.3	10.0	1.3	0.6	0.0	4.7	40.0	2.2	39.6	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	7.1	8.6	0.8	78.6	14.9	22.4	10.8	24.4	0.2	0.0	13.3	35.8	0.0	4.8	0.1	13.3	0.0	2.6	0.0	4.0	0.0	9.0	0.0	0.0	16.3	0.0	38.9	0.0	13.9	9.4	0.0	15.2	0.0	0.0	0.3	13.1	4.5	0.0	26.0	0.2	0.0	0.0	0.4	1.4	0.1	0.0	0.0	0.1	0.3	28.8	7.8	33.6	2.0	0.0	0.0	0.0	0.0	26.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.3	0.6	0.8	0.5	1.4	0.5	1.9	0.6
HSPB7	cvHSP	ENSG00000173641	"Heat shock protein family B (small) member 7"	Q9UBY9	1	16014028-16019594	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"heart muscle: 524.6;skeletal muscle: 551.1"	"Cell line enriched"	"Detected in some"	4	"fHDF/TERT166: 81.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA027639	Approved		Approved	Nucleoplasm		43000	43000	Nucleoplasm	Nucleoplasm	"HPA027639: AB_10601756"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-3)"	"unprognostic (7.44e-3)"	"unprognostic (8.35e-2)"	"prognostic unfavourable (5.29e-4)"	"unprognostic (1.02e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.47e-3)"	"unprognostic (3.19e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.51e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavourable (1.26e-4)"	32.3	9.6	0.1	3.3	0.1	0.1	9.0	0.9	0.2	7.0	8.4	0.3	1.3	0.7	12.6	8.0	15.7	4.5	8.2	524.6	0.1	0.0	4.1	0.2	1.2	2.7	0.2	0.3	4.8	1.0	1.1	0.2	0.7	0.9	4.7	0.9	1.7	4.4	2.7	551.1	1.0	2.1	20.1	0.4	0.3	6.1	1.3	0.0	0.0	9.6	70.1	7.2	12.0	4.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	19.1	0.8	0.3	4.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	81.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.7	0.0	0.0	0.0	0.4	0.0	2.9	0.0	0.0	0.3	0.0	3.8	0.1	0.4	0.0	2.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.2	0.1	0.0	0.2	0.3	0.9	0.0
METTL11B	"C1orf184, HOMT1B"	ENSG00000203740	"Methyltransferase like 11B"	Q5VVY1	1	170146001-170167790	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"heart muscle: 7.0;skeletal muscle: 3.6"	"Cell line enriched"	"Detected in single"	12	"NTERA-2: 6.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028049	Uncertain									"HPA028049: AB_10610139"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-1)"	"unprognostic (5.62e-2)"		"unprognostic (7.59e-2)"	"unprognostic (7.25e-2)"		"unprognostic (1.19e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.76e-3)"			"unprognostic (5.43e-2)"	"unprognostic (4.56e-1)"		"unprognostic (5.79e-4)"	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.2	7.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NEB	"NEB177D, NEM2"	ENSG00000183091	Nebulin	P20929	2	151485336-151734487	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 505.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.7;RH-30: 26.6;U-266/70: 10.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebellum: 7.4;olfactory region: 4.9"	"Region enriched"	"Detected in some"	7	"cerebellum: 25.3"	HPA016601	Enhanced									"HPA016601: AB_1854361"	"unprognostic (2.40e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.45e-13)"	"unprognostic (6.80e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.06e-2)"	9.6	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	5.2	4.0	0.0	0.8	1.5	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.0	0.0	3.8	0.0	505.8	0.3	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	3.0	65.9	2.6	0.1	0.0	1.3	0.5	1.7	0.6	0.8	0.9	0.3	0.3	0.3	0.6	0.5	0.1	0.1	1.7	0.3	0.0	0.0	0.0	4.6	0.5	1.2	0.9	0.1	0.9	0.1	0.0	0.0	0.6	0.7	0.4	0.6	1.5	0.0	0.8	1.1	4.0	0.2	0.0	0.0	0.6	0.9	6.7	0.4	0.5	0.4	0.7	1.1	0.8	1.1	26.6	0.1	0.0	0.9	1.5	0.2	0.2	0.3	0.1	0.7	0.8	0.6	0.7	0.9	0.1	0.9	10.0	1.4	0.3	0.1	0.6	1.1	1.2	0.6	1.7	0.9	0.0	0.9	1.2	0.8	0.5	0.0	1.3	0.3	0.4	1.1	0.8	0.0	0.5	0.4	0.3	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0
RASA4B		ENSG00000170667	"RAS p21 protein activator 4B"	C9J798	7	102482445-102517781	"Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 47.4"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 11.8;U-138 MG: 16.5;U-2 OS: 14.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	7	"classical monocyte: 3.7;intermediate monocyte: 3.7;myeloid DC: 6.2;plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 6.2;monocytes: 3.7"									HPA043010	Uncertain		Uncertain	"Vesicles,Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA043010: AB_2678267"	"unprognostic (1.05e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.44e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.10e-1)"	2.9	1.1	2.3	1.4	1.2	0.0	2.1	0.5	4.4	3.2	2.4			2.5	4.1	0.0	0.6	1.5	1.3	0.5	1.8	2.0	0.9	0.1	0.8	1.3	1.1		2.2	0.9	0.0	1.1	1.7		1.5	0.0		0.7	3.7	47.4	1.8	3.0	0.5	0.5	1.9	0.8	0.2			0.3		0.2	1.4	2.3	0.1	6.2	0.0	3.7	0.0	0.2	1.8	0.2	0.9	3.2	0.2	0.5	1.9	0.1	5.7	3.0	1.2	2.9	0.2	0.4	2.2	6.4	6.5	7.6	0.0	0.0	0.0	0.2	0.7	0.3	1.7	0.5	0.0	0.0	0.2	2.1	0.3	0.0	0.0	0.8	0.6	8.1	0.7	2.1	0.0	1.1	0.0	0.9	2.3	1.1	3.6	0.0	0.8	2.2	11.8	0.9	0.2	0.2	0.2	1.5	1.0	16.5	14.1	1.3	0.5	2.7	1.8	0.2	1.9	0.4	2.6	0.0	3.7	0.0	0.2	3.7	0.1	0.1	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.6	3.9	0.0	1.8										
TMEM233	IFITMD2	ENSG00000224982	"Transmembrane protein 233"	B4DJY2	12	119593459-119643066	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 88.0"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 11.3;RH-30: 6.0;U-2197: 9.0;U-87 MG: 36.2"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 12.6"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA047506, HPA075435"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA047506: , HPA075435: "	"unprognostic (1.46e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.71e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.10e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.66e-1)"	0.6	0.3	0.8	0.0	0.4	0.0	0.6	0.1	8.8	0.2	0.2	0.0	0.0	0.1	0.9	0.6	0.2	0.2	1.0	0.7	0.2	0.5	0.5	0.3	0.6	0.2	0.1	1.4	0.6	0.1	1.7	0.4	0.0	0.4	0.4	0.1	0.7	0.5	0.3	88.0	0.1	0.2	0.5	0.3	0.2	0.2	0.2	0.0	0.1	11.1	5.2	0.3	0.4	1.8	0.3	0.3	0.7	0.1	0.6	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.0	11.3	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.5	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	36.2	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.2	0.3	0.3	0.2	0.0	0.3	0.2	0.5	0.7	0.6	0.1	0.3	0.1	0.1	0.8	0.4	0.1	1.5	0.2	0.5	0.1	1.4	0.4	0.0
TNNT1	"ANM, FLJ98147, MGC104241, NEM5, STNT, TNT, TNTS"	ENSG00000105048	"Troponin T1, slow skeletal type"	P13805	19	55132794-55149354	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 1047.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 119.1;RH-30: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"eosinophil: 53.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 53.3"	"Region enriched"	"Detected in many"	5	"thalamus: 136.6"	"Low region specificity"	"Detected in many"			"CAB015168, HPA058448"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus, Cytosol"	"Nucleoplasm, Golgi apparatus, Cytosol"	"CAB015168: AB_2206426, HPA058448: AB_2683720"	"unprognostic (1.88e-1)"	"unprognostic (7.23e-2)"	"prognostic unfavourable (4.66e-4)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (3.47e-3)"	"unprognostic (3.92e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (2.53e-4)"	"unprognostic (3.23e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (4.91e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.14e-2)"	3.2	0.0	1.6	0.0	1.0	0.1	0.1	0.1	1.0	0.0	0.1	0.0	0.0	0.1	0.0	24.4	22.3	0.4	0.1	6.1	0.9	0.4	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	7.2	0.0	0.0	11.5	0.0	1047.7	1.8	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0	9.2	124.4	17.8	0.3	0.1	0.1	9.9	53.3	11.6	0.1	0.1	2.6	24.3	14.3	0.1	3.1	0.0	0.2	4.7	1.1	4.2	1.6	4.7	5.2	16.2	0.3	9.5	0.4	12.4	3.4	10.6	1.3	1.6	27.0	4.6	1.5	0.9	0.5	0.3	119.1	5.3	17.2	0.4	18.3	0.0	23.1	22.6	1.5	23.2	0.4	0.0	3.0	28.4	15.5	89.7	2.9	3.7	0.8	0.9	7.0	1.5	0.2	7.8	14.8	14.2	0.5	23.6	35.1	0.9	1.7	0.1	0.9	1.1	24.8	3.6	7.1	0.5	11.6	53.3	0.0	5.9	0.1	0.0	0.1	0.0	9.9	0.1	0.1	0.1	0.5	0.1	2.6	0.2	0.0	2.6	1.6	1.0	0.1	1.0	0.9	0.4	0.5	0.0	0.0	0.0
VGLL2		ENSG00000170162	"Vestigial like family member 2"	Q8N8G2	6	117265558-117273565	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 75.9"	"Group enriched"	"Detected in some"	6	"RH-30: 17.1;U-2 OS: 6.0"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 0.4"	"Low region specificity"	"Detected in many"																		"unprognostic (3.02e-2)"	"unprognostic (3.09e-2)"				"unprognostic (1.75e-1)"					"unprognostic (4.92e-1)"			0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.0	0.0	0.0	9.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	1.7	0.3	75.9	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	1.0	7.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	2.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	1.7	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.3	0.0
ADCY2	"AC2, HBAC2, KIAA1060"	ENSG00000078295	"Adenylate cyclase 2"	Q08462	5	7396208-7830081	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 35.9;skeletal muscle: 58.6"	"Group enriched"	"Detected in some"	7	"AF22: 9.2;NTERA-2: 7.0;SK-MEL-30: 7.7"	"Cancer enhanced"	"Detected in some"		"glioma: 4.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031482, HPA038015, HPA038483"	Approved									"CAB031482: AB_630838, HPA038015: AB_10673653, HPA038483: AB_10675799"	"unprognostic (6.48e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.65e-2)"	"unprognostic (3.77e-1)"	"unprognostic (4.03e-4)"	"unprognostic (1.94e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.67e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.09e-5)"	"unprognostic (1.05e-1)"	"unprognostic (7.33e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.92e-3)"	1.8	3.3	16.8	1.3	14.5	1.2	2.8	6.6	35.9	4.9	1.9	6.7	0.7	1.9	3.9	1.7	4.0	4.1	2.1	1.2	14.5	9.4	1.2	1.1	1.3	1.1	12.8	10.0	5.1	1.9	1.0	5.1	1.8	11.3	6.2	1.6	2.0	1.5	5.1	58.6	6.3	1.8	4.3	12.5	1.2	2.6	3.6	5.4	0.0	1.1	5.1	1.2	1.9	2.1	0.9	0.4	1.5	0.4	0.3	0.6	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.0	0.0	0.1	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.7	0.3	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.4	0.1	0.4	0.2	0.4	0.5	0.3	0.3	0.1	0.9	0.4	0.6	1.5	0.3	0.3	0.4	0.2	0.0	16.8	14.5	6.6	22.5	14.5	9.4	12.8	10.0	11.3	5.4
ATP2B2	PMCA2	ENSG00000157087	"ATPase plasma membrane Ca2+ transporting 2"	Q01814	3	10324023-10708007	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 55.1;liver: 15.2;salivary gland: 28.6;skeletal muscle: 30.3"	"Group enriched"	"Detected in some"	4	"EFO-21: 5.3;RPMI-8226: 15.0;SCLC-21H: 5.7"	"Cancer enhanced"	"Detected in some"		"liver cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005606	Enhanced									"CAB005606: AB_2243199"	"unprognostic (2.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.62e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.65e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.32e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.33e-2)"	"unprognostic (8.34e-2)"	"unprognostic (7.95e-3)"	1.0	1.5	7.6	1.0	23.0	0.9	1.0	39.9	55.1	3.0	1.0	2.4	0.0	1.0	3.2	1.1	1.1	4.3	1.0	1.0	10.0	6.2	1.1	15.2	1.0	1.0	7.9	14.7	1.0	1.1	0.9	1.7	0.9	15.5	1.0	1.0	0.7	28.6	0.9	30.3	1.3	1.0	2.3	2.5	1.0	1.0	1.5	4.2	0.0	0.9	0.0	1.0	0.9	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	15.0	0.0	0.0	5.7	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	7.6	23.0	39.9	55.1	10.0	6.2	7.9	14.7	15.5	4.2
CHMP1B	"C18orf2, CHMP1.5, Vps46B"	ENSG00000255112	"Charged multivesicular body protein 1B"	Q7LBR1	18	11851396-11854449	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"skeletal muscle: 250.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA061997, HPA062896"	Supported		Supported	Nucleoplasm,Midbody				"Nucleoplasm, Midbody"	"Nucleoplasm, Midbody"	"HPA061997: AB_2684653, HPA062896: AB_2684898"	"unprognostic (6.73e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.90e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.37e-3)"	"unprognostic (9.20e-2)"	"prognostic favourable (7.37e-8)"	"unprognostic (1.88e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.92e-1)"	16.0	13.6	14.9	12.5	11.6	19.5	13.3	8.8	16.0	10.1	14.1	10.0	13.8	14.0	10.4	14.7	14.5	9.1	14.6	17.0	11.2	12.3	12.2	11.2	11.3	14.0	11.6	11.9	11.3	11.2	9.7	12.4	11.8	12.1	10.3	14.1	9.4	12.6	29.5	250.9	15.2	20.4	11.6	13.8	11.3	12.8	6.8	10.0	14.2	19.9	19.4	9.9	14.3	10.1	6.7	13.1	34.4	16.5	7.4	9.1	10.6	12.8	12.6	16.4	13.8	21.5	15.1	23.8	13.8	23.3	9.4	12.6	16.3	13.0	8.0	20.7	14.9	11.0	7.4	19.2	8.4	7.4	9.2	5.8	19.2	13.4	15.9	22.1	10.0	21.9	41.6	10.5	24.5	13.6	9.8	10.4	14.8	15.9	15.3	17.0	6.8	6.3	7.9	8.4	13.7	25.2	17.7	16.0	16.0	23.4	11.0	21.1	9.0	20.4	19.8	21.2	11.2	16.7	14.7	12.5	14.3	10.2	19.6	10.3	10.0	10.9	16.5	27.7	7.2	15.3	6.6	6.5	6.7	8.5	13.1	6.7	8.4	7.7	34.4	7.4	15.0	11.7	9.1	10.6	14.9	11.6	8.8	16.0	11.2	12.3	11.6	11.9	12.1	10.0
DWORF		ENSG00000240045	"DWARF open reading frame"		3	155290229-155293775	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 173.0"	"Low cell line specificity"	"Detected in some"			"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"basophil: 2.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.9"	"Region enriched"	"Detected in some"	8	"basal ganglia: 19.5"																			"unprognostic (6.77e-4)"		"unprognostic (1.60e-2)"					"unprognostic (6.62e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.33e-2)"				0.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	5.2	2.9	0.0	0.0	0.6	0.0		0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.6	0.0	173.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.7	23.7	0.9	0.0	0.0	0.5	0.4	2.9	0.2	0.4	0.2	0.0	0.2	0.0	0.5	0.0	0.0	2.3	0.7	0.3	0.0	0.0	0.6	0.0	1.3	0.0	0.4	0.0	0.5	0.3	0.5	0.0	0.3	0.6	0.4	0.5	0.5	0.0	1.8	0.4	2.0	0.0	0.0	0.4	0.8	0.6	1.3	1.2	0.4	0.2	1.7	1.1	0.6	0.3	0.2	0.3	0.0	0.0	1.0	0.9	0.0	0.7	0.1	0.9	1.1	1.9	1.7	1.2	0.8	0.2	0.2	0.3	0.8	0.7	0.3	0.0	2.9	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.5	0.2	0.2	0.8	0.4	0.1	0.4	0.1	0.0										
FAM166B		ENSG00000215187	"Family with sequence similarity 166 member B"	A8MTA8	9	35561831-35563899	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 77.3;fallopian tube: 26.1;skeletal muscle: 102.9"	"Cell line enhanced"	"Detected in some"		"AF22: 2.5;Hep G2: 5.6"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 11.7;ovarian cancer: 4.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA045540	Enhanced									"HPA045540: AB_10962627"	"unprognostic (4.18e-5)"	"unprognostic (7.56e-3)"	"unprognostic (1.65e-1)"	"prognostic favourable (2.61e-5)"	"unprognostic (5.66e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.21e-1)"	"prognostic favourable (6.20e-6)"	"unprognostic (3.69e-3)"	"unprognostic (9.09e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.52e-5)"	2.8	77.3	0.9	0.7	1.2	0.0	0.7	0.1	0.5	1.3	0.6	3.1	0.3	0.0	0.5	9.4	0.8	26.1	0.9	0.1	1.3	1.5	0.4	0.1	2.7	0.1	0.1	0.2	2.5	0.1	0.0	0.2	0.1	3.8	0.1	0.0	0.7	0.6	0.6	102.9	0.2	0.3	0.3	0.4	0.2	0.0	0.5	0.6	0.1	0.3	1.3	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	2.5	0.7	0.6	0.0	0.5	0.4	0.0	0.0	0.0	0.2	0.0	0.3	1.3	0.0	0.2	1.4	0.5	0.9	0.0	0.3	0.0	0.0	5.6	0.0	0.4	0.4	0.0	0.5	0.0	0.5	0.4	0.0	0.6	0.0	0.1	0.0	0.4	0.5	0.6	0.0	0.2	0.0	2.0	0.3	0.8	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.7	0.4	0.8	0.0	1.3	0.8	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	1.2	0.1	0.5	1.3	1.5	0.1	0.2	3.8	0.6
HRASLS	"H-REV107, HRASLS1"	ENSG00000127252	"HRAS like suppressor"		3	193241125-193277738	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	7	"skeletal muscle: 40.9;testis: 42.1"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.5;NTERA-2: 7.4;PC-3: 16.5;RH-30: 7.2;SCLC-21H: 15.0;U-2 OS: 9.1;U-251 MG: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051179	Uncertain		Approved	"Focal adhesion sites,Cytosol"				"Focal adhesion sites"	"Focal adhesion sites"	"HPA051179: AB_2681375"	"unprognostic (3.01e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.93e-3)"	"unprognostic (4.82e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.97e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.77e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.38e-5)"	"unprognostic (1.61e-2)"	"prognostic favourable (4.36e-4)"	"unprognostic (2.98e-3)"	"unprognostic (1.13e-2)"	0.6	1.1	1.8	0.2	3.1	0.1	1.0	0.6	3.3	0.5	0.6	1.7	0.0	0.1	0.6	3.1	2.4	0.5	0.2	4.3	2.0	1.1	0.6	0.6	0.5	0.1	1.5	2.1	0.6	0.8	0.5	0.7	0.1	2.4	0.5	0.1	3.1	6.1	0.5	40.9	1.7	0.6	0.7	0.6	0.6	0.6	42.1	1.7	0.2	3.7	6.2	0.2	0.5	0.6	0.0	0.2	1.7	0.1	0.0	0.0	6.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.3	0.0	0.1	0.0	0.1	0.0	0.0	8.5	0.2	0.4	0.0	3.8	4.4	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.4	16.5	0.0	7.2	0.0	2.4	0.0	15.0	2.8	1.0	2.2	0.0	4.3	0.0	0.1	0.0	9.1	0.0	11.5	0.0	0.0	0.0	4.7	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	6.2	1.8	3.1	0.6	3.3	2.0	1.1	1.5	2.1	2.4	1.7
KBTBD12	"FLJ46299, KLHDC6"	ENSG00000187715	"Kelch repeat and BTB domain containing 12"	Q3ZCT8	3	127915232-127987671	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"heart muscle: 13.1;skeletal muscle: 44.5;tongue: 16.6"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 1.8;RT4: 2.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 3.1;neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 3.1"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in all"	5	"cerebellum: 14.9"												"unprognostic (3.60e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.69e-3)"	"unprognostic (3.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.41e-2)"	"unprognostic (5.70e-2)"	"unprognostic (9.49e-2)"	0.6	0.5	2.1	1.2	2.7	0.6	0.5	2.6	2.6	0.4	1.5	0.8	1.0	1.1	0.7	1.3	1.4	1.2	1.1	13.1	2.2	0.7	1.1	0.4	0.5	0.5	0.7	2.2	0.5	3.7	0.4	0.5	0.5	1.6	0.8	1.5	1.4	1.7	0.8	44.5	0.7	1.0	1.0	0.5	0.4	1.9	0.9	1.2	0.0	0.4	16.6	0.7	1.0	0.4	0.3	0.4	3.1	0.3	0.2	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.3	0.1	0.6	0.2	0.2	0.0	0.1	0.1	1.8	2.4	0.5	0.2	0.2	0.1	0.0	0.3	0.1	0.6	0.3	0.2	0.5	0.1	0.4	0.3	0.0	0.2	0.0	0.3	3.1	0.3	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.2	1.5	0.2	0.1	0.4	0.0	0.0	2.1	2.7	2.6	2.6	2.2	0.7	0.7	2.2	1.6	1.2
KLHL30	FLJ43374	ENSG00000168427	"Kelch like family member 30"	Q0D2K2	2	238138722-238152947	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"skeletal muscle: 62.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.0;CAPAN-2: 3.1;EFO-21: 3.0;RH-30: 8.6;THP-1: 4.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.5"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	35	"olfactory region: 11.6"	"Low region specificity"	"Detected in all"			HPA062095			Approved	"Centriolar satellite"				"Centriolar satellite"	"Centriolar satellite"	"HPA062095: AB_2684680"	"unprognostic (3.42e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.07e-4)"	"unprognostic (6.02e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.17e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.06e-1)"	4.4	0.1	0.1	0.3	0.1	0.1	2.4	0.1	0.1	1.2	0.5	0.1	0.1	0.2	1.2	2.3	1.3	0.4	0.4	6.1	0.1	0.1	0.3	0.1	0.3	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.7	0.3	1.4	0.1	0.8	1.7	0.6	62.8	0.2	0.3	1.5	0.1	0.1	0.3	0.4	0.0	0.0	0.9	8.7	0.2	1.6	1.4	0.7	1.4	1.1	2.5	0.5	0.3	0.3	0.1	0.1	0.0	0.1	0.0	0.0	6.0	0.0	0.1	0.1	0.0	0.2	3.1	0.0	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.6	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.0	0.2	2.1	0.2	0.0	2.6	8.6	1.4	0.6	0.0	0.1	0.2	0.1	0.8	0.2	0.0	4.2	0.0	0.1	0.5	0.2	0.0	0.3	0.3	0.1	0.2	0.5	0.1	0.5	2.5	0.3	0.2	0.5	0.2	0.7	0.1	0.1	1.4	0.6	0.2	0.3	1.1	0.5	0.3	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0
KLHL40	"KBTBD5, NEM8, SRYP"	ENSG00000157119	"Kelch like family member 40"	Q2TBA0	3	42685519-42692544	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 132.0"	"Group enriched"	"Detected in some"	19	"HSkMC: 3.1;RH-30: 3.7"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024463, HPA052201"	Enhanced									"HPA024463: AB_1852095, HPA052201: AB_2681759"					"unprognostic (1.13e-1)"	"unprognostic (3.28e-2)"			"unprognostic (1.19e-1)"	"unprognostic (2.09e-1)"		"unprognostic (7.85e-2)"			"unprognostic (2.50e-1)"	"unprognostic (4.04e-1)"		2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.1	0.0	132.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.7	19.6	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC20	"FLJ10751, FLJ10844"	ENSG00000172731	"Leucine rich repeat containing 20"	Q8TCA0	10	70298970-70382650	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"skeletal muscle: 111.8"	"Cell line enhanced"	"Detected in many"		"U-2 OS: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039630			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA039630: "	"unprognostic (3.14e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.30e-1)"	"prognostic favourable (1.41e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	1.3	2.5	5.6	1.4	7.2	1.6	1.4	5.2	11.2	3.3	3.2	2.5	0.0	1.4	2.7	3.1	7.1	2.4	2.1	15.8	5.0	3.9	1.2	8.3	2.2	1.7	3.7	6.3	2.2	1.3	2.1	3.6	1.1	4.9	2.6	2.0	1.8	1.8	2.4	111.8	1.6	1.4	3.5	2.0	1.4	1.6	3.5	1.9	1.6	2.6	14.3	3.1	2.2	4.8	0.9	2.6	0.0	1.0	1.1	4.1	1.1	14.6	11.3	7.3	15.6	4.1	3.3	0.0	1.9	6.6	5.0	4.7	9.6	15.3	2.9	7.8	1.4	5.3	7.1	10.6	3.5	8.2	2.3	1.7	2.5	22.0	4.5	4.2	1.4	1.3	3.2	6.9	2.3	9.7	2.1	4.7	4.6	2.3	16.0	3.5	2.4	25.7	13.4	4.2	8.3	6.5	1.5	18.5	8.0	1.2	1.3	5.1	1.9	4.3	5.9	4.0	34.6	5.3	4.5	7.6	13.4	4.8	6.5	17.4	0.8	0.0	0.9	0.0	1.7	1.0	1.4	0.9	1.3	1.9	2.6	0.0	4.1	1.5	0.0	1.1	0.7	0.4	0.2	1.1	5.6	7.2	5.2	11.2	5.0	3.9	3.7	6.3	4.9	1.9
MAP6D1	"FLJ12748, SL21"	ENSG00000180834	"MAP6 domain containing 1"	Q9H9H5	3	183815876-183825594	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 48.1;skeletal muscle: 33.5"	"Cell line enriched"	"Detected in many"	5	"T-47d: 38.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037991	Enhanced	Supported	Approved	Cytosol				Cytosol	Cytosol	"HPA037991: AB_10672503"	"unprognostic (9.23e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (8.81e-12)"	"unprognostic (1.08e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.86e-1)"	"unprognostic (5.72e-2)"	1.1	1.2	11.8	1.5	16.0	1.1	2.0	30.9	32.1	1.5	1.4	48.1	0.0	1.9	1.4	2.0	1.1	1.5	1.3	1.9	18.8	9.2	1.2	1.3	1.4	1.7	24.7	8.7	1.7	6.0	1.8	0.5	1.3	18.4	2.7	1.4	0.0	1.6	2.0	33.5	4.6	1.5	1.4	37.7	1.5	1.2	1.3	20.4	2.2	1.1	0.0	1.4	1.1	0.2	0.5	0.3	0.2	0.2	0.0	2.7	0.3	1.8	1.3	2.1	0.4	0.5	0.7	1.6	2.3	0.4	4.5	3.0	1.8	0.1	0.2	3.0	3.5	1.4	4.4	1.1	3.0	1.3	6.6	0.2	0.0	0.0	1.3	2.4	0.8	0.3	0.3	1.1	0.4	0.9	0.3	0.0	0.6	8.2	5.7	3.3	2.0	3.8	2.8	3.3	0.0	0.2	0.0	7.0	1.3	1.7	1.3	2.4	38.9	2.3	0.4	1.0	1.6	1.6	3.5	1.4	0.8	1.1	0.3	0.4	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.5	0.5	2.7	0.3	0.0	0.0	0.9	0.0	0.0	0.1	0.2	0.0	0.3	11.8	16.0	30.9	19.9	18.8	9.2	24.7	8.7	18.4	20.4
MUSK		ENSG00000030304	"Muscle associated receptor tyrosine kinase"	O15146	9	110668771-110801620	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	7	"skeletal muscle: 50.0"	"Group enriched"	"Detected in some"	15	"LHCN-M2: 19.3;RH-30: 19.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 4.5"	"Not detected"	"Not detected"														"unprognostic (6.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.20e-2)"		"unprognostic (1.50e-2)"		"unprognostic (2.46e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.58e-2)"	"unprognostic (6.03e-5)"	"unprognostic (4.58e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.11e-2)"	7.5	0.3	0.6	5.8	0.7	0.0	0.2	0.1	0.2	0.3	6.8	0.0	0.0	2.3	0.2	4.0	3.8	0.1	2.1	3.2	0.9	0.7	0.2	0.5	4.2	0.9	0.2	0.1	0.3	0.3	0.0	0.2	0.6	0.3	1.9	5.3	0.0	0.4	0.0	50.0	0.3	5.0	3.0	0.3	0.2	2.6	5.9	0.0	0.0	0.3	1.4	3.9	3.6	2.9	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.4	0.2	0.0	19.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.1	0.2	0.9	0.7	0.2	0.1	0.3	0.0
MYO18A	"KIAA0216, MysPDZ"	ENSG00000196535	"Myosin XVIIIA"	Q92614	17	29071124-29180412	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"skeletal muscle: 179.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA019646	Supported					80000	80000			"HPA019646: AB_1854249"	"unprognostic (2.54e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.70e-2)"	"prognostic unfavourable (3.28e-4)"	"unprognostic (1.94e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (3.18e-4)"	"unprognostic (6.94e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.95e-1)"	8.3	3.6	11.9	5.8	15.5	7.7	8.6	23.1	18.7	6.1	6.7	15.9	3.6	9.0	6.5	5.4	11.8	4.4	7.2	24.6	15.2	9.4	4.0	9.2	5.2	4.8	13.6	9.9	5.1	9.3	7.4	3.4	4.0	11.4	6.0	4.8	4.4	7.4	5.1	179.7	11.7	9.0	6.3	15.7	4.8	9.0	4.3	12.9	8.0	5.7	14.5	9.1	4.8	5.9	2.2	2.3	2.9	1.8	2.1	3.0	0.7	15.0	21.3	8.2	4.2	2.2	3.8	13.2	7.2	7.2	6.3	4.4	5.3	10.7	1.5	8.1	5.1	17.3	3.2	12.0	2.5	17.5	6.0	1.3	6.3	5.8	3.3	1.8	1.9	4.4	7.1	3.8	1.7	2.3	18.6	2.8	3.1	5.2	5.4	1.5	1.7	4.7	19.0	9.2	4.7	4.9	11.2	4.3	4.4	7.1	24.1	5.3	5.6	2.2	2.6	4.1	5.1	2.8	4.9	5.3	8.9	3.0	5.2	1.3	11.0	2.5	1.6	2.4	2.3	1.8	3.0	0.9	1.7	1.8	1.8	2.2	2.4	1.4	2.9	2.1	1.7	2.3	1.3	0.7	11.9	15.5	23.1	18.7	15.2	9.4	13.6	9.9	11.4	12.9
MYOD1	"bHLHc1, MYF3, MYOD, PUM"	ENSG00000129152	"Myogenic differentiation 1"	P15172	11	17719568-17722131	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 31.8"	"Cell line enriched"	"Detected in some"	15	"RH-30: 101.2"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"hippocampal formation: 0.5"	"HPA055436, HPA078647"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA055436: , HPA078647: "						"unprognostic (1.07e-3)"				"unprognostic (2.10e-1)"					"unprognostic (1.01e-1)"			1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.5	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	4.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	101.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0
MYOM3	FLJ35961	ENSG00000142661	"Myomesin 3"	Q5VTT5	1	24056035-24112175	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"heart muscle: 59.5;skeletal muscle: 104.6;tongue: 39.7"	"Group enriched"	"Detected in some"	6	"A549: 5.0;Hep G2: 19.3"	"Cancer enhanced"	"Detected in some"		"renal cancer: 6.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028132, HPA028340"			Approved	"Golgi apparatus,Vesicles,Cytokinetic bridge"		680000	680000	Vesicles	Vesicles	"HPA028132: AB_10599293, HPA028340: "	"unprognostic (8.59e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.52e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.66e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.73e-4)"	"unprognostic (2.09e-1)"	"prognostic favourable (4.28e-6)"	"unprognostic (2.77e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.68e-1)"	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	6.3	2.7	0.2	0.0	59.5	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.1	0.0	2.7	0.0	104.6	0.4	1.5	0.0	0.0	0.0	0.0	1.9	0.1	0.0	2.7	39.7	2.8	0.2	0.1	0.8	0.4	2.3	0.4	0.2	0.4	0.0	0.1	5.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	1.5	0.0	2.1	0.6	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.8	19.3	0.0	0.1	0.1	0.6	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.1	1.1	0.2	0.6	0.7	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.8	0.4	0.1	0.3	0.4	0.1	0.4	0.2	0.2	0.0	0.8	0.3	0.4	2.3	0.2	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1
SBK1	Sbk	ENSG00000188322	"SH3 domain binding kinase 1"	Q52WX2	16	28292519-28323849	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 31.1;lymphoid tissue: 22.1;skeletal muscle: 39.6"	"Cell line enhanced"	"Detected in some"		"AF22: 15.0;AN3-CA: 10.8;NTERA-2: 15.4;REH: 16.3;SCLC-21H: 23.8;SH-SY5Y: 22.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"gdTCR: 4.3;MAIT T-cell: 1.4;memory CD4 T-cell: 1.2;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.4;naive CD8 T-cell: 3.0;NK-cell: 1.4;T-reg: 1.4"	"Group enriched"	"Detected in many"	10	"NK-cells: 1.4;T-cells: 4.3"	"Region enriched"	"Detected in all"	5	"cerebellum: 306.7"																"unprognostic (5.15e-2)"	"prognostic favourable (6.88e-4)"	"unprognostic (2.08e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.71e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.87e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.50e-2)"	"unprognostic (7.91e-2)"	"unprognostic (5.03e-3)"	0.9	2.0	8.0	1.8	7.3	2.0	1.7	31.1	17.5	1.7	1.2	1.5	0.0	1.1	1.9	1.3	1.5	1.6	1.0	1.8	9.9	5.6	1.6	0.9	1.8	2.7	6.0	4.0	1.1	2.7	4.2	4.1	0.8	8.3	2.6	1.2	1.4	3.8	1.0	39.6	1.4	1.1	0.9	3.1	2.8	1.6	2.3	3.1	22.1	2.6	0.0	1.7	1.2	0.3	0.2	0.2	0.2	0.1	1.4	4.3	0.4	0.1	0.2	15.0	10.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.1	0.0	0.3	4.5	0.1	0.0	1.5	0.5	0.0	0.1	0.4	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	1.8	6.9	0.1	15.4	0.1	16.3	0.8	0.1	0.1	0.9	23.8	22.4	0.3	1.4	0.2	1.7	0.0	0.4	0.0	2.3	0.2	0.1	0.2	0.0	0.2	0.1	0.2	0.8	0.2	0.1	0.1	4.3	0.0	1.4	0.0	1.2	2.4	0.0	0.2	1.4	3.0	0.1	1.4	0.1	0.2	1.4	0.4	8.0	7.3	31.1	17.5	9.9	5.6	6.0	4.0	8.3	3.1
TNNC1	TNNC	ENSG00000114854	"Troponin C1, slow skeletal and cardiac type"	P63316	3	52451102-52454070	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"heart muscle: 431.6;skeletal muscle: 765.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 23.8;EFO-21: 23.9;HeLa: 15.7;Hep G2: 15.9;HSkMC: 24.8;U-2 OS: 36.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.0"	"Lineage enriched"	"Detected in single"	7	"T-cells: 4.0"	"Region enriched"	"Detected in many"	4	"cerebral cortex: 88.3"	"Region enriched"	"Detected in single"	7	"midbrain: 8.5"	"CAB002450, HPA044848, HPA056897"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Mitochondria"		260000	260000	"Nucleoplasm, Actin filaments, Mitochondria"	"Nucleoplasm, Actin filaments, Mitochondria"	"CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269"	"unprognostic (2.18e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.15e-2)"	"unprognostic (4.86e-1)"	2.0	0.3	0.1	0.0	0.1	0.0	0.7	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.1	17.8	12.8	0.1	0.0	431.6	0.1	0.1	0.6	0.1	2.6	0.0	0.1	0.0	0.1	0.2	0.0	0.6	0.2	0.5	5.5	0.1	0.7	10.4	0.0	765.7	0.4	0.1	0.1	0.7	0.1	0.1	0.7	0.0	0.0	3.0	86.9	8.7	0.4	0.2	0.2	0.6	0.0	0.0	0.0	4.0	0.5	0.2	1.8	1.3	0.2	0.0	0.2	2.9	0.1	0.1	0.1	0.1	23.8	11.9	0.2	23.9	3.4	0.1	0.0	0.1	0.0	0.4	0.5	0.1	15.7	15.9	0.1	0.1	0.0	24.8	0.4	0.0	0.2	0.0	0.0	1.8	0.7	0.0	0.0	0.2	0.1	0.2	0.0	1.0	0.8	1.1	4.5	0.0	0.0	0.1	2.4	0.0	9.6	0.2	0.0	0.0	36.7	0.3	0.0	1.0	0.4	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	4.0	0.2	0.9	0.5	0.0	0.1	1.4	0.5	0.0	0.0	0.0	0.6	2.5	0.5	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.5	0.0
TNNI1		ENSG00000159173	"Troponin I1, slow skeletal type"	P19237	1	201403768-201429866	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 559.6"	"Cell line enriched"	"Detected in some"	9	"RH-30: 103.8"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 9.6;prostate cancer: 3.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028190	Approved		Uncertain	Nucleoplasm,Nucleoli		25000	25000	Nucleoplasm	Nucleoplasm	"HPA028190: AB_10600831"	"unprognostic (2.82e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavourable (9.27e-4)"	"unprognostic (1.93e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.25e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.59e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-1)"	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	22.9	9.5	0.0	0.1	6.6	0.1	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	6.8	0.0	559.6	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	2.7	83.8	10.7	0.0	0.1	0.2	0.6	1.7	0.4	0.4	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	103.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.3	0.3	0.3	0.1	0.2	0.2	0.2	0.6	0.2	0.3	0.5	1.7	0.4	0.3	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
TRIM63	"IRF, MURF-1, RNF28, SMRZ"	ENSG00000158022	"Tripartite motif containing 63"	Q969Q1	1	26051304-26068436	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 271.4"	"Group enriched"	"Detected in some"	38	"ASC diff: 10.5;SK-MEL-30: 33.5"	"Cancer enriched"	"Detected in some"	10	"melanoma: 31.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (1.10e-1)"	"unprognostic (4.80e-4)"	"unprognostic (1.45e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.58e-2)"	3.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	1.2	1.7	0.0	0.6	38.2	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.5	0.0	3.6	1.0	0.0	271.4	0.6	0.1	0.9	0.1	0.0	0.1	0.1	0.0	0.0	1.7	12.7	0.8	1.2	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
YBX3	"CSDA, CSDA1, dbpA, ZONAB"	ENSG00000060138	"Y-box binding protein 3"	P16989	12	10699089-10723312	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"skeletal muscle: 612.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 9.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034838	Approved		Supported	Cytosol		56000	56000	Cytosol	Cytosol	"HPA034838: AB_10670980"	"unprognostic (1.93e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (6.17e-13)"	"unprognostic (2.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.44e-1)"	23.8	5.0	3.0	6.4	6.0	11.2	15.9	2.1	4.6	12.4	14.3	2.0	3.7	3.2	8.5	14.7	25.0	8.4	6.7	91.6	3.2	1.7	7.6	6.5	17.2	6.8	5.5	0.8	17.2	20.6	1.3	8.1	9.5	6.2	12.4	5.3	6.2	12.9	6.8	612.6	29.9	5.0	14.9	5.8	8.6	9.5	30.2	4.1	4.5	18.5	54.2	12.0	27.2	24.6	9.5	4.5	1.0	5.7	0.9	2.3	1.4	17.7	15.6	7.0	22.8	29.2	54.2	51.2	27.8	23.7	23.8	22.4	27.3	43.1	17.4	9.3	22.1	34.1	29.9	57.9	20.7	0.1	53.7	14.4	22.0	16.6	36.5	25.9	1.6	62.5	75.2	22.1	72.7	54.7	19.4	0.0	25.5	19.0	21.3	22.3	70.6	12.8	12.0	32.0	19.7	32.3	23.6	8.7	0.0	21.1	21.0	25.8	6.0	20.4	35.7	16.3	45.9	17.4	31.2	0.1	5.7	2.0	22.5	0.0	17.5	0.0	5.7	0.0	0.7	5.4	0.0	1.6	0.0	2.1	4.5	9.5	0.1	2.3	1.0	0.9	3.0	0.2	0.1	1.4	3.0	6.0	2.1	4.6	3.2	1.7	5.5	0.8	6.2	4.1
AC083902.2		ENSG00000248713	"Homo sapiens uncharacterized LOC285556 (LOC285556), mRNA."		4	99636529-99654648	"Disease related genes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 40.9"	"Cell line enhanced"	"Detected in some"		"RH-30: 5.4;SK-BR-3: 3.5;SK-MEL-30: 2.0;WM-115: 1.8"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"														"unprognostic (3.91e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.00e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.20e-1)"		"unprognostic (2.42e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.20e-3)"	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.2	0.0	4.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	40.9	0.0	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.1	0.7	6.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	3.5	2.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0
AKAP6	"ADAP6, AKAP100, KIAA0311, mAKAP, PRKA6"	ENSG00000151320	"A-kinase anchoring protein 6"	Q13023	14	32329273-32837681	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 47.0;heart muscle: 46.6;skeletal muscle: 37.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"naive B-cell: 7.8"	"Lineage enriched"	"Detected in many"	6	"B-cells: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001983, HPA048741"	Enhanced									"CAB001983: , HPA048741: AB_2680506"	"unprognostic (1.99e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.41e-4)"	"unprognostic (1.81e-3)"	"unprognostic (1.93e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.24e-3)"	"unprognostic (3.54e-1)"	"unprognostic (3.33e-16)"	"unprognostic (8.57e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.79e-3)"	2.1	5.9	17.9	2.9	28.0	1.2	4.5	32.5	34.3	2.3	4.1	28.3	0.0	2.3	4.2	5.9	5.6	3.2	4.0	46.6	16.8	13.7	3.4	2.6	2.8	1.3	27.5	22.2	3.0	1.5	5.3	3.1	4.5	47.0	2.5	2.7	2.3	2.6	1.8	37.0	1.8	2.8	7.3	16.5	1.4	2.1	5.5	29.8	0.0	5.0	6.6	1.4	3.2	1.4	7.8	0.8	1.2	0.3	0.3	1.2	0.5	0.6	0.9	1.2	1.1	0.2	2.0	0.3	1.4	4.1	0.2	0.5	1.3	1.1	1.5	1.1	17.3	0.9	1.3	1.5	0.6	1.4	1.1	1.4	1.8	1.2	0.6	0.1	0.4	2.0	1.5	0.0	0.5	0.1	0.3	4.6	1.2	0.8	0.8	0.3	0.2	1.2	0.8	5.5	0.6	0.5	1.4	5.9	4.7	1.2	0.8	3.7	3.3	0.1	0.3	0.2	0.9	0.9	0.5	2.9	2.5	0.6	1.8	0.1	6.1	0.5	0.3	0.1	0.1	0.2	0.2	0.5	0.1	0.4	0.4	7.8	0.8	1.2	1.2	0.3	0.2	0.8	0.1	0.5	17.9	28.0	32.5	34.3	16.8	13.7	27.5	22.2	47.0	29.8
ALDOA		ENSG00000149925	"Aldolase, fructose-bisphosphate A"	P04075	16	30064164-30070457	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 1296.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA004177, CAB006252"	Enhanced		Supported	Cytosol		1200000000	1200000000	Cytosol	Cytosol	"CAB006252: AB_437007, HPA004177: AB_1078128"	"unprognostic (2.63e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.28e-3)"	"prognostic unfavourable (5.79e-5)"	"prognostic unfavourable (7.32e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.19e-3)"	"unprognostic (4.48e-2)"	27.9	30.9	34.7	24.2	42.3	36.0	25.3	31.2	59.7	21.0	32.8	16.3	25.9	29.4	21.9	33.9	73.5	22.1	24.4	109.3	31.6	33.4	28.2	11.1	17.9	34.0	35.0	49.6	23.4	19.4	51.0	25.2	19.9	38.0	23.6	23.5	24.6	37.9	36.9	1296.2	28.4	21.5	30.1	22.7	17.4	24.4	9.2	18.9	18.5	26.6	189.8	29.0	36.8	27.7	61.1	142.9	165.7	166.3	50.5	93.2	217.0	138.7	104.6	31.5	101.2	48.3	55.1	100.7	84.0	87.6	85.7	107.2	73.9	107.0	94.6	137.8	84.8	106.0	63.1	183.2	62.9	41.6	83.0	77.4	83.9	163.2	75.4	112.5	83.1	75.5	64.7	96.2	64.7	63.1	66.6	62.5	90.8	197.9	68.4	93.0	78.3	88.2	102.1	50.6	211.5	106.7	79.0	63.1	44.4	52.4	221.1	78.4	94.0	76.3	75.0	126.6	50.5	69.0	90.8	123.5	84.3	86.6	235.6	109.3	99.9	106.7	164.0	130.3	70.2	156.8	79.1	61.1	76.8	72.5	142.9	55.5	73.8	70.3	165.7	50.5	166.3	53.8	93.2	217.0	34.7	42.3	31.2	59.7	31.6	33.4	35.0	49.6	38.0	18.9
ANK1	"ANK, SPH1"	ENSG00000029534	"Ankyrin 1"	P16157	8	41653220-41896762	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 166.5;tongue: 58.3"	"Group enriched"	"Detected in some"	4	"HEL: 37.1;K-562: 39.0;RH-30: 49.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 20.1"	"Group enriched"	"Detected in some"	8	"memory B-cell: 10.6;naive B-cell: 9.1;plasmacytoid DC: 3.5"	"Group enriched"	"Detected in many"	7	"B-cells: 10.6;dendritic cells: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004842, HPA056953"	Supported	Supported			"Intracellular and membrane"	33000000	33000000			"HPA004842: AB_1844827, HPA056953: AB_2683284"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.76e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-1)"	1.2	0.3	0.6	0.7	0.6	14.8	0.3	20.1	3.8	0.2	0.2	0.0	0.0	0.4	0.2	2.7	1.8	0.2	0.3	18.0	0.6	1.2	0.3	0.2	0.4	0.9	4.0	0.4	0.2	0.3	4.3	0.3	0.8	8.3	0.9	0.2	0.5	2.9	0.3	166.5	0.2	0.3	0.2	1.0	0.7	1.1	0.3	0.0	0.0	1.0	58.3	3.8	0.3	0.4	10.6	3.5	1.0	0.2	0.1	0.9	0.7	0.0	5.0	0.1	0.0	0.0	0.9	0.0	1.4	10.0	0.4	0.2	0.0	0.0	2.3	0.4	1.0	0.8	0.2	0.1	0.2	0.9	0.0	37.1	0.2	0.0	0.0	0.1	0.1	1.3	0.2	0.1	0.0	0.0	39.0	0.8	0.6	0.1	0.0	0.4	0.5	0.0	0.2	49.4	0.2	0.2	0.1	0.7	0.4	0.0	0.7	0.0	0.6	0.9	0.2	0.1	0.2	8.5	0.0	0.0	0.0	1.4	0.9	0.0	0.0	1.0	0.2	0.0	0.1	0.0	0.5	10.6	0.3	0.5	0.1	9.1	0.0	0.0	0.5	0.1	0.0	3.5	0.9	0.7	0.6	0.6	20.1	3.8	0.6	1.2	4.0	0.4	8.3	0.0
ARPP21	"ARPP-21, R3HDM3, TARPP"	ENSG00000172995	"CAMP regulated phosphoprotein 21"	Q9UBL0	3	35638945-35794496	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 146.9;lymphoid tissue: 41.2;skeletal muscle: 43.6"	"Group enriched"	"Detected in some"	8	"MOLT-4: 34.9;REH: 19.4;RH-30: 11.1"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Region enriched"	"Detected in all"	5	"basal ganglia: 146.9"	"Cell type enriched"	"Detected in single"	30	"plasmacytoid DC: 12.1"	"Lineage enriched"	"Detected in single"	30	"dendritic cells: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017303	Enhanced		Approved	Nucleoli,Cytosol				Nucleoli	Nucleoli	"HPA017303: AB_1845049"	"unprognostic (1.72e-4)"				"unprognostic (2.35e-1)"	"unprognostic (1.10e-2)"	"unprognostic (6.61e-2)"		"unprognostic (6.30e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.42e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.52e-1)"		1.2	1.3	12.3	1.5	146.9	4.6	1.1	27.8	67.9	1.1	1.4	0.3	0.0	1.3	1.1	1.1	3.2	1.1	1.1	1.1	6.8	2.8	2.0	2.9	1.2	1.2	3.9	11.5	1.1	1.1	1.1	1.9	1.1	6.7	2.0	1.5	0.0	1.1	1.3	43.6	1.1	1.4	1.1	0.8	1.2	1.1	1.1	14.8	41.2	1.5	3.5	1.5	1.1	0.1	0.1	12.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	34.9	0.0	0.0	1.4	19.4	11.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	12.1	0.0	0.0	12.3	146.9	27.8	14.7	6.8	2.8	3.9	11.5	6.7	14.8
ASB14	DKFZp313L0121	ENSG00000239388	"Ankyrin repeat and SOCS box containing 14"	A6NK59	3	57268347-57292682	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"skeletal muscle: 26.3;tongue: 33.6"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (2.14e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.14e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.81e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.69e-2)"	"unprognostic (6.87e-2)"	"unprognostic (9.68e-2)"	"unprognostic (5.93e-2)"	"unprognostic (5.71e-3)"	0.7	0.4	0.3	0.6	0.3	1.9	0.7	0.6	0.6	0.4	0.3	0.3	0.3	0.3	0.3	0.6	0.5	0.5	0.3	5.0	0.3	0.3	0.3	0.3	0.6	0.7	0.3	0.3	0.7	2.3	0.0	0.3	0.3	0.3	0.3	0.0	0.6	0.8	0.3	26.3	1.0	0.6	0.3	0.3	0.6	0.5	0.3	0.3	0.3	0.8	33.6	1.3	0.3	0.7	2.4	1.6	0.0	0.5	0.5	0.6	0.1	0.8	0.4	0.6	1.2	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.7	2.3	2.9	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.8	1.4	2.8	0.3	0.0	2.7	1.5	0.0	0.0	0.0	0.0	0.0	0.4	2.1	0.0	0.4	2.3	3.0	0.6	1.1	0.4	0.8	0.6	0.0	2.0	0.8	2.6	0.6	1.1	0.3	1.0	0.5	1.0	0.5	0.8	2.4	2.0	1.5	1.7	1.3	2.3	1.7	0.8	0.0	0.5	0.0	0.2	0.1	0.2	0.7	0.3	0.0	0.4	2.4	0.6	0.6	0.0	0.5	0.2	1.6	0.0	0.1	0.3	0.3	0.6	0.4	0.3	0.3	0.3	0.3	0.3	0.3
ATP1A2	"FHM2, MHP2"	ENSG00000018625	"ATPase Na+/K+ transporting subunit alpha 2"	P50993	1	160115759-160143591	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"brain: 109.8;skeletal muscle: 305.8"	"Cell line enhanced"	"Detected in some"		"AF22: 32.2;HHSteC: 9.4;RH-30: 10.5;U-87 MG: 6.5"	"Cancer enriched"	"Detected in many"	18	"glioma: 91.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022230	Enhanced									"CAB022230: "	"unprognostic (1.08e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.63e-4)"	"unprognostic (1.70e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.16e-2)"	"unprognostic (5.32e-3)"	12.6	3.9	61.4	2.8	80.1	2.3	6.5	30.4	109.8	4.7	6.6	27.4	2.4	3.7	4.2	7.4	15.3	6.0	5.3	35.4	42.2	27.0	3.3	2.5	3.8	2.4	45.6	37.9	9.9	2.6	2.4	4.6	3.6	58.0	13.8	5.6	12.5	3.1	14.2	305.8	2.8	4.4	5.4	51.5	2.7	2.8	3.9	28.3	0.0	2.6	17.7	2.5	5.5	1.3	0.6	1.4	1.7	0.4	0.6	0.5	0.3	0.0	0.0	32.2	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	2.8	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	1.3	0.4	0.3	0.3	0.3	0.2	0.4	0.3	0.2	0.7	0.6	0.3	0.5	1.7	0.6	0.2	1.4	0.2	0.3	61.4	80.1	30.4	52.0	42.2	27.0	45.6	37.9	58.0	28.3
B3GALT1	beta3Gal-T1	ENSG00000172318	"Beta-1,3-galactosyltransferase 1"	Q9Y5Z6	2	167868948-167874041	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 2.4;brain: 5.1;intestine: 5.8;skeletal muscle: 7.1"	"Cell line enriched"	"Detected in some"	8	"AN3-CA: 27.9"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.23e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.94e-2)"	"unprognostic (8.72e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.30e-3)"	"unprognostic (8.34e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.79e-1)"	0.1	0.6	0.5	0.0	1.6	0.0	0.3	0.9	5.1	0.2	5.6			0.0	0.2	0.3	0.0	0.8	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.3		0.1	0.2	0.0	0.8	0.0		0.1	5.8		0.1	0.9	7.1	0.0	0.1	0.0	0.1	0.0	0.0	0.5			0.1		0.0	0.0	0.1	1.4	0.8	2.0	0.5	1.0	2.4	0.4	0.0	0.0	2.2	27.9	0.2	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.0	0.1	0.0	0.0	0.0	0.0	3.6	1.0	0.0	0.1	0.0	0.4	0.0	1.8	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.2	0.3	0.0	0.6	0.0	0.5	0.0	2.6	2.0	0.5	0.3	0.6	0.3	0.7	1.1	0.7	0.7	0.2	1.4	2.4	1.3	1.5	1.0	0.3	0.8	0.6	0.4										
BEST3	"MGC13168, MGC40411, VMD2L3"	ENSG00000127325	"Bestrophin 3"	Q8N1M1	12	69643360-69699476	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 125.0"	"Group enriched"	"Detected in some"	16	"REH: 18.3;RPMI-8226: 19.6;U-698: 32.7"	"Cancer enriched"	"Detected in single"	9	"glioma: 2.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054582	Approved									"HPA054582: AB_2682530"	"unprognostic (1.53e-1)"	"unprognostic (7.00e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.26e-3)"		"unprognostic (7.30e-7)"	"unprognostic (1.81e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.47e-2)"		"unprognostic (3.03e-1)"	1.6	0.5	1.7	0.1	1.9	2.4	0.6	6.3	9.3	0.2	0.2	0.9	0.0	0.2	0.2	2.4	1.7	0.1	0.2	0.4	1.8	0.7	0.4	0.3	0.1	0.2	1.8	0.6	0.2	1.0	0.1	0.7	0.3	1.2	1.7	0.2	0.1	1.9	0.1	125.0	0.9	0.1	0.1	1.9	0.1	0.1	2.5	1.0	0.5	0.2	21.9	0.7	0.1	0.0	1.2	0.9	1.7	0.5	0.6	1.0	0.7	0.1	0.2	0.7	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.4	0.1	0.2	1.3	0.3	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.5	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.6	0.1	0.2	0.2	0.0	0.8	0.1	0.0	0.0	0.7	0.3	18.3	0.6	19.6	0.9	0.1	0.4	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.5	0.1	0.7	0.1	0.2	32.7	1.4	0.0	0.1	0.3	0.5	0.3	0.5	0.4	0.8	1.2	1.0	0.7	0.3	0.8	1.0	1.0	1.7	0.6	0.4	0.9	0.4	0.7	1.7	1.9	6.3	1.5	1.8	0.7	1.8	0.6	1.2	1.0
CACNB1	CACNLB1	ENSG00000067191	"Calcium voltage-gated channel auxiliary subunit beta 1"	Q02641	17	39173456-39197703	"FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 130.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023343	Approved									"HPA023343: AB_1845866"	"unprognostic (3.44e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.69e-3)"	"prognostic unfavourable (3.80e-4)"	"unprognostic (3.99e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.98e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.94e-11)"	"unprognostic (7.62e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.44e-3)"	2.0	2.4	7.8	2.2	14.9	1.6	2.0	5.4	22.0	3.3	2.3	2.0	6.0	1.7	2.3	3.7	4.2	2.3	2.0	2.8	8.6	6.4	1.3	1.1	3.0	2.1	3.3	11.0	2.6	1.4	1.6	2.0	1.8	7.6	3.6	2.2	0.8	3.4	5.7	130.9	5.8	1.7	2.4	1.9	2.0	1.8	2.3	2.1	1.7	2.0	7.3	1.8	1.8	1.6	0.1	3.1	0.1	1.2	1.8	3.2	0.8	6.0	2.7	3.4	7.8	3.8	4.7	0.1	3.6	4.5	3.4	4.3	2.0	6.1	10.4	3.8	5.4	5.6	3.3	6.0	2.6	4.9	3.7	1.4	6.4	0.8	7.8	0.3	0.9	5.1	1.9	7.1	8.1	2.4	0.9	9.1	3.5	1.6	7.4	2.7	2.4	2.0	5.1	11.3	4.5	1.4	1.9	8.5	5.2	2.1	11.5	3.4	8.1	4.1	3.4	6.1	7.1	4.5	3.6	4.3	1.4	1.7	5.1	0.0	2.5	0.0	1.2	0.0	2.0	0.6	3.2	0.1	1.9	2.6	0.5	0.1	0.6	1.2	0.1	1.8	0.3	3.1	0.5	0.8	7.8	14.9	5.4	22.0	8.6	6.4	3.3	11.0	7.6	2.1
CAV3	"LGMD1C, LQT9, VIP-21, VIP21"	ENSG00000182533	"Caveolin 3"	P56539	3	8733800-8841808	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 65.8;tongue: 44.6"	"Cell line enriched"	"Detected in some"	4	"RH-30: 45.1"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB017518, CAB018557, HPA054488"	Enhanced		Approved	"Vesicles,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: AB_2682504"	"unprognostic (1.79e-1)"				"unprognostic (1.43e-1)"	"unprognostic (1.40e-2)"		"unprognostic (6.43e-2)"		"unprognostic (8.79e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.38e-3)"		"unprognostic (9.79e-2)"	"unprognostic (1.36e-1)"			1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	6.3	2.3	0.0	0.3	10.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.7	1.3	0.1	65.8	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	44.6	1.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	45.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0
DDIT4L	"REDD2, Rtp801L"	ENSG00000145358	"DNA damage inducible transcript 4 like"	Q96D03	4	100185870-100190782	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 106.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 13.8;BJ: 20.2;fHDF/TERT166: 10.9;HSkMC: 10.5;RPTEC TERT1: 14.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 19.3"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA050903			Uncertain	"Nucleoplasm,Plasma membrane,Actin filaments"				"Plasma membrane"	"Plasma membrane"	"HPA050903: "	"unprognostic (2.21e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (5.77e-4)"	"unprognostic (1.66e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.21e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.09e-2)"	"unprognostic (7.53e-5)"	"unprognostic (4.99e-3)"	1.4	0.5	1.5	0.3	6.3	0.3	0.6	2.0	1.6	7.9	0.6	1.7	0.0	0.2	0.9	3.0	2.6	0.9	0.3	3.5	2.1	0.7	6.2	0.2	0.4	0.3	1.5	1.6	2.8	0.2	0.3	1.2	1.3	2.7	3.8	0.5	5.2	6.3	2.6	106.4	0.4	0.3	0.8	2.4	0.5	0.2	1.1	1.7	0.0	0.6	18.6	1.2	0.5	0.9	0.2	0.0	0.0	0.2	0.0	2.0	0.2	0.0	1.5	5.9	0.0	2.7	13.8	0.8	20.2	1.7	0.3	0.1	0.1	0.6	0.0	0.5	10.9	0.0	4.2	0.3	0.4	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	10.5	0.1	0.2	1.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	6.7	0.0	0.4	0.0	0.0	14.4	0.0	0.0	0.0	0.4	0.8	2.7	0.0	0.1	0.1	0.0	0.0	0.0	1.5	2.7	0.0	0.0	5.1	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.2	0.1	2.0	0.0	0.0	0.7	1.4	0.0	0.0	0.0	0.0	1.0	0.2	1.5	6.3	2.0	1.6	2.1	0.7	1.5	1.6	2.7	1.7
DTNA	"D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3"	ENSG00000134769	"Dystrobrevin alpha"	Q9Y4J8	18	34493290-34891844	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 106.3;heart muscle: 82.8;skeletal muscle: 90.2"	"Cell line enhanced"	"Detected in many"		"MCF7: 17.5;NTERA-2: 19.5;SCLC-21H: 27.5;U-87 MG: 28.1"	"Cancer enriched"	"Detected in many"	9	"glioma: 28.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 7.0;T-cells: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015196, HPA071177"	Enhanced		Approved	"Nucleoplasm,Cell Junctions,Intermediate filaments"				"Nucleoplasm, Cell Junctions, Intermediate filaments"	"Nucleoplasm, Cell Junctions, Intermediate filaments"	"CAB015196: AB_2261797, HPA071177: "	"unprognostic (1.57e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.13e-3)"	"unprognostic (7.82e-6)"	"unprognostic (5.03e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.73e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.35e-4)"	"unprognostic (6.89e-2)"	"prognostic favourable (2.64e-7)"	"unprognostic (6.08e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.27e-5)"	9.3	5.3	51.5	4.0	47.6	1.6	7.3	37.7	69.1	4.5	5.4	38.7	0.9	3.4	4.3	13.9	13.9	7.6	7.1	82.8	42.3	46.5	2.7	2.5	4.8	2.3	44.7	21.0	5.4	12.3	1.4	6.1	3.6	51.0	14.6	5.6	3.4	5.7	15.9	90.2	1.8	3.9	15.2	106.3	3.9	3.6	4.7	39.5	0.0	9.3	6.5	2.4	12.8	1.7	1.4	7.0	0.4	1.3	1.0	6.7	1.7	0.2	0.1	7.5	0.0	4.8	13.4	1.2	2.0	7.3	0.3	0.9	1.7	0.0	0.0	4.4	0.8	0.6	0.9	3.9	0.7	0.0	5.2	0.0	0.4	3.5	3.9	0.1	0.1	10.2	0.8	6.3	2.2	3.2	1.1	0.9	2.1	17.5	0.1	0.0	19.5	4.0	0.0	3.7	11.9	0.3	0.1	27.5	3.2	0.0	0.7	2.0	10.7	2.6	0.1	8.7	4.7	0.1	2.7	0.6	0.9	0.4	28.1	0.0	3.7	0.4	1.3	0.0	1.4	0.0	1.9	1.4	2.7	1.9	7.0	1.1	2.8	2.0	0.1	1.0	0.0	0.2	6.7	1.7	51.5	47.6	37.7	35.7	42.3	46.5	44.7	21.0	51.0	39.5
EEF1A2	"EEF1AL, HS1, STN, STNL"	ENSG00000101210	"Eukaryotic translation elongation factor 1 alpha 2"	Q05639	20	63488012-63499322	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 298.6"	"Cell line enhanced"	"Detected in many"		"HAP1: 55.3;HBF TERT88: 27.8;MCF7: 45.7;SCLC-21H: 29.1;T-47d: 23.7;U-2 OS: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034019, HPA051759, HPA053862, HPA056990"	Approved		Supported	Cytosol		55000000	55000000	Cytosol	Cytosol	"CAB034019: AB_1562672, HPA051759: AB_2681595, HPA053862: , HPA056990: AB_2683302"	"unprognostic (1.40e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavourable (2.90e-5)"	"unprognostic (5.17e-2)"	"prognostic unfavourable (9.11e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.29e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	2.2	8.0	21.3	2.3	23.5	1.9	2.2	41.1	51.3	1.9	2.3	2.3	0.1	2.2	2.0	2.3	4.1	2.1	2.6	51.9	23.0	21.0	2.0	2.0	2.0	2.1	13.9	31.0	2.0	3.5	6.1	16.6	2.0	23.1	3.7	2.1	1.8	3.4	2.2	298.6	2.2	2.3	2.1	4.8	2.0	3.6	2.3	3.6	0.0	2.0	23.9	2.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.3	0.1	10.6	0.2	2.5	0.0	0.1	1.3	2.1	0.3	10.5	3.5	1.4	7.0	0.0	18.6	0.1	5.0	55.3	0.1	27.8	0.1	2.5	0.0	4.0	0.4	0.6	0.0	2.5	0.2	0.3	0.0	0.2	0.0	0.6	0.0	0.1	45.7	0.1	0.1	1.9	17.8	1.3	0.0	1.7	0.4	0.5	29.1	17.7	16.8	1.9	0.1	23.7	0.6	0.0	0.0	32.4	0.1	0.3	0.0	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	21.3	23.5	41.1	51.3	23.0	21.0	13.9	31.0	23.1	3.6
FEM1A		ENSG00000141965	"Fem-1 homolog A"	Q9BSK4	19	4791681-4801273	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 103.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA016565, HPA063622"			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA016565: , HPA063622: AB_2685063"	"unprognostic (4.62e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.04e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.25e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.28e-3)"	"unprognostic (6.25e-2)"	"unprognostic (6.18e-5)"	"unprognostic (3.72e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.70e-2)"	3.0	2.4	3.3	2.2	4.4	3.3	4.0	4.1	5.0	2.0	2.7	3.0	0.9	2.2	2.7	4.0	4.2	2.1	1.9	8.6	3.3	2.6	2.2	4.4	2.3	3.8	3.2	2.5	2.1	4.2	4.4	2.3	4.5	3.1	2.8	2.0	2.7	3.1	2.1	103.9	6.9	2.3	2.3	2.2	2.7	2.2	2.2	3.2	4.2	2.1	18.6	3.0	2.5	2.3	7.2	6.8	9.1	8.2	6.8	6.9	4.2	7.2	5.0	4.7	10.2	5.3	3.1	6.8	4.3	3.6	7.0	4.9	7.8	3.4	8.2	4.5	5.4	7.5	8.2	7.2	4.6	9.7	9.4	8.0	4.0	5.8	7.9	13.2	10.3	4.5	11.1	5.4	7.8	5.0	11.7	15.8	4.8	7.3	11.0	4.9	14.5	12.2	10.3	6.1	8.7	6.3	9.3	15.3	10.9	5.7	10.8	8.1	8.3	11.5	7.0	6.5	4.6	10.0	11.4	18.4	15.2	7.1	6.6	9.6	9.0	9.1	7.3	7.1	6.9	8.2	6.0	5.3	5.5	6.3	6.8	7.2	5.0	5.7	6.6	6.8	7.3	6.6	3.9	4.2	3.3	4.4	4.1	5.0	3.3	2.6	3.2	2.5	3.1	3.2
FGF8	AIGF	ENSG00000107831	"Fibroblast growth factor 8"	P55075	10	101770130-101780369	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 30.5"	"Cell line enriched"	"Detected in some"	20	"RH-30: 30.6"	"Group enriched"	"Detected in some"	8	"endometrial cancer: 2.1;testis cancer: 3.3;urothelial cancer: 0.7"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted in other tissues"						"unprognostic (1.56e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.12e-2)"	"unprognostic (4.88e-1)"	"unprognostic (2.47e-2)"	"unprognostic (9.09e-2)"		"unprognostic (8.75e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.35e-9)"	"unprognostic (6.17e-3)"	"unprognostic (9.01e-2)"		"unprognostic (1.97e-1)"	0.3	0.0	0.6	0.1	0.6	0.0	0.2	0.1	2.2	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0.6	0.0	0.1	0.1	1.9	1.9	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	30.5	0.0	0.1	0.1	0.2	0.3	0.0	3.1	0.1	1.1	0.1	0.1	0.1	0.1	0.1	2.1	1.6	4.8	3.0	2.6	2.5	1.3	0.4	0.1	0.2	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.5	0.0	0.4	0.2	0.0	0.0	0.7	0.7	0.2	0.1	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.6	0.0	0.3	0.4	1.5	0.1	0.0	0.4	30.6	0.6	0.0	0.2	0.6	0.6	0.0	0.4	0.3	0.5	0.0	0.4	0.5	0.9	0.6	0.1	0.1	0.5	0.9	0.6	0.5	0.6	4.8	1.5	1.8	1.2	1.9	2.5	1.6	1.9	1.5	1.4	2.1	2.4	2.3	4.2	2.6	3.0	1.6	1.7	1.3	0.6	0.6	0.1	2.2	1.9	1.9	0.3	0.1	0.1	0.1
FITM1	FIT1	ENSG00000139914	"Fat storage inducing transmembrane protein 1"	A5D6W6	14	24131275-24132849	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 56.1;skeletal muscle: 94.7;tongue: 79.9"	"Cell line enriched"	"Detected in some"	17	"RH-30: 26.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA019842	Uncertain									"HPA019842: AB_1853025"	"unprognostic (1.81e-2)"	"unprognostic (4.29e-7)"	"unprognostic (2.77e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.24e-2)"	"unprognostic (6.68e-2)"	"prognostic favourable (1.00e-3)"	"unprognostic (1.20e-4)"	"unprognostic (4.57e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.62e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.12e-3)"	0.8	1.7	0.0	0.2	0.0	0.6	0.3	0.4	0.2	0.2	0.3	0.0	0.0	0.5	0.2	2.2	1.2	0.2	0.2	56.1	0.0	0.0	0.2	13.1	0.2	0.3	0.0	0.0	0.2	11.9	0.2	0.2	0.2	0.0	0.7	0.2	0.1	2.9	0.3	94.7	0.5	0.4	0.2	0.0	2.5	0.3	0.3	0.0	0.0	0.5	79.9	3.6	0.3	0.0	0.8	0.3	0.0	1.1	0.4	1.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.5	0.1	0.0	0.7	0.7	0.2	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.2	0.3	0.0	0.3	0.2	26.4	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.5	1.1	0.3	0.2	1.1	1.5	0.3	0.8	0.6	0.6	0.0	0.4	0.4	0.0	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FXR1		ENSG00000114416	"FMR1 autosomal homolog 1"	P51114	3	180868141-180982753	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 215.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018246, HPA055475"	Approved		Enhanced	Cytosol				Cytosol	Cytosol	"HPA018246: AB_1849204, HPA055475: AB_2682828"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavourable (5.96e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.90e-3)"	"prognostic unfavourable (2.70e-4)"	"unprognostic (7.77e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavourable (7.30e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavourable (2.19e-5)"	"unprognostic (7.85e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.84e-2)"	12.4	13.8	13.0	7.6	16.1	13.7	11.7	14.8	15.0	11.5	14.3	10.5	11.4	7.5	14.7	10.1	13.4	11.7	8.9	36.1	13.7	14.3	10.1	11.3	8.5	9.4	19.4	9.6	16.9	11.4	11.4	17.3	12.7	18.1	13.1	7.4	6.5	10.2	11.8	215.4	7.7	7.9	12.3	23.4	9.1	10.5	39.1	19.4	17.2	16.2	22.7	10.0	15.6	28.8	13.8	14.9	11.4	14.0	11.0	21.8	9.4	37.8	17.6	38.1	29.6	29.3	33.5	17.2	30.1	30.8	33.9	33.6	25.9	19.1	19.3	49.9	20.7	18.3	30.7	18.5	47.5	25.5	20.7	19.7	23.3	29.5	31.3	12.2	16.3	35.3	21.2	17.1	41.0	34.1	15.7	23.5	42.6	13.7	23.2	20.5	43.0	19.4	16.1	48.7	20.6	26.1	11.9	16.1	20.6	26.1	30.4	38.9	42.2	23.5	27.2	25.6	28.6	16.0	59.2	22.0	27.5	23.0	26.7	17.6	32.5	8.9	12.9	10.0	12.9	14.0	13.6	13.8	13.8	11.7	14.9	9.5	17.6	14.4	11.4	11.0	10.2	10.5	21.8	9.4	13.0	16.1	14.8	15.0	13.7	14.3	19.4	9.6	18.1	19.4
GADL1		ENSG00000144644	"Glutamate decarboxylase like 1"	Q6ZQY3	3	30726200-30894765	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 21.6"	"Cell line enhanced"	"Detected in many"		"HAP1: 9.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039160, HPA040229"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA039160: AB_10796222, HPA040229: AB_10796118"	"unprognostic (4.96e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.32e-2)"		"unprognostic (5.05e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.98e-5)"	"unprognostic (8.81e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.06e-1)"	0.5	0.3	0.2	0.2	0.3	1.0	0.4	0.5	0.7	0.4	0.2	0.0	0.0	0.1	0.2	1.6	1.4	0.2	2.0	2.3	0.2	0.3	0.7	0.2	1.6	0.3	0.3	0.8	0.5	0.3	0.1	0.6	0.5	2.1	0.5	0.1	0.3	0.3	0.0	21.6	0.8	0.2	2.5	0.7	0.5	0.2	1.1	0.0	0.0	1.2	3.3	0.7	0.5	0.3	1.7	0.5	1.9	0.8	0.5	1.3	0.3	1.3	0.3	0.8	1.1	0.9	0.5	1.5	0.6	0.3	0.3	0.2	1.3	1.2	1.1	0.5	0.2	0.9	9.7	0.3	0.4	1.7	0.5	1.6	1.5	0.5	0.4	0.9	3.3	0.4	0.5	0.7	0.3	0.6	1.2	4.0	0.9	1.1	0.6	1.3	1.8	0.5	1.9	2.1	1.0	1.0	1.5	1.1	0.9	1.1	0.7	2.9	1.1	0.8	5.0	1.5	1.4	1.9	0.7	1.6	0.8	0.7	0.6	0.9	1.9	1.9	0.7	0.8	1.0	0.6	0.8	1.2	0.9	0.6	0.4	1.7	1.1	1.0	1.7	0.5	0.8	0.5	1.3	0.3	0.2	0.3	0.5	0.7	0.2	0.3	0.3	0.8	2.1	0.0
KIAA1024L		ENSG00000186367	"KIAA1024 like"	P59773	5	129748079-129766732	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 26.0"	"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 4.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA013760	Uncertain									"HPA013760: AB_1852363"				"unprognostic (1.77e-1)"										"unprognostic (5.13e-1)"				0.0	0.0	0.1	0.0	0.9	0.1	0.1	0.0	2.8	1.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.1	2.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.1	0.0	26.0	0.0	0.0	0.0	0.3	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	2.8	4.1	1.1	0.8	0.8	0.1	0.6	0.1	0.1	1.9	0.2	0.1	0.5	0.3	0.2	0.3	0.4	0.1	3.1	1.0	1.3	0.2	1.6	0.0	0.3	0.2	1.6	1.2	0.4	0.7	0.8	0.0	0.2	1.4	0.6	0.4	0.1	0.4	0.2	0.4	2.1	0.5	0.4	1.5	1.7	1.2	1.6	0.3	0.5	0.6	0.5	0.8	0.8	4.7	0.2	3.1	0.5	1.2	0.3	0.2	1.6	1.2	0.9	0.3	0.2	0.8	0.5	1.2	0.1	2.4	4.1	1.1	0.6	0.8	0.6	0.8	0.6	0.6	0.5	0.3	1.6	0.6	0.8	2.6	0.8	1.0	2.8	0.3	0.1	0.1	0.9	0.0	2.8	0.1	2.0	0.3	0.0	1.9	0.0
LRRC14B		ENSG00000185028	"Leucine rich repeat containing 14B"	A6NHZ5	5	191511-195353	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 30.6;skeletal muscle: 45.2;tongue: 14.3"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 28.5"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"plasmacytoid DC: 4.8"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038046, HPA038047"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA038046: AB_10672504, HPA038047: AB_2675806"	"unprognostic (7.63e-4)"	"unprognostic (4.25e-3)"	"unprognostic (8.50e-3)"	"unprognostic (7.63e-4)"	"unprognostic (4.95e-2)"	"unprognostic (3.79e-2)"		"unprognostic (6.07e-3)"		"unprognostic (9.68e-2)"		"unprognostic (6.43e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.78e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.19e-1)"	0.1	0.0	0.0	0.2	0.5	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	30.6	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.9	0.4	0.0	45.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	14.3	0.7	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	3.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	7.0	28.5	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.3	0.2	0.0	0.5	0.0
LRRC39	MGC14816	ENSG00000122477	"Leucine rich repeat containing 39"	Q96DD0	1	100148449-100178273	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 30.7;skeletal muscle: 113.7;tongue: 28.5"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 11.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA077159	Enhanced									"HPA077159: AB_2732333"	"unprognostic (7.68e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.16e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.38e-4)"	1.8	3.2	1.6	0.4	1.3	0.4	0.5	0.6	3.0	0.2	0.3	0.5	0.0	0.3	0.4	2.6	1.3	0.3	0.4	30.7	0.8	0.5	0.3	0.5	0.3	0.6	0.8	1.3	0.3	0.3	0.3	0.5	1.3	0.5	1.3	0.3	9.5	1.1	0.3	113.7	1.1	0.3	0.3	0.7	0.5	0.3	1.7	0.6	0.1	0.5	28.5	1.2	0.3	0.1	1.1	0.4	0.2	0.6	0.2	0.9	0.0	0.6	0.9	3.0	4.2	0.7	1.8	2.5	1.3	0.6	0.6	1.4	0.2	1.8	3.3	1.4	0.6	1.9	0.3	0.4	1.3	0.4	2.8	1.4	3.1	0.6	0.5	1.0	1.8	3.2	0.7	0.7	0.3	0.7	1.4	2.9	1.1	0.6	1.7	4.0	1.3	1.1	1.5	1.4	1.3	0.6	1.0	1.3	4.2	1.0	1.1	11.8	1.0	2.2	0.9	1.6	1.6	2.4	2.7	5.6	2.8	1.0	3.1	2.1	0.4	0.0	0.4	0.2	0.4	0.6	0.6	0.9	0.4	0.4	0.1	1.1	0.9	0.9	0.2	0.2	0.3	0.4	0.4	0.0	1.6	1.3	0.6	3.0	0.8	0.5	0.8	1.3	0.5	0.6
LRRC3B	LRP15	ENSG00000179796	"Leucine rich repeat containing 3B"	Q96PB8	3	26622806-26710776	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 21.3;skeletal muscle: 17.4;testis: 12.0"	"Group enriched"	"Detected in some"	4	"NTERA-2: 5.4;REH: 2.5;THP-1: 3.2"	"Group enriched"	"Detected in some"	9	"endometrial cancer: 0.7;glioma: 2.6;ovarian cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015568	Approved									"HPA015568: AB_1853282"	"unprognostic (1.22e-2)"			"unprognostic (2.94e-1)"	"unprognostic (1.87e-1)"		"unprognostic (7.42e-2)"	"unprognostic (8.82e-4)"		"unprognostic (2.84e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.91e-4)"	"unprognostic (3.31e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.82e-1)"	0.8	0.9	15.5	0.7	13.6	0.6	1.6	18.5	21.3	0.8	1.2	2.2	0.0	0.8	2.3	0.7	1.5	1.6	0.7	1.4	9.5	7.3	0.8	0.8	0.8	0.6	8.7	5.6	2.9	0.6	0.7	0.8	0.7	5.7	0.8	1.9	3.0	1.9	1.1	17.4	0.7	1.2	2.0	4.9	0.8	1.5	12.0	1.7	0.0	0.7	0.1	0.7	2.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	5.4	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	15.5	13.6	18.5	10.1	9.5	7.3	8.7	5.6	5.7	1.7
LSMEM2	"C3orf45, FLJ38608"	ENSG00000179564	"Leucine rich single-pass membrane protein 2"	Q8N112	3	50279027-50288114	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"heart muscle: 26.6;skeletal muscle: 16.3;tongue: 7.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.7;WM-115: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.2"					"Low region specificity"	"Detected in all"														"unprognostic (2.84e-3)"	"unprognostic (6.54e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.71e-1)"	0.6	0.3	1.2	0.2	2.1	0.4	0.2	0.7	1.9	1.1	0.3	2.1	0.1	0.4	1.4	0.4	0.7	0.8	0.4	26.6	1.4	0.7	0.3	0.1	0.3	0.1	1.3	0.6	0.9	0.3	0.1	0.1	0.2	1.3	0.4	0.3	1.6	1.4	0.5	16.3	0.1	0.5	0.5	1.6	0.2	0.2	3.0	0.9	0.1	0.2	7.2	0.2	0.3	0.7	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	0.2	0.3	0.0	0.0	0.4	0.4	0.4	0.4	0.2	0.3	0.5	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.0	0.5	0.2	3.7	0.2	0.0	0.3	0.2	0.2	0.0	0.1	0.2	0.0	0.0	1.0	0.0	0.2	0.1	0.7	0.5	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.5	0.0	0.8	1.0	0.0	0.0	0.0	0.2	1.3	0.4	0.4	0.9	0.6	0.6	0.1	0.9	3.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.1	0.7	1.9	1.4	0.7	1.3	0.6	1.3	0.9
METTL21C	"C13orf39, LOC196541"	ENSG00000139780	"Methyltransferase like 21C"	Q5VZV1	13	102685744-102694504	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"epididymis: 28.8;skeletal muscle: 8.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.0;CACO-2: 1.6;HSkMC: 3.0;NB-4: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"																		"unprognostic (2.07e-1)"					"unprognostic (1.63e-6)"		"unprognostic (2.64e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.8	0.0	0.0			0.0	0.8	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	1.0		0.8	0.0		0.0	1.8	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.1	0.5	0.0	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MIB2	"FLJ39787, skeletrophin, ZZANK1, ZZZ5"	ENSG00000197530	"Mindbomb E3 ubiquitin protein ligase 2"	Q96AX9	1	1615415-1630610	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 72.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 13.1;SCLC-21H: 14.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068322	Enhanced									"HPA068322: AB_2685973"	"unprognostic (3.93e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.01e-2)"	6.4	3.9	8.7	6.4	10.0	4.5	4.7	8.8	11.5	4.8	6.9	7.1	4.7	5.3	5.1	5.4	11.4	4.1	3.7	6.1	9.1	7.9	5.5	6.2	5.1	3.7	5.3	7.1	5.8	7.0	3.7	9.4	4.0	5.7	4.7	3.7	6.6	5.4	6.5	72.5	9.6	4.6	5.4	3.4	9.0	8.5	5.2	5.8	7.4	5.9	9.7	4.1	4.5	4.1	2.9	9.2	1.9	0.1	7.3	4.7	1.0	6.5	0.9	0.4	1.5	1.7	0.6	9.1	3.1	1.4	1.0	2.3	1.3	1.6	0.7	4.4	0.9	13.1	0.5	2.0	0.0	3.4	5.6	0.5	1.9	1.2	2.4	0.8	2.2	1.4	1.4	0.6	0.2	0.5	2.6	1.2	0.2	1.0	3.6	8.3	1.1	10.4	6.1	1.9	8.9	0.1	0.8	14.0	5.1	5.2	0.7	5.0	1.0	3.2	0.6	0.9	2.1	5.1	0.9	6.8	2.0	1.8	2.3	2.6	1.1	0.0	0.1	1.9	4.3	0.1	4.3	2.6	3.3	4.7	0.0	2.9	3.9	2.9	0.5	7.3	0.0	9.2	2.3	1.0	8.7	10.0	8.8	11.5	9.1	7.9	5.3	7.1	5.7	5.8
MYH7	"CMD1S, CMH1, MPD1"	ENSG00000092054	"Myosin heavy chain 7"	P12883	14	23412738-23435718	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 644.7;skeletal muscle: 596.4"	"Cell line enriched"	"Detected in single"	32	"HSkMC: 16.0"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 12.2;prostate cancer: 15.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA001239, HPA001349, CAB015384"	Enhanced					31000000	31000000			"CAB015384: AB_2147279, HPA001239: AB_1079438, HPA001349: AB_1079437"	"unprognostic (6.49e-2)"	"unprognostic (8.27e-5)"	"unprognostic (1.56e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.30e-1)"	"unprognostic (7.33e-3)"		"unprognostic (8.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.28e-2)"	5.4	0.1	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	11.7	7.2	0.0	0.1	644.7	0.2	0.3	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.4	0.0	0.1	0.0	0.0	3.3	0.0	0.0	11.8	0.0	596.4	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	2.9	109.6	16.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.2	0.3	0.2	0.0	0.0	0.0
MYH7B	"dJ756N5.1, KIAA1512, MHC14, MYH14"	ENSG00000078814	"Myosin heavy chain 7B"	A7E2Y1	20	34975403-35002437	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"heart muscle: 48.1;skeletal muscle: 63.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 4.4;U-138 MG: 4.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (4.05e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.02e-4)"	"unprognostic (8.31e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.66e-1)"	"prognostic favourable (8.44e-5)"	0.4	0.4	2.2	0.4	2.6	0.3	0.4	1.8	3.5	0.4	0.4	1.1	0.4	0.7	0.7	0.8	0.9	0.4	0.4	48.1	2.8	2.3	0.4	0.4	0.4	0.4	3.2	0.4	0.8	0.4	0.1	0.4	0.4	1.0	1.1	0.2	0.8	3.4	0.4	63.0	0.6	0.4	0.4	2.9	0.5	0.3	5.1	0.9	0.4	1.0	8.5	1.1	0.4	0.4	0.3	0.1	2.0	0.4	1.1	0.7	0.0	2.5	0.8	0.7	1.1	0.2	0.6	1.9	0.1	0.0	0.0	0.0	4.4	1.4	0.6	1.7	0.0	1.5	0.0	0.0	0.3	0.3	0.7	1.5	1.3	2.1	0.4	0.6	0.9	0.8	0.4	0.1	0.0	0.0	0.8	1.6	0.4	1.1	0.4	2.7	0.5	0.4	0.5	0.8	0.4	0.3	0.8	0.9	1.1	0.2	0.6	0.6	3.6	0.8	1.1	4.5	2.0	0.7	0.5	2.6	0.5	1.0	1.2	0.5	1.0	1.6	0.4	0.2	0.1	0.2	0.2	0.1	0.2	0.1	0.0	0.3	0.3	0.7	2.0	1.1	0.1	0.1	0.2	0.0	2.2	2.6	1.8	3.5	2.8	2.3	3.2	0.4	1.0	0.9
MYLK3	"caMLCK, MLCK"	ENSG00000140795	"Myosin light chain kinase 3"	Q32MK0	16	46703369-46790407	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 62.2;skeletal muscle: 20.8;tongue: 31.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 9.5;HEL: 28.5;K-562: 4.4;SK-BR-3: 6.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 6.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebral cortex: 9.8;hippocampal formation: 5.7"	"Region enriched"	"Detected in some"	5	"hippocampal formation: 5.2"	HPA073447	Enhanced		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA073447: AB_2732225"	"unprognostic (6.01e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.97e-1)"	0.0	0.1	0.7	0.0	1.7	0.1	0.0	0.1	0.2	0.2	0.0	3.8	0.0	0.0	0.1	3.4	2.0	0.8	0.1	62.2	1.5	1.4	0.4	0.0	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.5	0.2	6.6	1.0	0.0	0.0	1.3	0.0	20.8	0.0	0.0	0.0	0.3	0.0	0.0	2.9	0.3	0.0	0.1	31.1	1.1	0.1	0.0	1.2	0.9	2.6	0.7	1.2	0.7	0.2	0.0	0.1	0.1	0.1	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	1.5	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	4.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.3	0.0	6.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.3	0.0	0.1	0.0	2.5	0.7	0.6	0.6	0.4	0.4	0.7	0.5	0.5	0.3	1.2	0.7	0.7	2.6	1.2	0.5	0.9	0.3	0.2	0.7	1.7	0.1	0.2	1.5	1.4	0.1	0.4	6.6	0.3
MYOM1		ENSG00000101605	"Myomesin 1"	P52179	18	3066807-3220108	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 111.4;skeletal muscle: 153.1;tongue: 51.6"	"Group enriched"	"Detected in some"	9	"HAP1: 16.2;HMC-1: 4.4;HSkMC: 7.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA014305, HPA049193"	Enhanced					32000	32000			"HPA014305: AB_1854257, HPA049193: AB_2680670"	"unprognostic (2.51e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.19e-3)"	"unprognostic (8.01e-3)"	"unprognostic (8.94e-2)"	"unprognostic (4.31e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.62e-1)"	6.2	0.6	1.3	0.9	1.2	0.3	0.8	0.6	0.7	1.0	2.4	0.3	0.4	0.5	2.9	10.1	6.0	1.3	3.0	111.4	1.1	1.3	0.4	16.6	0.4	0.4	2.2	0.1	0.9	6.4	0.3	0.3	0.5	0.9	2.6	0.7	3.4	4.6	1.1	153.1	0.3	0.9	9.3	2.0	0.3	0.7	1.2	0.1	0.0	1.6	51.6	4.6	5.0	0.5	0.7	3.0	0.6	0.4	0.8	2.1	1.1	0.0	0.1	0.3	0.0	0.8	1.0	0.3	0.5	0.6	0.0	0.0	0.1	0.1	0.5	0.1	0.2	0.0	16.2	0.1	0.2	0.5	0.1	0.1	0.1	0.1	0.1	0.0	4.4	7.9	0.4	0.3	0.1	0.1	0.0	0.5	0.3	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.1	0.0	0.1	0.3	0.0	0.7	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.7	0.0	0.4	0.6	0.9	0.4	0.5	0.7	0.6	0.5	0.5	0.6	1.0	2.1	0.5	0.8	0.0	3.0	0.2	1.1	1.3	1.2	0.6	0.7	1.1	1.3	2.2	0.1	0.9	0.1
NOS1	"nNOS, NOS"	ENSG00000089250	"Nitric oxide synthase 1"	P29475	12	117208142-117452170	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 13.4;skeletal muscle: 36.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 6.2;RH-30: 12.8;RPTEC TERT1: 8.0;U-2 OS: 2.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002167, HPA058312, HPA069509"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB002167: AB_564073, HPA058312: AB_2683676, HPA069509: "	"unprognostic (1.63e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.64e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.97e-4)"	"unprognostic (1.87e-1)"	0.5	0.6	3.8	3.5	13.4	0.7	0.6	4.4	4.8	0.7	2.0	1.1	0.0	0.5	0.6	0.7	1.3	0.8	0.5	0.5	2.8	4.4	1.9	0.5	1.4	0.6	2.4	1.6	0.5	1.9	0.4	0.8	0.4	5.9	1.6	0.9	0.6	3.8	0.6	36.3	2.2	0.6	0.8	1.2	0.5	0.5	0.9	3.0	0.0	0.6	0.0	0.5	0.9	0.6	0.9	0.6	2.1	0.5	0.8	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	6.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	1.4	0.0	12.8	0.1	8.0	0.0	0.3	1.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	2.5	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	2.1	0.5	0.5	0.5	0.4	0.4	0.7	0.4	0.3	0.2	0.9	0.5	0.5	1.9	0.8	0.5	0.6	0.3	0.0	3.8	13.4	4.4	4.8	2.8	4.4	2.4	1.6	5.9	3.0
PHKG1	PHKG	ENSG00000164776	"Phosphorylase kinase catalytic subunit gamma 1"	Q16816	7	56080283-56092996	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 105.6;tongue: 32.9"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in many"	18	"glioma: 23.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012057	Enhanced									"HPA012057: AB_1855305"	"unprognostic (2.00e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.09e-3)"	"unprognostic (5.87e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.69e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.14e-4)"	"unprognostic (1.92e-1)"	"unprognostic (7.97e-9)"	"unprognostic (6.61e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.85e-2)"	2.0	1.5	4.9	0.8	6.1	1.1	1.5	6.0	5.8	0.7	2.6	6.5	0.0	1.0	0.9	1.5	3.2	0.9	1.1	11.8	4.1	2.9	0.6	0.7	0.9	0.8	3.5	3.9	1.0	0.8	1.2	0.6	0.6	6.8	1.4	0.8	0.0	1.6	0.8	105.6	1.6	0.9	1.1	3.6	0.8	0.8	0.7	4.8	0.0	0.6	32.9	1.2	1.8	0.3	1.3	0.6	3.3	0.7	0.3	1.9	0.2	2.9	2.1	0.5	1.7	3.1	5.3	1.4	0.3	0.6	1.0	0.8	0.7	1.3	0.8	0.5	1.0	1.5	1.2	0.2	0.8	0.8	2.1	0.8	2.9	0.7	0.8	1.5	3.2	3.3	2.2	1.6	0.7	0.3	2.2	3.9	0.1	1.3	2.2	5.5	1.0	1.3	1.2	0.3	1.0	0.6	1.9	1.5	1.6	0.3	2.1	0.1	1.1	1.9	0.8	0.5	1.7	4.4	1.1	1.8	0.7	2.2	1.2	1.4	1.0	0.4	0.5	0.0	0.8	0.2	1.9	0.3	1.2	0.3	0.2	1.3	0.6	0.6	3.3	0.3	0.7	0.6	0.5	0.2	4.9	6.1	6.0	5.8	4.1	2.9	3.5	3.9	6.8	4.8
PKIA	PRKACN1	ENSG00000171033	"CAMP-dependent protein kinase inhibitor alpha"	P61925	8	78516139-78605267	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 258.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.3;HUVEC TERT2: 37.5;RT4: 35.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 16.5"	"Lineage enriched"	"Detected in many"	9	"T-cells: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042791	Uncertain									"HPA042791: AB_10795761"	"unprognostic (3.83e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.59e-6)"	"unprognostic (8.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.65e-3)"	"unprognostic (3.25e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.93e-1)"	"prognostic unfavourable (5.41e-4)"	"unprognostic (3.14e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.52e-3)"	1.6	3.5	17.8	2.4	28.9	1.7	2.1	17.2	18.2	1.6	1.7	4.6	0.0	1.4	1.8	3.1	6.4	2.5	3.1	46.4	13.7	14.9	2.3	1.1	3.2	2.8	8.9	15.8	2.6	1.4	21.2	3.7	1.5	6.7	6.1	1.8	0.7	2.2	2.5	258.0	3.3	1.5	1.7	6.0	2.0	1.5	1.3	6.7	6.2	9.7	46.1	3.7	3.5	1.2	1.9	0.1	0.3	0.1	1.3	16.5	2.1	0.2	0.1	12.5	0.0	6.9	1.8	0.0	11.5	2.2	1.2	2.6	0.0	1.9	5.2	0.0	1.7	0.1	4.0	3.6	8.2	22.3	8.9	6.4	1.4	0.0	0.4	0.0	3.8	2.8	0.5	0.0	3.5	37.5	0.0	5.7	18.6	1.9	9.7	0.0	2.9	12.8	0.0	10.7	0.0	6.8	35.7	6.1	11.9	1.5	9.6	0.0	0.0	0.0	14.7	2.9	2.4	0.6	6.8	2.3	2.3	1.7	13.6	0.0	3.5	0.0	0.0	0.0	0.4	0.0	0.3	1.9	7.7	1.5	0.0	1.8	6.8	3.9	0.3	1.3	0.1	0.1	16.5	2.1	17.8	28.9	17.2	15.5	13.7	14.9	8.9	15.8	6.7	6.7
PLIN4	"KIAA1881, S3-12"	ENSG00000167676	"Perilipin 4"	Q96Q06	19	4502180-4518465	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 155.0;breast: 80.6;skeletal muscle: 45.2"	"Cell line enriched"	"Detected in some"	9	"ASC diff: 75.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA044682, HPA054657"	Enhanced		Supported	"Vesicles,Lipid droplets,Plasma membrane,Cytosol"		11000	11000	"Lipid droplets, Plasma membrane"	"Lipid droplets, Plasma membrane"	"HPA044682: AB_2679044, HPA054657: AB_2682559"	"unprognostic (2.97e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavourable (8.31e-4)"	"prognostic unfavourable (2.31e-4)"	"unprognostic (6.65e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.94e-3)"	155.0	1.2	0.9	7.4	0.8	0.8	80.6	0.5	0.9	2.4	8.5	0.6	2.4	0.8	3.7	2.2	3.8	2.5	8.3	15.5	0.6	0.1	0.6	11.1	0.4	2.0	0.8	0.8	2.9	3.3	0.3	0.2	0.3	0.9	2.8	1.2	0.7	6.8	3.9	45.2	1.8	2.4	10.3	1.3	0.4	3.5	0.7	0.8	0.1	0.7	8.2	0.7	5.9	3.9	0.0	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	75.1	0.5	2.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.4	1.1	0.0	0.0	2.4	1.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.1	0.0	0.9	0.8	0.5	0.9	0.6	0.1	0.8	0.8	0.9	0.8
PROB1	C5orf65	ENSG00000228672	"Proline rich basic protein 1"	E7EW31	5	139390592-139395713	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 37.7"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 47.0"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.1;T-reg: 1.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060103	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA060103: AB_2684205"	"unprognostic (4.14e-2)"	"prognostic favourable (9.26e-4)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.53e-2)"	"unprognostic (9.27e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"unprognostic (3.21e-2)"	"unprognostic (4.84e-4)"	"unprognostic (7.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.89e-2)"	"unprognostic (8.24e-2)"	0.6	1.6	0.7	0.3	0.8	0.0	0.3	0.0	0.3	0.3	0.3			0.6	0.5	0.1	0.3	0.7	0.1	6.6	0.7	0.6	0.7	0.0	0.0	0.4	0.5		0.0	0.0	1.8	0.8	0.2		1.3	0.0		0.7	0.6	37.7	0.0	0.8	0.1	0.2	0.3	0.6	0.0			0.1		0.1	0.3	0.1	0.5	1.1	0.0	0.1	0.0	1.1	0.0	0.6	0.4	0.1	0.1	0.0	0.2	0.2	0.5	0.1	0.5	0.5	1.9	1.2	2.9	0.5	1.5	0.3	0.2	0.0	0.1	47.0	0.6	0.7	1.1	0.2	1.3	0.0	1.6	0.4	0.4	1.1	0.3	0.0	0.2	3.0	1.6	0.5	2.4	1.2	0.6	1.2	7.5	0.2	5.6	0.1	0.0	0.6	0.3	2.8	2.9	0.1	1.1	1.6	0.2	0.0	0.1	0.1	0.2	0.4	0.8	4.2	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.1	1.1	1.1	0.0										
RAD23A	"HHR23A, MGC111083"	ENSG00000179262	"RAD23 homolog A, nucleotide excision repair protein"	P54725	19	12945855-12953642	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 225.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026418, HPA053901, HPA057003, HPA065599"	Approved		Enhanced	Nucleoplasm,Cytosol		3100000	3100000	Nucleoplasm	Nucleoplasm	"HPA026418: AB_2732430, HPA053901: AB_2682300, HPA057003: AB_2683309, HPA065599: "	"unprognostic (2.09e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.23e-3)"	"unprognostic (7.90e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.57e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.32e-3)"	"unprognostic (9.99e-2)"	"unprognostic (8.56e-2)"	"unprognostic (6.59e-3)"	19.6	15.2	19.1	13.4	17.7	19.9	16.0	15.1	25.3	12.9	18.0	14.6	10.7	13.6	15.3	14.3	19.9	17.7	13.6	34.3	16.6	16.0	13.2	24.5	14.2	14.1	15.4	15.6	17.1	21.1	14.0	12.3	17.3	15.5	15.1	10.7	12.6	18.6	15.8	225.3	19.8	11.9	16.5	15.4	15.7	14.9	19.1	12.5	14.6	17.2	37.7	13.8	20.7	17.0	29.5	30.0	22.7	35.6	26.5	32.1	22.5	31.4	11.6	13.5	13.9	22.5	25.8	22.6	15.4	31.0	36.6	33.3	13.0	22.7	26.8	35.5	23.1	24.4	18.4	32.0	13.9	37.8	23.4	10.8	15.0	12.5	43.8	23.3	31.7	26.3	48.0	26.4	50.6	25.1	27.7	24.7	32.9	30.7	29.0	28.9	18.5	28.8	15.3	14.0	43.5	28.5	12.6	25.0	19.7	17.0	31.1	34.0	24.2	40.5	19.7	52.7	14.0	62.5	47.0	35.8	29.9	19.5	43.4	44.1	43.2	10.4	27.9	22.7	29.7	35.6	32.1	29.2	25.3	25.1	23.4	29.5	24.6	27.8	3.9	26.5	34.9	30.0	27.0	22.5	19.1	17.7	15.1	25.3	16.6	16.0	15.4	15.6	15.5	12.5
SCHIP1	SCHIP-1	ENSG00000151967	"Schwannomin interacting protein 1"	P0DPB3	3	159839861-159897360	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"brain: 55.0;heart muscle: 65.9;skeletal muscle: 54.5"	"Cell line enhanced"	"Detected in some"		"AF22: 9.3;AN3-CA: 16.9;HUVEC TERT2: 20.0;NTERA-2: 10.3;SH-SY5Y: 58.2"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 9.7"	"Group enriched"	"Detected in many"	58	"dendritic cells: 9.7;granulocytes: 3.1"									"HPA003243, HPA069824"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cell Junctions, Cytosol"	"Plasma membrane, Cell Junctions, Cytosol"	"HPA003243: AB_1079877, HPA069824: AB_2732142"	"unprognostic (1.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.36e-5)"	"prognostic favourable (2.80e-4)"	"unprognostic (6.25e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.45e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.66e-4)"	"unprognostic (2.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.96e-1)"	6.1	3.9	30.1	1.5	22.0	2.0	1.9	23.9	55.0	3.7	3.6	21.1	0.0	2.2	4.7	2.0	4.2	3.4	3.0	65.9	29.6	17.9	3.5	1.9	3.1	1.7	22.8	24.1	1.8	1.6	1.4	6.0	10.3	15.6	6.2	2.3	0.7	2.9	2.6	54.5	1.4	1.9	5.9	28.9	5.1	2.0	2.7	24.3	0.0	2.0	7.6	1.6	1.9	0.6	0.0	9.7	3.1	0.0	0.1	0.0	0.1	0.0	0.0	9.3	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.3	0.1	3.9	20.0	0.0	0.0	1.2	0.0	0.0	0.0	10.3	0.0	0.0	1.9	0.0	0.4	0.0	0.0	58.2	0.0	0.0	0.0	0.0	1.0	3.7	0.2	0.5	0.1	0.8	0.7	0.0	0.0	0.2	0.7	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	9.7	0.0	0.1	30.1	22.0	23.9	28.9	29.6	17.9	22.8	24.1	15.6	24.3
SCN2B		ENSG00000149575	"Sodium voltage-gated channel beta subunit 2"	O60939	11	118161951-118176673	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 37.0;heart muscle: 17.5;skeletal muscle: 9.7"	"Group enriched"	"Detected in some"	6	"HBEC3-KT: 1.5;U-2 OS: 2.5;U-2197: 5.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (9.01e-2)"	"unprognostic (3.50e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.71e-4)"	"unprognostic (5.17e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.35e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.88e-3)"	1.8	3.0	14.7	1.4	31.5	1.0	1.9	31.1	37.0	2.9	2.0	3.1	0.0	1.7	3.2	2.9	3.6	2.9	2.7	17.5	22.5	11.6	1.6	1.0	2.5	1.0	8.7	30.6	2.8	1.1	1.0	0.8	1.0	12.8	2.4	1.9	0.4	1.8	2.7	9.7	1.4	2.5	3.5	13.9	1.1	1.3	1.3	6.9	0.0	1.9	0.7	1.0	1.5	0.6	0.3	0.2	2.1	0.3	0.2	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.1	2.5	5.9	0.0	0.0	0.0	0.1	0.1	0.1	0.1	2.1	0.3	0.9	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.2	0.2	1.3	0.2	0.0	0.2	0.1	0.0	14.7	31.5	31.1	37.0	22.5	11.6	8.7	30.6	12.8	6.9
SLN	"MGC12301, MGC125854, MGC125855"	ENSG00000170290	Sarcolipin	O00631	11	107707378-107719693	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 446.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;HSkMC: 6.5;Karpas-707: 3.1;PC-3: 2.9;SCLC-21H: 2.0;U-2 OS: 3.0"	"Group enriched"	"Detected in many"	13	"glioma: 21.6;head and neck cancer: 22.4;prostate cancer: 4.5"	"Region enhanced"	"Detected in some"		"basal ganglia: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"basal ganglia: 19.0"	"Low region specificity"	"Detected in many"			CAB011628			Approved	Microtubules				Microtubules	Microtubules	"CAB011628: AB_2195046"	"unprognostic (6.85e-2)"	"unprognostic (6.18e-8)"	"unprognostic (2.60e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.40e-3)"	"unprognostic (4.12e-3)"		"unprognostic (5.28e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavourable (3.52e-9)"	"unprognostic (3.27e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.09e-4)"	"unprognostic (3.77e-2)"	4.8	0.5	0.2	0.0	1.9	0.0	0.1	0.4	1.0	0.0	0.2	0.0	0.0	0.0	0.0	5.3	9.1	0.1	0.0	72.9	0.2	0.0	0.1	0.0	0.2	0.2	0.0	0.0	1.1	0.1	0.0	0.0	0.1	0.1	2.3	0.0	0.4	4.3	0.0	446.6	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	1.9	40.1	6.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.4	0.5	0.2	0.0	0.2	0.6	0.1	0.2	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.4	0.3	6.5	0.0	0.8	0.0	0.0	0.1	3.1	0.0	0.4	0.3	0.4	0.1	2.9	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.2	1.2	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	1.9	0.4	1.0	0.2	0.0	0.0	0.0	0.1	0.0
TMEM182	FLJ30294	ENSG00000170417	"Transmembrane protein 182"	Q6ZP80	2	102736905-103019900	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 40.3;skeletal muscle: 53.9;tongue: 37.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA045861			Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA045861: AB_2679475"	"unprognostic (1.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.12e-4)"	"unprognostic (5.35e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.42e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.36e-2)"	2.4	1.1	1.2	1.0	1.3	0.3	1.1	1.7	1.8	1.4	1.0	0.5	1.5	1.0	0.6	2.3	1.8	1.1	0.8	40.3	1.2	1.9	1.4	1.7	0.6	0.8	1.2	0.5	1.0	1.1	1.5	6.8	0.8	2.8	1.9	1.0	0.9	3.8	1.2	53.9	0.5	0.9	1.1	1.2	0.8	1.0	0.8	0.4	1.8	2.0	37.8	4.0	1.2	0.7	4.4	3.1	0.3	0.3	2.4	4.1	1.1	4.8	2.8	2.1	6.5	2.7	2.6	7.6	2.6	2.3	2.7	3.8	9.0	6.8	4.0	9.1	0.9	2.8	2.3	3.7	5.6	9.0	1.8	6.0	1.3	5.7	3.1	5.4	4.8	3.3	6.7	4.2	3.8	0.3	4.2	1.6	2.7	3.5	2.9	5.2	3.6	2.9	3.1	5.5	3.8	3.7	4.2	5.4	1.9	3.5	3.9	8.5	3.2	2.9	0.2	4.3	3.1	3.3	3.3	3.9	9.9	3.3	4.4	9.0	6.4	0.0	0.0	0.3	3.9	0.3	3.2	4.4	2.8	2.2	1.3	1.9	3.8	4.1	0.1	2.4	0.3	3.1	0.8	1.1	1.2	1.3	1.7	1.8	1.2	1.9	1.2	0.5	2.8	0.4
WDR62	"C19orf14, DKFZP434J046, FLJ33298, MCPH2"	ENSG00000075702	"WD repeat domain 62"	O43379	19	36054881-36105106	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 25.6;testis: 88.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 3.7"	"Lineage enriched"	"Detected in single"	9	"monocytes: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043255, HPA043639"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"				Cytosol	Cytosol	"HPA043255: AB_2678393, HPA043639: AB_2678593"	"unprognostic (1.77e-1)"	"unprognostic (2.79e-3)"	"unprognostic (3.16e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.78e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.82e-3)"	"unprognostic (4.72e-2)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.73e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.67e-1)"	0.5	0.2	0.2	3.3	0.4	4.3	0.6	0.4	0.5	0.4	0.5	0.4	0.4	0.4	0.4	0.8	1.0	0.2	0.5	5.5	0.5	0.2	0.5	0.3	0.5	1.4	0.2	0.2	0.4	0.2	0.0	0.3	0.7	0.4	0.3	0.3	0.3	0.6	0.2	25.6	1.4	0.7	0.4	0.5	1.1	0.3	88.4	0.3	10.3	0.2	1.3	3.0	0.3	0.7	0.1	0.1	0.0	3.7	0.0	0.3	0.2	10.7	21.5	8.4	7.7	0.5	0.7	4.2	9.3	4.4	13.0	11.7	11.2	4.2	14.0	6.4	4.9	3.7	7.8	3.0	7.7	8.8	5.5	9.5	12.2	7.2	0.1	10.3	14.3	0.2	0.2	9.8	3.9	3.2	12.2	19.2	6.5	13.4	18.0	6.2	4.6	4.5	15.1	7.8	5.6	1.9	4.9	9.4	4.8	7.6	8.7	1.5	5.9	7.5	2.6	13.0	12.8	9.8	15.4	9.3	11.6	16.6	5.2	9.9	14.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.3	0.2	0.2	0.4	0.4	0.5	0.5	0.2	0.2	0.2	0.4	0.3
XIRP2	CMYA3	ENSG00000163092	"Xin actin binding repeat containing 2"	A4UGR9	2	166888487-167259753	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 292.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.2;HEL: 1.5;HUVEC TERT2: 8.5;U-2197: 6.0"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA034813, HPA074599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA034813: AB_10602588, HPA074599: "					"unprognostic (5.27e-4)"	"unprognostic (5.96e-3)"		"unprognostic (7.42e-2)"	"unprognostic (2.42e-1)"					"unprognostic (1.74e-1)"	"unprognostic (2.56e-1)"			7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.3	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	4.3	0.0	292.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	2.3	51.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.2	0.2	0.0	0.0	0.9	0.0	0.2	0.7	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACACB	"ACC2, ACCB, HACC275"	ENSG00000076555	"Acetyl-CoA carboxylase beta"	O00763	12	109116595-109268226	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"adipose tissue: 104.5;breast: 67.4;liver: 42.0;skeletal muscle: 154.2"	"Cell line enriched"	"Detected in many"	18	"ASC diff: 71.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 15.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006554	Enhanced				"Intracellular and membrane"					"HPA006554: AB_1844495"	"unprognostic (2.24e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.97e-2)"	"unprognostic (4.54e-6)"	"unprognostic (2.82e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.62e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.63e-2)"	"prognostic favourable (1.93e-4)"	"unprognostic (6.63e-2)"	"prognostic favourable (1.15e-5)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.58e-2)"	104.5	8.2	4.3	10.6	4.0	1.6	67.4	3.3	3.5	3.5	19.3	3.2	6.2	3.8	4.6	4.3	4.9	3.9	10.5	12.1	4.5	2.0	5.4	42.0	3.1	4.0	6.4	2.7	6.8	8.5	8.9	7.1	1.3	3.7	3.6	3.9	4.0	5.8	9.0	154.2	2.8	4.8	7.5	6.5	2.5	5.6	1.6	4.9	0.4	6.2	12.5	1.7	7.3	6.3	2.5	0.2	15.5	0.4	0.1	1.7	0.1	0.2	1.7	1.1	2.1	71.5	0.5	0.8	0.2	0.4	0.3	0.2	1.2	0.3	0.8	0.5	0.3	1.4	0.9	0.4	0.2	1.1	1.6	2.0	1.8	1.2	0.3	1.7	0.5	0.8	0.4	0.7	0.1	0.1	0.2	0.1	0.2	0.5	1.2	1.6	1.2	3.8	0.6	1.5	0.4	0.5	0.6	0.7	1.7	1.8	0.8	1.1	0.8	1.7	0.1	0.7	0.4	0.8	0.6	2.7	1.5	1.2	1.7	1.3	0.5	4.1	0.4	15.5	1.1	0.1	0.6	1.7	1.0	0.3	0.2	2.5	1.7	0.9	0.6	0.1	0.2	0.2	0.6	0.1	4.3	4.0	3.3	3.5	4.5	2.0	6.4	2.7	3.7	4.9
ADSSL1	FLJ38602	ENSG00000185100	"Adenylosuccinate synthase like 1"	Q8N142	14	104724186-104747325	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 200.5;tongue: 53.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 12.7;MCF7: 11.3;SiHa: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									220000	220000				"unprognostic (2.23e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.72e-3)"	"unprognostic (5.14e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.35e-1)"	"prognostic unfavourable (4.99e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.78e-2)"	2.5	1.1	0.8	0.5	1.8	0.4	0.9	0.3	1.2	0.8	0.7	3.4	0.3	0.8	0.9	3.5	3.9	1.5	2.2	27.8	1.2	1.5	2.9	7.2	0.7	0.5	3.3	0.4	0.8	1.7	1.9	2.2	1.6	2.0	1.9	0.6	4.6	3.2	1.1	200.5	1.3	0.8	1.0	2.1	0.5	1.2	3.4	2.0	0.0	1.7	53.2	2.8	6.1	3.8	0.0	0.4	1.2	2.1	0.0	0.5	0.0	0.1	2.6	2.0	5.8	1.4	0.9	0.6	0.7	1.1	0.2	0.6	0.2	2.0	0.0	12.7	0.6	1.0	0.2	0.4	0.5	0.8	0.4	0.0	6.2	0.9	1.5	0.0	5.0	2.8	1.9	0.0	2.1	0.4	2.3	0.1	1.0	11.3	0.0	0.6	1.7	1.1	0.1	0.3	0.7	0.4	1.4	1.7	3.5	19.0	0.8	2.5	5.9	1.6	0.6	0.1	0.5	1.3	0.0	3.7	2.7	0.0	1.8	0.8	1.2	0.0	0.1	1.2	0.5	2.1	0.0	0.0	0.1	0.4	0.4	0.0	0.4	0.5	0.8	0.0	0.1	0.0	0.0	0.0	0.8	1.8	0.3	1.2	1.2	1.5	3.3	0.4	2.0	2.0
AGL		ENSG00000162688	"Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase"	P35573	1	99850084-99924023	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 23.1;skeletal muscle: 85.6;tongue: 34.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028498, HPA054340"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		16000	16000	Nucleoplasm	Nucleoplasm	"HPA028498: AB_10600975, HPA054340: AB_2682455"	"unprognostic (2.90e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.18e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.10e-3)"	"unprognostic (7.61e-2)"	"prognostic favourable (1.73e-10)"	"unprognostic (6.38e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.13e-2)"	5.0	4.5	2.5	4.7	3.6	2.0	4.2	5.4	6.1	3.4	4.5	2.1	5.4	3.3	4.8	4.2	9.1	4.1	2.6	8.2	2.2	2.3	5.8	23.1	4.2	5.3	2.4	4.2	3.8	3.6	8.7	4.7	4.8	2.9	5.5	4.2	3.9	5.1	8.7	85.6	3.7	4.0	5.4	2.8	4.8	4.4	2.9	1.2	7.1	4.3	34.4	3.4	6.7	3.6	3.0	2.3	3.5	1.6	6.1	4.3	2.1	11.8	3.5	4.2	6.9	7.0	6.6	14.2	3.8	5.6	3.3	5.9	13.3	4.0	15.6	7.3	6.4	6.7	24.6	7.4	6.3	8.3	7.8	9.1	12.2	7.4	4.6	8.0	5.5	8.1	4.8	4.6	3.9	5.2	14.9	1.1	3.4	3.7	9.4	2.5	6.7	4.6	0.0	1.4	0.8	10.1	16.1	10.5	7.3	10.9	10.5	5.8	7.5	5.4	5.3	4.0	5.8	5.4	3.7	4.5	3.5	18.1	7.1	2.1	2.1	0.1	1.3	3.5	4.3	1.6	4.1	3.0	3.2	2.9	2.3	2.9	3.2	3.2	1.5	6.1	0.9	2.1	3.3	2.1	2.5	3.6	5.4	6.1	2.2	2.3	2.4	4.2	2.9	1.2
ANKS1B	"AIDA-1, ANKS2, cajalin-2, EB-1"	ENSG00000185046	"Ankyrin repeat and sterile alpha motif domain containing 1B"	Q7Z6G8	12	98726457-99984654	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 66.2;skeletal muscle: 28.2"	"Cell line enhanced"	"Detected in some"		"AF22: 11.8;ASC TERT1: 7.0;SCLC-21H: 12.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA044628, HPA078230"	Enhanced		Supported	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA044628: , HPA078230: "	"unprognostic (5.50e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.87e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.14e-4)"	"unprognostic (7.94e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.97e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.75e-3)"	2.3	4.5	21.4	1.7	41.2	1.2	3.7	21.0	66.2	3.3	2.3	27.5	0.0	1.5	3.3	2.4	3.9	4.4	2.2	2.2	28.3	17.3	5.4	1.8	2.0	1.6	20.3	24.8	9.7	2.1	1.9	4.4	2.7	16.0	4.1	2.1	0.1	3.8	3.7	28.2	1.9	1.6	3.3	25.8	2.0	1.8	7.6	23.0	0.0	6.3	0.0	1.3	2.1	0.8	2.1	2.4	5.3	3.1	3.1	8.3	1.3	0.3	2.5	11.8	2.8	4.8	7.0	0.7	0.0	1.2	0.9	0.9	0.2	0.9	1.0	0.5	1.7	0.5	0.1	0.1	0.2	1.4	0.8	0.1	0.8	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.3	0.3	0.9	0.2	0.7	0.5	0.5	3.4	2.2	0.8	0.0	0.3	0.1	0.0	12.9	1.4	1.1	3.8	1.5	4.4	0.1	0.1	1.0	1.1	0.7	0.7	0.1	0.7	0.6	1.1	0.3	1.1	5.3	1.4	2.1	1.7	2.1	2.5	1.9	2.9	1.6	1.3	2.1	2.4	2.3	3.9	3.1	3.1	2.4	8.3	1.3	21.4	41.2	21.0	27.9	28.3	17.3	20.3	24.8	16.0	23.0
ASB12	FLJ39577	ENSG00000198881	"Ankyrin repeat and SOCS box containing 12"	Q8WXK4	X	64224196-64230631	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"skeletal muscle: 43.4;tongue: 11.5"	"Cell line enhanced"	"Detected in some"		"AF22: 3.8;HEK 293: 2.1;HL-60: 2.1;HMC-1: 2.7;NB-4: 2.2;NTERA-2: 2.3;REH: 2.1;THP-1: 3.5"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 4.0;naive B-cell: 1.1;T-reg: 1.0"	"Group enriched"	"Detected in many"	6	"B-cells: 1.1;granulocytes: 4.0;T-cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA049542	Uncertain									"HPA049542: AB_2680810"	"unprognostic (6.52e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.76e-2)"	"unprognostic (4.23e-2)"	"unprognostic (6.50e-2)"	"unprognostic (8.25e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.69e-3)"	"unprognostic (6.75e-3)"	"unprognostic (5.18e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.32e-2)"	"unprognostic (4.63e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.0	1.0	0.7	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.2	43.4	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.6	11.5	0.7	0.0	0.0	1.1	0.0	4.0	0.3	0.1	1.0	0.3	0.0	0.2	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.5	0.6	0.0	0.0	0.9	0.0	0.4	0.0	2.1	1.8	0.0	0.0	0.0	2.1	2.7	0.0	0.5	0.0	0.0	0.0	0.3	1.1	0.0	0.1	0.5	2.2	2.3	0.4	2.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.6	0.0	0.0	0.0	4.0	0.0	0.0	0.3	0.3	0.4	0.0	0.4	0.2	0.0	1.1	0.3	0.2	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATP2A2	"ATP2B, DAR, SERCA2"	ENSG00000174437	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2"	P16615	12	110280756-110351093	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 188.3;skeletal muscle: 319.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062605	Enhanced					38000000	38000000			"HPA062605: AB_2684805"	"unprognostic (4.81e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.50e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.91e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.26e-1)"	"unprognostic (5.62e-2)"	"unprognostic (9.93e-2)"	8.4	8.8	7.3	8.5	14.5	5.7	7.5	7.4	20.8	8.2	9.6	8.0	8.3	7.3	9.4	10.3	24.1	9.4	9.3	188.3	10.1	5.0	6.7	11.8	8.9	5.6	5.6	13.1	8.5	7.6	8.7	6.1	8.1	10.2	13.0	11.2	22.3	18.3	9.6	319.7	9.3	9.3	14.3	7.4	5.4	7.9	11.9	7.1	3.1	12.6	51.3	12.7	13.4	11.4	0.8	2.2	0.2	4.4	1.7	1.7	0.7	34.9	69.8	35.4	28.4	23.5	30.2	51.0	43.7	55.0	44.3	29.9	50.5	37.3	43.2	37.0	41.5	51.2	58.5	69.0	50.4	35.7	29.3	37.7	28.0	29.5	40.0	43.0	36.5	31.7	48.6	56.3	54.6	34.2	43.9	21.2	36.0	33.6	23.2	26.7	40.3	35.3	24.6	31.8	35.7	21.8	72.3	37.4	28.1	54.9	45.2	25.5	60.7	23.2	36.7	41.1	22.1	27.3	33.3	43.6	53.0	48.5	37.4	18.6	46.5	0.0	1.9	0.0	1.7	4.4	0.9	0.7	1.3	1.1	1.9	0.8	1.3	1.2	0.2	1.7	2.3	2.2	1.2	0.7	7.3	14.5	7.4	20.8	10.1	5.0	5.6	13.1	10.2	7.1
C10orf71	FLJ45913	ENSG00000177354	"Chromosome 10 open reading frame 71"	Q711Q0	10	49299193-49327487	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skeletal muscle: 104.2;tongue: 35.0"	"Group enriched"	"Detected in some"	21	"K-562: 8.9;RH-30: 13.6"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057556			Approved	Nucleoplasm,Mitochondria				Nucleoplasm	Nucleoplasm	"HPA057556: AB_2683467"				"unprognostic (1.25e-2)"		"unprognostic (3.97e-2)"		"unprognostic (4.16e-2)"		"unprognostic (5.58e-2)"		"unprognostic (1.66e-1)"		"unprognostic (1.17e-1)"	"unprognostic (1.81e-1)"			2.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	2.0	1.7	0.1	0.0	13.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	3.3	15.3	0.1	0.0	0.0	0.3	0.0	0.0	1.1	0.0	104.2	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.5	35.0	3.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
CACNG1	CACNLG	ENSG00000108878	"Calcium voltage-gated channel auxiliary subunit gamma 1"	Q06432	17	67044590-67056797	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 126.7"	"Group enriched"	"Detected in some"	5	"HSkMC: 8.1;SH-SY5Y: 2.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"basal ganglia: 3.0"	"Not detected"	"Not detected"														"unprognostic (1.76e-1)"	"unprognostic (9.83e-3)"		"unprognostic (1.75e-5)"	"unprognostic (2.60e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-2)"		"unprognostic (4.84e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-2)"		"unprognostic (1.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.94e-1)"	5.7	0.4	0.3	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	1.6	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	126.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.7	25.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0
CACNG6		ENSG00000130433	"Calcium voltage-gated channel auxiliary subunit gamma 6"	Q9BXT2	19	53992288-54012669	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"blood: 11.4;skeletal muscle: 45.4"	"Cell line enhanced"	"Detected in some"		"A549: 12.4;EFO-21: 21.8;HHSteC: 5.7"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	96	"basophil: 11.4;eosinophil: 7.8"	"Lineage enriched"	"Detected in single"	114	"granulocytes: 11.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056615			Approved	"Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA056615: AB_2683192"	"unprognostic (1.83e-1)"	"unprognostic (9.51e-2)"		"unprognostic (7.07e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.89e-2)"		"unprognostic (2.27e-1)"		"unprognostic (7.69e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.07e-8)"	"unprognostic (9.79e-2)"	"unprognostic (1.28e-1)"			0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0			0.0	0.0	0.0	0.1	5.9	0.0	0.0	0.2	0.2	0.0	0.0	1.1	0.0	0.0		0.0	0.0	0.0	0.9	0.0		0.1	0.0		0.4	0.0	45.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0			0.0		0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	12.4	0.3	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	1.0	0.0	21.8	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	5.7	0.0	0.1	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.5	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	2.5	0.0	0.0	0.0	3.0	0.1	0.2	0.0	0.0	11.4	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CAP2		ENSG00000112186	"Cyclase associated actin cytoskeleton regulatory protein 2"	P40123	6	17393216-17557792	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 165.7"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"MAIT T-cell: 2.9"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050530, HPA054147"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA050530: AB_2681159, HPA054147: AB_2682400"	"unprognostic (7.27e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.58e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.75e-3)"	5.8	4.1	13.8	3.0	20.1	0.7	3.9	7.5	26.4	5.6	7.7	1.9	2.0	1.9	9.2	5.9	7.0	5.8	3.8	31.2	19.9	8.7	3.3	2.0	2.1	1.1	5.3	17.3	2.1	1.6	3.2	1.7	6.2	8.6	8.4	3.6	2.9	2.5	10.1	165.7	0.9	2.6	13.1	2.0	1.6	3.3	1.1	1.3	0.0	2.3	14.5	1.3	4.6	6.4	0.0	0.0	0.0	0.0	0.0	2.9	0.1	5.4	8.4	16.3	19.6	0.1	0.0	3.5	19.3	14.1	15.9	14.5	2.8	2.4	0.0	18.2	20.7	2.8	7.2	7.2	23.0	0.0	2.7	0.0	5.4	9.2	1.5	0.0	0.0	1.2	3.5	8.0	3.5	0.7	0.0	0.0	33.5	8.7	0.0	0.0	6.2	4.8	1.8	21.7	0.3	8.3	2.2	2.1	4.1	6.5	21.0	11.4	23.2	3.9	0.0	12.9	12.3	0.3	16.9	0.0	0.0	0.0	4.2	0.0	17.5	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.8	20.1	7.5	26.4	19.9	8.7	5.3	17.3	8.6	1.3
CKM	CKMM	ENSG00000104879	"Creatine kinase, M-type"	P06732	19	45306414-45322977	"Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skeletal muscle: 1374.7;tongue: 354.9"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 36.8"	"Group enriched"	"Detected in many"	33	"head and neck cancer: 64.4;prostate cancer: 14.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"classical monocyte: 2.8;intermediate monocyte: 1.1;myeloid DC: 2.1"	"Group enriched"	"Detected in many"	25	"dendritic cells: 2.1;monocytes: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047859	Enhanced					190000000	190000000			"HPA047859: AB_2680186"	"unprognostic (3.51e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.14e-1)"	"unprognostic (7.68e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.85e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.00e-1)"	"unprognostic (9.46e-3)"	"unprognostic (9.67e-8)"	"unprognostic (3.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.95e-1)"	13.9	0.1	0.2	0.1	0.2	0.1	0.4	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.1	23.5	21.1	0.1	0.1	187.9	0.2	0.1	0.2	0.2	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.0	2.8	0.1	0.8	17.6	0.2	1374.7	0.2	0.2	0.2	0.3	0.1	0.5	0.3	0.0	0.0	11.1	354.9	24.8	0.2	0.1	0.0	2.1	0.0	2.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	2.9	0.0	0.1	8.7	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	3.3	0.1	0.1	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.0
CMBL	FLJ23617	ENSG00000164237	"Carboxymethylenebutenolidase homolog"	Q96DG6	5	10275875-10308026	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"gallbladder: 21.6;intestine: 71.4;kidney: 81.7;liver: 83.7;skeletal muscle: 70.6"	"Cell line enhanced"	"Detected in many"		"HSkMC: 30.2;K-562: 30.7;PC-3: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036571	Uncertain					590000	590000			"HPA036571: AB_10670114"	"unprognostic (1.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.20e-1)"	"unprognostic (8.64e-2)"	"prognostic favourable (1.99e-4)"	"unprognostic (1.76e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.44e-1)"	5.7	13.9	8.1	6.1	7.7	2.0	13.1	4.1	7.8	5.6	38.3	2.9	5.2	47.0	4.3	6.1	3.0	5.1	21.6	11.4	7.8	5.1	81.7	83.7	5.5	2.1	5.8	7.6	10.6	6.5	13.9	6.0	1.3	5.1	8.6	17.8	4.8	3.5	8.4	70.6	1.4	71.4	5.0	7.0	1.4	14.4	3.9	4.1	1.3	7.3	10.5	1.6	6.4	4.8	0.8	0.6	3.0	1.2	0.7	2.1	0.8	3.6	4.3	5.0	12.6	20.1	23.1	27.4	6.2	6.7	2.0	2.8	1.7	18.7	0.0	10.4	4.5	0.1	11.7	7.9	2.4	0.2	8.8	16.4	19.7	14.1	6.2	0.1	0.1	30.2	5.2	4.1	3.8	6.0	30.7	0.2	7.0	0.7	0.1	0.6	7.7	29.6	3.6	0.0	0.4	18.5	2.3	4.0	6.2	14.8	1.3	0.4	10.3	0.6	1.7	3.0	3.9	4.8	0.0	0.1	0.0	0.0	4.9	0.0	0.0	2.1	1.2	0.5	1.5	0.5	2.1	0.3	1.7	0.7	0.6	0.8	0.8	1.6	3.0	0.7	0.3	0.5	0.2	0.8	8.1	7.7	4.1	7.8	7.8	5.1	5.8	7.6	5.1	4.1
COQ10A	FLJ32452	ENSG00000135469	"Coenzyme Q10A"	Q96MF6	12	56266858-56270966	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 43.5;skeletal muscle: 103.7;tongue: 46.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068931			Approved	"Endoplasmic reticulum,Golgi apparatus,Cytosol"				Cytosol	Cytosol	"HPA068931: AB_2686061"	"unprognostic (4.55e-2)"	"unprognostic (4.88e-3)"	"prognostic unfavourable (5.46e-4)"	"unprognostic (8.99e-3)"	"unprognostic (2.77e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.86e-3)"	"unprognostic (6.09e-2)"	"unprognostic (8.57e-2)"	"prognostic favourable (2.06e-4)"	"unprognostic (5.03e-2)"	"prognostic favourable (3.44e-4)"	"unprognostic (1.67e-1)"	"unprognostic (8.07e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.15e-1)"	2.9	12.4	5.0	2.3	6.8	2.2	3.1	7.6	7.3	3.7	2.9	4.8	5.9	1.9	3.6	7.7	4.3	5.2	3.2	43.5	4.5	5.4	7.2	12.8	3.5	3.4	5.6	3.9	4.5	5.5	6.0	9.9	1.7	4.8	4.1	2.7	14.0	6.5	5.6	103.7	2.2	2.9	3.7	3.6	3.8	2.6	2.4	3.0	4.9	5.4	46.1	6.2	2.7	3.3	11.7	6.8	8.0	1.1	5.0	8.6	3.6	2.4	10.2	9.9	6.4	5.7	5.7	4.2	3.5	8.5	12.6	12.6	7.9	3.8	14.6	8.1	8.9	2.3	11.4	2.0	7.5	2.2	12.7	6.8	9.3	8.2	7.8	5.3	4.1	5.9	3.3	9.3	3.7	6.6	4.5	6.0	11.6	3.3	7.6	19.1	8.4	5.9	16.4	10.8	9.6	6.9	1.5	14.3	15.5	12.2	2.5	3.8	3.9	5.9	4.6	2.4	7.0	6.7	3.6	12.6	13.5	7.1	7.0	5.0	1.8	8.0	1.0	0.9	7.7	1.1	7.9	11.7	7.1	8.2	1.7	6.7	8.6	8.4	0.4	5.0	0.8	6.8	4.6	3.6	5.0	6.8	7.6	7.3	4.5	5.4	5.6	3.9	4.8	3.0
CORO6	FLJ14871	ENSG00000167549	"Coronin 6"	Q6QEF8	17	29614756-29622907	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 130.9"	"Cell line enhanced"	"Detected in many"		"REH: 12.2;RH-30: 13.9;SH-SY5Y: 17.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	19	"basophil: 3.9;eosinophil: 2.4"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021556			Supported	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA021556: "	"unprognostic (7.12e-3)"	"unprognostic (2.68e-2)"	"unprognostic (2.60e-4)"	"unprognostic (9.25e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.00e-4)"	"unprognostic (6.70e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (9.61e-7)"	"unprognostic (8.48e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.13e-2)"	2.7	1.6	5.7	1.2	17.7	0.9	2.2	4.5	12.4	1.4	4.4	0.7	1.6	1.3	3.3	3.4	6.9	3.5	2.4	28.4	5.2	3.3	0.9	0.8	2.1	1.0	1.8	8.7	1.2	1.0	11.7	1.0	25.7	8.1	4.0	1.7	1.2	3.8	2.7	130.9	2.0	2.4	5.6	1.3	1.1	2.1	1.0	3.6	0.0	21.3	18.3	1.1	4.9	1.9	0.0	0.0	3.9	0.0	0.0	0.1	0.1	7.5	3.3	2.9	0.0	4.6	2.5	4.7	2.5	0.9	1.6	0.7	0.2	0.0	0.1	0.6	4.0	8.0	2.2	0.4	0.8	0.1	3.8	0.0	6.3	0.9	7.5	0.0	0.4	9.1	0.7	0.8	0.0	1.7	0.5	0.1	5.4	0.0	5.0	0.2	1.0	0.1	12.2	13.9	0.3	0.4	0.0	0.0	17.1	0.7	2.3	0.0	0.0	1.1	0.5	1.1	0.0	1.3	1.1	6.4	3.4	0.9	2.4	0.0	0.0	3.9	0.0	2.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	17.7	4.5	12.4	5.2	3.3	1.8	8.7	8.1	3.6
DCUN1D2	"C13orf17, FLJ10704, FLJ20092"	ENSG00000150401	"Defective in cullin neddylation 1 domain containing 2"	Q6PH85	13	113455819-113490952	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 24.0;heart muscle: 59.1;skeletal muscle: 65.6"	"Cell line enhanced"	"Detected in all"		"SCLC-21H: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039349	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA039349: AB_10673240"	"unprognostic (3.09e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.43e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.02e-2)"	"prognostic favourable (5.65e-5)"	"unprognostic (1.21e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.25e-2)"	4.9	4.5	6.2	6.0	7.0	7.8	4.6	24.0	13.3	4.1	4.3	6.5	3.4	3.1	6.2	6.6	4.7	4.0	4.9	59.1	5.9	7.2	4.3	4.0	3.8	4.6	7.2	5.9	5.5	4.5	3.5	7.1	5.2	9.7	3.9	4.5	6.2	4.5	4.5	65.6	9.1	5.4	5.2	8.5	4.9	4.3	5.6	6.1	5.3	3.3	7.5	4.9	3.8	3.7	3.5	2.7	10.9	2.2	2.8	4.1	1.8	6.7	4.2	7.1	5.4	5.2	4.6	5.5	5.3	6.5	5.0	5.7	15.0	4.1	4.9	1.7	6.1	9.8	7.6	4.0	7.2	3.2	12.8	8.3	19.2	4.1	2.7	12.6	6.2	6.8	6.7	5.6	4.5	4.2	4.6	4.7	4.8	4.8	8.6	20.8	4.5	6.6	9.0	11.7	6.5	3.7	4.5	31.6	7.0	4.1	14.2	3.9	8.1	5.9	7.0	6.6	9.0	5.0	7.6	14.0	5.9	9.8	15.0	5.6	4.4	10.9	1.9	3.6	3.1	1.7	4.1	3.5	2.8	1.9	2.7	1.9	3.0	1.6	1.5	2.8	2.2	0.3	2.9	1.8	6.2	7.0	24.0	13.3	5.9	7.2	7.2	5.9	9.7	6.1
DUSP26	"DUSP24, MGC1136"	ENSG00000133878	"Dual specificity phosphatase 26"	Q9BV47	8	33591332-33600106	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 147.1"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 45.1"	"Cancer enhanced"	"Detected in some"		"glioma: 6.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"B-cells: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018221	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA018221: AB_2669813"	"unprognostic (2.77e-4)"	"unprognostic (2.70e-2)"	"unprognostic (2.70e-3)"	"unprognostic (5.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.15e-2)"	"unprognostic (5.80e-2)"	1.3	9.3	11.5	1.4	13.1	1.1	1.2	18.2	14.8	1.1	1.7	4.2	0.0	2.4	1.5	3.4	3.0	2.3	1.5	20.1	9.1	15.9	1.6	1.0	1.7	1.1	10.6	8.8	15.1	2.2	1.0	14.0	1.0	7.6	2.6	1.5	4.4	1.5	1.3	147.1	1.0	1.9	2.0	10.0	1.2	2.6	1.6	3.8	0.0	1.1	27.0	1.3	1.4	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	45.1	10.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	13.1	18.2	14.8	9.1	15.9	10.6	8.8	7.6	3.8
ENDOG		ENSG00000167136	"Endonuclease G"	Q14249	9	128818474-128822677	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 91.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021335, HPA021830"	Approved				"Intracellular and membrane"					"HPA021335: AB_1848151, HPA021830: AB_1848152"	"unprognostic (1.35e-1)"	"unprognostic (3.41e-1)"	"unprognostic (4.86e-2)"	"prognostic favourable (5.12e-4)"	"unprognostic (2.51e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.90e-1)"	"unprognostic (6.97e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.03e-1)"	"prognostic favourable (1.06e-7)"	"unprognostic (1.69e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	5.8	6.4	8.6	3.2	9.1	3.9	8.1	8.1	15.0	4.4	8.4	5.3	8.8	10.3	3.1	2.6	5.7	7.7	4.3	19.9	8.0	8.3	9.9	18.5	3.8	5.7	7.2	7.2	3.5	8.4	8.0	4.8	3.9	6.0	6.9	5.5	4.8	5.9	7.0	91.2	5.2	7.6	3.4	4.1	3.4	7.6	6.1	6.5	5.2	8.1	18.1	3.7	4.3	7.1	3.9	6.9	1.5	3.8	2.3	3.1	1.3	6.6	7.2	1.9	9.9	5.0	4.3	8.5	6.4	3.4	6.1	4.2	4.4	5.3	2.1	5.8	4.2	18.8	6.0	5.6	1.1	4.2	10.7	3.7	7.0	7.7	2.3	11.5	14.3	4.5	6.9	3.6	2.5	4.6	11.6	3.4	3.8	9.6	8.9	23.7	4.7	27.2	10.7	2.1	22.3	9.0	2.4	16.6	16.5	14.3	13.2	3.2	12.6	5.7	4.7	4.3	2.5	6.1	4.7	10.9	1.5	4.1	8.6	8.3	4.4	0.0	2.3	1.5	2.8	3.8	2.5	3.2	2.8	1.3	3.6	3.9	2.7	3.1	0.0	2.3	1.7	6.9	1.1	1.3	8.6	9.1	8.1	15.0	8.0	8.3	7.2	7.2	6.0	6.5
EXTL1	"EXTL, MGC70794"	ENSG00000158008	"Exostosin like glycosyltransferase 1"	Q92935	1	26019884-26036464	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 21.1;heart muscle: 6.0;skeletal muscle: 20.5"	"Cell line enriched"	"Detected in some"	10	"WM-115: 57.4"	"Cancer enriched"	"Detected in some"	13	"melanoma: 21.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA037749	Approved				"Intracellular and membrane"	68000	68000			"HPA037749: AB_10805350"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.14e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.35e-2)"	0.6	2.1	15.3	0.6	9.5	0.5	2.0	1.1	21.1	1.3	0.6	1.4	0.0	0.7	2.5	0.7	1.5	1.7	1.2	6.0	12.7	3.7	0.7	0.5	0.7	0.8	3.7	7.9	2.3	1.0	0.5	0.5	1.0	2.9	1.2	0.6	2.7	0.8	0.9	20.5	1.6	0.7	2.9	2.7	2.2	0.6	1.0	0.8	0.0	0.9	3.2	0.6	0.9	0.2	0.1	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	57.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.1	15.3	9.5	1.1	21.1	12.7	3.7	3.7	7.9	2.9	0.8
EYA4	"CMD1J, DFNA10"	ENSG00000112319	"EYA transcriptional coactivator and phosphatase 4"	O95677	6	133240598-133532120	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 65.6"	"Cell line enhanced"	"Detected in many"		"A549: 12.6;HeLa: 35.3;RH-30: 12.0;U-87 MG: 12.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA004805, HPA038771, HPA038772"	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA004805: AB_10669750, HPA038771: AB_10671865, HPA038772: AB_10673119"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-9)"	"unprognostic (1.64e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.44e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.27e-4)"	"unprognostic (1.82e-3)"	"unprognostic (6.67e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.51e-2)"	1.6	3.0	1.2	0.2	1.3	0.1	2.4	0.4	1.2	9.7	0.6	2.5	11.1	0.4	2.6	1.9	0.7	8.3	0.7	6.2	1.5	1.2	6.1	0.4	2.0	0.2	2.1	0.8	1.6	0.4	0.2	7.2	0.2	3.5	6.6	0.4	2.7	0.8	13.9	65.6	0.4	0.5	1.9	3.5	0.6	0.7	7.4	1.4	1.8	2.5	5.5	0.7	2.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	1.2	0.0	0.0	0.0	0.0	0.0	10.1	0.2	1.5	0.0	0.0	0.0	10.0	0.0	0.0	7.6	3.2	0.0	0.0	9.9	1.3	35.3	0.0	0.3	0.0	3.4	2.6	0.0	7.3	2.2	0.0	0.0	5.4	4.0	0.0	0.0	0.0	0.0	0.7	0.1	12.0	0.0	0.0	1.9	1.8	2.0	0.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	9.0	3.6	1.6	0.0	12.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.4	1.2	1.5	1.2	2.1	0.8	3.5	1.4
FAM184B	KIAA1276	ENSG00000047662	"Family with sequence similarity 184 member B"	Q9ULE4	4	17629306-17781512	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 5.1;skeletal muscle: 11.1"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 6.8;T-47d: 1.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA044119, HPA048458"	Enhanced									"HPA044119: AB_2678817, HPA048458: AB_2680401"	"unprognostic (1.20e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.13e-4)"	"unprognostic (2.04e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.54e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.54e-4)"	1.5	0.6	3.2	0.5	5.0	0.8	0.6	2.0	5.1	0.3	1.1	2.5	0.0	0.3	0.4	0.8	0.4	0.3	0.4	0.3	3.6	2.7	1.2	0.3	0.4	0.5	3.3	1.2	0.5	0.3	0.8	0.4	0.3	3.7	0.5	0.8	0.1	0.9	0.3	11.1	1.1	0.4	0.3	2.0	0.5	0.5	0.6	2.9	0.0	0.4	0.4	0.4	0.3	0.0	0.2	0.0	0.2	0.1	0.0	0.9	0.0	0.0	0.2	0.3	0.8	0.0	0.0	0.2	0.7	0.0	0.2	0.0	0.2	0.1	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.3	0.5	0.1	0.2	0.9	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.8	1.3	0.0	0.1	0.2	0.0	0.0	0.1	6.8	0.2	0.0	0.0	0.9	1.7	0.2	0.3	0.0	0.0	0.1	0.3	0.2	0.2	0.1	0.1	0.3	0.6	0.0	0.1	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.2	0.3	0.9	0.2	0.0	0.1	0.0	0.0	0.0	3.2	5.0	2.0	3.1	3.6	2.7	3.3	1.2	3.7	2.9
FBXO32	"ATROGIN1, Fbx32, MAFbx"	ENSG00000156804	"F-box protein 32"	Q969P5	8	123497889-123541206	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 200.5"	"Group enriched"	"Detected in some"	5	"HDLM-2: 59.7;U-251 MG: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 2.9;gdTCR: 3.7;MAIT T-cell: 3.6;memory CD4 T-cell: 5.1;memory CD8 T-cell: 5.4;naive CD4 T-cell: 6.0;naive CD8 T-cell: 7.6;NK-cell: 4.4;T-reg: 4.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 2.9;NK-cells: 4.4;T-cells: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA058955, HPA065209"			Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA058955: , HPA065209: AB_2685433"	"unprognostic (2.55e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavourable (6.73e-4)"	"unprognostic (8.58e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.97e-3)"	3.5	1.5	2.4	4.9	5.1	0.8	13.2	1.0	3.8	5.6	31.1	8.9	14.4	2.6	25.3	5.8	8.1	15.8	16.6	26.1	2.9	2.1	1.5	1.0	1.7	4.1	10.2	2.5	9.5	2.0	0.9	5.6	4.9	7.3	19.7	8.0	4.2	8.0	23.1	200.5	3.7	6.5	36.9	8.8	1.7	10.8	3.5	7.6	0.2	9.0	15.1	3.1	24.8	16.1	0.6	0.2	2.9	0.3	4.4	7.6	1.4	1.8	0.3	0.0	0.0	3.8	0.9	0.6	0.3	4.0	0.2	0.4	0.0	1.0	0.0	1.1	2.9	0.1	0.0	0.3	0.3	59.7	1.4	0.0	2.1	0.0	5.2	0.0	0.2	7.7	2.6	0.9	1.1	0.2	0.1	0.5	0.2	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.3	0.6	0.6	0.1	0.4	0.4	6.8	6.9	6.6	0.1	0.2	1.1	0.3	0.4	17.9	6.2	0.8	0.1	4.5	0.0	0.8	2.9	0.3	0.0	3.7	0.2	3.6	0.6	5.1	5.4	0.2	0.6	6.0	7.6	0.2	4.4	0.2	0.1	4.5	1.4	2.4	5.1	1.0	3.8	2.9	2.1	10.2	2.5	7.3	7.6
FHL1	"bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA"	ENSG00000022267	"Four and a half LIM domains 1"	Q13642	X	136146702-136211359	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 557.6;tongue: 239.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 57.7;fHDF/TERT166: 52.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 20.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 12.5;NK-cells: 20.6;T-cells: 11.4"	"Low region specificity"	"Detected in all"							"HPA001040, HPA001391, CAB020817"	Enhanced		Supported	"Plasma membrane,Cytosol"		18000000	18000000	Cytosol	Cytosol	"CAB020817: , HPA001040: AB_1848541, HPA001391: AB_1848542"	"unprognostic (2.16e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.34e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (4.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.05e-3)"	"prognostic unfavourable (2.11e-4)"	61.9	4.1	7.6	11.0	9.5	0.7	30.6	6.3	7.2	31.5	30.6	3.9	10.0	5.0	25.5	27.7	43.2	14.2	11.7	79.0	6.1	8.1	3.3	2.5	13.7	2.5	5.5	8.1	6.7	2.4	13.4	5.0	13.5	4.4	23.4	10.0	13.5	16.5	30.1	557.6	4.9	11.4	77.7	4.3	2.5	22.1	5.7	3.0	0.6	18.2	239.4	22.1	47.0	14.3	3.4	12.5	0.7	0.4	20.6	11.4	6.2	0.0	9.4	13.1	12.3	28.5	11.5	0.2	36.7	57.7	7.3	17.8	0.0	2.7	0.1	12.8	52.2	0.1	25.3	31.3	6.2	0.1	29.2	0.1	7.8	0.0	26.7	0.0	6.1	21.4	5.1	8.9	28.1	7.7	0.0	5.5	17.2	0.4	5.1	0.3	4.0	11.1	14.4	0.5	7.8	0.2	0.0	9.2	13.8	1.3	0.0	2.6	0.0	0.5	21.6	34.1	15.8	1.3	9.2	1.4	3.2	0.2	2.5	0.2	3.8	0.0	0.4	0.0	3.2	0.0	8.6	3.4	11.4	4.5	1.8	2.3	7.6	2.3	0.7	20.6	0.0	12.5	1.2	6.2	7.6	9.5	6.3	7.2	6.1	8.1	5.5	8.1	4.4	3.0
GAPDH	GAPD	ENSG00000111640	"Glyceraldehyde-3-phosphate dehydrogenase"	P04406	12	6533927-6538374	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 1236.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005197, CAB016392, HPA040067, HPA061280"	Supported		Supported	"Nuclear membrane,Vesicles,Plasma membrane,Cytosol"		2200000000	2200000000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB005197: AB_641107, CAB016392: AB_627678, HPA040067: AB_10965903, HPA061280: AB_2684463"	"unprognostic (3.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.58e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.77e-3)"	"prognostic unfavourable (1.79e-6)"	"unprognostic (2.89e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (9.50e-3)"	"unprognostic (4.52e-1)"	"prognostic unfavourable (6.25e-10)"	"unprognostic (2.33e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.26e-2)"	50.0	59.4	104.1	57.6	101.0	195.5	38.4	58.0	151.3	49.4	73.3	80.7	24.0	75.8	37.3	46.8	146.9	50.2	58.0	215.1	95.0	95.5	88.4	221.0	41.3	90.1	111.8	58.0	62.0	27.0	66.1	46.1	98.2	115.9	48.3	76.7	74.5	60.8	63.2	1236.8	54.4	74.4	68.0	95.6	50.7	41.1	36.4	35.9	101.9	38.3	238.7	105.3	89.5	50.5	57.9	171.0	110.0	201.6	60.5	108.8	271.9	196.0	345.9	99.8	155.5	97.4	160.6	217.5	149.0	212.2	218.1	227.7	244.1	134.6	229.2	29.5	175.6	111.7	92.7	345.6	151.4	201.0	100.7	126.8	217.1	207.3	131.3	204.9	102.1	134.3	112.9	214.3	242.1	240.0	68.1	48.3	247.7	391.1	233.5	107.9	368.8	115.3	189.9	177.7	109.1	248.1	239.9	70.7	113.5	131.5	343.1	197.9	53.6	144.8	149.7	170.2	205.7	87.8	257.4	109.8	79.8	295.4	360.8	129.9	266.3	110.0	201.6	37.0	74.1	103.2	65.3	57.9	77.9	74.4	171.0	32.2	44.1	51.2	106.5	60.5	92.3	25.2	108.8	271.9	104.1	101.0	58.0	151.3	95.0	95.5	111.8	58.0	115.9	35.9
GDF1		ENSG00000130283	"Growth differentiation factor 1"	P27539	19	18868545-18896096	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"brain: 36.4;skeletal muscle: 15.5"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.4;EFO-21: 5.2;HEK 293: 6.3;NB-4: 8.2;NTERA-2: 4.2;SCLC-21H: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"																							2.2	2.1	25.6	2.2	28.6	1.9	1.9	11.7	32.1	2.0	2.0	36.4	0.0	1.9	2.0	1.9	2.0	2.0	2.0	2.1	24.6	18.0	2.0	1.9	1.9	1.9	26.2	18.3	2.4	2.0	2.0	1.1	1.9	30.4	2.2	1.9	1.4	2.1	2.0	15.5	1.9	2.0	2.0	33.7	1.9	2.0	4.9	19.8	0.0	2.0	0.0	1.9	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	3.4	0.0	0.0	0.3	0.2	0.0	0.3	0.3	0.8	0.0	0.0	5.2	0.0	0.1	0.1	0.0	0.0	0.0	6.3	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.7	0.0	8.2	4.2	0.1	0.0	0.0	0.1	0.0	0.0	3.5	2.2	0.0	0.0	1.5	0.6	2.5	0.0	0.0	1.0	0.8	0.5	0.3	0.0	0.0	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	28.6	11.7	32.1	24.6	18.0	26.2	18.3	30.4	19.8
GHR	GHBP	ENSG00000112964	"Growth hormone receptor"	P10912	5	42423777-42721878	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 44.4;breast: 31.5;liver: 82.4;skeletal muscle: 23.4"	"Group enriched"	"Detected in some"	5	"HSkMC: 13.3;T-47d: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045339, HPA057705"	Enhanced		Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"	"Secreted to blood"	21000000	21000000	"Plasma membrane, Cytosol, Cytoplasmic bodies"	"Plasma membrane, Cytosol, Cytoplasmic bodies"	"HPA045339: AB_2679294, HPA057705: AB_2683507"	"unprognostic (2.18e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.57e-1)"	"prognostic favourable (2.73e-6)"	"unprognostic (1.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.73e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.29e-4)"	"unprognostic (7.82e-2)"	"unprognostic (7.33e-4)"	"unprognostic (8.35e-6)"	44.4	2.8	0.7	5.4	1.3	0.3	31.5	0.4	1.4	4.0	6.9	0.5	1.7	0.6	5.7	3.9	2.4	2.5	3.9	6.0	1.3	1.6	5.3	82.4	2.3	2.2	1.2	1.4	5.0	1.3	3.6	2.0	4.0	2.0	8.7	2.5	2.4	2.3	7.4	23.4	3.0	2.4	5.2	1.0	2.6	3.5	1.6	0.2	0.1	2.9	4.3	0.5	3.8	8.4	0.6	0.3	1.8	0.5	0.4	0.3	0.1	0.0	0.0	0.3	3.0	2.0	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	2.5	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	13.3	4.3	0.0	0.6	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	2.1	33.9	0.0	1.8	3.0	1.3	1.6	0.3	0.3	0.0	0.0	0.3	0.0	1.5	1.8	0.3	0.4	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.6	0.2	0.3	1.7	0.4	0.5	0.3	0.2	0.1	0.7	1.3	0.4	1.4	1.3	1.6	1.2	1.4	2.0	0.2
HRC	MGC133236	ENSG00000130528	"Histidine rich calcium binding protein"	P23327	19	49151198-49155424	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 155.8;skeletal muscle: 82.1"	"Group enriched"	"Detected in some"	6	"Hep G2: 6.3;HSkMC: 6.4;K-562: 8.5;THP-1: 15.2;U-266/84: 4.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA004833	Enhanced				"Intracellular and membrane"	23000	23000			"HPA004833: AB_1079083"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.46e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.75e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.09e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.41e-3)"	"unprognostic (5.85e-3)"	"unprognostic (4.04e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.46e-1)"	2.4	0.8	0.2	0.1	0.5	0.0	0.8	0.0	0.6	1.6	0.3	0.3	0.3	0.2	1.8	4.3	1.3	1.0	0.5	155.8	0.2	0.2	0.7	0.4	0.3	0.4	0.4	0.3	0.7	0.3	0.4	0.2	0.4	0.3	1.4	0.2	1.3	1.4	0.6	82.1	0.3	0.3	0.5	0.2	0.1	0.2	0.7	0.1	0.0	1.7	25.9	2.0	0.4	0.6	0.5	0.1	0.9	0.5	0.2	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.5	6.3	0.0	0.0	1.2	6.4	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	15.2	0.2	0.0	0.0	0.3	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.9	0.0	0.3	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.2	0.4	0.1	0.2	0.0	0.2	0.5	0.0	0.6	0.2	0.2	0.4	0.3	0.3	0.1
IP6K3	"IHPK3, INSP6K3"	ENSG00000161896	"Inositol hexakisphosphate kinase 3"	Q96PC2	6	33721670-33746905	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"brain: 22.5;skeletal muscle: 87.9"	"Cell line enhanced"	"Detected in some"		"HHSteC: 15.8;HSkMC: 5.7;LHCN-M2: 25.1;RH-30: 11.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 13.0;cerebral cortex: 6.2;midbrain: 22.5;pons and medulla: 7.7;thalamus: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA053644	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA053644: AB_2682214"	"unprognostic (3.23e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.07e-5)"	"unprognostic (1.07e-3)"	"unprognostic (2.20e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.94e-3)"	"prognostic unfavourable (6.09e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.33e-1)"	2.2	1.0	2.1	0.8	13.0	0.5	0.9	0.6	6.2	1.2	2.2	11.8	1.4	0.8	1.6	1.4	5.2	1.3	0.6	10.0	3.2	1.3	4.7	7.7	2.0	0.6	22.5	1.1	0.6	0.7	0.5	0.5	3.8	7.7	2.8	1.0	1.2	1.4	1.8	87.9	0.5	1.1	1.8	9.2	1.4	0.9	0.6	15.2	0.0	9.9	8.1	0.5	1.5	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.5	0.1	0.2	0.2	1.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	5.7	0.8	0.1	0.4	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.1	0.0	0.0	11.1	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.1	13.0	0.6	6.2	3.2	1.3	22.5	1.1	7.7	15.2
JPH1	JP-1	ENSG00000104369	"Junctophilin 1"	Q9HDC5	8	74234700-74321328	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 97.2"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 10.2;RT4: 9.0;SK-BR-3: 24.3;T-47d: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008996, HPA009413, CAB013461"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB013461: , HPA008996: AB_1852023, HPA009413: AB_1079163"	"unprognostic (2.91e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.73e-6)"	"unprognostic (2.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.63e-2)"	"prognostic favourable (5.77e-5)"	"unprognostic (8.97e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.38e-1)"	"unprognostic (5.99e-2)"	"unprognostic (9.80e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.08e-2)"	1.7	0.6	1.8	0.7	5.7	0.5	0.8	13.7	3.1	0.8	1.9	0.8	0.4	0.8	1.5	1.7	1.8	0.6	0.6	3.3	2.1	0.7	0.8	0.5	2.2	0.5	1.0	4.2	0.5	3.5	1.1	0.4	1.1	2.4	1.8	2.8	0.0	1.3	0.8	97.2	0.7	0.9	1.4	2.4	0.5	0.9	0.9	2.3	2.4	1.2	21.5	1.4	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.4	0.1	3.1	0.0	1.0	0.0	4.6	3.9	3.1	1.0	0.0	5.9	0.0	3.7	0.0	0.5	2.0	0.2	0.6	2.6	0.0	2.9	0.0	0.5	0.0	0.3	2.8	10.2	0.0	6.8	2.0	5.2	3.9	0.0	0.1	9.0	5.2	0.7	0.0	24.3	1.2	17.3	0.1	0.0	1.2	1.7	0.4	1.0	0.0	0.0	0.0	2.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	5.7	13.7	3.1	2.1	0.7	1.0	4.2	2.4	2.3
KCNJ11	"BIR, Kir6.2"	ENSG00000187486	"Potassium voltage-gated channel subfamily J member 11"	Q14654	11	17385859-17389331	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 63.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 7.1;HEK 293: 13.4;MCF7: 10.7;SCLC-21H: 9.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							HPA048891	Approved									"HPA048891: AB_2680547"	"unprognostic (1.95e-2)"	"unprognostic (6.18e-3)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.81e-5)"	"unprognostic (1.83e-3)"	"unprognostic (5.45e-2)"	"unprognostic (8.09e-3)"	"unprognostic (3.72e-3)"	"unprognostic (9.23e-3)"	"prognostic favourable (1.56e-4)"	"unprognostic (4.05e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.75e-2)"	2.5	1.1	2.9	1.0	7.8	0.8	2.7	13.6	7.8	1.0	1.1	0.7	4.9	1.4	1.1	2.1	1.7	1.1	1.1	6.2	3.5	2.4	1.3	0.9	1.3	1.2	2.7	5.2	0.8	8.7	2.7	3.3	0.7	3.5	2.5	1.0	0.1	1.2	7.6	63.1	1.0	1.1	0.8	1.7	1.0	4.6	0.8	1.9	0.0	4.1	4.5	1.0	0.9	1.1	0.8	0.4	1.4	0.3	0.8	0.4	0.4	1.5	2.3	0.3	4.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	2.5	0.2	7.1	0.2	0.0	0.3	4.8	0.1	0.3	1.6	13.4	3.6	0.9	0.8	0.1	0.4	0.3	0.1	0.3	0.0	0.1	0.0	3.7	3.8	0.0	10.7	0.7	0.1	1.0	0.3	1.4	1.7	2.0	0.4	0.9	9.1	0.8	0.0	3.5	0.0	4.6	0.2	0.0	0.0	1.2	0.0	0.1	0.2	6.0	0.9	0.0	1.0	0.0	1.4	0.3	0.2	0.4	0.3	0.3	0.7	0.4	0.4	0.1	0.8	0.4	0.4	1.3	0.8	0.1	0.4	0.3	0.4	2.9	7.8	13.6	7.8	3.5	2.4	2.7	5.2	3.5	1.9
KCNQ5	Kv7.5	ENSG00000185760	"Potassium voltage-gated channel subfamily Q member 5"	Q9NR82	6	72621792-73198851	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 6.6;brain: 23.0;skeletal muscle: 26.1;thyroid gland: 6.9"	"Cell line enhanced"	"Detected in many"		"BJ: 20.1;HL-60: 17.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA016655	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA016655: AB_1855557"	"unprognostic (4.91e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.09e-2)"	"unprognostic (8.55e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.39e-3)"	0.7	2.8	4.2	3.0	14.9	6.6	1.1	0.6	19.6	0.6	0.9	0.0	0.0	0.8	0.7	0.6	1.7	1.0	0.9	0.6	6.9	2.7	0.6	0.8	0.8	3.4	3.0	7.5	0.7	0.6	0.6	0.5	1.0	23.0	2.4	0.9	2.2	2.1	1.9	26.1	0.6	0.9	1.7	0.9	2.0	0.8	2.0	0.7	1.6	6.9	0.4	3.1	1.2	0.7	2.7	0.5	1.2	0.0	2.2	1.7	0.2	2.5	0.6	0.0	0.1	0.0	0.9	0.0	20.1	3.0	3.0	2.6	0.0	0.0	12.0	0.0	6.8	0.4	0.1	1.2	3.6	0.1	4.2	13.1	0.0	0.0	0.5	17.6	0.0	0.2	0.5	8.6	9.0	0.0	0.7	8.3	5.9	0.1	0.0	7.5	0.7	4.2	0.0	0.6	8.2	1.1	0.0	3.4	1.6	0.0	0.0	8.2	2.5	1.3	0.0	12.5	5.5	0.0	13.3	8.7	0.2	5.5	0.1	8.5	0.7	1.2	0.0	0.0	0.2	0.0	1.1	2.7	0.5	1.5	0.5	1.4	1.7	1.2	0.0	2.2	0.0	0.0	0.0	0.2	4.2	14.9	0.6	19.6	6.9	2.7	3.0	7.5	23.0	0.7
LINGO4	LRRN6D	ENSG00000213171	"Leucine rich repeat and Ig domain containing 4"	Q6UY18	1	151800264-151806154	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 5.4;skeletal muscle: 17.7"	"Group enriched"	"Detected in some"	4	"HDLM-2: 4.0;Karpas-707: 1.1;SH-SY5Y: 1.7"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA060781	Uncertain									"HPA060781: AB_2684361"	"unprognostic (2.71e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.49e-5)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.94e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.94e-4)"	"unprognostic (3.84e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.06e-2)"	"unprognostic (5.60e-2)"	0.0	2.5	0.0	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0			0.0	0.0	0.9	0.0	0.8	0.0	0.3	0.0	0.1	0.3	0.7	0.1	0.1	0.0		0.0	0.3	0.4	1.2	0.0		0.8	0.0		0.4	0.1	17.7	0.3	0.0	0.0	0.3	0.0	0.3	0.4			0.4		0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.7	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LMO1	"RBTN1, RHOM1, TTG1"	ENSG00000166407	"LIM domain only 1"	P25800	11	8224304-8268716	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"retina: 29.4;skeletal muscle: 29.1"	"Cell line enhanced"	"Detected in some"		"HeLa: 21.2;SCLC-21H: 8.3;SH-SY5Y: 25.4;SiHa: 5.1"	"Cancer enriched"	"Detected in many"	6	"glioma: 6.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.74e-3)"	"unprognostic (1.45e-1)"		"unprognostic (4.75e-6)"	"unprognostic (9.34e-2)"	"unprognostic (2.37e-1)"		"unprognostic (1.98e-1)"	"unprognostic (7.06e-3)"	"unprognostic (8.09e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.05e-2)"	"unprognostic (4.36e-12)"	"unprognostic (1.76e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.13e-2)"	0.3	1.7	2.5	0.3	2.1	0.2	0.6	0.4	3.0	0.2	0.2	1.5	0.1	0.4	0.3	2.1	0.6	0.3	0.2	0.5	2.3	5.9	1.0	0.2	0.2	0.2	3.5	0.6	0.2	1.6	0.2	2.1	0.3	2.1	0.3	0.2	29.4	0.2	0.2	29.1	6.4	0.3	0.5	1.2	0.6	0.6	1.6	2.0	0.1	0.2	0.1	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.9	0.0	21.2	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	8.3	25.4	5.1	2.9	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.1	0.4	3.0	2.3	5.9	3.5	0.6	2.1	2.0
LRRC2		ENSG00000163827	"Leucine rich repeat containing 2"	Q9BYS8	3	46515423-46580099	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 53.9;skeletal muscle: 70.3;tongue: 20.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.6;HEL: 6.1;LHCN-M2: 6.1;TIME: 4.9"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 5.6"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064844			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA064844: "	"unprognostic (1.32e-4)"	"unprognostic (3.44e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.24e-1)"	1.8	0.5	1.9	0.4	1.4	0.4	1.0	1.4	3.0	2.6	1.1	0.2	0.0	0.4	3.9	1.4	1.1	1.1	1.4	53.9	1.3	0.4	2.2	2.5	0.6	0.3	0.5	2.3	2.8	0.7	0.1	2.2	0.5	1.0	1.2	0.8	0.4	1.4	0.2	70.3	1.2	0.6	2.3	0.4	1.3	1.0	0.4	0.0	1.4	10.1	20.0	1.2	1.7	1.8	1.2	0.8	2.6	0.7	1.1	2.5	0.3	0.2	0.0	0.2	0.3	1.0	2.2	0.1	0.8	1.5	0.5	0.8	0.0	0.2	0.3	0.2	10.6	0.2	3.7	0.0	1.4	0.5	0.1	6.1	0.4	0.2	0.2	0.2	0.1	0.2	0.1	4.3	0.0	0.2	0.1	0.4	6.1	0.1	0.8	0.1	1.5	0.2	0.1	0.1	0.3	0.1	0.3	0.5	1.2	0.8	0.2	1.6	0.2	0.8	4.9	0.3	0.6	2.5	1.6	0.4	0.3	2.9	0.2	0.1	1.4	2.2	0.7	0.6	0.6	0.4	0.4	0.7	1.6	0.3	0.2	1.2	0.8	0.6	2.6	1.1	0.5	0.8	2.5	0.3	1.9	1.4	1.4	3.0	1.3	0.4	0.5	2.3	1.0	0.0
LRRC37A	KIAA0563	ENSG00000176681	"Leucine rich repeat containing 37A"	A6NMS7	17	46292733-46337794	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 9.4;testis: 15.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 7.8"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA042121, HPA043056, HPA045090, HPA049080"	Supported		Approved	Vesicles				Vesicles	Vesicles	"HPA042121: AB_2677858, HPA043056: AB_2678294, HPA045090: AB_2679211, HPA049080: "	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.75e-2)"	"unprognostic (6.02e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.20e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.37e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.30e-2)"	0.9	0.4	1.4	2.0	1.8	1.4	1.7	2.6	1.7	0.7	0.9			0.5	1.1	0.4	1.1	1.0	0.5	1.1	1.5	1.2	0.9	0.6	0.9	1.5	0.6		1.2	0.9	0.5	2.1	0.7		1.3	1.0		1.0	0.9	9.4	1.8	1.3	0.6	0.8	1.2	0.8	15.2			1.2		0.9	1.1	1.1	1.4	1.7	2.1	1.4	2.1	1.5	0.2	0.2	0.2	1.5	0.2	0.3	0.0	0.5	0.1	0.4	0.1	0.2	3.5	0.3	7.8	0.3	0.2	0.3	0.0	0.0	0.0	0.5	1.2	0.4	3.9	2.7	0.6	0.0	0.2	0.0	1.0	0.0	0.0	0.5	0.2	0.5	0.9	0.0	0.3	0.7	1.2	0.0	2.7	2.8	1.8	0.0	1.8	0.4	1.0	0.2	0.6	0.1	0.5	3.6	1.2	1.4	2.3	0.4	0.2	3.5	2.5	0.5	1.2	2.4	2.2	2.1	1.1	1.0	1.0	1.0	0.9	0.8	0.8	1.5	1.1	1.4	1.3	1.1	1.9	2.1	1.4	1.7	1.0	0.2										
LRTM1	HT017	ENSG00000144771	"Leucine rich repeats and transmembrane domains 1"	Q9HBL6	3	54918237-54967088	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"lymphoid tissue: 12.2;retina: 18.8;skeletal muscle: 22.5;tongue: 15.3"	"Cell line enhanced"	"Detected in some"		"HEL: 4.2"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.5"	"Region enriched"	"Detected in single"	7	"pons and medulla: 2.9"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																		"unprognostic (2.28e-1)"	"unprognostic (1.58e-2)"								"unprognostic (9.56e-2)"	"unprognostic (2.16e-1)"		"unprognostic (1.87e-3)"	0.3	0.1	0.3	0.0	0.3	0.0	0.3	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.3	3.6	0.1	0.4	0.1	0.3	0.2	0.1	0.2	0.1	0.0	0.3	0.0	0.1	0.1	0.3	0.1	0.4	2.9	1.2	0.0	18.8	2.1	0.4	22.5	0.1	0.3	0.0	1.0	12.2	0.1	0.3	0.0	0.0	0.1	15.3	0.5	0.1	0.1	0.7	1.0	2.3	1.9	0.7	0.9	0.5	0.5	0.3	1.7	0.2	0.2	0.0	1.7	0.0	0.5	0.9	1.6	0.3	1.3	0.0	0.8	0.8	1.0	0.4	1.5	0.5	1.0	0.2	4.2	1.1	0.9	0.2	0.4	1.1	1.8	0.4	0.7	0.2	0.1	0.1	1.6	0.3	0.1	0.4	2.3	1.5	0.5	0.1	0.3	1.3	0.2	0.7	0.4	0.7	0.5	2.2	0.3	1.2	0.3	0.0	0.7	0.9	0.7	0.1	0.0	1.0	0.1	0.4	0.6	0.9	2.3	0.5	0.6	0.7	0.6	0.9	0.7	0.6	0.3	1.0	0.3	0.8	0.6	1.5	0.7	1.9	0.6	0.7	0.5	0.3	0.3	0.1	0.2	0.3	0.2	0.3	0.0	2.9	0.0
MACROD1	LRP16	ENSG00000133315	"MACRO domain containing 1"	Q9BQ69	11	63998558-64166106	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 142.5"	"Cell line enhanced"	"Detected in many"		"MCF7: 26.5;RPMI-8226: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041031, HPA071075"	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA041031: AB_10794435, HPA071075: AB_2686341"	"unprognostic (1.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (1.15e-1)"	"prognostic favourable (4.68e-6)"	"unprognostic (2.45e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.86e-2)"	4.9	3.0	2.9	2.8	3.3	2.5	3.9	6.2	4.6	3.6	6.9	2.8	7.0	4.3	3.4	6.5	7.8	3.2	3.9	29.0	2.2	3.4	10.6	10.4	3.0	1.8	3.0	3.1	5.2	16.6	2.5	2.7	2.1	3.1	6.1	1.9	4.6	16.4	8.1	142.5	5.5	3.9	6.2	2.4	2.7	5.6	1.9	2.7	0.8	12.7	25.0	3.3	4.6	4.5	0.6	0.7	0.0	1.2	0.0	2.0	0.4	3.9	2.1	0.6	3.7	0.6	0.4	3.6	2.3	1.1	1.9	1.7	2.0	10.8	15.1	8.3	0.2	10.2	0.5	0.0	0.1	1.1	7.1	5.4	8.6	10.7	2.2	4.5	0.6	0.9	1.2	0.2	0.5	0.6	4.9	3.0	0.3	26.5	6.2	15.6	1.8	8.0	5.6	4.3	50.0	0.6	0.2	5.2	10.8	2.1	15.6	14.2	11.2	0.1	1.0	1.7	2.5	2.5	0.2	6.1	0.9	2.4	1.1	4.6	1.5	0.0	0.2	0.0	2.0	1.2	1.9	0.6	1.8	1.1	0.4	0.4	0.9	0.8	0.0	0.0	0.0	0.7	0.0	0.4	2.9	3.3	6.2	4.6	2.2	3.4	3.0	3.1	3.1	2.7
MAFA	"hMafA, RIPE3b1"	ENSG00000182759	"MAF bZIP transcription factor A"	Q8NHW3	8	143419182-143430406	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 25.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.7;MCF7: 4.4;RH-30: 2.7;SCLC-21H: 6.4;T-47d: 6.1;U-2 OS: 4.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"amygdala: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"														"unprognostic (5.92e-3)"	"unprognostic (9.89e-3)"	"unprognostic (2.81e-3)"	"unprognostic (1.42e-8)"	"unprognostic (1.75e-2)"	"unprognostic (8.67e-2)"	"unprognostic (6.08e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.41e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.68e-5)"	"unprognostic (2.11e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.38e-2)"	0.2	0.1	2.5	0.1	0.2	0.2	0.1	0.0	0.6	0.2	0.2	0.0	0.0	0.1	0.1	0.3	0.6	0.1	0.1	2.1	0.4	0.2	0.3	0.1	0.7	0.1	0.1	0.2	0.1	2.2	0.2	0.5	1.8	0.9	0.3	0.1	0.7	0.4	0.1	25.6	0.1	0.1	0.1	0.7	0.1	0.1	3.4	0.0	0.4	2.5	5.5	0.4	0.1	0.1	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	2.7	0.9	0.0	0.0	0.1	1.8	0.9	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.4	0.1	0.0	4.4	0.1	0.6	0.6	0.4	0.6	2.7	0.4	0.0	0.0	6.4	0.2	1.5	0.0	0.0	6.1	0.1	0.0	0.1	4.2	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	2.5	0.2	0.0	0.6	0.4	0.2	0.1	0.2	0.9	0.0
MLIP	"C6orf142, CIP, MGC18257"	ENSG00000146147	"Muscular LMNA interacting protein"	Q5VWP3	6	53929982-54266280	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 61.7;liver: 47.4;skeletal muscle: 101.9;tongue: 31.6"	"Group enriched"	"Detected in some"	8	"HUVEC TERT2: 17.7;SK-MEL-30: 17.0"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA029252, HPA046654"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA029252: AB_2732446, HPA046654: "	"unprognostic (7.95e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.26e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.91e-5)"	"unprognostic (7.49e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.29e-3)"	5.7	1.9	4.2	0.2	5.2	0.1	1.6	0.8	11.5	0.8	0.5	0.0	0.0	0.3	0.4	3.5	4.9	0.5	0.8	61.7	1.8	0.8	0.5	47.4	0.4	0.2	7.2	8.3	0.4	0.6	0.3	0.5	0.2	1.8	0.8	0.4	1.3	2.6	0.3	101.9	6.5	1.1	0.3	2.9	0.3	0.4	0.5	0.0	0.0	2.7	31.6	2.2	0.6	1.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.4	2.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.7	2.2	0.0	0.0	17.7	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.1	0.6	1.3	0.0	0.0	0.5	17.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.2	5.2	0.8	11.5	1.8	0.8	7.2	8.3	1.8	0.0
MYH13	MyHC-eo	ENSG00000006788	"Myosin heavy chain 13"	Q9UKX3	17	10300865-10373130	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"placenta: 1.9;skeletal muscle: 5.2;stomach 1: 4.8"	"Cell line enriched"	"Detected in some"	4	"U-2 OS: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"														"unprognostic (8.86e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.81e-2)"	"unprognostic (3.95e-1)"		"unprognostic (8.35e-2)"		"unprognostic (1.42e-2)"	"unprognostic (7.50e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.40e-9)"	"unprognostic (2.44e-2)"	"unprognostic (1.08e-1)"		"unprognostic (2.06e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.9	0.1	0.1	0.0	0.1	0.1	0.1	5.2	0.0	0.8	0.1	0.1	0.4	4.8	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
MYO18B	BK125H2.1	ENSG00000133454	"Myosin XVIIIB"		22	25742144-26031041	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 141.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.6;REH: 10.9;RH-30: 23.3;U-2 OS: 10.3;U-266/70: 7.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA000953	Uncertain		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"	"Nucleoplasm, Centrosome"	"HPA000953: AB_1079440"	"unprognostic (3.28e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-2)"	"unprognostic (5.93e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.96e-3)"	"unprognostic (3.93e-7)"	"unprognostic (1.14e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.65e-1)"	3.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.4	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	1.0	0.0	141.2	0.1	0.0	1.5	0.0	0.0	0.3	2.4	0.0	0.3	1.1	16.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	3.9	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	1.9	0.7	2.9	0.0	0.3	1.1	0.0	0.0	10.9	23.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	7.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYOG	"bHLHc3, MYF4"	ENSG00000122180	Myogenin	P15173	1	203083132-203086036	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 60.0"	"Group enriched"	"Detected in some"	200	"HSkMC: 17.6;RH-30: 33.6"	"Group enriched"	"Detected in some"	6	"head and neck cancer: 3.9;testis cancer: 1.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA028336			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA028336: AB_2672562"	"unprognostic (1.71e-1)"				"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"				"unprognostic (2.22e-1)"			"unprognostic (2.79e-9)"	"unprognostic (3.96e-1)"	"unprognostic (2.56e-1)"			1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.3	0.0	0.0	2.4	0.0	60.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.7	13.3	1.7	0.0	0.0	0.8	0.8	2.3	1.3	1.8	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	33.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.4	0.8	0.4	0.7	1.0	0.8	0.5	0.6	0.3	0.6	0.9	1.0	1.4	1.8	1.3	0.8	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NDUFS7	"CI-20, FLJ45860, FLJ46880, PSST"	ENSG00000115286	"NADH:ubiquinone oxidoreductase core subunit S7"	O75251	19	1383527-1395589	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 198.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (7.36e-2)"	"prognostic favourable (2.03e-4)"	"unprognostic (5.30e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.99e-3)"	"unprognostic (8.12e-2)"	"prognostic favourable (4.90e-7)"	"unprognostic (2.95e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.34e-2)"	22.4	17.6	15.3	10.1	17.6	9.9	7.0	16.6	22.7	6.1	18.7	20.6	7.6	34.5	7.1	9.6	13.3	6.7	10.0	35.9	16.1	15.1	20.7	20.7	7.1	9.1	19.6	11.9	7.2	28.7	5.0	12.0	6.8	17.6	11.9	4.0	12.0	23.6	10.2	198.0	8.3	25.2	7.5	20.1	11.5	18.2	14.2	14.6	9.7	8.0	39.2	10.0	6.7	7.9	29.1	41.8	19.8	39.1	17.2	29.2	20.8	18.2	18.5	0.6	4.3	0.6	1.7	9.5	11.0	1.1	2.3	2.5	30.3	4.5	27.0	11.3	0.6	9.6	0.8	2.2	0.1	30.1	21.3	8.5	19.8	18.8	2.8	14.7	9.5	1.4	3.8	0.4	0.0	3.2	16.8	10.6	0.6	19.1	14.6	6.1	6.6	22.9	14.2	7.1	27.5	1.1	14.1	10.4	10.6	9.7	9.2	17.9	7.3	9.2	13.8	4.4	6.1	9.6	14.2	42.7	37.2	18.3	11.1	19.9	6.2	19.8	33.6	16.1	21.3	39.1	18.1	29.1	20.1	20.0	41.8	27.1	19.7	19.1	9.1	17.2	31.7	31.6	29.2	20.8	15.3	17.6	16.6	22.7	16.1	15.1	19.6	11.9	17.6	14.6
OBSCN	"ARHGEF30, KIAA1556, KIAA1639, UNC89"	ENSG00000154358	"Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF"	Q5VST9	1	228208130-228378874	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 180.2;tongue: 48.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 16.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"HPA021186, HPA065801"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA021186: AB_1854761, HPA065801: "	"unprognostic (8.47e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.99e-2)"	"prognostic unfavourable (1.64e-4)"	"unprognostic (5.30e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.16e-2)"	2.5	0.9	0.5	0.9	4.4	0.6	0.7	3.1	0.6	0.6	0.8	0.5	0.5	0.6	0.8	4.4	2.4	1.0	0.6	21.2	0.5	0.7	1.6	0.5	1.0	1.0	0.5	0.5	1.7	1.4	0.4	2.4	0.5	0.9	1.7	0.3	5.2	2.6	1.1	180.2	1.1	0.8	0.5	0.6	1.4	0.5	0.7	0.6	0.5	2.2	48.4	3.5	0.6	0.7	1.0	1.1	0.1	0.4	0.6	3.2	0.7	2.9	2.8	8.0	4.5	0.2	0.1	5.6	1.5	0.5	1.0	0.9	2.0	2.1	5.7	8.1	0.5	1.0	0.4	1.1	0.2	2.1	5.1	1.9	16.0	0.0	2.0	1.3	6.1	3.0	1.0	0.4	0.2	0.4	5.3	1.3	0.3	5.0	2.0	1.6	8.8	1.7	8.1	0.1	1.3	4.6	1.5	3.0	9.0	0.2	2.9	1.1	8.0	3.7	0.7	0.0	9.3	0.2	0.1	4.7	0.9	1.4	0.0	0.8	2.1	0.1	0.4	0.0	0.9	0.1	0.9	0.5	0.9	0.7	0.9	1.0	3.2	0.5	0.1	0.6	0.1	1.1	0.8	0.7	0.5	4.4	3.1	0.6	0.5	0.7	0.5	0.5	0.9	0.6
OPN4	"melanopsin, MOP"	ENSG00000122375	"Opsin 4"	Q9UHM6	10	86654557-86666848	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 21.2;skeletal muscle: 14.6"	"Cell line enhanced"	"Detected in single"		"PC-3: 1.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 21.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039147	Approved									"HPA039147: AB_10673304"	"unprognostic (3.67e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.89e-2)"		"unprognostic (3.26e-1)"	"unprognostic (9.54e-2)"	"unprognostic (5.68e-2)"	"unprognostic (8.88e-3)"		"unprognostic (1.93e-6)"	"unprognostic (4.10e-2)"		"unprognostic (5.58e-2)"	"unprognostic (6.76e-2)"	3.5	0.3	5.4	0.4	21.2	0.2	1.1	0.0	5.1	0.6	0.9	0.0	0.0	0.5	0.4	0.4	0.6	0.4	0.5	3.1	3.0	0.1	0.3	0.2	0.3	0.2	0.2	3.3	0.3	0.4	3.6	0.6	0.5	0.0	0.2	0.7	1.2	1.6	0.2	14.6	1.2	1.1	0.5	0.0	0.3	0.5	0.5	2.0	0.0	1.4	2.7	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	21.2	0.0	3.5	3.0	0.1	0.2	3.3	0.0	2.0
OPTN	"FIP-2, FIP2, GLC1E, HIP7, HYPL, NRP, TFIIIA-INTP"	ENSG00000123240	Optineurin	Q96CV9	10	13099449-13138308	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 170.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003279, HPA003360, CAB019303"	Approved		Enhanced	Cytosol				Cytosol	Cytosol	"CAB019303: , HPA003279: AB_1079527, HPA003360: AB_1079528"	"unprognostic (2.84e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.79e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.58e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.15e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.14e-1)"	"prognostic unfavourable (5.81e-5)"	"unprognostic (7.62e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	19.3	21.4	16.1	8.4	15.4	9.6	17.9	17.1	20.4	9.5	11.8	9.4	5.8	14.3	9.4	6.9	14.5	7.3	10.1	32.5	11.9	13.6	16.6	16.7	12.0	9.5	16.2	18.0	22.1	8.2	8.9	9.9	13.0	21.0	9.9	13.4	5.8	10.2	10.2	170.7	17.6	16.0	10.3	16.9	12.4	12.7	16.0	12.5	4.9	6.4	24.5	8.4	11.0	19.8	6.0	1.8	11.9	1.1	16.0	34.5	9.2	18.5	5.3	3.0	4.1	41.1	42.4	3.5	22.4	25.6	17.0	28.2	9.3	24.9	0.1	8.9	30.5	17.4	3.9	21.5	13.0	43.2	2.1	3.8	7.4	5.0	42.1	0.1	14.0	22.7	17.0	16.2	17.0	14.4	4.7	28.8	22.8	3.9	1.8	0.5	1.2	2.4	0.3	5.9	1.9	20.7	13.3	0.8	3.2	19.4	5.9	14.5	12.7	2.6	39.2	14.0	6.9	18.9	6.2	14.9	5.1	0.1	21.0	3.2	2.6	11.9	0.8	0.1	19.7	0.5	15.0	6.0	24.9	22.6	0.1	3.4	10.1	12.3	0.7	16.0	1.1	1.8	34.5	9.2	16.1	15.4	17.1	20.4	11.9	13.6	16.2	18.0	21.0	12.5
OR9Q1		ENSG00000186509	"Olfactory receptor family 9 subfamily Q member 1"	Q8NGQ5	11	58023881-58181616	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	5	"skeletal muscle: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																										"unprognostic (2.65e-3)"	"unprognostic (2.27e-1)"				0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.1		0.0	0.0		0.1	0.0	3.1	0.5	0.0	0.0	0.0	0.1	0.0	0.6			0.0		0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.5	0.4	0.3	0.7	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.5	0.2	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.3	0.3	0.2	0.2	0.1	0.1	0.1	0.8	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0										
PDLIM3	ALP	ENSG00000154553	"PDZ and LIM domain 3"	Q53GG5	4	185500660-185535612	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 447.7"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 50.0;RH-30: 12.3;U-266/70: 40.2;U-266/84: 11.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA004749	Enhanced		Supported	Cytosol		270000	270000	Cytosol	Cytosol	"HPA004749: AB_1855150"	"unprognostic (2.75e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavourable (7.22e-4)"	"unprognostic (3.15e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.46e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavourable (4.97e-7)"	"unprognostic (1.64e-3)"	"unprognostic (7.77e-2)"	"prognostic unfavourable (2.13e-6)"	"unprognostic (2.78e-3)"	7.8	1.2	1.6	5.2	1.9	0.1	3.7	2.2	1.0	6.6	16.5	1.4	7.9	2.3	22.2	17.0	27.2	9.3	9.9	29.5	1.5	1.6	0.8	0.8	5.6	1.4	1.6	1.0	11.1	2.1	0.1	1.9	2.2	1.6	15.2	3.6	4.8	5.3	18.7	447.7	1.0	6.1	49.5	1.4	3.4	10.2	3.9	0.7	0.1	6.2	87.3	9.1	28.4	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.4	1.9	5.5	0.0	0.0	3.9	0.0	1.2	0.0	4.1	0.0	0.0	50.0	0.0	0.0	0.0	0.9	0.3	0.0	12.3	0.1	0.0	0.0	7.4	5.6	0.0	0.0	2.9	0.2	0.0	2.7	0.0	3.0	0.0	2.5	40.2	11.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	2.2	1.0	1.5	1.6	1.6	1.0	1.6	0.7
PFKM	"PFK-1, PFKX, PPP1R122"	ENSG00000152556	"Phosphofructokinase, muscle"	P08237	12	48105139-48146404	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 284.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002117	Approved		Approved	"Endoplasmic reticulum"		1100000	1100000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA002117: AB_1855245"	"unprognostic (4.60e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavourable (5.85e-6)"	"unprognostic (4.97e-1)"	"prognostic unfavourable (7.91e-5)"	"unprognostic (5.93e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.29e-3)"	"unprognostic (6.73e-2)"	"prognostic favourable (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.30e-2)"	4.4	11.6	10.0	3.0	16.2	2.3	3.9	13.0	23.6	5.8	5.3	6.1	5.4	3.0	6.4	5.8	9.1	5.4	4.8	55.5	8.2	10.1	10.9	2.7	3.6	2.4	9.4	10.8	10.8	3.0	14.2	11.4	3.3	17.9	7.1	4.2	10.8	5.2	9.4	284.3	2.6	2.8	8.3	4.6	2.7	4.1	10.3	3.8	0.0	5.5	54.9	4.6	5.3	3.7	10.7	6.7	8.7	3.2	2.2	5.4	3.5	8.7	8.5	27.0	24.6	27.6	20.1	5.5	23.7	21.8	20.5	14.6	21.0	11.0	52.2	19.7	11.5	9.8	23.4	23.9	19.3	1.2	12.2	14.9	19.4	0.7	14.8	0.7	8.6	28.4	14.1	18.0	29.7	23.3	17.8	26.4	18.9	6.6	18.3	1.2	19.3	26.5	30.9	15.8	40.1	14.0	9.7	32.0	23.5	14.0	22.3	23.7	22.5	3.2	20.9	9.5	13.2	13.9	19.7	14.4	38.4	28.6	18.4	1.5	8.0	0.4	3.2	8.7	2.5	2.8	1.0	10.7	4.3	2.4	6.7	7.0	5.4	3.0	0.8	2.2	2.3	1.0	3.8	3.5	10.0	16.2	13.0	23.6	8.2	10.1	9.4	10.8	17.9	3.8
PKM	"OIP3, PK3, PKM2, THBP1"	ENSG00000067225	"Pyruvate kinase M1/2"	P14618	15	72199029-72231822	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 541.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019421, HPA029501"	Uncertain		Enhanced	Cytosol		540000000	540000000	Cytosol	Cytosol	"CAB019421: AB_2252325, HPA029501: AB_10602118"	"unprognostic (8.73e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavourable (1.30e-4)"	"prognostic unfavourable (2.74e-6)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (5.17e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-2)"	23.2	76.8	53.8	49.8	70.4	57.5	41.6	56.6	85.9	65.7	31.2	32.1	31.5	26.4	24.7	41.8	76.4	37.9	32.9	94.8	50.1	57.1	60.9	6.1	33.3	39.4	62.5	63.6	26.2	15.6	33.3	28.3	27.1	80.5	34.8	31.9	54.4	47.1	47.5	541.2	51.8	25.1	44.7	34.9	30.7	26.7	29.0	29.4	23.5	23.8	114.4	60.6	53.1	40.9	25.1	79.6	14.9	90.6	11.6	37.4	114.9	81.5	209.8	42.3	50.0	50.9	57.2	35.0	88.5	206.7	142.1	143.9	59.0	100.5	62.1	89.6	165.6	118.9	133.7	180.0	111.4	109.0	63.2	38.0	105.5	48.8	35.5	49.3	82.0	51.9	83.9	109.5	45.0	83.6	9.5	49.8	224.1	50.7	18.4	21.2	52.3	80.1	54.7	135.4	118.3	188.7	105.0	44.0	48.0	115.4	71.2	90.5	49.9	35.9	65.1	161.9	88.6	158.2	160.5	64.0	90.4	54.7	199.3	81.6	158.6	12.6	90.6	14.9	23.5	52.6	22.8	25.1	31.3	23.2	79.6	16.1	27.3	20.2	11.8	11.6	40.2	16.2	37.4	114.9	53.8	70.4	56.6	85.9	50.1	57.1	62.5	63.6	80.5	29.4
POPDC3	"bA355M14.1, MGC22671, POP3"	ENSG00000132429	"Popeye domain containing 3"	Q9HBV1	6	105158280-105179995	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"heart muscle: 23.9;skeletal muscle: 68.9"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 13.2;RH-30: 14.7;SH-SY5Y: 12.2;U-87 MG: 13.3;WM-115: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA012514			Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"	"Nucleoli, Cytosol"	"HPA012514: "	"unprognostic (2.17e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.74e-2)"	"prognostic unfavourable (4.43e-4)"	"unprognostic (2.24e-3)"	"prognostic unfavourable (5.79e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.12e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.83e-9)"	"unprognostic (6.25e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.33e-2)"	0.9	0.8	2.2	1.4	4.5	0.6	2.5	0.4	6.8	0.8	1.4	2.1	0.8	0.7	1.3	2.2	2.1	0.7	1.1	23.9	3.7	2.3	0.6	0.6	0.7	0.7	6.1	3.5	0.7	0.6	0.6	3.2	1.2	4.0	1.2	0.6	1.9	1.0	0.8	68.9	0.6	0.6	0.6	3.6	0.6	1.6	3.6	4.0	0.0	0.8	8.8	0.6	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.6	0.4	0.1	2.7	6.9	0.6	2.7	2.8	4.7	5.8	0.0	1.5	0.1	1.1	5.4	0.0	1.3	1.2	3.9	0.0	2.9	0.0	1.0	0.0	0.1	0.0	0.0	2.7	0.2	7.6	1.0	0.3	2.8	8.1	13.2	0.0	0.0	1.0	3.0	4.6	0.4	14.7	0.0	0.0	0.0	6.7	12.2	0.0	0.0	9.5	0.0	5.2	6.0	2.9	0.0	1.9	9.9	0.0	0.0	0.0	13.3	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	4.5	0.4	6.8	3.7	2.3	6.1	3.5	4.0	4.0
PPDPFL	C8orf22	ENSG00000168333	"Pancreatic progenitor cell differentiation and proliferation factor like"	Q8WWR9	8	49054311-49076090	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 311.2"	"Cell line enriched"	"Detected in single"	10	"HEL: 5.6"	"Group enriched"	"Detected in some"	9	"glioma: 0.7;renal cancer: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060329	Uncertain									"HPA060329: AB_2684255"					"unprognostic (6.33e-2)"							"unprognostic (2.72e-1)"	"prognostic unfavourable (2.06e-10)"					0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.7	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.5	0.1	311.2	0.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	57.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0
PPP1R3C	"PPP1R5, PTG"	ENSG00000119938	"Protein phosphatase 1 regulatory subunit 3C"	Q9UQK1	10	91628442-91633054	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 259.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 17.3;HHSteC: 21.9;LHCN-M2: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027041	Uncertain									"HPA027041: AB_1855649"	"unprognostic (2.11e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.57e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.63e-3)"	"unprognostic (1.59e-2)"	"unprognostic (5.48e-3)"	"unprognostic (8.44e-3)"	"unprognostic (4.86e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.61e-3)"	4.0	5.4	10.4	2.8	18.9	1.5	3.5	1.1	15.8	24.9	4.1	8.0	8.3	2.7	7.1	6.5	26.5	4.5	6.0	53.3	13.1	5.7	5.4	39.5	5.4	1.8	6.1	8.1	6.6	5.6	2.8	1.7	6.3	12.2	11.0	2.8	4.5	10.0	13.4	259.9	4.4	2.2	14.8	9.1	2.2	5.2	2.2	6.1	0.0	2.4	28.2	7.7	11.4	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.7	10.9	5.0	2.4	0.0	12.1	9.4	4.9	5.3	0.0	0.9	0.0	0.5	11.2	0.6	0.2	1.3	9.2	0.0	0.0	0.1	17.3	1.9	21.9	0.0	0.0	8.1	2.1	3.1	0.2	1.2	5.6	0.0	41.9	0.4	0.0	0.0	0.7	0.0	0.0	2.6	0.0	0.4	10.5	0.3	0.7	0.0	0.0	0.0	0.0	1.8	8.2	2.2	2.2	2.9	1.7	0.0	0.2	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	18.9	1.1	15.8	13.1	5.7	6.1	8.1	12.2	6.1
PRKAG3		ENSG00000115592	"Protein kinase AMP-activated non-catalytic subunit gamma 3"	Q9UGI9	2	218822383-218832086	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 40.4"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 2.3;HSkMC: 4.6;LHCN-M2: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (3.51e-1)"	"unprognostic (4.41e-3)"		"unprognostic (2.05e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.86e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.44e-2)"	"unprognostic (5.85e-2)"	"unprognostic (3.27e-1)"	"unprognostic (9.04e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.97e-1)"	"unprognostic (7.69e-2)"	2.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.8	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.6	0.0	40.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	8.2	0.7	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS42	TESSP2	ENSG00000178055	"Serine protease 42"	Q7Z5A4	3	46829542-46834095	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"heart muscle: 12.9;skeletal muscle: 19.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.3;Daudi: 3.9;Karpas-707: 2.4;NTERA-2: 3.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046925	Uncertain				"Secreted - unknown location"					"HPA046925: AB_10961401"	"unprognostic (6.53e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.57e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.26e-1)"		"unprognostic (2.37e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.54e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.98e-2)"	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.2			0.0	0.2	3.4	0.0	0.2	0.0	12.9	0.0	0.0	1.3	0.5	0.2	0.0	0.0		0.2	0.2	1.6	0.0	0.1		0.4	0.0		0.3	0.2	19.2	0.0	0.0	0.0	0.0	0.4	0.0	0.7			0.8		0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.8	0.2	1.6	0.0	0.0	0.0	0.7	0.2	2.3	3.9	0.4	0.0	0.0	0.0	0.2	1.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.0	0.4	3.6	0.0	1.2	0.0	0.0	0.1	0.0	0.6	0.5	0.5	0.0	0.3	0.0	0.5	0.0	1.0	0.7	0.0	0.0	0.0	0.3	0.9	0.1	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RASA4	"CAPRI, GAPL, KIAA0538"	ENSG00000105808	"RAS p21 protein activator 4"	O43374	7	102573807-102616757	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 58.0"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 27.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA043010	Uncertain		Uncertain	Vesicles				Vesicles	Vesicles	"HPA043010: AB_2678267"	"unprognostic (6.44e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.62e-3)"	"unprognostic (4.19e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.18e-2)"	5.5	2.3	4.2	2.5	2.6	1.6	4.4	2.7	4.7	4.9	4.0			3.6	6.3	1.8	1.9	3.6	1.9	1.5	3.6	3.0	3.3	0.2	2.7	3.6	1.9		4.1	2.1	6.8	3.7	4.0		3.3	1.6		2.0	5.6	58.0	5.4	4.3	3.2	1.2	4.1	2.2	0.6			2.2		2.4	3.9	4.7	3.6	11.3	2.2	9.4	1.5	3.7	3.1	0.7	1.2	9.1	1.8	1.6	4.7	0.3	9.3	4.7	3.1	3.3	3.7	2.7	7.1	6.9	14.1	9.1	0.4	0.1	2.3	1.3	2.4	2.0	3.6	0.9	1.8	1.3	2.7	4.3	1.1	0.8	0.4	1.6	3.1	10.5	0.7	3.6	7.1	4.9	0.7	4.7	9.7	2.0	10.2	0.3	3.4	8.9	18.6	1.7	2.1	1.2	1.8	3.6	2.3	27.3	13.3	3.1	2.3	16.6	10.2	6.1	3.4	3.0	3.3	0.4	8.4	0.3	1.9	9.4	3.7	2.8	3.2	2.2	11.3	3.6	3.4	2.4	2.2	1.5	1.2	9.8	3.5	3.1										
RBFOX1	"A2BP1, FOX-1, HRNBP1"	ENSG00000078328	"RNA binding fox-1 homolog 1"	Q9NWB1	16	5239802-7713338	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 57.2;heart muscle: 17.6;skeletal muscle: 67.6"	"Cell line enriched"	"Detected in some"	15	"RH-30: 24.5"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040809, HPA066746"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA040809: AB_10796228, HPA066746: "	"unprognostic (3.75e-3)"		"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.19e-3)"		"unprognostic (8.82e-5)"	"unprognostic (5.02e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.28e-1)"		1.2	2.4	19.9	1.5	33.0	1.6	1.3	31.5	57.2	1.4	1.9	1.9	0.0	1.3	1.3	5.0	2.0	2.2	1.3	17.6	16.4	6.7	1.5	1.3	1.2	1.2	3.7	21.7	1.4	1.3	1.2	0.5	1.3	13.5	2.6	1.7	0.0	1.7	4.9	67.6	1.5	1.4	1.2	3.5	1.2	1.4	1.7	5.6	0.0	1.3	9.7	1.2	1.5	0.3	1.7	0.7	3.1	0.7	1.2	1.4	0.0	0.1	0.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	1.4	0.0	0.0	24.5	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.1	0.2	0.2	0.0	2.4	0.6	2.0	1.1	0.3	0.7	1.0	0.9	0.8	0.3	1.7	1.4	1.0	3.1	1.2	0.7	0.7	1.0	0.0	19.9	33.0	31.5	34.3	16.4	6.7	3.7	21.7	13.5	5.6
SCN1B		ENSG00000105711	"Sodium voltage-gated channel beta subunit 1"	Q07699	19	35030466-35040449	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 78.5;skeletal muscle: 161.9"	"Cell line enhanced"	"Detected in many"		"A549: 13.4;EFO-21: 10.0;TIME: 20.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 458.8"						"Intracellular and membrane"						"unprognostic (8.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.34e-2)"	"unprognostic (4.72e-3)"	"prognostic favourable (1.38e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.05e-2)"	"unprognostic (9.68e-3)"	"unprognostic (5.81e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.78e-2)"	5.0	5.4	9.3	2.6	16.4	2.1	2.9	45.8	78.5	5.2	2.8	4.5	0.3	2.0	2.7	3.5	5.0	4.3	3.3	24.9	12.7	7.3	2.2	3.3	2.7	2.4	14.3	7.4	2.6	2.4	10.5	2.6	3.5	33.6	2.7	2.4	3.5	2.5	2.9	161.9	2.1	2.5	3.2	7.0	6.7	2.7	2.0	3.0	0.0	2.4	16.1	1.6	3.9	1.5	1.3	1.5	7.0	0.8	1.7	1.7	1.8	0.3	13.4	0.1	0.7	4.2	6.4	0.2	5.4	4.8	2.7	0.7	0.5	0.1	0.2	10.0	5.4	0.2	0.8	0.5	1.3	0.1	0.7	0.2	1.9	3.4	5.5	0.1	0.1	2.0	0.1	0.3	0.2	9.0	0.3	0.1	1.7	1.3	0.1	0.1	0.7	3.9	0.7	1.4	0.1	0.4	0.1	6.3	3.4	0.6	0.1	1.0	1.3	0.4	20.1	5.3	5.3	0.2	3.4	0.3	0.4	0.8	3.1	0.6	3.8	7.0	0.8	0.9	1.1	0.4	1.7	0.6	0.6	0.4	1.5	1.3	0.5	0.7	3.1	1.7	0.4	1.1	0.7	1.8	9.3	16.4	45.8	78.5	12.7	7.3	14.3	7.4	33.6	3.0
SEMA6C	KIAA1869	ENSG00000143434	"Semaphorin 6C"	Q9H3T2	1	151131685-151146664	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 124.1;tongue: 43.4"	"Cell line enhanced"	"Detected in many"		"AF22: 11.7;HUVEC TERT2: 20.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA076150, HPA077625"			Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	290000	290000	"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"HPA076150: , HPA077625: "	"unprognostic (6.97e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.56e-3)"	"prognostic unfavourable (3.27e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.25e-2)"	"prognostic favourable (3.06e-5)"	"unprognostic (3.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-1)"	3.2	1.9	2.3	1.5	3.0	1.3	3.4	16.8	5.8	4.2	2.6	1.5	0.8	6.7	4.1	3.5	3.2	2.9	3.9	12.7	2.3	3.5	3.0	3.3	1.9	3.4	1.7	3.3	4.8	1.7	1.7	4.3	1.6	2.7	2.8	1.6	3.4	3.1	1.9	124.1	3.4	5.2	3.6	1.1	1.3	1.6	15.0	0.6	0.5	1.3	43.4	2.9	2.2	3.6	0.9	0.6	0.7	0.0	0.1	1.4	0.2	0.7	0.8	11.7	4.5	4.9	1.6	1.0	0.8	0.4	0.8	1.1	0.2	0.5	0.5	3.4	2.7	1.1	1.1	0.4	0.7	1.0	3.4	6.1	0.5	0.9	0.6	0.1	2.3	2.8	1.4	1.0	0.5	20.4	0.5	0.6	1.9	0.4	1.0	0.8	5.2	1.3	7.2	2.6	0.2	0.4	0.3	5.9	7.7	1.1	0.5	0.9	1.3	1.0	9.5	2.0	2.8	2.9	0.4	4.9	0.9	5.0	0.5	0.2	0.7	0.0	0.0	0.7	0.1	0.0	1.4	0.0	0.2	0.0	0.0	0.9	0.5	0.0	0.5	0.1	0.0	0.6	0.3	0.2	2.3	3.0	16.8	5.8	2.3	3.5	1.7	3.3	2.7	0.6
SGCG	"A4, DAGA4, DMDA, DMDA1, LGMD2C, MAM, MGC130048, SCARMD2, SCG3, TYPE"	ENSG00000102683	"Sarcoglycan gamma"	Q13326	13	23180952-23325165	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 40.9;skeletal muscle: 53.3;tongue: 44.3"	"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 37.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA007476	Enhanced									"HPA007476: AB_1079946"	"unprognostic (5.19e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.64e-4)"	"unprognostic (3.00e-3)"	"unprognostic (3.61e-2)"		"unprognostic (8.14e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.49e-1)"	"unprognostic (6.05e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.07e-1)"	8.6	0.1	0.1	0.2	0.1	0.0	2.9	0.2	0.6	0.1	0.4	0.1	0.1	0.0	0.1	3.8	2.6	0.3	0.3	40.9	0.3	0.1	0.1	0.1	1.7	0.1	0.1	0.1	0.1	0.1	1.6	0.1	0.1	0.1	1.2	0.1	0.5	2.1	0.1	53.3	1.3	0.2	0.1	0.1	0.1	0.4	0.6	0.1	0.1	0.7	44.3	3.3	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	37.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.2	0.0	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.2	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.6	0.3	0.1	0.1	0.1	0.1	0.1
SH3BGR	21-GARP	ENSG00000185437	"SH3 domain binding glutamate rich protein"	P55822	21	39445855-39515506	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 219.7"	"Cell line enhanced"	"Detected in many"		"U-266/70: 15.3;U-87 MG: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.5"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"cerebellum: 34.0;midbrain: 14.7;olfactory region: 12.3;pons and medulla: 29.7"	"Low region specificity"	"Detected in all"			"CAB003685, HPA030690"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB003685: AB_425682, HPA030690: AB_2673570"	"unprognostic (3.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.68e-3)"	"unprognostic (6.05e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.89e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.97e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.75e-1)"	"unprognostic (5.98e-3)"	"unprognostic (7.16e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.06e-2)"	2.4	5.2	7.2	1.2	7.3	0.9	2.9	1.1	4.3	2.9	6.1	3.0	2.0	1.9	2.1	6.6	5.3	2.1	5.0	30.0	6.6	5.4	3.2	2.8	1.5	0.9	7.5	5.0	1.8	2.8	2.1	4.5	1.1	6.1	5.8	2.0	1.2	3.2	5.2	219.7	0.9	1.4	12.4	7.9	1.2	2.9	3.7	5.9	0.1	3.9	41.5	2.2	7.3	8.6	2.7	11.5	2.6	1.7	2.8	4.0	1.2	1.0	1.3	1.7	2.5	3.7	4.3	0.5	1.9	0.9	0.9	0.7	0.7	2.2	3.3	5.1	5.0	0.1	0.9	1.5	1.4	2.0	3.4	3.3	0.6	1.3	7.6	1.2	0.7	3.5	6.2	3.2	6.3	1.0	2.5	4.3	3.5	4.1	2.2	1.9	1.7	2.9	3.5	6.4	2.1	4.6	0.8	4.8	2.0	2.9	2.4	3.1	9.0	0.6	0.8	2.5	0.3	1.5	3.7	15.3	3.2	3.3	47.5	2.9	3.3	2.3	0.7	0.0	1.2	1.7	3.1	2.7	1.1	1.8	1.9	1.4	4.0	3.0	2.6	2.8	1.7	11.5	0.7	1.2	7.2	7.3	1.1	4.3	6.6	5.4	7.5	5.0	6.1	5.9
SHISA4	"C1orf40, hShisa4, TMEM58"	ENSG00000198892	"Shisa family member 4"	Q96DD7	1	201888680-201892306	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 175.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"eosinophil: 18.3;intermediate monocyte: 6.4;neutrophil: 8.2;non-classical monocyte: 7.8"	"Group enriched"	"Detected in many"	9	"granulocytes: 18.3;monocytes: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061273, HPA067885"	Uncertain									"HPA061273: AB_2684460, HPA067885: "	"unprognostic (1.13e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.48e-3)"	"unprognostic (2.12e-3)"	"unprognostic (6.59e-2)"	"unprognostic (8.29e-3)"	"unprognostic (7.06e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-1)"	5.2	15.8	22.2	3.8	18.8	2.5	3.3	9.6	34.8	4.7	3.3	29.1	2.1	2.7	4.4	4.5	4.0	3.9	4.7	14.7	17.5	14.6	4.1	3.8	4.0	2.7	19.2	14.8	6.8	4.1	4.1	3.8	3.8	21.3	6.2	2.9	7.2	12.1	5.1	175.2	4.2	3.2	4.7	14.0	3.4	3.2	4.2	8.2	0.0	6.3	18.8	2.7	3.9	2.6	0.0	0.7	18.3	7.8	0.0	1.5	0.5	1.2	9.4	1.1	6.7	10.2	6.1	1.0	8.2	13.4	3.4	4.8	1.6	2.5	0.0	11.2	10.1	2.4	0.1	1.3	2.2	1.0	0.6	0.1	2.8	1.1	7.2	0.0	6.0	6.2	3.0	4.4	2.2	6.2	0.1	0.3	6.0	1.1	0.0	0.0	0.7	11.4	0.1	0.0	1.8	3.3	3.6	0.4	6.1	2.9	1.3	8.3	3.8	0.8	6.2	4.8	4.8	2.7	4.2	1.6	1.3	0.0	7.9	0.0	8.4	0.0	1.4	18.3	1.5	6.4	0.6	0.0	0.3	0.3	0.7	0.0	0.0	0.3	8.2	0.0	7.8	0.0	0.0	0.5	22.2	18.8	9.6	34.8	17.5	14.6	19.2	14.8	21.3	8.2
SLC25A4	"ANT1, PEO2, PEO3, T1"	ENSG00000151729	"Solute carrier family 25 member 4"	P12235	4	185143241-185150382	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 163.7;skeletal muscle: 92.5;tongue: 62.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.5;dendritic cells: 3.0;T-cells: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (4.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.90e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (3.41e-4)"	"unprognostic (2.05e-1)"	"prognostic favourable (0.00e+0)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.28e-3)"	3.0	4.2	6.9	2.0	10.8	1.4	3.1	19.4	14.4	2.6	6.6	3.7	2.9	2.8	3.0	3.4	6.7	3.7	3.5	163.7	7.4	7.3	8.3	4.3	3.0	2.0	6.3	6.1	3.6	3.0	4.6	4.6	2.2	12.8	6.2	3.4	7.9	4.4	8.5	92.5	2.3	4.1	5.5	4.5	2.1	5.3	3.1	2.3	0.0	4.6	62.4	3.4	4.4	2.1	3.5	3.0	0.4	0.0	0.7	4.1	1.5	0.7	3.2	2.7	5.4	2.9	0.3	4.9	2.7	0.9	3.3	3.3	7.0	1.8	2.3	1.9	3.2	2.6	10.3	2.8	2.1	4.0	8.8	1.6	4.9	8.2	6.0	1.4	1.6	2.2	7.0	5.0	1.4	2.4	3.8	1.8	2.0	5.1	1.6	3.1	4.3	7.0	2.6	1.4	3.3	7.4	5.0	8.7	6.6	3.2	1.4	12.4	2.5	1.2	1.8	0.2	1.5	1.6	3.4	7.8	3.5	3.0	2.4	0.3	3.0	0.0	0.0	0.0	4.1	0.0	3.1	3.5	1.4	3.5	0.1	2.2	1.2	3.0	0.4	0.7	0.0	3.0	1.2	1.5	6.9	10.8	19.4	14.1	7.4	7.3	6.3	6.1	12.8	2.3
SLC8A3	NCX3	ENSG00000100678	"Solute carrier family 8 member A3"	P57103	14	70044217-70189070	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 17.0;skeletal muscle: 32.1"	"Cell line enhanced"	"Detected in some"		"AF22: 3.9;LHCN-M2: 7.2;SH-SY5Y: 23.3"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.65e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.45e-3)"	"unprognostic (8.53e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.38e-1)"	0.7	2.8	6.1	1.2	6.1	1.0	0.9	3.8	17.0	1.4	1.1	3.1	0.0	1.1	0.9	1.0	1.1	0.7	1.3	1.5	5.8	8.2	0.6	0.6	1.6	1.0	4.7	7.1	0.6	1.0	0.6	1.5	0.7	6.4	1.2	1.1	1.5	0.6	0.8	32.1	0.8	1.2	1.2	2.8	0.7	1.2	0.8	1.9	0.0	0.6	4.9	0.9	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	23.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	6.1	6.1	3.8	10.6	5.8	8.2	4.7	7.1	6.4	1.9
STK25	"SOK1, YSK1"	ENSG00000115694	"Serine/threonine kinase 25"	O00506	2	241492674-241509730	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 164.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047147	Uncertain									"HPA047147: AB_10966137"	"unprognostic (1.75e-1)"	"unprognostic (8.29e-2)"	"prognostic unfavourable (6.03e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (3.91e-8)"	"unprognostic (6.16e-2)"	"unprognostic (7.15e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.58e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.58e-1)"	17.8	13.6	22.3	14.2	26.0	16.3	12.9	22.3	35.3	16.4	17.1	17.0	13.0	14.6	17.7	15.9	19.3	15.4	16.7	19.0	19.4	20.0	17.3	13.5	13.4	13.5	16.3	20.4	17.5	19.2	18.9	17.1	15.6	16.4	15.1	12.9	13.5	14.2	17.6	164.2	15.3	14.2	17.3	12.6	15.8	16.1	16.8	14.4	15.2	20.0	24.6	12.6	14.6	16.6	15.0	13.6	13.7	16.4	21.5	19.9	10.6	18.3	11.7	23.4	29.0	28.8	20.1	36.0	30.7	20.7	23.4	26.8	13.0	16.2	7.0	8.7	40.9	15.7	32.9	33.4	28.5	26.2	34.5	19.6	24.8	33.6	26.1	11.9	15.1	28.9	24.0	22.6	18.2	52.8	30.2	6.2	42.8	19.3	17.6	18.5	32.6	16.8	29.7	29.8	10.4	20.6	15.6	39.3	18.0	14.9	11.3	19.2	9.0	21.1	61.5	17.7	21.7	20.3	21.7	12.9	2.9	11.9	17.1	9.8	20.0	13.7	14.8	11.5	16.9	13.4	15.5	14.5	15.5	17.5	13.6	15.0	12.0	11.6	5.5	21.5	16.4	10.7	19.9	10.6	22.3	26.0	22.3	35.3	19.4	20.0	16.3	20.4	16.4	14.4
SYNPO	KIAA1029	ENSG00000171992	Synaptopodin	Q8N3V7	5	150601080-150659220	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 66.1;placenta: 63.4;skeletal muscle: 222.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 25.8;EFO-21: 21.3;HUVEC TERT2: 20.9;TIME: 50.7;U-87 MG: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	25	"memory B-cell: 2.9;naive B-cell: 3.3"	"Lineage enriched"	"Detected in single"	27	"B-cells: 3.3"	"Group enriched"	"Detected in many"	6	"amygdala: 75.9;basal ganglia: 61.9;cerebral cortex: 93.2;hippocampal formation: 69.5;olfactory region: 42.1"	"Low region specificity"	"Detected in all"			"CAB033265, HPA034631, CAB037325, HPA071347"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB033265: AB_2201163, CAB037325: , HPA034631: AB_10669994, HPA071347: "	"unprognostic (2.09e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (1.53e-6)"	"unprognostic (1.23e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.35e-2)"	17.3	14.6	17.7	4.4	18.9	0.6	5.7	1.4	24.9	4.3	5.5	2.4	0.8	6.6	5.1	4.8	6.7	4.4	6.8	66.1	16.6	4.0	15.8	7.8	11.7	2.4	4.5	5.6	23.3	6.8	2.5	2.8	63.4	3.7	7.6	4.1	16.4	2.6	6.7	222.7	1.8	7.6	8.2	4.8	14.5	4.7	17.4	3.9	0.5	4.0	5.7	2.6	6.2	17.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	6.9	0.0	0.1	1.0	0.9	25.8	3.9	5.4	1.3	1.1	6.0	2.8	0.0	21.3	5.6	2.5	0.0	3.8	0.5	0.0	0.0	0.0	10.4	1.3	5.8	0.0	0.2	1.1	6.2	1.5	1.1	20.9	0.0	0.0	1.2	0.4	0.0	0.1	0.8	3.3	0.1	0.2	0.0	1.0	0.5	2.4	11.5	5.6	6.2	0.2	0.4	1.8	50.7	5.1	15.9	0.1	1.0	0.2	0.0	0.3	44.9	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.7	18.9	1.4	24.9	16.6	4.0	4.5	5.6	3.7	3.9
TBX1	"CATCH22, VCF"	ENSG00000184058	"T-box 1"	O43435	22	19756703-19783593	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 36.5"	"Cell line enhanced"	"Detected in some"		"HEK 293: 9.9;K-562: 47.6;NB-4: 11.2;TIME: 15.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"basal ganglia: 3.0"	"Group enriched"	"Detected in some"	13	"basophil: 1.0;eosinophil: 2.7"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029330			Approved	"Nuclear bodies,Cytoplasmic bodies"				"Nuclear bodies, Cytoplasmic bodies"	"Nuclear bodies, Cytoplasmic bodies"	"HPA029330: AB_2673002"	"unprognostic (2.54e-1)"	"unprognostic (4.28e-3)"	"unprognostic (7.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.30e-3)"	"unprognostic (9.14e-2)"	"unprognostic (4.44e-1)"	"unprognostic (8.31e-2)"	"prognostic favourable (8.90e-4)"	1.4	0.2	0.6	0.6	3.0	0.0	3.7	0.6	0.6	2.5	2.3	0.6	0.6	0.4	0.9	0.6	2.5	2.8	0.6	0.6	0.6	0.0	0.6	0.6	2.2	1.7	0.6	0.6	0.7	0.6	3.7	0.6	0.6	0.6	2.3	0.2	0.6	3.4	0.6	36.5	4.6	0.8	0.6	0.6	0.6	0.1	7.0	0.6	0.6	5.3	0.6	1.9	1.1	3.3	0.0	0.1	2.7	0.0	0.0	0.1	0.0	5.9	0.6	0.1	4.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.1	0.3	5.1	4.4	0.0	0.2	9.9	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	47.6	0.0	3.2	1.1	0.1	11.2	0.7	6.9	0.1	4.5	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	2.0	3.0	15.2	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	1.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	3.0	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6
TMEM38A	"MGC3169, TRIC-A"	ENSG00000072954	"Transmembrane protein 38A"	Q9H6F2	19	16661127-16690029	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 158.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 12.1;U-266/70: 12.2;U-698: 20.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 20.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048100, HPA050463"	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA048100: , HPA050463: AB_2681137"	"unprognostic (1.56e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.49e-1)"	"prognostic favourable (2.78e-5)"	"unprognostic (2.94e-2)"	"prognostic unfavourable (7.96e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-1)"	"prognostic favourable (2.99e-10)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.96e-2)"	1.3	1.6	3.6	1.1	7.9	2.3	1.2	5.1	12.2	1.3	1.4	2.1	3.1	1.3	1.1	6.6	3.5	1.8	1.0	5.4	3.0	3.8	2.0	2.7	2.1	1.3	5.2	3.7	1.2	1.3	1.7	2.2	0.9	4.8	2.9	1.5	8.3	2.7	2.4	158.8	1.0	1.1	1.1	1.9	1.0	5.3	1.6	1.4	0.0	1.8	30.1	1.9	1.1	0.4	3.9	0.5	20.3	2.9	2.1	0.5	0.6	3.0	0.6	0.8	4.7	2.6	0.3	0.4	1.1	0.6	0.7	1.5	0.9	4.4	12.1	1.9	0.2	2.5	6.2	1.3	0.7	0.8	1.8	0.0	1.8	1.0	0.7	0.1	0.2	1.1	4.8	0.9	0.5	0.3	0.1	1.1	0.5	4.6	0.1	1.2	1.2	7.2	6.3	1.1	3.2	4.6	2.3	7.8	5.4	3.3	0.4	1.5	2.3	1.0	0.0	0.9	2.3	2.9	0.5	12.2	8.8	20.3	1.1	7.2	0.9	20.3	2.9	8.2	0.0	1.1	0.0	2.8	0.4	0.0	0.2	3.9	0.1	0.1	1.6	2.1	0.7	0.5	0.5	0.6	3.6	7.9	5.1	12.2	3.0	3.8	5.2	3.7	4.8	1.4
TMPRSS5	"MGC141886, MGC148044"	ENSG00000166682	"Transmembrane serine protease 5"	Q9H3S3	11	113687546-113706373	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 24.0;salivary gland: 15.0;skeletal muscle: 6.0"	"Cell line enhanced"	"Detected in some"		"AF22: 4.4;CAPAN-2: 7.1;WM-115: 5.8"	"Cancer enhanced"	"Detected in some"		"glioma: 5.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010992			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA010992: "	"unprognostic (1.53e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.08e-1)"	"unprognostic (5.19e-3)"	"unprognostic (8.49e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.04e-3)"	2.1	1.7	10.8	1.0	24.0	3.2	2.2	2.1	14.8	1.2	1.0	21.6	0.0	1.0	1.2	0.9	1.8	1.1	2.2	1.2	11.5	5.7	0.9	0.9	0.9	1.1	11.6	12.7	1.4	1.2	0.6	1.5	1.2	16.5	1.2	1.3	0.9	15.0	1.4	6.0	2.7	0.7	1.2	16.9	1.1	2.4	2.3	8.8	0.0	1.1	0.4	1.3	0.9	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.8	4.4	2.5	0.5	0.4	0.6	1.2	0.5	0.6	0.9	2.5	7.1	0.3	3.2	0.5	0.8	0.4	0.4	0.3	0.5	1.3	1.0	0.6	0.0	0.3	1.0	0.8	0.6	0.6	0.6	1.2	0.8	0.8	0.5	0.9	0.0	0.8	1.2	0.5	0.2	0.9	0.5	0.0	0.7	0.4	0.6	1.0	0.5	0.1	3.5	0.5	0.6	0.5	0.9	1.7	0.6	0.7	0.5	0.2	0.1	0.4	0.9	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	24.0	2.1	12.3	11.5	5.7	11.6	12.7	16.5	8.8
TNNC2		ENSG00000101470	"Troponin C2, fast skeletal type"	P02585	20	45823214-45833745	"FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 851.6"	"Group enriched"	"Detected in some"	7	"Hep G2: 9.7;HSkMC: 15.3;SCLC-21H: 11.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 6.0"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043174, HPA058481"	Enhanced		Approved	Nucleoplasm,Vesicles		63000	63000	Nucleoplasm	Nucleoplasm	"HPA043174: AB_10806380, HPA058481: AB_2683729"	"unprognostic (1.13e-1)"	"unprognostic (7.25e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.21e-5)"	"unprognostic (1.80e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.12e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.03e-3)"	"unprognostic (7.15e-3)"	"unprognostic (4.79e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.13e-1)"	12.0	0.2	0.1	0.1	0.4	0.1	0.3	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.1	2.7	4.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	1.4	0.1	0.0	7.8	0.1	851.6	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.6	169.1	6.6	0.1	0.1	6.0	0.8	2.4	1.1	0.3	4.1	11.9	0.1	0.0	0.2	0.5	1.7	1.2	1.7	0.2	0.4	0.0	0.1	0.2	1.1	0.4	1.2	1.0	0.4	0.0	0.4	0.0	0.0	0.3	0.0	0.9	9.7	0.4	0.3	0.2	15.3	0.2	0.1	0.7	0.0	0.1	0.5	0.2	1.2	0.7	0.1	0.0	0.6	0.2	0.6	0.2	0.3	0.0	11.5	0.5	1.7	0.1	0.4	1.3	0.4	0.5	0.3	0.4	0.9	0.2	1.5	0.4	0.3	1.6	0.1	0.2	0.0	0.7	1.4	0.2	1.1	0.7	6.0	1.5	0.2	0.3	3.8	0.0	0.3	2.4	0.3	0.8	0.8	4.1	11.9	0.1	0.4	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0
TRIM54	"MURF, MURF-3, RNF30"	ENSG00000138100	"Tripartite motif containing 54"	Q9BYV2	2	27282392-27307439	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 187.1"	"Group enriched"	"Detected in some"	9	"HAP1: 8.2;NTERA-2: 17.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"	"Cell type enriched"	"Detected in single"	16	"NK-cell: 7.0"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 7.0"	"Region enhanced"	"Detected in some"		"amygdala: 3.2"	"Group enriched"	"Detected in some"	11	"cerebral cortex: 1.4;hippocampal formation: 0.8"	HPA019690	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA019690: AB_1858306"	"unprognostic (6.98e-3)"	"unprognostic (4.56e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.25e-7)"	"unprognostic (3.88e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.56e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavourable (6.46e-4)"	"unprognostic (2.41e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.92e-2)"	2.1	1.8	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.9	0.1	6.3	1.6	0.0	0.0	35.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.8	0.0	187.1	0.0	0.4	0.0	0.0	0.1	0.0	3.5	0.0	0.0	1.3	40.3	2.2	0.1	0.0	0.3	0.0	0.0	0.0	7.0	0.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	8.2	0.0	0.0	0.0	0.3	0.0	1.4	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	17.6	0.0	0.6	0.7	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.1	0.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.2	0.3	0.0	0.0	0.1	0.0	0.0
UQCRHL		ENSG00000233954	"Ubiquinol-cytochrome c reductase hinge protein like"	A0A096LP55	1	15807169-15809348	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"blood: 5.5;bone marrow: 2.2;epididymis: 1.6;skeletal muscle: 4.4;skin 1: 2.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in all"											HPA042574	Approved									"HPA042574: AB_10960998"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.01e-3)"	"unprognostic (4.83e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.60e-1)"	"unprognostic (9.67e-3)"	"unprognostic (9.76e-3)"	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.02e-1)"	0.0	0.1		0.2		2.2	0.4		0.4	0.0	0.0			0.2	0.4	1.6	0.1	0.4	0.4	0.1			0.0	0.4	0.2	0.2			0.5	0.0	0.0		0.0		0.1	0.1		0.5	0.0	4.4	2.1	0.4	0.1		0.6	0.0	0.5			0.2		0.0	0.0		1.5	1.2	5.5	1.0	1.3	1.0	0.5	0.7	0.5	3.1	3.2	0.7	0.8	1.2	0.6	0.3	0.1	0.3	0.7	2.5	1.2	0.9	0.5	1.3	0.6	0.5	0.7	2.2	0.3	1.1	1.9	0.5	0.7	0.9	1.4	0.5	1.0	0.3	0.3	0.0	1.1	2.3	0.2	1.9	0.4	1.4	1.5	1.2	1.1	0.7	1.0	0.0	1.7	2.7	1.7	1.0	2.1	0.8	0.9	2.7	0.5	2.0	1.1	1.2	0.8	2.2	0.9	1.3	0.9	2.1	0.9	3.6	1.0	0.9	0.8	0.7	0.6	1.1	0.6	0.8	0.6	1.5	1.0	1.0	5.5	1.3	0.7	1.2	0.5	0.5										
ZBTB18	"C2H2-171, RP58, TAZ-1, ZNF238"	ENSG00000179456	"Zinc finger and BTB domain containing 18"	Q99592	1	244048939-244057476	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 114.4;skeletal muscle: 40.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 114.4"	"Cell type enhanced"	"Detected in many"		"neutrophil: 5.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024656			Supported	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA024656: "	"unprognostic (3.48e-3)"	"unprognostic (9.17e-3)"	"unprognostic (3.69e-3)"	"prognostic favourable (1.34e-4)"	"unprognostic (6.83e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.54e-3)"	"prognostic favourable (6.78e-6)"	4.1	3.4	20.1	7.3	14.7	13.4	4.7	114.4	26.0	4.1	4.7	5.4	8.1	6.9	3.5	10.3	3.0	4.6	3.8	7.4	24.8	6.3	6.4	10.0	5.1	8.8	7.1	19.1	4.0	13.0	3.1	2.7	4.9	11.7	5.5	5.8	4.6	5.2	6.7	40.3	4.1	6.2	5.9	7.5	10.0	5.8	11.4	4.6	16.4	4.4	2.8	8.1	6.5	9.3	2.4	2.2	5.8	1.5	0.3	1.4	0.2	11.5	4.1	15.9	0.6	2.1	2.2	11.1	6.5	4.8	10.5	6.4	3.1	9.4	8.8	0.6	12.5	1.2	10.1	3.2	13.2	3.1	8.9	1.5	1.4	1.5	3.3	1.8	4.7	1.8	2.7	6.3	3.9	11.3	1.1	3.8	12.4	0.1	15.1	7.4	8.2	1.8	4.4	10.8	2.5	6.6	4.0	23.5	23.0	2.7	0.1	7.1	0.2	13.4	16.8	5.4	6.6	3.3	13.7	1.6	0.2	3.5	5.5	5.7	10.9	0.2	0.7	2.9	0.3	0.7	0.4	1.6	0.7	0.5	0.9	2.4	1.4	0.9	5.8	0.3	1.5	2.2	0.5	0.2	20.1	14.7	114.4	24.1	24.8	6.3	7.1	19.1	11.7	4.6
AC002996.1		ENSG00000257767			12	111753890-111791418	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	4	"adipose tissue: 27.0;blood: 29.9;skeletal muscle: 16.3;stomach 1: 8.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 8.8;EFO-21: 17.3;SK-BR-3: 8.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"classical monocyte: 29.4;myeloid DC: 29.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 29.9;monocytes: 29.4"																										"unprognostic (4.89e-1)"						"unprognostic (1.20e-1)"					27.0	2.5	0.7	0.8	1.3	0.0	0.4	1.3	1.3	0.6	4.8			4.4	0.2	0.0	0.5	0.3	0.0	0.5	0.6	0.4	4.0	1.6	2.1	0.0	0.5		1.0	0.6	0.0	0.4	0.0		0.3	0.0		2.4	0.5	16.3	0.9	1.7	0.0	0.8	0.4	8.0	0.0			0.3		0.0	0.8	0.6	1.1	29.9	6.2	29.4	0.3	0.2	14.8	3.3	0.0	0.0	0.9	0.0	1.4	8.8	0.9	4.2	1.6	0.8	0.0	2.0	0.0	17.3	1.8	3.0	0.0	0.7	0.1	0.5	0.4	0.0	2.5	0.0	0.0	0.3	0.0	0.0	2.0	1.8	0.0	4.3	1.5	0.2	0.7	0.0	0.0	0.6	5.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	4.7	0.0	8.5	0.1	6.2	3.3	0.0	0.0	2.0	0.2	0.0	1.3	1.9	4.5	2.5	0.1	0.0	0.4	29.4	6.2	0.1	13.0	0.2	1.1	0.0	0.0	29.9	0.4	0.0	0.0	1.1	0.3	3.9	8.0	0.1	14.8										
ACHE	YT	ENSG00000087085	"Acetylcholinesterase (Cartwright blood group)"	P22303	7	100889994-100896974	"Blood group antigen proteins, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 43.8;skeletal muscle: 98.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 8.0;CACO-2: 12.6;K-562: 14.8;Karpas-707: 24.7;U-2 OS: 5.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027098			Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	650000	650000	"Golgi apparatus"	"Golgi apparatus"	"HPA027098: AB_2672111"	"unprognostic (2.23e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.71e-2)"	"unprognostic (5.80e-3)"	"prognostic unfavourable (5.27e-4)"	"unprognostic (2.49e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (3.88e-5)"	"unprognostic (2.95e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.28e-2)"	"unprognostic (8.38e-2)"	1.4	4.8	5.8	3.5	16.1	10.3	1.4	22.8	11.8	1.4	4.2	2.7	1.4	5.7	1.9	2.6	2.8	1.8	3.1	4.5	5.5	43.8	1.4	1.8	1.8	5.9	22.2	4.8	1.7	1.6	7.0	3.2	2.0	37.9	3.3	3.4	4.6	6.5	3.3	98.2	1.4	7.9	1.9	8.7	2.3	2.1	1.9	2.6	3.5	1.6	15.9	3.2	2.1	1.2	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.3	0.2	0.5	0.0	8.0	0.3	0.0	0.1	0.2	12.6	0.3	0.0	0.4	0.0	0.4	2.1	0.1	0.0	4.3	0.5	0.2	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.1	0.0	0.0	14.8	24.7	0.1	3.5	0.0	0.1	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.0	1.0	0.0	0.0	0.0	0.1	0.7	5.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	16.1	22.8	11.8	5.5	43.8	22.2	4.8	37.9	2.6
AF241726.2		ENSG00000250349			X	37349330-38687674	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	4	"brain: 17.4;skeletal muscle: 16.5"	"Cell line enhanced"	"Detected in some"		"A-431: 1.3;CACO-2: 2.0;HDLM-2: 1.7;HEK 293: 2.0;MOLT-4: 1.2;SCLC-21H: 1.5;U-266/70: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA003140	Uncertain									"HPA003140: AB_1078454"																		2.7	1.9	3.3	1.7	10.2	1.8	1.9	2.1	6.1	1.7	1.9	17.4	1.3	1.7	1.7	1.7	1.8	1.7	1.7	2.1	3.7	1.9	2.2	2.0	2.1	1.7	14.9	4.1	1.9	1.8	1.7	1.7	3.7	9.9	1.8	1.7	0.6	1.8	1.7	16.5	1.8	1.8	1.7	12.2	1.9	1.7	1.7	11.1	0.0	2.0	0.5	1.7	1.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.7	2.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.4	0.0	0.0	0.4	0.3	0.0	0.4	0.0	1.2	0.1	0.0	0.0	0.5	0.4	0.0	0.5	0.0	1.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.3	10.2	2.1	6.1	3.7	1.9	14.9	4.1	9.9	11.1
AGBL1	"CCP4, FLJ32310"	ENSG00000273540	"ATP/GTP binding protein like 1"	Q96MI9	15	86079973-87029052	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 16.7;tongue: 35.5"	"Cell line enhanced"	"Detected in some"		"AF22: 2.5;RH-30: 1.8;SCLC-21H: 2.8"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"																						"unprognostic (3.70e-2)"	"unprognostic (4.46e-2)"		"unprognostic (1.06e-1)"										0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.4	0.0	0.0	0.0	5.8	1.3	0.0	0.0	0.0	0.1		0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.6	0.0	0.0	1.3	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	35.5	1.0	0.0	0.0	0.5	0.3	1.3	0.3	0.3	0.2	0.0	0.0	0.1	2.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.2	0.0	0.1	0.1	1.8	0.1	0.0	0.2	2.8	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.7	0.3	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.0	0.5	0.1	0.1	1.3	0.3	0.0	0.3	0.1	0.0										
ASB5		ENSG00000164122	"Ankyrin repeat and SOCS box containing 5"	Q8WWX0	4	176213673-176277571	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 133.4"	"Cell line enriched"	"Detected in some"	16	"LHCN-M2: 161.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028870			Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA028870: "					"unprognostic (1.76e-1)"	"prognostic unfavourable (5.67e-4)"		"unprognostic (1.90e-1)"			"unprognostic (7.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.65e-1)"		"unprognostic (6.80e-3)"	2.3	0.0	0.3	0.3	0.2	0.0	0.0	0.2	0.2	0.3	3.5	0.0	0.0	0.1	0.2	6.3	7.9	0.0	0.4	1.3	0.2	0.2	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	9.6	1.3	0.0	8.0	0.1	133.4	0.0	0.5	23.5	1.0	0.0	2.0	2.2	0.0	0.0	2.3	31.4	2.2	15.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.9	0.0	3.5	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	161.1	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.5	0.0	0.0	0.0
ATP5F1D	ATP5D	ENSG00000099624	"ATP synthase F1 subunit delta"	P30049	19	1241746-1244826	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 337.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002865	Approved					4200000	4200000			"HPA002865: AB_1078244"	"unprognostic (4.80e-2)"	"unprognostic (9.34e-2)"	"unprognostic (7.77e-2)"	"prognostic favourable (1.23e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.91e-1)"	"prognostic favourable (4.60e-4)"	"unprognostic (6.95e-2)"	"prognostic favourable (3.46e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.74e-1)"	"unprognostic (3.49e-2)"	30.4	25.7	27.4	13.7	30.1	19.5	19.8	22.6	51.7	14.4	36.7	16.7	16.0	42.7	14.3	14.9	23.9	15.3	18.1	59.3	25.9	20.6	33.3	51.8	12.2	33.4	25.6	24.1	15.2	46.5	15.5	18.4	12.4	28.5	17.6	14.1	17.9	48.1	23.1	337.3	24.3	33.2	21.1	14.5	19.2	33.4	10.2	9.8	21.5	23.0	60.6	22.9	17.6	14.5	67.7	78.2	33.9	64.6	52.8	64.3	50.8	24.2	13.3	4.1	15.5	4.8	7.2	15.6	16.7	7.1	9.9	7.3	13.9	6.5	24.7	10.8	5.8	20.9	4.6	17.3	1.3	17.0	45.2	14.9	16.4	18.1	12.1	26.0	22.2	14.2	4.8	4.0	5.5	10.5	21.6	19.8	4.5	36.9	28.2	18.8	18.1	65.7	27.0	11.0	51.3	16.5	16.0	16.6	19.1	11.1	17.7	27.5	13.2	12.4	15.1	9.1	12.4	21.7	13.8	50.6	25.5	9.2	16.7	12.3	13.6	33.9	64.6	27.1	50.7	61.3	61.1	64.8	64.3	55.7	72.1	67.7	59.9	54.9	22.5	52.8	49.0	78.2	62.0	50.8	27.4	30.1	22.6	51.7	25.9	20.6	25.6	24.1	28.5	9.8
CAND2	"KIAA0667, TIP120B, Tp120b"	ENSG00000144712	"Cullin associated and neddylation dissociated 2 (putative)"	O75155	3	12796472-12871916	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 76.2"	"Cell line enhanced"	"Detected in many"		"HEK 293: 18.2;REH: 11.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005777	Approved		Approved	"Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nuclear bodies"	"HPA005777: AB_2667431"	"unprognostic (6.11e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.52e-3)"	"unprognostic (6.09e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.03e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.78e-5)"	"unprognostic (1.31e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.96e-3)"	2.9	2.8	6.4	1.4	7.6	1.4	1.4	7.2	11.8	2.3	3.2	3.7	0.5	1.5	3.7	2.6	2.6	3.6	2.1	17.8	4.7	4.3	1.7	1.7	1.9	1.4	2.7	5.5	3.3	2.5	6.4	4.9	1.4	3.1	3.0	1.4	4.2	2.2	3.4	76.2	1.6	1.7	5.2	2.2	2.2	2.1	11.4	2.6	0.1	2.4	11.1	1.2	3.0	5.0	1.2	0.2	0.7	0.5	0.0	2.2	0.6	0.7	1.5	5.8	0.2	0.2	0.1	0.3	1.6	0.6	3.1	4.2	0.8	0.3	0.9	1.7	0.8	0.2	6.4	0.1	2.8	1.6	18.2	1.3	2.2	1.2	4.9	0.1	0.1	1.3	0.3	3.0	0.1	0.7	4.7	0.9	0.9	2.9	2.3	0.7	4.0	1.8	11.2	1.1	0.9	0.2	1.3	3.9	5.2	0.1	0.8	1.0	1.7	5.5	0.4	0.9	1.0	0.9	1.2	1.5	8.9	8.6	0.5	1.1	1.9	0.0	0.5	0.0	1.2	0.2	0.6	1.2	0.6	2.2	0.1	0.5	1.3	0.9	0.7	0.0	0.1	0.2	1.6	0.6	6.4	7.6	7.2	11.8	4.7	4.3	2.7	5.5	3.1	2.6
CASTOR2	"GATSL1, GATSL2"	ENSG00000274070	"Cytosolic arginine sensor for mTORC1 subunit 2"	A6NHX0	7	74964818-75024798	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 7.5;skeletal muscle: 28.1"	"Cell line enhanced"	"Detected in many"		"A549: 21.8"	"Cancer enhanced"	"Detected in all"		"testis cancer: 11.6"					"Cell type enriched"	"Detected in single"	6	"neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.2"									HPA057229	Uncertain									"HPA057229: AB_2683374"	"unprognostic (1.07e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.78e-5)"	"unprognostic (1.28e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.27e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.20e-3)"	1.3	1.2	4.1	0.4	4.8	4.4	0.7	2.6	7.5	1.1	1.9	5.0	0.0	1.8	1.7	1.2	2.1	1.4	1.7	2.7	5.6		0.8	0.1	0.8	0.1	3.3	4.5	3.7	3.6	1.4	1.3	2.2	4.2	1.7	0.4	1.1	2.1	2.1	28.1	0.9	1.1	1.7	2.8	0.3	0.7	2.1	4.0	2.1	0.4	1.4	0.8	0.9	0.5	0.0	0.0	2.2	0.0	0.0	0.3	0.0	2.4	21.8	3.4	10.4	4.5	2.3	7.4	2.6	2.0	1.8	1.9	7.8	1.0	0.4	1.8	5.7	1.2	6.5	1.8	1.3	2.0	3.4	1.7	8.9	8.0	1.9	0.4	3.0	5.3	0.8	4.3	0.6	3.5	3.1	1.1	1.1	4.3	3.6	1.3	5.8	2.6	8.3	2.4	2.3	4.4	5.0	10.3	5.7	3.0	5.5	0.6	3.3	0.7	4.8	2.9	5.1	5.2	0.9	1.2	3.4	2.6	1.8	2.0	1.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.2	0.0										
CAVIN4	"cavin-4, MURC"	ENSG00000170681	"Caveolae associated protein 4"	Q5BKX8	9	100578079-100587906	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 83.8;tongue: 52.4"	"Cell line enhanced"	"Detected in many"		"AF22: 7.2;NTERA-2: 10.1;SCLC-21H: 15.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA020973, HPA020987, HPA021021"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"				"Golgi apparatus, Plasma membrane"	"Golgi apparatus, Plasma membrane"	"HPA020973: AB_1853079, HPA020987: AB_1853080, HPA021021: AB_1853082"	"unprognostic (9.54e-5)"	"unprognostic (1.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.14e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.74e-8)"	"unprognostic (1.14e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.55e-3)"	3.5	0.0	0.3	0.1	0.6	0.0	0.0	0.5	0.3	0.1	0.1	0.0	0.0	0.0	0.2	2.7	1.9	0.0	0.1	16.4	0.5	0.3	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	2.8	0.0	83.8	0.1	0.0	0.1	0.7	0.0	0.1	1.4	0.0	0.1	0.2	52.4	1.6	0.0	0.0	0.4	0.3	1.4	0.4	0.7	0.7	0.0	0.5	0.4	7.2	2.7	1.6	2.4	5.2	1.3	1.0	1.0	1.2	0.0	0.5	0.3	0.3	0.6	0.3	3.4	0.1	2.1	1.7	2.4	0.0	1.1	0.0	0.5	0.3	0.4	5.8	0.3	1.0	0.6	1.2	0.2	0.3	4.5	0.1	2.0	0.3	10.1	0.8	2.9	6.8	0.0	0.8	0.4	15.5	4.1	0.2	0.3	1.4	0.2	0.2	1.3	1.8	1.4	1.3	1.1	0.4	1.3	0.7	1.9	0.1	1.3	0.6	0.3	0.2	0.5	0.4	0.2	0.2	0.7	0.5	0.1	0.4	0.5	0.5	1.4	0.7	0.3	0.3	0.2	0.0	0.3	0.6	0.5	0.3	0.5	0.3	0.5	0.1	0.0	0.0
CCDC28B	"MGC1203, RP4-622L5.5"	ENSG00000160050	"Coiled-coil domain containing 28B"	Q9BUN5	1	32200386-32205387	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 66.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 140.1"	"Low region specificity"	"Detected in all"			HPA028589	Uncertain									"HPA028589: AB_10602175"	"prognostic favourable (2.92e-4)"	"unprognostic (6.01e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.59e-3)"	"unprognostic (5.18e-2)"	"unprognostic (7.50e-3)"	"unprognostic (7.87e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.79e-2)"	"prognostic favourable (1.10e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.07e-2)"	2.0	6.5	7.0	4.1	7.2	3.4	1.6	12.4	6.5	2.2	3.1	2.0	1.4	2.4	3.1	3.2	3.2	2.7	3.9	8.6	6.3	4.6	2.9	1.1	2.0	6.8	5.0	6.0	3.4	3.5	4.4	10.1	3.0	4.3	2.7	1.7	4.7	4.0	2.6	66.7	2.6	1.9	3.8	3.6	3.4	2.8	11.7	5.2	4.5	3.2	11.7	4.7	3.2	1.9	9.3	14.2	3.1	4.3	15.8	15.6	8.4	4.6	1.6	10.3	9.9	3.0	3.9	0.8	3.3	4.8	5.9	4.0	3.0	5.3	10.3	5.4	4.0	1.3	8.3	3.9	1.1	11.7	11.8	13.3	7.2	1.8	4.3	0.3	4.6	4.7	1.8	6.6	0.1	8.0	8.5	1.3	3.9	0.6	17.3	2.6	10.5	2.5	18.4	5.0	8.3	5.3	0.7	20.1	8.9	4.8	1.0	5.8	3.2	3.9	4.7	3.4	4.4	4.5	2.1	2.8	0.7	0.6	5.6	17.9	3.2	3.1	4.3	0.9	15.6	2.0	7.8	7.8	7.4	13.2	9.8	9.3	12.4	12.3	0.4	15.8	0.5	14.2	9.6	8.4	7.0	7.2	12.4	6.5	6.3	4.6	5.0	6.0	4.3	5.2
CMYA5	"C5orf10, DKFZp451G223, myospryn, SPRYD2, TRIM76"	ENSG00000164309	"Cardiomyopathy associated 5"	Q8N3K9	5	79689877-79800240	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 119.1;skeletal muscle: 329.3"	"Cell line enhanced"	"Detected in some"		"MCF7: 2.6;RT4: 3.0;THP-1: 10.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA077831	Enhanced									"HPA077831: "	"unprognostic (5.53e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.01e-4)"	"unprognostic (7.00e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.04e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.93e-2)"	"unprognostic (6.30e-3)"	"unprognostic (3.88e-2)"	"unprognostic (7.69e-2)"	"unprognostic (9.74e-2)"	2.4	0.2	0.3	0.0	0.3	0.0	0.9	0.3	0.4	0.4	0.4	0.0	0.0	0.0	1.4	2.6	2.0	0.5	0.2	119.1	0.3	0.3	0.6	0.3	0.3	0.0	0.3	0.0	3.6	0.2	2.2	1.1	0.3	0.3	1.4	0.0	0.0	2.4	0.5	329.3	0.5	0.2	1.1	0.4	0.2	0.3	0.2	0.1	0.0	2.3	54.0	2.5	0.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.0	0.9	1.3	0.4	0.0	0.1	0.2	0.2	0.4	0.1	0.0	1.9	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.1	1.5	0.4	0.1	0.0	0.0	0.0	0.1	0.0	2.6	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.1	3.0	0.1	0.0	0.1	0.0	0.2	1.9	10.4	0.0	0.1	0.4	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.0	0.3	0.1
COQ8A	"ADCK3, CABC1, COQ8, SCAR9"	ENSG00000163050	"Coenzyme Q8A"	Q8NI60	1	226897536-226987545	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 216.5"	"Cell line enhanced"	"Detected in many"		"HEK 293: 33.0;RPMI-8226: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061662			Supported	Mitochondria				Mitochondria	Mitochondria	"HPA061662: AB_2684578"	"unprognostic (6.37e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.15e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.62e-1)"	13.3	25.4	2.8	2.7	4.5	5.3	8.5	14.5	3.9	3.2	7.3	4.1	4.2	6.9	3.6	5.5	7.3	5.0	6.1	41.0	2.7	1.8	3.8	17.7	2.7	4.1	5.0	2.4	7.2	20.3	1.6	1.6	2.0	3.8	6.5	2.0	1.9	7.2	5.0	216.5	4.4	4.4	7.8	2.9	3.5	8.8	3.0	4.7	2.7	4.6	50.2	5.8	10.2	3.5	15.2	9.3	32.3	11.5	9.9	11.8	11.6	3.2	5.8	1.5	4.5	4.7	3.1	23.6	1.5	1.3	2.2	2.9	9.2	5.2	9.5	7.3	1.0	3.7	2.9	3.3	0.5	9.9	33.0	6.6	4.8	15.1	1.0	10.0	4.1	5.9	5.1	1.7	2.3	1.0	11.4	7.8	0.3	4.3	5.8	14.7	6.4	12.0	5.7	7.1	30.2	0.7	2.4	24.3	9.9	3.0	11.8	8.5	6.2	13.6	1.2	2.5	2.3	3.5	5.5	17.6	15.4	5.0	2.3	11.4	2.4	19.7	11.5	32.3	8.7	8.6	8.3	12.1	8.5	7.7	9.3	15.2	11.8	9.0	21.9	9.9	6.5	4.1	10.6	11.6	2.8	4.5	14.5	3.9	2.7	1.8	5.0	2.4	3.8	4.7
COX7A1	"COX7A, COX7AH"	ENSG00000161281	"Cytochrome c oxidase subunit 7A1"	P24310	19	36150922-36152869	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 114.9;skeletal muscle: 404.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 24.0;ASC TERT1: 17.6;BJ: 16.1;BJ hTERT+: 13.4;fHDF/TERT166: 24.6;HHSteC: 16.0;HSkMC: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.9"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.3;granulocytes: 1.4;monocytes: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (5.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.13e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.33e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.84e-3)"	"unprognostic (7.27e-3)"	"unprognostic (9.44e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.54e-2)"	15.7	8.1	5.3	2.5	3.6	1.2	8.8	2.1	13.1	4.1	8.0	0.8	2.6	2.0	3.9	6.1	6.6	3.1	5.0	114.9	3.3	2.4	5.0	1.6	4.0	2.7	2.6	4.6	4.2	3.5	6.0	7.9	2.6	1.7	5.9	2.3	5.9	6.2	7.1	404.3	2.0	2.2	12.3	1.4	3.1	3.6	1.6	1.5	1.6	5.1	59.7	2.6	7.0	4.7	0.0	1.3	1.4	1.9	0.0	0.1	0.3	0.1	2.6	0.2	0.0	24.0	17.6	0.1	16.1	13.4	0.5	0.0	0.0	0.8	0.6	6.7	24.6	0.3	0.0	0.0	0.1	0.0	0.8	0.1	0.9	0.1	16.0	0.0	0.2	16.6	0.0	0.0	0.0	1.8	0.2	0.2	0.0	0.3	0.0	0.1	0.4	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.2	0.1	3.6	0.0	0.6	0.2	0.1	0.4	0.4	0.3	0.1	0.3	0.5	0.0	1.9	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	1.4	0.0	0.5	0.4	0.1	0.3	5.3	3.6	2.1	13.1	3.3	2.4	2.6	4.6	1.7	1.5
CSRP3	"CLP, CMD1M, MLP"	ENSG00000129170	"Cysteine and glycine rich protein 3"	P50461	11	19182030-19210573	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"heart muscle: 223.9;skeletal muscle: 156.7"	"Cell line enhanced"	"Detected in some"		"HSkMC: 3.5;RH-30: 1.5;U-2 OS: 2.7"	"Cancer enriched"	"Detected in some"	6	"head and neck cancer: 18.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA042581	Enhanced					240000	240000			"HPA042581: AB_2678061"				"unprognostic (1.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-2)"				"unprognostic (4.72e-2)"				"unprognostic (5.99e-2)"	"unprognostic (1.08e-1)"			0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	3.4	0.0	0.0	223.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	4.5	0.0	156.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	46.9	2.3	0.0	0.0	0.4	0.0	0.3	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.2	0.0	0.1	0.6	3.5	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.2	2.7	0.5	0.7	0.0	0.2	0.4	0.8	0.9	0.1	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTNNA3	"MGC26194, VR22"	ENSG00000183230	"Catenin alpha 3"	Q9UI47	10	65912518-67696169	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 28.8;heart muscle: 27.5;liver: 12.9;skeletal muscle: 16.2;tongue: 7.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.0;Karpas-707: 2.5;NTERA-2: 3.0;RPMI-8226: 3.9;SCLC-21H: 2.6;U-266/70: 11.1"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.2;plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061818	Enhanced									"HPA061818: AB_2684618"	"unprognostic (2.19e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.64e-4)"	"unprognostic (8.13e-3)"	"unprognostic (6.43e-3)"	"unprognostic (9.90e-2)"	"unprognostic (2.60e-4)"	"unprognostic (8.27e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.09e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.67e-3)"	"unprognostic (7.93e-5)"	"unprognostic (6.43e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.24e-1)"	1.8	1.4	6.3	3.6	19.3	0.8	1.5	6.6	10.3	2.1	2.5	26.0	0.0	1.1	2.5	0.8	2.9	1.7	1.6	27.5	7.6	2.3	1.1	12.9	1.1	0.9	25.9	5.8	3.4	1.1	1.2	1.1	1.2	16.2	1.2	1.6	0.0	1.2	1.0	16.2	1.2	1.9	4.5	26.8	1.1	1.8	3.6	28.8	0.0	1.4	7.9	1.1	1.3	1.9	0.7	1.4	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.3	4.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.2	0.1	0.0	3.0	1.2	0.2	0.0	3.9	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.8	0.0	0.0	11.1	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.3	0.0	0.7	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.2	6.3	19.3	6.6	10.3	7.6	2.3	25.9	5.8	16.2	28.8
EGF		ENSG00000138798	"Epidermal growth factor"	P01133	4	109912884-110012266	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 48.4;pancreas: 41.2;skeletal muscle: 19.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 8.0;SK-BR-3: 14.6;U-251 MG: 4.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"									25000	25000				"unprognostic (2.83e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.88e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.64e-3)"	"unprognostic (5.06e-4)"	"unprognostic (8.30e-2)"	"unprognostic (2.21e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.72e-3)"	"unprognostic (4.64e-5)"	"unprognostic (2.63e-1)"	"unprognostic (9.80e-5)"	"unprognostic (3.92e-3)"	0.8	0.1	0.4	0.0	0.4	0.0	5.9	0.1	0.9	0.2	0.2	0.3	0.3	0.0	0.3	2.6	0.9	0.2	0.3	2.3	0.8	0.3	48.4	0.0	0.6	0.0	1.2	0.7	0.0	41.2	0.0	0.4	0.0	1.4	0.6	0.4	3.9	8.4	0.1	19.8	0.5	0.2	1.9	0.6	0.2	0.0	0.2	0.2	0.0	1.2	4.5	0.4	0.4	0.5	0.0	0.4	1.7	0.0	0.0	0.0	2.6	0.2	0.3	2.4	0.1	0.0	0.1	0.0	0.6	1.5	0.8	0.5	0.1	0.0	0.0	8.0	0.8	0.0	0.3	0.0	0.6	0.1	0.4	0.1	0.9	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.2	0.8	0.1	0.0	0.0	2.9	0.5	0.2	0.1	0.6	0.6	0.2	0.0	0.0	0.0	14.6	0.5	3.5	0.0	0.0	1.2	2.0	0.0	4.6	0.0	0.0	0.0	1.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	2.6	0.4	0.4	0.1	0.9	0.8	0.3	1.2	0.7	1.4	0.2
EGLN1	"C1orf12, HIFPH2, PHD2, SM-20, ZMYND6"	ENSG00000135766	"Egl-9 family hypoxia inducible factor 1"	Q9GZT9	1	231363751-231425044	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 14.9;skeletal muscle: 46.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"neutrophil: 14.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022129	Approved									"HPA022129: AB_1848046"	"unprognostic (4.20e-1)"	"prognostic unfavourable (2.99e-7)"	"unprognostic (8.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.81e-2)"	4.9	4.2	4.4	1.4	4.5	0.8	3.5	3.6	4.3	3.0	3.3			3.9	3.1	2.6	3.5	2.3	2.9	7.0	4.4	3.5	5.2	7.2	1.6	1.6	4.1		4.1	4.4	5.5	2.1	4.4		2.6	2.8		2.3	3.5	46.9	5.6	3.9	2.8	4.1	3.0	2.0	1.3			2.8		1.8	2.5	2.7	0.6	0.7	14.9	1.4	0.7	1.1	0.3	13.4	12.9	4.1	7.9	10.9	7.6	4.6	6.6	9.7	9.2	12.7	9.4	10.7	4.0	11.6	9.4	6.8	5.8	7.7	16.4	5.8	14.7	1.9	5.3	8.0	7.8	9.5	2.7	6.0	7.1	6.2	7.7	12.0	9.1	7.6	8.7	2.6	2.3	3.5	4.9	7.2	5.0	5.7	4.9	11.7	4.8	4.2	11.2	8.2	10.7	21.8	5.7	27.3	14.2	10.8	5.9	10.7	12.4	18.9	11.5	3.6	15.0	3.6	15.0	4.1	0.6	2.5	0.7	0.9	0.5	0.6	0.8	0.6	0.7	0.6	0.9	1.1	14.9	0.7	1.4	0.6	0.6	0.3										
EN1		ENSG00000163064	"Engrailed homeobox 1"	Q05925	2	118842171-118847678	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 5.6;brain: 11.4;skeletal muscle: 20.1;skin 1: 10.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.1;ASC TERT1: 6.4;fHDF/TERT166: 11.1;HSkMC: 11.9;PC-3: 6.6;U-138 MG: 8.6;U-2197: 9.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.6"	"Group enriched"	"Detected in some"	10	"midbrain: 11.4;pons and medulla: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"midbrain: 5.9"	"Region enriched"	"Detected in some"	5	"midbrain: 23.9"	"CAB014884, HPA073141"	Enhanced		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoli	"CAB014884: , HPA073141: AB_2686573"	"unprognostic (5.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.84e-7)"	"unprognostic (1.87e-3)"	"unprognostic (1.90e-1)"		"unprognostic (1.95e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.38e-9)"	"unprognostic (2.15e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.30e-3)"	5.6	0.1	0.0	0.1	0.4	0.0	2.7	0.9	0.4	0.0	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	2.4	11.4	0.0	0.1	0.0	0.1	0.0	0.0	8.8	0.1	0.1	0.2	0.7	0.1	20.1	10.0	0.1	0.1	2.7	0.1	0.1	0.4	0.1	0.2	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.5	0.2	14.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.4	0.5	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.1	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	8.6	0.8	9.6	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.4	0.2	0.1	11.4	0.0	8.8	0.1
FXYD1	PLM	ENSG00000266964	"FXYD domain containing ion transport regulator 1"	O00168	19	35138808-35143109	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 134.1;liver: 137.1;skeletal muscle: 299.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 30.3;ASC TERT1: 8.8;HSkMC: 12.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 11.7"	"Group enriched"	"Detected in many"	5	"B-cells: 11.7;T-cells: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026873			Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA026873: AB_1855471"	"unprognostic (5.58e-3)"	"unprognostic (6.60e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (6.91e-4)"	"unprognostic (1.54e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.54e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavourable (7.59e-8)"	"unprognostic (9.97e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	28.2	8.1	35.7	5.2	40.7	2.0	21.8	16.8	34.7	46.5	16.9	25.5	7.1	5.0	26.3	17.9	18.8	31.1	14.8	134.1	23.8	19.9	4.5	137.1	14.1	3.0	36.1	23.7	34.0	6.2	2.1	4.3	8.6	21.5	21.6	7.9	14.1	6.4	20.7	299.8	5.8	7.5	27.7	19.0	6.2	8.4	7.5	14.8	0.0	3.9	29.0	3.5	12.7	23.7	11.7	0.7	1.2	0.7	2.0	7.1	0.7	0.7	0.0	0.0	0.1	30.3	8.8	0.8	3.6	0.1	0.0	0.0	0.0	0.2	2.4	0.9	0.0	0.6	0.7	0.4	0.0	2.1	0.8	0.4	0.0	1.1	3.5	0.2	0.2	12.5	0.0	0.1	0.3	0.1	0.6	2.5	0.1	0.0	0.0	0.5	0.1	0.4	0.0	0.1	0.6	0.0	0.0	0.2	0.1	0.4	0.1	1.0	0.1	3.9	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.6	0.4	5.0	1.2	0.3	0.0	1.4	0.7	0.9	11.7	4.1	1.7	0.3	6.6	0.8	1.0	0.6	2.0	0.7	0.7	7.1	0.7	35.7	40.7	16.8	34.7	23.8	19.9	36.1	23.7	21.5	14.8
GPR85	SREB2	ENSG00000164604	"G protein-coupled receptor 85"	P60893	7	113078331-113087778	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"brain: 15.0;skeletal muscle: 30.4"	"Cell line enriched"	"Detected in many"	5	"HEL: 48.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.80e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.98e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.41e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.34e-5)"	"unprognostic (5.89e-3)"	"unprognostic (9.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-2)"	2.1	1.1	8.9	1.2	15.0	1.9	0.9	12.2	11.2	0.7	0.9	2.4	0.0	0.9	1.2	1.1	1.1	1.9	4.4	2.4	11.8	9.2	0.7	4.5	2.5	1.6	10.8	7.7	0.5	1.6	2.0	4.0	5.3	6.2	1.2	0.8	0.9	2.8	0.8	30.4	0.9	1.0	1.2	8.1	3.1	1.0	3.4	4.3	0.0	0.9	0.0	1.0	1.4	0.3	1.3	1.0	3.0	2.1	1.5	1.1	0.5	0.1	0.1	0.3	0.3	1.0	1.5	0.3	1.3	1.9	2.7	3.7	0.1	0.5	0.1	0.3	1.1	0.2	0.2	1.2	5.7	0.2	0.1	48.3	0.5	0.1	0.5	9.0	0.5	1.9	0.2	4.6	0.1	0.1	0.2	0.5	3.0	0.2	0.9	5.7	0.6	0.3	0.2	0.6	0.2	0.0	0.8	1.4	1.1	0.1	0.6	0.4	0.3	2.1	0.3	3.3	0.5	0.9	1.2	1.1	0.1	0.5	3.9	3.5	1.2	3.0	1.2	1.0	1.0	1.4	1.0	0.9	0.8	0.6	0.6	1.3	1.1	1.0	2.1	1.5	2.1	1.0	0.9	0.5	8.9	15.0	12.2	10.8	11.8	9.2	10.8	7.7	6.2	4.3
HOXC10	HOX3I	ENSG00000180818	"Homeobox C10"	Q9NYD6	12	53985065-53990279	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 16.2;skeletal muscle: 53.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 76.4;ASC diff: 22.6;ASC TERT1: 20.8;fHDF/TERT166: 17.6;T-47d: 26.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053919	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA053919: AB_2682308"	"unprognostic (1.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.56e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.98e-1)"		"unprognostic (1.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.60e-3)"	"unprognostic (3.96e-2)"	"unprognostic (7.37e-3)"	"unprognostic (2.25e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.91e-1)"	8.0	0.7	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.5	0.3	0.0	0.4	0.0	1.6	6.8	0.1	2.5	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.8	0.0	0.0	3.4	0.0	0.1	0.0	0.3	0.0	1.0	0.0	0.0	0.0	1.3	53.2	6.8	0.8	0.5	0.9	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.8	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.8	0.0	76.4	22.6	20.8	0.1	2.6	6.4	3.6	3.4	0.1	0.2	0.1	0.7	17.6	8.2	1.1	0.0	1.7	3.8	1.4	0.7	9.5	0.0	0.1	0.0	0.9	9.8	0.1	0.2	0.0	0.0	0.5	0.0	2.5	0.4	0.0	1.9	0.0	0.3	0.0	0.1	0.0	8.1	0.0	0.0	1.0	1.8	2.6	3.9	26.0	0.5	0.0	2.1	2.7	0.0	3.4	0.3	0.0	0.0	0.0	0.4	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
KCNJ12	"hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v"	ENSG00000184185	"Potassium voltage-gated channel subfamily J member 12"	Q14500	17	21376197-21419872	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"brain: 39.4;skeletal muscle: 47.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.7;HeLa: 6.2;PC-3: 6.5;SCLC-21H: 7.6;SiHa: 3.8;U-2197: 6.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 39.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA027021	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Golgi apparatus"	"HPA027021: AB_10602912"	"unprognostic (3.81e-3)"	"unprognostic (2.69e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavourable (7.84e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.91e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.90e-2)"	"unprognostic (9.70e-3)"	1.2	1.3	1.9	0.9	2.9	0.7	0.9	39.4	5.8	1.2	0.8	1.1	0.5	0.5	0.8	1.4	1.5	2.1	0.7	5.1	0.9	1.4	1.2	0.5	1.3	0.4	1.3	3.4	0.7	0.5	10.6	0.7	0.7	4.0	0.9	0.6	1.7	0.6	0.9	47.8	6.0	0.6	1.0	0.9	1.3	0.9	1.3	0.9	0.0	1.0	7.5	1.1	0.8	1.5	0.0	0.9	0.0	0.5	0.0	0.1	0.0	0.0	1.1	0.4	2.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	3.7	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	6.2	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.5	0.1	0.1	0.0	1.5	6.5	0.0	1.0	1.7	0.0	0.0	7.6	0.4	3.8	0.0	1.6	0.0	0.0	2.9	0.0	0.5	6.6	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.1	0.0	1.9	2.9	39.4	5.8	0.9	1.4	1.3	3.4	4.0	0.9
KLHL31	"bA345L23.2, BKLHD6, KBTBD1"	ENSG00000124743	"Kelch like family member 31"	Q9H511	6	53647901-53665708	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"heart muscle: 77.7;skeletal muscle: 57.7;tongue: 40.9"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.5;RH-30: 2.8;SCLC-21H: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (7.27e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.67e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.98e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.09e-4)"	"unprognostic (8.73e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.40e-1)"	13.1	0.5	0.1	0.3	0.3	0.0	2.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.2	1.2	1.3	0.6	0.1	77.7	0.2	0.1	0.1	0.2	0.1	0.4	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.1	0.6	0.1	0.0	1.6	0.0	57.7	0.6	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.5	40.9	2.2	0.3	0.2	0.7	0.0	0.0	0.1	0.9	0.6	0.0	1.0	0.7	0.2	0.2	0.0	0.0	0.5	0.0	0.2	0.2	0.1	1.1	2.5	0.0	0.2	0.0	1.9	0.7	0.4	0.1	0.1	1.3	0.4	1.7	1.6	0.1	0.6	0.0	2.1	2.5	0.0	0.5	0.0	0.0	0.2	0.0	0.8	0.8	0.0	0.3	0.7	0.1	2.8	0.1	0.8	0.9	3.6	0.3	0.2	0.6	0.0	1.2	0.0	0.0	0.1	0.5	0.0	0.2	0.5	0.1	0.0	0.3	2.1	0.1	0.0	0.0	0.0	0.4	0.0	0.6	0.7	0.0	0.2	0.0	0.3	0.2	0.2	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0
KLHL33		ENSG00000185271	"Kelch like family member 33"	A6NCF5	14	20425852-20436158	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 39.2"	"Cell line enriched"	"Detected in some"	9	"REH: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	24	"plasmacytoid DC: 9.3"	"Lineage enriched"	"Detected in single"	24	"dendritic cells: 9.3"	"Low region specificity"	"Detected in many"							"HPA049985, HPA056560"	Enhanced									"HPA049985: , HPA056560: AB_2683174"	"unprognostic (6.92e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.60e-2)"	"unprognostic (7.43e-3)"	"unprognostic (4.88e-3)"	"unprognostic (3.32e-5)"	"unprognostic (2.32e-1)"	1.2	0.1	0.1	0.1	0.1	0.0	0.3	0.6	0.6	0.6	0.4	0.3	0.1	0.0	0.8	0.7	0.4	0.4	0.3	0.5	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.6	0.1	0.7	0.1	0.1	0.4	0.5	0.0	0.1	0.8	0.5	39.2	0.0	0.3	0.2	0.1	0.2	0.1	0.2	0.1	0.1	0.2	8.5	0.6	0.3	0.8	0.3	9.3	0.3	0.1	0.1	0.3	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.3	0.3	0.1	0.2	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.4	0.3	0.3	0.1	0.2	0.4	0.7	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.2	0.2	0.4	0.0	9.3	0.1	0.2	0.0	0.2	0.2	0.3	0.0	0.1	0.1	0.2	0.4	0.2	1.0	0.5	0.1	0.1	0.3	0.3	0.2	0.1	0.6	0.2	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.3	0.2	0.1	0.0	9.3	0.0	0.2	0.1	0.1	0.6	0.6	0.1	0.1	0.1	0.1	0.4	0.1
KLHL38	C8ORFK36	ENSG00000175946	"Kelch like family member 38"	Q2WGJ6	8	123645527-123652950	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 72.0"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.3;HHSteC: 1.9;SK-BR-3: 5.4;SK-MEL-30: 1.7;U-2197: 9.5"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA024770, HPA027115"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA024770: AB_10599286, HPA027115: AB_10599950"	"unprognostic (8.62e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.02e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.09e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-2)"	"unprognostic (5.73e-6)"	"unprognostic (8.46e-3)"	"unprognostic (3.82e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.84e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.5	0.7	0.6	0.1	0.1	16.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.2	0.1	72.0	0.0	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	1.7	1.0	0.0	0.0	0.0	0.2	9.5	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KPNA3	"hSRP1, IPOA4, SRP1gamma, SRP4"	ENSG00000102753	"Karyopherin subunit alpha 3"	O00505	13	49699307-49792921	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 71.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046852	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA046852: AB_2679840"	"unprognostic (4.20e-2)"	"prognostic unfavourable (2.80e-4)"	"unprognostic (3.69e-2)"	"unprognostic (1.23e-1)"	"prognostic favourable (2.03e-4)"	"unprognostic (6.27e-3)"	"unprognostic (6.79e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.56e-2)"	"unprognostic (4.57e-3)"	"unprognostic (3.93e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavourable (3.81e-4)"	"unprognostic (9.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.60e-3)"	12.4	8.0	15.2	9.1	11.8	14.1	12.4	10.9	14.4	8.5	11.4	7.5	8.1	7.0	9.5	6.8	14.5	7.3	8.4	17.2	12.3	11.4	8.0	13.6	9.6	9.4	11.1	11.4	8.1	6.3	9.1	8.1	8.3	13.0	9.4	9.7	5.9	8.3	11.4	71.8	9.0	8.5	14.3	13.2	8.1	8.3	15.1	11.8	11.4	10.9	14.6	10.8	15.0	16.3	6.0	5.0	7.6	6.8	8.1	12.1	4.1	13.8	9.6	18.5	15.4	18.9	20.9	9.3	25.3	20.9	22.2	16.2	29.1	13.0	29.9	5.2	29.3	16.4	22.0	20.3	37.1	17.9	15.4	21.9	9.5	33.9	18.5	32.7	14.2	15.3	14.7	18.6	24.6	27.4	12.1	8.1	30.6	6.3	17.5	17.8	21.3	6.8	23.0	18.2	9.1	13.6	11.5	7.8	12.4	9.2	11.6	10.0	6.8	13.2	24.8	16.5	13.4	15.0	16.8	6.6	9.2	26.4	10.0	15.1	16.3	7.6	4.6	4.3	8.6	5.5	12.1	6.0	8.8	8.4	5.0	4.0	8.8	7.9	2.8	8.1	6.8	2.9	10.1	4.1	15.2	11.8	10.9	14.4	12.3	11.4	11.1	11.4	13.0	11.8
MAPT	"DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau"	ENSG00000186868	"Microtubule associated protein tau"	P10636	17	45894382-46028334	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 89.9;skeletal muscle: 43.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 27.3;SCLC-21H: 9.8;T-47d: 12.4"	"Group enriched"	"Detected in many"	11	"breast cancer: 9.5;glioma: 13.3;prostate cancer: 3.0;renal cancer: 4.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000151, HPA048895, HPA069524, HPA069570, CAB072344"	Enhanced		Supported	"Nuclear speckles,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB000151: , CAB072344: , HPA048895: AB_2680550, HPA069524: , HPA069570: AB_2686155"	"unprognostic (1.78e-3)"	"unprognostic (7.51e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.40e-5)"	"unprognostic (1.40e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.06e-5)"	"unprognostic (6.04e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.47e-2)"	3.8	7.1	28.9	2.4	31.2	2.1	8.8	40.1	89.9	2.4	2.7	21.4	1.7	2.5	2.6	2.3	6.4	2.5	2.8	6.5	28.7	29.7	15.3	2.2	2.4	2.3	22.6	35.2	2.3	2.8	8.5	8.8	5.2	29.1	5.1	2.5	2.2	8.1	5.3	43.7	4.6	2.8	2.5	13.6	2.2	2.3	6.5	27.7	0.0	2.3	3.1	2.3	3.2	0.8	0.0	0.0	0.3	0.1	0.5	1.7	0.1	0.8	0.3	0.2	2.6	0.0	0.5	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	1.3	0.1	0.0	27.3	1.4	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.2	1.3	0.0	4.1	0.5	0.1	0.0	1.1	0.0	2.2	2.7	0.0	3.5	9.8	4.6	1.0	0.0	0.9	12.4	0.0	0.0	0.2	0.3	0.6	0.1	0.5	0.1	0.0	0.2	0.5	0.3	0.0	0.1	0.3	0.8	0.0	0.6	0.0	0.4	1.2	0.0	0.0	0.9	0.9	0.0	0.5	0.1	0.0	1.7	0.1	28.9	31.2	40.1	46.3	28.7	29.7	22.6	35.2	29.1	27.7
MTRNR2L11		ENSG00000270188	"MT-RNR2-like 11"	S4R3Y5	1	237943724-237945275	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"blood: 64.8;skeletal muscle: 46.5"	"Cell line enhanced"	"Detected in many"		"HeLa: 65.5;Hep G2: 41.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 64.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 64.8"														"Secreted to blood"										"unprognostic (1.07e-1)"					"unprognostic (9.70e-2)"			"unprognostic (4.49e-2)"	"unprognostic (5.26e-2)"				9.9	11.8	3.7	0.9	3.8	1.4	5.5	2.1	8.5	2.0	7.0	1.4	3.7	2.9	2.0	3.1	2.0	2.0	0.2	12.4	4.2	2.3	11.1	7.2	3.0	2.8	2.2	2.6	2.0	3.3	0.0	2.0	1.3	4.6	2.1	3.1	0.9	4.4	6.5	46.5	2.0	3.5	0.7	3.3	2.0	4.3	4.0	3.0	0.8	2.0	7.4	0.3	2.0	2.0	5.9	3.4	64.8	7.0	2.9	3.1	8.2	7.0	16.5	7.7	21.7	6.6	1.7	6.2	11.7	0.9	0.6	0.9	6.9	10.2	12.0	7.5	2.3	21.4	0.2	1.5	0.6	5.2	11.6	12.1	65.5	41.9	2.2	3.3	9.7	6.7	2.3	0.8	2.9	0.9	8.4	7.2	2.0	6.0	3.3	11.5	2.0	3.0	6.4	6.2	4.9	4.5	9.7	2.9	5.2	4.6	5.4	8.6	6.6	10.6	19.0	8.8	6.2	7.0	3.3	5.5	1.8	4.9	4.8	11.8	2.1	14.8	7.0	16.1	1.4	3.2	1.7	5.5	2.2	1.9	2.7	5.9	3.1	3.1	64.8	2.9	3.1	3.4	2.0	8.2	3.7	3.8	2.1	5.1	4.2	2.3	2.2	2.6	4.6	3.0
MTRNR2L4		ENSG00000232196	"MT-RNR2-like 4"	P0CJ71	16	3370979-3372740	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"blood: 49.5;skeletal muscle: 52.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.0;HaCaT: 23.0;HeLa: 30.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 49.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 49.5"														"Secreted to blood"						"unprognostic (8.53e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	2.5	10.3	3.5	1.3	4.4	0.9	1.2	2.7	6.6	1.5	2.2	0.5	0.3	3.4	1.6	0.9	1.5	2.0	1.7	11.7	2.3	1.2	5.8	2.5	1.0	0.3	6.3	4.8	5.8	9.7	0.0	3.1	1.0	2.5	1.7	1.1	1.2	2.7	3.3	52.2	1.2	3.6	2.1	1.5	1.1	3.1	2.3	3.1	0.3	2.6	1.1	0.8	1.5	1.3	5.4	3.8	49.5	6.4	2.5	2.5	5.0	5.9	3.9	1.2	22.0	0.5	0.7	6.8	3.2	0.1	0.4	0.3	1.8	12.9	4.5	6.6	0.2	23.0	0.0	0.2	0.2	3.3	2.2	3.9	30.8	15.9	0.1	1.2	10.7	0.4	0.3	0.1	0.2	0.0	2.9	6.2	0.7	1.3	2.7	10.4	1.7	0.8	5.1	3.1	4.0	0.9	4.5	2.6	5.9	2.0	5.2	7.9	7.3	9.9	2.9	7.1	6.3	8.2	2.3	3.2	1.1	4.1	4.9	10.1	1.6	12.1	6.4	19.1	1.4	3.7	1.7	4.2	1.9	1.9	3.1	5.4	2.1	2.5	49.5	2.5	3.6	3.8	2.1	5.0	3.5	4.4	2.7	5.5	2.3	1.2	6.3	4.8	2.5	3.1
MYBPC1		ENSG00000196091	"Myosin binding protein C, slow type"	Q00872	12	101568353-101686018	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 739.9"	"Cell line enhanced"	"Detected in some"		"AF22: 2.5;HSkMC: 3.3;SCLC-21H: 1.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 33.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	14	"intermediate monocyte: 1.4"	"Lineage enriched"	"Detected in single"	14	"monocytes: 1.4"	"Group enriched"	"Detected in some"	9	"cerebellum: 41.6;olfactory region: 12.2"	"Low region specificity"	"Detected in all"			"HPA021004, HPA027614"	Enhanced									"HPA021004: AB_1854232, HPA027614: AB_10602711"	"prognostic favourable (4.76e-5)"	"unprognostic (7.72e-2)"	"unprognostic (1.09e-1)"		"unprognostic (1.81e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.63e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.93e-1)"	"unprognostic (9.98e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.96e-2)"	"unprognostic (6.13e-2)"	"unprognostic (5.55e-3)"	10.4	0.1	0.2	0.1	0.2	0.1	3.3	0.1	0.6	0.2	0.3	0.0	0.0	0.1	0.1	20.1	6.2	0.1	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.0	4.5	0.1	0.0	8.1	0.1	739.9	0.2	0.5	0.1	0.2	0.1	0.2	0.3	0.0	0.0	2.7	164.9	9.7	0.1	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.7	1.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.6	0.2	0.2	0.2	0.0	0.0	0.0
MYBPC2	"MGC163408, MYBPC, MYBPCF"	ENSG00000086967	"Myosin binding protein C, fast type"	Q14324	19	50432903-50466321	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 311.8;tongue: 133.8"	"Group enriched"	"Detected in some"	17	"HDLM-2: 21.4;Karpas-707: 54.4"	"Cancer enriched"	"Detected in some"	9	"head and neck cancer: 9.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 1.5;naive B-cell: 3.3"	"Lineage enriched"	"Detected in single"	6	"B-cells: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA042991	Enhanced									"HPA042991: AB_2678257"	"unprognostic (6.48e-3)"	"unprognostic (2.65e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.26e-3)"	"unprognostic (1.91e-3)"	"unprognostic (2.15e-2)"	"unprognostic (6.22e-3)"	"unprognostic (2.46e-1)"	"unprognostic (5.38e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.19e-8)"	"unprognostic (1.85e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.73e-1)"	9.6	0.1	0.2	0.0	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.1	42.6	1.6	0.1	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.3	0.2	0.0	0.1	0.2	50.3	0.1	0.0	0.0	0.5	0.0	0.0	4.5	0.0	311.8	0.2	0.2	0.0	0.2	0.1	0.1	0.1	0.0	0.1	1.3	133.8	4.0	0.1	0.1	3.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	54.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.5	0.0	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.2	0.0	0.0	0.0
MYBPH		ENSG00000133055	"Myosin binding protein H"	Q13203	1	203167811-203175813	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 53.8"	"Group enriched"	"Detected in some"	5	"CACO-2: 17.2;HSkMC: 33.7;THP-1: 8.4"	"Group enriched"	"Detected in many"	7	"glioma: 4.9;head and neck cancer: 20.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 6.1"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 6.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA061383	Enhanced		Approved	Nucleoplasm,Nucleoli,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA061383: AB_2684497"	"unprognostic (2.26e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.42e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.62e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.74e-1)"	0.8	0.1	1.1	0.8	0.8	0.3	0.4	0.4	0.6	0.1	0.1	0.0	0.0	0.1	0.4	4.4	3.9	0.2	0.1	0.2	0.4	0.3	1.1	1.5	0.2	0.3	1.3	0.0	0.1	0.2	0.1	0.6	0.3	1.0	4.2	0.1	0.0	8.8	0.1	53.8	0.2	0.1	0.1	0.4	0.4	0.1	0.2	2.1	0.9	3.9	12.7	2.0	0.3	0.8	0.0	6.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.3	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.5	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	6.1	0.0	0.1	1.1	0.8	0.4	0.6	0.4	0.3	1.3	0.0	1.0	2.1
P2RX5	"LRH-1, P2X5"	ENSG00000083454	"Purinergic receptor P2X 5"	Q93086	17	3672199-3696404	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 30.4;intestine: 12.0;lymphoid tissue: 39.1;skeletal muscle: 11.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 24.0;Karpas-707: 15.5;RPMI-8226: 27.0;U-698: 22.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	18	"memory B-cell: 28.1;naive B-cell: 30.4"	"Lineage enriched"	"Detected in many"	19	"B-cells: 30.4"									"HPA021948, HPA067827"	Supported		Supported	Cytosol				Cytosol	Cytosol	"HPA021948: AB_1854878, HPA067827: AB_2685908"	"unprognostic (1.08e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.99e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.63e-2)"	0.6	0.3	2.2	32.0	4.9	4.8	0.5	4.1	5.1	0.3	1.4	0.0	0.4	0.9	0.2	0.2	2.4	0.2	0.8	4.9	1.8	3.0	0.8	0.4	1.0	39.1	1.5	2.1	0.2	0.8	0.1	1.2	0.2	1.7	0.5	1.2	0.0	5.4	0.1	11.4	0.2	12.0	0.4	0.6	29.6	1.8	0.6	0.2	9.3	0.5	1.9	27.6	2.2	0.3	30.4	0.1	0.7	0.0	0.0	1.6	1.6	3.8	3.2	0.0	0.0	0.1	0.6	0.0	4.0	1.8	0.4	1.3	2.4	4.7	24.0	2.4	1.9	2.0	8.6	0.0	0.8	0.4	1.5	1.2	8.5	2.9	0.6	1.6	2.1	1.0	0.9	0.1	5.6	0.0	0.2	15.5	8.7	0.0	10.8	3.6	2.4	9.7	0.4	0.0	27.0	0.1	2.9	2.0	0.0	3.3	1.1	1.8	1.0	1.5	0.0	0.0	2.2	0.1	0.7	5.5	11.7	22.3	0.0	2.3	0.2	0.0	0.0	0.7	1.1	0.0	1.6	28.1	1.0	0.8	0.1	30.4	0.1	0.1	0.0	0.0	0.0	0.0	0.5	1.6	2.2	4.9	4.1	5.1	1.8	3.0	1.5	2.1	1.7	0.2
PACSIN3	SDPIII	ENSG00000165912	"Protein kinase C and casein kinase substrate in neurons 3"	Q9UKS6	11	47177525-47186443	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 40.6;skeletal muscle: 121.6;tongue: 44.6"	"Cell line enhanced"	"Detected in many"		"T-47d: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039480, HPA043904"	Approved	Approved	Supported	"Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA039480: AB_2676531, HPA043904: AB_2678725"	"unprognostic (1.75e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.66e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.85e-1)"	"prognostic favourable (2.09e-4)"	"unprognostic (3.86e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.75e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.76e-2)"	4.1	17.0	3.9	2.2	5.7	0.4	4.3	3.5	4.7	6.5	8.5	8.6	7.1	1.6	6.7	7.6	12.6	4.8	5.8	40.6	4.0	2.4	2.9	10.0	3.9	0.8	7.6	3.6	6.3	14.6	4.8	1.0	8.0	4.4	8.6	1.1	4.6	11.3	6.7	121.6	11.9	1.9	7.4	8.3	1.5	6.0	1.6	6.5	0.3	8.5	44.6	7.1	6.4	5.7	0.0	0.1	0.0	0.9	0.0	0.2	0.9	16.4	8.3	3.8	16.6	3.3	3.3	18.6	5.1	7.4	10.8	6.1	12.3	2.3	0.1	1.6	2.8	27.1	7.6	12.5	4.3	2.5	12.9	2.5	31.3	28.2	6.5	0.5	2.6	9.3	16.8	5.7	9.1	4.8	5.4	0.2	4.4	32.6	0.3	12.1	4.7	16.6	10.1	14.4	2.6	4.5	15.6	0.1	13.0	8.1	5.8	7.6	41.0	2.2	2.3	18.9	19.0	2.4	14.1	2.8	1.3	1.5	6.1	5.7	9.7	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.9	5.7	3.5	4.7	4.0	2.4	7.6	3.6	4.4	6.5
PCNT	"KEN, KIAA0402, PCN, PCNT2, PCNTB, SCKL4"	ENSG00000160299	Pericentrin	O95613	21	46324122-46445769	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 82.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 10.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.3;granulocytes: 4.9;T-cells: 10.7"	"Low region specificity"	"Detected in all"							"HPA016820, HPA019887, HPA032101"	Enhanced		Enhanced	Centrosome				Centrosome	Centrosome	"HPA016820: AB_1855079, HPA019887: AB_1855080, HPA032101: AB_2674151"	"unprognostic (9.07e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.95e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.86e-2)"	4.7	4.7	16.6	6.9	20.4	12.6	3.6	8.3	16.5	3.2	4.0	4.4	3.8	3.7	3.7	4.1	5.1	3.4	5.0	8.2	12.0	4.2	3.2	4.4	4.3	6.4	7.0	9.7	4.9	3.3	5.9	8.0	3.4	5.6	4.0	4.1	2.0	4.1	4.1	82.3	10.4	4.0	4.2	4.3	5.5	4.6	14.5	9.7	9.1	4.4	2.2	4.8	4.7	5.1	0.4	5.3	4.9	1.2	0.5	10.7	2.3	9.2	7.3	11.3	6.9	5.7	5.8	7.1	7.2	5.0	7.2	6.4	8.8	6.0	9.3	4.6	8.2	6.7	9.1	6.2	5.0	27.0	12.8	24.6	13.6	6.8	1.9	12.4	10.2	3.1	4.7	9.6	4.8	5.5	12.4	14.0	9.8	15.4	12.2	12.8	11.2	5.0	15.2	4.6	8.1	5.6	10.0	13.9	6.2	15.5	9.7	4.7	9.2	9.7	7.5	12.9	6.5	7.3	11.4	12.1	10.1	10.0	8.0	12.2	6.9	4.9	0.8	1.3	2.0	0.6	5.9	0.4	0.9	5.9	2.3	0.2	0.7	10.7	0.5	0.5	1.2	5.3	0.9	2.3	16.6	20.4	8.3	16.5	12.0	4.2	7.0	9.7	5.6	9.7
PGM1		ENSG00000079739	"Phosphoglucomutase 1"	P36871	1	63593276-63660245	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 233.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004666, HPA024190, HPA024637, HPA046329"	Enhanced		Approved	Cytosol		20000000	20000000	Cytosol	Cytosol	"CAB004666: AB_425590, HPA024190: AB_1855266, HPA024637: AB_1855267, HPA046329: "	"unprognostic (2.50e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (8.74e-5)"	"unprognostic (7.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.74e-3)"	17.8	14.1	7.0	4.4	8.3	3.5	9.8	4.4	8.3	6.7	12.9	5.2	4.6	10.6	4.6	7.7	8.8	3.3	8.9	36.9	6.4	5.4	10.0	56.4	7.6	2.7	6.2	6.3	9.7	21.6	12.9	6.2	11.5	8.5	8.7	9.1	5.4	7.9	9.4	233.5	5.3	12.4	8.4	5.6	3.0	5.7	3.0	5.5	3.0	6.0	42.8	6.3	9.4	4.7	12.2	25.9	25.6	17.9	21.1	23.3	16.6	30.2	12.7	4.8	15.7	31.7	23.4	38.9	12.5	17.0	13.6	22.3	10.5	14.1	9.6	26.2	19.2	7.2	6.6	26.3	16.1	11.7	8.8	20.2	21.5	10.8	26.2	17.7	1.2	29.5	17.0	15.9	25.2	8.1	0.0	12.8	21.8	1.8	5.1	9.7	21.8	20.4	7.2	22.3	3.1	19.8	9.5	2.9	18.7	27.3	28.6	41.6	8.9	6.7	0.8	20.2	10.3	17.9	10.6	8.1	11.9	15.6	33.0	15.6	8.6	20.5	17.9	25.6	23.3	12.0	18.6	12.2	13.7	17.5	25.9	6.9	12.5	14.5	21.2	21.1	10.2	7.5	10.6	16.6	7.0	8.3	4.4	8.3	6.4	5.4	6.2	6.3	8.5	5.5
PGPEP1L		ENSG00000183571	"Pyroglutamyl-peptidase I-like"	A6NFU8	15	98968230-99007795	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 34.7"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.9;U-2 OS: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"basophil: 2.0;neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.0"					"Not detected"	"Not detected"			HPA041781	Uncertain									"HPA041781: AB_10795642"	"unprognostic (2.48e-1)"	"unprognostic (2.82e-2)"		"unprognostic (8.26e-2)"	"unprognostic (2.43e-3)"	"unprognostic (7.18e-2)"		"unprognostic (3.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.44e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.65e-1)"	0.7	0.1	0.5	0.2	1.4	0.1	0.6	0.2	0.5	0.4	0.4	0.4	0.0	0.2	0.2	0.4	0.8	0.2	0.5	3.6	0.6	0.4	0.4	0.0	0.2	0.3	0.4	0.2	0.2	0.5	0.0	0.1	0.3	0.4	0.6	0.0	1.6	0.9	0.5	34.7	0.1	0.2	0.3	0.3	0.1	0.2	5.0	0.2	0.1	0.1	8.6	0.5	0.2	0.3	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.1	0.7	0.0	0.2	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	1.9	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.9	1.4	0.1	0.0	0.2	0.4	1.3	0.4	0.4	0.1	1.2	0.0	0.9	0.3	0.4	0.5	1.4	0.2	0.8	0.0	0.7	0.0	4.4	0.2	0.1	0.8	0.2	0.7	0.0	0.5	0.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	1.4	0.2	0.5	0.6	0.4	0.4	0.2	0.4	0.2
PLCD4		ENSG00000115556	"Phospholipase C delta 4"	Q9BRC7	2	218607765-218637184	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"retina: 23.0;skeletal muscle: 62.5;smooth muscle: 33.1"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 21.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009914, HPA038139, HPA038140"	Enhanced		Approved	"Nuclear membrane,Plasma membrane,Cytosol"				Cytosol	Cytosol	"CAB009914: AB_2252306, HPA038139: AB_2675855, HPA038140: AB_2675856"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.65e-5)"	"unprognostic (7.77e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.87e-3)"	"unprognostic (7.54e-5)"	"unprognostic (3.28e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.32e-2)"	"unprognostic (8.46e-3)"	"unprognostic (3.09e-1)"	1.1	2.5	1.5	1.0	1.6	0.5	1.0	0.9	2.4	0.6	6.4	0.3	3.8	0.9	0.8	1.1	3.7	0.6	0.9	0.9	1.0	1.5	3.9	0.5	0.7	0.7	1.6	1.0	0.7	0.4	1.4	4.7	0.6	2.6	6.4	1.5	23.0	1.4	0.6	62.5	0.8	1.4	33.1	1.1	0.5	3.5	3.9	0.5	0.0	1.4	6.8	0.5	9.6	5.3	0.9	1.2	0.3	0.4	0.9	0.9	1.0	0.6	1.5	2.1	0.4	0.2	1.4	1.2	1.2	2.6	0.4	1.4	2.4	0.3	1.4	1.8	0.4	1.0	0.0	1.5	0.3	0.5	1.8	1.2	3.5	1.9	0.2	1.2	0.6	3.0	0.1	1.9	0.5	2.7	1.0	1.1	2.2	1.8	0.4	1.2	0.7	3.4	0.9	0.8	0.5	4.3	3.0	2.3	21.1	1.0	0.8	0.3	2.5	0.5	6.0	1.5	1.2	0.7	0.7	0.5	0.8	0.9	4.6	0.3	1.6	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.3	0.9	0.3	0.9	0.7	0.8	0.3	0.9	0.0	1.2	0.7	1.0	1.5	1.6	0.9	2.4	1.0	1.5	1.6	1.0	2.6	0.5
PRKCQ		ENSG00000065675	"Protein kinase C theta"	Q04759	10	6427143-6580301	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 19.7;lymphoid tissue: 32.1;skeletal muscle: 63.4"	"Cell line enhanced"	"Detected in some"		"HEL: 30.9;MOLT-4: 23.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"gdTCR: 12.7;MAIT T-cell: 9.8;memory CD4 T-cell: 13.5;memory CD8 T-cell: 13.2;naive CD4 T-cell: 10.7;naive CD8 T-cell: 10.0;NK-cell: 6.5;T-reg: 19.7"	"Group enriched"	"Detected in many"	11	"NK-cells: 6.5;T-cells: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065279, HPA073098"			Enhanced	"Centriolar satellite"		200000	200000	"Centriolar satellite"	"Centriolar satellite"	"HPA065279: AB_2685453, HPA073098: AB_2686571"	"unprognostic (6.61e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.46e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.26e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (5.27e-4)"	"unprognostic (3.51e-2)"	0.9	0.7	3.6	9.4	4.3	3.1	0.8	0.9	5.2	1.3	1.1	7.4	0.1	1.2	1.8	5.4	1.6	2.6	1.3	0.5	4.4	4.0	4.6	0.9	3.3	6.6	4.0	2.2	1.1	7.7	0.3	1.0	0.4	2.7	1.4	1.3	5.4	2.8	1.0	63.4	0.6	2.5	0.8	3.6	3.4	1.4	0.9	4.5	32.1	9.1	7.5	6.8	1.9	0.8	0.0	0.1	1.1	0.2	6.5	19.7	5.2	0.0	2.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.2	1.8	0.2	0.0	0.0	0.0	1.8	3.3	0.0	0.0	2.1	30.9	0.0	0.2	0.4	1.5	0.3	0.1	2.0	0.1	0.1	0.3	6.7	0.0	0.0	0.0	23.2	4.3	3.2	0.0	4.5	0.7	0.0	6.5	1.6	0.2	1.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	1.1	0.1	0.1	12.7	0.2	9.8	0.0	13.5	13.2	0.1	0.0	10.7	10.0	0.8	6.5	0.0	0.0	19.7	5.2	3.6	4.3	0.9	5.2	4.4	4.0	4.0	2.2	2.7	4.5
RILPL1	FLJ39378	ENSG00000188026	"Rab interacting lysosomal protein like 1"	Q5EBL4	12	123470054-123533718	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 21.1;heart muscle: 43.8;skeletal muscle: 66.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041314	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA041314: AB_10795587"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.71e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.30e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.81e-1)"	6.1	5.7	9.9	3.5	12.3	3.0	3.7	5.2	11.3	4.8	4.7	12.6	4.4	2.1	6.6	5.0	4.8	5.0	4.3	43.8	9.6	7.5	3.8	3.0	5.5	2.3	21.1	5.8	7.2	3.2	5.7	3.6	7.1	11.1	6.2	2.2	4.9	8.0	7.8	66.2	6.2	2.7	9.8	14.4	3.8	3.0	2.9	15.1	0.3	8.2	9.7	1.9	4.7	5.3	1.6	1.2	4.6	1.2	1.2	2.0	0.7	6.0	8.5	7.7	6.0	8.7	8.2	8.1	10.9	6.1	6.0	5.3	5.3	1.4	0.3	5.5	10.6	6.6	5.7	5.2	2.4	6.1	10.4	0.8	5.5	7.7	15.2	0.3	2.3	9.3	10.4	6.7	9.7	6.0	4.8	0.4	6.0	10.0	0.7	1.9	5.6	9.0	1.0	4.2	0.3	4.2	6.3	1.2	7.2	5.8	5.1	13.0	6.8	0.2	12.0	7.8	3.9	11.3	6.9	1.3	0.6	0.2	8.0	0.1	4.9	1.4	1.0	0.7	0.9	0.5	0.8	0.9	1.0	0.8	0.3	1.6	2.0	1.6	4.6	1.2	1.2	1.2	0.9	0.7	9.9	12.3	5.2	9.9	9.6	7.5	21.1	5.8	11.1	15.1
RRAD	"RAD, REM3"	ENSG00000166592	"RRAD, Ras related glycolysis inhibitor and calcium channel regulator"	P55042	16	66921679-66925644	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 246.0"	"Group enriched"	"Detected in some"	8	"HDLM-2: 60.8;U-87 MG: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041755	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA041755: AB_2677655"	"unprognostic (1.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.06e-3)"	"unprognostic (3.46e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.80e-3)"	7.3	2.1	0.4	2.4	2.7	1.3	5.0	1.2	1.7	4.7	2.0	3.2	1.8	1.2	3.3	8.5	20.4	6.3	4.1	61.2	0.7	0.6	5.6	0.8	6.3	1.3	1.5	0.8	4.7	0.7	1.0	2.0	10.7	4.6	4.2	0.4	3.9	4.3	1.4	246.0	2.2	1.2	5.7	1.7	0.8	1.7	2.3	1.2	0.3	3.9	14.7	4.3	4.5	5.7	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	2.8	0.0	0.0	0.0	0.3	0.1	1.6	0.1	0.2	1.4	0.6	1.9	0.0	1.6	0.1	0.1	0.0	0.1	0.2	60.8	0.1	0.0	0.0	0.7	2.7	0.0	0.2	0.8	0.3	4.9	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.3	0.0	0.1	0.2	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	2.0	0.0	0.1	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	2.7	1.2	1.0	0.7	0.6	1.5	0.8	4.6	1.2
RXRG	NR2B3	ENSG00000143171	"Retinoid X receptor gamma"	P48443	1	165400917-165445355	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 14.9;pituitary gland: 29.8;retina: 13.5;skeletal muscle: 44.8"	"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 28.3"	"Group enriched"	"Detected in many"	13	"melanoma: 25.7;thyroid cancer: 34.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"basal ganglia: 89.8"	"Low region specificity"	"Detected in all"			"CAB002615, HPA012933"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"CAB002615: , HPA012933: AB_2732406"	"unprognostic (2.29e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.29e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.18e-1)"	"prognostic favourable (9.40e-5)"	"unprognostic (5.03e-2)"	1.9	3.9	5.4	1.0	14.9	0.6	1.0	0.3	5.9	4.0	2.5	5.3	0.6	1.3	1.8	1.3	1.7	3.6	1.2	5.8	7.5	8.9	0.7	0.8	3.4	0.8	4.1	4.3	1.7	2.7	0.8	29.8	1.3	14.1	1.1	2.7	13.5	1.9	2.1	44.8	2.9	2.0	1.8	8.9	1.0	1.1	1.5	5.4	0.0	1.1	2.5	0.6	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	14.9	0.3	5.9	7.5	8.9	4.1	4.3	14.1	5.4
RYR1	"CCO, MHS, MHS1, PPP1R137, RYR"	ENSG00000196218	"Ryanodine receptor 1"	P21817	19	38433699-38587564	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 231.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 13.7;RH-30: 11.3;SiHa: 22.3;U-2 OS: 9.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 3.2;myeloid DC: 5.3;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.3;monocytes: 6.3"	"Low region specificity"	"Detected in some"							HPA056416	Enhanced		Approved	"Golgi apparatus,Vesicles,Cytosol"				"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA056416: AB_2683121"	"unprognostic (2.22e-3)"	"unprognostic (1.91e-3)"	"unprognostic (9.59e-2)"	"unprognostic (5.34e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.07e-5)"	"unprognostic (1.13e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.34e-1)"	5.3	0.7	3.0	0.6	1.9	0.4	0.6	2.7	1.7	0.6	0.4	2.7	0.0	0.4	0.4	6.7	3.0	0.6	0.5	0.4	1.8	4.0	0.5	0.4	0.7	0.6	1.5	1.3	0.4	0.4	0.3	0.3	0.6	1.9	0.9	0.4	0.4	2.2	0.6	231.0	2.4	0.5	0.4	1.1	0.6	0.5	1.6	1.9	0.0	1.6	55.1	3.2	0.6	0.5	0.7	5.3	0.1	6.3	0.0	0.6	0.6	0.0	5.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.0	0.3	0.3	4.7	0.0	13.7	0.2	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.4	1.3	5.6	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	11.3	1.0	0.6	0.0	0.0	1.1	22.3	0.0	0.0	0.5	4.2	0.0	0.0	9.4	0.2	0.0	0.3	0.9	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.4	3.2	0.5	0.4	0.3	0.6	5.3	0.7	0.0	0.0	0.1	0.0	6.3	0.0	0.6	0.6	3.0	1.9	2.7	1.7	1.8	4.0	1.5	1.3	1.9	1.9
S100A1	"S100-alpha, S100A"	ENSG00000160678	"S100 calcium binding protein A1"	P23297	1	153627926-153632039	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 465.5;skeletal muscle: 423.5"	"Group enriched"	"Detected in some"	5	"Hep G2: 42.7;SK-MEL-30: 146.4"	"Group enriched"	"Detected in all"	5	"melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002599, HPA006462"	Enhanced					240000	240000			"CAB002599: AB_2315307, HPA006462: AB_1079857"	"unprognostic (6.13e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.96e-5)"	"prognostic unfavourable (1.12e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.83e-3)"	"unprognostic (5.22e-1)"	"unprognostic (5.04e-3)"	"unprognostic (9.62e-2)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (1.68e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.74e-4)"	27.7	3.2	70.0	2.8	67.3	2.2	14.3	4.1	42.5	2.0	2.4	47.3	0.0	3.5	2.6	8.5	14.1	8.8	2.6	465.5	44.9	42.9	20.0	2.6	2.4	2.5	85.0	30.7	2.2	4.5	2.0	4.3	4.5	31.4	6.3	2.1	4.3	99.3	3.7	423.5	4.0	2.9	2.1	87.7	2.4	3.3	2.8	31.8	0.0	29.0	57.6	4.7	2.9	0.1	0.6	0.6	2.1	1.0	0.3	0.5	0.5	0.7	0.3	0.5	4.5	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.9	0.4	0.5	19.1	0.0	1.1	0.0	0.0	0.0	0.4	0.4	1.0	0.6	42.7	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	3.4	0.5	0.0	1.2	0.1	0.5	0.2	0.3	3.0	0.4	1.0	0.8	1.6	0.7	0.2	0.3	1.3	146.4	4.4	2.2	0.3	0.4	0.3	0.3	0.4	0.7	0.7	0.7	0.3	0.7	0.2	2.1	0.3	0.0	0.1	0.3	0.1	0.0	0.2	0.5	0.0	0.6	0.3	0.0	0.0	0.3	1.0	0.6	0.0	0.5	70.0	67.3	4.1	42.5	44.9	42.9	85.0	30.7	31.4	31.8
SEC14L5	"KIAA0420, PRELID4B"	ENSG00000103184	"SEC14 like lipid binding 5"	O43304	16	4958317-5019158	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 29.4;heart muscle: 7.5;skeletal muscle: 11.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.1;RPMI-8226: 4.1;SCLC-21H: 6.4;T-47d: 4.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041492, HPA041825"			Uncertain	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"	"Golgi apparatus, Cytosol"	"HPA041492: AB_10794519, HPA041825: AB_10794526"	"unprognostic (1.90e-3)"	"unprognostic (4.08e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.68e-2)"	"unprognostic (7.33e-3)"	"unprognostic (8.71e-4)"	"unprognostic (6.87e-2)"	"unprognostic (1.56e-4)"	"unprognostic (1.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.45e-2)"	1.1	1.7	7.4	1.3	17.5	1.5	1.2	2.2	22.1	2.8	1.7	29.4	0.0	1.4	0.9	1.2	2.0	2.2	1.1	7.5	13.5	6.1	1.1	0.8	1.0	1.4	25.8	8.8	1.7	1.8	0.8	1.7	1.3	15.2	1.7	2.1	0.3	1.9	1.1	11.0	2.9	1.1	0.9	25.2	1.2	3.7	1.4	15.6	0.0	0.9	0.5	1.7	0.9	0.4	0.1	0.4	1.6	0.0	0.1	0.2	2.9	0.0	0.4	0.6	0.3	0.6	4.1	0.5	0.1	0.0	0.1	0.0	0.5	0.2	0.2	0.3	0.5	0.6	0.2	0.1	0.0	0.0	0.5	1.9	0.4	1.0	0.2	0.0	0.4	0.6	0.8	0.1	0.1	0.1	0.2	0.4	0.1	0.3	0.0	0.2	1.3	0.3	0.1	0.4	4.1	0.3	0.1	6.4	0.2	0.4	0.3	0.4	4.2	0.0	0.5	0.2	0.4	0.3	0.0	0.2	0.0	0.2	1.1	0.2	0.2	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	1.6	0.1	0.0	0.4	0.0	2.9	7.4	17.5	2.2	20.0	13.5	6.1	25.8	8.8	15.2	15.6
SMIM37	"LINC00116, NCRNA00116"	ENSG00000175701	"Small integral membrane protein 37"	Q8NCU8	2	110211529-110245420	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 39.5;skeletal muscle: 119.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"														"unprognostic (3.74e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.68e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.49e-3)"	"unprognostic (8.20e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.08e-2)"	"unprognostic (5.08e-3)"	"unprognostic (8.27e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.95e-2)"	5.1	4.6	3.6	3.3	5.1	1.2	6.3	1.6	5.7	3.1	4.8	0.9	2.8	7.0	1.9	9.8	6.6	2.4	2.5	15.0	3.3		7.4	8.4	2.9	3.9	3.2	3.3	2.2	5.2	2.4	1.2	2.0	4.8	4.2	1.9	1.9	5.9	6.2	119.5	2.8	5.4	2.9	2.3	3.5	4.3	2.5	2.8	1.8	6.1	19.2	2.5	3.9	3.8	31.8	39.5	3.4	28.8	20.4	37.1	20.0	0.1	37.1	4.1	4.6	4.4	5.4	24.8	15.1	11.5	17.9	11.8	25.0	11.6	4.9	29.4	4.0	15.6	3.9	16.4	2.8	21.2	15.6	2.9	9.1	20.6	18.5	10.2	15.4	14.0	19.7	15.1	0.0	15.5	8.3	12.2	8.3	37.2	14.3	35.2	10.2	10.9	1.5	8.4	14.7	10.6	22.6	9.0	5.9	8.3	28.7	16.5	8.0	17.5	12.4	17.8	24.6	17.2	22.4	20.9	13.4	1.4	18.5	16.2	12.5	2.4	28.8	3.4	31.0	28.5	34.8	27.9	34.8	33.2	29.0	31.8	37.1	37.0	1.4	20.4	16.7	39.5	29.9	20.0										
SMTNL2	FLJ42461	ENSG00000188176	"Smoothelin like 2"	Q2TAL5	17	4583999-4608319	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 99.7"	"Cell line enriched"	"Detected in some"	4	"CACO-2: 32.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 2.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (8.62e-2)"	"unprognostic (5.40e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.73e-1)"	"unprognostic (3.73e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.89e-2)"	"prognostic favourable (1.28e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.22e-1)"	3.0	0.1	0.1	0.5	0.2	0.1	0.5	0.1	0.5	1.0	0.3	0.0	0.0	0.1	0.9	4.7	3.4	1.8	2.4	4.8	0.8	0.1	17.9	0.1	1.0	0.1	0.1	0.0	5.3	0.1	0.2	0.6	1.4	0.1	2.7	0.2	0.1	1.4	0.4	99.7	0.2	0.2	2.1	0.1	0.2	0.3	0.6	0.0	0.0	0.8	24.6	1.1	3.3	0.7	0.0	0.4	0.0	2.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	32.1	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.4	0.0	1.9	0.0	0.0	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	3.6	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.5	0.8	0.1	0.1	0.0	0.1	0.0
SRPK3	"MSSK1, STK23"	ENSG00000184343	"SRSF protein kinase 3"	Q9UPE1	X	153776412-153785732	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 73.4"	"Cell line enhanced"	"Detected in many"		"RH-30: 30.8;U-266/70: 12.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.47e-4)"	"unprognostic (2.83e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.10e-4)"	"unprognostic (8.70e-2)"	"unprognostic (5.38e-7)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.07e-4)"	1.6	1.8	1.3	0.9	1.8	0.8	0.3	7.7	1.5	0.9	4.5	1.1	0.2	1.3	2.5	3.3	2.6	0.7	1.7	16.7	2.0	1.8	0.2	0.2	0.4	0.8	2.0	0.7	0.7	0.7	1.0	5.8	0.3	1.1	2.8	0.8	0.9	2.9	0.5	73.4	2.3	1.3	4.0	2.0	0.8	1.3	0.5	0.9	0.3	0.6	18.3	1.6	2.0	0.8	0.4	2.6	0.9	0.3	0.1	0.6	0.3	3.2	4.3	0.7	2.2	0.0	0.1	1.0	0.4	0.0	0.2	0.0	3.6	0.6	3.2	0.4	0.3	0.9	0.0	0.1	0.0	2.8	3.0	1.7	2.7	0.5	0.0	0.8	5.0	2.7	0.0	0.0	0.0	0.0	2.1	3.8	0.8	6.9	0.6	4.7	0.8	1.2	1.5	30.8	0.9	0.0	1.4	5.2	2.5	0.0	2.3	1.0	2.9	3.7	0.0	1.2	2.8	2.3	0.4	12.8	2.0	2.2	0.6	6.1	1.6	0.8	0.3	0.2	0.5	0.1	0.6	0.2	0.1	0.1	0.0	0.4	0.1	0.1	0.9	0.1	0.0	2.6	0.0	0.3	1.3	1.8	7.7	1.5	2.0	1.8	2.0	0.7	1.1	0.9
TMEM52		ENSG00000178821	"Transmembrane protein 52"	Q8NDY8	1	1917590-1919273	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"pancreas: 67.1;skeletal muscle: 77.9;tongue: 38.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 14.3;PC-3: 7.7;RPMI-8226: 26.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"						"unprognostic (4.39e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.76e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.04e-5)"	"unprognostic (1.46e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.68e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.83e-3)"	"unprognostic (5.80e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.18e-2)"	1.7	12.5	0.5	0.2	0.5	0.1	1.3	1.5	0.4	0.3	0.9	0.4	0.1	1.0	0.3	1.5	2.0	0.8	0.4	0.4	0.4	0.5	0.6	3.3	1.0	0.1	0.2	0.5	0.5	67.1	0.9	0.3	0.2	0.4	0.5	0.4	0.5	13.8	0.1	77.9	0.8	1.7	0.2	0.3	0.7	1.2	7.9	0.2	0.2	0.9	38.9	2.5	0.3	0.4	0.2	2.3	0.0	0.4	0.0	0.6	0.0	2.4	0.2	0.6	1.3	0.2	0.1	5.5	0.3	0.1	1.6	1.0	4.0	1.6	0.6	1.6	2.5	0.8	4.0	1.1	0.3	0.2	2.9	0.0	0.6	14.3	0.8	0.0	0.9	0.0	2.3	0.5	0.2	0.1	3.5	1.4	0.0	4.5	0.3	1.1	2.1	7.7	1.0	0.0	26.1	0.8	0.1	2.7	1.9	0.0	2.3	0.3	1.5	0.3	0.0	0.0	1.1	0.7	0.0	1.8	0.6	0.7	0.0	0.4	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.5	1.5	0.4	0.4	0.5	0.2	0.5	0.4	0.2
TMOD4	Sk-Tmod	ENSG00000163157	"Tropomodulin 4"	Q9NZQ9	1	151169986-151176284	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 153.5"	"Cell line enhanced"	"Detected in many"		"HEK 293: 6.4;NB-4: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdTCR: 1.5;memory B-cell: 1.7;memory CD4 T-cell: 1.5;naive B-cell: 1.0;naive CD4 T-cell: 1.6;naive CD8 T-cell: 3.5;plasmacytoid DC: 1.0"	"Group enriched"	"Detected in many"	5	"B-cells: 1.7;dendritic cells: 1.0;T-cells: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA028203	Enhanced									"HPA028203: AB_10600830"																		2.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	4.0	1.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.2	0.1	0.0	1.6	0.1	153.5	0.2	0.1	0.7	0.1	0.1	0.1	0.1	0.0	0.0	0.3	35.0	1.6	0.4	0.1	1.7	1.0	0.4	0.3	0.0	3.5	0.6	0.5	0.4	0.9	0.1	0.7	0.2	1.6	0.1	0.6	0.4	0.1	0.0	0.6	1.4	0.7	1.6	0.5	1.4	0.3	0.5	2.7	6.4	2.6	2.2	0.0	1.0	1.4	3.2	0.0	0.4	1.2	3.0	0.8	1.6	2.3	0.2	2.3	0.7	8.0	1.4	2.6	2.5	0.3	0.1	0.5	1.5	1.8	1.1	0.7	0.0	0.1	0.8	4.9	1.0	0.2	1.1	2.3	0.7	2.9	5.5	1.2	0.8	4.4	0.6	0.0	0.3	0.4	1.5	0.0	0.4	1.7	1.5	0.2	0.1	1.0	1.6	3.5	0.2	0.0	0.3	1.0	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
TRIM55	"MURF-2, RNF29"	ENSG00000147573	"Tripartite motif containing 55"	Q9BYV6	8	66126896-66175487	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 34.3;liver: 22.0;skeletal muscle: 37.0;tongue: 24.4"	"Cell line enriched"	"Detected in some"	15	"LHCN-M2: 96.9"	"Group enriched"	"Detected in some"	10	"liver cancer: 12.3;renal cancer: 5.8"	"Region enriched"	"Detected in single"	4	"cerebellum: 3.3"	"Cell type enhanced"	"Detected in single"		"T-reg: 1.3"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	8	"olfactory region: 0.5"	"Group enriched"	"Detected in some"	9	"hippocampal formation: 0.8;pons and medulla: 1.1"	"HPA038793, HPA053691"	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	"Golgi apparatus"	"HPA038793: AB_10673289, HPA053691: AB_2682231"	"unprognostic (5.44e-3)"	"unprognostic (1.25e-2)"		"unprognostic (5.93e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.77e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.77e-3)"	2.1	0.0	0.3	0.2	0.2	0.0	0.1	3.3	0.1	0.4	0.1	0.1	0.3	0.0	0.0	6.6	0.8	3.0	0.1	34.3	0.4	0.1	2.7	22.0	0.1	0.4	0.1	0.1	0.5	0.1	0.0	2.0	1.4	0.8	0.3	0.0	0.1	1.0	0.0	37.0	0.3	0.1	0.0	0.1	0.1	0.1	3.8	0.0	0.0	0.9	24.4	1.2	0.1	0.0	0.6	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	96.9	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.3	6.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.2	3.3	0.1	0.4	0.1	0.1	0.1	0.8	0.0
UBAC1	"GBDR1, KPC2, UBADC1"	ENSG00000130560	"UBA domain containing 1"	Q9BSL1	9	135932969-135961380	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 113.2"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 59.3;K-562: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005651	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		54000	54000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA005651: AB_1858489"	"unprognostic (8.41e-2)"	"prognostic favourable (4.34e-6)"	"unprognostic (2.10e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.11e-1)"	"unprognostic (3.85e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.85e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.20e-1)"	"prognostic favourable (3.58e-7)"	"unprognostic (1.95e-3)"	"unprognostic (9.46e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.78e-2)"	7.6	5.7	12.4	5.8	13.4	27.1	6.2	10.9	12.7	6.1	11.0	8.0	6.8	9.9	6.2	10.3	10.0	9.4	5.1	22.2	11.0	8.6	8.8	7.6	6.4	5.8	11.6	7.4	7.8	6.7	6.9	6.6	9.3	8.7	7.4	7.8	7.7	9.2	9.2	113.2	15.7	9.6	9.3	10.1	5.7	6.1	10.9	7.8	3.9	6.1	21.9	9.0	7.6	8.3	3.2	9.7	5.1	18.8	2.2	3.6	4.0	8.9	10.5	7.5	10.8	5.6	6.6	14.0	7.9	6.7	9.8	7.9	14.5	11.5	10.8	7.6	6.4	30.7	10.4	9.1	4.4	59.3	9.8	9.0	18.9	8.1	5.9	11.7	8.7	6.2	12.0	6.2	6.0	8.1	75.2	8.8	7.7	18.5	9.6	12.1	17.7	17.9	10.8	14.1	14.3	7.0	5.8	11.6	12.8	11.4	10.3	8.0	8.7	12.7	6.6	5.6	8.4	6.6	9.7	5.1	9.6	12.9	10.3	10.7	7.6	3.4	11.3	5.1	3.1	17.2	3.3	3.2	3.6	2.1	9.7	2.0	1.9	2.2	2.5	2.2	18.8	1.0	2.7	4.0	12.4	13.4	10.9	12.7	11.0	8.6	11.6	7.4	8.7	7.8
UBE2QL1	FLJ25076	ENSG00000215218	"Ubiquitin conjugating enzyme E2 Q family like 1"	A1L167	5	6448623-6494909	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"brain: 28.1;heart muscle: 11.3;retina: 8.2;seminal vesicle: 8.6;skeletal muscle: 21.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 17.8;PC-3: 14.9;SCLC-21H: 13.9;U-266/70: 33.3;U-266/84: 29.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057414			Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	Nucleoplasm	"HPA057414: "	"unprognostic (1.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.15e-3)"	"unprognostic (8.41e-2)"	"prognostic favourable (6.81e-8)"	"unprognostic (3.18e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.41e-2)"	0.6	2.3	8.6	0.8	4.2	0.3	0.9	20.7	28.1	1.0	1.8	1.0	0.5	0.7	1.4	1.8	1.0	0.5	0.8	11.3	12.6	8.2	2.6	1.1	0.4	0.7	5.2	4.6	3.6	0.8	0.3	1.3	0.3	8.7	3.1	0.8	8.2	1.0	8.6	21.3	2.4	1.0	1.3	1.4	0.4	2.2	0.9	0.0	0.0	1.9	2.0	0.5	0.5	0.9	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.8	0.0	3.0	0.0	0.0	0.2	14.9	0.1	0.0	6.6	0.0	0.0	13.9	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	33.3	29.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	4.2	20.7	19.4	12.6	8.2	5.2	4.6	8.7	0.0
YBX1	"BP-8, CSDA2, CSDB, DBPB, MDR-NF1, NSEP-1, NSEP1, YB-1, YB1"	ENSG00000065978	"Y-box binding protein 1"	P67809	1	42682427-42702349	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 128.1;testis: 426.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005875, HPA040304, HPA057159"	Approved		Enhanced	Vesicles,Cytosol	"Intracellular and membrane"	870000	870000	Cytosol	Cytosol	"CAB005875: AB_2219278, HPA040304: AB_10795364, HPA057159: AB_2683355"	"unprognostic (8.59e-2)"	"unprognostic (5.16e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.68e-3)"	"unprognostic (7.76e-2)"	"unprognostic (8.03e-3)"	"prognostic unfavourable (9.87e-10)"	"unprognostic (2.80e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.79e-3)"	"unprognostic (7.51e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavourable (3.59e-7)"	"unprognostic (3.66e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.25e-1)"	47.5	20.6	15.6	36.4	18.4	57.6	35.2	13.7	14.4	27.9	44.5	21.2	20.1	25.6	35.1	36.4	40.0	25.6	32.5	57.8	15.2	12.3	33.1	38.1	35.3	49.8	17.6	13.2	30.2	36.7	9.4	12.2	26.1	15.5	32.0	33.1	31.1	26.6	23.0	128.1	22.5	27.1	50.0	21.0	47.9	33.2	426.5	15.9	53.2	31.4	64.1	37.2	39.4	41.0	23.5	26.9	21.8	40.5	11.6	23.0	10.6	91.5	54.0	86.5	86.7	84.3	76.3	77.1	67.6	63.0	94.0	73.8	74.0	85.6	116.2	70.9	67.8	55.5	97.4	102.6	93.4	62.0	90.3	118.6	107.3	94.9	68.0	159.2	88.9	70.2	88.4	93.8	116.2	77.7	123.3	50.7	87.5	57.7	179.8	155.0	195.0	73.0	108.8	155.5	125.6	93.1	67.8	119.7	84.4	66.3	89.8	126.2	29.9	317.1	60.6	66.8	114.0	90.5	137.5	74.3	93.1	132.3	63.2	119.4	70.8	4.3	18.1	21.8	16.3	37.8	19.9	23.5	19.5	15.8	26.9	20.1	16.8	17.2	3.3	11.6	40.5	20.9	23.0	10.6	15.6	18.4	13.7	14.4	15.2	12.3	17.6	13.2	15.5	15.9
AAMDC	"C11orf67, CK067, FLJ21035, PTD015"	ENSG00000087884	"Adipogenesis associated Mth938 domain containing"	Q9H7C9	11	77821109-77918432	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 155.8"	"Cell line enhanced"	"Detected in all"		"CACO-2: 72.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037918, HPA037919"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA037918: AB_2675737, HPA037919: AB_2675738"	"unprognostic (3.10e-2)"	"unprognostic (9.04e-3)"	"unprognostic (6.02e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.84e-2)"	18.8	42.2	7.5	7.5	11.4	5.2	16.2	10.9	8.6	13.8	15.8	9.5	16.9	10.1	18.0	9.5	12.4	13.4	11.8	35.0	7.5	6.4	12.8	15.5	11.8	3.5	13.0	6.8	14.3	18.1	6.9	11.1	7.9	9.9	12.6	8.3	10.0	16.7	14.5	155.8	13.0	13.6	21.0	15.3	7.4	14.2	14.4	13.1	6.5	14.1	15.7	5.0	14.4	17.0	8.1	13.2	43.3	11.9	13.7	18.0	6.4	7.6	6.3	9.8	7.0	28.7	20.0	2.7	12.7	8.7	11.6	14.5	72.2	11.6	5.2	12.4	21.4	4.3	14.7	8.5	13.9	11.9	11.9	5.0	10.9	13.2	14.2	2.8	4.5	26.6	5.9	12.2	6.5	34.3	5.7	8.4	24.4	9.1	5.9	11.1	4.6	10.7	5.7	16.8	5.0	15.3	4.6	3.5	13.1	16.2	7.0	9.0	10.9	5.6	35.7	12.3	6.7	23.2	4.2	9.1	14.2	9.5	4.7	4.6	6.8	43.3	11.9	12.3	6.1	6.6	7.8	7.0	11.9	10.0	12.7	8.1	10.4	7.8	6.9	13.7	6.4	13.2	18.0	6.4	7.5	11.4	10.9	8.6	7.5	6.4	13.0	6.8	9.9	13.1
ABCA5	EST90625	ENSG00000154265	"ATP binding cassette subfamily A member 5"	Q8WWZ7	17	69244311-69327244	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 52.8"	"Cell line enhanced"	"Detected in many"		"SiHa: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022032, HPA062904"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA022032: AB_1844427, HPA062904: AB_2732692"	"unprognostic (1.24e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.17e-2)"	"unprognostic (8.05e-4)"	"unprognostic (3.05e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.52e-1)"	"prognostic favourable (9.97e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.55e-1)"	"unprognostic (8.52e-2)"	10.5	8.6	6.7	3.8	9.8	6.0	12.7	35.6	12.4	8.8	9.6	4.3	13.5	9.7	6.0	7.7	8.6	6.6	4.6	5.2	5.3	6.2	7.9	21.7	4.9	3.3	4.1	7.9	6.9	20.3	13.0	35.9	5.3	13.6	7.4	10.6	15.5	8.2	11.4	52.8	24.0	15.5	3.4	7.6	4.3	8.9	9.0	3.9	1.7	7.9	10.3	5.9	5.5	8.1	4.2	3.9	4.5	0.7	3.0	4.2	1.2	4.2	2.0	1.6	2.4	7.7	5.6	0.5	4.4	4.8	4.6	6.9	0.6	1.6	0.0	2.4	3.8	6.3	1.0	3.7	5.2	0.1	2.9	0.0	4.7	2.9	10.3	0.0	2.7	5.5	4.5	1.9	5.3	10.0	0.0	1.7	0.4	3.6	2.6	0.0	1.6	2.9	0.3	0.1	0.4	0.9	7.0	8.8	1.4	15.8	7.3	4.5	7.5	2.7	7.3	5.3	1.5	4.8	0.9	9.0	0.2	0.3	2.1	0.0	4.7	0.7	0.7	4.5	3.1	0.2	4.2	2.4	4.0	3.4	0.5	4.2	2.1	3.4	1.9	3.0	0.1	3.9	2.4	1.2	6.7	9.8	35.6	12.4	5.3	6.2	4.1	7.9	13.6	3.9
ABCF1	"ABC50, EST123147"	ENSG00000204574	"ATP binding cassette subfamily F member 1"	Q8NE71	6	30571376-30597179	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 70.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017578	Approved		Enhanced	Cytosol				Cytosol	Cytosol	"HPA017578: AB_1844438"	"unprognostic (5.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.31e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavourable (9.47e-4)"	"unprognostic (5.50e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.68e-3)"	"unprognostic (7.16e-2)"	16.1	12.5	12.1	11.8	13.9	31.9	12.4	12.1	15.7	11.4	13.7	9.8	9.5	7.1	17.0	9.6	14.6	10.9	10.6	13.1	12.0	7.3	15.5	18.3	13.5	9.4	10.6	10.5	12.5	14.0	23.1	16.6	21.6	13.7	12.4	13.6	9.2	14.1	15.3	70.6	21.3	17.6	15.2	12.7	13.9	19.6	22.0	13.2	14.7	13.8	14.9	13.0	14.2	13.5	10.1	9.3	4.1	7.9	11.9	14.3	6.5	12.0	5.4	7.1	9.6	7.9	5.2	3.2	10.2	5.3	7.1	9.8	17.9	3.0	10.1	11.2	6.4	8.7	10.4	5.9	13.7	7.2	9.0	12.3	7.5	5.6	2.5	12.5	4.0	4.6	6.2	11.0	2.8	2.2	22.5	3.7	7.8	2.6	6.5	2.8	4.9	3.3	20.6	7.0	10.6	5.4	11.0	6.5	13.3	5.6	15.5	3.0	3.9	3.4	7.1	13.8	4.2	3.2	5.5	13.5	21.8	17.6	1.5	14.6	10.0	4.1	7.9	3.4	14.3	6.7	12.2	10.1	10.4	12.8	7.1	9.1	9.5	9.7	3.7	11.9	7.3	9.3	5.9	6.5	12.1	13.9	12.1	15.7	12.0	7.3	10.6	10.5	13.7	13.2
ABLIM2	KIAA1808	ENSG00000163995	"Actin binding LIM protein family member 2"	Q6H8Q1	4	7965310-8158832	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.0;skeletal muscle: 71.8"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 12.9;SiHa: 5.7;U-2197: 19.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.0"	"Lineage enriched"	"Detected in single"	4	"T-cells: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035808	Uncertain		Uncertain	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"HPA035808: AB_10601962"	"unprognostic (7.57e-2)"	"unprognostic (3.24e-3)"	"unprognostic (7.78e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.01e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.45e-2)"	4.0	3.8	8.2	1.9	19.1	0.8	2.1	4.0	26.0	1.4	2.1	2.3	0.0	1.1	1.2	1.3	10.5	1.4	1.7	5.7	3.4	5.1	2.5	1.2	1.8	1.4	2.8	7.6	1.1	3.3	2.4	6.1	1.2	9.9	1.8	2.1	1.3	2.6	1.2	71.8	3.8	1.8	2.1	1.8	14.8	1.8	1.5	4.0	0.0	2.4	1.9	2.3	1.5	1.7	0.7	0.5	0.0	0.2	0.0	3.0	0.2	1.0	0.0	0.2	1.5	0.4	0.1	0.4	0.0	0.0	0.1	0.0	0.0	1.3	2.8	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.7	0.0	0.0	0.1	1.0	0.0	0.2	0.0	0.0	0.0	0.6	1.9	0.1	0.0	1.1	0.9	0.1	1.0	0.6	0.2	0.0	12.9	1.0	5.7	0.0	0.3	0.0	0.0	0.0	0.0	0.4	19.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	1.0	0.1	3.0	0.0	2.5	0.0	0.5	0.7	1.2	0.9	0.0	0.0	0.2	0.0	1.2	0.2	8.2	19.1	4.0	26.0	3.4	5.1	2.8	7.6	9.9	4.0
AC005702.1		ENSG00000267318			17	59940908-59973101	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"skeletal muscle: 15.6"	"Cell line enhanced"	"Detected in many"		"MCF7: 7.9;U-266/84: 19.9"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"																																							4.6	2.0	0.4	0.0	0.6	0.0	2.7	0.5	0.7	0.1	1.1			0.6	0.3	5.3	0.7	0.4	0.4	4.4	0.5	0.6	2.8	7.1	0.6	0.1	0.8		0.3	1.5	0.0	0.6	0.0		0.8	1.1		1.1	0.0	15.6	1.0	0.6	0.0	0.6	0.6	0.5	3.7			0.5		0.1	0.3	0.5	2.7	1.6	3.3	6.1	3.7	7.2	1.3	0.6	1.1	0.4	2.0	1.2	0.2	2.3	0.6	0.3	1.0	1.2	0.3	7.0	0.6	4.0	0.8	0.1	1.4	1.3	1.2	4.8	1.0	3.2	0.5	0.8	1.8	0.7	6.6	1.8	0.6	1.6	1.3	0.0	0.9	2.7	0.7	7.9	0.4	0.4	0.0	0.9	1.0	2.1	0.7	0.2	0.3	0.1	0.5	1.4	1.2	2.3	4.3	3.0	0.0	1.5	2.0	1.1	1.2	5.9	19.9	4.5	1.0	2.4	0.8	0.0	0.8	3.3	1.9	1.9	5.0	2.7	3.2	2.7	1.2	0.9	2.2	3.4	0.2	3.7	6.1	1.6	7.2	1.3										
AC007325.4		ENSG00000278817			Unmapped	131494-137392	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"heart muscle: 15.9;skeletal muscle: 32.8"	"Cell line enhanced"	"Detected in many"		"A549: 14.6;AN3-CA: 8.9;HEK 293: 9.3;T-47d: 10.6"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																																							0.3	0.8		0.0		0.0	1.5		5.0	0.0	0.0			0.0	0.0	0.0	0.5	0.0	0.0	15.9			0.1	1.7	0.1	0.0			0.0	3.6	0.0		0.0		0.3	0.0		2.7	0.0	32.8	1.3	0.0	0.0		0.0	0.0	0.5			2.3		0.0	0.0		1.0	6.3	5.0	9.6	0.8	5.0	5.6	0.6	14.6	0.2	8.9	2.3	0.0	0.5	1.4	0.0	1.6	0.1	0.7	3.1	0.0	3.7	0.0	0.1	0.7	0.8	0.1	1.2	9.3	0.1	1.7	0.0	6.9	1.5	0.0	0.6	2.3	0.0	0.1	0.8	0.8	6.5	0.1	2.9	0.0	0.4	0.3	6.5	0.6	7.2	0.1	1.8	0.0	0.1	1.6	4.9	2.4	3.7	10.6	0.8	0.0	0.1	1.0	0.1	0.2	1.5	0.1	0.0	0.9	4.0	2.1	1.9	7.6	5.0	2.1	8.8	5.0	1.0	3.8	2.4	6.3	1.0	4.9	4.2	0.4	0.8	9.6	0.5	3.5	5.6										
AC007326.5		ENSG00000283809			22	18906238-18947732	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"skeletal muscle: 38.6"	"Cell line enhanced"	"Detected in many"		"HAP1: 80.1;NTERA-2: 25.6"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"																																							3.9	4.2	7.3	3.8	11.5	5.2	4.5	9.8	10.5	1.2	1.7	4.3	0.1	7.4	3.1	7.7	1.9	2.1	2.4	16.8	7.0		6.8	4.4	3.5	5.6	5.9	9.5	3.5	2.6	1.9	2.5	3.0	9.0	2.9	2.1	3.8	5.0	2.2	38.6	8.6	7.1	1.7	4.6	6.3	3.5	6.8	6.7	1.9	6.0	14.8	2.4	1.3	0.3	8.6	8.1	18.4	14.1	6.6	10.5	6.2	3.1	3.0	2.3	3.0	1.8	2.2	13.4	2.4	0.8	0.8	1.0	2.7	6.3	2.0	4.8	1.7	2.9	80.1	1.4	1.2	7.4	2.1	1.5	6.6	2.5	1.6	2.1	2.0	1.9	2.2	1.9	0.7	0.4	2.3	3.5	0.9	3.0	2.9	2.1	25.6	2.4	3.6	1.7	3.7	2.2	2.4	3.8	2.7	2.4	2.0	9.2	3.4	1.8	2.6	3.1	3.5	2.2	1.8	3.2	1.7	2.4	4.2	2.8	1.7	6.4	14.1	6.4	10.3	12.4	7.3	5.6	7.5	7.9	8.1	8.6	8.8	10.5	18.4	6.6	8.0	3.6	5.9	6.2										
AC008878.1		ENSG00000267952			19	7507052-7519622	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"retina: 19.5;skeletal muscle: 21.3"	"Cell line enhanced"	"Detected in many"		"AF22: 10.9;ASC diff: 12.3;fHDF/TERT166: 13.1;HBF TERT88: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 1.2"																													"unprognostic (4.56e-1)"							"unprognostic (8.56e-2)"	2.1	2.0	3.1	1.2	6.3	1.6	3.5	4.9	6.8	0.4	1.9	0.9	1.2	0.4	2.6	0.4	2.5	2.2	2.0	1.5	2.2	1.8	5.4	1.5	1.9	0.6	3.9	1.0	1.7	0.4	0.4	0.6	0.9	3.3	0.8	1.7	19.5	0.7	0.6	21.3	0.9	1.7	0.7	7.1	2.4	1.2	1.0	2.5	0.0	2.0	0.0	0.4	0.9	2.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	10.9	1.2	12.3	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	1.1	2.5	6.9	0.2	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.3	4.4	0.0	0.0	2.9	0.6	0.2	0.0	0.2	0.0	2.6	3.9	1.8	4.0	0.0	0.0	3.3	1.2	1.1	0.0	0.6	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.1	6.3	4.9	5.2	2.2	1.8	3.9	1.0	3.3	2.5
AC010531.1		ENSG00000131152			16	87302876-87334273	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"skeletal muscle: 6.8"	"Cell line enhanced"	"Detected in many"		"U-266/70: 6.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA040850	Approved									"HPA040850: AB_10794882"	"unprognostic (1.44e-1)"	"unprognostic (5.07e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.65e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.21e-3)"	"unprognostic (7.78e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.72e-3)"	1.1	0.5	0.3	0.2	0.4	1.2	1.2	1.8	0.9	0.6	0.9			2.3	1.4	0.0	1.1	1.2	1.0	1.2	0.3	0.4	0.7	2.4	0.4	1.8	0.6		1.7	1.1	0.0	1.6	1.3		1.3	0.3		0.5	0.6	6.8	0.5	1.0	0.7	0.2	0.7	0.6	2.0			0.5		0.6	0.8	1.0	0.8	0.0	0.0	0.0	0.1	0.3	0.0	0.9	0.4	0.3	0.0	3.9	1.7	0.3	0.3	0.0	0.7	0.2	1.1	0.0	3.1	0.7	3.2	3.0	0.8	0.0	0.4	0.7	2.5	4.9	0.3	3.3	1.9	0.0	0.6	0.0	0.0	0.0	0.6	1.5	4.4	0.7	0.0	1.1	1.6	3.6	1.0	0.7	1.5	0.2	3.2	0.0	0.1	2.6	0.7	1.6	0.5	1.0	0.4	0.0	0.0	2.1	0.3	0.0	0.6	6.5	2.0	2.2	0.4	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0										
AC011448.1		ENSG00000258674			19	19516227-19536076	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"skeletal muscle: 41.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 20.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"																						"unprognostic (8.39e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.69e-3)"	"unprognostic (5.40e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.73e-5)"	"unprognostic (7.15e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.46e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.89e-2)"	5.9	7.9	9.7	7.4	19.9	8.7	3.8	12.4	13.5	4.1	6.0	3.6	7.8	6.7	4.5	13.8	4.8	5.6	5.9	35.1	11.0	7.0	5.8	7.2	4.6	6.0	9.6	10.9	5.0	8.3	5.3	5.3	5.6	9.7	6.0	4.9	4.3	8.7	7.3	41.4	10.4	9.7	5.5	6.2	6.9	7.1	9.8	7.6	3.1	5.2	13.9	3.8	4.8	4.5	8.8	8.1	7.2	9.4	4.7	10.0	13.3	2.5	2.5	3.0	2.2	1.9	2.2	20.9	1.4	2.1	1.7	1.9	3.4	4.8	3.1	7.0	1.3	3.9	1.4	1.3	0.5	2.4	11.8	1.3	2.2	1.1	2.1	1.4	3.2	1.6	1.4	2.0	0.5	1.1	3.6	2.7	1.0	4.5	1.5	5.7	11.7	6.5	6.5	1.4	1.9	1.9	2.5	2.2	3.8	2.0	0.9	2.1	3.4	5.3	1.1	3.5	3.9	7.9	3.2	8.2	3.7	2.6	1.8	5.9	1.9	7.2	8.9	6.7	5.9	9.4	5.1	8.8	7.7	6.3	8.1	7.8	6.7	6.8	2.8	4.7	7.6	6.7	10.0	13.3	9.7	19.9	12.4	12.4	11.0	7.0	9.6	10.9	9.7	7.6
AC011530.1		ENSG00000268434			19	45779437-45785973	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"epididymis: 4.2;lymphoid tissue: 3.1;skeletal muscle: 3.4"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 2.6;HBEC3-KT: 4.1;HBF TERT88: 1.7;T-47d: 2.1;U-87 MG: 1.7;U-937: 2.8"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"																										"unprognostic (3.77e-2)"					"unprognostic (2.87e-1)"		"unprognostic (2.00e-1)"		"unprognostic (1.29e-1)"				0.1	0.8	0.0	3.1	0.1	0.0	0.0	0.1	0.5	0.3	0.9			0.0	0.8	4.2	0.0	0.4	0.0	2.4	0.0	0.0	0.2	0.2	0.9	0.3	0.0		0.2	0.1	0.0	0.0	0.9		0.4	0.0		0.0	0.0	3.4	0.0	0.2	0.0	0.1	0.0	0.4	0.8			0.0		0.7	0.3	0.2	0.1	0.3	0.0	0.0	0.0	1.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.6	0.8	0.4	4.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	1.0	0.0	1.1	0.0	1.4	0.3	1.7	2.8	1.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.5	0.0	0.3	0.1	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.3										
AC012531.3		ENSG00000273049			12	53985845-54034888	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"adipose tissue: 8.6;kidney: 24.3;skeletal muscle: 10.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 13.3;fHDF/TERT166: 3.2;HDLM-2: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"gdTCR: 2.5"	"Lineage enriched"	"Detected in single"	26	"T-cells: 2.5"																																					8.6	0.9	0.1	0.1	0.2	0.0	1.2	0.1	0.1	1.0	0.4	0.0	0.0	0.2	2.0	4.5	0.8	2.8	0.0	0.4	0.1	0.1	24.3	0.3	0.3	1.2	0.1	0.0	3.2	0.5	0.8	0.2	1.1	0.1	0.7	0.0	0.0	0.3	0.0	10.3	0.8	1.2	1.3	0.4	0.3	0.7	1.1	0.0	0.0	0.4	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	2.5	0.4	0.6	0.8	0.0	13.3	1.1	0.0	0.0	0.2	0.2	0.6	0.2	0.0	1.2	0.0	0.3	3.2	1.5	0.0	0.0	0.0	4.8	0.0	0.0	0.3	0.3	0.3	0.0	0.3	0.4	0.0	0.4	0.4	0.0	0.2	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.7	0.1	0.3	1.3	2.4	0.1	0.0	0.8	1.8	1.2	0.3	0.0	0.0	0.0	0.2	0.1	1.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
AC022506.1		ENSG00000285133			12	57517712-57520480	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"skeletal muscle: 36.7"	"Cell line enriched"	"Detected in some"	14	"U-266/70: 24.1"									"Group enriched"	"Detected in some"	12	"basophil: 4.6;neutrophil: 17.4"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 17.4"	"Not detected"	"Not detected"																																			9.9	1.6	2.5	8.2	6.0	1.6	3.8	2.6	4.8	2.2	1.8	3.5	2.4	1.6	2.2	3.0	1.7	1.6	1.6	1.6	3.1		2.4	1.6	5.5	1.6	7.1	2.4	3.9	1.6	1.6	1.9	1.6	6.5	4.2	1.6	5.3	3.6	1.6	36.7	1.6	10.9	2.3	3.6	2.4	12.0	2.2	7.3	0.0	15.0	1.6	1.6	6.0	2.7	0.4	0.0	17.4	0.5	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	24.1	0.0	0.0	0.0	1.7	0.0	4.6	0.5	0.1	0.0	0.3	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	17.4	0.9	0.0	0.0	0.0	0.0										
AC037459.1		ENSG00000248235			8	22589274-22602084	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"skeletal muscle: 35.8"	"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 3.8;U-2 OS: 3.8;U-2197: 7.5;U-87 MG: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA024667	Uncertain									"HPA024667: AB_1845783"	"unprognostic (3.72e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.29e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.64e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.55e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.23e-3)"	5.0	4.0	4.1	5.4	5.2	1.9	6.1	9.4	4.0	7.8	12.1	3.1	4.7	3.7	10.1	5.3	5.9	3.9	9.2	6.5	3.7	3.6	3.9	2.8	5.4	4.7	5.7	3.6	5.0	4.4	1.5	1.3	3.3	6.4	6.1	1.5	3.8	6.9	3.6	35.8	2.5	10.3	11.1	2.3	14.2	5.7	2.3	2.0	0.0	1.6	6.1	1.6	7.5	5.6	0.7	0.2	0.0	0.1	0.0	0.5	0.3	0.2	1.3	0.6	3.2	0.0	3.1	0.5	1.9	2.6	1.0	2.3	0.1	0.0	1.8	0.1	0.7	0.0	0.3	0.3	0.2	0.0	0.6	0.0	0.0	0.4	0.5	0.5	0.0	1.0	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.4	3.8	1.3	1.7	2.8	1.3	0.7	0.0	1.9	3.8	7.5	0.2	0.0	0.1	0.2	4.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	4.1	5.2	9.4	4.0	3.7	3.6	5.7	3.6	6.4	2.0
AC051649.2		ENSG00000283787			11	1888577-1891895	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 7.0;skeletal muscle: 18.5"	"Group enriched"	"Detected in some"	5	"Daudi: 4.3;HDLM-2: 11.7;Karpas-707: 7.9;NB-4: 3.2;U-937: 5.9"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"																															0.0	4.9		3.0		4.5	0.0		0.0	0.0	0.0			0.3	0.0	0.0	0.1	0.0	0.3	0.2			0.0	0.0	0.0	3.0			0.0	0.0	0.0		0.3		0.0	0.0		0.7	0.0	18.5	6.0	0.6	0.0		4.5	0.8	0.0			0.0		0.0	0.2		1.6	2.8	7.0	3.1	1.0	1.9	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.7	3.2	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.0	5.9	0.0	1.1	2.8	2.8	1.5	2.9	0.7	1.6	1.2	1.3	2.8	1.2	0.8	1.1	7.0	1.0	3.1	2.7	1.9	4.0										
AC073610.2		ENSG00000255863			12	48921963-48939663	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 1.0;skeletal muscle: 1.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.4;MOLT-4: 1.7;NB-4: 1.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"																																							0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.8		0.0	0.0	0.0	0.0	0.4	0.7	0.8	0.3	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.4	0.0	0.6	0.5	0.7	0.3	0.7	0.0	1.0	0.8										
AC092073.1		ENSG00000266953			19	34396315-34409364	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"skeletal muscle: 14.4"	"Cell line enhanced"	"Detected in some"		"A-431: 5.3;HaCaT: 5.4;HMC-1: 4.1;U-251 MG: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																							"unprognostic (1.18e-1)"			"unprognostic (2.34e-2)"	"unprognostic (3.43e-1)"			"unprognostic (6.48e-3)"			"unprognostic (3.25e-2)"	"unprognostic (2.61e-1)"			"unprognostic (6.67e-2)"		2.8	1.3	1.6	0.6	2.2	3.5	5.5	3.0	3.9	1.3	2.1	0.0	1.1	1.9	1.2	0.6	1.4	0.6	1.2	4.6	1.4	1.9	1.2	6.3	1.5	1.7	1.6	3.2	1.5	0.6	1.4	1.1	0.9	2.6	0.9	0.9	0.3	0.6	4.0	14.4	1.0	5.0	0.6	1.3	1.5	2.1	2.4	0.3	2.1	1.4	2.3	1.1	2.4	0.9	1.2	0.4	0.5	0.6	0.5	1.1	1.1	5.3	0.9	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.5	0.7	2.8	0.0	5.4	0.0	0.6	0.3	0.5	0.0	0.9	2.2	0.9	0.0	2.6	4.1	0.0	0.8	0.0	0.0	0.0	1.2	0.6	0.0	0.7	4.0	1.5	3.2	0.0	1.9	1.1	0.0	0.0	1.6	1.1	0.3	0.0	0.0	0.1	0.0	0.6	0.0	0.0	3.3	0.9	4.6	0.2	4.0	0.8	0.5	0.4	0.0	0.0	0.3	0.5	1.1	0.6	0.7	1.2	0.0	0.3	0.4	0.6	0.3	0.0	0.3	0.5	0.3	0.0	0.0	1.1	1.6	2.2	3.0	3.9	1.4	1.9	1.6	3.2	2.6	0.3
AC129492.3		ENSG00000263620			17	8150816-8162975	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"blood: 49.9;brain: 39.2;skeletal muscle: 55.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 22.9;HEK 293: 9.4;PC-3: 7.5;REH: 11.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"																																							14.0	6.0	11.2	2.6	25.6	2.6	2.7	14.6	39.2	4.9	20.3	11.0	1.3	2.6	5.9	2.6	3.4	3.3	2.6	32.0	8.5	3.0	3.6	4.4	7.5	2.9	5.3	15.7	2.6	2.6	2.6	5.4	2.6	19.9	3.3	2.6	7.6	3.1	2.6	55.4	2.6	2.6	2.6	3.7	14.9	18.7	3.0	7.0	0.7	2.6	0.6	2.6	5.2	3.1	31.4	23.7	49.9	12.9	29.2	45.5	15.5	1.5	0.2	0.2	0.0	0.0	0.0	3.5	3.2	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	3.8	0.0	0.0	0.0	22.9	9.4	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	7.5	11.3	0.0	3.0	0.0	0.0	1.1	0.0	0.0	0.0	0.4	0.5	0.5	0.7	0.0	2.8	0.0	2.6	3.8	5.7	2.6	0.0	0.0	3.6	18.0	9.8	36.6	37.5	11.4	33.1	31.4	38.0	42.3	8.7	28.3	45.5	39.7	49.9	29.2	12.9	23.7	27.2	15.5	11.2	25.6	14.6	39.2	8.5	3.0	5.3	15.7	19.9	7.0
ACADM	"ACAD1, MCAD, MCADH"	ENSG00000117054	"Acyl-CoA dehydrogenase medium chain"	P11310	1	75724347-75787575	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.7;skeletal muscle: 82.8"	"Cell line enhanced"	"Detected in all"		"Daudi: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006198, HPA026542"	Enhanced		Enhanced	Mitochondria		1200000	1200000	Mitochondria	Mitochondria	"HPA006198: AB_1078087, HPA026542: AB_1844469"	"unprognostic (9.04e-3)"	"unprognostic (2.36e-1)"	"prognostic favourable (7.30e-4)"	"unprognostic (5.09e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.68e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.35e-1)"	"prognostic favourable (3.83e-8)"	"unprognostic (1.27e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.24e-1)"	18.1	25.0	12.3	11.3	13.0	3.9	18.0	12.0	10.8	8.4	21.6	8.3	10.1	25.1	6.7	8.6	21.9	7.6	6.7	49.7	10.5	11.2	71.1	89.7	6.3	9.4	13.0	9.2	10.5	10.3	8.1	12.0	4.2	14.3	9.2	12.1	8.0	9.0	11.7	82.8	5.6	25.1	9.8	10.7	12.3	12.0	8.5	11.0	11.0	12.2	42.1	10.0	9.5	8.1	29.7	16.7	14.1	13.8	16.8	20.0	13.2	6.9	5.5	17.4	7.6	15.0	12.3	4.9	13.0	10.6	12.8	10.8	10.3	11.1	75.9	11.5	9.3	6.4	14.7	11.0	15.9	29.3	7.2	24.9	16.9	15.8	10.5	21.2	6.9	14.2	6.4	11.1	6.7	10.0	25.3	17.2	13.7	2.6	24.9	10.0	14.0	13.3	32.5	22.9	7.9	21.2	18.3	9.4	11.9	10.5	31.4	27.1	9.3	26.9	5.4	8.7	8.6	7.4	21.3	11.2	16.0	33.7	7.4	17.3	9.9	10.7	9.6	14.1	13.2	13.8	20.0	29.7	13.8	15.9	14.3	18.0	15.8	17.6	0.8	16.8	12.7	16.7	13.8	13.2	12.3	13.0	12.0	10.8	10.5	11.2	13.0	9.2	14.3	11.0
ACADS	"ACAD3, SCAD"	ENSG00000122971	"Acyl-CoA dehydrogenase short chain"	P16219	12	120725735-120740008	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.4;skeletal muscle: 50.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004799, CAB019284, HPA022271"	Enhanced		Enhanced	Nucleoplasm,Mitochondria		15000	15000	Mitochondria	Mitochondria	"CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472"	"unprognostic (7.14e-2)"	"unprognostic (3.03e-3)"	"unprognostic (8.15e-2)"	"prognostic favourable (5.05e-4)"	"unprognostic (1.11e-3)"	"unprognostic (5.75e-2)"	"prognostic favourable (2.43e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.04e-2)"	"prognostic favourable (3.33e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.21e-1)"	"prognostic favourable (6.34e-5)"	19.5	14.5	5.7	10.0	5.2	5.3	18.0	2.3	4.6	2.9	26.2	4.7	4.5	35.8	2.8	5.3	5.0	2.9	9.1	32.6	3.7	3.3	13.2	58.4	5.6	7.8	5.0	4.1	2.3	14.4	3.0	2.4	4.3	3.8	4.1	9.0	5.6	8.9	4.6	50.7	3.4	35.3	6.5	3.8	8.6	9.5	10.7	5.4	4.0	8.1	16.8	4.3	5.0	3.2	6.8	11.4	7.2	14.0	15.3	14.7	10.0	2.0	7.2	0.4	6.3	8.6	3.4	7.3	3.0	3.0	3.9	2.9	5.6	5.1	0.2	7.8	2.5	3.3	4.3	1.3	0.5	10.5	5.3	5.2	2.2	12.0	6.2	0.4	23.7	10.3	2.0	1.7	0.1	4.0	4.2	0.0	1.7	4.2	7.2	12.0	1.3	3.0	5.4	2.7	1.4	7.3	11.6	0.7	4.0	6.2	0.0	9.9	5.0	8.2	4.4	0.1	3.1	3.0	0.6	10.1	5.7	2.5	6.7	4.4	2.6	7.2	13.0	6.4	12.4	14.0	8.8	5.9	11.3	13.0	11.4	6.8	14.7	13.2	1.3	15.3	8.7	9.5	11.9	10.0	5.7	5.2	2.3	4.6	3.7	3.3	5.0	4.1	3.8	5.4
ACO2	ACONM	ENSG00000100412	"Aconitase 2"	Q99798	22	41469125-41528989	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 121.0;skeletal muscle: 157.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001097	Enhanced	Approved	Approved	Mitochondria		4000000	4000000	Mitochondria	Mitochondria	"HPA001097: AB_1078092"	"unprognostic (1.95e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.07e-2)"	"prognostic favourable (0.00e+0)"	"unprognostic (1.46e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.12e-2)"	22.8	18.5	41.4	11.1	38.2	9.8	12.2	21.0	43.5	12.2	25.4	27.7	12.3	45.1	9.5	9.9	17.5	15.7	11.1	121.0	33.8	24.2	37.9	22.2	10.0	11.1	27.6	32.7	8.6	17.2	48.5	7.6	9.1	24.9	12.5	20.0	14.7	20.1	15.2	157.9	9.8	46.6	12.5	28.6	10.0	21.0	9.6	23.1	9.5	16.0	42.7	12.0	12.3	8.8	22.9	28.1	7.3	36.6	15.8	16.4	19.4	16.1	18.8	18.9	39.0	32.6	21.3	26.5	14.9	18.8	25.1	23.5	27.7	21.1	37.1	24.4	22.1	37.1	35.1	27.2	13.2	24.5	25.0	18.0	26.3	29.4	28.5	47.9	27.6	37.8	21.9	26.0	27.7	24.8	23.2	40.5	19.7	30.3	24.4	16.2	12.9	37.7	33.2	13.0	51.4	32.3	32.1	13.6	11.6	36.6	43.3	27.6	25.1	25.6	17.6	21.4	24.0	19.5	16.3	24.1	29.9	25.9	34.6	20.9	23.1	4.5	21.1	7.3	14.7	31.3	14.0	22.9	12.5	15.8	28.1	20.2	14.2	14.6	5.3	15.8	36.6	11.2	16.4	19.4	41.4	38.2	21.0	43.5	33.8	24.2	27.6	32.7	24.9	23.1
ACOT6	C14orf42	ENSG00000205669	"Acyl-CoA thioesterase 6"	Q3I5F7	14	73610945-73619888	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 6.8;liver: 6.1;skeletal muscle: 6.5"	"Cell line enriched"	"Detected in some"	5	"T-47d: 14.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.8"	"Low lineage specificity"	"Detected in many"											HPA058258	Uncertain									"HPA058258: AB_2683656"	"unprognostic (1.88e-1)"				"unprognostic (1.77e-1)"		"unprognostic (5.17e-2)"	"unprognostic (1.24e-1)"		"unprognostic (3.15e-2)"		"unprognostic (6.52e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.07e-2)"		"unprognostic (2.28e-1)"	"unprognostic (5.04e-1)"	2.6	1.0	1.5	0.0	2.0	0.0	0.1	0.8	1.2	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.8	0.6	6.8	6.1	0.0	0.0	0.8		0.7	0.4	0.0	0.0	0.0		0.0	0.0		0.0	0.0	6.5	0.0	0.0	0.0	0.2	0.1	0.0	0.9			1.4		0.0	0.0	0.0	0.1	1.8	0.0	0.6	0.0	1.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.1	0.8	0.0	1.0	2.7	0.1	14.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.1	0.8	1.8	0.1	0.3	0.8	0.0	0.0	0.0	0.2	0.0	0.1										
ACSS2	"ACAS2, AceCS, ACS, ACSA, dJ1161H23.1"	ENSG00000131069	"Acyl-CoA synthetase short chain family member 2"	Q9NR19	20	34872146-34927962	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 63.4"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 12.6;granulocytes: 17.0;monocytes: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004141	Approved		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA004141: AB_1078094"	"unprognostic (1.97e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.42e-2)"	"prognostic favourable (2.04e-4)"	"unprognostic (2.72e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.54e-1)"	30.3	12.6	2.8	9.2	7.0	1.9	12.4	5.6	7.0	6.8	21.0	10.6	8.3	21.4	6.6	7.0	8.1	4.5	7.7	24.8	2.9	2.5	11.2	15.7	11.7	3.2	6.8	3.2	5.1	3.2	4.7	2.5	4.6	5.5	3.4	10.4	3.5	9.8	6.8	63.4	6.8	24.1	3.0	6.1	2.7	13.4	3.1	7.1	1.1	3.9	7.3	3.0	6.5	6.1	0.7	12.6	17.0	11.6	0.3	3.0	4.7	11.6	1.6	1.1	1.6	8.3	8.8	12.2	7.0	5.4	1.9	3.4	4.2	6.5	0.0	7.9	3.0	8.9	2.9	17.6	1.4	0.0	2.8	16.3	0.8	2.0	6.1	1.5	9.0	6.0	3.8	2.9	2.7	3.0	10.3	1.2	2.7	1.3	0.5	7.1	0.8	19.9	4.3	7.6	25.7	6.7	1.2	1.0	5.3	8.5	6.3	6.8	3.1	3.6	11.5	2.3	3.2	4.2	2.3	11.1	8.1	3.8	6.6	2.6	1.9	17.0	11.6	3.0	0.6	7.2	0.5	0.4	1.6	0.7	12.6	0.7	3.0	1.5	6.5	0.3	3.4	2.1	1.1	4.7	2.8	7.0	5.6	7.0	2.9	2.5	6.8	3.2	5.5	7.1
ACTN2		ENSG00000077522	"Actinin alpha 2"	P35609	1	236686454-236764631	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 141.3;skeletal muscle: 320.9;tongue: 75.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.0;HSkMC: 11.9;hTEC/SVTERT24-B: 7.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 59.7"	"Low region specificity"	"Detected in all"			"HPA006035, HPA008315"	Enhanced		Uncertain	"Actin filaments"		69000000	69000000	"Actin filaments"	"Actin filaments"	"HPA006035: AB_1078095, HPA008315: AB_1844543"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.91e-1)"	"unprognostic (4.32e-3)"	"unprognostic (7.85e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-11)"	"unprognostic (1.30e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	3.5	0.6	1.6	0.6	10.7	0.6	0.7	0.3	2.5	0.6	0.6	5.1	0.0	0.6	0.7	4.4	3.7	0.7	0.7	141.3	2.5	1.4	0.6	0.6	0.9	0.6	4.7	1.4	0.7	0.7	0.6	0.1	0.6	2.7	2.8	0.6	0.0	4.9	0.6	320.9	0.6	0.7	1.5	3.9	0.6	0.7	0.9	4.3	0.0	3.5	75.4	4.8	0.9	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.7	11.9	0.0	7.5	0.0	0.3	0.6	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.6	10.7	0.3	2.5	2.5	1.4	4.7	1.4	2.7	4.3
ACYP2		ENSG00000170634	"Acylphosphatase 2"	P14621	2	53970838-54305300	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 116.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035301	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA035301: AB_10670291"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.90e-3)"	"unprognostic (6.21e-2)"	"unprognostic (2.03e-3)"	"unprognostic (3.17e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.83e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.24e-2)"	12.9	24.0	31.0	4.6	33.9	5.6	10.1	15.5	29.3	6.7	6.2	19.4	4.4	6.2	6.7	10.5	6.6	7.1	7.3	39.6	29.1	28.4	8.8	18.7	7.2	7.5	35.7	18.2	5.7	10.3	9.1	9.7	5.9	28.1	10.4	4.8	6.3	11.5	8.4	116.4	6.6	5.6	6.9	35.7	7.8	7.5	6.5	22.7	3.5	8.2	22.9	6.4	8.2	4.1	20.9	23.7	24.1	10.2	12.6	15.9	8.9	7.6	4.3	4.5	3.7	16.6	13.1	4.1	9.2	6.9	5.7	5.0	1.0	5.6	14.9	24.4	9.1	6.6	2.4	7.7	5.3	12.9	10.2	11.5	4.6	11.4	6.8	9.6	5.6	9.5	14.5	4.1	6.8	2.6	4.7	8.0	12.1	4.9	5.9	11.9	5.2	5.3	4.7	4.3	8.4	13.5	7.0	13.2	8.7	11.1	7.0	4.1	2.6	8.8	9.2	8.1	7.8	3.5	8.5	16.9	9.3	8.3	11.7	16.4	8.9	24.1	10.2	19.8	13.4	9.0	11.9	20.9	13.4	12.7	14.7	19.7	15.9	13.4	8.5	12.6	8.8	23.7	11.6	8.9	31.0	33.9	15.5	29.3	29.1	28.4	35.7	18.2	28.1	22.7
ADCY9	AC9	ENSG00000162104	"Adenylate cyclase 9"	O60503	16	3953387-4116185	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 36.4"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041328, HPA044225"	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA041328: AB_2677414, HPA044225: AB_2678863"	"unprognostic (1.78e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.57e-1)"	"prognostic unfavourable (2.55e-5)"	"unprognostic (6.62e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.93e-2)"	"unprognostic (4.76e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.37e-1)"	"prognostic favourable (5.24e-8)"	"unprognostic (1.19e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.55e-2)"	5.2	4.8	7.1	3.2	10.9	0.9	5.4	8.5	9.6	7.0	6.4	4.1	4.4	6.5	6.5	4.4	6.8	7.7	6.5	13.3	6.2	3.0	8.0	9.6	11.1	2.5	3.0	6.2	9.4	12.5	12.3	5.8	7.8	7.7	3.6	5.5	9.0	10.1	5.0	36.4	4.4	10.9	6.3	2.2	3.2	5.5	4.4	3.4	0.7	21.8	7.7	3.0	7.9	4.8	0.1	1.0	3.2	1.5	1.0	1.9	0.9	4.8	7.5	2.3	4.2	8.2	10.1	3.4	8.6	9.0	4.8	3.9	6.2	4.3	0.0	13.3	23.6	4.8	8.9	5.4	3.3	6.0	8.6	0.2	17.2	11.9	8.9	0.6	3.9	10.7	8.3	5.6	3.0	3.2	2.6	0.0	4.9	8.9	0.0	2.5	4.1	4.1	7.7	10.9	0.2	1.7	1.3	5.2	2.3	6.7	7.9	5.8	20.1	8.7	3.0	9.7	2.7	9.4	3.7	1.9	1.1	1.0	2.1	2.6	3.7	3.2	1.5	1.0	1.9	1.5	1.7	0.0	0.6	0.6	0.1	0.1	0.1	1.1	0.3	1.0	0.0	1.0	0.0	0.9	7.1	10.9	8.5	9.6	6.2	3.0	3.0	6.2	7.7	3.4
ADGRF2	"GPR111, hGPCR35, PGR20"	ENSG00000164393	"Adhesion G protein-coupled receptor F2"	Q8IZF7	6	47656436-47697797	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 6.0;lymphoid tissue: 5.0;skeletal muscle: 4.7;skin 1: 6.0;tongue: 7.7"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.4;U-87 MG: 3.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA035507	Uncertain									"HPA035507: AB_10601809"	"unprognostic (1.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.95e-1)"	"unprognostic (1.59e-1)"		"unprognostic (1.53e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.51e-4)"		"unprognostic (3.05e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (7.99e-2)"	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.4	1.2	0.3	0.1	0.0	0.0	0.0	0.2	0.0	6.0	4.2	0.0	0.5	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.8	0.6	0.3	0.2	0.0	0.0	0.4	0.0	4.7	6.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	7.7	5.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.2	0.0	0.0	0.0	0.0	0.3	0.0
ADPRHL1	ARH2	ENSG00000153531	"ADP-ribosylhydrolase like 1"	Q8NDY3	13	113399610-113453524	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 89.6;skeletal muscle: 68.1"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 14.6;T-47d: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebellum: 2.6"	"Low region specificity"	"Detected in some"			HPA066478	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA066478: AB_2685673"	"unprognostic (3.03e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.31e-1)"	"unprognostic (8.88e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (4.88e-4)"	"prognostic unfavourable (2.55e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.02e-1)"	1.8	1.0	0.6	0.2	1.1	0.0	0.8	0.5	3.0	0.4	1.4	0.3	0.0	0.9	0.4	4.0	2.2	1.9	0.7	89.6	0.5	0.8	0.2	0.4	0.5	0.1	0.7	1.1	0.5	1.5	0.0	1.8	1.4	0.3	0.9	0.5	0.0	1.9	0.1	68.1	0.9	3.0	0.2	0.5	0.3	1.0	1.3	0.0	0.1	0.7	21.8	0.6	0.3	0.5	1.9	2.8	1.7	1.6	1.1	2.5	1.0	3.9	9.5	0.9	3.0	3.1	5.0	2.7	1.5	0.7	0.5	0.4	2.6	9.8	1.4	5.7	1.7	2.2	3.7	0.2	0.4	1.4	1.6	4.1	2.3	0.7	1.0	0.3	1.7	1.7	2.3	3.1	0.4	0.1	1.1	0.4	3.9	8.6	0.6	2.4	2.1	5.0	6.3	2.5	3.6	1.0	0.4	14.6	3.3	1.0	4.7	1.2	26.2	0.5	0.3	0.1	1.8	4.4	0.5	1.4	1.1	4.6	2.9	0.8	2.1	0.4	1.2	0.1	0.1	1.6	1.8	1.9	0.8	2.5	2.8	0.8	1.4	1.5	1.7	1.1	1.3	0.5	1.3	1.0	0.6	1.1	0.5	3.0	0.5	0.8	0.7	1.1	0.3	0.0
ADSL		ENSG00000239900	"Adenylosuccinate lyase"	P30566	22	40346500-40390463	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 79.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000525, CAB019285"	Enhanced		Enhanced	Cytosol		180000	180000	Cytosol	Cytosol	"CAB019285: , HPA000525: AB_1078106"	"unprognostic (2.80e-1)"	"unprognostic (2.12e-1)"	"prognostic favourable (2.38e-4)"	"unprognostic (2.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	"prognostic unfavourable (5.81e-8)"	"unprognostic (1.35e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.44e-2)"	9.3	11.6	5.0	13.7	8.5	11.2	9.0	6.8	10.1	7.9	9.5	7.3	4.4	6.0	10.8	9.4	9.7	9.0	6.9	14.6	4.5	4.7	12.0	17.3	6.8	17.6	4.9	4.9	10.5	21.8	5.4	9.1	9.5	5.1	7.1	9.7	9.2	14.7	6.4	79.0	6.2	9.4	10.7	4.9	14.5	9.6	10.9	4.4	18.8	8.4	23.6	15.5	9.5	7.4	15.3	28.8	11.0	22.7	19.8	34.0	24.6	21.0	24.9	21.4	30.5	14.5	20.4	24.8	19.3	19.1	41.8	32.0	41.1	12.4	61.3	16.4	22.3	15.9	47.7	31.0	43.0	16.3	44.9	27.8	28.1	37.8	30.3	90.4	23.4	21.9	17.6	36.7	39.0	30.9	32.8	26.9	31.2	23.5	27.9	32.3	34.9	26.6	42.6	45.0	43.5	26.9	16.7	13.8	13.6	23.0	12.7	36.5	17.6	28.6	20.4	22.4	41.5	19.7	36.9	25.6	44.6	47.0	18.6	33.6	21.8	11.0	19.3	7.8	16.2	22.7	22.8	15.3	34.0	21.7	28.8	14.9	27.0	20.8	1.9	19.8	20.2	14.9	34.0	24.6	5.0	8.5	6.8	10.1	4.5	4.7	4.9	4.9	5.1	4.4
AGPAT3	LPAAT-gamma	ENSG00000160216	"1-acylglycerol-3-phosphate O-acyltransferase 3"	Q9NRZ7	21	43865186-43986536	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.36e-2)"	"prognostic unfavourable (8.31e-4)"	"unprognostic (5.50e-2)"	"unprognostic (4.56e-3)"	"unprognostic (4.70e-2)"	"unprognostic (8.55e-2)"	"unprognostic (4.88e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.84e-1)"	"prognostic favourable (2.29e-4)"	"unprognostic (1.50e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.60e-2)"	12.0	10.2	21.5	11.1	23.0	5.8	12.7	14.6	22.7	6.4	20.1	18.9	8.5	27.4	5.1	10.4	13.4	8.1	8.6	11.6	19.9	15.1	33.8	30.2	9.9	9.0	21.7	11.4	5.4	12.7	17.1	7.3	7.6	13.6	7.9	7.6	10.6	24.0	8.0	59.1	10.2	34.6	5.8	25.2	10.2	11.1	11.7	11.4	7.2	14.1	15.0	7.0	9.8	6.6	1.3	4.5	2.4	10.6	0.7	3.5	2.0	26.7	15.2	3.8	10.4	7.7	8.5	2.9	12.4	15.5	15.8	9.7	15.0	19.6	9.1	9.4	14.7	10.4	6.6	13.7	4.6	43.1	17.5	4.0	9.4	20.1	13.5	14.5	9.1	10.1	11.8	13.9	5.8	11.8	22.3	15.0	5.7	11.6	0.1	9.0	1.8	10.9	15.0	4.3	24.4	12.5	26.4	13.2	9.6	15.1	17.2	11.5	11.9	15.9	17.5	10.0	0.1	14.9	12.6	12.0	17.9	5.7	13.0	29.2	9.1	0.0	4.1	2.4	1.5	8.9	1.5	1.3	2.1	2.2	4.5	1.2	1.7	1.9	1.0	0.7	10.6	1.1	3.5	2.0	21.5	23.0	14.6	22.7	19.9	15.1	21.7	11.4	13.6	11.4
AIMP2	"JTV-1, JTV1, p38, PRO0992"	ENSG00000106305	"Aminoacyl tRNA synthetase complex interacting multifunctional protein 2"	Q13155	7	6009245-6023834	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 66.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019098, HPA020057"	Supported		Approved	Cytosol		8200	8200	Cytosol	Cytosol	"HPA019098: AB_1852040, HPA020057: AB_1852042"	"unprognostic (1.24e-3)"	"unprognostic (1.66e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (3.69e-4)"	"unprognostic (9.29e-2)"	"unprognostic (3.41e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.96e-1)"	"prognostic favourable (1.38e-5)"	"unprognostic (7.44e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavourable (3.09e-4)"	10.2	11.2	6.3	6.9	7.3	5.3	11.2	5.3	11.0	5.6	14.9	10.2	7.1	22.8	8.9	10.8	11.2	7.7	8.7	17.7	6.5	5.8	18.6	30.7	6.8	15.1	6.8	8.2	7.5	9.6	12.3	4.5	9.0	7.6	6.1	12.2	6.6	13.6	9.0	66.1	10.3	21.0	9.8	7.2	9.4	7.5	20.4	5.1	9.3	12.9	28.4	9.1	8.2	6.6	19.0	37.3	13.8	30.0	17.8	17.7	16.1	26.2	29.8	10.1	14.5	10.7	11.8	34.6	14.9	10.0	24.6	18.3	32.6	17.5	32.4	14.1	15.3	29.3	34.2	22.4	15.3	10.4	26.0	17.9	17.6	24.3	33.3	25.1	16.2	18.1	33.2	22.1	36.3	18.2	25.0	10.7	17.8	41.7	10.9	45.7	41.2	21.7	24.4	22.5	27.3	35.8	12.3	20.3	19.2	15.0	30.5	20.4	28.5	20.5	15.3	14.1	35.0	23.3	32.5	13.7	20.8	27.9	11.8	35.9	22.7	13.8	25.0	7.6	17.7	30.0	15.0	19.0	12.2	14.0	37.3	13.3	12.2	12.8	2.5	17.8	22.1	23.9	13.0	16.1	6.3	7.3	5.3	11.0	6.5	5.8	6.8	8.2	7.6	5.1
AK1		ENSG00000106992	"Adenylate kinase 1"	P00568	9	127866480-127877743	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 84.5;skeletal muscle: 279.0"	"Cell line enhanced"	"Detected in many"		"U-2197: 46.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006456, CAB009893"	Enhanced		Supported	Cytosol		32000000	32000000	Cytosol	Cytosol	"CAB009893: AB_2225151, HPA006456: AB_1078116"	"unprognostic (6.07e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.74e-2)"	"unprognostic (6.65e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.81e-2)"	"prognostic favourable (7.31e-4)"	"unprognostic (2.62e-1)"	"unprognostic (8.40e-3)"	"unprognostic (6.99e-3)"	7.7	9.2	19.6	3.7	18.8	6.5	3.9	9.8	17.3	10.5	8.6	18.1	12.2	5.2	3.4	17.3	9.0	84.5	12.0	60.4	17.6	18.5	6.3	10.7	18.7	2.2	16.4	15.3	12.3	4.6	5.6	7.1	2.9	17.5	5.2	10.8	7.0	13.4	15.7	279.0	3.4	2.6	6.3	11.5	5.6	5.8	9.8	11.1	0.0	10.5	61.5	4.0	4.4	4.4	1.2	3.4	2.8	0.4	1.4	1.5	1.2	15.2	6.6	8.4	11.5	20.5	41.8	7.7	10.6	10.7	18.9	11.5	4.8	9.7	0.4	11.6	21.8	22.0	0.0	11.8	7.6	2.4	7.3	2.2	18.9	8.4	11.5	0.0	0.3	31.7	23.0	14.0	10.2	25.2	8.9	0.6	21.4	14.5	0.0	0.3	3.0	20.4	0.4	8.5	3.3	12.6	1.1	13.7	8.5	28.0	16.1	8.1	12.9	9.1	20.8	13.2	5.4	46.5	10.1	1.0	0.1	0.0	16.6	0.0	9.2	0.9	0.4	0.4	1.5	0.3	1.1	0.3	0.6	1.1	0.1	1.2	0.3	1.1	2.8	1.4	0.4	3.4	0.3	1.2	19.6	18.8	9.8	17.3	17.6	18.5	16.4	15.3	17.5	11.1
AKAP1	"AKAP121, AKAP149, AKAP84, D-AKAP1, PPP1R43, PRKA1, S-AKAP84, SAKAP84, TDRD17"	ENSG00000121057	"A-kinase anchoring protein 1"	Q92667	17	57085092-57121349	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 80.1;testis: 75.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008620, HPA008691, CAB019286"	Supported		Supported	Mitochondria				Mitochondria	Mitochondria	"CAB019286: , HPA008620: AB_2668104, HPA008691: AB_1078119"	"unprognostic (5.52e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.79e-2)"	"unprognostic (6.38e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.00e-1)"	"prognostic favourable (7.86e-9)"	"unprognostic (6.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.38e-1)"	16.4	6.1	13.5	9.2	16.3	2.8	14.7	13.4	12.5	10.3	28.1	8.7	9.3	22.6	10.2	14.3	18.1	12.5	19.2	35.0	10.0	6.6	11.9	26.4	8.3	4.4	13.6	9.9	9.0	16.4	18.8	7.1	3.3	7.9	15.5	20.6	9.3	13.6	13.9	80.1	10.2	25.2	23.5	8.4	4.9	22.2	75.4	10.1	4.7	14.9	19.7	7.4	20.5	9.8	3.3	6.5	2.8	3.3	6.0	7.4	2.1	16.5	20.7	28.8	9.4	7.5	4.9	17.3	6.9	6.7	9.1	6.5	22.1	14.9	26.6	19.7	5.3	26.3	16.1	15.2	9.2	14.5	23.4	22.6	18.3	42.0	7.0	21.2	8.7	4.3	15.1	10.1	14.2	9.2	15.0	10.3	5.2	14.1	26.7	8.1	10.5	22.3	20.6	12.2	21.7	6.1	19.6	22.1	14.5	5.5	16.1	9.0	11.0	21.9	6.8	8.0	9.0	10.3	15.6	10.2	12.7	20.0	5.1	16.6	7.1	2.8	1.7	0.6	4.7	3.3	4.1	3.3	3.8	3.8	4.0	2.4	7.4	4.0	0.2	6.0	0.9	6.5	2.8	2.1	13.5	16.3	13.4	12.5	10.0	6.6	13.6	9.9	7.9	10.1
AL139300.1		ENSG00000256500			14	103562962-103685924	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"skeletal muscle: 37.2"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA044617, HPA052450"	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA044617: AB_2679024, HPA052450: AB_2681838"					"unprognostic (1.56e-1)"													10.2	7.5	16.6	7.8	20.3	2.8	15.5	21.9	25.1	5.9	4.8	3.2	5.1	2.0	5.5	4.6	5.8	3.9	4.2	20.0	17.2	17.2	5.3	5.6	4.2	7.7	17.3	6.2	5.0	15.8	9.9	5.8	4.2	5.2	5.0	2.9	2.7	7.7	6.3	37.2	2.0	4.2	8.5	22.6	2.9	2.8	18.5	4.0	2.2	7.8	9.2	5.4	6.6	6.9	4.2	4.9	4.2	5.1	2.3	4.4	1.3	6.3	11.9	13.1	1.1	7.2	8.9	5.7	18.3	14.1	20.7	13.1	7.2	9.6	16.0	11.9	13.2	6.2	8.7	10.5	13.1	5.4	1.0	6.1	6.2	6.7	9.6	8.4	3.7	6.9	2.8	9.8	11.3	11.8	8.2	4.1	14.9	11.9	13.1	3.1	9.0	14.9	5.8	10.3	8.6	10.6	7.3	17.1	10.5	10.9	4.6	10.2	10.1	4.8	8.3	9.1	7.2	14.6	8.6	5.3	6.2	18.3	15.3	3.5	8.3	0.7	3.2	4.2	2.8	4.3	2.9	1.9	3.4	4.1	1.9	4.2	4.4	1.9	2.8	2.3	5.1	4.9	4.2	1.3	16.6	20.3	21.9	25.1	17.2	17.2	17.3	6.2	5.2	4.0
AL672142.1		ENSG00000251184			9	128941478-128957021	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"skeletal muscle: 5.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.0;BJ: 4.3;HL-60: 3.9;RH-30: 4.4;U-138 MG: 3.4;U-698: 3.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.2	0.3	0.7	0.0	1.1	0.0	0.2	1.2	0.6	1.4	0.1			0.0	1.3	1.6	0.0	0.5	0.0	0.3	0.1	0.3	0.3	0.3	0.3	0.5	0.7		0.4	0.0	0.0	0.0	0.3		0.0	0.0		0.0	0.0	5.3	0.0	0.0	0.4	0.7	0.0	0.8	0.3			0.2		0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	1.1	3.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	1.7	0.0	1.0	0.0	1.4	1.6	0.0	0.0	0.0	1.7	0.0	0.8	0.0	0.7	4.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	2.4	0.0	1.0	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ALKBH5	"FLJ20308, OFOXD1"	ENSG00000091542	"AlkB homolog 5, RNA demethylase"	Q6P6C2	17	18183078-18209954	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 130.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007196	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus, Cytosol"	"Nucleoplasm, Golgi apparatus, Cytosol"	"HPA007196: AB_1850461"	"unprognostic (1.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.94e-2)"	"prognostic favourable (3.75e-4)"	"unprognostic (6.54e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.68e-3)"	"prognostic unfavourable (5.69e-4)"	18.0	19.5	17.1	14.6	21.9	19.1	26.2	23.4	25.3	18.2	21.8	20.1	18.8	15.1	22.1	12.1	17.3	30.5	18.7	45.8	16.5	18.9	16.0	24.2	14.7	16.9	19.0	16.9	20.9	25.0	22.7	20.2	14.8	15.4	19.4	8.9	19.9	23.7	21.1	130.4	12.7	16.9	20.4	15.3	18.8	16.2	29.7	17.6	26.8	23.5	19.5	13.7	26.8	44.8	11.5	8.9	17.6	10.6	7.6	17.0	5.7	33.5	32.4	13.2	23.7	19.4	13.4	11.5	16.2	20.1	26.7	24.9	36.6	8.9	21.3	24.0	17.8	22.2	19.8	17.1	13.7	24.3	27.0	15.6	18.4	20.4	18.1	11.2	20.9	12.8	11.7	20.0	11.9	15.4	16.9	9.7	14.8	24.9	24.2	12.6	11.1	16.6	22.0	26.0	37.3	7.8	11.6	13.6	17.9	20.2	14.1	18.5	14.2	9.7	15.6	25.7	18.0	37.7	31.7	11.4	8.6	12.8	46.7	18.5	16.8	4.3	7.2	17.6	15.1	7.4	14.0	7.9	13.6	17.0	8.9	11.5	10.9	11.0	4.6	7.6	10.6	6.6	7.9	5.7	17.1	21.9	23.4	25.3	16.5	18.9	19.0	16.9	15.4	17.6
ALPK2	HAK	ENSG00000198796	"Alpha kinase 2"	Q86TB3	18	58481247-58628957	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 35.3;skeletal muscle: 35.3;tongue: 12.4"	"Cell line enhanced"	"Detected in many"		"BJ: 26.0;BJ hTERT+: 15.8;fHDF/TERT166: 23.5;U-138 MG: 13.3"	"Cancer enriched"	"Detected in some"	6	"renal cancer: 7.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.8"	"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Low region specificity"	"Detected in many"			"HPA027377, HPA027976, HPA028084, HPA029801"	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA027377: AB_10600635, HPA027976: AB_10611246, HPA028084: AB_10601996, HPA029801: AB_10602006"	"unprognostic (7.35e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.60e-3)"	"unprognostic (2.64e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavourable (8.20e-5)"	"unprognostic (5.27e-3)"	"unprognostic (2.50e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.20e-2)"	0.8	0.0	0.1	2.8	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.9	0.8	0.0	0.4	35.3	0.1	0.0	5.2	2.8	0.1	3.3	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.0	0.2	0.4	0.1	35.3	0.3	0.6	0.1	0.1	0.2	1.2	0.6	0.1	5.5	0.3	12.4	7.9	0.5	0.1	0.0	0.5	0.0	1.8	0.0	0.3	0.0	0.0	6.9	0.5	0.0	0.2	1.8	0.1	26.0	15.8	11.0	9.5	1.6	0.0	0.0	2.7	23.5	0.0	0.0	0.0	11.3	5.6	0.0	0.0	2.1	0.9	1.4	0.0	0.0	1.6	0.0	3.3	0.1	0.0	0.0	0.2	7.0	0.0	0.0	0.0	0.1	0.0	0.0	5.7	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.3	5.8	1.8	4.4	10.7	9.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.5	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
ALPK3	"KIAA1330, MAK, Midori"	ENSG00000136383	"Alpha kinase 3"	Q96L96	15	84816680-84873482	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 18.4;skeletal muscle: 47.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 9.2;HDLM-2: 6.9;HUVEC TERT2: 9.9;LHCN-M2: 13.6;NTERA-2: 8.3;RH-30: 24.4"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA026558	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA026558: AB_1844774"	"unprognostic (2.69e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.23e-1)"	"prognostic favourable (3.95e-7)"	"unprognostic (1.76e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.96e-2)"	"unprognostic (4.87e-2)"	3.7	1.8	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.5	1.4			0.0	0.1	1.7	0.8	0.2	0.3	18.4	0.0	0.6	1.6	1.3	1.0	0.0	0.1		0.0	2.1	8.8	6.9	0.6		0.4	0.0		0.4	0.2	47.6	0.0	0.2	0.8	0.0	0.0	1.2	0.0			0.6		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.1	0.1	0.1	0.2	0.0	9.2	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	6.9	1.1	1.1	0.2	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	9.9	0.0	0.0	13.6	0.5	0.0	0.1	8.3	0.0	0.0	24.4	0.1	0.0	2.5	0.0	0.1	0.0	1.3	0.0	0.0	6.0	0.2	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0										
AMOTL1	JEAP	ENSG00000166025	"Angiomotin like 1"	Q8IY63	11	94706431-94876753	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 78.2"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 36.0;WM-115: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.3;NK-cell: 2.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001196	Approved		Approved	"Cell Junctions,Cytosol"		11000	11000	Cytosol	Cytosol	"HPA001196: AB_1078147"	"unprognostic (2.21e-1)"	"unprognostic (5.25e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.43e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.95e-2)"	"prognostic favourable (5.03e-6)"	"unprognostic (7.47e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.29e-2)"	14.4	5.7	3.3	6.9	4.0	0.6	9.2	3.7	4.8	12.8	15.4	2.7	9.1	2.2	16.4	11.4	19.3	7.5	10.9	10.1	3.1	3.9	4.4	4.8	10.0	2.5	3.2	2.5	7.3	10.8	13.5	13.9	25.4	3.5	18.7	4.0	11.3	8.9	13.6	78.2	11.7	4.8	32.8	2.6	6.2	8.1	7.1	1.8	12.9	8.6	21.9	10.1	24.4	9.5	2.3	1.0	0.0	0.7	2.3	0.1	0.5	18.0	5.1	13.8	0.0	14.9	12.9	6.6	10.0	17.5	4.6	5.4	9.4	0.5	0.8	4.9	13.5	23.5	6.5	36.0	4.8	1.4	5.0	9.7	5.4	0.0	3.4	2.1	0.0	7.6	22.3	15.7	26.3	9.5	24.5	0.9	10.8	5.2	6.6	1.3	2.0	3.4	0.0	25.1	1.5	6.5	7.6	10.5	12.7	0.6	13.9	3.6	0.7	3.0	8.7	12.6	9.3	0.2	6.8	0.5	0.0	5.1	3.5	0.0	34.4	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.6	2.3	0.0	0.0	0.0	2.3	0.2	1.0	0.0	0.5	3.3	4.0	3.7	3.0	3.1	3.9	3.2	2.5	3.5	1.8
AMPD3		ENSG00000133805	"Adenosine monophosphate deaminase 3"	Q01432	11	10308313-10507579	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.2;skeletal muscle: 61.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.3;CAPAN-2: 19.0;HMC-1: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038662, HPA047408"	Uncertain		Enhanced	"Nuclear membrane"				"Nuclear membrane"	"Nuclear membrane"	"HPA038662: AB_2676136, HPA047408: AB_2680034"	"unprognostic (2.24e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.44e-2)"	"prognostic favourable (2.37e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.25e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.12e-2)"	2.9	13.7	5.3	13.8	14.0	39.2	2.3	2.3	7.8	3.3	3.4	19.6	0.7	4.7	3.1	4.2	5.2	8.0	4.6	2.1	7.4	7.1	4.2	1.5	4.5	12.7	15.2	5.7	2.3	2.5	24.9	14.5	3.7	11.2	5.5	4.9	4.3	4.7	2.8	61.0	10.8	5.0	3.1	12.8	8.3	4.6	1.4	12.6	14.8	2.7	7.6	14.2	6.1	5.1	7.6	3.9	17.0	6.0	3.3	5.3	2.3	7.4	1.1	0.3	0.1	4.0	2.9	0.4	6.8	24.3	1.7	1.7	3.7	19.0	2.7	0.6	3.1	4.7	0.1	6.4	5.0	6.7	0.2	6.7	0.9	0.5	1.3	9.1	20.2	10.6	10.0	3.3	4.3	0.7	10.1	2.9	5.5	0.2	5.3	11.9	0.9	6.7	2.0	8.8	9.8	0.3	6.3	2.8	1.5	1.5	0.2	0.4	0.2	3.1	1.8	7.7	0.1	5.3	0.2	2.7	1.5	2.9	8.9	9.1	0.2	6.6	6.0	17.0	2.3	3.8	5.3	7.6	3.3	2.5	3.9	5.8	3.7	2.5	8.3	3.3	1.6	2.5	1.9	2.3	5.3	14.0	2.3	7.8	7.4	7.1	15.2	5.7	11.2	12.6
ANGPTL7	"AngX, CDT6"	ENSG00000171819	"Angiopoietin like 7"	O43827	1	11189341-11195981	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 22.9"	"Cell line enriched"	"Detected in single"	263	"SCLC-21H: 30.3"	"Cancer enriched"	"Detected in some"	14	"melanoma: 18.4"	"Region enriched"	"Detected in single"	6	"cerebellum: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"								"Secreted in other tissues"	490000	490000				"unprognostic (3.23e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.80e-1)"		"unprognostic (4.89e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.49e-2)"	12.8	3.7	0.1	2.0	0.2	0.0	4.8	3.2	0.2	5.4	8.0	0.3	9.3	1.3	1.4	4.3	7.0	1.7	5.9	10.4	0.1	0.3	6.5	0.4	2.1	1.0	0.1	0.4	1.9	0.6	0.0	7.8	0.9	0.5	4.7	2.4	5.3	4.2	11.4	22.9	5.9	2.6	16.5	3.5	0.4	2.2	3.9	0.5	0.1	0.7	13.8	1.4	6.2	4.5	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.2	0.2	0.1	0.3	0.1	0.4	0.5	0.5
ANK2	LQT4	ENSG00000145362	"Ankyrin 2"	Q01484	4	112818109-113383740	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.5;heart muscle: 56.7;kidney: 59.8;skeletal muscle: 66.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 16.1;ASC TERT1: 22.5;RH-30: 30.8;SH-SY5Y: 15.5"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008007, CAB015178, HPA035970"	Enhanced	Approved	Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB015178: AB_2242828, HPA008007: AB_2667965, HPA035970: "	"unprognostic (8.33e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavourable (2.41e-6)"	"unprognostic (1.18e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.04e-3)"	17.3	8.7	34.0	6.3	42.1	0.8	10.7	43.7	58.5	20.9	9.5	24.5	0.6	4.3	10.5	4.3	8.3	5.8	13.0	56.7	29.4	30.3	59.8	2.0	4.6	5.1	28.7	38.7	19.0	2.4	1.6	8.6	2.0	42.1	5.4	7.2	7.8	2.6	8.7	66.9	3.5	4.7	15.2	19.0	15.1	3.8	5.8	24.2	0.0	5.6	4.4	4.5	4.5	4.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	10.2	4.2	16.1	22.5	0.0	1.0	1.8	0.7	2.0	4.0	0.0	4.2	1.4	3.6	0.0	7.5	0.4	0.6	1.9	6.2	2.4	0.0	1.7	1.0	1.0	0.7	9.6	1.6	0.9	3.9	0.0	0.0	6.9	3.4	0.1	0.2	0.0	5.3	1.7	0.5	30.8	0.0	0.1	0.0	8.3	15.5	0.1	0.3	5.3	0.1	0.6	0.0	3.2	1.7	0.2	1.9	4.1	1.1	0.6	12.7	0.4	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.0	42.1	43.7	54.3	29.4	30.3	28.7	38.7	42.1	24.2
ANKRD9		ENSG00000156381	"Ankyrin repeat domain 9"	Q96BM1	14	102501760-102509799	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 67.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055985	Uncertain									"HPA055985: AB_2682996"	"unprognostic (1.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.76e-2)"	"unprognostic (7.31e-3)"	"unprognostic (6.78e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.17e-1)"	"prognostic favourable (1.17e-7)"	"unprognostic (3.89e-1)"	"unprognostic (4.74e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.15e-1)"	5.5	5.1	7.1	2.6	4.5	10.0	4.6	5.6	11.8	2.5	12.6	3.6	2.3	31.6	2.0	4.9	5.8	1.5	6.7	27.0	6.0	4.2	6.3	3.8	3.8	0.9	5.5	4.3	2.8	5.2	8.0	1.8	8.3	9.0	5.4	6.8	4.6	7.1	3.9	67.4	6.2	20.5	3.0	6.1	2.6	10.2	10.1	4.6	0.4	2.6	13.3	2.7	4.7	4.1	0.5	0.4	1.2	2.3	0.9	1.1	0.4	8.9	4.3	7.8	7.3	8.2	3.4	12.3	10.8	4.0	4.9	4.8	1.1	6.1	0.0	12.2	3.0	14.8	3.8	2.2	2.5	6.3	15.5	2.3	7.2	2.0	4.2	0.8	7.9	1.6	13.3	2.7	2.7	2.1	4.5	0.8	2.3	7.9	1.2	2.5	3.7	19.5	12.1	7.4	0.5	5.0	9.3	6.4	6.8	7.7	5.0	13.2	7.6	3.4	4.8	5.0	6.5	24.3	8.3	7.0	3.8	0.2	5.9	1.7	4.8	0.7	0.4	0.2	0.3	0.5	0.6	0.2	0.3	0.2	0.4	0.5	0.5	0.3	1.2	0.9	2.3	0.4	1.1	0.4	7.1	4.5	5.6	11.8	6.0	4.2	5.5	4.3	9.0	4.6
ANO5	"GDD1, LGMD2L, TMEM16E"	ENSG00000171714	"Anoctamin 5"	Q75V66	11	22193176-22283357	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 37.7;parathyroid gland: 26.9;skeletal muscle: 43.7"	"Cell line enhanced"	"Detected in some"		"A549: 6.5;HAP1: 7.1;HEK 293: 8.9;NTERA-2: 4.9;RPTEC TERT1: 4.4;U-266/84: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA058857	Uncertain									"HPA058857: AB_2683835"	"unprognostic (5.25e-3)"	"unprognostic (1.36e-3)"	"unprognostic (2.43e-1)"	"unprognostic (7.67e-3)"	"unprognostic (3.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (8.17e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.54e-4)"	"unprognostic (8.55e-2)"	"prognostic favourable (2.50e-7)"	"unprognostic (3.65e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.77e-4)"	"unprognostic (7.94e-2)"	1.0	3.8	3.9	0.9	3.8	0.3	0.9	0.9	7.9	1.7	2.6	1.1	1.0	2.9	1.5	1.6	2.4	1.1	1.6	37.7	4.5	4.2	3.1	2.3	1.4	0.6	3.4	6.3	1.0	3.3	26.9	5.0	0.4	3.5	3.8	2.9	2.7	3.4	3.7	43.7	0.5	3.1	4.1	1.9	1.0	3.0	2.3	1.7	0.0	3.9	14.2	0.6	3.2	1.9	0.0	0.9	0.0	1.5	0.0	0.1	0.1	0.0	6.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.4	4.3	0.0	0.0	0.0	0.0	4.9	0.0	0.1	0.0	0.0	4.4	0.1	3.9	3.6	0.0	0.0	0.0	3.3	2.5	0.0	0.0	2.9	0.0	0.0	2.8	5.2	0.0	4.0	0.0	0.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	3.8	0.9	7.9	4.5	4.2	3.4	6.3	3.5	1.7
APOL5	APOLV	ENSG00000128313	"Apolipoprotein L5"	Q9BWW9	22	35717872-35729483	"Plasma proteins, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"liver: 1.8;skeletal muscle: 5.4;testis: 2.6"	"Cell line enriched"	"Detected in single"	13	"U-698: 6.1"	"Cancer enriched"	"Detected in single"	7	"liver cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA040968	Uncertain									"HPA040968: AB_10963933"	"unprognostic (2.23e-1)"				"unprognostic (7.61e-4)"	"unprognostic (9.34e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.23e-1)"			"unprognostic (4.18e-2)"		"unprognostic (4.37e-5)"	"unprognostic (3.23e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.59e-1)"	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.5	1.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ARID5B	"FLJ21150, MRF2"	ENSG00000150347	"AT-rich interaction domain 5B"	Q14865	10	61901300-62096944	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015037	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA015037: AB_1845015"	"unprognostic (3.31e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.75e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.93e-2)"	43.3	5.6	7.8	13.8	9.9	4.2	22.6	3.3	11.5	27.5	14.0	9.5	4.4	6.8	29.4	10.4	14.0	15.6	27.2	16.0	5.9	5.1	14.6	5.7	14.6	14.4	11.8	6.5	18.6	4.3	14.7	11.4	22.4	9.4	16.6	8.2	6.9	14.5	7.3	88.6	15.0	12.1	29.4	10.4	12.7	9.4	7.7	10.5	8.6	7.5	11.7	18.0	22.5	17.1	21.2	1.0	4.3	3.6	5.7	14.7	2.6	0.8	0.3	2.3	5.7	5.1	13.7	0.4	16.6	44.8	11.8	9.3	20.1	0.9	1.4	4.0	15.9	5.5	8.0	2.5	14.3	5.2	2.4	0.7	4.1	5.0	9.5	0.2	9.9	17.3	1.3	7.0	8.0	1.4	0.7	2.2	3.8	2.8	5.4	0.4	0.4	5.2	6.6	3.8	0.4	7.8	9.0	1.3	1.7	7.4	4.1	4.8	3.4	0.2	1.2	6.6	8.9	9.9	4.2	0.1	0.0	4.3	5.7	0.3	2.1	4.3	0.6	0.4	7.3	1.4	0.9	19.0	10.5	6.3	1.0	21.2	6.9	4.5	1.2	5.7	3.6	0.5	14.7	2.6	7.8	9.9	3.3	11.5	5.9	5.1	11.8	6.5	9.4	10.5
ARRDC2	"CLONE24945, PP2703"	ENSG00000105643	"Arrestin domain containing 2"	Q8TBH0	19	18001132-18014102	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.7"	"Cell line enhanced"	"Detected in many"		"REH: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053788, HPA074216"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA053788: AB_2682262, HPA074216: "	"unprognostic (8.10e-2)"	"prognostic favourable (5.93e-4)"	"unprognostic (2.20e-3)"	"unprognostic (8.67e-2)"	"unprognostic (4.81e-3)"	"unprognostic (4.26e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.40e-2)"	"prognostic unfavourable (5.84e-4)"	"unprognostic (1.16e-1)"	"unprognostic (8.37e-2)"	"unprognostic (4.87e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.01e-1)"	"prognostic favourable (6.91e-4)"	"prognostic favourable (2.92e-4)"	26.7	5.3	10.4	12.5	34.6	39.3	27.7	3.2	19.5	10.9	9.6	28.3	7.3	6.9	7.6	4.7	8.1	8.5	13.1	8.5	14.1	8.2	10.7	9.8	22.6	19.0	47.5	9.0	4.9	6.2	18.7	5.7	8.1	20.1	10.1	7.2	6.0	15.3	11.6	60.7	9.4	13.3	6.7	16.8	18.7	12.1	3.2	32.9	10.5	14.3	4.9	19.1	9.3	11.3	5.9	3.1	3.7	6.3	7.2	16.0	4.7	5.8	10.5	0.2	5.4	4.4	4.1	4.2	3.4	9.7	2.8	2.8	2.3	11.4	10.9	9.7	2.8	3.9	4.2	3.1	2.3	7.0	6.2	8.2	8.2	3.2	4.1	6.2	12.3	4.4	4.9	3.3	5.1	4.8	9.4	0.3	2.7	8.9	4.7	17.3	1.3	17.4	28.0	0.1	8.1	4.1	5.4	2.5	2.6	5.5	5.6	5.6	3.3	16.1	10.3	5.0	3.9	16.7	4.2	0.8	0.0	12.2	8.0	23.8	3.8	3.7	6.3	3.7	4.0	5.2	2.8	3.9	6.7	5.1	3.1	5.9	16.0	8.4	2.4	7.2	5.4	2.0	5.0	4.7	10.4	34.6	3.2	19.5	14.1	8.2	47.5	9.0	20.1	32.9
ART5		ENSG00000167311	"ADP-ribosyltransferase 5"	Q96L15	11	3638503-3642316	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 12.1;testis: 33.3"	"Cell line enhanced"	"Detected in some"		"AF22: 3.3;AN3-CA: 3.5;BEWO: 6.1;BJ hTERT+ SV40 Large T+ RasG12V: 3.5;HEK 293: 4.2;U-2 OS: 4.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 4.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"memory CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Region enriched"	"Detected in single"	5	"olfactory region: 0.5"	"Not detected"	"Not detected"			"HPA041637, HPA044099"	Uncertain				"Secreted in other tissues"					"HPA041637: AB_2677589, HPA044099: AB_2678808"	"unprognostic (6.32e-2)"	"unprognostic (3.26e-5)"	"unprognostic (4.09e-3)"	"unprognostic (2.06e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.67e-1)"	"prognostic favourable (1.85e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.18e-1)"	0.8	0.1	0.3	0.3	0.5	0.0	0.8	0.3	0.6	3.3	0.3	0.3	1.0	0.0	3.3	0.9	0.4	1.5	1.2	2.9	0.3	0.2	0.7	0.6	0.9	0.3	0.3	0.3	9.3	0.3	1.7	0.6	1.7	0.5	1.1	0.0	5.3	1.2	0.8	12.1	0.3	0.4	1.0	0.3	0.5	0.3	33.3	0.5	0.3	3.5	5.2	0.5	0.5	1.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	3.3	3.5	0.0	0.0	6.1	0.4	3.0	1.5	3.5	0.1	0.0	0.0	1.6	0.4	0.0	2.9	0.0	0.8	0.0	4.2	0.0	0.6	0.3	0.1	0.0	2.7	1.0	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.6	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	2.9	0.1	1.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.6	0.3	0.2	0.3	0.3	0.5	0.5
ARX	"CT121, EIEE1, ISSX, MRX29, MRX32, MRX33, MRX36, MRX38, MRX43, MRX54, MRX76, MRX87, MRXS1, PRTS"	ENSG00000004848	"Aristaless related homeobox"	Q96QS3	X	25003694-25016420	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 25.2;ovary: 58.7;skeletal muscle: 16.9"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.9;PC-3: 6.0;THP-1: 2.5;U-266/70: 12.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 9.5;basal ganglia: 6.7;cerebral cortex: 25.2;hippocampal formation: 10.4;olfactory region: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (8.28e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (3.54e-7)"	"unprognostic (9.85e-2)"	"unprognostic (7.96e-3)"		"unprognostic (1.18e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-6)"	"unprognostic (6.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.91e-1)"	0.5	0.5	9.5	0.5	6.7	0.5	0.7	0.3	25.2	0.5	1.1	1.9	0.0	2.9	0.5	1.8	0.5	1.1	0.5	0.5	10.4	2.6	0.6	0.5	0.8	0.5	0.9	17.1	58.7	2.7	4.4	0.5	0.5	0.0	0.7	1.1	0.0	0.5	0.5	16.9	0.5	1.0	0.5	0.3	0.6	4.9	13.6	3.1	0.0	0.5	0.5	0.8	0.5	0.5	0.0	0.1	0.6	0.4	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	6.0	0.6	0.0	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.1	0.5	2.5	0.0	0.0	0.2	0.0	0.0	12.8	0.4	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	9.5	6.7	0.3	25.2	10.4	2.6	0.9	17.1	0.0	3.1
ASB16	FLJ30165	ENSG00000161664	"Ankyrin repeat and SOCS box containing 16"	Q96NS5	17	44170447-44179083	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 38.4;tongue: 17.6"	"Cell line enhanced"	"Detected in many"		"U-266/70: 12.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	13	"cerebellum: 11.4"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA066834	Approved		Approved	"Focal adhesion sites"				"Focal adhesion sites"	"Focal adhesion sites"	"HPA066834: AB_2685732"	"unprognostic (2.72e-2)"	"unprognostic (8.47e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.03e-2)"	"unprognostic (6.13e-2)"	"unprognostic (7.23e-4)"	"unprognostic (5.84e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.53e-3)"	"unprognostic (7.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.07e-3)"	0.9	0.6	0.2	1.3	0.3	1.2	0.5	11.4	0.7	0.6	1.2	0.3	0.9	1.3	1.3	1.9	1.1	1.0	0.6	12.6	0.7	0.4	0.8	0.4	0.7	1.9	0.6	0.2	1.1	7.0	1.6	1.8	0.3	0.8	1.7	0.0	2.7	1.2	0.1	38.4	1.9	1.3	4.1	0.2	1.8	1.3	0.6	0.3	0.0	0.9	17.6	1.1	1.6	1.5	4.4	2.9	9.6	2.4	4.0	4.5	2.7	2.1	4.0	4.9	4.5	0.0	0.0	4.0	4.4	0.0	0.0	0.0	3.0	2.4	3.2	2.7	0.0	5.1	0.0	0.0	0.0	5.0	7.2	2.0	7.0	3.4	0.0	2.2	6.5	0.0	0.0	0.0	0.0	0.0	3.7	8.1	0.0	3.5	2.6	4.0	1.4	4.8	8.2	4.7	4.9	0.0	3.3	5.0	2.8	2.0	0.6	0.7	6.4	2.0	2.2	6.1	5.6	3.7	2.8	12.5	6.1	3.1	1.4	3.1	4.0	4.0	2.4	9.6	3.1	2.2	3.7	4.4	3.3	3.0	1.2	3.8	4.5	2.8	7.3	4.0	1.9	2.9	3.2	2.7	0.2	0.3	11.4	0.6	0.7	0.4	0.6	0.2	0.8	0.3
ASB2	ASB-2	ENSG00000100628	"Ankyrin repeat and SOCS box containing 2"	Q96Q27	14	93934153-93976791	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 96.9"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.6;RPMI-8226: 7.8;U-266/70: 23.4;U-266/84: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in many"	8	"eosinophil: 23.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 23.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001546			Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA001546: "	"unprognostic (5.65e-4)"	"unprognostic (8.19e-2)"	"unprognostic (1.31e-1)"	"prognostic favourable (3.62e-6)"	"unprognostic (4.11e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.05e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.49e-7)"	"unprognostic (2.51e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.27e-1)"	3.1	0.5	0.2	7.9	0.8	0.4	0.5	0.2	1.7	7.4	14.0	0.0	4.6	2.2	11.9	5.7	7.2	6.5	7.7	17.2	0.2	0.2	0.3	0.3	0.8	2.3	0.3	0.6	2.3	0.3	0.3	0.2	0.3	0.5	8.5	1.5	1.5	1.6	5.8	96.9	0.5	4.4	24.4	0.3	1.5	5.0	0.3	0.0	0.0	0.7	25.7	4.7	14.3	4.5	0.9	2.6	23.1	3.0	0.0	1.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	7.8	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.0	1.7	0.0	0.0	0.0	0.1	0.0	23.4	5.2	0.8	0.2	2.4	0.5	0.0	0.0	23.1	0.8	1.0	0.1	0.9	0.8	1.7	2.6	0.2	0.1	0.2	0.0	0.0	3.0	0.1	1.1	0.5	0.2	0.8	0.2	1.7	0.2	0.2	0.3	0.6	0.5	0.0
ASB8	"FLJ21255, MGC5540"	ENSG00000177981	"Ankyrin repeat and SOCS box containing 8"	Q9H765	12	48147788-48181213	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003299	Approved									"HPA003299: AB_1845072"	"unprognostic (1.35e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.40e-3)"	"unprognostic (3.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.29e-3)"	"unprognostic (3.82e-3)"	"unprognostic (1.14e-1)"	"prognostic favourable (6.57e-6)"	"unprognostic (2.88e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.26e-2)"	12.6	12.8	11.1	8.2	13.8	22.7	9.1	18.2	17.2	9.8	9.7	12.2	7.4	9.0	11.5	9.9	10.7	8.3	8.6	19.0	10.2	10.4	13.3	13.4	7.5	9.2	10.9	10.2	9.8	10.3	14.5	14.7	7.7	16.8	9.3	11.5	15.4	10.2	10.0	106.4	9.3	11.3	10.6	9.6	10.1	9.0	8.5	8.8	15.7	10.2	22.3	11.1	10.5	7.2	11.1	9.3	42.7	12.3	13.1	14.2	8.2	9.2	7.6	9.4	13.8	13.9	12.3	6.6	17.8	11.6	11.6	11.0	12.3	11.7	15.7	13.6	14.8	8.4	14.8	10.2	13.1	18.9	12.1	19.0	10.8	6.4	10.6	18.2	17.7	12.0	9.7	15.1	9.9	11.6	14.4	19.7	10.4	8.7	16.6	13.0	3.4	14.2	11.0	14.3	16.4	9.1	9.9	14.1	9.4	10.6	12.5	10.3	22.9	12.4	8.9	10.1	7.4	10.2	7.5	17.5	20.4	13.7	12.8	40.5	5.6	25.6	8.7	42.7	12.3	9.7	11.5	11.1	13.3	12.3	8.5	8.9	13.6	14.2	20.7	13.1	12.3	9.3	12.6	8.2	11.1	13.8	18.2	17.2	10.2	10.4	10.9	10.2	16.8	8.8
ATP5ME	ATP5I	ENSG00000169020	"ATP synthase membrane subunit e"	P56385	4	672436-674338	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 221.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035010	Enhanced		Supported	Mitochondria		220000	220000	Mitochondria	Mitochondria	"HPA035010: AB_10669853"	"unprognostic (1.42e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.89e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.45e-3)"	41.2	48.1	69.3	30.8	69.0	34.4	34.2	27.7	67.6	29.3	66.6	28.2	44.4	60.0	20.5	34.1	40.1	23.1	31.6	95.8	62.0	49.2	47.5	68.9	25.8	25.2	68.6	48.7	26.2	57.9	24.5	26.6	19.6	62.2	23.9	43.9	17.8	40.7	37.2	221.8	22.3	55.6	45.8	67.2	23.3	40.7	14.1	47.7	10.9	22.1	98.7	28.1	18.9	31.1	166.1	148.1	142.2	135.7	107.4	127.6	158.4	49.1	46.5	67.0	54.6	56.5	52.5	37.4	47.9	38.4	36.4	32.3	44.7	48.7	25.5	46.1	50.6	31.5	54.0	75.5	20.0	22.5	99.7	75.0	86.2	111.5	58.7	95.4	33.0	65.1	44.4	41.7	42.2	44.5	62.0	27.9	41.3	70.8	82.2	125.0	78.8	121.8	50.1	49.0	55.5	69.5	85.8	65.1	51.1	34.8	46.9	53.2	53.6	65.8	51.5	32.7	31.1	28.8	66.8	65.3	107.7	80.6	48.1	65.8	35.8	103.7	135.7	142.2	98.5	112.1	101.0	166.1	121.1	109.2	135.4	123.2	110.3	110.3	122.3	107.4	97.7	148.1	127.6	158.4	69.3	69.0	27.7	67.6	62.0	49.2	68.6	48.7	62.2	47.7
ATP5PB	ATP5F1	ENSG00000116459	"ATP synthase peripheral stalk-membrane subunit b"	P24539	1	111448864-111462773	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 83.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046067, HPA057347"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	640000	640000	Mitochondria	Mitochondria	"HPA046067: AB_10960850, HPA057347: AB_2683416"	"unprognostic (4.18e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.56e-2)"	"unprognostic (8.18e-2)"	"unprognostic (8.52e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.18e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.92e-1)"	"prognostic favourable (3.26e-9)"	"prognostic favourable (8.07e-4)"	"unprognostic (1.60e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.93e-1)"	11.6	16.0	16.8	11.4	22.6	8.0	10.4	30.7	28.8	10.7	30.0	10.4	11.3	16.1	14.4	10.7	21.1	13.7	9.7	57.1	16.4	15.4	30.5	26.2	10.2	14.2	16.1	15.5	12.6	15.3	18.0	13.3	16.3	22.8	13.4	17.8	9.8	20.4	12.4	83.6	9.7	25.4	13.7	13.9	13.7	13.1	11.4	10.1	18.7	18.6	34.0	15.4	15.5	11.5	8.3	10.8	4.3	10.0	5.9	11.9	22.9	15.3	3.5	13.1	10.1	8.4	7.6	8.4	17.0	18.8	17.7	14.8	6.2	7.8	21.0	15.9	11.2	16.0	19.0	21.0	15.9	16.6	7.4	21.0	4.9	4.2	6.2	26.4	21.2	6.6	9.0	19.5	18.3	14.1	18.4	9.3	10.1	7.1	45.0	6.2	9.9	24.1	11.6	40.7	8.2	14.0	5.2	9.6	3.0	13.3	19.0	14.0	15.2	9.5	13.6	8.3	14.8	16.2	16.8	12.8	12.1	49.9	20.2	20.1	15.5	1.9	10.0	4.3	9.7	6.4	8.6	7.5	10.8	9.2	10.8	8.3	11.9	7.3	2.9	5.9	5.0	5.9	9.0	22.9	16.8	22.6	30.7	28.8	16.4	15.4	16.1	15.5	22.8	10.1
BAG3		ENSG00000151929	"BCL2 associated athanogene 3"	O95817	10	119651370-119677819	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 115.2;vagina: 160.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.6"	"Lineage enriched"	"Detected in many"	7	"T-cells: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018493, HPA020586"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		890000	890000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA018493: AB_1845257, HPA020586: AB_1845258"	"unprognostic (1.18e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.31e-3)"	"unprognostic (4.51e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.18e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.03e-2)"	17.8	14.1	18.8	7.7	25.7	2.7	38.3	18.4	20.7	11.7	14.1	7.3	6.5	6.3	10.1	10.6	23.3	8.7	17.0	38.2	20.6	14.3	16.8	10.1	14.3	5.9	20.9	4.5	7.3	9.3	27.6	8.8	16.5	27.4	14.4	6.7	5.5	14.6	12.9	115.2	18.5	5.6	20.4	35.8	4.4	15.1	8.1	20.6	1.3	11.1	32.7	12.8	14.0	160.1	0.3	0.8	0.4	1.1	0.2	7.6	1.0	26.1	29.8	8.3	10.8	21.6	15.2	15.6	23.9	20.3	18.3	15.8	12.6	12.8	1.0	11.4	20.5	39.1	8.5	42.2	12.7	12.8	14.0	1.4	8.0	15.7	18.3	0.0	6.1	15.3	24.4	13.3	21.1	20.4	11.2	6.5	18.2	37.4	1.4	5.8	3.2	34.1	0.0	11.8	4.5	13.8	5.9	1.5	1.4	9.5	16.9	12.4	10.5	3.5	25.4	9.7	8.4	13.1	34.1	6.0	3.5	0.6	18.1	0.4	7.3	0.0	1.0	0.0	1.2	1.1	2.0	0.3	4.4	1.5	0.8	0.0	7.6	2.7	0.4	0.2	0.5	0.2	3.0	1.0	18.8	25.7	18.4	20.7	20.6	14.3	20.9	4.5	27.4	20.6
BCCIP	"BCCIPalpha, TOK-1"	ENSG00000107949	"BRCA2 and CDKN1A interacting protein"	Q9P287	10	125823546-125853695	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 132.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038011			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA038011: AB_2675784"	"unprognostic (1.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.93e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.90e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	24.0	25.0	27.9	28.8	28.0	32.3	33.4	28.0	30.2	20.8	23.0	15.0	27.8	19.7	21.1	35.9	27.6	21.3	17.9	28.7	28.7	21.3	35.0	45.9	19.0	27.6	23.6	22.0	28.0	29.2	19.8	27.6	19.8	33.5	27.3	26.3	14.4	34.7	26.7	132.7	19.3	23.5	29.7	35.6	27.2	28.2	28.6	24.1	24.6	26.0	32.0	28.7	24.0	47.9	30.9	30.7	16.1	35.4	26.0	33.8	19.0	53.9	28.1	31.9	35.3	18.2	20.1	26.7	29.1	27.8	36.0	33.4	45.9	36.3	38.0	18.3	26.5	30.0	54.4	41.2	50.4	34.9	37.0	38.2	24.3	50.6	23.1	52.4	24.3	20.6	24.9	42.9	45.4	34.1	42.2	19.5	30.4	32.3	33.8	53.0	24.6	42.4	32.4	33.6	22.8	31.8	26.0	17.0	17.3	21.7	35.6	35.6	19.2	23.3	22.8	16.8	29.7	24.7	52.3	20.0	22.3	56.5	33.0	27.3	12.9	12.4	28.7	16.1	24.6	34.7	33.8	30.9	28.2	26.8	30.7	28.9	31.9	28.6	4.7	26.0	35.4	26.5	29.7	19.0	27.9	28.0	28.0	30.2	28.7	21.3	23.6	22.0	33.5	24.1
BCL6	"BCL5, BCL6A, LAZ3, ZBTB27, ZNF51"	ENSG00000113916	"B cell CLL/lymphoma 6"	P41182	3	187721377-187745727	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 114.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.8;Daudi: 42.1;HSkMC: 30.6;U-698: 58.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 63.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 63.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000307, HPA004899, HPA050645"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"CAB000307: AB_2063451, HPA004899: AB_1078273, HPA050645: AB_2681199"	"unprognostic (5.36e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.85e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.62e-2)"	"unprognostic (3.33e-3)"	"unprognostic (8.75e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (1.27e-9)"	"unprognostic (5.22e-2)"	"unprognostic (7.82e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.58e-2)"	47.1	14.3	21.8	23.2	25.9	50.6	48.0	58.7	23.7	21.2	21.2	19.2	11.5	4.1	17.7	8.8	20.9	28.3	22.3	18.6	21.5	8.0	10.1	20.1	26.3	24.5	31.6	9.3	20.2	15.6	9.1	23.3	7.5	28.5	17.3	5.8	15.9	19.1	11.8	114.3	36.4	8.1	24.4	50.1	27.2	16.1	10.2	26.6	18.9	14.8	10.4	22.4	24.9	20.0	3.9	5.6	63.4	15.4	0.9	1.3	5.2	1.2	3.6	3.5	0.8	26.8	21.4	3.9	4.2	10.4	4.9	5.2	2.5	2.0	42.1	3.1	5.3	2.0	1.1	2.8	4.2	8.9	1.4	0.0	1.7	6.0	13.9	0.5	0.2	30.6	17.9	6.0	9.2	2.7	0.4	7.3	4.7	1.4	1.4	0.3	0.3	2.7	11.7	1.8	0.2	3.4	6.2	0.8	0.0	4.9	2.1	2.7	9.2	1.5	5.5	11.9	1.9	4.3	1.9	5.4	1.7	58.5	6.5	1.5	8.4	1.6	6.9	4.1	1.3	8.7	1.3	1.4	0.8	1.2	5.6	3.9	0.5	0.6	63.4	0.9	15.4	0.9	0.6	5.2	21.8	25.9	58.7	23.7	21.5	8.0	31.6	9.3	28.5	26.6
BHLHE41	"BHLHB3, bHLHe41, DEC2, SHARP-1, SHARP1"	ENSG00000123095	"Basic helix-loop-helix family member e41"	Q9C0J9	12	26120026-26125127	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 15.1;RT4: 47.2;U-266/70: 20.2;U-87 MG: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	35	"memory B-cell: 5.3;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	54	"B-cells: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056035, HPA077617"			Supported	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA056035: AB_2683017, HPA077617: "	"unprognostic (1.57e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.32e-2)"	"unprognostic (6.62e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.96e-2)"	"prognostic unfavourable (8.73e-5)"	"unprognostic (5.23e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.61e-3)"	"prognostic favourable (1.09e-4)"	7.0	11.7	23.8	5.8	32.3	1.2	10.7	22.9	26.9	30.6	7.6	33.3	3.0	2.8	6.9	15.6	3.2	34.5	14.1	14.7	25.9	19.6	3.8	1.4	9.1	6.0	38.9	14.0	10.9	6.4	6.2	11.2	8.3	28.3	8.2	9.1	19.0	13.4	11.7	58.9	3.8	4.3	4.3	49.6	6.2	4.4	4.0	44.0	0.9	43.6	6.4	13.3	16.5	6.7	5.3	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.0	8.0	3.7	1.8	0.8	1.4	0.1	0.5	0.0	5.0	0.0	0.7	1.6	4.2	0.1	0.7	0.4	0.0	0.6	0.3	0.0	0.0	0.3	2.1	0.1	0.6	0.4	2.9	5.8	0.0	0.0	15.1	0.9	0.4	0.0	1.4	3.9	2.9	0.0	0.7	11.5	1.9	47.2	0.0	0.1	0.5	0.2	10.6	0.0	0.0	2.5	2.7	3.2	0.3	2.2	20.2	11.6	0.0	17.4	1.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	32.3	22.9	26.9	25.9	19.6	38.9	14.0	28.3	44.0
BLCAP	BC10	ENSG00000166619	"Bladder cancer associated protein"	P62952	20	37492472-37527931	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 102.5"	"Cell line enhanced"	"Detected in all"		"RT4: 70.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047390			Approved	Nucleoli				Nucleoli	Nucleoli	"HPA047390: AB_2680025"	"unprognostic (1.05e-2)"	"unprognostic (7.91e-3)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (7.08e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.91e-3)"	"unprognostic (4.91e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.96e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.37e-2)"	"prognostic favourable (7.28e-5)"	18.9	16.7	31.6	12.9	89.5	10.7	16.4	23.2	40.1	14.3	15.6	13.3	11.4	17.6	9.8	19.9	18.5	50.5	17.9	23.5	26.5	44.4	21.3	23.8	12.2	12.5	22.5	28.3	15.1	7.9	15.4	34.4	26.1	27.6	18.9	18.8	13.4	17.7	21.1	102.5	30.3	18.9	13.4	13.4	14.2	12.4	12.2	10.6	8.5	14.0	27.3	17.8	20.2	12.7	48.0	20.5	26.6	22.2	17.0	28.4	18.7	26.4	7.8	9.2	9.5	17.8	13.7	13.0	12.7	12.4	11.3	9.3	27.2	21.6	13.8	12.8	17.7	51.4	6.8	52.7	11.8	2.8	6.1	4.5	17.4	25.2	11.4	8.9	6.0	17.4	56.8	10.9	20.7	15.8	4.3	10.4	22.8	14.9	7.4	7.1	7.3	22.0	7.0	34.4	9.2	13.0	70.9	8.4	10.2	15.2	44.3	10.3	14.6	8.6	15.0	29.5	7.5	10.3	5.4	5.7	7.0	6.6	12.2	8.2	5.2	26.6	22.2	25.9	18.7	21.5	20.4	37.5	21.4	19.8	20.5	48.0	28.4	22.0	23.2	17.0	19.3	8.8	20.6	18.7	31.6	89.5	23.2	40.1	26.5	44.4	22.5	28.3	27.6	10.6
BTBD1		ENSG00000064726	"BTB domain containing 1"	Q9H0C5	15	83016422-83067354	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 96.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024263, HPA067671"	Enhanced		Uncertain	"Nucleoplasm,Cytoplasmic bodies,Rods & Rings"				Nucleoplasm	Nucleoplasm	"HPA024263: , HPA067671: AB_2685882"	"unprognostic (1.63e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (6.21e-7)"	"unprognostic (8.94e-3)"	"unprognostic (8.27e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.89e-2)"	11.6	9.4	17.6	7.9	17.3	10.4	10.0	11.9	22.5	9.2	11.0	13.8	4.7	10.8	8.5	9.8	10.4	10.9	9.8	35.0	17.0	14.3	13.0	11.3	8.1	11.1	17.0	11.5	8.5	6.1	12.8	10.0	8.0	18.0	10.6	12.3	6.9	8.7	8.7	96.2	6.6	10.6	9.3	18.2	9.2	7.9	18.4	11.5	10.5	12.7	21.3	11.0	9.8	7.4	4.6	8.8	9.3	6.7	3.9	7.2	2.1	15.2	14.8	13.1	12.8	20.6	35.6	6.8	22.3	30.5	19.3	21.5	9.3	16.0	30.8	27.8	25.0	19.4	28.6	17.8	22.9	24.6	23.3	26.2	22.1	13.3	24.3	24.7	29.3	28.9	16.1	13.1	19.6	28.4	23.2	17.3	40.6	8.0	18.7	12.9	18.2	16.3	19.1	33.2	15.3	19.4	36.4	22.9	16.4	25.9	21.5	36.6	16.2	20.8	28.5	21.9	16.4	30.1	30.8	17.8	27.5	30.0	23.7	41.9	15.2	2.2	4.9	9.3	5.5	5.4	4.9	4.5	5.2	7.2	8.8	4.6	5.9	5.8	2.9	3.9	6.7	3.8	4.8	2.1	17.6	17.3	11.9	22.5	17.0	14.3	17.0	11.5	18.0	11.5
BTBD6	BDPL	ENSG00000184887	"BTB domain containing 6"	Q96KE9	14	105248490-105251093	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031355	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA031355: AB_10611812"	"prognostic favourable (1.11e-4)"	"unprognostic (2.01e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.44e-1)"	"prognostic favourable (2.25e-4)"	"unprognostic (8.48e-3)"	"prognostic favourable (6.51e-5)"	"unprognostic (6.55e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.86e-2)"	"unprognostic (9.85e-2)"	25.9	9.4	19.9	9.4	17.7	11.8	53.4	18.1	27.0	13.6	14.6	5.4	15.2	14.1	9.9	14.7	17.4	11.4	13.6	19.8	17.9	12.9	9.7	12.3	17.7	11.3	11.3	15.9	13.1	5.6	7.7	12.4	7.7	9.5	13.1	11.7	11.6	20.5	12.6	73.0	19.4	14.3	14.4	6.1	9.3	13.7	24.7	6.2	8.2	9.3	31.3	10.6	11.5	22.3	2.4	2.7	4.6	1.6	0.6	8.1	1.1	17.5	14.1	7.7	20.5	24.9	17.3	0.0	16.3	14.8	25.3	17.3	11.0	16.2	5.6	10.0	23.7	23.7	14.8	15.7	12.6	14.3	12.0	4.1	20.5	0.0	17.0	12.3	7.9	18.0	21.7	11.6	9.5	20.1	0.0	0.1	13.4	25.0	12.9	5.0	3.3	24.4	14.0	0.0	5.2	9.6	19.5	12.7	5.4	15.3	12.4	12.0	25.3	15.9	13.5	20.4	0.5	29.8	20.1	3.7	4.9	2.7	21.0	5.7	15.8	0.6	1.1	4.6	4.1	1.6	4.0	2.4	4.3	4.2	1.1	1.3	3.3	2.3	0.7	0.6	1.2	2.7	8.1	1.1	19.9	17.7	18.1	27.0	17.9	12.9	11.3	15.9	9.5	6.2
BTNL2	"BTL-II, BTN7, HSBLMHC1"	ENSG00000204290	"Butyrophilin like 2"	Q9UIR0	6	32393963-32407128	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"skeletal muscle: 3.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;Karpas-707: 2.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (4.04e-2)"	"unprognostic (1.54e-1)"			"unprognostic (1.50e-2)"	"unprognostic (8.13e-4)"		"unprognostic (3.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (9.36e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.67e-1)"	"unprognostic (8.03e-2)"		0.0	1.0	0.7	0.0	1.3	0.0	0.1	0.2	0.5	0.2	0.0			1.3	0.3	0.2	0.0	0.3	0.0	0.0	0.6	1.4	0.0	0.0	0.0	0.1	0.3		1.2	0.0	0.0	0.5	0.0		1.0	0.0		0.1	0.0	3.0	0.1	0.9	0.0	0.3	0.7	0.5	0.4			0.4		0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
BVES	"HBVES, POP1, POPDC1"	ENSG00000112276	"Blood vessel epicardial substance"	Q8NE79	6	105096822-105137174	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 29.3;skeletal muscle: 37.1"	"Cell line enhanced"	"Detected in many"		"RH-30: 18.4;WM-115: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.2;granulocytes: 2.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA014788, HPA018176"	Enhanced		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"HPA014788: AB_1845504, HPA018176: "	"unprognostic (2.91e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.37e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.29e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.84e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.24e-4)"	2.9	1.0	2.3	2.4	7.6	0.6	8.9	0.7	4.1	2.6	11.5	6.7	6.7	1.7	5.3	2.8	5.3	2.5	2.1	29.3	2.8	2.5	1.5	0.7	2.3	0.9	10.4	1.3	1.2	1.0	0.8	3.5	3.5	6.1	5.4	3.5	3.6	1.6	10.0	37.1	0.8	2.7	19.4	10.7	0.7	5.9	10.0	6.3	0.0	1.6	8.6	0.8	10.3	8.6	0.5	1.2	2.9	0.3	0.4	0.4	0.1	0.8	1.2	4.7	0.8	6.9	9.5	2.1	3.5	2.5	5.5	7.3	0.3	0.0	0.0	0.0	6.6	0.0	2.0	1.2	5.1	0.0	1.7	0.0	0.6	0.2	1.5	0.0	0.3	5.5	4.3	8.5	0.7	2.4	0.0	11.9	12.1	0.1	0.1	0.6	1.0	0.0	3.4	18.4	0.0	0.0	0.0	6.2	10.7	2.2	0.0	4.7	0.0	12.0	5.4	8.8	0.0	0.0	9.2	1.1	0.4	0.0	5.2	0.0	18.5	2.9	0.3	0.3	0.2	0.1	0.2	0.3	0.2	0.4	0.0	0.5	0.3	0.3	1.7	0.4	0.1	1.2	0.1	0.1	2.3	7.6	0.7	4.1	2.8	2.5	10.4	1.3	6.1	6.3
BZW2	"HSPC028, MST017, MSTP017"	ENSG00000136261	"Basic leucine zipper and W2 domains 2"	Q9Y6E2	7	16646131-16706523	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 104.4;skeletal muscle: 89.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022813, HPA026709"	Approved		Approved	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane, Actin filaments, Cytosol"	"Plasma membrane, Actin filaments, Cytosol"	"HPA022813: AB_1845511, HPA026709: AB_10600752"	"unprognostic (2.27e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.91e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.08e-3)"	"prognostic unfavourable (7.86e-8)"	"unprognostic (9.13e-3)"	"unprognostic (8.49e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.37e-2)"	"prognostic unfavourable (6.01e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.25e-1)"	10.6	7.2	4.2	7.8	8.5	10.1	13.5	3.4	8.9	7.9	13.6	3.4	22.0	7.7	7.6	7.6	17.9	7.1	6.1	70.8	4.4	2.8	8.4	10.2	8.1	11.4	3.5	5.8	6.4	12.3	1.8	5.7	104.4	2.5	9.8	16.2	13.2	10.1	25.3	89.7	16.8	8.0	16.6	2.8	8.4	15.6	3.5	3.4	14.5	13.6	41.1	11.1	16.8	10.3	17.2	37.3	1.7	20.3	20.1	23.6	16.3	16.8	16.4	27.9	40.2	13.6	24.2	25.0	24.1	31.7	23.9	25.4	39.7	25.7	39.4	28.7	18.7	35.2	32.8	27.5	31.6	5.2	18.9	24.5	18.5	22.3	14.2	33.5	15.4	18.5	14.9	20.8	38.5	34.0	46.9	8.5	19.3	19.8	17.0	38.9	28.4	33.9	20.4	18.2	41.4	22.5	30.8	35.7	21.0	9.5	85.1	12.6	37.5	29.1	19.3	18.9	23.9	27.7	26.5	16.4	17.1	55.5	9.2	42.2	67.6	0.9	17.4	1.7	11.0	20.3	17.9	17.2	16.1	14.9	37.3	15.8	23.6	19.5	0.7	20.1	14.5	14.4	11.9	16.3	4.2	8.5	3.4	8.9	4.4	2.8	3.5	5.8	2.5	3.4
C12orf73	"DKFZp547P055, FLJ13975"	ENSG00000204954	"Chromosome 12 open reading frame 73"	Q69YU5	12	103950202-103965708	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA038883	Uncertain		Approved	"Plasma membrane,Centrosome,Mitochondria"	"Secreted - unknown location"			"Centrosome, Mitochondria"	"Centrosome, Mitochondria"	"HPA038883: AB_10794735"	"unprognostic (9.24e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.66e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (6.98e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.27e-2)"	"prognostic favourable (1.61e-4)"	6.7	11.4	14.3	8.3	14.5	4.4	9.7	15.5	17.5	7.2	7.4	11.4	7.2	7.7	9.5	13.2	7.0	8.9	5.5	11.1	13.0	14.6	9.4	8.3	5.8	10.0	13.3	13.3	11.5	9.7	9.4	21.0	7.3	13.6	10.7	9.5	8.3	8.3	11.1	43.8	9.0	7.7	7.9	14.1	7.0	9.9	10.1	13.8	11.4	11.5	12.9	10.2	6.6	6.9	11.7	11.3	8.6	5.1	12.0	14.5	3.9	5.9	11.2	16.9	10.4	4.9	6.5	11.0	6.5	3.9	7.2	5.9	11.9	5.2	7.1	8.6	3.9	9.6	10.1	8.2	5.5	10.1	20.4	10.7	16.3	14.9	7.2	15.7	9.8	5.7	9.5	3.6	6.4	6.6	13.7	4.9	6.6	6.8	17.4	23.7	8.2	19.1	10.1	6.3	7.0	9.5	8.1	27.8	9.5	6.5	11.4	15.0	19.4	8.5	3.4	8.9	5.0	6.6	6.6	13.2	20.2	14.8	10.1	8.9	7.7	7.3	5.1	8.6	10.5	4.2	10.4	11.7	9.8	10.0	7.2	10.7	14.5	13.5	1.4	12.0	3.8	11.3	13.8	3.9	14.3	14.5	15.5	17.5	13.0	14.6	13.3	13.3	13.6	13.8
C15orf61	LOC145853	ENSG00000189227	"Chromosome 15 open reading frame 61"	A6NNL5	15	67521068-67530143	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 45.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062820			Approved	Nucleoli,Vesicles,Cytosol	"Secreted - unknown location"			"Nucleoli, Vesicles"	"Nucleoli, Vesicles"	"HPA062820: AB_2684874"	"unprognostic (1.35e-1)"	"unprognostic (9.42e-3)"	"unprognostic (2.11e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.87e-3)"	"unprognostic (8.95e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.45e-2)"	"prognostic favourable (5.31e-5)"	"unprognostic (2.42e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.32e-2)"	9.9	10.0	10.8	4.7	18.1	11.0	17.9	14.5	17.2	5.5	6.0	2.4	5.6	7.5	6.3	5.9	5.5	5.2	5.1	21.0	8.7	7.2	8.4	6.4	7.2	7.5	6.9	10.9	7.9	20.7	8.8	10.9	5.8	7.3	7.2	6.4	5.9	7.0	6.4	45.8	8.4	5.0	7.0	5.8	5.0	6.6	25.2	5.5	3.6	7.7	16.9	3.7	4.6	8.0	7.2	7.2	10.7	6.6	5.1	9.8	5.0	4.3	4.6	1.2	5.1	5.4	7.9	3.3	1.9	3.4	3.6	2.8	3.5	3.1	3.6	4.1	2.1	5.1	4.6	1.3	2.9	2.1	10.9	3.9	3.5	4.6	3.5	4.7	3.2	8.1	3.6	1.2	4.3	1.6	4.3	8.1	1.1	2.4	3.8	7.7	2.0	5.9	5.2	2.6	13.2	2.5	3.0	6.9	5.2	3.3	3.2	5.8	2.8	7.3	1.7	4.8	7.3	5.9	4.9	7.7	11.1	8.8	2.0	9.3	2.4	8.6	6.6	10.7	7.0	5.2	8.0	7.2	9.2	6.9	6.9	5.6	9.8	7.9	0.8	5.1	4.4	7.2	5.6	5.0	10.8	18.1	14.5	17.2	8.7	7.2	6.9	10.9	7.3	5.5
C19orf47	FLJ36888	ENSG00000160392	"Chromosome 19 open reading frame 47"	Q8N9M1	19	40319536-40348527	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 35.4;skeletal muscle: 118.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 20.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041843, HPA046309"	Enhanced		Enhanced	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA041843: AB_10959886, HPA046309: AB_10960266"	"prognostic favourable (6.50e-4)"	"unprognostic (1.35e-3)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (7.10e-5)"	"unprognostic (2.75e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.25e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.28e-2)"	3.2	2.9	4.5	4.2	5.7	4.7	4.4	5.8	9.1	3.5	3.3	9.2	3.6	3.8	3.8	3.1	7.4	2.8	3.5	35.4	4.2	3.8	2.9	4.4	3.4	4.5	6.2	5.0	3.6	3.8	3.7	3.7	4.8	5.6	4.5	2.5	3.6	4.9	4.6	118.0	5.2	3.6	3.7	4.8	3.7	3.0	10.0	5.3	5.0	3.8	6.4	4.7	4.1	5.0	2.1	1.6	20.2	1.6	1.7	2.3	1.3	12.9	19.9	8.4	9.1	5.0	4.5	11.6	13.4	6.2	12.7	15.4	16.5	5.4	15.1	7.5	6.3	6.5	10.2	12.3	5.3	18.5	12.5	12.3	12.4	12.5	3.7	12.4	8.0	4.5	7.3	17.1	6.1	7.7	15.0	8.9	10.7	12.6	18.5	7.0	5.4	7.6	18.4	13.8	7.6	4.1	11.4	10.8	8.8	14.4	13.6	5.2	8.1	10.3	10.1	16.0	11.2	10.8	18.3	10.7	14.7	15.0	6.8	11.9	11.0	20.2	1.6	4.7	1.3	1.4	1.6	1.6	2.3	2.1	1.6	2.1	1.6	1.2	5.7	1.7	1.6	1.6	1.6	1.3	4.5	5.7	5.8	9.1	4.2	3.8	6.2	5.0	5.6	5.3
C1orf127	FLJ37118	ENSG00000175262	"Chromosome 1 open reading frame 127"		1	10946471-10982037	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"pancreas: 5.1;skeletal muscle: 17.3"	"Cell line enriched"	"Detected in some"	4	"THP-1: 7.4"	"Cancer enriched"	"Detected in single"	9	"pancreatic cancer: 2.8"					"Group enriched"	"Detected in some"	4	"classical monocyte: 1.7;myeloid DC: 4.2"	"Group enriched"	"Detected in many"	30	"dendritic cells: 4.2;monocytes: 1.7"									HPA027654	Uncertain									"HPA027654: AB_10611814"	"unprognostic (1.82e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.03e-1)"	0.1	0.6	0.0	0.0	0.4	0.0	0.0	3.3	0.0	0.0	0.2			0.6	0.0	0.0	0.5	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.3	0.5	0.8		0.0	5.1	0.0	0.2	0.1		0.0	0.5		0.2	0.0	17.3	0.0	0.2	0.0	0.1	0.5	2.5	0.6			0.1		0.0	0.0	0.0	0.0	4.2	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	1.4	0.5	0.0	7.4	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	1.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2										
C1QTNF9	"AQL1, C1QTNF9A, CTRP9, MGC48915"	ENSG00000240654	"C1q and TNF related 9"	P0C862	13	24307166-24322535	"Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 15.2;skeletal muscle: 14.1"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA056632	Uncertain				"Secreted to blood"					"HPA056632: AB_2683197"	"unprognostic (1.18e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.14e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.22e-1)"	5.6	0.3	0.2	2.4	0.9	0.3	4.9	0.1	0.2	0.7	2.8	0.1	0.1	1.1	1.6	1.6	4.8	0.3	1.9	15.2	0.9	0.3	0.3	0.8	0.4	0.4	0.2	0.1	0.4	1.2	0.5	0.2	4.8	0.1	2.6	0.7	0.1	0.9	1.0	14.1	0.6	1.2	1.8	0.2	0.6	1.1	1.6	0.1	0.3	0.5	5.2	0.9	1.0	7.1	0.5	0.7	0.7	0.3	0.0	0.2	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.1	0.5	0.1	0.9	0.0	1.3	0.7	0.5	0.3	0.0	0.2	0.1	0.0	0.5	0.5	0.8	0.0	0.4	0.0	0.0	0.2	0.5	0.3	0.1	0.0	0.5	0.0	0.3	1.7	0.0	1.9	0.7	1.2	0.2	1.4	0.2	0.2	0.0	0.6	0.5	0.1	0.2	0.5	0.0	0.2	0.4	0.3	0.0	0.4	0.6	1.1	0.4	0.9	0.4	0.6	0.7	0.7	1.1	0.1	0.1	0.0	0.2	0.1	0.0	0.5	0.1	0.2	0.0	0.5	0.0	0.2	0.7	0.0	0.3	0.7	0.0	0.0	0.2	0.9	0.1	0.1	0.9	0.3	0.2	0.1	0.1	0.1
CA14		ENSG00000118298	"Carbonic anhydrase 14"	Q9ULX7	1	150257159-150265078	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.9;retina: 29.4;seminal vesicle: 16.5;skeletal muscle: 24.1"	"Group enriched"	"Detected in some"	18	"AF22: 28.0;AN3-CA: 16.6;NTERA-2: 21.8;SK-MEL-30: 55.8"	"Group enriched"	"Detected in many"	7	"glioma: 4.9;melanoma: 23.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008482	Approved		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA008482: AB_1078395"	"unprognostic (3.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.25e-2)"	"prognostic favourable (8.47e-4)"	"unprognostic (7.28e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.89e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.80e-2)"	0.1	0.3	4.6	0.2	5.2	0.9	0.3	1.4	6.8	0.1	1.7	10.8	0.1	0.3	0.1	0.5	1.6	1.3	0.7	4.4	6.4	4.1	0.3	6.3	0.2	0.2	11.3	3.2	1.4	0.3	0.8	0.1	0.3	4.4	3.2	0.7	29.4	0.6	16.5	24.1	3.7	0.6	0.5	20.9	0.3	0.8	0.5	2.7	0.1	0.9	0.1	0.1	0.2	0.1	2.8	2.2	2.1	2.0	0.2	1.6	0.2	0.2	0.0	28.0	16.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	21.8	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.1	55.8	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	1.2	0.1	0.1	0.1	0.0	0.0	0.9	1.3	1.6	2.0	0.6	2.0	1.0	1.2	0.2	2.8	1.2	1.3	2.1	0.2	0.5	2.2	0.0	0.2	4.6	5.2	1.4	4.7	6.4	4.1	11.3	3.2	4.4	2.7
CACNA2D1	"CACNA2, CACNL2A, LINC01112, lncRNA-N3, MHS3"	ENSG00000153956	"Calcium voltage-gated channel auxiliary subunit alpha2delta 1"	P54289	7	81946444-82443798	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 59.0"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 18.1;HUVEC TERT2: 24.7;SH-SY5Y: 28.7;TIME: 17.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008213, HPA008621"	Enhanced				"Intracellular and membrane"	310000000	310000000			"HPA008213: AB_1233654, HPA008621: AB_1845863"	"unprognostic (5.07e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.24e-3)"	"unprognostic (2.23e-2)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (4.28e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.03e-4)"	9.9	13.4	15.7	4.2	18.1	0.7	4.3	8.8	20.8	5.7	11.3	7.3	1.0	5.0	7.1	2.9	5.4	4.1	6.3	25.8	12.7	14.9	8.0	1.8	3.6	2.2	6.3	15.6	7.8	2.0	1.9	8.3	4.2	8.6	12.8	5.3	1.9	3.3	6.6	59.0	4.7	3.5	13.0	5.6	4.3	5.5	3.7	8.0	0.0	16.9	14.6	3.3	6.8	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	4.8	0.0	8.5	10.8	0.0	10.5	6.8	5.2	5.1	0.0	1.5	0.0	0.0	9.1	0.0	5.0	0.0	6.9	0.0	6.8	0.3	6.8	0.0	5.6	2.3	0.0	6.3	0.0	18.1	0.0	24.7	0.0	0.1	11.6	0.0	0.0	0.0	5.7	2.2	1.0	0.9	0.0	0.4	0.4	9.7	28.7	2.0	0.0	0.0	0.0	0.0	17.7	9.3	7.0	9.2	0.0	0.0	0.0	0.0	7.8	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	18.1	8.8	20.8	12.7	14.9	6.3	15.6	8.6	8.0
CACNA2D3	HSA272268	ENSG00000157445	"Calcium voltage-gated channel auxiliary subunit alpha2delta 3"	Q8IZS8	3	54122547-55074557	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.2;skeletal muscle: 19.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.0;HAP1: 2.7;HeLa: 13.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA030849			Uncertain	Nucleoplasm		49000	49000	Nucleoplasm	Nucleoplasm	"HPA030849: "	"unprognostic (6.92e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.34e-5)"	"unprognostic (5.53e-3)"	"unprognostic (2.64e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.84e-3)"	"unprognostic (7.22e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.62e-2)"	"unprognostic (6.95e-2)"	1.5	10.3	6.4	1.3	21.9	1.0	1.5	2.4	23.2	1.5	2.0	1.4	0.2	1.4	1.4	4.0	2.1	2.1	1.6	5.1	8.9	8.0	3.8	1.1	2.2	2.2	4.8	12.8	6.7	1.2	1.1	2.4	2.1	9.0	3.4	1.7	2.4	1.9	4.4	19.5	1.2	1.7	2.4	1.7	1.6	1.9	3.9	4.2	0.0	2.1	3.6	2.1	1.0	2.1	0.2	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	1.6	0.2	13.7	0.0	0.8	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	6.4	21.9	2.4	16.1	8.9	8.0	4.8	12.8	9.0	4.2
CAMK2B	"CAM2, CAMK2, CAMKB"	ENSG00000058404	"Calcium/calmodulin dependent protein kinase II beta"	Q13554	7	44217150-44334577	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.9;heart muscle: 39.2;skeletal muscle: 70.7"	"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 41.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006849, HPA026307, HPA051783, HPA051785, HPA053973"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions,Cytosol"		680000	680000	"Plasma membrane"	"Plasma membrane"	"CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: , HPA053973: AB_2682328"	"unprognostic (1.88e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.23e-7)"	"unprognostic (7.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.95e-2)"	1.4	8.1	20.6	1.4	46.7	1.2	2.0	60.1	81.9	1.2	1.4	4.0	0.7	1.7	1.3	18.8	2.0	1.8	1.2	39.2	36.5	18.0	1.7	3.5	1.2	1.8	10.3	21.3	1.1	3.3	5.6	9.9	1.1	13.4	3.0	1.4	2.7	1.8	2.2	70.7	1.8	1.6	1.2	4.1	1.3	2.4	2.3	4.8	0.0	7.7	2.4	2.0	1.1	0.0	1.3	1.0	3.2	1.2	3.2	1.2	0.8	0.0	0.3	0.2	0.3	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.8	0.2	0.1	0.2	0.7	0.0	1.0	2.4	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	5.2	0.0	0.2	0.1	2.3	0.1	0.9	0.1	0.0	0.0	41.0	2.2	0.2	0.0	0.0	1.9	0.1	0.2	0.2	0.3	0.2	0.0	0.5	0.4	0.1	0.1	0.0	0.2	3.2	0.7	1.0	0.8	0.9	1.2	1.1	1.0	0.5	0.5	1.3	1.2	1.1	2.0	3.2	1.2	1.0	0.9	0.8	20.6	46.7	60.1	42.4	36.5	18.0	10.3	21.3	13.4	4.8
CAMK2G	CAMKG	ENSG00000148660	"Calcium/calmodulin dependent protein kinase II gamma"	Q13555	10	73812501-73874591	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.0"	"Cell line enhanced"	"Detected in all"		"PC-3: 45.4;SK-BR-3: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"granulocytes: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040656, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		170000	170000	"Plasma membrane"	"Plasma membrane"	"HPA040656: , HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (8.63e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.62e-2)"	9.1	8.8	27.4	9.4	20.7	17.4	6.8	22.2	53.8	9.0	37.3	13.3	9.7	19.7	20.1	9.1	20.6	13.2	10.6	6.7	22.8	24.4	11.6	5.9	10.7	8.9	26.8	31.2	6.4	5.7	8.0	6.0	15.8	38.6	18.5	15.5	8.5	12.4	29.8	73.0	9.1	18.1	29.6	29.8	11.0	14.2	3.8	13.4	4.4	6.4	7.6	8.7	26.5	10.8	4.2	7.1	39.8	5.6	9.8	9.2	5.0	10.9	7.9	7.1	13.6	5.2	8.6	8.4	7.5	12.9	10.4	8.5	12.2	11.8	8.1	7.9	9.7	17.0	5.6	6.4	8.3	7.3	6.7	5.5	6.1	5.5	2.6	7.5	9.3	4.5	5.8	10.3	7.2	8.8	6.0	12.1	5.7	7.6	12.5	11.2	5.2	45.4	11.4	7.5	4.3	5.4	15.9	3.7	8.6	4.3	57.2	3.7	10.7	4.7	10.8	7.7	12.4	4.2	10.1	3.7	4.4	7.5	8.3	21.5	2.7	8.5	5.6	39.8	7.5	2.3	9.2	4.2	8.4	8.0	7.1	3.9	8.1	7.9	36.4	9.8	4.0	2.4	8.1	5.0	27.4	20.7	22.2	53.8	22.8	24.4	26.8	31.2	38.6	13.4
CAPN3	"CANP3, LGMD2, LGMD2A, nCL-1, p94"	ENSG00000092529	"Calpain 3"	P20807	15	42359500-42412318	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.6;skeletal muscle: 210.9"	"Cell line enriched"	"Detected in some"	23	"SK-MEL-30: 75.1"	"Cancer enriched"	"Detected in some"	10	"melanoma: 9.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040052	Enhanced									"HPA040052: AB_2676821"	"unprognostic (1.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.00e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.11e-4)"	"unprognostic (3.12e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.37e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.91e-4)"	"unprognostic (5.56e-3)"	"unprognostic (2.43e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.38e-1)"	5.7	1.8	13.0	2.3	32.1	16.7	3.8	3.1	22.9	2.1	2.4	65.6	0.0	2.2	3.1	47.0	4.2	2.5	3.0	3.6	19.9	11.5	22.1	6.3	6.7	3.4	50.7	19.5	3.1	1.4	3.4	1.7	2.0	39.0	3.0	3.2	5.0	3.1	3.1	210.9	19.7	2.3	2.8	52.6	3.3	2.1	4.1	47.3	0.0	1.6	27.6	3.0	2.7	2.3	1.5	1.7	0.9	2.6	1.3	3.2	1.4	0.1	0.2	0.2	0.3	3.2	3.1	0.3	1.2	0.7	0.1	0.2	0.3	0.2	0.0	0.4	0.6	1.8	0.1	1.3	0.1	0.3	0.3	0.2	0.4	1.0	0.1	0.5	0.6	2.1	1.9	0.2	0.5	0.0	0.0	0.9	0.1	0.0	0.0	0.5	0.1	0.2	0.5	0.0	0.7	0.8	0.5	0.0	0.0	0.0	0.1	75.1	0.0	1.7	0.3	0.0	0.1	1.6	0.2	0.4	0.7	0.0	0.2	0.9	0.7	0.0	2.6	0.0	2.8	0.6	2.8	0.4	0.3	1.0	1.7	1.5	0.2	3.2	0.9	1.3	0.2	1.6	1.3	1.4	13.0	32.1	3.1	22.9	19.9	11.5	50.7	19.5	39.0	47.3
CARM1	PRMT4	ENSG00000142453	"Coactivator associated arginine methyltransferase 1"	Q86X55	19	10871513-10923070	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 64.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032961, HPA043561, HPA048073"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"CAB032961: AB_2068446, HPA043561: AB_2678554, HPA048073: "	"unprognostic (9.46e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.76e-2)"	"unprognostic (7.81e-2)"	"unprognostic (6.18e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.25e-2)"	"prognostic unfavourable (7.88e-6)"	"unprognostic (1.71e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (8.37e-4)"	12.2	8.8	12.3	12.6	16.1	13.2	9.6	12.5	17.7	15.8	14.0	9.3	9.0	11.5	19.6	9.1	20.5	14.8	12.4	14.7	11.2	7.2	9.3	14.5	8.9	12.4	7.8	10.2	13.0	16.9	8.2	6.9	15.3	9.5	12.6	10.2	12.0	11.4	13.2	64.3	12.5	12.0	15.6	6.6	9.8	11.1	17.5	8.6	9.4	10.0	12.7	15.6	15.8	15.9	1.3	1.6	0.3	1.4	0.1	2.6	0.4	22.4	16.7	24.1	32.6	20.1	27.5	23.1	16.2	28.1	24.1	23.2	25.8	8.3	31.0	19.4	28.2	21.5	24.5	24.3	15.2	34.7	20.0	9.5	10.9	31.3	17.2	14.3	12.4	18.8	15.9	16.4	19.8	30.4	22.8	27.9	14.1	40.7	24.9	12.3	29.7	27.9	34.9	12.3	36.0	14.5	11.7	17.5	16.8	11.6	14.0	15.6	14.0	12.3	18.2	29.0	16.4	27.5	18.9	27.2	21.4	27.1	19.1	23.0	12.6	0.0	1.4	0.2	1.2	1.4	0.5	1.3	0.9	2.6	1.3	1.3	1.0	0.9	0.3	0.1	0.7	1.6	0.8	0.4	12.3	16.1	12.5	17.7	11.2	7.2	7.8	10.2	9.5	8.6
CASQ2	PDIB2	ENSG00000118729	"Calsequestrin 2"	O14958	1	115700007-115768781	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 172.4;skeletal muscle: 46.5;smooth muscle: 45.9"	"Cell line enriched"	"Detected in single"	20	"HSkMC: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.7"	"Region enriched"	"Detected in many"	5	"cerebellum: 48.4"	"Low region specificity"	"Detected in many"			"HPA027285, HPA055298"	Enhanced				"Intracellular and membrane"					"HPA027285: AB_1845933, HPA055298: AB_2682777"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavourable (2.30e-4)"	"unprognostic (1.03e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.83e-1)"	"prognostic unfavourable (2.25e-5)"	4.9	0.6	0.4	1.8	0.7	0.1	1.6	0.7	0.5	4.3	11.1	0.6	1.1	0.6	6.2	6.3	13.6	3.0	1.9	172.4	0.4	0.5	0.7	0.2	1.1	0.2	0.6	0.5	5.0	0.3	0.5	0.2	0.3	1.0	12.1	3.1	4.6	1.8	3.6	46.5	1.0	3.2	45.9	0.5	0.2	3.5	1.9	0.0	0.0	1.4	17.2	1.8	36.4	1.8	0.0	0.1	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.4	0.7	0.7	0.5	0.4	0.5	0.6	0.5	1.0	0.0
CAST		ENSG00000153113	Calpastatin	P20810	5	96525267-96779595	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 201.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009491, HPA036881, HPA036882"	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		18000000	18000000	"Endoplasmic reticulum, Cytosol"	"Endoplasmic reticulum, Cytosol"	"CAB009491: AB_2259755, HPA036881: AB_2675359, HPA036882: "	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.94e-2)"	"unprognostic (6.11e-3)"	"prognostic unfavourable (9.27e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (1.16e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (4.98e-4)"	38.3	20.7	10.4	25.0	16.3	22.1	32.0	8.7	21.7	38.0	44.6	10.5	18.6	25.6	24.8	25.9	87.4	19.5	25.5	98.5	11.9	10.6	27.2	38.2	29.5	21.1	14.3	12.5	26.9	14.8	22.3	25.3	52.6	24.8	30.0	34.5	12.7	38.7	23.2	201.9	40.7	56.3	36.2	18.7	21.7	22.2	21.2	15.6	10.1	25.6	51.2	34.1	42.2	57.0	24.5	32.7	12.4	48.0	18.3	26.6	27.2	47.9	39.6	6.7	17.5	40.6	75.7	23.7	34.2	48.4	27.4	35.7	9.7	29.3	6.9	32.4	46.3	81.7	12.7	46.5	33.2	44.6	12.0	8.9	41.9	11.6	31.2	5.8	15.5	34.2	43.1	39.3	64.1	30.6	7.5	22.4	33.3	15.1	2.8	0.2	5.2	14.7	2.7	22.7	11.8	54.4	20.3	28.4	6.8	34.9	19.2	22.3	11.7	6.3	40.6	37.4	15.9	24.9	34.5	7.5	20.0	3.2	42.4	3.1	10.3	2.5	48.0	7.0	26.6	29.0	25.2	24.5	23.9	26.5	32.7	22.7	12.2	16.3	12.4	18.3	32.2	9.0	24.2	27.2	10.4	16.3	8.7	21.7	11.9	10.6	14.3	12.5	24.8	15.6
CASTOR3	"DKFZp686B07267, GATS, STAG3OS"	ENSG00000239521	"CASTOR family member 3"	Q8NAP1	7	100200653-100272218	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 14.8;skeletal muscle: 20.4"	"Cell line enhanced"	"Detected in some"		"A549: 4.3;HMC-1: 3.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA043176	Uncertain									"HPA043176: AB_10794883"	"unprognostic (8.29e-2)"	"prognostic favourable (7.56e-7)"	"unprognostic (7.67e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.66e-3)"	"unprognostic (9.42e-2)"	"unprognostic (3.90e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.56e-3)"	"unprognostic (5.14e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.86e-2)"	1.8	1.6	3.8	1.3	8.2	4.4	1.5	10.0	10.2	1.8	1.4	14.8	0.0	1.2	2.1	1.2	1.5	1.7	2.1	1.7	4.5		1.4	1.2	1.5	1.8	6.5	5.6	2.6	1.7	1.2	2.6	1.3	10.4	1.6	1.3	0.6	1.9	2.1	20.4	1.4	2.1	1.5	5.3	1.4	1.2	1.5	7.4	2.6	1.5	2.5	1.4	1.2	0.0	0.8	0.0	1.8	0.3	0.6	1.6	0.1	0.5	4.3	1.6	0.0	0.3	0.0	2.5	0.0	0.3	0.3	0.4	1.6	0.3	0.2	2.0	0.3	0.5	0.1	0.7	0.0	2.8	0.5	0.1	0.4	1.1	0.2	0.0	3.5	0.0	0.9	0.3	0.0	0.9	0.1	0.5	0.0	0.3	2.5	0.2	0.3	1.3	0.9	0.3	0.0	0.7	0.0	2.6	3.0	0.5	0.0	0.0	0.0	0.0	1.2	0.1	0.6	0.0	0.0	1.8	1.9	0.9	0.1	0.1	0.3	0.0	0.0	1.6	1.6	0.3	0.5	0.8	0.3	0.1	0.0	0.0	0.9	0.6	1.8	0.6	0.1	0.0	0.0	0.1										
CCDC140	FLJ32447	ENSG00000163081	"Coiled-coil domain containing 140"	Q96MF4	2	222298147-222305217	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.6;salivary gland: 1.2;skeletal muscle: 3.1;skin 1: 1.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.2;BJ hTERT+ SV40 Large T+ RasG12V: 2.1;NB-4: 3.7;RH-30: 2.1;SK-MEL-30: 3.9;WM-115: 2.3"	"Cancer enriched"	"Detected in single"	9	"melanoma: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA042500, HPA048166"	Uncertain									"HPA042500: AB_2678028, HPA048166: AB_2680295"					"unprognostic (2.50e-2)"	"unprognostic (3.54e-1)"			"unprognostic (5.25e-2)"									0.3	0.0	0.0	0.0	0.0	0.4	0.2	1.5	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4		0.0	0.0	0.0	0.0	0.0		0.0	0.0		1.2	0.0	3.1	1.8	0.0	0.0	1.6	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	2.2	1.5	2.1	0.0	0.5	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.1	0.0	2.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CCDC195		ENSG00000283428	"Coiled-coil domain containing 195"	A0A1B0GUA6	2	224703764-224716365	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"kidney: 1.0;lymphoid tissue: 2.1;skeletal muscle: 1.8"	"Group enriched"	"Detected in some"	7	"Daudi: 6.8;RPMI-8226: 2.8"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																			0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			1.0	0.0	0.0	0.8			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.3	1.8	0.0	0.0	0.0		0.0	0.0	0.1			0.0		2.1	0.0		0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1										
CCDC39	"CILD14, DKFZp434A128, FAP59"	ENSG00000145075	"Coiled-coil domain containing 39"		3	180614008-180870933	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"skeletal muscle: 12.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.9;ASC TERT1: 2.6;HSkMC: 3.7;HUVEC TERT2: 1.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"																						"unprognostic (3.37e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.35e-4)"	"unprognostic (1.34e-1)"	"unprognostic (6.62e-2)"	"unprognostic (6.88e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.88e-4)"	"unprognostic (7.40e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.16e-4)"	7.9	0.5	0.4	1.0	0.4	1.5	2.6	0.4	0.4	10.7	2.2	0.0	0.7	0.1	5.2	4.8	1.1	1.0	2.2	2.3	0.4	0.4	0.4	0.8	1.1	0.3	0.4	0.0	7.5	0.5	0.0	1.1	0.3	0.2	2.0	0.3	4.7	1.6	0.1	12.4	0.8	0.6	6.0	0.4	4.5	0.6	8.3	0.0	0.0	0.6	1.8	0.0	2.4	0.9	0.5	0.1	1.1	0.8	0.1	0.7	0.0	0.0	0.0	0.0	0.2	1.9	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.4	3.7	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.8	0.4	0.7	0.1	0.6	0.4	0.6	0.2	0.0	0.5	0.4	0.5	1.1	0.1	0.1	0.1	0.1	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.2	0.0
CCDC43	FLJ31795	ENSG00000180329	"Coiled-coil domain containing 43"	Q96MW1	17	44673069-44689779	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 50.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA023391	Approved		Enhanced	Cytosol				Cytosol	Cytosol	"HPA023391: AB_1846146"	"unprognostic (6.05e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (3.42e-5)"	"prognostic unfavourable (1.33e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.14e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavourable (3.19e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.11e-1)"	10.4	10.4	14.3	8.5	15.6	13.8	10.0	14.9	14.7	7.9	9.3	9.8	7.2	9.1	8.2	9.0	10.7	7.6	6.1	16.3	13.8	10.4	11.2	7.5	7.5	9.6	11.9	9.2	7.3	9.4	12.3	5.8	14.2	14.4	9.8	12.0	6.9	8.9	7.6	50.6	8.8	8.8	8.6	14.4	9.8	8.5	7.3	9.6	10.9	10.8	17.1	10.9	9.1	7.8	11.5	17.5	10.7	17.9	15.8	14.7	10.0	12.2	14.7	14.0	12.3	9.6	14.2	25.7	18.7	11.1	18.4	18.2	19.8	13.2	21.4	14.6	15.1	9.7	22.9	21.6	26.9	26.1	26.7	19.2	24.2	29.1	17.1	26.7	14.4	12.7	22.0	19.1	26.1	17.8	20.2	14.9	18.6	15.2	26.0	19.1	14.4	18.9	17.0	35.1	18.5	18.8	8.0	14.1	13.9	13.7	11.0	18.9	28.2	18.2	15.3	22.9	16.9	13.6	24.8	15.2	19.2	24.8	16.7	15.6	16.3	10.5	16.0	10.7	12.9	17.9	11.9	9.3	12.2	14.3	17.5	11.5	12.0	13.0	3.3	15.8	11.7	12.4	14.7	10.0	14.3	15.6	14.9	14.7	13.8	10.4	11.9	9.2	14.4	9.6
CCDC85B	DIPA	ENSG00000175602	"Coiled-coil domain containing 85B"	Q15834	11	65890112-65891635	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 24.5"	"Cell line enhanced"	"Detected in many"		"PC-3: 34.7;WM-115: 80.0"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054415	Uncertain									"HPA054415: AB_2682481"	"unprognostic (4.58e-2)"	"unprognostic (1.64e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.43e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.87e-2)"	"unprognostic (5.33e-2)"	"prognostic unfavourable (3.78e-5)"	"unprognostic (4.44e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.87e-2)"	16.6	6.4	17.5	4.8	13.2	6.5	2.5	5.0	16.3	1.9	3.6			4.1	3.5	0.8	1.4	3.0	2.0	6.6	18.9	5.9	2.9	3.3	6.0	2.5	9.5		3.8	3.8	1.8	1.5	3.2		4.9	0.5		3.7	3.0	24.5	3.7	3.5	1.3	2.9	12.9	5.5	2.4			1.8		1.0	2.5	2.2	10.6	8.6	9.6	5.2	8.3	13.6	2.5	20.2	3.2	0.7	2.7	0.9	1.7	2.5	21.9	2.3	0.7	0.9	0.8	8.9	11.2	16.2	1.1	8.3	0.3	1.2	0.0	12.3	5.7	8.3	1.6	2.6	1.4	7.3	4.2	1.5	0.5	0.7	1.1	2.6	6.4	4.2	0.5	6.4	4.9	23.4	8.3	34.7	13.1	5.2	9.9	0.4	0.6	5.7	6.2	4.6	2.8	17.9	2.2	2.4	19.0	10.9	11.0	23.8	19.9	4.5	4.7	2.7	22.8	6.3	80.0	0.9	4.7	9.6	8.7	3.3	11.7	10.6	10.4	12.0	4.3	8.7	13.6	11.1	1.2	8.3	5.2	8.6	7.7	2.5										
CD99L2	"CD99B, MIC2L1"	ENSG00000102181	"CD99 molecule like 2"	Q8TCZ2	X	150766337-150898816	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 72.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038782, HPA038783, HPA061400"	Enhanced		Supported	"Plasma membrane"		790000	790000	"Plasma membrane"	"Plasma membrane"	"HPA038782: AB_10795139, HPA038783: AB_10794734, HPA061400: AB_2732660"	"unprognostic (2.10e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.12e-3)"	"unprognostic (6.03e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.66e-1)"	"unprognostic (5.56e-2)"	"prognostic favourable (4.96e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"prognostic favourable (2.74e-5)"	"unprognostic (5.50e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.74e-2)"	"unprognostic (9.23e-2)"	"prognostic unfavourable (8.74e-4)"	27.1	16.5	23.3	9.2	30.1	4.5	17.8	27.5	56.7	19.2	12.6	21.0	5.5	6.7	17.6	16.5	9.7	17.6	12.4	32.1	26.3	32.0	14.0	17.0	14.9	9.6	30.5	26.6	26.0	8.4	9.7	8.7	21.5	43.1	13.9	7.4	11.9	8.3	22.0	72.2	6.7	8.0	20.8	31.9	12.5	8.0	7.6	13.3	3.0	7.3	6.9	7.0	10.7	7.7	7.2	10.7	9.4	15.1	8.8	8.9	8.4	2.2	22.6	8.6	10.7	45.6	28.5	2.5	18.6	21.9	9.4	13.6	1.6	2.9	8.2	45.3	32.4	3.7	11.7	12.6	7.8	19.1	9.1	3.5	5.4	2.2	12.3	5.9	6.8	26.9	4.2	6.9	13.3	11.1	2.4	21.6	11.8	4.8	5.2	8.6	3.6	12.3	5.2	7.0	11.2	9.2	1.5	11.4	5.8	7.3	6.3	8.3	1.8	10.2	13.0	14.0	4.3	18.1	13.4	18.4	30.4	8.0	17.6	11.9	10.5	9.4	11.2	7.6	8.8	9.9	7.8	6.4	8.2	8.9	10.7	7.2	8.3	8.5	2.8	8.8	15.1	7.8	5.9	8.4	23.3	30.1	27.5	55.2	26.3	32.0	30.5	26.6	43.1	13.3
CDC37L1	"CDC37B, FLJ20639, HARC"	ENSG00000106993	"Cell division cycle 37 like 1"	Q7L3B6	9	4679559-4708398	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.8"	"Cell line enriched"	"Detected in all"	4	"HDLM-2: 52.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021175	Approved		Supported	Cytosol				Cytosol	Cytosol	"HPA021175: AB_10959752"	"unprognostic (1.18e-2)"	"unprognostic (8.52e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.66e-3)"	"unprognostic (2.71e-2)"	"unprognostic (9.89e-2)"	"unprognostic (7.82e-3)"	"unprognostic (2.78e-2)"	"unprognostic (7.97e-2)"	"prognostic favourable (2.66e-7)"	"unprognostic (8.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.28e-2)"	14.9	12.6	10.4	7.1	15.4	5.6	10.5	12.4	14.9	12.2	10.0	7.1	11.2	7.8	10.9	12.0	15.8	10.1	11.6	28.6	11.2	12.6	13.4	42.0	8.4	9.0	10.0	9.9	12.4	15.1	9.3	13.7	7.5	17.3	13.0	6.5	6.2	9.4	11.1	58.8	8.1	8.0	17.9	8.8	6.3	9.5	10.8	8.9	7.0	12.2	14.0	7.2	18.0	16.1	10.7	6.2	14.8	6.8	8.1	20.7	7.9	7.1	6.4	3.4	5.5	12.4	9.2	5.2	8.4	5.8	5.1	5.8	2.0	4.4	4.5	2.3	6.1	3.1	3.8	5.0	5.0	52.8	3.2	12.0	7.0	5.5	7.5	4.8	4.9	5.9	6.7	3.8	6.0	3.6	1.4	7.0	5.6	3.4	3.7	10.0	8.7	2.3	3.0	4.2	2.6	7.3	2.9	9.8	4.9	6.2	5.0	4.1	4.2	4.6	3.9	7.7	3.6	4.3	5.5	5.4	8.6	3.3	6.9	3.4	2.4	14.8	5.7	11.0	13.3	5.3	13.1	10.7	13.4	14.0	5.4	10.5	20.7	18.5	6.8	8.1	6.8	6.2	12.1	7.9	10.4	15.4	12.4	14.9	11.2	12.6	10.0	9.9	17.3	8.9
CDH4		ENSG00000179242	"Cadherin 4"	P55283	20	61252426-61940617	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.4;lymphoid tissue: 10.2;skeletal muscle: 9.8"	"Cell line enhanced"	"Detected in some"		"AF22: 7.9;hTERT-HME1: 10.4;U-2 OS: 14.2;U-251 MG: 24.7"	"Group enriched"	"Detected in many"	6	"glioma: 6.9;renal cancer: 3.4;thyroid cancer: 2.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.4"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015613			Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA015613: AB_2732414"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.39e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.72e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.78e-2)"	1.0	1.2	17.4	0.7	15.8	0.9	0.9	1.3	13.6	0.9	0.7	4.0	0.0	0.8	0.9	0.7	1.4	2.6	0.9	1.0	10.2	6.9	0.8	0.9	1.0	0.9	2.8	11.8	6.2	2.0	0.7	0.5	0.9	3.3	0.8	0.7	0.6	1.5	3.6	9.8	2.7	0.8	0.7	1.6	10.2	0.8	1.9	3.1	0.0	1.7	0.0	0.7	0.8	0.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.9	7.9	0.0	0.1	0.5	0.1	2.2	0.0	4.0	0.4	0.2	0.0	0.0	0.2	2.6	2.9	0.0	4.3	1.6	0.2	0.0	0.0	0.1	0.1	5.5	0.0	0.1	0.8	1.0	0.8	10.4	0.8	0.0	0.0	1.6	0.3	0.1	0.0	0.9	0.0	0.0	0.0	1.1	2.5	0.0	0.7	1.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	14.2	0.1	24.7	4.6	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.4	0.0	17.4	15.8	1.3	13.6	10.2	6.9	2.8	11.8	3.3	3.1
CDK16	"FLJ16665, PCTAIRE, PCTAIRE1, PCTGAIRE, PCTK1"	ENSG00000102225	"Cyclin dependent kinase 16"	Q00536	X	47217860-47229997	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 91.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000974, HPA001366, CAB016535"	Approved		Uncertain	"Plasma membrane,Microtubules,Cytosol"				"Plasma membrane, Microtubules, Cytosol"	"Plasma membrane, Microtubules, Cytosol"	"CAB016535: AB_785112, HPA000974: AB_2666162, HPA001366: AB_1079584"	"unprognostic (2.37e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.16e-3)"	"unprognostic (8.80e-2)"	"unprognostic (2.92e-2)"	"prognostic unfavourable (2.02e-6)"	"unprognostic (2.85e-1)"	"unprognostic (5.59e-2)"	"unprognostic (7.62e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.89e-3)"	"unprognostic (2.55e-1)"	22.0	20.1	32.3	13.9	25.0	26.6	17.6	51.5	49.0	17.2	19.3	15.5	17.0	16.4	14.8	12.8	23.8	18.8	14.1	47.3	29.2	18.0	19.9	12.7	14.0	10.8	22.0	21.1	16.7	18.6	22.8	14.9	18.6	28.5	12.7	14.7	13.7	20.1	16.1	91.2	17.0	15.3	18.2	14.8	12.0	14.7	28.7	12.1	10.4	20.9	36.3	12.6	12.9	12.1	8.5	13.5	8.5	10.7	6.3	7.7	5.7	41.2	31.7	30.4	44.9	22.3	19.2	30.4	19.6	24.2	29.9	22.3	35.6	20.0	9.9	12.5	35.2	23.4	32.3	41.8	20.2	11.9	51.3	10.8	44.5	27.7	29.0	11.3	25.2	23.9	26.8	42.4	51.2	26.7	16.0	16.9	26.1	35.9	9.8	26.0	23.8	34.2	10.5	24.1	17.4	22.5	32.7	25.7	19.4	53.3	41.3	20.2	36.8	13.9	26.8	20.0	32.8	30.5	23.4	13.3	13.0	9.7	17.6	52.7	22.4	3.1	8.8	8.5	4.8	10.7	6.2	3.8	6.2	7.7	11.6	8.5	5.6	5.8	4.2	6.3	9.6	13.5	6.0	5.7	32.3	25.0	51.5	49.0	29.2	18.0	22.0	21.1	28.5	12.1
CDNF	ARMETL1	ENSG00000185267	"Cerebral dopamine neurotrophic factor"	Q49AH0	10	14819250-14838575	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 30.8"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 15.3;U-266/70: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044587	Uncertain				"Secreted in other tissues"					"HPA044587: AB_10795881"	"unprognostic (2.80e-3)"	"unprognostic (2.51e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.66e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.62e-1)"	3.8	3.3	2.1	4.1	2.4	0.5	3.5	1.9	2.4	3.5	2.2	3.2	5.6	2.1	2.3	10.0	1.9	4.5	2.3	3.7	2.3	2.2	3.8	9.4	1.4	2.8	2.8	3.8	3.2	7.7	5.1	3.5	1.7	3.8	3.4	1.3	4.7	8.8	4.5	30.8	5.0	1.8	1.2	3.1	1.6	2.8	10.0	2.5	2.0	4.4	16.1	2.7	3.0	1.9	1.4	1.9	0.3	0.5	2.7	5.4	0.9	0.5	0.6	1.7	0.8	3.2	2.7	0.3	1.6	2.8	0.9	0.8	1.3	1.4	5.0	1.1	0.7	0.7	0.0	0.1	1.0	0.4	1.4	0.8	0.7	0.4	2.2	0.4	0.2	2.1	1.4	0.3	1.6	1.0	1.8	3.9	1.8	1.2	0.8	0.9	1.1	0.6	0.8	1.3	15.3	0.5	0.1	1.6	2.1	0.4	1.2	2.0	2.4	0.4	0.9	0.5	0.6	2.2	0.2	7.5	2.5	0.8	1.0	0.3	0.1	0.1	0.4	0.3	1.4	0.5	0.6	1.4	1.2	1.9	1.1	1.3	4.9	2.6	0.2	2.7	0.5	1.9	5.4	0.9	2.1	2.4	1.9	2.4	2.3	2.2	2.8	3.8	3.8	2.5
CEBPB	"C/EBP-beta, CRP2, IL6DBP, LAP, NFIL6, TCF5"	ENSG00000172216	"CCAAT/enhancer binding protein beta"	P17676	20	50190734-50192689	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 121.9"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 45.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 13.6;monocytes: 6.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB004213, HPA061355, HPA062267"	Supported		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB004213: AB_626772, HPA061355: AB_2684487, HPA062267: "	"unprognostic (2.30e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.85e-3)"	"unprognostic (9.26e-3)"	"unprognostic (6.55e-2)"	"prognostic unfavourable (2.44e-12)"	"unprognostic (7.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-2)"	"unprognostic (7.63e-2)"	56.9	54.7	7.0	35.9	9.9	21.1	34.4	1.8	6.2	22.8	25.2	6.4	8.0	8.0	19.4	11.2	19.2	21.7	20.2	33.6	8.4	4.4	15.3	92.5	51.3	20.4	9.5	3.0	33.6	18.6	4.1	7.4	75.1	7.7	21.1	5.0	14.0	14.6	11.7	121.9	23.9	19.4	12.6	9.5	40.3	15.3	14.3	8.1	1.5	46.1	25.3	10.7	30.8	30.6	0.4	1.2	13.6	6.1	0.4	0.5	0.5	7.5	3.4	0.3	4.1	19.5	7.7	34.0	10.3	16.2	7.1	6.3	3.4	7.0	4.9	19.7	4.2	10.4	1.1	10.0	4.8	3.6	2.5	1.5	4.5	5.0	24.1	2.4	9.9	8.2	26.6	9.0	16.0	0.9	7.2	9.3	4.4	2.8	1.1	5.4	2.2	10.0	3.5	1.0	5.6	2.3	1.8	2.0	1.3	8.5	21.1	45.6	5.6	14.0	1.3	14.8	11.2	12.6	9.9	19.7	8.1	4.4	27.0	5.7	6.4	5.9	3.0	9.1	0.4	5.3	0.1	0.4	0.4	0.5	1.2	0.3	0.3	0.2	13.6	0.4	6.1	0.0	0.2	0.5	7.0	9.9	1.8	6.2	8.4	4.4	9.5	3.0	7.7	8.1
CECR2	KIAA1740	ENSG00000099954	"CECR2, histone acetyl-lysine reader"	Q9BXF3	22	17359949-17558149	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.1;skeletal muscle: 30.6"	"Cell line enhanced"	"Detected in some"		"AF22: 12.6;HAP1: 11.6;HEK 293: 5.8;K-562: 6.4;NTERA-2: 18.5;SCLC-21H: 8.3"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 8.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA002943	Approved		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA002943: AB_1078496"	"unprognostic (2.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.92e-3)"	"unprognostic (7.48e-3)"	"unprognostic (2.46e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.94e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.13e-6)"	"unprognostic (1.13e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.94e-2)"	1.8	1.3	4.6	1.0	8.8	1.5	2.0	25.1	8.4	1.1	1.2	10.6	0.8	1.0	4.3	1.7	1.4	2.5	1.0	4.4	6.1	2.8	1.9	6.5	4.1	0.9	8.0	4.0	5.4	5.6	0.8	8.4	4.7	5.8	2.3	1.1	4.9	1.9	1.1	30.6	1.6	1.2	2.2	5.7	1.4	1.1	6.0	8.0	0.0	2.7	2.2	0.9	2.3	2.5	0.2	0.1	0.9	0.8	0.5	0.1	0.0	0.1	0.0	12.6	4.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	11.6	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.4	0.0	0.0	0.1	0.0	0.4	18.5	0.0	1.4	0.8	0.0	0.0	4.0	8.3	0.0	0.0	0.1	0.7	1.3	1.9	0.1	0.1	2.8	0.0	0.0	4.7	1.1	1.0	0.0	0.0	0.1	0.3	0.8	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.9	0.5	0.1	0.0	0.0	0.0	4.6	8.8	25.1	5.0	6.1	2.8	8.0	4.0	5.8	8.0
CEP85	"CCDC21, DKFZP434L0117"	ENSG00000130695	"Centrosomal protein 85"	Q6P2H3	1	26234153-26279038	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 15.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028252	Approved		Supported	"Nucleoli,Golgi apparatus,Centrosome,Cytosol"				Nucleoli	Nucleoli	"HPA028252: AB_1846142"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.30e-3)"	"prognostic unfavourable (4.39e-6)"	"unprognostic (3.72e-2)"	"unprognostic (5.30e-2)"	"unprognostic (8.24e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.33e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.60e-2)"	2.1	2.7	4.8	3.8	11.0	12.4	3.1	7.7	8.8	2.4	3.7	15.5	4.6	3.5	2.6	3.3	5.6	2.7	2.6	19.4	5.5	4.0	3.8	3.7	3.2	5.3	20.4	4.9	2.4	3.3	4.4	4.7	3.6	7.8	3.0	4.5	4.0	3.5	2.5	87.8	8.4	3.3	2.9	10.4	4.3	3.7	26.8	13.5	12.1	5.4	5.5	6.6	3.0	3.8	2.4	3.8	15.6	5.0	2.1	3.4	2.8	13.4	6.7	10.8	11.4	3.0	2.8	21.1	6.8	3.2	9.5	10.1	8.6	12.6	12.8	9.3	2.8	11.9	12.0	5.7	9.5	9.4	10.4	18.1	13.1	9.0	3.1	16.5	20.0	1.4	5.6	7.9	5.8	4.2	24.3	17.9	6.9	4.8	15.8	20.0	10.4	11.1	16.1	12.5	11.9	4.7	2.0	18.3	8.4	9.6	8.0	8.0	7.3	11.8	4.9	7.7	12.9	9.0	10.5	14.1	20.6	16.0	4.8	29.1	14.6	3.4	4.6	15.6	3.0	4.4	2.5	2.4	2.0	2.3	3.8	1.3	1.8	3.4	0.5	2.1	5.0	1.3	3.2	2.8	4.8	11.0	7.7	8.8	5.5	4.0	20.4	4.9	7.8	13.5
CFAP46	"bA288G11.4, bA288G11.5, bB137A17.2, bB137A17.3, C10orf123, C10orf124, C10orf92, C10orf93, DKFZp434A1721, FLJ25954, TTC40"	ENSG00000171811	"Cilia and flagella associated protein 46"	Q8IYW2	10	132808392-132942823	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 32.8;testis: 35.5"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.0;CAPAN-2: 2.5;HAP1: 3.3;RPTEC TERT1: 3.0;SH-SY5Y: 3.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 2.7"	"Lineage enhanced"	"Detected in single"		"monocytes: 2.7"					"Low region specificity"	"Detected in all"			"HPA037786, HPA038034, HPA038867, HPA038868"	Uncertain									"HPA037786: AB_10672392, HPA038034: AB_2675796, HPA038867: , HPA038868: AB_2676247"	"unprognostic (2.83e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.11e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.64e-4)"	"unprognostic (1.21e-2)"	"unprognostic (8.08e-2)"	"unprognostic (4.56e-3)"	"unprognostic (2.08e-2)"	0.4	0.7	3.4	0.4	6.7	0.4	0.6	0.7	4.6	1.1	0.4	6.8	2.7	0.6	0.6	9.9	0.7	8.7	0.6	0.8	5.3	3.9	2.4	0.6	2.1	0.4	2.7	3.8	2.3	0.9	1.5	4.2	0.4	9.0	0.5	0.4	1.5	0.6	1.0	32.8	0.5	0.6	0.4	0.9	0.5	3.1	35.5	2.0	0.0	3.5	0.0	0.4	0.4	0.2	0.0	0.0	0.0	2.7	0.7	0.0	0.0	0.0	0.1	0.6	2.0	0.0	0.0	0.0	0.9	0.0	0.6	0.1	0.0	2.5	0.0	0.2	0.1	0.8	3.3	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	1.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.7	0.0	0.0	0.0	3.4	6.7	0.7	4.6	5.3	3.9	2.7	3.8	9.0	2.0
CFAP61	"C20orf26, CaM-IP3, dJ1002M8.3, DKFZP434K156"	ENSG00000089101	"Cilia and flagella associated protein 61"	Q8NHU2	20	20052514-20360702	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.1;heart muscle: 14.8;pituitary gland: 15.0;skeletal muscle: 23.9;testis: 25.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.2;HMC-1: 4.1;SCLC-21H: 9.5;SK-MEL-30: 3.7;U-87 MG: 7.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdTCR: 2.3;plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA009079	Approved									"HPA009079: AB_1078344"	"unprognostic (5.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.20e-3)"	"unprognostic (3.67e-3)"	"unprognostic (8.58e-4)"	"unprognostic (8.24e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.76e-4)"	"unprognostic (2.77e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.06e-1)"	0.2	1.2	1.0	0.2	9.5	0.1	0.5	0.6	2.6	0.9	0.2	5.3	0.8	0.1	1.1	4.5	0.2	15.1	0.3	14.8	4.0	1.9	1.1	0.2	3.5	0.2	0.9	2.0	3.3	0.5	1.0	15.0	0.2	11.4	0.5	0.2	0.1	0.3	0.4	23.9	0.5	0.3	0.3	0.7	0.2	0.3	25.5	1.1	0.0	1.1	0.0	0.2	0.2	0.2	0.0	1.5	0.0	0.0	0.6	2.3	0.0	0.4	1.3	0.2	0.5	0.0	0.0	0.5	0.1	0.4	0.0	0.4	0.0	0.7	4.2	0.1	0.0	0.1	0.2	0.0	0.1	1.1	1.5	0.0	0.4	0.0	0.0	0.0	4.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.3	0.3	0.0	0.3	2.1	0.7	0.0	9.5	0.2	0.2	0.4	3.7	0.7	0.0	0.7	0.0	0.4	0.6	0.3	1.4	0.4	0.0	7.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.6	0.0	1.5	0.0	0.0	1.0	9.5	0.6	2.6	4.0	1.9	0.9	2.0	11.4	1.1
CFL2	NEM7	ENSG00000165410	"Cofilin 2"	Q9Y281	14	34706769-34714823	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 88.5;skeletal muscle: 185.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037078, HPA045599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		90000000	90000000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB037078: AB_259128, HPA045599: AB_2679383"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.13e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (2.16e-5)"	14.0	16.5	15.9	8.8	17.7	5.0	6.7	13.6	16.6	13.7	23.2	25.8	9.2	4.7	21.3	10.2	20.7	11.2	7.2	88.5	19.0	14.5	8.7	33.0	7.8	3.7	22.7	10.6	12.9	3.0	9.3	4.5	10.3	28.9	22.4	8.6	7.8	5.4	31.8	185.9	2.6	6.7	38.1	24.6	4.2	11.9	6.9	20.1	0.5	9.0	30.8	3.4	34.7	9.3	8.5	2.9	3.6	1.8	3.2	5.8	1.6	17.6	15.9	10.2	6.6	10.4	39.0	5.8	30.8	35.5	29.5	31.5	11.9	7.6	6.3	12.6	49.1	3.5	21.8	6.5	52.0	0.8	9.0	1.3	18.8	28.2	17.0	1.6	1.0	29.5	2.3	25.1	13.9	29.2	1.9	5.0	36.2	5.0	1.2	0.8	3.3	24.4	1.1	32.5	0.9	10.7	3.6	2.1	8.8	20.1	4.3	10.4	9.6	1.5	25.6	29.4	19.6	13.8	14.7	7.0	4.5	2.4	10.8	2.3	6.9	3.6	1.8	2.1	3.7	1.8	5.8	8.5	4.3	4.0	2.9	5.0	3.4	3.5	0.7	3.2	0.8	2.8	3.6	1.6	15.9	17.7	13.6	16.6	19.0	14.5	22.7	10.6	28.9	20.1
CHAC1	MGC4504	ENSG00000128965	"ChaC glutathione specific gamma-glutamylcyclotransferase 1"	Q9BUX1	15	40952962-40956519	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 53.0;salivary gland: 39.9;skeletal muscle: 52.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 34.7;HHSteC: 26.5;hTCEpi: 42.0;SK-MEL-30: 29.6;U-266/70: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.8"	"Group enriched"	"Detected in many"	6	"B-cells: 1.8;monocytes: 1.1;T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042708, HPA043505"	Approved		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA042708: AB_2678125, HPA043505: AB_2678518"	"unprognostic (6.04e-3)"	"unprognostic (2.81e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.84e-3)"	"unprognostic (6.57e-3)"	"unprognostic (2.00e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (2.23e-7)"	"unprognostic (1.37e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.91e-2)"	6.0	1.0	2.6	1.5	2.1	1.7	1.0	1.7	5.6	1.1	1.9	0.3	1.1	1.9	1.1	1.8	18.6	1.5	5.7	2.2	2.6	4.8	3.1	14.1	1.5	1.1	2.6	2.2	11.3	53.0	0.9	1.3	1.1	6.2	1.5	1.1	0.2	39.9	1.3	52.4	1.3	1.5	1.1	5.3	1.1	11.2	0.9	1.0	0.0	1.7	4.7	4.6	2.7	2.7	1.8	0.1	0.2	1.1	0.0	1.3	0.2	2.8	1.9	0.5	8.7	1.4	1.0	3.5	16.8	34.7	1.8	5.0	4.6	0.7	0.8	1.3	1.5	1.8	3.8	1.3	1.3	3.2	0.7	0.7	0.5	0.0	26.5	2.2	0.0	11.8	42.0	5.5	7.6	1.7	2.3	4.0	1.5	1.6	1.6	0.0	1.6	6.5	1.4	0.0	3.8	0.9	1.0	1.7	2.5	0.5	3.0	29.6	1.1	15.9	0.5	0.3	5.2	0.4	3.0	26.0	5.5	3.3	1.6	3.1	3.9	0.0	0.4	0.0	1.3	0.4	0.0	1.8	0.2	0.8	0.1	0.0	0.0	1.0	0.2	0.0	1.1	0.0	0.0	0.2	2.6	2.1	1.7	5.6	2.6	4.8	2.6	2.2	6.2	1.0
CHAF1B	"CAF-1, CAF1, CAF1A, CAF1P60, MPHOSPH7, MPP7"	ENSG00000159259	"Chromatin assembly factor 1 subunit B"	Q13112	21	36385378-36419015	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 20.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021679, CAB033604"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB033604: AB_2229411, HPA021679: AB_1846621"	"unprognostic (2.28e-2)"	"prognostic favourable (5.44e-5)"	"prognostic favourable (7.92e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavourable (6.14e-6)"	"unprognostic (2.14e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.27e-2)"	"unprognostic (7.66e-6)"	"unprognostic (5.89e-2)"	"unprognostic (5.00e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.36e-1)"	2.4	1.4	2.8	3.7	5.9	9.3	4.1	7.2	9.4	2.4	3.0	2.0	1.2	2.8	3.9	2.8	4.4	2.3	1.6	2.9	2.0	2.7	1.7	1.4	2.1	4.5	1.8	4.1	2.7	6.9	3.1	2.1	2.1	3.8	2.9	3.6	4.6	5.2	1.6	20.7	4.4	3.1	2.4	1.5	2.5	2.1	6.2	0.2	12.3	1.7	3.6	7.3	1.8	2.6	2.8	1.3	3.7	0.8	4.4	5.1	1.7	14.7	8.9	15.3	8.7	1.1	3.1	8.4	10.5	6.0	13.0	13.7	10.1	7.9	11.6	4.7	5.4	4.9	15.7	6.9	10.6	11.7	12.3	18.0	9.6	7.1	0.8	11.4	8.8	1.9	1.7	12.1	5.3	6.1	15.6	10.9	6.6	10.3	17.7	6.7	10.7	6.5	26.1	8.3	6.6	4.5	7.3	9.3	7.7	16.0	12.3	5.7	9.6	7.8	3.7	10.6	5.3	9.4	12.1	8.0	14.8	13.6	6.7	12.6	13.4	3.1	0.8	1.0	3.7	0.4	3.3	2.6	2.9	2.8	0.7	2.8	1.9	3.0	3.7	4.4	0.7	1.3	5.1	1.7	2.8	5.9	7.2	9.4	2.0	2.7	1.8	4.1	3.8	0.2
CHCHD10	"C22orf16, N27C7-4"	ENSG00000250479	"Coiled-coil-helix-coiled-coil-helix domain containing 10"	Q8WYQ3	22	23765834-23768443	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 127.0;skeletal muscle: 226.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003440	Enhanced		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA003440: AB_1078348"	"unprognostic (3.88e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.90e-2)"	"unprognostic (9.80e-2)"	"unprognostic (7.68e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.13e-2)"	"prognostic favourable (2.15e-7)"	"unprognostic (5.19e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.68e-3)"	"unprognostic (2.62e-3)"	23.1	14.9	25.8	16.4	33.9	5.7	20.0	11.8	31.0	17.3	39.4	9.6	18.3	30.6	6.1	15.5	20.2	7.6	11.3	127.0	23.7	23.5	40.4	86.1	8.3	16.9	25.8	18.4	4.8	24.3	36.4	12.7	11.7	14.5	11.7	31.6	24.3	33.7	22.2	226.6	7.2	30.2	12.8	12.2	13.0	17.3	4.1	9.6	3.0	27.8	73.1	15.8	13.8	9.3	9.4	7.3	7.6	7.8	0.8	5.0	1.0	6.0	16.4	5.1	21.2	11.2	7.1	8.2	2.1	5.8	6.0	7.0	30.6	8.2	18.5	5.7	10.4	19.5	27.8	8.7	5.5	6.0	30.3	4.7	13.0	28.9	19.1	13.6	22.0	13.8	23.1	9.1	2.4	7.3	8.4	11.9	5.4	30.5	4.3	8.6	3.7	41.6	16.0	0.8	42.6	28.4	13.7	9.0	4.8	2.9	36.5	28.0	13.0	10.7	3.2	0.2	0.2	3.7	0.0	4.7	2.0	12.8	5.0	11.4	2.7	0.2	3.9	7.6	2.8	7.8	1.9	9.4	3.2	4.0	1.7	7.8	5.0	3.6	0.1	0.8	6.9	7.3	3.7	1.0	25.8	33.9	11.8	31.0	23.7	23.5	25.8	18.4	14.5	9.6
CHCHD3	"FLJ20420, Mic19, MINOS3, PPP1R22"	ENSG00000106554	"Coiled-coil-helix-coiled-coil-helix domain containing 3"	Q9NX63	7	132784868-133082088	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 109.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042935	Enhanced		Supported	Mitochondria		110000	110000	Mitochondria	Mitochondria	"HPA042935: AB_10794538"	"unprognostic (1.53e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.00e-3)"	"unprognostic (5.69e-2)"	"unprognostic (4.75e-3)"	"prognostic unfavourable (3.25e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.04e-1)"	"prognostic favourable (1.15e-4)"	"unprognostic (4.98e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.03e-2)"	15.2	15.8	9.9	13.4	11.6	15.4	13.7	10.1	14.2	10.5	17.3	9.8	7.9	19.9	13.2	9.7	10.5	9.7	10.4	42.6	9.5	8.9	23.2	17.9	11.7	10.6	10.4	8.0	11.6	9.8	13.9	17.0	10.7	10.9	10.5	18.3	11.5	10.6	11.1	109.1	9.0	20.5	13.9	9.7	12.2	13.9	6.4	10.8	19.7	14.6	30.1	13.2	12.9	13.6	19.0	28.2	15.4	29.9	21.2	19.9	15.3	23.8	24.5	25.0	34.4	18.1	16.6	14.8	23.5	22.3	26.7	29.7	28.8	26.6	19.9	9.3	14.8	16.8	28.9	20.2	37.8	25.9	27.3	20.5	25.3	16.7	35.8	45.9	15.3	15.0	13.9	36.6	38.4	18.7	43.6	18.3	24.8	31.5	66.8	40.4	40.9	28.4	33.3	36.5	28.4	26.1	19.9	31.8	39.8	19.5	15.3	44.3	12.9	27.5	15.4	25.7	11.0	40.2	42.0	17.6	22.5	50.1	40.4	39.4	35.9	14.9	21.8	15.4	16.1	29.9	15.3	19.0	14.7	15.5	28.2	11.7	13.0	14.5	3.1	21.2	24.1	24.6	19.9	15.3	9.9	11.6	10.1	14.2	9.5	8.9	10.4	8.0	10.9	10.8
CHRNB1	CHRNB	ENSG00000170175	"Cholinergic receptor nicotinic beta 1 subunit"	P11230	17	7445061-7457707	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.6;tongue: 33.9"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 18.1;RH-30: 37.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005822, CAB011200"	Approved									"CAB011200: AB_262151, HPA005822: AB_1079484"	"unprognostic (2.89e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.13e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.59e-1)"	4.5	11.5	5.7	1.9	5.1	6.1	3.7	2.3	4.4	3.4	2.0	4.5	3.7	2.3	2.4	5.5	3.6	2.9	1.6	5.0	4.8	3.9	3.9	5.5	2.4	2.6	6.0	3.5	2.9	18.2	8.3	2.5	5.8	4.0	2.6	2.1	4.5	4.5	2.6	81.6	4.0	2.2	2.6	5.1	3.1	2.0	1.2	4.4	4.5	6.0	33.9	3.2	2.4	2.5	7.8	8.2	15.2	11.1	12.3	11.7	7.1	0.8	1.1	2.0	2.4	3.2	2.2	4.5	0.6	2.0	3.0	2.5	0.7	1.1	3.2	2.2	1.2	7.1	0.7	13.0	1.1	3.9	2.5	1.8	1.2	4.1	1.4	1.1	4.6	4.8	3.6	1.8	5.8	2.0	2.3	1.8	18.1	0.5	3.4	2.1	1.4	0.6	2.2	37.6	8.0	8.1	0.7	0.3	5.9	1.2	2.2	2.4	2.1	1.5	1.9	1.3	3.5	0.9	2.5	4.3	4.7	0.9	1.1	2.5	1.1	10.6	6.6	15.2	9.9	7.2	7.7	7.8	11.0	10.0	8.2	7.6	9.0	11.7	2.2	12.3	11.1	6.3	8.9	7.1	5.7	5.1	2.3	4.1	4.8	3.9	6.0	3.5	4.0	4.4
CIPC	KIAA1737	ENSG00000198894	"CLOCK interacting pacemaker"	Q9C0C6	14	77098097-77117287	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 77.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"																						"unprognostic (3.93e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.20e-1)"	"prognostic favourable (1.77e-10)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.21e-1)"	8.9	7.3	20.8	5.9	20.7	3.1	11.4	29.0	24.2	12.8	14.1	27.9	9.9	7.5	10.7	10.0	15.5	21.2	6.7	26.1	21.6	17.5	10.4	10.9	7.9	5.8	22.2	14.9	7.1	7.1	15.8	9.4	6.6	20.5	18.3	14.1	10.6	13.3	18.2	77.7	8.6	7.9	11.8	21.6	6.3	7.1	8.0	23.4	3.4	14.4	13.1	7.1	11.4	8.8	11.4	7.2	7.7	6.7	7.6	5.8	4.2	6.1	8.2	17.4	11.6	7.1	5.6	10.7	4.1	6.4	7.3	6.7	6.6	13.2	15.1	3.9	6.5	9.3	16.2	6.2	10.1	7.8	4.4	10.1	6.3	6.1	6.7	5.5	7.4	6.5	12.4	7.2	4.5	8.5	8.7	6.1	5.5	13.3	13.1	6.7	7.3	7.1	13.1	7.6	9.1	7.5	10.4	24.8	9.2	7.3	12.0	9.6	18.7	5.6	10.2	4.9	10.4	6.8	5.0	5.4	3.8	7.3	9.2	4.7	10.1	5.8	5.8	2.1	3.7	6.7	5.8	11.4	5.2	3.9	7.2	9.4	5.6	3.9	7.7	7.6	4.8	2.7	5.3	4.2	20.8	20.7	29.0	22.4	21.6	17.5	22.2	14.9	20.5	23.4
CLCN4	"ClC-4, CLC4"	ENSG00000073464	"Chloride voltage-gated channel 4"	P51793	X	10156945-10237660	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.1;epididymis: 22.8;skeletal muscle: 34.6"	"Cell line enhanced"	"Detected in many"		"HEL: 16.7;SCLC-21H: 17.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 2.3;memory B-cell: 1.7;naive B-cell: 6.8;neutrophil: 4.4"	"Group enriched"	"Detected in many"	9	"B-cells: 6.8;granulocytes: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031313, HPA063637"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA031313: AB_10601358, HPA063637: AB_2685069"	"unprognostic (1.01e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.07e-2)"	"prognostic unfavourable (2.13e-5)"	"unprognostic (2.96e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.99e-2)"	"prognostic favourable (9.55e-4)"	"unprognostic (9.70e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	3.1	3.4	9.7	2.0	21.3	2.1	1.6	18.6	29.1	2.0	1.4	15.7	0.0	1.2	1.3	22.8	2.3	3.0	2.8	11.4	13.0	10.5	3.4	3.5	3.4	2.9	23.5	10.4	2.2	2.4	8.9	3.9	1.7	18.2	2.1	1.1	6.0	2.3	1.7	34.6	1.2	1.2	1.4	15.2	3.2	2.1	2.2	17.9	0.0	6.8	2.0	2.2	2.3	0.8	6.8	0.6	4.4	0.5	0.0	0.0	0.6	4.9	3.1	2.3	0.0	1.1	2.0	0.1	0.1	0.0	0.0	0.0	6.0	3.4	3.7	9.0	1.0	1.1	1.4	3.4	0.1	0.0	3.5	16.7	1.7	2.5	5.5	0.0	0.0	10.0	2.7	4.3	1.1	6.4	1.2	0.0	2.3	0.5	0.0	0.1	2.9	10.8	0.0	3.8	0.0	1.5	0.5	17.3	6.5	7.1	0.7	0.0	1.8	2.1	6.3	2.7	4.6	11.8	0.4	0.4	8.3	1.3	8.6	0.0	3.4	2.3	0.5	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.6	6.8	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.6	9.7	21.3	18.6	26.7	13.0	10.5	23.5	10.4	18.2	17.9
CLIC5	DFNB102	ENSG00000112782	"Chloride intracellular channel 5"	Q9NZA1	6	45880827-46080348	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 65.6;intestine: 46.2;skeletal muscle: 99.9"	"Group enriched"	"Detected in some"	8	"CAPAN-2: 13.3;EFO-21: 9.4;HDLM-2: 4.9;REH: 11.4;U-266/70: 12.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 8.8"	"Lineage enriched"	"Detected in single"	23	"T-cells: 8.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA074371			Supported	"Nuclear speckles,Plasma membrane"		1000000	1000000	"Plasma membrane"	"Plasma membrane"	"HPA074371: "	"unprognostic (4.95e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.73e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.46e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.65e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.01e-1)"	7.4	0.6	0.8	3.2	1.5	0.0	2.3	0.6	1.1	6.0	10.2	0.3	0.4	5.6	0.8	2.5	2.2	1.2	2.1	65.6	0.9	1.2	17.5	0.5	32.8	0.4	1.1	1.4	0.7	0.7	0.4	1.3	22.0	0.8	0.9	7.5	7.8	2.0	0.4	99.9	0.7	46.2	1.4	0.9	16.1	0.9	1.0	0.0	0.2	4.8	18.8	1.5	1.0	4.3	0.3	0.0	0.0	0.0	0.3	8.8	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	13.3	0.0	9.4	0.0	0.3	0.0	0.1	0.0	4.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.3	0.0	11.4	0.3	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	12.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	8.8	0.3	3.6	2.2	0.0	0.0	0.6	0.5	0.0	0.3	0.0	0.0	1.6	0.8	0.8	1.5	0.6	1.1	0.9	1.2	1.1	1.4	0.8	0.0
CLIP1	"CLIP, CLIP-170, CLIP170, CYLN1, RSN"	ENSG00000130779	"CAP-Gly domain containing linker protein 1"	P30622	12	122271432-122422632	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 96.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004399, HPA026678"	Approved		Supported	"Microtubule ends,Cytosol"		7700	7700	"Microtubule ends, Cytosol"	"Microtubule ends, Cytosol"	"CAB004399: AB_671001, HPA026678: AB_1846954"	"unprognostic (1.18e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.91e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.52e-3)"	14.4	12.6	9.8	9.1	10.9	6.4	11.7	44.5	11.5	11.6	19.5	4.3	13.9	5.7	14.3	10.1	24.8	7.5	7.7	11.8	9.3	7.5	10.0	15.2	10.0	5.8	6.5	9.5	6.3	9.1	37.8	10.9	36.5	8.7	13.2	7.1	6.7	11.8	15.1	96.5	16.8	9.1	31.1	7.2	5.9	9.6	6.1	6.9	3.7	24.1	25.9	10.1	22.2	16.6	5.3	5.4	18.2	10.6	3.9	7.2	3.7	15.3	19.4	12.0	12.1	10.3	15.9	20.9	21.9	20.9	14.9	9.3	9.0	7.6	6.9	14.8	28.4	19.7	7.6	9.0	16.9	28.9	5.5	2.3	12.9	9.5	20.5	7.9	12.7	10.5	31.0	17.1	25.9	14.9	8.6	4.7	14.9	8.9	4.9	2.8	4.5	17.2	4.6	9.3	3.4	13.4	17.6	4.6	2.9	47.0	11.5	19.2	9.9	4.7	28.8	11.3	12.2	26.5	14.3	5.3	4.1	4.1	19.4	4.0	7.8	3.6	6.5	5.2	7.2	10.6	5.4	5.3	6.7	6.5	5.4	3.6	5.0	3.7	18.2	3.9	8.6	3.5	5.8	3.7	9.8	10.9	44.5	11.5	9.3	7.5	6.5	9.5	8.7	6.9
CLTCL1	"CHC22, CLH22, CLTCL, CLTD"	ENSG00000070371	"Clathrin heavy chain like 1"	P53675	22	19179473-19291716	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 53.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 34.3;K-562: 16.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 3.3;neutrophil: 8.4"	"Group enriched"	"Detected in many"	15	"granulocytes: 8.4;monocytes: 3.3"									"HPA075327, HPA075795"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA075327: , HPA075795: AB_2686764"	"unprognostic (1.29e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.16e-3)"	"unprognostic (8.20e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.71e-4)"	"unprognostic (1.61e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.06e-1)"	2.9	3.3	1.1	0.9	2.0	9.7	1.6	3.4	1.8	1.3	1.0	3.7	1.2	0.4	2.3	3.1	2.2	1.4	0.9	5.6	1.3	1.7	1.0	1.7	1.2	0.6	2.7	1.4	1.4	0.9	2.1	14.9	1.1	4.1	1.8	0.8	4.2	1.5	1.1	53.0	2.1	0.9	2.4	3.6	0.9	1.0	17.2	1.2	1.3	2.7	10.4	0.7	1.2	1.3	0.2	0.3	8.4	3.3	0.0	0.3	0.6	2.2	2.3	1.5	2.5	5.8	3.2	0.7	1.6	1.7	2.3	3.4	0.8	0.7	0.9	0.2	3.6	0.8	2.4	4.5	1.8	0.1	2.4	0.1	2.2	2.7	2.9	3.2	34.3	13.7	3.7	4.1	5.8	1.4	16.0	0.9	5.2	1.8	0.4	11.4	2.0	1.9	1.2	13.1	0.0	1.7	0.9	3.7	0.6	3.4	2.1	0.2	4.6	13.8	0.4	4.0	8.6	2.2	2.6	1.8	4.2	0.4	2.4	8.8	0.8	0.0	3.3	0.3	0.1	0.7	0.0	0.0	0.1	0.3	0.3	0.2	0.3	0.0	8.4	0.0	0.0	0.1	0.0	0.6	1.1	2.0	3.4	1.8	1.3	1.7	2.7	1.4	4.1	1.2
CNTFR		ENSG00000122756	"Ciliary neurotrophic factor receptor"	P26992	9	34551432-34590140	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 44.7;skeletal muscle: 33.6"	"Group enriched"	"Detected in some"	6	"AF22: 46.8;SH-SY5Y: 22.4"	"Cancer enhanced"	"Detected in many"		"glioma: 22.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025310	Approved					36000000	36000000			"CAB025310: "	"unprognostic (1.39e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.70e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.72e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.99e-3)"	"unprognostic (7.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	44.7	9.4	17.0	2.2	27.9	0.7	17.3	30.6	28.7	11.1	5.8	8.2	1.1	3.4	2.6	2.9	3.9	5.6	5.7	10.1	18.6	11.7	1.9	6.5	2.2	1.5	15.5	9.8	4.5	2.4	0.8	2.5	4.8	12.0	5.3	2.5	7.5	9.0	7.6	33.6	4.4	6.0	1.8	6.3	16.1	3.0	4.9	10.9	0.2	3.2	3.8	1.0	1.4	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.8	0.0	6.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	22.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	27.9	30.6	22.0	18.6	11.7	15.5	9.8	12.0	10.9
COBL	KIAA0633	ENSG00000106078	"Cordon-bleu WH2 repeat protein"	O75128	7	51016212-51316818	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 68.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 15.9;HeLa: 28.3;RPMI-8226: 21.8;SK-BR-3: 12.7;U-266/84: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	46	"plasmacytoid DC: 4.6"	"Lineage enriched"	"Detected in single"	46	"dendritic cells: 4.6"	"Low region specificity"	"Detected in many"							"HPA019033, HPA019167"	Enhanced		Approved	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"HPA019033: AB_2083648, HPA019167: AB_1847070"	"unprognostic (8.09e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-3)"	"unprognostic (3.13e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.92e-2)"	"prognostic favourable (5.21e-12)"	"unprognostic (7.64e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.41e-3)"	1.8	1.3	27.5	1.8	26.1	0.7	9.5	12.5	23.8	3.9	11.6	27.9	2.2	11.6	2.0	4.4	9.5	12.7	5.8	32.8	27.7	14.5	8.3	12.3	8.8	0.7	23.8	13.8	2.6	11.4	24.7	5.2	3.4	10.8	9.4	7.3	2.8	26.9	3.7	68.7	10.7	20.7	2.2	25.0	0.8	7.4	2.5	16.8	0.0	5.5	12.2	3.1	1.0	2.3	0.0	4.6	0.0	0.0	0.0	0.0	0.0	5.8	4.3	0.0	0.1	0.0	0.0	15.9	0.0	0.0	0.0	0.0	10.4	9.4	0.0	0.4	0.0	10.9	6.0	0.0	0.0	0.0	4.6	0.0	28.3	2.2	0.0	0.0	0.0	0.8	1.4	0.0	0.0	0.0	3.0	0.1	0.0	3.6	0.0	0.0	4.2	3.6	0.0	0.2	21.8	8.5	0.0	5.7	0.1	2.0	12.7	1.8	9.1	0.0	0.0	0.0	5.2	0.1	0.4	0.0	16.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	27.5	26.1	12.5	19.0	27.7	14.5	23.8	13.8	10.8	16.8
COMP	"EDM1, EPD1, MED, PSACH, THBS5"	ENSG00000105664	"Cartilage oligomeric matrix protein"	P49747	19	18782773-18791314	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 39.1;skeletal muscle: 59.6"	"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 134.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA077555			Approved	"Golgi apparatus"	"Secreted to extracellular matrix"	1100000000	1100000000	"Golgi apparatus"	"Golgi apparatus"	"HPA077555: "	"unprognostic (1.26e-1)"	"unprognostic (7.22e-2)"	"prognostic unfavourable (9.08e-5)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (8.05e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.85e-1)"	"prognostic unfavourable (1.52e-6)"	"unprognostic (5.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.87e-2)"	"prognostic unfavourable (6.95e-4)"	39.1	0.2	0.0	1.0	0.0	0.0	4.1	1.8	0.2	2.7	2.0	0.1	2.5	0.0	3.0	24.2	4.7	0.4	16.2	21.6	0.2	0.0	4.5	0.4	2.9	2.7	0.0	0.6	0.9	3.3	0.1	0.1	8.2	0.2	8.7	0.0	0.1	6.0	7.4	59.6	31.8	0.3	13.0	0.2	0.1	0.9	11.5	0.0	0.3	8.9	27.6	0.9	10.8	11.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	134.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.2	0.0	0.0	0.6	0.2	0.0
COQ9	"C16orf49, DKFZP434K046"	ENSG00000088682	"Coenzyme Q9"	O75208	16	57447425-57461275	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 86.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040918	Supported									"HPA040918: AB_10794154"	"unprognostic (9.18e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.46e-1)"	"prognostic favourable (9.03e-11)"	"unprognostic (7.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.23e-2)"	8.8	19.3	11.5	7.8	12.4	3.7	9.3	11.2	13.8	7.9	17.9	9.4	14.7	17.6	7.2	9.9	16.6	9.5	11.3	46.1	9.5	8.8	28.8	29.1	5.8	6.4	9.7	8.6	6.9	12.6	23.6	8.9	8.1	8.8	10.4	14.5	12.2	17.7	14.5	86.0	9.4	23.7	22.1	6.9	5.3	13.6	8.9	8.5	5.4	11.8	31.1	9.4	16.3	8.4	13.6	23.3	14.7	24.1	15.2	18.7	14.1	11.8	24.3	6.6	16.5	13.2	10.2	7.9	11.5	9.0	16.3	9.1	14.7	15.5	14.4	22.3	10.1	25.5	19.0	20.2	10.3	7.7	16.4	9.9	16.6	22.6	14.7	12.7	16.3	17.0	26.4	13.0	25.2	18.1	19.1	6.6	9.8	16.9	10.5	9.1	10.9	32.0	21.3	21.7	37.1	25.4	13.3	20.8	21.0	39.1	37.7	19.1	21.7	14.1	12.4	11.9	14.6	12.8	14.5	16.0	9.8	17.2	16.5	18.3	13.5	11.5	19.3	14.7	13.9	24.1	14.4	13.6	12.0	12.2	23.3	12.0	13.0	18.7	6.0	15.2	23.5	14.5	16.8	14.1	11.5	12.4	11.2	13.8	9.5	8.8	9.7	8.6	8.8	8.5
COX10		ENSG00000006695	"COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor"	Q12887	17	14069496-14208677	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 34.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032005, HPA032006"	Supported		Supported	Nucleoli,Mitochondria,Cytosol				Mitochondria	Mitochondria	"HPA032005: AB_10603560, HPA032006: AB_10670554"	"unprognostic (6.17e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.40e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.46e-3)"	"unprognostic (6.46e-2)"	"prognostic favourable (4.32e-6)"	"prognostic favourable (8.73e-4)"	"unprognostic (8.82e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.71e-2)"	5.5	6.9	5.3	5.7	6.5	7.0	5.4	6.5	7.2	4.4	11.8	4.1	2.9	9.7	5.1	3.6	9.4	4.8	3.5	18.9	5.8	3.8	10.0	9.3	5.2	8.4	4.5	2.8	4.9	9.6	7.2	6.4	6.6	5.7	5.2	10.1	5.5	6.7	4.8	34.9	6.0	10.9	7.2	4.0	4.6	7.7	15.5	4.9	5.9	5.2	9.6	7.4	7.2	5.8	11.9	13.6	4.0	14.1	8.8	17.5	9.8	8.6	16.6	6.9	9.9	6.9	6.3	15.7	10.5	7.4	19.2	13.3	14.5	6.4	20.4	8.3	10.5	16.7	14.1	13.5	15.5	11.0	14.1	12.1	13.4	16.0	12.2	12.5	11.4	9.1	17.0	12.0	15.3	10.1	16.4	7.0	8.4	10.7	10.6	8.2	10.5	8.6	8.9	23.4	14.4	12.1	16.2	5.2	8.8	10.8	14.4	13.0	8.1	7.1	8.3	8.4	7.0	8.5	13.2	8.5	11.9	9.2	12.6	13.0	10.3	3.0	10.6	4.0	9.9	14.1	10.4	11.9	11.6	10.3	13.6	8.2	12.6	11.9	1.2	8.8	11.9	4.6	17.5	9.8	5.3	6.5	6.5	7.2	5.8	3.8	4.5	2.8	5.7	4.9
COX5A		ENSG00000178741	"Cytochrome c oxidase subunit 5A"	P20674	15	74919791-74938168	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 209.7;skeletal muscle: 222.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027526	Supported					5400000	5400000			"HPA027526: AB_10602802"	"unprognostic (7.32e-2)"	"prognostic favourable (2.15e-4)"	"unprognostic (4.06e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.79e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.62e-2)"	"prognostic favourable (6.06e-7)"	"unprognostic (9.78e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.81e-3)"	22.4	20.1	30.4	25.9	29.1	20.6	36.1	22.4	57.9	15.0	70.8	12.1	21.6	51.5	11.6	19.3	31.6	14.6	22.7	209.7	26.7	25.4	42.6	49.4	17.7	29.0	32.7	27.3	8.7	41.1	27.7	16.4	15.0	26.7	15.6	65.7	13.7	32.2	23.1	222.8	17.2	49.4	15.9	20.9	17.3	31.7	26.2	12.2	21.9	19.9	86.5	30.6	17.9	15.1	52.2	81.2	47.3	80.6	58.8	64.1	65.7	34.5	38.5	47.7	41.6	29.4	34.0	52.5	31.5	27.9	40.4	37.8	42.8	43.9	79.3	38.8	27.1	68.5	112.6	45.8	33.9	44.8	105.1	65.8	40.1	53.2	36.9	75.1	41.4	34.5	49.7	25.2	57.1	47.2	60.4	54.0	40.3	27.2	62.7	57.8	50.6	57.0	58.5	45.7	92.1	59.0	58.6	69.9	30.0	47.7	71.7	98.6	35.9	61.3	31.9	30.6	28.9	38.2	49.9	61.9	113.5	87.9	32.8	99.8	27.8	47.3	65.5	36.1	37.6	80.6	44.9	52.2	46.7	44.2	81.2	37.8	33.2	38.5	15.8	58.8	72.1	64.7	64.1	65.7	30.4	29.1	22.4	57.9	26.7	25.4	32.7	27.3	26.7	12.2
COX5B		ENSG00000135940	"Cytochrome c oxidase subunit 5B"	P10606	2	97646040-97648383	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 336.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA034517	Supported		Enhanced	Mitochondria		2200000	2200000	Mitochondria	Mitochondria	"HPA034517: AB_10603561"	"unprognostic (4.61e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.20e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (2.73e-4)"	39.8	25.3	54.5	20.8	46.1	27.6	23.9	22.6	46.4	19.5	58.6	16.0	27.6	44.5	13.1	22.3	31.9	19.4	24.0	160.6	39.9	36.0	44.8	52.5	13.8	16.1	48.1	32.5	17.7	24.6	19.9	17.5	18.1	39.0	21.5	31.5	14.3	36.5	29.2	336.2	18.9	38.6	19.9	30.8	17.9	40.4	13.4	23.0	14.2	25.8	65.4	15.3	19.4	16.7	85.1	111.2	115.8	122.5	48.1	83.6	145.2	19.5	22.9	14.1	23.4	16.7	15.2	61.0	25.2	14.1	16.7	18.7	63.1	20.5	33.0	54.2	16.1	29.9	16.3	25.3	7.6	25.7	69.2	44.4	25.3	75.3	32.1	42.2	32.6	28.1	22.4	16.1	12.6	14.3	32.6	14.6	12.9	48.4	26.6	61.1	27.8	120.1	26.1	24.3	49.4	22.5	30.1	28.1	30.0	24.5	29.6	47.3	15.7	44.1	26.0	15.3	26.1	24.5	16.2	38.1	36.0	25.2	27.8	36.2	15.8	96.9	122.5	99.8	54.7	114.1	52.6	85.1	66.3	57.1	111.2	68.8	64.5	57.5	115.8	48.1	95.9	75.8	83.6	145.2	54.5	46.1	22.6	46.4	39.9	36.0	48.1	32.5	39.0	23.0
COX6C		ENSG00000164919	"Cytochrome c oxidase subunit 6C"	P09669	8	99873200-99894062	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 232.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014295, CAB016244"	Enhanced		Enhanced	Mitochondria		53000	53000	Mitochondria	Mitochondria	"CAB016244: AB_2085703, HPA014295: AB_2668966"	"unprognostic (4.91e-2)"	"unprognostic (2.90e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.86e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.99e-3)"	20.5	43.1	66.1	21.6	56.2	44.4	23.3	28.5	63.8	18.7	46.0	14.3	29.4	113.7	38.8	64.1	31.6	27.4	23.5	113.0	54.8	46.9	38.7	66.8	18.2	23.2	58.8	36.7	32.7	26.5	12.1	24.0	30.7	38.8	23.3	38.1	20.6	32.4	30.1	232.1	31.2	55.8	38.7	40.4	23.7	35.1	29.6	23.5	17.9	19.5	80.6	17.8	31.0	21.3	45.9	62.3	55.7	50.6	37.2	73.5	48.0	16.7	6.7	7.9	32.2	18.0	13.1	13.2	5.5	5.2	3.8	4.3	6.8	35.9	40.7	41.6	8.5	22.3	4.5	45.6	6.3	7.3	11.4	84.4	8.1	19.8	11.7	38.9	26.1	12.1	60.7	3.1	7.0	5.6	5.9	73.1	6.3	16.0	40.4	35.8	15.1	15.6	46.9	2.6	39.8	57.2	89.2	24.5	14.9	3.8	83.6	40.8	58.9	24.9	4.8	28.6	37.2	30.2	7.8	18.2	14.6	24.1	40.2	15.8	25.3	55.7	29.3	22.1	40.1	42.3	41.8	45.9	61.0	42.5	43.8	41.7	73.5	65.7	3.5	37.2	50.6	62.3	56.9	48.0	66.1	56.2	28.5	63.8	54.8	46.9	58.8	36.7	38.8	23.5
COX7C		ENSG00000127184	"Cytochrome c oxidase subunit 7C"	P15954	5	86617904-86620962	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 298.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046647	Approved									"HPA046647: AB_2679736"	"unprognostic (1.45e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.70e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.21e-1)"	"prognostic favourable (1.23e-5)"	"unprognostic (4.56e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.46e-2)"	43.3	60.4	76.4	35.7	68.1	36.8	49.6	41.1	65.0	35.0	74.8	22.7	44.0	76.0	50.7	55.5	53.7	32.6	44.4	150.2	61.8	57.6	91.6	83.1	36.0	66.1	72.0	44.2	51.9	88.8	39.3	47.3	26.5	51.5	42.7	53.9	36.2	127.6	46.1	298.4	28.0	73.3	71.5	39.7	35.5	54.2	31.2	32.1	39.7	56.3	84.9	40.1	53.9	58.0	92.8	91.6	54.1	73.4	51.2	96.5	113.9	54.3	62.8	56.4	105.2	52.7	53.1	63.3	42.3	33.9	28.1	39.7	72.9	99.1	74.0	46.2	31.2	59.2	49.9	80.3	46.1	54.9	76.6	59.2	97.1	75.2	44.2	70.3	70.6	62.1	69.3	35.7	49.1	44.8	35.8	87.2	41.0	108.5	72.9	88.7	60.0	181.9	70.9	65.8	136.2	83.8	104.2	70.5	51.5	40.6	95.7	89.1	97.2	96.0	44.3	26.2	47.9	44.7	80.7	84.5	97.7	85.5	67.0	82.3	49.3	38.0	72.1	54.1	58.1	73.4	72.5	92.8	91.1	71.8	91.6	79.4	96.5	84.2	7.3	51.2	68.2	85.2	80.2	113.9	76.4	68.1	41.1	65.0	61.8	57.6	72.0	44.2	51.5	32.1
COX8A	"COX, COX8, COX8-2, COX8L, VIII, VIII-L"	ENSG00000176340	"Cytochrome c oxidase subunit 8A"	P10176	11	63974607-63976543	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 275.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA055942	Supported									"HPA055942: AB_2682979"	"unprognostic (6.93e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.70e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.46e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (2.51e-6)"	"unprognostic (2.70e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.44e-2)"	41.4	42.8	54.0	32.8	53.4	50.4	47.4	40.9	60.3	30.2	76.6	18.2	35.5	69.0	23.3	31.2	63.3	35.9	43.9	154.9	41.5	41.0	78.8	61.1	38.1	50.8	54.5	34.0	24.7	43.0	38.7	37.6	32.2	35.7	37.9	51.6	35.9	54.4	50.2	275.5	31.2	66.7	29.9	37.0	31.0	50.8	18.7	24.3	44.6	42.4	121.7	34.8	38.8	29.8	52.7	114.8	87.8	108.6	51.0	75.7	80.3	59.6	79.6	51.4	51.0	22.0	27.0	37.2	31.6	35.5	62.8	48.9	53.2	49.0	28.4	70.0	43.9	59.6	39.6	54.5	21.6	41.8	68.7	41.4	64.6	62.3	35.4	41.7	53.9	34.7	41.4	50.3	40.6	38.9	48.1	62.1	39.5	155.2	59.0	142.0	46.7	139.9	46.3	41.3	119.6	50.8	50.4	46.6	66.0	37.6	54.7	77.5	80.4	45.3	23.9	36.6	49.6	78.3	36.8	78.0	61.1	43.8	47.5	41.2	43.8	78.3	101.8	87.8	57.5	108.6	42.4	52.7	63.2	56.4	114.8	46.4	49.0	53.4	71.3	51.0	97.9	113.0	75.7	80.3	54.0	53.4	40.9	60.3	41.5	41.0	54.5	34.0	35.7	24.3
CPEB4	KIAA1673	ENSG00000113742	"Cytoplasmic polyadenylation element binding protein 4"	Q17RY0	5	173888280-173961976	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.1"	"Cell line enhanced"	"Detected in many"		"U-266/70: 38.3;U-266/84: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 9.6"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038394			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA038394: AB_10671226"	"unprognostic (2.12e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.99e-1)"	"unprognostic (8.80e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.58e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.37e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.84e-2)"	"prognostic favourable (4.99e-8)"	"unprognostic (2.66e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.83e-2)"	11.9	42.2	25.9	10.3	21.0	39.7	11.5	29.7	30.9	11.3	7.5	10.5	9.8	8.1	8.6	6.0	18.6	6.4	12.1	26.4	22.3	14.7	30.3	44.6	12.5	6.9	15.1	20.7	6.6	21.1	45.7	20.5	17.8	33.3	7.7	8.0	14.4	17.3	13.5	106.1	10.8	8.8	12.5	38.4	9.7	11.3	8.4	18.9	1.5	20.0	16.9	9.3	11.6	15.8	1.6	0.8	9.6	2.3	0.8	1.3	0.6	3.9	5.4	2.7	1.5	4.9	2.8	5.4	7.1	6.6	2.4	2.9	5.1	2.6	4.9	5.0	3.9	0.3	2.4	3.7	4.0	9.8	2.7	3.3	13.0	3.0	10.5	1.1	6.4	4.4	8.5	6.3	9.8	2.3	10.7	12.0	5.6	2.8	0.9	1.0	1.5	5.4	0.8	2.2	16.3	3.5	7.1	3.0	3.4	0.8	9.9	12.7	6.9	2.2	7.0	4.1	2.0	2.0	4.5	38.3	55.0	2.5	9.9	2.3	5.1	0.5	1.8	2.0	1.0	1.7	1.0	1.6	1.1	0.8	0.6	1.2	1.3	0.7	9.6	0.8	2.3	0.8	1.0	0.6	25.9	21.0	29.7	30.9	22.3	14.7	15.1	20.7	33.3	18.9
CPT1B	"CPT1-M, M-CPT1"	ENSG00000205560	"Carnitine palmitoyltransferase 1B"	Q92523	22	50568861-50578465	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 162.2;skeletal muscle: 59.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA029583	Approved									"HPA029583: AB_10600864"	"unprognostic (1.66e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.71e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-3)"	"unprognostic (8.89e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.10e-3)"	"unprognostic (9.76e-3)"	"unprognostic (7.37e-2)"	"unprognostic (4.98e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.43e-2)"	"unprognostic (3.15e-5)"	4.3	1.5	1.7	2.9	2.7	3.3	2.8	9.1	2.0	1.7	3.1	1.8	1.6	3.8	1.6	2.9	3.7	0.9	1.6	162.2	2.1	1.9	4.0	4.2	1.9	3.5	2.5	1.6	1.6	3.1	17.2	4.5	2.3	2.2	2.5	2.9	5.2	4.3	1.6	59.8	3.8	3.7	1.6	2.2	5.0	3.8	19.7	2.3	1.9	5.2	39.6	4.5	2.0	1.6	0.5	2.3	0.7	0.4	2.3	1.6	0.3	5.2	4.8	15.5	5.7	3.5	2.1	12.2	0.6	2.0	2.6	3.0	2.3	4.6	10.4	1.7	1.2	8.7	8.2	1.8	2.3	4.2	9.1	5.2	14.1	2.4	0.9	5.4	15.2	1.2	14.1	1.9	3.1	0.4	1.8	17.6	2.5	7.4	2.1	10.6	3.4	3.2	9.6	5.1	2.3	6.6	12.4	4.3	8.4	3.9	6.3	6.5	6.9	11.4	1.1	7.6	8.1	5.0	1.8	15.0	3.4	5.4	3.5	9.7	5.1	0.0	0.4	0.5	1.0	0.1	0.0	0.5	1.6	0.3	2.3	0.2	0.4	0.2	0.7	2.3	0.2	0.3	0.1	0.3	1.7	2.7	9.1	2.0	2.1	1.9	2.5	1.6	2.2	2.3
CRAT	CAT1	ENSG00000095321	"Carnitine O-acetyltransferase"	P43155	9	129094810-129111189	"Enzymes, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 98.6;testis: 71.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019230, HPA020260, HPA022815"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		13000	13000	"Nucleoplasm, Nuclear membrane"	"Nucleoplasm, Nuclear membrane"	"HPA019230: AB_1847212, HPA020260: AB_1847210, HPA022815: AB_2732427"	"unprognostic (5.13e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.99e-2)"	"prognostic favourable (2.36e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.03e-1)"	"prognostic favourable (0.00e+0)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.65e-2)"	11.6	13.4	8.4	4.6	9.2	5.9	10.7	7.5	15.9	8.3	15.4	8.6	6.2	24.3	6.5	9.5	9.4	5.4	10.0	17.3	7.7	7.9	12.9	50.0	4.2	3.1	8.3	9.1	7.3	33.1	16.8	3.2	7.9	9.3	10.5	4.4	8.1	14.7	7.9	98.6	7.0	22.8	8.3	5.2	4.6	8.1	71.7	4.4	2.4	8.0	20.2	4.4	9.3	6.8	2.6	11.3	6.0	11.3	6.0	10.0	8.1	0.1	18.3	6.4	13.2	12.0	16.1	9.4	7.8	8.7	9.5	6.0	3.8	7.4	0.7	4.7	13.1	3.3	1.7	2.8	3.4	11.8	0.4	3.6	9.2	14.8	17.1	0.1	14.0	14.7	0.0	8.0	0.2	12.4	1.7	3.8	9.8	3.7	0.3	8.1	1.5	8.2	9.1	12.3	6.1	9.2	0.3	2.1	6.6	0.0	4.2	2.7	26.7	4.0	11.2	14.3	1.0	17.9	7.7	13.0	11.0	0.0	16.9	2.2	9.1	2.5	11.3	6.0	5.0	7.4	10.0	2.4	6.9	6.6	11.3	2.6	4.3	4.7	2.9	6.0	7.3	5.3	6.4	8.1	8.4	9.2	7.5	15.9	7.7	7.9	8.3	9.1	9.3	4.4
CRYAB	"CRYA2, HSPB5"	ENSG00000109846	"Crystallin alpha B"	P02511	11	111908565-111923722	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 743.1;skeletal muscle: 581.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 230.1;fHDF/TERT166: 75.0"	"Group enriched"	"Detected in all"	6	"glioma: 426.4;renal cancer: 575.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002053, CAB040560, HPA057100"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		12000	12000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB002053: AB_442024, CAB040560: , HPA057100: AB_2683337"	"unprognostic (1.06e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavourable (4.90e-5)"	"unprognostic (2.46e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.41e-3)"	"unprognostic (9.29e-3)"	"unprognostic (7.35e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.68e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (1.70e-5)"	107.4	11.5	47.8	16.7	82.3	2.1	69.5	24.8	153.7	22.4	23.6	132.9	7.2	5.5	14.8	25.9	41.9	13.5	14.0	743.1	65.9	44.0	151.8	3.8	8.4	3.9	139.2	29.7	8.8	6.6	3.3	8.6	16.1	80.7	30.3	12.9	23.3	30.6	75.1	581.1	18.1	6.2	45.2	168.0	5.5	11.6	3.9	101.8	0.0	40.7	94.1	9.2	16.2	53.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.3	230.1	10.1	1.6	6.4	0.2	0.1	0.2	0.1	0.0	0.0	3.8	75.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	1.2	0.6	1.9	0.0	0.0	8.1	1.0	0.0	0.5	0.0	0.5	0.2	18.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.4	0.8	3.4	0.5	0.0	0.1	29.8	10.7	0.8	0.3	0.1	0.0	0.0	0.6	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.8	82.3	24.8	48.5	65.9	44.0	139.2	29.7	80.7	101.8
CS		ENSG00000062485	"Citrate synthase"	O75390	12	56271699-56300392	"Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 125.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA038460, HPA038461, CAB075750, CAB075751, CAB075752, CAB075753, CAB075754"	Enhanced		Enhanced	Mitochondria		4400000	4400000	Mitochondria	Mitochondria	"CAB075750: AB_2665756, CAB075751: AB_2665757, CAB075752: , CAB075753: AB_2665759, CAB075754: , HPA038460: AB_2676023, HPA038461: AB_2676024"	"unprognostic (7.67e-3)"	"unprognostic (3.80e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.97e-2)"	"prognostic favourable (1.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.02e-1)"	37.1	35.5	11.9	16.3	20.4	19.3	55.6	28.5	43.8	17.2	27.4	14.1	11.3	25.3	19.9	10.8	31.7	16.5	14.0	79.2	11.2	14.5	26.7	12.3	17.3	30.8	12.3	14.2	16.9	20.7	28.1	14.3	11.9	24.8	16.2	32.7	19.8	23.1	17.5	125.9	22.8	27.0	21.2	15.0	18.4	21.4	7.9	11.1	20.7	17.9	48.2	26.1	22.9	19.1	19.5	37.1	59.6	27.8	15.9	19.7	18.2	35.4	38.4	31.3	40.7	41.7	38.8	20.4	29.6	29.1	52.1	36.5	54.1	34.9	69.4	29.1	37.3	38.5	86.6	44.5	49.9	24.1	44.0	47.7	27.9	39.0	23.4	58.3	34.3	42.7	42.6	40.9	49.6	58.6	49.3	41.7	45.5	28.5	48.2	18.0	24.9	55.5	47.0	36.8	52.4	32.3	36.1	41.2	27.0	38.3	45.6	30.0	63.5	34.0	38.8	26.3	36.9	37.1	31.2	27.5	41.9	45.2	24.3	42.9	24.7	14.5	22.0	59.6	15.2	27.8	19.7	19.5	18.3	14.3	37.1	16.7	19.4	15.4	9.8	15.9	27.0	20.5	19.3	18.2	11.9	20.4	28.5	43.8	11.2	14.5	12.3	14.2	24.8	11.1
CSDE1	"D1S155E, UNR"	ENSG00000009307	"Cold shock domain containing E1"	O75534	1	114716913-114758676	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 266.5"	"Cell line enhanced"	"Detected in all"		"MCF7: 222.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018846, HPA052221"	Supported		Enhanced	"Plasma membrane,Cytosol"		13000	13000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA018846: AB_1847266, HPA052221: AB_2681767"	"unprognostic (2.84e-1)"	"unprognostic (9.18e-3)"	"unprognostic (4.86e-3)"	"unprognostic (3.30e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.32e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.54e-2)"	71.2	31.4	33.5	25.8	33.2	37.9	42.1	29.6	35.4	39.0	64.7	29.6	35.9	29.5	46.4	38.9	58.8	30.3	29.4	64.2	33.2	31.7	37.4	39.5	34.2	31.4	41.6	31.4	43.9	37.2	50.3	38.4	38.8	44.4	52.6	32.9	32.0	43.2	42.0	266.5	33.8	46.5	88.3	42.4	32.2	39.9	41.5	35.1	39.6	55.7	73.9	31.9	75.4	45.5	43.9	59.0	57.9	65.2	48.1	62.3	80.5	60.6	21.4	38.1	38.0	43.5	56.6	53.3	53.6	40.1	36.1	29.4	31.3	18.4	47.8	45.3	51.1	25.8	42.2	41.6	52.7	58.4	28.8	46.9	39.0	27.7	38.5	34.8	28.0	41.0	45.3	43.2	57.1	41.3	47.5	31.4	44.1	222.4	46.7	22.2	72.6	28.9	35.0	118.0	22.5	28.7	47.8	47.1	31.3	52.5	43.8	40.6	22.5	55.7	49.7	42.7	58.9	56.0	58.8	48.0	52.2	53.6	55.2	39.6	130.2	46.4	57.7	57.9	40.9	60.8	55.5	43.9	52.2	49.7	59.0	34.7	62.3	52.3	40.9	48.1	65.2	23.0	56.7	80.5	33.5	33.2	29.6	35.4	33.2	31.7	41.6	31.4	44.4	35.1
CTAG2	"CAMEL, CT6.2a, CT6.2b, ESO2, LAGE-1, LAGE-1a, LAGE-1b, LAGE1, MGC138724, MGC3803"	ENSG00000126890	"Cancer/testis antigen 2"	O75638	X	154651972-154653579	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 8.5;skeletal muscle: 5.7;testis: 11.9"	"Group enriched"	"Detected in some"	37	"K-562: 28.2;RPMI-8226: 62.9;SK-BR-3: 41.1;U-266/84: 71.2"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA071467, HPA076586"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Vesicles"				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA071467: AB_2686402, HPA076586: "							"prognostic unfavourable (2.35e-4)"		"unprognostic (3.87e-1)"						"unprognostic (1.00e-1)"		"unprognostic (1.25e-2)"	0.2	1.0	0.4	0.0	0.0	0.2	0.1	0.2	0.5	0.0	0.2			0.0	0.0	0.0	1.0	2.9	0.0	8.5	0.0	0.0	0.1	0.8	0.2	0.0	0.2		0.8	3.6	0.0	0.4	4.4		0.2	0.0		0.1	0.0	5.7	0.2	0.0	0.0	0.0	0.3	0.6	11.9			0.0		0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.9	0.0	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.1	0.0	1.3	0.0	0.1	0.0	0.5	71.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CTDNEP1	"DULLARD, HSA011916, NET56"	ENSG00000175826	"CTD nuclear envelope phosphatase 1"	O95476	17	7243591-7252491	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 140.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037439, HPA066466"	Uncertain		Approved	"Lipid droplets"				"Lipid droplets"	"Lipid droplets"	"HPA037439: AB_10601264, HPA066466: AB_2732745"	"unprognostic (7.11e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.33e-2)"	"prognostic favourable (6.45e-4)"	"unprognostic (3.12e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.90e-2)"	"prognostic favourable (1.81e-4)"	"unprognostic (3.37e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.02e-2)"	27.1	23.1	21.4	22.4	21.0	24.2	38.8	21.8	26.6	25.3	24.8	26.6	16.7	20.8	31.2	22.8	26.6	27.3	18.8	29.0	21.5	12.9	23.8	20.6	26.5	39.4	24.7	17.1	31.1	27.9	30.7	26.1	30.4	20.5	25.2	27.9	20.4	23.0	23.8	140.1	35.5	30.9	26.7	25.6	38.3	24.3	26.6	24.3	43.8	26.0	31.5	34.1	22.4	26.7	13.0	17.3	18.3	11.8	7.2	11.2	3.8	38.1	57.2	32.2	34.5	50.4	62.1	24.4	28.6	48.0	46.2	39.8	27.3	26.7	35.4	30.5	51.1	32.0	42.2	44.1	51.6	52.5	35.8	24.7	38.4	46.9	46.8	28.1	46.8	50.0	53.7	52.8	56.4	49.1	22.0	26.3	43.3	24.1	31.3	30.1	22.4	24.3	38.1	28.7	28.2	36.7	20.1	12.4	35.5	22.8	22.9	30.5	21.5	23.2	27.9	33.7	29.0	26.9	53.7	22.7	19.8	18.2	43.4	38.8	34.8	6.3	11.8	18.3	10.5	11.7	8.5	13.0	10.1	11.0	8.4	12.4	7.8	11.2	15.6	7.2	7.7	17.3	9.6	3.8	21.4	21.0	21.8	26.6	21.5	12.9	24.7	17.1	20.5	24.3
CUTC	CGI-32	ENSG00000119929	"CutC copper transporter"	Q9NTM9	10	99702558-99756134	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 122.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038619	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA038619: AB_10672649"	"unprognostic (1.25e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (3.81e-7)"	"unprognostic (1.00e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.97e-1)"	11.6	4.9	5.7	9.8	8.7	7.9	9.8	3.5	6.5	5.3	5.9	7.2	3.5	4.4	4.9	8.0	6.2	5.1	5.8	13.2	5.9	4.7	5.3	11.0	5.1	7.9	8.6	6.6	4.6	4.5	3.5	3.6	4.5	5.5	6.0	6.4	6.9	5.7	5.4	122.1	5.8	6.2	11.6	7.4	9.2	6.0	14.1	8.3	9.2	4.3	25.1	7.3	13.5	11.4	32.8	24.2	47.1	19.4	25.5	36.3	19.3	9.3	20.2	7.1	21.6	26.4	12.1	3.9	7.7	9.9	7.8	8.8	9.3	7.2	34.2	6.9	13.1	8.1	14.5	12.8	8.7	10.1	13.8	11.3	9.1	14.6	12.2	21.0	5.6	12.5	8.0	12.4	25.8	13.3	10.0	7.6	5.8	6.5	18.8	21.7	7.1	7.6	12.8	8.3	13.1	8.1	3.9	2.3	5.3	3.5	5.6	9.7	9.0	12.0	7.4	3.2	4.4	3.5	10.1	12.5	16.2	24.0	10.6	45.1	2.9	26.5	19.4	47.1	27.2	15.2	28.3	32.8	25.9	25.9	21.0	29.0	36.3	27.8	30.8	25.5	18.5	24.2	24.7	19.3	5.7	8.7	3.5	6.5	5.9	4.7	8.6	6.6	5.5	8.3
CYB5R1	"humb5R2, NQO3A2"	ENSG00000159348	"Cytochrome b5 reductase 1"	Q9UHQ9	1	202961869-202967280	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 119.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010641, HPA014147"	Enhanced		Uncertain	Nucleoli,Mitochondria,Cytosol		860000	860000	"Nucleoli, Mitochondria, Cytosol"	"Nucleoli, Mitochondria, Cytosol"	"HPA010641: AB_1078600, HPA014147: AB_1847370"	"unprognostic (6.36e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.16e-2)"	"prognostic favourable (1.14e-4)"	"unprognostic (1.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.69e-1)"	9.6	14.5	7.8	5.0	8.4	3.9	16.9	6.2	11.0	11.6	7.5	8.7	10.6	4.4	10.1	32.3	13.7	16.4	9.2	33.9	7.3	9.2	15.5	18.4	10.1	11.7	10.0	9.1	10.8	11.1	16.3	11.1	63.8	11.9	10.5	5.0	15.7	14.4	10.1	119.2	28.5	6.9	10.6	7.4	10.8	18.6	20.1	6.7	11.7	13.5	26.4	10.0	13.6	10.1	20.2	21.9	25.7	33.3	17.2	26.5	28.8	8.3	5.2	4.6	9.4	42.9	9.9	45.1	16.8	15.8	10.9	9.8	4.3	9.9	5.2	14.3	16.7	46.3	3.7	14.4	7.2	7.5	9.5	2.9	6.3	4.9	15.5	2.5	7.4	15.8	47.6	12.0	6.6	7.2	8.8	9.4	39.4	9.8	3.2	2.2	3.0	10.0	5.3	22.2	11.1	10.3	10.0	3.9	4.8	9.4	31.4	13.6	14.5	5.7	7.0	12.5	5.3	4.7	9.3	8.8	10.4	2.4	13.8	3.9	9.3	11.6	33.3	25.6	16.7	24.2	22.2	13.6	19.3	17.8	21.9	20.2	26.5	18.8	25.7	17.2	15.7	15.1	19.1	28.8	7.8	8.4	6.2	11.0	7.3	9.2	10.0	9.1	11.9	6.7
CYC1	UQCR4	ENSG00000179091	"Cytochrome c1"	P08574	8	144095027-144097525	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 145.2"	"Cell line enhanced"	"Detected in all"		"PC-3: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001247	Supported		Supported	"Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol"		110000	110000	Mitochondria	Mitochondria	"HPA001247: AB_1078602"	"unprognostic (3.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.92e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"prognostic favourable (5.89e-6)"	"unprognostic (6.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.13e-2)"	16.0	31.3	16.2	13.2	20.1	19.5	12.1	19.1	32.1	13.0	33.3	13.4	14.4	38.1	13.9	10.1	36.2	15.5	13.1	92.1	16.6	14.1	44.8	55.9	11.2	16.5	18.0	18.6	15.0	21.4	17.9	10.6	16.0	17.7	16.5	25.3	13.3	23.3	17.2	145.2	17.7	42.6	16.3	11.8	18.3	22.4	13.9	11.5	21.5	21.7	43.8	18.5	19.9	14.4	34.9	76.7	22.1	60.0	30.2	26.1	58.5	22.2	50.4	13.4	28.0	11.1	12.3	25.8	12.8	15.6	32.7	21.5	35.2	27.8	31.5	28.9	17.1	33.0	29.2	25.4	12.3	19.3	38.7	33.8	42.5	32.2	19.9	19.9	22.1	17.9	31.8	20.8	41.3	18.9	30.7	28.2	17.0	79.8	37.3	18.5	15.5	151.2	33.0	17.9	55.2	26.8	35.8	36.0	15.9	35.7	49.4	26.2	40.6	30.6	14.4	20.8	44.4	23.0	38.9	31.3	22.7	23.4	26.5	34.1	26.6	22.1	59.7	15.9	24.1	60.0	25.4	34.9	20.1	25.8	76.7	29.4	19.7	25.4	5.8	30.2	44.8	42.9	26.1	58.5	16.2	20.1	19.1	32.1	16.6	14.1	18.0	18.6	17.7	11.5
CYCS	"CYC, HCS"	ENSG00000172115	"Cytochrome c, somatic"	P99999	7	25120091-25125361	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 109.6;skeletal muscle: 103.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB004222, CAB005126, CAB018597"	Enhanced		Supported	Mitochondria		190000000	190000000	Mitochondria	Mitochondria	"CAB004222: AB_627385, CAB005126: AB_2090472, CAB018597: AB_627383"	"unprognostic (3.06e-2)"	"unprognostic (3.39e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (2.81e-4)"	"unprognostic (4.44e-2)"	"unprognostic (7.04e-3)"	"unprognostic (5.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	"prognostic favourable (1.30e-5)"	"unprognostic (1.18e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.75e-3)"	"unprognostic (7.04e-2)"	20.3	29.3	29.8	20.0	44.8	17.1	14.7	25.1	41.1	12.1	62.1	13.3	9.6	35.4	11.4	10.7	26.6	11.0	13.1	109.6	30.2	26.4	39.8	37.0	13.4	13.8	30.7	34.7	12.2	9.3	24.8	18.6	10.3	29.9	13.7	58.5	13.5	14.9	15.7	103.7	11.3	30.2	21.8	28.0	15.6	24.3	23.5	18.1	17.3	18.3	41.2	20.0	15.9	14.3	35.5	38.0	17.1	38.3	25.2	31.0	25.2	43.0	24.1	26.1	36.3	15.0	11.6	26.9	41.5	17.1	31.1	36.2	39.9	29.5	49.6	20.4	18.1	51.2	53.0	39.1	55.0	14.7	23.8	41.3	28.6	28.3	23.6	94.3	36.8	15.4	35.0	31.1	67.5	27.8	75.6	52.6	33.0	19.9	51.5	36.7	48.9	45.7	36.3	31.4	47.4	48.4	42.3	53.0	25.2	21.6	92.4	33.4	47.9	56.5	20.1	28.6	52.1	44.1	76.6	54.4	63.0	110.8	38.1	68.7	79.2	17.1	20.0	14.0	25.3	38.3	31.0	35.5	23.4	26.8	38.0	26.0	22.4	26.8	3.0	25.2	33.6	27.8	29.5	25.2	29.8	44.8	25.1	41.1	30.2	26.4	30.7	34.7	29.9	18.1
DAPK2	"DRP-1, MGC119312"	ENSG00000035664	"Death associated protein kinase 2"	Q9UIK4	15	63907036-64072033	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.8;skeletal muscle: 46.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 10.0;HaCaT: 8.3;HMC-1: 17.0;MCF7: 8.6"	"Cancer enriched"	"Detected in many"	15	"thyroid cancer: 30.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"basophil: 19.1;eosinophil: 51.8;neutrophil: 16.4"	"Lineage enriched"	"Detected in many"	23	"granulocytes: 51.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA071581			Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA071581: AB_2686421"	"unprognostic (3.20e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.32e-1)"	"prognostic favourable (5.63e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.77e-7)"	"unprognostic (5.98e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.07e-2)"	8.2	1.6	2.6	6.8	5.0	10.3	5.2	1.4	3.9	3.6	16.6	12.0	8.3	14.2	1.7	1.5	2.1	1.2	1.7	17.6	3.6	2.0	2.2	1.4	14.0	2.5	6.8	3.0	0.7	1.7	1.1	1.1	0.3	4.7	3.1	4.7	1.9	4.8	4.8	46.1	4.6	25.8	1.2	3.4	4.7	6.9	2.0	6.5	1.1	22.3	8.7	3.3	2.1	9.6	0.3	2.2	51.8	0.0	0.7	0.6	0.3	2.8	2.0	5.6	1.4	10.0	0.4	0.1	1.9	6.0	1.0	1.1	0.8	1.4	0.2	0.6	6.0	8.3	3.5	0.1	0.6	0.2	0.1	1.1	3.9	0.1	0.1	0.1	17.0	1.0	7.2	0.3	0.2	0.6	0.4	0.1	0.7	8.6	0.0	0.3	0.6	2.0	2.6	0.0	0.3	0.0	2.8	0.4	0.3	0.4	1.1	0.0	4.8	0.4	0.4	0.8	1.0	1.3	1.6	0.6	0.2	0.0	0.0	2.7	0.2	19.1	0.0	51.8	0.6	0.0	0.2	0.3	0.1	0.5	0.0	0.1	0.0	0.4	16.4	0.7	0.0	2.2	0.0	0.3	2.6	5.0	1.4	3.9	3.6	2.0	6.8	3.0	4.7	6.5
DBNDD1	"FLJ12582, MGC3101"	ENSG00000003249	"Dysbindin domain containing 1"	Q9H9R9	16	90004865-90020128	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.6;skeletal muscle: 39.7"	"Cell line enhanced"	"Detected in many"		"MCF7: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"naive B-cell: 14.4"	"Lineage enriched"	"Detected in many"	6	"B-cells: 14.4"									HPA043018	Uncertain		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nuclear speckles"	"HPA043018: AB_10794921"	"unprognostic (1.07e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.07e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.86e-2)"	"prognostic favourable (2.75e-7)"	"unprognostic (1.03e-1)"	"unprognostic (5.67e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.00e-2)"	2.1	6.9	21.5	2.3	13.7	0.8	4.7	16.1	31.6	2.6	2.0	6.5	1.9	1.9	1.4	9.6	13.9	3.9	3.9	3.4	15.7	14.6	6.9	6.2	3.0	3.9	17.6	9.4	3.1	14.1	6.3	3.0	0.6	19.2	3.7	1.8	3.9	11.9	3.8	39.7	3.9	1.2	1.6	6.8	1.6	4.3	1.1	4.5	0.0	3.6	2.3	4.7	2.0	2.3	14.4	0.1	0.6	0.0	0.0	2.5	0.8	7.7	11.8	1.1	14.2	0.3	0.1	8.4	1.7	2.1	3.5	1.7	11.4	6.3	0.0	0.9	0.3	8.0	12.4	0.3	3.3	0.0	22.7	0.0	1.6	18.7	0.5	0.1	1.3	0.3	1.0	5.9	0.0	14.9	2.2	0.1	1.2	46.7	0.0	9.7	19.8	5.0	4.7	10.8	0.2	19.4	1.4	17.1	18.3	1.9	1.7	14.6	11.0	1.3	12.0	2.7	5.3	0.1	7.7	0.0	0.1	0.0	1.1	0.9	6.8	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.6	0.4	0.0	14.4	2.5	0.4	0.0	0.0	0.0	0.1	0.0	0.8	21.5	13.7	16.1	31.6	15.7	14.6	17.6	9.4	19.2	4.5
DBNDD2	"C20orf35, HSMNP1"	ENSG00000244274	"Dysbindin domain containing 2"	Q9BQY9	20	45406057-45410610	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 160.5;skeletal muscle: 84.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"dendritic cells: 15.0;monocytes: 9.3;T-cells: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043991	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA043991: AB_10966212"	"unprognostic (6.33e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-3)"	"unprognostic (8.24e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.48e-1)"	12.2	7.8	56.5	9.9	64.9	2.1	15.3	21.3	88.8	11.0	26.4	132.3	5.0	16.6	14.9	13.6	18.3	17.7	10.2	68.4	85.1	47.3	5.9	2.5	13.9	5.8	98.2	31.5	6.5	6.7	18.4	5.0	13.2	51.8	14.2	28.4	3.1	9.0	29.1	84.2	10.4	19.4	31.0	160.5	5.0	13.3	3.0	70.7	2.7	4.8	10.5	8.2	16.8	8.2	0.3	15.0	0.3	9.3	0.6	7.9	3.5	21.4	3.8	3.1	21.7	2.0	0.9	4.3	12.6	13.8	10.6	7.2	10.4	29.4	0.3	2.2	12.4	31.8	21.2	1.1	6.5	0.1	12.5	17.9	16.6	9.4	12.7	0.9	27.3	0.3	3.6	4.0	3.7	7.2	1.2	0.4	0.8	27.2	1.5	1.3	4.0	22.9	0.0	0.3	0.2	30.2	0.4	7.1	3.6	4.4	2.4	27.2	29.8	5.5	11.6	0.4	21.1	14.0	13.8	0.3	0.4	0.1	1.5	0.1	3.1	0.0	8.4	0.0	7.9	9.3	2.9	0.1	6.9	5.8	6.0	0.3	6.4	6.0	0.3	0.6	5.0	15.0	5.8	3.5	56.5	64.9	21.3	62.5	85.1	47.3	98.2	31.5	51.8	70.7
DCAF6	"IQWD1, PC326"	ENSG00000143164	"DDB1 and CUL4 associated factor 6"	Q58WW2	1	167935783-168075843	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 155.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054305			Supported	"Nucleoplasm,Focal adhesion sites"				"Nucleoplasm, Focal adhesion sites"	"Nucleoplasm, Focal adhesion sites"	"HPA054305: AB_2682444"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.20e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.06e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	10.6	17.0	10.9	7.8	12.2	6.2	8.8	10.5	17.8	10.2	11.5	3.9	8.4	6.2	9.5	11.4	9.3	7.7	8.2	43.8	7.6	5.5	9.5	26.2	7.3	4.8	5.2	11.5	8.3	6.1	10.8	11.3	7.8	6.5	10.5	8.7	5.7	10.3	11.9	155.9	6.4	7.8	10.2	4.8	5.9	9.8	21.5	4.8	7.8	8.2	27.3	7.3	9.1	7.3	6.2	7.7	12.5	13.9	4.4	7.2	5.0	22.9	11.0	6.1	9.9	20.2	28.8	21.5	23.5	35.3	16.7	24.9	18.2	19.4	19.0	13.7	30.3	17.3	9.5	17.6	23.7	10.7	10.2	20.2	16.7	13.1	16.3	9.0	9.7	20.4	17.8	15.8	13.2	18.2	22.8	15.7	24.5	5.3	10.0	8.3	3.9	12.2	7.8	12.6	14.7	41.7	11.2	9.0	7.1	18.8	17.3	12.9	29.6	11.1	25.6	16.7	10.4	16.1	9.7	16.9	13.7	14.8	22.3	7.8	6.8	6.0	7.0	12.5	6.7	9.6	7.2	6.2	5.4	5.8	7.7	4.5	5.0	6.4	7.2	4.4	13.9	4.6	6.1	5.0	10.9	12.2	10.5	17.8	7.6	5.5	5.2	11.5	6.5	4.8
DCUN1D3	"DKFZp686O0290, FLJ41725, MGC48972, SCCRO3"	ENSG00000188215	"Defective in cullin neddylation 1 domain containing 3"	Q8IWE4	16	20854925-20900384	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 38.4"	"Cell line enhanced"	"Detected in all"		"ASC diff: 30.1;ASC TERT1: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041983, HPA043511"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA041983: , HPA043511: AB_2678521"	"unprognostic (9.34e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.24e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.31e-2)"	"prognostic unfavourable (5.41e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.42e-1)"	19.2	9.9	4.3	6.0	4.6	2.7	17.2	7.9	5.6	7.5	6.0	5.5	3.2	3.4	7.7	5.9	8.5	6.6	9.6	8.9	2.5	2.8	10.0	17.4	9.7	3.1	5.2	3.0	5.3	6.6	6.4	9.5	9.4	6.7	6.6	4.1	6.3	3.9	4.5	38.4	7.1	4.9	11.9	3.9	4.5	6.4	7.9	3.8	1.5	4.8	11.5	4.5	6.7	15.8	1.4	1.6	4.8	2.5	2.6	2.7	1.0	2.6	4.7	2.4	5.1	30.1	22.7	3.2	8.9	7.7	4.5	6.1	5.9	5.1	1.7	7.3	8.7	3.7	2.7	3.7	6.0	2.3	1.9	1.4	3.7	8.5	7.9	2.2	13.7	14.9	5.1	8.6	4.9	12.3	1.6	4.6	9.2	3.6	2.0	3.1	5.6	1.6	3.4	2.7	1.6	4.0	2.8	2.2	2.9	3.5	3.9	2.0	2.6	1.0	6.0	9.6	3.4	4.0	2.4	3.9	2.3	1.2	10.2	2.3	4.9	4.8	1.4	1.2	1.7	2.5	1.7	1.0	1.2	2.7	1.6	1.4	1.5	2.7	1.9	2.6	2.2	1.2	1.0	1.0	4.3	4.6	7.9	5.6	2.5	2.8	5.2	3.0	6.7	3.8
DDI2	MGC14844	ENSG00000197312	"DNA damage inducible 1 homolog 2"	Q5TDH0	1	15617500-15669044	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 54.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA043119, HPA043225"	Approved		Enhanced	Nucleoplasm,Cytosol		170000	170000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA043119: AB_2678326, HPA043225: AB_2678369"	"unprognostic (1.93e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.04e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.02e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.63e-2)"	"unprognostic (3.77e-2)"	14.8	8.1	5.1	10.5	7.1	10.5	15.0	8.7	8.4	8.7	10.8	8.2	9.8	9.0	12.3	9.6	19.4	7.7	8.3	12.5	5.8	4.7	10.4	24.9	10.2	9.1	6.7	5.2	8.3	9.4	14.8	8.0	11.5	7.5	12.1	7.9	11.5	13.5	13.8	54.8	13.3	9.2	8.0	6.5	9.9	6.9	4.3	6.0	11.1	7.6	11.7	16.4	12.1	12.3	3.8	5.4	0.8	2.3	2.0	3.5	1.4	7.4	4.3	7.9	8.2	10.9	8.6	7.7	4.7	3.6	4.1	3.6	10.6	6.8	18.8	5.5	5.1	8.0	17.2	7.6	7.0	8.6	11.5	14.7	7.3	10.4	4.7	19.4	7.4	8.5	9.0	7.7	8.3	8.4	23.5	7.0	5.0	5.0	11.2	6.4	7.6	3.6	10.6	11.2	11.1	5.8	6.2	9.7	5.4	8.8	14.2	13.0	7.4	5.1	7.3	6.0	5.1	6.7	5.7	6.6	7.9	15.2	4.7	14.2	4.6	0.7	2.3	0.4	3.3	2.1	2.9	2.6	2.5	2.6	2.3	3.8	2.8	3.5	0.8	2.0	1.6	5.4	2.3	1.4	5.1	7.1	8.7	8.4	5.8	4.7	6.7	5.2	7.5	6.0
DENND2C	"dJ1156J9.1, DKFZp686G0351, DKFZp779P1149, FLJ37099, RP5-1156J9.1"	ENSG00000175984	"DENN domain containing 2C"	Q68D51	1	114582848-114670422	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.7;skeletal muscle: 31.1"	"Cell line enhanced"	"Detected in many"		"U-2197: 10.1;U-266/70: 22.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 6.1;eosinophil: 2.1"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 6.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA054955	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA054955: AB_2682648"	"unprognostic (2.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.89e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.57e-2)"	1.9	0.7	1.5	0.7	1.5	0.8	1.7	1.4	1.1	8.6	1.1	0.5	0.8	0.6	4.2	1.7	28.7	1.0	1.1	1.5	1.3	0.5	0.8	2.1	1.7	1.7	0.6	0.3	1.1	4.0	2.4	3.6	0.3	1.9	2.5	0.6	1.6	3.0	1.4	31.1	10.6	0.6	2.4	0.6	0.5	0.8	4.5	0.2	0.0	1.3	16.0	10.4	6.2	6.6	0.6	0.1	6.1	0.2	0.3	0.5	0.3	1.7	0.0	0.1	1.2	1.5	1.6	0.3	0.5	0.9	0.6	0.9	0.2	0.0	0.0	0.8	3.4	6.3	1.1	3.9	0.6	0.0	1.5	1.0	0.3	0.1	0.5	0.0	1.6	1.6	3.8	2.3	2.0	0.2	0.1	0.3	2.0	5.0	0.2	0.1	0.8	0.9	0.0	5.4	0.1	0.1	4.8	0.0	0.0	3.9	0.1	0.4	0.8	0.3	0.2	0.9	1.3	10.1	0.1	22.1	3.9	0.0	0.9	0.0	0.7	6.1	0.2	2.1	0.5	0.0	0.5	0.6	0.1	0.4	0.0	0.4	0.3	0.2	0.5	0.3	0.1	0.1	0.2	0.3	1.5	1.5	1.4	1.1	1.3	0.5	0.6	0.3	1.9	0.2
DEPTOR	"DEP.6, DEPDC6, FLJ12428"	ENSG00000155792	"DEP domain containing MTOR interacting protein"	Q8TB45	8	119873717-120050913	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 67.6;skeletal muscle: 65.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 29.8;RPMI-8226: 53.0;RPTEC TERT1: 43.9;U-698: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"myeloid DC: 17.1"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 17.1"	"Low region specificity"	"Detected in all"							"CAB020841, HPA023938, HPA023945, HPA024011"	Enhanced		Supported	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"CAB020841: , HPA023938: AB_1847606, HPA023945: AB_1847607, HPA024011: AB_1847608"	"unprognostic (3.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.29e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.84e-2)"	8.1	30.2	6.4	5.2	11.0	1.1	9.7	5.1	9.2	18.9	12.7	17.8	5.7	7.8	16.0	5.7	7.2	12.7	6.1	4.3	7.3	6.3	22.7	7.5	2.7	8.5	9.5	6.1	12.5	5.6	13.3	13.6	4.4	7.5	6.4	4.8	0.7	67.6	7.9	65.0	4.3	7.4	7.7	8.2	5.3	20.0	2.1	11.5	0.7	45.0	20.7	2.7	4.8	5.7	0.1	17.1	0.3	1.5	0.3	0.8	0.8	0.0	1.0	0.1	0.3	6.3	1.9	0.1	0.0	0.1	0.1	0.1	0.7	0.1	29.8	0.7	0.3	0.1	1.6	0.0	0.1	0.6	0.8	4.0	0.2	0.1	3.8	0.8	6.9	1.7	2.8	0.2	0.1	0.0	0.0	4.9	0.1	2.0	0.0	0.7	0.4	1.0	0.1	1.4	53.0	43.9	1.2	0.9	0.2	0.5	3.2	0.9	2.8	0.1	0.0	0.1	0.2	6.3	0.1	13.2	3.1	15.6	1.9	1.1	0.2	0.0	0.8	0.0	0.2	1.5	0.7	0.1	0.3	0.6	17.1	0.1	0.8	0.5	0.3	0.3	0.1	0.8	0.3	0.8	6.4	11.0	5.1	9.2	7.3	6.3	9.5	6.1	7.5	11.5
DES	"CMD1I, CSM1, CSM2"	ENSG00000175084	Desmin	P17661	2	219418377-219426739	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 531.0;skeletal muscle: 600.8;smooth muscle: 439.9"	"Cell line enhanced"	"Detected in some"		"HSkMC: 17.6;LHCN-M2: 35.2;RH-30: 81.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 562.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.7;intermediate monocyte: 1.9;non-classical monocyte: 1.4"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 45.7"	"CAB000034, HPA018803"	Enhanced		Supported	"Intermediate filaments"		1300000	1300000	"Intermediate filaments"	"Intermediate filaments"	"CAB000034: , HPA018803: AB_1847616"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.76e-2)"	"unprognostic (7.75e-3)"	"unprognostic (6.61e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.72e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.43e-2)"	"prognostic unfavourable (5.08e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.25e-3)"	9.1	2.5	0.1	35.1	0.2	0.1	1.9	0.1	0.3	41.3	238.3	0.4	69.1	12.6	95.6	80.2	209.7	33.0	149.8	531.0	0.1	0.1	2.1	0.3	4.8	3.0	0.3	0.8	20.3	0.7	0.0	0.1	2.4	0.8	101.0	11.2	3.8	11.9	104.2	600.8	4.2	43.2	439.9	0.3	0.6	72.6	10.9	0.0	0.0	9.4	161.2	12.5	343.7	34.4	0.0	0.2	0.4	2.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.3	17.6	0.0	0.0	0.0	0.0	0.6	0.0	35.2	0.0	0.0	9.2	0.1	0.0	0.0	81.8	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.7	0.1	0.2	0.1	0.3	0.1	0.1	0.3	0.8	0.8	0.0
DEXI	MYLE	ENSG00000182108	"Dexi homolog"	O95424	16	10928891-10942460	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041511	Approved		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nuclear speckles"	"HPA041511: AB_10796675"	"unprognostic (4.14e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.47e-2)"	"prognostic favourable (4.23e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.33e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.83e-2)"	15.0	25.2	15.7	8.0	20.8	4.1	10.7	14.0	27.5	12.2	13.9	9.8	12.7	11.1	11.7	18.5	12.9	14.5	11.6	32.2	13.1	13.6	13.3	26.3	9.5	9.9	18.8	12.3	15.9	18.0	22.1	12.9	13.3	21.3	13.6	6.6	13.7	15.4	16.6	81.6	10.3	11.1	12.1	9.4	12.7	10.6	8.9	11.9	13.7	18.4	10.6	8.1	10.9	10.5	4.0	2.4	8.2	0.7	3.9	7.0	1.2	9.3	13.7	7.4	13.0	30.2	16.6	6.8	14.5	15.1	9.5	9.1	6.4	9.9	11.2	21.9	16.4	12.2	8.7	15.6	8.2	26.2	19.5	5.5	9.0	27.1	17.3	9.5	10.5	16.9	18.0	9.3	10.8	13.7	12.6	11.2	10.5	16.5	11.8	10.3	10.3	14.3	11.0	9.8	17.1	11.8	7.0	15.3	13.5	13.8	15.3	11.5	12.1	16.5	14.9	9.6	10.4	22.7	9.4	14.9	11.4	3.2	8.4	20.4	10.8	1.7	0.6	8.2	6.0	0.7	5.6	0.6	5.2	7.0	0.4	4.0	6.4	6.0	0.7	3.9	0.3	2.4	3.9	1.2	15.7	20.8	14.0	27.5	13.1	13.6	18.8	12.3	21.3	11.9
DGCR6		ENSG00000183628	"DiGeorge syndrome critical region gene 6"	Q14129	22	18906028-18914238	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 49.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 9.5;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.4;granulocytes: 9.5"																				"unprognostic (9.80e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.42e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.38e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.28e-1)"	4.5	5.6	13.5	2.3	14.4	4.7	6.2	12.2	17.7	4.2	2.2	5.6	0.5	4.0	4.6	6.4	3.2	3.8	3.4	20.7	12.2	12.5	3.0	7.4	4.5	4.5	13.4	11.9	6.2	7.5	7.3	6.4	3.8	11.3	4.9	3.1	5.0	8.9	4.4	49.2	8.6	2.8	2.8	6.6	4.1	2.4	9.0	8.6	2.7	7.7	18.3	3.9	2.4	2.1	0.4	2.4	9.5	1.2	0.7	1.3	1.4	1.1	4.2	6.5	5.0	3.0	2.7	1.4	1.5	1.3	2.5	1.6	1.1	2.6	0.6	2.1	2.3	2.9	4.9	2.6	1.9	2.0	6.9	1.1	4.4	1.0	2.1	2.5	0.9	1.8	3.6	1.9	0.7	1.1	6.3	3.1	2.2	2.9	2.2	3.6	2.6	2.1	3.7	5.6	0.3	1.2	0.4	6.0	2.9	2.0	0.8	0.7	2.3	0.6	0.6	4.3	3.7	1.2	1.2	3.1	0.4	0.7	2.9	4.2	3.1	9.5	1.0	1.4	0.4	1.2	0.7	0.4	0.9	1.1	2.4	0.3	1.3	0.8	0.6	0.7	0.5	0.3	0.9	1.4	13.5	14.4	12.2	13.1	12.2	12.5	13.4	11.9	11.3	8.6
DGLUCY	"C14orf159, FLJ39975"	ENSG00000133943	"D-glutamate cyclase"	Q7Z3D6	14	91060333-91225632	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 57.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041423, HPA052932"	Approved		Supported	Cytosol				Cytosol	Cytosol	"HPA041423: AB_10795540, HPA052932: AB_2681991"	"unprognostic (5.02e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.56e-1)"	"prognostic favourable (4.28e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.58e-2)"	"prognostic favourable (9.48e-5)"	"unprognostic (3.56e-1)"	"prognostic favourable (7.28e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (3.77e-15)"	"unprognostic (1.50e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.57e-3)"	12.5	18.7	23.4	15.9	23.1	10.7	9.3	27.3	22.6	14.6	16.7	18.1	16.0	13.8	16.8	13.1	16.0	21.9	12.5	63.9	18.8	16.6	20.1	13.1	13.7	11.2	20.1	19.2	13.4	9.3	29.3	14.2	9.2	19.0	13.3	17.0	11.3	17.4	22.3	82.9	13.9	12.3	20.0	18.5	17.3	18.9	12.2	21.6	11.2	16.8	29.1	14.1	19.4	11.4	9.4	19.8	57.9	19.3	5.6	12.0	7.0	2.7	7.4	3.8	9.1	15.5	14.7	9.9	2.8	8.0	8.9	9.2	4.8	21.4	18.5	21.5	8.5	8.2	10.4	11.3	3.7	10.2	4.3	12.4	3.7	6.1	22.8	12.6	18.1	22.6	4.9	4.9	1.9	15.8	6.2	25.3	8.4	0.7	9.9	12.0	7.6	0.7	17.1	7.4	13.4	15.1	11.7	10.5	5.3	4.8	8.3	3.4	14.7	10.7	11.3	2.7	2.3	8.0	2.6	14.5	10.3	6.2	13.9	16.6	1.7	13.7	13.6	8.1	8.8	19.3	9.0	9.4	5.9	7.2	19.8	7.0	4.9	6.0	57.9	5.6	15.5	6.2	12.0	7.0	23.4	23.1	27.3	22.6	18.8	16.6	20.1	19.2	19.0	21.6
DHRS7	"retDSR4, SDR34C1"	ENSG00000100612	"Dehydrogenase/reductase 7"	Q9Y394	14	60144120-60169856	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 123.5"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	5	"prostate cancer: 199.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031121	Approved		Approved	Nucleoplasm,Mitochondria		63000	63000	"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA031121: AB_10600803"	"prognostic favourable (6.42e-4)"	"unprognostic (5.20e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-1)"	"prognostic unfavourable (2.51e-4)"	"unprognostic (4.65e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavourable (7.99e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.59e-1)"	"prognostic favourable (1.92e-10)"	"unprognostic (8.35e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	15.0	24.6	12.3	10.1	10.9	10.5	17.9	10.6	12.4	11.1	30.6	10.7	57.3	20.7	11.7	19.4	12.3	9.9	15.3	17.4	11.0	11.4	22.6	27.9	13.1	13.9	14.1	8.8	13.4	17.2	40.2	17.2	6.1	17.8	83.4	13.4	9.1	113.7	93.0	123.5	9.8	48.7	9.6	15.5	11.1	32.6	4.9	11.0	6.4	24.8	16.7	10.1	12.4	15.6	26.0	56.6	121.4	32.2	37.3	50.8	54.0	51.8	15.7	9.1	19.9	47.0	18.4	11.5	16.7	43.2	6.1	13.6	8.6	35.1	5.4	10.1	15.6	22.4	11.8	23.6	8.9	37.7	11.0	13.3	7.7	14.2	24.7	15.8	0.4	13.6	28.3	9.7	32.8	11.7	4.0	11.7	15.3	15.6	9.2	15.1	4.3	15.9	9.5	12.2	6.3	27.3	17.7	19.5	24.4	17.0	25.7	37.1	18.0	7.0	8.2	30.5	10.3	8.3	9.6	4.2	1.9	9.6	16.6	15.3	20.8	80.1	32.2	71.6	50.8	22.6	49.9	26.0	36.0	43.9	27.1	21.8	20.2	38.9	121.4	37.3	29.0	56.6	29.0	54.0	12.3	10.9	10.6	12.4	11.0	11.4	14.1	8.8	17.8	11.0
DIAPH1	"DFNA1, hDIA1, LFHL1"	ENSG00000131504	"Diaphanous related formin 1"	O60610	5	141515016-141619055	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 79.8"	"Cell line enhanced"	"Detected in all"		"HMC-1: 105.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004916, HPA076913"	Approved		Approved	"Plasma membrane"		10000000	10000000	"Plasma membrane"	"Plasma membrane"	"HPA004916: AB_1847668, HPA076913: "	"unprognostic (6.79e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.73e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.54e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.27e-2)"	"prognostic unfavourable (7.81e-5)"	"unprognostic (2.88e-3)"	"prognostic favourable (1.29e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.65e-1)"	14.5	10.0	5.2	22.3	10.4	27.9	10.6	8.8	7.8	11.6	17.1	3.9	11.4	14.2	9.9	16.8	26.5	9.1	15.7	21.3	5.1	6.3	30.1	48.7	22.4	21.7	3.8	4.3	9.7	20.2	17.6	22.1	28.2	7.2	7.8	11.0	8.8	18.0	13.8	79.8	19.1	24.1	9.6	3.4	20.2	15.5	12.1	2.9	44.2	14.9	23.8	34.1	12.3	13.3	5.9	8.6	19.2	9.3	8.2	22.7	9.3	25.5	16.6	9.6	12.6	7.7	10.4	13.3	10.5	11.2	12.3	12.9	56.6	24.5	28.6	16.1	15.4	28.5	21.4	35.8	15.6	15.4	11.9	49.3	21.9	18.4	7.3	34.3	105.8	6.6	19.0	17.7	17.9	16.1	17.3	20.2	12.1	24.9	38.1	44.8	9.5	11.0	42.8	15.8	15.8	23.6	28.2	12.8	6.8	26.0	34.7	10.4	14.5	16.6	9.3	17.3	9.2	9.5	21.4	10.1	16.0	19.8	9.4	27.5	10.7	12.7	8.6	19.2	22.7	9.2	15.2	5.9	14.4	17.6	8.6	5.0	10.5	17.3	9.4	8.2	9.3	6.6	11.9	9.3	5.2	10.4	8.8	7.8	5.1	6.3	3.8	4.3	7.2	2.9
DMPK	"DM, DM1, DM1PK, DMK, MDPK, MT-PK"	ENSG00000104936	"DM1 protein kinase"	Q09013	19	45769717-45782552	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 79.6"	"Cell line enhanced"	"Detected in many"		"RH-30: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdTCR: 2.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007164, HPA008905"	Enhanced		Approved	Vesicles,Cytosol				Cytosol	Cytosol	"HPA007164: AB_1078687, HPA008905: AB_1078685"	"unprognostic (7.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.46e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-1)"	"prognostic favourable (9.39e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.24e-3)"	9.0	18.7	5.1	9.7	6.3	1.7	4.9	8.8	6.2	16.5	23.4	4.4	15.6	8.7	21.2	15.0	31.2	13.7	20.3	56.7	5.0	5.3	4.9	2.2	6.5	4.1	4.8	6.5	8.4	33.3	3.1	10.7	6.8	5.6	16.3	3.8	22.0	6.1	19.7	79.6	5.1	11.3	65.1	4.2	5.3	12.0	5.9	4.0	1.1	6.1	36.6	5.0	44.9	8.2	1.5	0.0	0.0	0.8	0.3	2.2	0.0	7.2	10.1	12.0	7.4	8.1	11.3	7.2	16.2	12.0	6.5	6.3	1.2	3.9	2.3	2.4	18.5	10.6	3.4	1.6	2.4	11.3	10.6	0.9	12.6	1.7	7.9	0.1	4.1	16.5	5.7	5.6	2.7	3.0	7.1	5.8	9.4	8.0	1.1	2.7	7.1	2.2	3.7	44.2	3.7	3.5	8.3	6.5	10.3	8.8	18.5	5.2	15.2	3.5	9.1	7.6	7.5	7.2	11.8	11.2	9.6	2.3	6.9	1.0	10.6	0.0	0.0	0.0	2.2	0.8	0.5	0.3	0.7	0.2	0.0	1.5	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	5.1	6.3	8.8	6.2	5.0	5.3	4.8	6.5	5.6	4.0
DNAJA4	PRO1472	ENSG00000140403	"DnaJ heat shock protein family (Hsp40) member A4"	Q8WW22	15	78264086-78282196	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 63.2;skeletal muscle: 69.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.4;HeLa: 18.2;RT4: 33.9;SCLC-21H: 21.8;SiHa: 17.0;THP-1: 15.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004646, HPA041790"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB004646: AB_426011, HPA041790: AB_2677674"	"unprognostic (8.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-1)"	"prognostic favourable (1.08e-7)"	"unprognostic (1.89e-1)"	"unprognostic (2.84e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.93e-2)"	7.3	10.1	29.6	7.6	33.7	28.6	7.6	20.1	25.8	8.6	8.7	10.5	10.4	7.8	5.1	25.3	9.1	21.7	6.6	63.2	22.3	33.8	7.7	1.9	7.0	6.0	26.0	28.1	3.6	3.2	9.5	11.9	5.5	29.2	15.4	10.6	7.2	6.8	9.6	69.0	15.5	9.0	10.7	16.0	5.1	10.8	26.8	14.9	2.0	6.3	15.2	6.9	12.6	62.3	1.9	1.1	2.7	1.0	0.4	4.7	1.6	13.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.2	0.0	17.4	0.0	0.1	1.2	12.5	0.0	0.0	0.0	0.0	0.0	7.8	18.2	0.0	3.9	0.0	8.4	1.5	1.7	1.0	0.0	2.6	0.0	0.0	0.1	13.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	33.9	21.8	0.0	17.0	3.4	1.5	13.1	15.7	0.2	0.0	3.6	1.6	0.1	0.2	0.9	0.0	0.0	1.6	0.0	0.0	0.8	2.7	1.8	0.9	2.6	1.9	2.5	2.5	1.1	0.4	4.7	3.9	0.0	0.4	1.0	0.6	1.4	1.6	29.6	33.7	20.1	25.8	22.3	33.8	26.0	28.1	29.2	14.9
DNAJB5	Hsc40	ENSG00000137094	"DnaJ heat shock protein family (Hsp40) member B5"	O75953	9	34989641-34998900	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 99.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"myeloid DC: 7.7;neutrophil: 7.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.7;granulocytes: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023818, HPA050794"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA023818: AB_1847793, HPA050794: AB_2681241"	"unprognostic (1.41e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.53e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.00e-3)"	7.2	6.3	5.9	5.1	7.2	0.9	2.6	8.6	13.0	6.5	19.1	6.2	9.2	3.8	18.5	9.7	15.7	9.6	8.7	29.3	6.6	6.3	3.7	2.0	3.7	2.2	4.7	3.4	6.5	3.1	2.2	8.6	1.4	6.0	13.8	6.2	5.7	3.7	26.2	99.4	1.5	6.1	29.9	4.5	5.6	11.3	8.1	3.5	1.6	4.4	38.0	2.9	23.0	3.6	0.7	7.7	7.6	1.5	0.5	1.3	0.7	2.6	2.1	13.6	7.2	8.0	6.2	1.5	11.3	8.3	17.5	15.6	1.6	0.6	2.5	2.8	12.4	0.3	5.2	8.9	14.9	3.5	1.6	0.9	3.1	0.7	9.2	0.3	8.2	9.0	0.6	10.3	5.2	11.1	0.2	5.3	14.1	1.8	4.2	3.6	6.4	4.6	3.3	14.1	1.4	2.5	0.2	5.8	9.5	6.1	0.3	1.3	2.2	0.8	4.9	8.4	18.5	4.3	3.5	2.0	1.3	1.8	9.6	1.0	9.0	0.1	1.5	0.0	0.4	0.4	1.3	0.7	0.3	0.1	7.7	0.3	0.5	1.1	7.6	0.5	0.1	0.2	1.3	0.7	5.9	7.2	8.6	8.5	6.6	6.3	4.7	3.4	6.0	3.5
DNASE1L1	"DNAS1L1, DNASEX, DNL1L, XIB"	ENSG00000013563	"Deoxyribonuclease 1 like 1"	P49184	X	154401238-154412112	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA072635	Approved				"Intracellular and membrane"	60000	60000			"HPA072635: AB_2686542"	"unprognostic (5.27e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.57e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.82e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.98e-1)"	"prognostic favourable (2.19e-4)"	"unprognostic (7.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.75e-2)"	12.3	11.8	5.6	6.9	7.4	10.1	9.9	3.3	7.7	7.5	7.7	4.5	7.8	7.5	6.9	15.5	9.6	6.8	10.2	16.3	5.5	6.5	11.4	9.0	10.5	11.7	5.6	5.8	6.1	9.7	9.0	8.7	13.0	4.6	6.2	6.0	12.9	9.1	6.1	76.7	4.5	10.2	5.5	4.7	12.7	7.0	3.8	4.1	3.9	10.2	24.3	9.0	6.7	6.8	4.5	10.7	12.8	16.1	3.0	3.6	4.2	6.7	7.1	2.2	4.2	20.9	27.5	2.9	19.4	29.8	6.2	12.3	1.9	10.0	11.0	24.7	35.7	3.2	2.5	10.7	4.6	3.1	4.7	1.6	7.3	2.4	14.4	2.9	11.9	20.5	12.5	13.8	14.5	26.3	2.2	11.5	21.5	11.4	1.1	1.4	1.7	8.3	2.3	10.4	17.4	10.6	3.4	7.0	4.1	5.9	10.5	7.8	4.0	2.7	38.7	6.2	7.4	9.2	3.8	21.9	4.8	11.2	9.6	5.0	7.7	10.1	8.8	12.8	2.7	16.1	3.1	4.5	2.5	2.4	10.7	3.4	1.9	1.6	5.2	3.0	15.4	6.1	3.6	4.2	5.6	7.4	3.3	7.7	5.5	6.5	5.6	5.8	4.6	4.1
DOK5	"C20orf180, dJ805C22.1"	ENSG00000101134	"Docking protein 5"	Q9P104	20	54475597-54651171	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 41.3"	"Cell line enhanced"	"Detected in some"		"AF22: 19.3;ASC diff: 7.9;hTEC/SVTERT24-B: 8.1;U-138 MG: 30.5"	"Group enriched"	"Detected in many"	6	"glioma: 18.0;ovarian cancer: 29.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054460, HPA065235"	Uncertain		Approved	"Focal adhesion sites"				"Focal adhesion sites"	"Focal adhesion sites"	"HPA054460: AB_2682495, HPA065235: AB_2685441"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (8.90e-2)"	"prognostic unfavourable (8.99e-7)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.88e-4)"	"unprognostic (5.12e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.49e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.08e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.99e-2)"	3.5	2.7	15.5	2.3	11.0	0.6	2.0	1.4	14.8	1.8	1.3	6.6	0.4	1.0	2.1	1.0	2.4	13.6	10.6	18.1	11.0	12.5	3.6	3.2	1.0	1.2	8.4	6.2	2.4	1.9	0.9	1.2	2.4	7.3	1.6	1.4	7.6	1.7	1.5	41.3	0.6	1.1	3.5	5.4	0.9	0.9	2.2	6.4	0.0	5.9	6.4	1.0	3.6	3.5	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	19.3	0.0	7.9	6.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	2.6	0.0	8.1	0.0	1.0	0.0	2.3	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	2.0	4.1	0.0	5.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	30.5	1.9	0.8	0.0	0.0	0.0	0.1	1.3	0.0	2.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	11.0	1.4	12.6	11.0	12.5	8.4	6.2	7.3	6.4
DOK7	"C4orf25, Dok-7, FLJ33718, FLJ39137"	ENSG00000175920	"Docking protein 7"	Q18PE1	4	3463311-3501473	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 19.1;skeletal muscle: 17.0"	"Cell line enriched"	"Detected in some"	4	"MCF7: 27.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.0"	"Group enriched"	"Detected in some"	8	"cerebellum: 8.7;pons and medulla: 2.5"	"Group enriched"	"Detected in some"	14	"memory B-cell: 6.3;naive B-cell: 3.8;NK-cell: 3.2"	"Group enriched"	"Detected in many"	15	"B-cells: 6.3;NK-cells: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059449, HPA062780"	Approved		Enhanced	Nucleoplasm,Mitochondria				Nucleoplasm	Nucleoplasm	"HPA059449: AB_2684023, HPA062780: AB_2732688"	"prognostic favourable (8.45e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-2)"	"prognostic favourable (2.19e-4)"	"unprognostic (5.96e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.61e-3)"	"unprognostic (5.09e-1)"	"unprognostic (3.16e-2)"	"prognostic favourable (1.28e-4)"	1.2	0.5	0.1	0.2	0.2	0.2	0.5	8.7	0.7	1.5	0.3	1.4	0.1	0.1	1.3	4.7	1.1	5.0	3.7	19.1	0.4	0.6	1.4	0.4	1.7	0.7	0.1	0.1	1.3	4.3	0.0	9.7	0.1	2.5	0.7	0.1	2.4	2.0	6.4	17.0	0.3	0.1	0.7	0.1	0.6	2.2	5.3	0.4	0.1	0.6	1.8	0.6	0.6	0.1	6.3	0.0	0.0	0.0	3.2	0.3	0.2	2.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.9	0.0	1.0	0.0	3.4	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.3	27.1	0.0	1.1	0.2	0.1	0.0	5.3	0.2	1.8	2.3	0.4	0.1	2.2	0.0	0.0	6.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.3	0.0	3.8	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.2	0.1	0.2	8.7	0.7	0.4	0.6	0.1	0.1	2.5	0.4
DPF3	"BAF45c, cer-d4, Cerd4, FLJ14079"	ENSG00000205683	"Double PHD fingers 3"	Q92784	14	72619296-72894116	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.3;skeletal muscle: 28.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 13.4;BJ hTERT+ SV40 Large T+: 9.2;HEL: 22.8;Karpas-707: 9.3"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Region enriched"	"Detected in all"	5	"cerebellum: 56.3"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.1;naive B-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA066790, HPA070601"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA066790: AB_2685724, HPA070601: AB_2686284"	"unprognostic (2.38e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.98e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.54e-2)"	"unprognostic (9.71e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.85e-3)"	"unprognostic (4.08e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.96e-1)"	0.7	2.2	6.2	1.1	10.3	3.2	0.8	56.3	7.6	0.9	2.7	8.4	0.0	0.8	0.8	0.5	1.2	0.7	1.0	16.8	6.4	2.5	2.2	4.3	0.8	1.5	8.9	4.5	17.8	0.7	8.4	0.9	0.9	10.4	0.7	2.4	3.4	0.8	0.7	28.4	1.1	1.7	1.2	10.1	1.4	1.1	6.6	10.7	0.0	0.8	6.3	1.8	0.8	0.7	1.9	0.0	0.0	0.3	0.4	0.8	0.2	1.5	0.0	1.2	0.1	0.2	2.2	13.4	4.0	3.8	9.2	3.5	0.0	0.1	0.2	0.2	1.2	0.1	1.3	0.6	5.6	0.2	0.4	22.8	0.1	0.0	0.3	0.1	0.4	0.6	0.2	2.1	1.5	2.9	2.0	9.3	2.9	0.1	1.9	0.2	0.0	1.3	5.0	0.6	0.3	1.6	0.0	0.9	0.5	0.0	0.1	0.0	0.0	0.0	6.4	4.5	0.0	1.6	0.5	3.3	0.8	0.3	0.4	0.8	0.1	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.2	6.2	10.3	56.3	7.6	6.4	2.5	8.9	4.5	10.4	10.7
DPRX		ENSG00000204595	"Divergent-paired related homeobox"	A6NFQ7	19	53632056-53637009	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"placenta: 4.9;skeletal muscle: 4.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;HEK 293: 1.0;Hep G2: 1.1"	"Cancer enriched"	"Detected in single"	20	"thyroid cancer: 2.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043682	Uncertain									"HPA043682: AB_10963073"												"unprognostic (2.47e-1)"			"unprognostic (1.89e-1)"			2.0	0.0	0.1	0.0	0.1	0.0	1.3	0.1	0.0	0.2	0.1			0.0	0.1	1.8	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.1	1.6	0.0	0.1		0.0	0.0	0.0	0.0	4.9		0.7	0.0		0.0	0.1	4.2	0.5	0.0	0.1	0.1	0.1	0.0	1.6			0.0		0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0										
DUSP13	"BEDP, DUSP13A, DUSP13B, FLJ32450, TMDP"	ENSG00000079393	"Dual specificity phosphatase 13"	"Q6B8I1, Q9UII6"	10	75094432-75109221	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 75.2;testis: 18.6;tongue: 26.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.9;EFO-21: 5.7;Hep G2: 11.9;K-562: 4.6;LHCN-M2: 10.6;RH-30: 9.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	39	"neutrophil: 3.9"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 3.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"														"unprognostic (1.79e-1)"	"unprognostic (2.39e-2)"		"unprognostic (2.39e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.47e-3)"	"unprognostic (8.63e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.22e-7)"	"unprognostic (1.93e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.09e-2)"	0.8	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.3	1.2	0.0	0.0	5.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	2.3	0.0	75.2	0.1	0.0	0.0	0.0	0.1	0.0	18.6	0.0	0.0	1.0	26.0	1.9	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	1.1	0.1	0.0	5.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	11.9	0.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	4.6	0.0	10.6	0.6	0.0	0.0	0.7	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0
DUSP3	VHR	ENSG00000108861	"Dual specificity phosphatase 3"	P51452	17	43766121-43778988	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 19.5;granulocytes: 5.2;monocytes: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063616			Supported	Nucleoplasm,Cytosol		1300000	1300000	Nucleoplasm	Nucleoplasm	"HPA063616: AB_2685061"	"unprognostic (1.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-3)"	"prognostic unfavourable (3.00e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.98e-2)"	"unprognostic (5.13e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.40e-3)"	"prognostic favourable (5.49e-5)"	"unprognostic (2.67e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.37e-2)"	17.1	17.8	23.1	10.2	20.8	4.6	22.0	14.3	28.6	12.8	28.4	11.1	16.7	13.4	17.5	18.7	23.6	10.6	19.3	64.0	21.5	18.1	27.1	39.9	17.2	9.0	17.6	19.1	9.1	19.2	27.5	11.4	15.0	17.1	22.6	13.1	14.3	11.1	36.6	106.9	8.9	15.2	31.1	12.7	14.5	19.6	8.0	10.8	1.2	13.9	22.8	6.5	20.7	24.1	1.7	19.5	5.2	17.0	0.9	1.7	5.8	10.9	19.8	7.6	8.1	22.3	12.0	6.5	8.3	19.9	19.4	23.5	19.0	7.4	1.7	13.2	15.5	9.5	11.8	10.2	20.5	3.7	9.0	5.5	9.1	15.5	27.3	0.6	5.7	11.1	18.4	14.9	13.1	13.5	4.9	1.9	22.6	7.8	2.8	2.8	3.5	14.5	3.6	23.0	4.1	26.9	11.5	4.3	7.7	9.7	6.5	24.4	29.1	15.4	14.0	22.0	14.9	31.2	13.7	10.2	13.4	0.4	26.1	7.7	7.3	5.2	17.0	3.5	1.0	8.9	1.7	1.7	1.5	1.2	19.5	1.6	1.2	1.1	4.1	0.9	10.8	8.2	0.9	5.8	23.1	20.8	14.3	28.6	21.5	18.1	17.6	19.1	17.1	10.8
DVL1		ENSG00000107404	"Dishevelled segment polarity protein 1"	O14640	1	1335276-1349350	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 120.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011538	Approved									"CAB011538: AB_2093326"	"unprognostic (2.67e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.05e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.81e-3)"	"unprognostic (5.03e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.62e-3)"	"unprognostic (5.35e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.47e-1)"	"prognostic favourable (3.33e-4)"	"unprognostic (2.34e-2)"	"unprognostic (2.55e-2)"	13.2	14.1	18.8	7.7	17.1	5.9	12.5	13.9	25.7	8.4	10.4	13.3	12.2	17.9	9.4	8.0	15.4	11.6	8.0	21.4	18.1	11.9	8.0	12.2	9.6	6.2	12.7	17.3	12.5	34.3	10.3	10.6	10.0	13.5	10.8	4.7	7.3	36.5	10.4	120.4	17.0	16.1	12.7	11.8	9.3	18.3	15.0	12.2	2.8	9.0	13.9	6.8	9.8	17.5	2.1	2.0	0.9	2.1	0.8	1.6	0.6	25.3	13.2	5.4	11.5	5.3	6.5	13.3	15.6	7.5	12.4	6.2	10.2	32.2	8.1	23.6	6.9	15.8	4.3	15.8	1.9	9.9	24.8	4.6	23.6	18.3	11.3	7.0	7.2	5.5	9.8	16.5	11.4	4.2	17.6	5.7	5.0	10.3	6.8	11.7	8.6	50.5	11.6	4.3	13.9	9.0	4.0	21.1	14.5	7.5	20.5	20.7	11.3	11.9	8.3	7.0	18.2	27.1	26.0	9.1	3.6	9.8	20.7	9.9	4.4	0.9	2.1	0.1	1.6	1.8	1.5	2.1	1.3	1.3	0.7	0.3	1.4	0.7	0.8	0.8	1.2	2.0	0.9	0.6	18.8	17.1	13.9	25.7	18.1	11.9	12.7	17.3	13.5	12.2
DYRK1B	MIRK	ENSG00000105204	"Dual specificity tyrosine phosphorylation regulated kinase 1B"	Q9Y463	19	39825350-39834201	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.1"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 12.1;SH-SY5Y: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028522, HPA028786"	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA028522: AB_2672656, HPA028786: AB_10670831"	"unprognostic (2.22e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.67e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.22e-2)"	"prognostic favourable (8.83e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.88e-2)"	4.8	7.9	7.4	3.7	10.2	5.0	4.0	10.1	13.1	4.5	4.2	7.4	6.1	6.2	6.4	12.3	6.7	8.0	4.6	9.0	6.6	6.1	6.1	3.2	5.4	5.1	4.4	6.7	6.1	5.2	7.1	12.3	3.8	6.4	5.5	3.4	6.7	5.5	5.8	89.1	6.3	5.1	3.9	3.4	5.9	5.2	28.8	4.6	11.2	6.4	25.3	5.3	5.6	4.1	4.7	8.3	4.8	3.2	6.2	7.0	2.6	0.4	8.6	8.3	5.9	4.7	4.5	0.7	2.7	1.7	2.5	2.2	0.8	3.3	1.3	10.6	3.2	2.9	1.2	1.9	2.2	4.9	7.2	0.6	5.3	0.8	4.0	0.3	1.8	6.0	1.2	0.8	2.8	0.6	1.3	1.9	0.4	4.2	1.9	0.7	2.0	1.9	0.9	0.1	0.6	5.4	2.1	12.1	13.7	4.2	4.2	0.2	4.1	0.5	4.2	1.1	1.9	0.9	0.8	3.1	1.0	0.9	7.1	0.8	0.4	1.2	3.1	3.2	5.9	3.2	7.0	4.7	4.0	5.9	3.5	3.5	2.2	3.5	4.8	6.2	2.9	8.3	4.2	2.6	7.4	10.2	10.1	13.1	6.6	6.1	4.4	6.7	6.4	4.6
DYSF	"FER1L1, LGMD2B"	ENSG00000135636	Dysferlin	O75923	2	71453722-71686768	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 39.9;skeletal muscle: 53.3"	"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 32.4;LHCN-M2: 29.4;RH-30: 31.1;TIME: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 19.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 19.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002510, HPA017071, HPA021945"	Enhanced		Supported	"Plasma membrane,Centriolar satellite"				"Plasma membrane, Centriolar satellite"	"Plasma membrane, Centriolar satellite"	"CAB002510: AB_442097, HPA017071: AB_1847927, HPA021945: AB_1847928"	"unprognostic (1.04e-1)"	"unprognostic (7.66e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.43e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.97e-3)"	6.6	2.1	1.1	7.2	1.3	18.6	7.9	1.2	2.0	1.9	6.4	0.0	3.9	1.6	4.2	4.9	5.1	3.6	3.3	20.8	1.2	2.0	4.7	13.4	9.1	17.8	2.1	0.7	4.1	1.4	2.0	2.1	39.9	7.0	4.8	1.9	3.3	1.9	3.6	53.3	1.7	3.3	12.1	1.4	26.5	3.2	1.5	0.3	0.8	4.9	8.3	1.0	8.7	11.9	0.0	0.0	19.9	2.6	0.3	0.3	0.7	0.4	0.0	1.3	1.1	0.0	0.0	2.4	0.0	0.3	0.8	0.6	0.1	0.3	0.0	4.8	0.0	0.9	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.9	4.2	32.4	3.1	0.0	29.4	0.0	0.0	2.1	3.2	0.3	0.0	31.1	0.0	1.0	0.0	0.0	0.0	1.5	0.2	0.0	0.1	0.3	21.2	0.1	1.5	0.1	0.4	0.0	0.0	0.0	0.0	5.1	0.0	0.0	2.6	0.0	0.3	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	19.9	0.3	0.1	0.0	0.0	0.7	1.1	1.3	1.2	2.0	1.2	2.0	2.1	0.7	7.0	0.3
ECHDC3	FLJ20909	ENSG00000134463	"Enoyl-CoA hydratase domain containing 3"	Q96DC8	10	11742366-11764070	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.1;skeletal muscle: 77.7"	"Cell line enhanced"	"Detected in many"		"A-431: 28.3;BEWO: 16.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"pons and medulla: 7.5"	"Cell type enhanced"	"Detected in many"		"eosinophil: 14.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 14.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA038306	Enhanced					93000	93000			"HPA038306: AB_10672586"	"unprognostic (8.74e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.07e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.53e-1)"	"prognostic favourable (3.43e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavourable (3.91e-4)"	29.9	9.9	0.7	4.7	1.3	2.5	53.8	1.2	1.3	5.1	5.9	1.5	4.4	0.6	3.3	4.9	14.0	3.5	2.3	47.7	0.6	0.5	26.4	64.1	9.8	8.2	0.8	0.4	4.6	23.6	0.8	4.4	6.8	7.5	6.9	1.4	7.7	16.0	6.4	77.7	5.7	3.2	2.5	1.0	6.1	6.7	6.7	0.8	1.4	11.2	10.8	6.2	3.4	4.6	1.2	1.8	14.3	1.8	0.5	0.5	0.3	28.3	4.2	0.0	0.0	0.0	0.0	16.2	3.6	0.0	2.6	2.3	10.4	0.2	0.0	3.2	7.7	6.9	6.6	1.0	1.1	0.0	0.3	0.0	4.3	0.0	11.8	0.0	4.2	8.0	6.6	2.7	0.0	5.1	10.3	0.0	0.8	3.9	0.0	0.1	7.5	0.0	8.7	0.0	0.0	2.0	0.0	3.1	4.7	0.0	7.3	0.0	11.4	1.3	1.5	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.9	1.8	14.3	0.0	0.6	0.1	0.2	0.2	0.5	1.8	1.2	0.3	0.1	3.6	0.5	0.6	0.6	0.0	0.3	0.7	1.3	1.2	1.3	0.6	0.5	0.8	0.4	7.5	0.8
ECI1	DCI	ENSG00000167969	"Enoyl-CoA delta isomerase 1"	P42126	16	2239395-2252300	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 90.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041746, HPA043227"	Enhanced		Enhanced	Mitochondria		11000000	11000000	Mitochondria	Mitochondria	"HPA041746: AB_10960693, HPA043227: AB_10960273"	"unprognostic (4.99e-2)"	"prognostic favourable (3.04e-5)"	"unprognostic (3.75e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.85e-2)"	"prognostic favourable (1.07e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.66e-2)"	"prognostic favourable (8.99e-8)"	"unprognostic (2.61e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.08e-3)"	15.7	12.5	12.5	9.8	10.8	9.1	16.8	12.8	11.3	10.9	27.6	9.7	20.3	30.9	10.6	16.7	15.5	13.4	17.3	56.4	10.1	10.3	36.5	57.4	10.3	10.7	12.4	8.8	10.8	30.4	11.1	11.9	10.6	13.0	13.4	8.4	16.3	40.9	19.1	90.3	10.4	31.2	14.1	10.1	8.0	17.2	8.4	9.6	10.4	38.7	25.4	10.5	14.4	11.5	7.6	6.5	3.9	7.1	5.8	6.7	1.7	7.3	17.5	6.7	27.6	2.6	3.6	25.3	7.4	5.1	6.1	9.0	30.9	22.5	10.6	18.6	4.6	18.1	7.9	7.0	0.8	18.4	40.4	3.2	16.4	38.1	23.6	9.5	1.5	6.8	16.7	5.0	11.0	6.1	17.6	22.6	2.0	30.2	0.9	14.3	15.6	17.8	33.4	7.3	51.1	11.6	8.3	23.2	14.7	17.9	33.9	22.4	21.8	17.0	5.0	4.8	18.0	5.1	8.2	25.0	14.7	17.3	6.3	8.9	6.7	3.2	6.8	2.7	3.8	7.1	6.0	7.6	5.5	2.9	5.5	7.4	6.7	5.6	3.9	5.8	4.2	6.5	6.7	1.7	12.5	10.8	12.8	11.3	10.1	10.3	12.4	8.8	13.0	9.6
ECPAS	"ECM29, FLJ22036, KIAA0368"	ENSG00000136813	"Ecm29 proteasome adaptor and scaffold"	Q5VYK3	9	111360692-111484745	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 92.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021646, HPA059795"	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA021646: AB_2670788, HPA059795: AB_2684127"	"unprognostic (1.64e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.42e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.72e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.05e-1)"	21.0	17.2	16.4	12.9	29.0	13.2	19.4	18.4	18.1	16.6	16.6	14.1	20.8	17.1	18.9	17.2	13.6	14.3	13.2	19.9	27.4	13.7	16.0	16.6	12.7	13.8	15.1	12.8	17.9	19.2	28.5	20.8	12.8	15.7	19.2	16.4	13.7	14.9	23.3	92.6	15.3	17.8	19.5	11.5	13.9	15.7	18.3	11.5	8.7	17.7	23.7	14.5	17.8	18.5	5.6	11.6	4.0	8.6	6.6	8.2	3.6	20.6	19.1	12.8	13.8	30.7	30.8	21.2	25.5	21.9	21.0	14.5	17.7	12.9	21.0	12.1	22.4	30.2	16.4	17.0	19.6	23.0	10.3	12.9	23.1	25.4	22.8	24.0	14.1	27.9	18.0	21.1	31.4	21.3	29.6	29.7	17.1	17.6	0.1	14.0	25.2	16.0	11.8	39.5	12.6	17.9	18.7	24.6	11.7	21.8	23.5	15.9	18.5	12.9	23.2	14.2	16.2	21.1	23.3	26.3	49.1	25.7	20.7	9.9	13.1	4.0	8.2	2.7	6.9	8.6	8.2	5.6	7.4	8.0	11.6	5.3	4.5	7.6	2.6	6.6	6.2	5.3	5.8	3.6	16.4	29.0	18.4	18.1	27.4	13.7	15.1	12.8	15.7	11.5
EFR3B	"FLJ37871, KIAA0953"	ENSG00000084710	"EFR3 homolog B"	Q9Y2G0	2	25042130-25159137	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.5;retina: 21.1;skeletal muscle: 25.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.9;BEWO: 10.4;SH-SY5Y: 9.3;SK-BR-3: 15.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038089, HPA071831"	Uncertain		Supported	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA038089: AB_10672618, HPA071831: "	"unprognostic (9.31e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (3.82e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.49e-6)"	"unprognostic (4.83e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-1)"	1.9	3.2	13.1	1.7	22.9	1.3	1.3	15.5	30.5	1.4	1.7	9.4	0.0	1.4	1.8	8.4	1.3	1.8	1.5	6.9	11.4	8.7	1.4	1.1	4.4	1.3	8.7	13.5	1.4	1.3	2.4	4.1	3.2	29.9	1.5	1.8	21.1	1.1	2.0	25.1	1.7	1.3	2.6	7.8	4.3	2.2	3.5	9.0	0.0	4.5	0.2	1.1	1.4	0.7	1.0	0.6	4.4	0.5	1.0	0.7	0.1	0.1	7.0	8.2	8.9	0.5	0.1	10.4	0.8	0.2	0.4	0.1	5.6	0.3	0.1	0.5	1.2	0.5	6.5	0.0	0.1	1.3	1.6	1.3	0.3	0.5	0.0	0.1	0.7	0.1	0.0	2.0	0.1	0.2	0.1	0.4	0.2	0.8	0.2	0.4	1.6	5.6	0.6	7.9	0.2	0.1	0.2	3.5	9.3	1.0	15.6	5.0	0.8	0.1	0.5	0.5	2.4	3.6	1.7	0.6	0.7	0.1	6.4	0.1	1.7	4.4	0.4	1.1	0.7	0.3	0.5	0.6	0.4	0.6	0.3	1.0	0.4	0.7	1.7	1.0	0.5	0.6	0.2	0.1	13.1	22.9	15.5	22.7	11.4	8.7	8.7	13.5	29.9	9.0
EGFLAM	"AGRINL, AGRNL, FLJ39155, PIKA"	ENSG00000164318	"EGF like, fibronectin type III and laminin G domains"	Q63HQ2	5	38258409-38465021	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 54.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 7.0;HBEC3-KT: 8.5;hTERT-HME1: 11.3;HUVEC TERT2: 10.9;LHCN-M2: 25.0;U-2 OS: 10.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA066577	Approved				"Secreted - unknown location"					"HPA066577: "	"unprognostic (2.05e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.63e-3)"	"unprognostic (6.31e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.80e-2)"	"prognostic unfavourable (4.47e-5)"	"unprognostic (7.02e-6)"	"unprognostic (2.60e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.04e-2)"	18.6	10.4	0.8	3.1	2.6	0.0	25.9	1.5	0.7	7.8	4.0	1.5	5.1	0.8	9.3	9.2	6.3	3.9	4.0	7.8	0.6	1.1	4.8	3.5	1.5	11.0	1.3	0.6	16.6	1.4	2.1	3.0	25.7	3.5	9.9	1.5	19.8	6.6	11.1	54.7	2.9	2.3	3.5	2.2	8.1	1.8	9.1	1.3	4.9	4.6	19.4	4.2	6.0	6.9	0.1	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.0	4.5	0.1	0.5	0.1	0.0	1.9	0.0	0.3	0.0	0.0	0.0	0.1	7.0	0.0	0.0	0.0	8.5	0.0	0.0	1.1	0.0	4.0	0.0	2.0	0.0	0.0	3.8	0.0	0.0	11.3	10.9	0.0	0.0	25.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	2.7	0.0	2.5	0.1	0.0	0.1	0.0	0.1	10.9	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	2.6	1.5	0.7	0.6	1.1	1.3	0.6	3.5	1.3
EHBP1L1	"DKFZp762C186, TANGERIN"	ENSG00000173442	"EH domain binding protein 1 like 1"	Q8N3D4	11	65576038-65592650	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA039479	Approved					25000	25000			"HPA039479: AB_10795678"	"unprognostic (1.87e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.41e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (1.45e-4)"	"unprognostic (6.10e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.10e-1)"	11.7	3.3	3.7	21.1	5.7	19.9	7.9	2.4	2.9	17.5	30.7	3.6	15.5	10.1	20.9	16.6	22.5	15.1	29.7	14.3	3.9	2.3	5.4	3.6	12.0	17.9	5.9	2.1	9.7	2.7	2.6	3.3	8.1	6.1	17.7	5.1	11.2	7.2	16.9	87.8	6.8	17.6	50.3	4.5	32.4	14.6	3.7	4.2	7.9	4.2	36.2	19.4	27.8	19.7	0.3	0.6	2.8	1.9	0.1	0.4	0.2	14.6	15.4	0.5	8.3	4.1	10.4	3.1	11.7	8.7	5.7	3.0	5.1	13.1	5.1	19.8	17.0	20.8	2.9	11.1	1.3	14.0	0.4	11.9	18.0	4.4	3.9	2.5	11.3	8.9	7.6	14.2	2.6	5.7	18.1	21.3	5.2	12.7	4.5	10.0	0.6	12.9	12.0	0.1	17.1	5.2	7.5	0.3	6.5	6.5	5.8	11.8	8.3	12.5	9.8	15.6	16.6	21.8	0.2	36.9	23.1	2.6	23.3	7.0	9.0	0.3	1.5	0.1	0.4	1.9	0.2	0.3	0.2	0.1	0.5	0.1	0.1	0.2	2.8	0.1	0.8	0.6	0.1	0.2	3.7	5.7	2.4	2.9	3.9	2.3	5.9	2.1	6.1	4.2
EIF1	"A121, EIF-1, EIF1A, ISO1, SUI1"	ENSG00000173812	"Eukaryotic translation initiation factor 1"	P41567	17	41688885-41692668	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 310.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"														"unprognostic (1.43e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.13e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.23e-3)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (9.45e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.63e-3)"	82.5	56.0	51.7	44.2	59.6	197.5	80.3	43.2	63.7	53.0	55.1	54.5	43.6	54.6	54.7	33.1	55.5	46.0	46.9	86.0	48.2	41.8	51.4	70.8	51.3	72.4	87.8	55.0	68.1	104.6	35.3	51.6	44.0	67.8	44.8	32.3	43.7	92.7	45.9	310.6	54.2	47.2	67.3	63.5	52.8	61.2	54.7	68.3	44.4	46.2	78.7	41.4	60.3	80.6	48.0	42.4	138.7	61.5	30.3	60.0	68.8	38.4	20.2	23.4	22.0	47.3	44.0	22.5	51.5	36.9	28.3	27.9	11.8	27.7	52.2	40.9	38.8	48.7	31.3	34.9	27.5	55.2	26.6	27.3	10.5	17.3	98.4	43.2	54.5	52.9	67.7	38.5	94.8	27.7	43.3	80.5	26.5	10.7	50.8	27.6	20.1	38.9	25.8	50.4	51.5	24.8	18.4	29.0	37.2	31.0	58.0	112.2	40.7	31.5	43.4	27.9	42.8	57.9	51.0	119.7	99.1	42.2	39.6	27.2	35.1	138.7	50.8	63.8	38.9	61.4	48.1	48.0	52.9	45.3	42.4	45.2	55.7	47.7	52.8	30.3	61.5	42.3	60.0	68.8	51.7	59.6	43.2	63.7	48.2	41.8	87.8	55.0	67.8	68.3
EIF1AY		ENSG00000198692	"Eukaryotic translation initiation factor 1A, Y-linked"	O14602	Y	20575725-20593154	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 78.3;skeletal muscle: 124.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 37.3;HEL: 45.7;U-266/84: 32.3;U-698: 73.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA002561	Uncertain	Supported	Approved	Cytosol				Cytosol	Cytosol	"HPA002561: AB_1078724"			"unprognostic (4.31e-2)"		"unprognostic (3.74e-1)"	"unprognostic (2.14e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.89e-2)"		"unprognostic (4.18e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.10e-2)"	"unprognostic (8.53e-3)"	"unprognostic (2.89e-1)"		"unprognostic (6.03e-2)"	5.9	8.3	7.0	18.6	8.3	29.2	5.0	4.5	10.9	0.0	12.6	10.0	22.2	9.0	0.1	20.2	9.9	0.0	10.5	78.3	6.5	10.4	9.1	23.0	13.3	22.8	8.2	0.0	0.1	15.0	0.2	11.4	10.3	13.4	17.4	16.1	8.8	13.1	22.9	124.6	4.2	17.9	28.2	9.2	45.8	6.5	13.1	0.0	28.7	6.2	48.9	15.9	8.9	0.0	22.1	23.0	44.5	8.0	7.8	11.9	5.0	0.1	5.4	0.0	0.0	0.0	0.0	11.3	12.1	8.1	8.4	8.3	0.0	0.0	37.3	0.0	6.4	0.0	0.0	0.0	11.6	20.1	0.0	45.7	0.0	13.6	8.4	0.0	0.0	4.5	9.3	0.0	0.0	0.0	0.0	0.0	13.5	0.0	29.4	0.0	8.1	0.0	0.0	15.3	14.8	11.8	14.1	10.8	0.0	0.0	0.0	8.3	0.0	6.4	12.0	6.5	0.1	0.0	13.1	22.5	32.3	73.3	2.5	0.0	0.0	10.0	6.7	9.3	5.2	7.7	7.3	19.2	9.5	6.1	5.7	22.1	11.9	9.0	44.5	7.8	8.0	23.0	10.9	5.0	7.0	8.3	4.5	10.9	6.5	10.4	8.2	0.0	13.4	0.0
EIF3J	"eIF3-alpha, eIF3-p35, eIF3j, EIF3S1"	ENSG00000104131	"Eukaryotic translation initiation factor 3 subunit J"	O75822	15	44537057-44563029	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 134.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA050977	Approved		Enhanced	Cytosol		8600	8600	Cytosol	Cytosol	"HPA050977: AB_2681297"	"unprognostic (4.47e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.47e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.01e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.52e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.76e-1)"	"prognostic unfavourable (4.96e-5)"	23.7	17.8	24.7	21.0	21.9	16.4	22.8	16.6	23.1	15.6	18.4	13.2	20.5	17.7	15.8	17.2	28.0	11.9	14.8	36.8	22.8	23.7	23.3	46.3	14.7	18.3	26.3	19.2	15.0	35.1	17.3	22.9	22.9	31.6	17.1	20.0	6.9	27.0	25.4	134.3	18.9	16.6	18.6	29.0	20.9	18.4	14.7	20.9	17.0	19.2	27.3	24.9	23.0	20.6	26.7	33.2	22.6	19.2	28.2	23.9	6.4	22.3	11.9	19.5	12.2	13.9	14.1	23.9	35.4	10.5	24.7	16.8	37.7	13.7	20.7	41.7	14.8	42.4	31.3	22.6	30.3	23.1	15.9	47.1	29.4	23.9	26.2	50.4	21.0	12.5	30.3	17.0	33.4	26.5	61.2	27.3	22.1	15.7	25.3	34.4	11.9	19.5	29.6	33.5	30.7	28.1	26.8	26.4	16.2	32.7	31.1	19.6	26.1	41.9	31.2	26.9	31.9	28.8	47.6	32.5	61.1	52.2	18.7	55.1	25.3	22.6	19.2	16.8	17.4	18.3	21.0	26.7	23.2	22.3	22.2	24.7	22.8	23.9	7.7	28.2	16.3	33.2	23.6	6.4	24.7	21.9	16.6	23.1	22.8	23.7	26.3	19.2	31.6	20.9
EMC10	"C19orf63, HSM1, HSS1, INM02"	ENSG00000161671	"ER membrane protein complex subunit 10"	Q5UCC4	19	50476400-50490870	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 147.8"	"Cell line enhanced"	"Detected in many"		"HEK 293: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053905	Uncertain				"Secreted to blood"					"HPA053905: AB_2682303"	"unprognostic (2.48e-1)"	"unprognostic (1.93e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.65e-1)"	"unprognostic (6.94e-2)"	"unprognostic (8.38e-3)"	"unprognostic (3.23e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.99e-1)"	"prognostic favourable (4.39e-4)"	"unprognostic (5.01e-2)"	"prognostic favourable (6.64e-6)"	"unprognostic (2.81e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.44e-1)"	17.8	24.4	21.9	12.4	21.2	17.2	11.1	10.8	32.1	14.5	22.4	41.1	23.1	23.4	17.4	24.9	14.4	22.7	24.9	21.9	21.8	19.2	33.8	43.2	15.3	19.8	23.0	20.0	22.4	25.6	32.5	48.2	21.1	22.2	20.5	8.7	29.8	29.4	19.0	147.8	13.9	28.7	8.5	31.4	14.6	33.1	24.3	19.1	15.4	34.0	13.7	16.4	12.6	11.7	12.2	10.8	11.2	10.5	4.7	10.3	6.8	16.9	21.0	0.8	8.2	2.4	3.0	0.2	16.6	3.0	1.4	1.6	0.2	11.7	5.6	0.2	2.9	14.3	1.0	2.7	0.5	21.6	51.3	1.1	9.3	0.0	4.0	4.9	33.0	3.6	3.0	1.5	1.1	3.6	10.8	12.0	3.0	11.9	7.7	0.1	0.0	36.6	13.3	2.6	18.0	6.6	15.5	13.1	29.1	24.4	7.9	8.6	8.2	8.9	6.8	1.0	22.6	6.2	8.9	13.3	33.2	4.7	6.7	3.4	8.2	7.8	10.5	11.2	8.1	8.0	6.9	9.4	8.6	8.6	7.7	12.2	10.3	10.0	4.5	4.7	5.9	10.8	6.8	6.8	21.9	21.2	10.8	32.1	21.8	19.2	23.0	20.0	22.2	19.1
EMC6	"MGC2963, TMEM93"	ENSG00000127774	"ER membrane protein complex subunit 6"	Q9BV81	17	3668815-3669668	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062681	Uncertain		Approved	Nucleoplasm,Centrosome				Centrosome	Centrosome	"HPA062681: AB_2684831"	"unprognostic (2.21e-1)"	"prognostic unfavourable (7.73e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.20e-3)"	"unprognostic (4.03e-2)"	"prognostic unfavourable (9.39e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.58e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.32e-2)"	14.6	18.5	15.5	12.2	15.5	21.4	12.5	9.9	21.2	8.9	15.9	14.9	10.0	16.9	9.8	10.8	15.6	9.5	12.1	26.2	14.5	12.3	19.8	42.1	10.2	10.7	14.2	11.0	8.7	24.5	7.6	9.3	16.6	12.2	12.9	9.7	14.6	17.8	10.5	100.1	10.6	16.8	10.1	13.6	12.5	18.8	27.4	11.1	14.3	14.9	31.5	14.3	9.7	9.1	34.5	56.1	40.7	42.0	25.2	43.4	38.5	30.6	30.2	13.2	13.8	9.5	7.7	25.5	22.0	10.8	18.1	16.7	18.2	11.5	19.3	32.1	10.2	29.6	15.3	15.5	13.1	18.6	57.1	14.0	21.2	25.3	13.8	9.7	14.4	9.6	17.7	16.6	11.7	13.7	17.5	14.0	13.2	18.6	19.8	28.6	19.0	34.1	18.5	12.3	18.3	25.3	8.7	10.9	19.8	18.1	14.2	23.4	16.5	10.5	15.0	15.2	18.9	22.9	32.2	13.7	15.1	12.7	23.8	12.7	18.2	34.5	42.0	40.7	34.9	39.7	32.0	34.5	39.0	38.3	35.8	32.3	40.6	36.7	31.6	25.2	27.9	56.1	43.4	38.5	15.5	15.5	9.9	21.2	14.5	12.3	14.2	11.0	12.2	11.1
EPDR1	"EPDR, MERP-1, MERP1, UCC1"	ENSG00000086289	"Ependymin related 1"	Q9UM22	7	37683843-37951941	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 57.6;skeletal muscle: 55.8"	"Cell line enhanced"	"Detected in many"		"U-937: 36.6;WM-115: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 5.4"	"Group enriched"	"Detected in many"	9	"dendritic cells: 5.4;NK-cells: 1.9;T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB026298	Approved				"Intracellular and membrane"					"CAB026298: AB_425991"	"unprognostic (1.99e-2)"	"unprognostic (9.30e-2)"	"unprognostic (4.44e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.85e-2)"	"prognostic unfavourable (6.97e-4)"	"unprognostic (2.53e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.88e-2)"	"prognostic unfavourable (3.43e-4)"	"unprognostic (4.13e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (1.00e-4)"	11.2	23.3	21.9	2.2	16.0	2.1	4.8	30.5	30.5	21.5	4.9	7.5	1.6	7.0	22.4	7.4	4.6	15.5	5.3	13.9	20.3	34.3	8.6	6.0	13.8	2.9	25.3	18.8	18.6	5.7	5.8	4.6	2.8	57.6	18.5	4.7	8.0	7.3	22.6	55.8	1.5	6.8	16.4	13.9	8.3	3.4	6.7	5.2	5.2	16.1	7.7	1.7	4.7	8.5	0.0	5.4	0.2	0.3	1.9	1.9	0.4	0.0	23.9	2.0	0.0	18.8	6.8	0.0	1.8	0.0	0.9	2.9	2.3	1.5	0.0	27.1	26.5	0.0	0.5	0.2	0.0	0.0	3.0	10.4	3.3	14.6	0.1	8.6	0.0	11.4	0.0	6.7	0.1	0.0	0.0	7.9	15.9	1.5	3.3	7.3	7.4	3.5	10.6	6.9	9.1	14.7	5.8	2.6	9.2	0.0	1.2	8.3	0.0	6.1	0.0	5.3	8.9	14.4	11.0	10.7	4.5	0.1	24.1	36.6	35.6	0.0	0.3	0.2	1.7	0.3	0.0	0.0	0.0	1.9	1.0	0.0	0.1	1.1	0.2	1.9	0.0	5.4	0.0	0.4	21.9	16.0	30.5	30.5	20.3	34.3	25.3	18.8	57.6	5.2
EPM2A	"LD, LDE"	ENSG00000112425	"EPM2A, laforin glucan phosphatase"	O95278	6	145382535-145736023	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 19.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 5.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA053643, HPA055468"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA053643: AB_2797247, HPA055468: AB_2797252"	"unprognostic (2.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-4)"	"unprognostic (2.28e-1)"	"prognostic favourable (4.08e-7)"	"unprognostic (4.12e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.23e-1)"	5.4	6.0	8.8	1.9	9.0	2.2	3.6	4.0	8.9	3.9	11.1	8.6	2.5	3.4	4.8	4.8	8.9	4.3	3.9	19.4	9.6	8.7	8.0	5.7	3.5	3.4	11.9	5.5	5.9	2.9	5.5	3.3	2.0	9.6	6.2	3.4	5.6	3.1	9.2	60.9	2.4	3.3	13.9	13.6	2.5	4.6	3.3	7.1	3.7	4.2	15.7	2.9	10.4	6.0	1.4	1.0	0.3	1.4	5.4	2.4	1.0	1.1	1.7	3.2	6.2	8.0	2.5	1.4	2.9	3.4	2.7	3.4	1.5	1.6	19.9	2.5	3.5	1.7	1.2	1.2	2.5	7.7	1.6	3.2	2.3	2.5	4.9	11.0	2.0	2.0	6.6	1.6	0.5	1.9	1.4	5.1	3.4	2.6	7.3	2.4	3.3	1.7	4.2	2.9	5.8	2.4	1.6	6.0	5.9	5.2	3.1	6.8	1.8	6.4	4.2	2.8	1.3	2.6	2.3	3.7	3.7	8.0	2.4	2.7	4.3	0.0	0.1	0.1	0.4	1.4	1.1	1.3	1.1	0.9	1.0	1.4	1.2	2.4	0.3	5.4	0.3	0.9	0.2	1.0	8.8	9.0	4.0	8.9	9.6	8.7	11.9	5.5	9.6	7.1
ERFE	"C1QTNF15, CTRP15, FAM132B, FLJ37034"	ENSG00000178752	Erythroferrone	Q4G0M1	2	238158982-238168900	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 12.4;testis: 13.8;thyroid gland: 25.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 13.9;REH: 13.8;RH-30: 17.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.2"	"Region enhanced"	"Detected in many"		"cerebellum: 9.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"						"unprognostic (1.66e-1)"	"unprognostic (9.14e-2)"	"unprognostic (3.64e-4)"	"prognostic unfavourable (3.75e-4)"	"unprognostic (2.84e-1)"	"unprognostic (9.61e-4)"	"unprognostic (4.68e-3)"	"unprognostic (3.16e-3)"	"unprognostic (9.63e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.31e-4)"	"unprognostic (7.13e-2)"	"prognostic unfavourable (2.46e-4)"	"unprognostic (4.10e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.33e-2)"	1.6	0.0	2.4	2.5	1.0	3.5	0.1	9.2	2.5	2.1	0.5	0.4	0.1	0.6	0.9	3.0	0.8	0.1	0.3	3.2	1.9	0.1	3.3	0.3	0.5	0.1	0.1	0.7	0.4	0.3	0.2	0.1	3.5	0.5	0.4	0.3	0.4	1.5	1.6	12.4	0.0	1.1	0.5	0.1	0.5	0.7	13.8	0.1	0.4	25.6	4.8	0.4	1.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.9	2.1	0.6	0.9	1.9	0.1	3.3	0.2	1.3	2.0	3.5	5.7	0.1	5.1	0.0	3.9	0.3	0.2	9.1	0.4	3.1	0.0	13.9	0.0	0.2	0.1	1.2	0.0	0.9	7.2	1.0	13.5	9.6	0.1	3.0	0.0	8.9	2.8	0.0	5.7	1.5	0.9	13.8	17.5	0.5	7.1	0.0	0.3	5.3	2.1	0.3	7.8	0.3	10.3	0.8	5.4	5.0	2.1	7.1	0.0	0.0	0.6	9.1	2.9	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.4	1.0	9.2	2.5	1.9	0.1	0.1	0.7	0.5	0.1
ESRRA	"ERR1, ERRa, ERRalpha, ESRL1, NR3B1"	ENSG00000173153	"Estrogen related receptor alpha"	P11474	11	64305572-64316743	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 78.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053785			Supported	"Nucleoplasm,Nucleoli fibrillar center,Microtubules,Cytokinetic bridge"				"Nucleoplasm, Nucleoli fibrillar center, Microtubules"	"Nucleoplasm, Nucleoli fibrillar center, Microtubules"	"HPA053785: AB_2682260"	"unprognostic (7.63e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-1)"	"prognostic favourable (1.34e-7)"	"unprognostic (3.43e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.38e-2)"	"unprognostic (7.20e-2)"	8.2	9.6	6.0	8.9	7.7	7.9	17.8	9.8	9.4	4.3	32.4	4.9	18.3	43.1	4.6	6.2	17.1	4.1	15.7	45.2	6.8	5.0	21.4	26.9	8.7	9.2	10.4	5.2	2.5	20.5	10.1	4.6	11.0	8.0	7.5	12.6	6.0	28.7	14.9	78.3	10.5	46.4	7.1	7.4	9.3	14.1	2.2	6.0	6.0	8.2	27.1	10.0	8.5	12.0	4.1	4.2	8.5	8.4	2.6	5.4	2.4	9.7	15.6	3.9	9.4	5.3	5.1	21.2	9.6	4.7	3.6	3.6	14.4	11.9	13.4	18.0	5.1	25.1	6.5	12.9	1.4	9.0	8.4	8.6	18.5	11.3	7.3	14.6	21.8	7.2	19.7	8.1	10.7	5.0	14.5	7.4	5.9	21.9	7.1	20.8	10.8	29.7	7.7	7.6	29.9	12.0	20.6	8.2	10.1	4.9	32.7	30.9	10.1	14.5	10.8	6.6	7.9	18.5	9.7	11.4	9.4	8.8	10.7	14.4	5.2	0.3	4.7	7.1	4.4	8.4	4.4	2.9	3.8	3.1	4.2	4.1	4.1	5.4	8.5	2.6	7.5	3.2	5.1	2.4	6.0	7.7	9.8	9.4	6.8	5.0	10.4	5.2	8.0	6.0
FAM160A1	FLJ43373	ENSG00000164142	"Family with sequence similarity 160 member A1"	Q05DH4	4	151409216-151663632	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 33.6"	"Cell line enhanced"	"Detected in many"		"A-431: 8.1;HaCaT: 7.4;HeLa: 9.9;hTERT-HME1: 9.3;SiHa: 8.8;SK-BR-3: 7.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"amygdala: 3.0;cerebellum: 7.5;pons and medulla: 4.8"	"Cell type enriched"	"Detected in single"	13	"plasmacytoid DC: 5.8"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046348	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA046348: AB_10966145"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.37e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.51e-12)"	"unprognostic (2.41e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.28e-1)"	1.4	1.2	3.0	3.4	0.8	1.5	3.8	7.5	0.9	6.3	5.2	0.6	10.4	1.7	6.1	5.9	13.1	2.8	4.9	6.5	0.7	0.7	7.0	1.6	5.4	0.1	0.6	0.0	3.7	23.7	11.1	9.4	1.8	4.8	4.5	3.3	10.0	11.1	12.5	33.6	12.6	9.0	1.8	0.7	0.7	2.3	3.5	0.0	0.9	11.4	22.0	10.0	6.2	5.0	0.0	5.8	0.4	0.0	0.1	0.1	0.0	8.1	0.7	0.0	0.2	0.0	0.0	3.0	0.4	1.9	0.8	0.2	3.5	3.0	0.0	0.9	0.1	7.4	2.1	6.2	1.2	0.0	3.6	0.0	9.9	0.8	0.0	0.0	0.1	0.1	6.2	0.0	9.3	0.1	0.0	0.0	0.5	1.2	0.0	0.0	2.9	0.8	0.0	2.0	0.3	4.3	5.6	1.4	0.4	8.8	7.8	0.0	3.3	0.0	0.0	0.5	3.6	0.2	1.4	0.0	0.0	0.0	2.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	5.8	0.0	0.0	3.0	0.8	7.5	0.9	0.7	0.7	0.6	0.0	4.8	0.0
FAM189A2	"C9orf61, X123"	ENSG00000135063	"Family with sequence similarity 189 member A2"	Q15884	9	69324567-69392558	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 40.1;thyroid gland: 38.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.3;NTERA-2: 8.3;RPTEC TERT1: 3.1;RT4: 3.6;SK-MEL-30: 8.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 22.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029411, HPA057207"	Approved									"HPA029411: AB_10602338, HPA057207: AB_2683369"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"prognostic favourable (1.16e-6)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.71e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.07e-2)"	"prognostic favourable (1.75e-5)"	"unprognostic (3.42e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.14e-1)"	3.2	3.1	9.2	1.5	11.6	0.8	13.2	4.5	12.2	25.6	3.9	11.4	8.3	1.8	5.6	2.5	5.3	6.0	2.9	11.5	10.3	4.1	2.0	0.8	21.4	1.3	7.2	4.9	15.0	5.2	8.5	4.7	2.2	20.0	8.9	1.9	6.7	6.4	5.0	40.1	6.7	2.3	6.0	17.1	1.1	9.0	1.5	9.3	3.7	38.0	6.0	1.6	4.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.1	1.1	0.0	0.0	0.9	2.7	0.1	2.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	8.3	0.0	0.0	0.2	0.0	3.1	3.6	0.0	0.1	0.0	0.0	8.0	0.2	0.0	1.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	11.6	4.5	12.2	10.3	4.1	7.2	4.9	20.0	9.3
FAM220A	"ACPIN1, C7orf70, MGC12966, SIPAR"	ENSG00000178397	"Family with sequence similarity 220 member A"	Q7Z4H9	7	6329409-6348981	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.7;testis: 40.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA055050			Approved	Vesicles				Vesicles	Vesicles	"HPA055050: AB_2682684"	"unprognostic (3.49e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.69e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.26e-2)"	"unprognostic (4.02e-2)"	"prognostic unfavourable (5.17e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.14e-2)"	"prognostic unfavourable (3.47e-4)"	"unprognostic (3.71e-2)"	5.8	6.9	10.5	5.1	9.3	2.3	7.7	14.0	16.6	7.5	6.1	6.8	3.8	4.3	8.1	6.1	8.9	6.2	5.9	12.6	10.3	9.7	6.5	5.1	4.9	6.8	8.3	11.6	8.7	10.5	15.3	7.2	6.0	7.9	6.6	4.4	5.6	7.2	6.9	56.7	7.7	4.6	7.3	7.9	5.8	5.3	40.9	5.4	9.7	9.1	11.8	7.7	7.5	6.3	11.1	9.6	9.5	5.5	16.2	10.2	3.8	15.8	10.0	7.4	17.2	17.1	14.5	8.1	8.1	10.2	9.9	11.6	6.6	8.9	13.2	9.4	9.6	11.7	11.1	6.9	12.9	9.2	7.1	4.4	8.0	7.4	18.5	7.9	6.7	8.1	23.3	7.4	17.9	9.2	8.5	12.7	8.5	12.4	4.9	14.6	17.2	13.1	12.7	11.1	11.1	9.0	5.8	7.5	13.1	11.4	14.1	17.0	13.6	20.9	6.9	7.8	18.0	15.2	10.4	13.7	21.2	14.4	9.1	14.4	24.0	6.7	5.5	9.5	5.5	4.5	5.7	11.1	6.6	8.5	9.6	10.6	10.2	8.4	2.4	16.2	4.7	7.7	8.3	3.8	10.5	9.3	14.0	16.6	10.3	9.7	8.3	11.6	7.9	5.4
FAM47E-STBD1		ENSG00000272414	"FAM47E-STBD1 readthrough"		4	76251721-76311129	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"liver: 38.2;skeletal muscle: 41.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 17.5;Karpas-707: 24.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA053331	Approved		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA053331: AB_2682115"	"unprognostic (3.52e-3)"		"unprognostic (3.44e-1)"		"unprognostic (1.53e-1)"		"unprognostic (8.98e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.92e-6)"	"unprognostic (5.59e-2)"		"unprognostic (1.52e-1)"	"unprognostic (3.77e-1)"	17.4	2.3	7.8	1.6	8.0	4.0	7.6	1.9	13.9	2.5	8.2	8.6	4.1	2.1	3.0	7.3	3.5	5.0	4.2	16.5	9.4	3.9	4.2	38.2	7.5	0.6	5.4	14.6	2.6	4.6	2.8	9.2	9.4	11.4	6.3	9.0	2.5	5.0	5.0	41.3	1.6	10.7	6.5	9.6	1.6	3.7	6.1	5.8	0.0	8.1	1.3	0.9	4.9	2.5	0.2	1.0	2.2	1.5	3.4	1.6	0.4	2.0	2.4	1.0	2.2	17.5	5.9	2.3	3.4	7.2	3.0	3.1	4.1	2.3	0.0	2.1	8.3	1.2	3.6	1.5	2.7	2.7	0.5	0.8	4.9	5.8	1.9	1.8	2.5	2.5	9.2	2.8	3.7	0.3	0.2	24.4	7.2	3.8	0.0	1.8	1.0	1.7	0.0	0.5	1.5	3.4	6.1	1.0	4.3	1.5	4.8	0.1	1.0	1.0	0.9	1.5	0.7	3.9	3.0	5.8	2.7	0.0	4.3	1.9	1.3	0.0	0.5	2.2	1.1	1.5	0.6	0.2	1.1	1.2	0.9	0.1	0.9	1.3	1.3	3.4	0.1	1.0	1.6	0.4	7.8	8.0	1.9	13.9	9.4	3.9	5.4	14.6	11.4	5.8
FAM78A	"C9orf59, FLJ00024"	ENSG00000126882	"Family with sequence similarity 78 member A"	Q5JUQ0	9	131258076-131276547	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.7;skeletal muscle: 32.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 18.1;HEL: 17.1;HL-60: 16.9;NB-4: 26.6;THP-1: 23.8;U-937: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021472, HPA023914"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"			"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA021472: AB_1848411, HPA023914: AB_1848412"	"unprognostic (5.16e-2)"	"prognostic favourable (3.67e-4)"	"unprognostic (3.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.71e-1)"	"prognostic favourable (2.00e-4)"	"unprognostic (3.24e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.83e-1)"	"unprognostic (5.84e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.61e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.39e-1)"	4.9	1.5	2.9	9.3	4.6	12.4	2.5	1.1	4.3	1.0	1.6	3.4	0.8	1.8	1.2	1.1	1.1	1.1	2.0	19.2	3.8	2.0	2.1	2.5	8.0	18.4	4.3	1.0	1.8	0.8	0.8	1.0	5.8	3.2	1.3	1.1	5.4	2.7	0.7	32.3	0.8	6.1	1.2	3.6	15.9	2.3	20.1	2.4	23.7	1.5	1.8	15.0	3.1	0.8	14.4	5.2	14.5	10.9	2.5	10.5	6.9	0.3	0.1	1.1	2.5	0.8	0.2	18.1	0.2	0.1	0.2	0.1	0.1	0.1	7.5	0.1	0.1	0.0	7.3	0.1	0.0	1.9	0.6	17.1	0.2	0.1	0.3	16.9	0.7	0.2	0.3	0.0	0.0	10.0	6.0	2.1	0.2	2.6	0.7	26.6	1.2	0.2	1.8	1.0	10.5	0.1	0.0	0.7	0.9	1.0	0.3	1.0	0.6	23.8	0.2	1.0	1.1	0.6	0.0	1.6	0.8	4.4	0.1	15.9	0.2	0.4	8.6	14.5	8.6	10.9	6.8	12.5	8.3	9.3	5.2	14.4	10.5	8.7	8.8	2.5	8.1	2.4	8.2	6.9	2.9	4.6	1.1	4.3	3.8	2.0	4.3	1.0	3.2	2.4
FASTK	FAST	ENSG00000164896	"Fas activated serine/threonine kinase"	Q14296	7	151076593-151080866	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031621, CAB032539"	Approved		Approved	"Nuclear speckles,Mitochondria"				Mitochondria	Mitochondria	"CAB032539: AB_2101115, HPA031621: AB_10611966"	"unprognostic (7.67e-2)"	"unprognostic (6.41e-3)"	"prognostic unfavourable (4.73e-4)"	"unprognostic (2.60e-1)"	"unprognostic (1.75e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.66e-2)"	"prognostic favourable (3.99e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.79e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.17e-2)"	13.8	16.8	18.8	15.7	19.0	6.4	10.2	19.0	26.4	18.0	20.6	13.4	20.3	21.2	12.4	14.6	20.3	16.7	16.8	35.7	17.6	12.9	17.7	25.6	9.5	10.4	12.0	15.0	14.4	20.7	20.2	21.8	18.5	12.0	16.8	10.6	14.0	21.7	17.9	89.5	14.4	25.8	11.3	9.2	14.9	14.8	10.6	10.9	11.2	16.8	28.1	16.9	17.4	11.8	15.4	26.0	19.7	22.3	13.1	19.0	14.5	15.7	18.4	5.9	14.1	22.0	9.9	9.8	12.7	17.3	10.8	13.0	12.7	13.7	3.7	17.3	17.1	10.3	5.6	15.2	2.9	10.8	10.1	4.6	4.6	10.8	27.9	3.2	10.4	13.0	22.3	12.5	9.2	12.7	6.7	7.9	12.5	31.7	7.7	9.2	9.9	21.7	5.1	7.1	11.8	14.7	10.9	7.0	7.3	16.7	26.0	16.9	14.0	12.6	10.4	13.8	3.0	12.9	11.2	21.2	12.9	2.4	27.5	7.2	15.8	10.5	22.3	19.7	16.4	21.7	17.1	13.7	17.3	16.9	19.4	15.4	19.0	16.3	4.8	13.1	20.8	26.0	18.7	14.5	18.8	19.0	19.0	26.4	17.6	12.9	12.0	15.0	12.0	10.9
FGF13	"FGF2, FHF2"	ENSG00000129682	"Fibroblast growth factor 13"	Q92913	X	138614731-139222777	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.7;parathyroid gland: 44.3;skeletal muscle: 37.0"	"Cell line enhanced"	"Detected in some"		"AF22: 19.5;fHDF/TERT166: 16.8;HAP1: 17.8;RPMI-8226: 15.1;U-2197: 31.4;WM-115: 16.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 7.4"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002809			Supported	Cytosol				Cytosol	Cytosol	"HPA002809: AB_1078855"	"unprognostic (3.23e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.87e-3)"	"unprognostic (9.92e-3)"	"unprognostic (2.97e-3)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-3)"	"unprognostic (5.22e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.96e-4)"	"unprognostic (4.36e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.48e-2)"	11.1	1.9	30.0	1.9	29.5	2.7	4.2	0.9	22.9	7.9	3.1	1.5	2.4	2.7	7.0	2.8	4.4	2.6	4.1	1.3	36.7	22.3	4.9	1.4	1.7	3.1	19.7	12.9	6.0	0.9	44.3	2.4	8.4	7.8	11.6	3.3	4.8	6.5	3.5	37.0	1.1	3.1	4.5	3.3	3.8	2.9	2.7	4.1	0.0	3.6	7.9	1.6	3.5	5.7	0.5	0.9	7.4	0.5	0.2	0.3	0.1	0.0	0.2	19.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	16.8	1.2	17.8	0.0	0.0	0.2	5.0	0.1	0.1	0.7	0.7	0.1	0.2	0.2	0.4	0.0	0.0	0.0	0.7	5.6	2.0	0.1	0.0	0.1	2.0	6.4	2.9	1.2	15.1	2.8	0.1	0.1	0.0	0.0	0.1	11.9	0.0	0.1	0.4	0.6	0.8	31.4	8.3	7.4	4.1	0.0	7.0	5.6	16.8	2.7	0.5	1.6	0.2	0.3	0.1	0.5	0.2	0.1	0.1	0.4	0.3	0.2	7.4	0.2	0.5	0.9	0.2	0.1	30.0	29.5	0.9	22.9	36.7	22.3	19.7	12.9	7.8	4.1
FHOD1	FHOS	ENSG00000135723	"Formin homology 2 domain containing 1"	Q9Y613	16	67229387-67247658	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 38.0;skeletal muscle: 61.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024468	Approved		Supported	Cytosol		2500000	2500000	Cytosol	Cytosol	"HPA024468: AB_1848568"	"unprognostic (6.53e-3)"	"prognostic unfavourable (9.57e-4)"	"unprognostic (5.42e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-2)"	"unprognostic (4.27e-2)"	"prognostic unfavourable (1.90e-8)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-3)"	"unprognostic (4.70e-2)"	8.3	7.5	2.5	5.1	4.4	2.9	7.9	4.7	2.8	4.2	5.3	2.5	3.8	3.3	3.9	4.7	2.5	3.4	5.6	3.7	2.3	1.3	4.8	2.3	12.5	4.4	4.0	0.7	12.9	3.4	2.5	2.5	5.8	4.2	4.2	2.6	4.0	5.7	4.0	61.1	2.5	3.9	3.5	5.6	38.0	2.9	2.2	3.0	2.7	8.2	11.1	5.8	2.6	3.5	0.5	2.0	2.2	3.0	1.3	1.4	2.1	4.3	11.9	4.4	3.6	18.1	10.9	15.0	9.2	7.6	10.6	10.3	8.2	5.7	5.2	6.7	6.7	5.3	5.2	7.5	5.3	4.1	8.3	23.2	4.6	8.9	4.8	9.5	42.6	13.5	0.9	16.2	1.5	16.4	12.0	3.2	6.6	14.9	6.4	17.1	6.7	3.8	7.4	10.0	12.3	3.3	1.7	1.4	7.4	14.5	8.3	8.4	8.9	7.6	19.0	14.4	8.4	8.8	7.4	11.1	11.3	7.6	29.6	9.0	13.1	1.5	3.0	0.5	1.1	1.2	1.4	0.1	1.3	1.0	2.0	0.5	0.8	0.6	2.2	1.3	1.0	1.2	1.2	2.1	2.5	4.4	4.7	2.8	2.3	1.3	4.0	0.7	4.2	3.0
FKBP3	"FKBP-25, PPIase"	ENSG00000100442	"FK506 binding protein 3"	Q00688	14	45115600-45135319	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 113.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000864, CAB012232, CAB012520"	Supported		Supported	Cytosol		980000	980000	Cytosol	Cytosol	"CAB012232: , CAB012520: AB_873554, HPA000864: AB_1078873"	"unprognostic (7.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.82e-3)"	"unprognostic (3.58e-3)"	"unprognostic (2.28e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.22e-3)"	"unprognostic (7.47e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.47e-1)"	11.7	13.2	28.1	10.2	40.7	9.8	15.5	25.1	32.1	12.0	14.6	11.4	8.3	13.2	9.9	20.4	14.6	8.8	9.1	31.3	26.0	24.4	16.5	20.5	8.0	14.6	23.2	23.8	9.9	10.9	15.0	17.1	14.0	22.9	17.9	15.2	6.6	10.7	12.2	113.3	11.3	13.9	12.8	19.6	9.9	10.6	13.5	22.4	12.7	12.4	24.2	16.5	12.7	9.3	19.5	27.5	13.5	17.4	15.4	19.4	13.0	36.9	41.2	60.0	31.5	26.7	29.2	23.7	22.7	26.1	36.0	39.7	36.0	31.8	19.7	24.0	25.6	30.8	44.5	29.3	51.3	28.5	26.6	16.2	32.0	46.5	26.4	28.0	17.6	27.5	30.6	20.9	19.5	46.8	23.4	14.9	42.6	45.2	44.8	37.5	30.4	39.1	43.2	44.2	23.9	57.5	42.8	36.6	14.3	36.4	22.7	34.8	53.1	21.0	30.1	27.5	47.6	14.4	17.4	25.1	44.6	30.7	16.6	19.3	25.6	11.6	14.6	13.5	13.0	17.2	15.7	19.5	17.5	17.6	21.8	13.6	16.8	18.8	2.3	15.4	17.4	27.5	19.4	13.0	28.1	40.7	25.1	32.1	26.0	24.4	23.2	23.8	22.9	22.4
FKBP5	"FKBP51, FKBP54, P54, PPIase, Ptg-10"	ENSG00000096060	"FK506 binding protein 5"	Q13451	6	35573585-35728583	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 277.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 101.4;ASC TERT1: 63.1;HHSteC: 79.4;HSkMC: 95.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009315, HPA031092, HPA031093, HPA031095"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB009315: AB_2278350, HPA031092: AB_10600195, HPA031093: AB_10601748, HPA031095: "	"unprognostic (2.09e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.72e-1)"	"unprognostic (6.30e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.18e-3)"	"unprognostic (8.31e-2)"	"unprognostic (4.22e-2)"	"unprognostic (6.90e-3)"	78.8	20.7	9.5	14.2	15.6	4.9	36.7	2.4	10.9	16.5	29.0	5.1	29.8	2.2	18.6	16.9	29.2	19.4	17.9	26.3	10.6	4.2	44.9	30.7	19.7	55.9	15.7	3.6	27.2	43.7	8.6	33.8	6.0	13.1	18.3	8.2	11.8	30.4	25.1	277.2	20.2	36.7	18.6	18.2	32.3	25.0	14.3	12.4	20.1	24.2	9.8	16.8	22.5	18.4	4.0	30.6	24.9	31.2	11.8	42.3	39.9	4.9	2.1	9.5	14.2	101.4	63.1	0.1	2.7	0.1	1.7	4.1	3.7	0.8	24.5	2.5	0.5	0.0	5.6	11.9	4.2	9.6	5.3	10.5	1.8	5.2	79.4	6.6	1.0	95.9	48.2	3.1	29.1	10.3	11.2	10.0	18.6	3.1	27.3	12.4	2.4	1.6	12.2	2.4	11.9	7.9	3.0	3.6	2.2	2.2	2.5	0.5	14.0	7.8	22.7	2.5	2.2	0.3	3.7	4.5	5.2	31.1	0.8	12.9	0.9	13.7	31.2	19.4	20.0	27.0	23.8	3.0	28.2	20.8	30.6	4.0	42.3	30.2	24.9	11.8	12.0	9.2	10.3	39.9	9.5	15.6	2.4	10.9	10.6	4.2	15.7	3.6	13.1	12.4
FNDC5	FRCP2	ENSG00000160097	"Fibronectin type III domain containing 5"	Q8NAU1	1	32862268-32872482	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 110.0;tongue: 33.3"	"Cell line enriched"	"Detected in some"	6	"RH-30: 31.9"	"Group enriched"	"Detected in many"	7	"glioma: 4.2;liver cancer: 10.0;testis cancer: 14.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051290	Enhanced				"Intracellular and membrane"					"HPA051290: AB_2681422"	"unprognostic (4.36e-2)"	"unprognostic (9.08e-3)"	"unprognostic (7.62e-4)"	"unprognostic (1.03e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.26e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.07e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.33e-2)"	1.2	6.3	3.4	0.6	5.1	0.6	0.9	26.7	13.6	1.0	0.8	1.7	0.0	0.9	2.1	1.5	4.9	2.6	1.4	15.9	3.6	4.1	0.9	8.6	1.0	0.6	5.0	3.7	3.0	0.8	2.5	2.3	0.8	9.5	2.0	0.7	8.2	12.3	1.0	110.0	0.6	1.0	1.5	2.8	0.6	2.3	1.3	1.7	0.0	1.0	33.3	1.3	0.9	0.4	0.6	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.9	0.2	0.0	1.3	0.1	0.4	0.1	0.5	0.1	0.9	0.2	0.1	0.6	0.3	0.0	3.8	0.0	0.1	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	2.4	0.0	0.3	0.0	0.0	0.7	0.1	0.8	0.1	0.1	0.1	1.3	0.1	0.4	31.9	0.2	0.0	0.0	5.4	0.9	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.6	1.5	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	5.1	26.7	13.6	3.6	4.1	5.0	3.7	9.5	1.7
FOXO1	"FKH1, FKHR, FOXO1A"	ENSG00000150907	"Forkhead box O1"	Q12778	13	40469953-40666597	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 85.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 18.9;Daudi: 20.0;HSkMC: 25.2;U-698: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001252, CAB022326"	Approved	Approved	Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB022326: , HPA001252: AB_1078906"	"unprognostic (4.72e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.54e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.52e-1)"	"prognostic favourable (3.74e-4)"	"unprognostic (6.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.65e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.31e-1)"	"prognostic favourable (1.33e-5)"	"unprognostic (1.93e-1)"	"unprognostic (5.44e-1)"	"unprognostic (9.09e-2)"	"unprognostic (9.63e-2)"	41.6	6.9	7.0	18.4	11.2	8.0	35.5	2.3	5.0	21.4	13.4	8.4	7.7	3.5	27.4	9.8	9.5	17.2	13.3	9.9	7.8	3.9	8.3	25.6	15.3	22.4	8.3	3.9	46.0	12.2	3.8	6.2	9.5	6.5	7.9	6.8	5.7	7.5	9.3	85.9	12.3	7.6	18.6	9.7	10.8	7.4	12.3	9.0	9.4	13.1	9.0	15.6	14.4	16.2	6.1	0.5	2.8	1.6	1.1	7.1	1.0	0.3	0.6	5.6	0.1	18.9	3.7	5.4	0.8	1.1	0.2	0.1	1.4	1.3	20.0	3.7	0.5	4.8	4.4	2.4	0.3	9.1	4.6	0.0	0.6	4.4	9.0	0.1	0.5	25.2	16.4	0.1	3.1	14.2	0.3	6.4	1.4	0.7	0.0	0.2	8.2	1.4	14.2	6.5	1.5	10.5	2.5	1.2	0.3	0.7	3.8	0.8	0.6	0.5	8.3	0.1	1.1	0.0	0.5	3.6	1.3	25.9	0.5	0.9	2.6	0.9	0.8	0.5	1.5	1.0	2.3	3.2	3.9	2.2	0.5	6.1	7.1	5.3	2.8	1.1	1.6	0.0	5.5	1.0	7.0	11.2	2.3	5.0	7.8	3.9	8.3	3.9	6.5	9.0
FRMD3	"EPB41L4O, MGC20553"	ENSG00000172159	"FERM domain containing 3"	A2A2Y4	9	83242990-83538546	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 48.5;skeletal muscle: 42.1"	"Cell line enhanced"	"Detected in some"		"HEL: 11.6;RPMI-8226: 39.2;SCLC-21H: 14.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 27.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.8;intermediate monocyte: 4.7;neutrophil: 3.8;non-classical monocyte: 2.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.8;monocytes: 4.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017285	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"				"Golgi apparatus, Plasma membrane"	"Golgi apparatus, Plasma membrane"	"HPA017285: AB_2669569"	"unprognostic (4.45e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.87e-2)"	"prognostic favourable (7.24e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.88e-1)"	"prognostic favourable (1.79e-4)"	"unprognostic (1.68e-3)"	12.7	4.6	3.5	2.8	2.3	3.0	16.8	2.0	3.0	4.6	7.1	1.7	14.3	1.9	5.5	9.8	4.1	1.9	2.9	48.5	3.2	4.5	11.7	0.7	2.9	0.9	3.6	1.7	1.4	1.4	8.9	6.1	8.7	2.9	5.1	4.1	5.3	2.1	35.3	42.1	1.6	10.9	3.5	2.8	4.3	2.2	6.1	0.8	0.0	8.8	11.1	0.7	3.8	5.0	0.6	0.6	3.8	4.7	0.4	0.6	9.2	0.0	2.2	1.9	0.1	0.4	0.1	0.1	2.0	0.1	0.0	0.0	0.2	2.6	0.4	2.4	0.9	0.1	0.1	0.0	0.0	0.1	0.1	11.6	2.5	1.4	0.1	0.0	0.1	0.5	0.0	0.0	0.1	1.3	0.0	0.0	2.5	0.3	0.0	0.0	0.2	3.6	0.0	1.5	39.2	3.2	5.1	14.5	7.0	0.7	0.1	0.4	0.8	0.4	2.2	0.1	0.3	0.0	1.4	0.2	0.1	0.0	0.5	3.8	1.4	0.0	2.8	0.0	0.4	4.7	0.6	0.5	0.2	0.1	0.4	0.6	0.1	0.0	3.8	0.4	2.1	0.6	0.0	9.2	3.5	2.3	2.0	3.0	3.2	4.5	3.6	1.7	2.9	0.8
FXR2	FMR1L2	ENSG00000129245	"FMR1 autosomal homolog 2"	P51116	17	7591230-7614871	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 55.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011205, HPA022997"	Supported		Supported	Cytosol				Cytosol	Cytosol	"CAB011205: AB_476964, HPA022997: AB_1849208"	"unprognostic (9.57e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.18e-1)"	"prognostic favourable (3.49e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.79e-2)"	"unprognostic (7.67e-2)"	10.4	13.6	15.9	7.4	22.5	5.8	7.5	21.2	25.2	9.6	9.5	14.5	11.2	9.2	9.7	8.3	11.1	9.0	7.4	31.9	16.1	18.1	11.1	9.6	10.5	8.5	18.8	18.5	10.2	11.2	19.2	13.9	10.6	22.4	11.8	8.0	13.5	10.9	13.2	55.0	9.1	8.5	11.7	15.1	8.4	7.8	13.5	18.2	8.3	9.4	9.5	9.8	8.9	8.3	2.4	3.1	6.0	2.2	2.1	4.6	1.9	15.3	20.4	18.9	19.7	16.2	11.1	14.6	23.1	19.3	33.5	23.3	11.3	5.0	14.4	15.4	15.6	16.9	24.8	10.5	22.5	16.1	26.7	8.1	17.8	6.5	15.8	0.1	17.4	10.4	15.5	25.4	24.7	11.6	14.4	4.9	16.5	7.7	11.1	7.9	11.3	11.0	16.1	11.4	8.7	12.3	5.4	11.3	21.0	15.7	10.5	15.7	10.8	6.0	10.7	15.7	10.0	10.3	27.3	8.3	7.4	6.4	18.0	6.6	20.6	6.0	2.0	5.8	2.4	2.2	3.2	1.1	3.8	4.6	3.1	2.4	3.1	3.3	5.1	2.1	1.4	2.1	3.8	1.9	15.9	22.5	21.2	25.2	16.1	18.1	18.8	18.5	22.4	18.2
FYCO1	"FLJ13335, ZFYVE7"	ENSG00000163820	"FYVE and coiled-coil domain containing 1"	Q9BQS8	3	45917899-45995824	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 105.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035526, HPA057966"	Uncertain		Enhanced	Vesicles				Vesicles	Vesicles	"HPA035526: AB_10672867, HPA057966: AB_2683567"	"unprognostic (2.45e-1)"	"unprognostic (6.62e-2)"	"unprognostic (6.97e-3)"	"unprognostic (1.14e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.85e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.98e-1)"	"prognostic favourable (3.33e-11)"	"unprognostic (2.90e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.89e-2)"	"unprognostic (6.99e-2)"	11.6	7.8	4.1	11.4	4.7	3.1	11.6	1.4	3.5	13.5	20.2	7.3	11.4	4.2	19.8	11.1	12.6	7.9	22.0	29.1	4.2	2.7	5.7	6.2	7.9	5.0	4.7	3.5	14.8	15.9	11.4	4.9	4.3	6.1	14.5	5.6	16.2	9.5	11.6	105.8	9.9	7.7	39.9	6.4	6.4	11.6	5.0	5.3	8.5	10.4	25.5	9.5	23.3	27.0	0.6	2.8	1.1	1.1	3.0	6.0	1.3	6.3	6.2	1.8	8.0	17.6	13.9	3.0	6.2	14.4	8.3	9.1	3.4	5.6	4.8	3.5	8.7	4.8	5.2	10.4	9.8	2.0	5.5	6.7	5.1	3.7	12.0	5.1	4.9	15.4	10.4	13.0	12.9	16.3	4.4	6.9	5.8	3.9	5.2	3.2	2.8	5.9	1.8	5.1	2.6	9.9	22.5	1.3	2.1	3.9	12.3	10.7	6.0	3.4	12.5	3.1	3.7	10.5	3.4	3.9	2.5	1.6	10.8	6.6	5.8	1.1	1.0	0.6	4.4	1.1	6.0	0.6	2.6	4.6	0.4	0.6	1.1	1.8	0.9	3.0	0.7	2.8	2.6	1.3	4.1	4.7	1.4	3.5	4.2	2.7	4.7	3.5	6.1	5.3
FYTTD1	"DKFZp761B1514, UIF"	ENSG00000122068	"Forty-two-three domain containing 1"	Q96QD9	3	197737179-197787596	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054474			Supported	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA054474: "	"unprognostic (3.61e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.88e-2)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (2.33e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.69e-2)"	"unprognostic (9.57e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.04e-3)"	"unprognostic (8.74e-2)"	"unprognostic (8.49e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.15e-1)"	12.0	10.2	12.8	13.6	13.1	14.5	24.5	20.5	13.9	11.3	11.9	6.9	13.3	6.6	13.2	10.2	19.0	13.2	10.3	19.4	11.0	12.5	11.1	12.0	11.8	13.5	11.1	10.9	13.3	17.0	13.8	13.2	13.9	13.4	11.0	9.2	6.0	10.0	13.9	82.6	11.6	10.1	21.8	17.1	11.4	10.3	16.7	10.7	10.5	12.6	15.8	15.3	15.7	21.8	11.2	15.9	23.7	16.6	32.5	22.7	21.5	29.6	6.6	13.0	12.3	15.3	17.0	4.0	14.5	14.9	22.6	18.5	10.2	10.2	19.1	53.5	17.2	10.7	16.4	14.9	24.1	4.2	7.4	28.5	10.0	4.6	15.0	21.2	13.9	12.2	19.3	12.2	17.6	17.7	12.8	41.1	19.9	24.9	23.0	5.1	2.8	12.1	21.4	15.9	13.4	16.4	19.5	24.7	10.7	22.4	17.8	16.5	41.7	11.3	15.6	11.6	11.6	14.6	15.3	25.0	37.9	22.9	12.3	30.7	11.9	23.7	14.2	13.6	18.3	16.6	22.7	11.2	17.6	20.1	15.9	9.9	19.4	18.7	4.6	32.5	15.2	8.9	15.5	21.5	12.8	13.1	20.5	13.9	11.0	12.5	11.1	10.9	13.4	10.7
FZD9	"CD349, FZD3"	ENSG00000188763	"Frizzled class receptor 9"	O00144	7	73433783-73436120	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 14.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 8.2;MCF7: 3.6;NTERA-2: 6.4"	"Cancer enhanced"	"Detected in many"		"melanoma: 6.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (9.60e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.90e-5)"	"unprognostic (8.99e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.21e-2)"	4.4	1.2	6.8	0.7	4.7	2.4	1.1	3.3	7.0	1.1	1.3	4.5	0.0	1.9	0.9	0.9	1.3	0.9	0.7	0.8	7.1	6.3	0.9	0.8	0.9	0.9	7.0	4.5	0.9	3.8	1.6	4.3	1.9	5.0	3.0	0.8	1.4	4.4	1.4	14.4	1.7	2.9	0.9	3.6	1.0	1.0	5.4	6.7	0.3	0.9	1.7	0.8	0.7	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.6	2.6	2.8	3.0	0.0	0.1	0.0	1.9	0.0	0.4	0.1	0.7	0.0	0.0	0.9	0.1	0.2	1.3	0.0	0.0	0.0	8.2	0.0	0.6	0.8	1.1	0.0	0.3	0.3	0.0	0.1	0.0	0.2	2.7	0.0	0.2	3.6	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.6	2.3	1.7	1.7	1.7	0.8	0.1	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	6.8	4.7	3.3	7.0	7.1	6.3	7.0	4.5	5.0	6.7
GADD45A	"DDIT1, GADD45"	ENSG00000116717	"Growth arrest and DNA damage inducible alpha"	P24522	1	67685061-67688338	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 86.7;skeletal muscle: 102.1"	"Cell line enhanced"	"Detected in many"		"HHSteC: 59.4;hTERT-HME1: 91.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 24.9"	"Group enriched"	"Detected in all"	5	"granulocytes: 24.9;T-cells: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA053420			Supported	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA053420: AB_2682144"	"unprognostic (1.36e-2)"	"unprognostic (3.29e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.76e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.43e-2)"	"unprognostic (5.21e-2)"	"prognostic favourable (8.06e-6)"	"unprognostic (6.11e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.93e-1)"	29.6	6.8	10.7	8.2	20.9	46.2	20.9	1.7	15.8	11.7	10.8	5.8	18.8	10.1	23.3	13.8	12.2	8.8	16.7	12.9	18.1	9.8	86.7	66.9	17.1	4.9	11.4	4.1	13.8	8.3	4.1	5.1	10.8	21.2	16.5	9.0	9.4	9.5	15.6	102.1	14.8	20.4	16.1	15.5	7.4	14.1	9.2	7.5	9.2	26.2	10.1	10.9	23.9	11.1	1.1	2.2	24.9	3.2	3.1	9.3	4.8	21.9	1.4	3.7	1.1	6.7	7.0	35.4	39.1	18.2	13.0	14.2	7.7	3.7	9.5	12.0	6.3	13.2	0.4	33.4	24.6	6.9	3.8	11.8	3.5	7.7	59.4	3.4	1.1	11.8	16.9	16.5	91.6	9.3	25.3	16.9	15.3	0.7	1.0	4.2	4.8	15.5	2.5	29.1	9.7	6.7	16.6	16.2	2.8	8.2	2.3	23.4	0.4	3.7	9.6	13.6	18.3	14.4	27.3	43.3	8.4	17.2	6.0	1.6	13.3	7.2	3.2	24.9	3.7	1.5	3.0	1.1	2.5	3.0	1.4	0.7	0.7	1.2	4.1	3.1	1.0	2.2	9.3	4.8	10.7	20.9	1.7	15.8	18.1	9.8	11.4	4.1	21.2	7.5
GALR3		ENSG00000128310	"Galanin receptor 3"	O60755	22	37823382-37825495	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 2.0;skeletal muscle: 2.5"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.9;HEK 293: 2.3;Hep G2: 2.9;REH: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"														"unprognostic (4.45e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.60e-3)"	"unprognostic (7.07e-2)"	"unprognostic (7.63e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.49e-1)"		"unprognostic (2.07e-1)"		"unprognostic (1.66e-2)"	"unprognostic (7.37e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.45e-2)"	0.0	0.0	0.6	0.0	1.3	0.7	0.0	2.0	1.1	0.0	0.1			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.0	0.0	0.9	0.0	0.0	0.2		0.4	1.2	0.0	0.0	0.0		0.2	0.0		0.0	0.1	2.5	0.0	0.0	0.0	0.1	0.1	0.0	1.0			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.9	0.4	0.0	0.2	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	2.9	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	1.2	0.0	1.0	0.4	0.3	1.9	0.0	0.0	0.0	0.0	0.4	0.3	1.1	0.0	0.1	0.9	1.3	0.0	0.1	0.4	0.3	0.0	0.3	0.4	0.3	0.1	0.6	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GAMT	"PIG2, TP53I2"	ENSG00000130005	"Guanidinoacetate N-methyltransferase"	Q14353	19	1397026-1401570	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 73.0;skeletal muscle: 222.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 51.2"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 173.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051806	Approved					38000	38000			"HPA051806: AB_2681619"	"unprognostic (3.25e-1)"	"unprognostic (7.74e-3)"	"unprognostic (3.22e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.36e-2)"	"prognostic unfavourable (6.57e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.54e-2)"	5.1	4.6	9.1	1.5	8.7	2.2	3.2	5.1	11.4	2.3	1.4	15.1	5.1	1.3	2.0	31.3	5.3	3.8	2.6	10.8	9.2	7.7	8.0	73.0	1.5	2.0	8.7	5.2	3.8	47.0	5.4	4.9	1.6	5.9	5.6	1.1	4.5	9.1	4.7	222.2	6.0	1.4	2.1	8.8	2.1	3.2	7.7	4.5	5.6	3.3	26.7	2.8	1.9	1.7	15.7	23.0	6.9	2.6	8.0	21.6	7.7	6.2	7.1	7.6	17.2	9.6	11.7	10.4	7.5	12.5	9.7	8.8	16.0	4.5	3.3	5.3	8.9	2.7	12.0	4.6	2.6	23.8	13.7	10.2	5.9	51.2	5.7	0.2	3.5	13.0	1.6	10.3	0.0	2.1	14.5	8.0	15.8	6.4	29.8	3.5	8.6	22.6	29.9	6.8	23.8	11.4	5.8	2.5	17.9	0.5	4.3	9.2	19.8	14.2	3.6	10.7	11.1	0.6	3.4	36.3	7.0	5.6	9.9	13.5	12.2	1.6	1.2	6.9	9.9	1.6	13.9	10.6	13.7	12.2	5.4	15.7	21.6	16.1	0.8	8.0	2.6	23.0	7.5	7.7	9.1	8.7	5.1	11.4	9.2	7.7	8.7	5.2	5.9	4.5
GBE1		ENSG00000114480	"1,4-alpha-glucan branching enzyme 1"	Q04446	3	81489699-81762161	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.9"	"Cell line enhanced"	"Detected in all"		"ASC diff: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038073, HPA038074, HPA038075"	Enhanced		Approved	Nucleoplasm,Cytosol		5900000	5900000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA038073: AB_10673040, HPA038074: AB_10672403, HPA038075: AB_10674545"	"unprognostic (3.10e-1)"	"unprognostic (1.02e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.19e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.36e-2)"	"unprognostic (4.42e-1)"	"unprognostic (2.83e-3)"	"unprognostic (3.78e-3)"	23.1	22.4	2.2	7.8	4.2	5.6	19.2	4.2	4.6	6.4	7.7	5.2	5.2	4.1	8.4	4.9	7.5	4.9	11.5	19.7	3.6	4.3	14.0	36.3	11.3	7.5	7.9	3.4	8.2	5.7	8.2	11.6	11.4	8.4	5.7	4.5	9.9	8.0	10.1	56.9	5.9	6.3	7.2	6.1	8.0	4.5	4.6	4.1	5.4	6.5	11.2	4.5	9.6	10.0	11.6	13.6	14.5	11.4	13.0	7.2	6.1	12.0	7.3	2.4	34.6	60.9	46.3	4.4	20.0	28.6	12.0	20.4	1.4	3.1	13.5	8.8	24.6	1.4	2.0	9.2	28.3	6.3	1.1	4.2	15.1	4.5	41.9	14.1	3.7	34.1	6.9	19.3	19.9	26.6	3.2	7.8	39.0	3.5	2.3	16.8	2.4	11.1	4.4	11.0	15.8	8.5	4.1	1.2	1.6	13.0	3.8	4.1	2.7	11.7	37.0	24.9	5.8	17.4	18.5	35.7	4.1	4.9	40.5	9.5	10.1	6.3	11.4	14.5	5.6	10.4	5.4	11.0	6.0	5.9	13.6	11.6	7.0	7.2	11.0	13.0	10.8	4.5	5.0	6.1	2.2	4.2	4.2	4.6	3.6	4.3	7.9	3.4	8.4	4.1
GDNF	"ATF1, ATF2, HFB1-GDNF"	ENSG00000168621	"Glial cell derived neurotrophic factor"	P39905	5	37812677-37839686	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 14.1;skeletal muscle: 12.4"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 24.6;U-87 MG: 7.4;WM-115: 27.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 14.1"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"basal ganglia: 2.5"	"Low region specificity"	"Detected in many"			"CAB005210, HPA070283"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"			Vesicles	Vesicles	"CAB005210: AB_2247684, HPA070283: AB_2686246"	"unprognostic (1.08e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.16e-4)"	"unprognostic (2.04e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.42e-2)"	1.9	0.3	0.6	1.9	2.3	0.0	0.4	14.1	1.3	0.8	9.4	0.4	0.4	1.6	1.7	3.4	1.0	0.9	0.9	0.9	0.6	0.4	1.0	0.7	0.4	0.4	0.6	1.2	4.5	0.4	0.0	0.4	6.3	1.4	1.6	3.1	1.1	0.4	6.3	12.4	1.4	2.5	2.5	0.5	0.4	1.9	3.9	2.4	0.4	0.4	1.5	0.4	0.6	1.1	0.8	0.4	1.2	0.3	0.9	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	3.3	2.1	0.6	0.9	0.0	0.0	0.0	0.0	4.4	0.1	0.0	0.0	1.2	0.0	0.1	0.0	0.2	0.3	0.1	0.0	0.0	1.0	0.1	24.6	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	0.0	0.0	5.3	0.0	0.0	0.1	0.2	0.0	0.1	0.1	1.6	0.0	0.0	0.0	3.3	0.0	0.8	3.8	2.3	0.0	0.0	7.4	0.0	27.0	0.4	0.3	0.2	0.3	0.2	0.3	0.2	0.3	0.3	0.1	0.8	0.2	0.4	1.2	0.9	0.2	0.4	0.1	0.0	0.6	2.3	14.1	1.3	0.6	0.4	0.6	1.2	1.4	2.4
GLRX	"GRX, GRX1"	ENSG00000173221	Glutaredoxin	P35754	5	95751319-95823005	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 94.4;skeletal muscle: 141.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 83.5;U-87 MG: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB008634, HPA046431, CAB069419"	Approved		Approved	"Plasma membrane,Cytosol"		13000000	13000000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB008634: AB_1616672, CAB069419: AB_1616670, HPA046431: AB_2679663"	"unprognostic (1.69e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.62e-3)"	"unprognostic (9.31e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.61e-1)"	17.7	20.7	6.2	15.0	6.6	30.6	10.5	15.5	15.5	5.4	22.6	3.1	4.0	40.2	2.9	4.6	3.1	3.7	9.5	25.2	12.1	7.8	45.9	46.9	23.1	21.5	7.8	5.9	3.5	2.6	9.5	6.4	63.9	7.6	5.7	8.8	2.4	17.9	5.5	141.6	7.3	42.5	4.5	7.3	15.2	8.2	2.2	4.0	14.4	6.3	6.4	14.3	11.6	5.8	16.0	52.2	94.4	81.6	11.2	48.9	71.1	3.2	14.7	1.1	2.4	31.8	45.8	0.2	49.2	83.5	5.3	8.9	3.6	1.5	12.8	7.0	14.8	1.2	1.8	23.4	14.8	11.1	3.7	9.3	9.7	33.8	60.6	9.8	27.5	28.5	2.8	33.7	3.3	10.1	1.2	7.7	33.4	1.1	16.9	17.4	3.2	16.8	27.4	10.1	15.8	63.9	2.4	3.3	1.8	12.9	6.4	5.6	1.7	9.7	11.7	14.0	15.8	11.1	2.0	5.5	28.2	10.2	68.6	24.7	2.9	3.8	81.6	94.4	26.2	51.0	35.7	16.0	24.1	19.5	52.2	10.7	24.1	22.1	85.7	11.2	40.5	18.0	48.9	71.1	6.2	6.6	15.5	15.5	12.1	7.8	7.8	5.9	7.6	4.0
GMPR		ENSG00000137198	"Guanosine monophosphate reductase"	P36959	6	16238580-16295549	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 103.3"	"Cell line enhanced"	"Detected in many"		"HEL: 45.2;HMC-1: 77.1;SK-MEL-30: 17.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 95.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.8;NK-cell: 8.3"	"Group enriched"	"Detected in many"	5	"granulocytes: 7.8;monocytes: 4.2;NK-cells: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000904, HPA021476"	Uncertain					3800000	3800000			"HPA000904: AB_1078998, HPA021476: AB_1849858"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.06e-1)"	"prognostic favourable (8.07e-4)"	"unprognostic (4.12e-1)"	"prognostic favourable (2.06e-4)"	"unprognostic (3.15e-1)"	"unprognostic (2.86e-1)"	"prognostic favourable (2.94e-5)"	"unprognostic (3.01e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.17e-1)"	2.8	7.3	14.6	1.4	11.0	9.6	6.5	3.8	6.9	2.7	3.7	9.1	2.0	1.5	4.2	7.9	2.5	22.4	1.9	31.5	13.3	11.5	10.3	2.7	3.7	2.5	14.0	5.7	15.7	7.4	4.4	6.8	3.4	21.3	25.5	1.8	22.0	5.2	4.2	103.3	4.3	1.5	4.3	11.8	3.3	8.3	25.1	10.9	1.4	2.7	16.2	1.5	2.0	1.2	0.7	1.3	7.8	4.2	8.3	1.0	14.1	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.9	3.7	6.6	13.6	0.3	0.1	0.0	2.1	1.4	0.0	1.6	0.2	1.1	0.0	1.2	45.2	0.0	0.0	2.9	0.2	77.1	0.9	0.7	2.0	0.0	11.9	10.0	0.0	1.1	0.8	0.0	0.9	0.4	1.8	0.0	10.2	0.0	8.8	1.2	2.3	0.3	0.4	0.7	17.2	0.7	0.3	2.9	0.1	0.0	0.3	1.7	0.5	0.0	0.0	0.2	4.8	5.2	7.8	2.9	0.4	0.6	4.2	1.0	0.2	0.1	0.4	1.3	0.7	0.0	0.2	3.0	8.3	1.3	1.2	0.0	14.1	14.6	11.0	3.8	6.9	13.3	11.5	14.0	5.7	21.3	10.9
GOT1	AST1	ENSG00000120053	"Glutamic-oxaloacetic transaminase 1"	P17174	10	99396870-99430624	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 116.9;liver: 82.9;skeletal muscle: 102.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064532, HPA072629"	Enhanced		Supported	Nucleoplasm,Cytosol		130000000	130000000	Nucleoplasm	Nucleoplasm	"HPA064532: AB_2685279, HPA072629: AB_2686540"	"unprognostic (6.40e-2)"	"prognostic favourable (6.23e-4)"	"unprognostic (5.99e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.96e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.79e-1)"	"prognostic favourable (3.72e-13)"	"unprognostic (1.93e-2)"	"unprognostic (4.23e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.00e-1)"	3.3	14.0	15.7	3.6	32.1	2.0	5.9	22.9	56.4	13.5	12.0	9.7	5.9	14.7	3.4	7.0	10.3	4.6	12.2	116.9	19.4	19.0	34.6	82.9	3.5	3.4	17.8	16.4	3.8	8.2	15.9	4.9	3.7	49.9	5.9	14.7	9.0	12.4	7.2	102.1	4.5	12.7	5.4	7.7	3.6	10.1	9.3	4.7	3.3	11.7	31.3	7.1	4.9	4.0	10.6	21.4	3.9	16.8	11.4	15.6	8.8	16.9	9.4	11.1	28.0	8.6	7.4	31.4	13.9	25.6	24.3	26.5	21.3	13.8	16.6	4.8	11.7	21.3	25.3	18.3	26.8	5.7	10.8	6.3	12.1	27.7	45.6	18.0	10.8	11.6	19.8	20.6	55.9	11.7	16.2	26.0	15.5	15.3	9.6	13.5	7.1	13.1	10.5	10.6	17.3	42.4	9.3	4.8	7.1	10.5	14.9	51.9	28.5	6.2	5.4	6.2	13.8	6.7	15.9	18.6	21.9	16.9	16.3	9.4	8.2	2.4	5.3	3.9	12.4	14.7	11.4	10.6	13.5	12.9	12.9	10.2	10.2	14.5	0.5	11.4	16.8	21.4	15.6	8.8	15.7	32.1	22.9	56.4	19.4	19.0	17.8	16.4	49.9	4.7
GOT2	"KAT4, KATIV, KYAT4, mitAAT"	ENSG00000125166	"Glutamic-oxaloacetic transaminase 2"	P00505	16	58707131-58734357	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 167.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018139	Enhanced				"Intracellular and membrane"	7000000	7000000			"HPA018139: AB_1849903"	"unprognostic (1.50e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.63e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavourable (1.61e-4)"	"prognostic favourable (5.75e-5)"	"unprognostic (1.12e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.00e-1)"	"prognostic favourable (2.90e-9)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.22e-1)"	6.1	21.0	12.7	8.0	19.1	5.5	10.7	19.4	35.7	10.6	15.9	16.0	33.3	10.6	10.4	19.5	17.7	13.5	8.9	78.1	15.8	16.7	24.6	85.5	7.1	11.1	16.2	17.8	8.7	8.8	27.0	13.0	7.3	27.7	17.2	18.8	23.4	13.0	20.5	167.8	10.4	9.4	13.5	12.3	8.0	13.6	10.8	9.9	10.7	12.3	53.9	15.0	15.5	11.2	14.3	17.6	3.5	9.9	14.5	24.5	14.3	27.1	36.9	19.5	23.6	14.1	12.8	25.5	20.9	22.3	41.2	22.6	31.9	24.6	60.8	24.9	23.1	40.2	41.6	40.6	52.6	16.7	38.2	16.4	20.1	35.6	17.9	26.2	15.1	12.3	23.1	25.9	22.7	41.3	32.8	6.3	20.9	24.3	32.6	25.4	26.4	71.7	35.8	29.7	58.3	38.9	40.0	31.1	22.6	40.0	43.1	15.0	21.8	8.6	16.6	15.0	27.5	11.7	26.5	14.6	13.5	49.8	16.1	26.3	15.1	2.3	9.9	3.5	15.2	8.6	23.5	14.3	18.0	18.4	17.6	10.6	16.7	15.3	0.9	14.5	8.5	15.5	24.5	14.3	12.7	19.1	19.4	35.7	15.8	16.7	16.2	17.8	27.7	9.9
GPD1		ENSG00000167588	"Glycerol-3-phosphate dehydrogenase 1"	P21695	12	50103819-50111319	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 116.3;skeletal muscle: 106.9"	"Cell line enriched"	"Detected in some"	4	"ASC diff: 52.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044620	Enhanced					3800000	3800000			"HPA044620: AB_10796803"	"unprognostic (2.65e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (7.19e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-2)"	116.3	1.2	2.4	3.6	3.0	0.3	44.9	1.6	3.9	0.3	13.4	12.2	0.4	16.2	0.3	3.0	1.2	0.3	8.1	3.9	4.3	2.7	30.6	31.4	4.0	1.6	6.8	1.2	0.2	1.8	2.3	0.3	0.2	13.5	0.5	0.9	0.1	17.7	0.5	106.9	2.0	23.5	0.5	24.7	0.2	0.8	0.3	2.0	0.0	0.7	14.1	0.3	1.1	0.3	0.7	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	52.2	0.0	0.1	0.0	0.0	0.0	0.0	10.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	9.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.6	0.1	0.0	0.2	0.0	0.0	0.6	0.3	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.4	3.0	1.6	3.9	4.3	2.7	6.8	1.2	13.5	2.0
GPD1L	KIAA0089	ENSG00000152642	"Glycerol-3-phosphate dehydrogenase 1 like"	Q8N335	3	32105689-32168713	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 65.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 50.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.23e-1)"	"unprognostic (3.12e-2)"	"prognostic favourable (7.05e-4)"	"unprognostic (2.63e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.24e-1)"	"prognostic unfavourable (1.35e-5)"	"prognostic favourable (5.71e-5)"	"unprognostic (2.49e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.53e-1)"	"prognostic favourable (3.33e-15)"	"unprognostic (1.50e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.31e-3)"	"unprognostic (5.51e-3)"	14.6	18.8	7.4	4.5	12.2	2.9	13.3	8.3	15.7	10.0	16.1	7.2	5.3	10.6	7.1	6.7	17.0	11.0	6.7	49.5	8.3	8.4	14.2	1.4	12.7	6.1	8.2	11.7	7.5	9.0	7.9	5.7	8.3	10.8	25.1	15.2	8.5	15.2	18.0	65.5	5.4	15.5	14.5	11.6	4.9	11.9	3.2	6.3	0.8	16.9	22.5	9.6	22.4	9.0	1.9	6.6	6.5	4.1	8.3	10.1	3.2	3.9	3.5	1.2	5.7	18.4	4.4	50.2	3.2	1.1	3.6	2.6	3.8	2.0	7.0	4.9	2.2	4.6	8.4	3.3	4.3	2.9	7.7	4.0	5.6	5.9	4.6	10.2	14.5	13.3	4.4	3.4	4.5	5.9	2.7	2.2	2.6	5.2	4.4	3.4	0.7	16.4	8.3	5.8	14.1	5.4	23.9	5.6	5.5	2.5	22.1	8.8	14.4	5.0	3.0	3.9	2.0	6.2	8.5	1.7	0.7	6.9	9.0	7.9	2.2	0.4	3.2	6.5	4.3	4.1	10.1	1.9	5.5	5.1	6.6	1.7	3.2	4.7	1.9	8.3	2.5	5.3	10.0	3.2	7.4	12.2	8.3	15.7	8.3	8.4	8.2	11.7	10.8	6.3
GPR157	FLJ12132	ENSG00000180758	"G protein-coupled receptor 157"	Q5UAW9	1	9100305-9129170	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 32.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 16.9;SK-BR-3: 33.2;U-266/70: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA028697	Uncertain		Uncertain	"Nucleoli,Plasma membrane,Cell Junctions"				Nucleoli	Nucleoli	"HPA028697: AB_10601810"	"unprognostic (2.83e-3)"	"unprognostic (1.13e-2)"	"unprognostic (5.91e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.13e-4)"	"unprognostic (7.11e-2)"	"unprognostic (7.52e-3)"	"unprognostic (3.60e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.04e-3)"	3.5	3.1	0.3	3.7	0.6	0.5	3.5	0.5	0.4	6.2	2.8	0.9	3.9	2.2	2.1	2.1	23.4	2.1	6.9	10.7	0.8	0.4	2.9	6.9	5.5	3.1	0.3	0.1	4.5	4.3	9.8	1.2	19.0	1.4	2.9	1.2	5.2	14.7	7.1	32.2	14.2	3.3	4.0	0.4	2.4	2.2	2.1	0.8	3.6	4.8	25.2	16.2	4.4	8.3	2.4	1.1	4.6	1.5	1.2	2.6	0.7	4.6	2.6	0.8	2.1	0.7	0.7	4.3	1.4	0.9	1.2	1.6	2.1	1.8	0.6	1.8	1.5	9.9	2.4	0.9	1.8	12.8	3.9	0.0	7.7	3.1	2.6	0.0	1.0	0.7	2.0	2.1	1.3	0.9	0.7	16.9	0.5	3.4	1.9	0.9	0.9	3.3	0.3	0.7	2.2	0.8	3.1	1.2	3.2	5.7	33.2	2.8	4.7	0.5	7.0	4.2	1.1	10.9	0.6	16.3	2.6	0.0	3.1	6.6	1.7	1.9	1.5	0.4	2.6	1.2	2.0	1.5	1.9	2.3	0.8	2.4	1.9	2.2	4.6	1.2	0.6	1.1	0.8	0.7	0.3	0.6	0.5	0.4	0.8	0.4	0.3	0.1	1.4	0.8
GPT	"ALT1, GPT1"	ENSG00000167701	"Glutamic--pyruvic transaminase"	P24298	8	144502973-144507174	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 56.8;skeletal muscle: 27.0"	"Cell line enhanced"	"Detected in many"		"Hep G2: 4.7;Karpas-707: 5.6;U-266/70: 6.0"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 38.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 2.3;non-classical monocyte: 2.9"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.9"	"Low region specificity"	"Detected in all"							"HPA031059, HPA031060, CAB032997, CAB032999"	Enhanced					15000000	15000000			"CAB032997: AB_2261949, CAB032999: AB_2095427, HPA031059: AB_10600214, HPA031060: AB_10602178"	"unprognostic (8.22e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.37e-2)"	"prognostic favourable (1.47e-5)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.41e-1)"	"unprognostic (9.22e-2)"	"prognostic favourable (2.19e-4)"	"unprognostic (2.83e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.98e-2)"	9.0	0.8	1.7	8.7	2.2	1.1	3.9	1.5	2.3	0.2	17.4	2.0	4.6	10.9	0.2	1.7	0.9	0.5	19.8	16.9	1.7	0.9	8.7	56.8	0.2	0.2	1.3	2.2	0.4	3.6	0.5	1.1	0.1	2.0	0.7	3.5	1.6	17.0	2.7	27.0	6.1	19.2	0.2	0.7	0.4	8.6	0.8	1.6	0.0	0.6	13.9	3.3	0.3	0.5	0.0	0.5	0.0	2.9	0.0	0.0	0.0	0.5	1.5	0.4	1.1	0.9	0.0	1.3	0.8	0.0	0.0	0.0	0.4	1.9	0.8	0.7	0.0	4.3	0.0	0.0	0.0	1.5	2.7	0.7	2.5	4.7	0.0	0.1	0.8	0.0	0.4	0.0	0.0	0.0	0.5	5.6	0.0	2.6	0.9	0.9	0.6	1.0	0.9	0.3	3.0	0.0	1.8	1.2	1.7	0.5	1.4	0.2	3.8	0.2	0.4	0.3	1.3	1.3	0.2	6.0	0.4	0.4	0.8	1.9	0.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	1.7	2.2	1.5	2.3	1.7	0.9	1.3	2.2	2.0	1.6
GPT2	ALT2	ENSG00000166123	"Glutamic--pyruvic transaminase 2"	Q8TD30	16	46884378-46931297	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 103.0;skeletal muscle: 60.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051514	Approved		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA051514: AB_2681516"	"unprognostic (1.65e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.12e-2)"	"prognostic favourable (3.17e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.86e-1)"	"unprognostic (3.54e-3)"	"unprognostic (3.18e-1)"	19.9	4.1	20.2	2.1	17.8	1.9	6.4	3.9	15.1	2.5	3.4	11.8	10.0	1.3	2.1	13.4	30.8	3.7	4.4	3.0	13.4	8.0	9.8	40.4	1.4	2.1	12.9	7.8	1.5	103.0	4.3	4.3	1.8	11.3	10.2	2.6	1.5	27.6	8.5	60.9	14.9	1.7	1.9	11.3	1.4	15.4	6.0	12.3	0.7	3.6	19.0	14.6	1.9	2.1	4.2	1.4	1.3	0.7	0.0	0.4	0.4	12.9	5.9	7.5	28.5	10.6	2.3	13.7	9.0	3.4	9.7	6.2	20.1	5.5	9.1	7.9	6.4	10.4	13.5	13.3	6.5	4.2	6.6	3.2	3.4	48.5	7.3	22.7	3.0	4.9	11.7	9.5	14.8	4.7	2.6	7.3	3.2	23.1	4.5	19.0	7.9	17.0	0.1	8.3	21.1	3.9	6.4	23.5	12.0	4.6	24.1	12.2	6.2	20.8	3.5	6.8	13.3	4.5	7.2	35.1	10.6	25.7	10.4	14.8	3.6	1.3	0.7	0.0	0.3	0.0	0.0	4.2	0.0	0.3	1.4	2.5	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.4	20.2	17.8	3.9	15.1	13.4	8.0	12.9	7.8	11.3	12.3
GRIP2	KIAA1719	ENSG00000144596	"Glutamate receptor interacting protein 2"		3	14489111-14556075	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"heart muscle: 10.3;skeletal muscle: 25.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.1;BJ hTERT+ SV40 Large T+ RasG12V: 3.3;NTERA-2: 3.5;PC-3: 10.0;SCLC-21H: 5.6;U-2 OS: 3.8"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035673			Approved	Cytosol				Cytosol	Cytosol	"HPA035673: "	"unprognostic (1.48e-1)"	"unprognostic (6.26e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.13e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.19e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.82e-1)"	"unprognostic (4.01e-1)"	0.5	0.8	3.2	0.4	2.6	0.0	0.5	0.7	6.0	0.4	0.4	1.2	1.9	0.1	1.3	0.5	1.7	0.3	1.0	10.3	3.2		1.5	0.1	0.2	0.1	0.0	3.3	2.0	0.2	0.1	0.1	3.0	1.1	0.4	0.7	0.6	0.4	0.2	25.7	1.4	0.4	0.6	0.0	1.0	2.7	0.4	1.0	0.0	0.0	4.6	0.4	0.5	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.5	0.3	0.0	0.5	5.1	0.6	3.3	2.0	0.0	0.0	1.2	0.3	0.3	1.2	0.0	0.0	0.0	0.3	0.0	0.4	0.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	10.0	0.0	0.1	0.0	0.0	0.0	5.6	1.1	0.5	0.0	1.7	0.0	0.0	0.0	0.3	3.8	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0										
GRSF1		ENSG00000132463	"G-rich RNA sequence binding factor 1"	Q12849	4	70815782-70839945	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 101.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036984, HPA036985"	Enhanced		Enhanced	Mitochondria				Mitochondria	Mitochondria	"HPA036984: AB_2675415, HPA036985: AB_10672785"	"unprognostic (1.45e-3)"	"unprognostic (1.82e-2)"	"prognostic favourable (1.47e-5)"	"unprognostic (8.63e-2)"	"unprognostic (6.73e-2)"	"unprognostic (4.15e-3)"	"prognostic unfavourable (8.29e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.05e-2)"	"prognostic favourable (2.72e-9)"	"unprognostic (6.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (9.65e-3)"	17.9	33.4	21.3	22.3	19.9	8.8	29.0	19.1	42.5	16.8	22.7	19.7	15.0	18.1	17.2	18.2	21.7	18.9	22.9	33.3	22.9	22.6	23.9	23.6	23.7	24.6	24.8	20.2	17.3	26.9	19.6	13.7	18.3	23.6	17.7	27.1	12.0	32.1	20.9	101.8	18.7	17.2	18.1	24.1	17.3	22.5	13.6	19.1	37.0	19.7	31.1	21.7	21.1	15.4	5.7	20.0	7.6	11.6	14.3	11.7	5.6	31.9	21.8	25.7	26.7	27.3	31.9	36.9	38.8	24.6	29.3	24.1	22.2	32.9	46.2	29.7	39.9	12.2	45.4	30.3	39.3	25.1	14.9	24.3	22.4	30.7	33.7	35.5	14.0	26.8	29.2	29.6	20.6	30.1	27.8	26.9	40.7	34.2	58.3	25.0	27.4	23.1	24.1	40.0	19.6	36.2	40.0	26.8	24.2	18.3	52.2	64.0	22.6	17.4	27.5	27.4	29.0	22.6	24.4	22.4	17.8	29.7	22.7	23.1	26.7	7.6	11.6	5.2	7.6	8.8	9.5	5.7	11.2	11.7	20.0	4.9	11.2	9.5	1.6	14.3	10.5	19.3	9.3	5.6	21.3	19.9	19.1	42.5	22.9	22.6	24.8	20.2	23.6	19.1
GTF2IRD1	"BEN, Cream1, GTF3, MusTRD1, RBAP2, WBSCR11, WBSCR12"	ENSG00000006704	"GTF2I repeat domain containing 1"	Q9UHL9	7	74453790-74602604	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 62.8"	"Cell line enhanced"	"Detected in many"		"HHSteC: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044254	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA044254: AB_10964747"	"unprognostic (8.92e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (9.71e-5)"	"unprognostic (2.24e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.89e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.25e-3)"	4.6	7.6	4.3	5.1	6.8	0.6	6.3	4.4	7.8	9.4	8.2	8.2	9.2	7.0	7.4	8.7	16.4	7.0	8.6	7.7	3.9	5.5	9.3	3.6	7.2	2.6	8.5	5.3	8.6	10.0	21.1	25.3	5.3	6.6	8.2	5.5	21.6	11.3	8.3	62.8	15.6	5.2	12.1	5.6	1.6	8.8	4.5	5.7	1.3	16.4	12.9	7.3	10.5	13.2	0.6	1.8	2.7	0.5	0.6	0.7	0.1	9.3	5.9	12.9	14.1	10.4	5.1	0.1	4.0	10.6	7.8	8.2	10.2	13.5	2.4	3.0	8.0	5.4	10.2	4.7	5.8	0.1	6.1	0.4	19.9	11.5	33.4	0.1	0.3	7.1	19.2	5.5	22.7	4.0	6.9	0.0	8.7	11.8	1.2	8.2	10.3	6.1	12.6	7.5	8.8	14.9	6.5	10.7	14.5	9.8	17.9	8.7	10.6	9.4	2.2	8.1	8.3	5.2	9.0	0.5	1.4	3.9	3.3	0.1	6.5	1.2	0.5	0.5	0.3	0.2	0.3	0.4	0.7	0.2	1.8	0.6	0.3	0.4	2.7	0.6	0.1	0.6	0.2	0.1	4.3	6.8	4.4	7.8	3.9	5.5	8.5	5.3	6.6	5.7
GTF3C6	"bA397G5.3, C6orf51, TFIIIC35"	ENSG00000155115	"General transcription factor IIIC subunit 6"	Q969F1	6	110958560-110967890	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 95.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056179, HPA061345"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA056179: AB_2683058, HPA061345: AB_2684485"	"unprognostic (6.98e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavourable (7.27e-6)"	"unprognostic (2.08e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.89e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.42e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.14e-2)"	17.0	21.6	26.4	14.3	25.3	12.8	14.6	10.9	17.4	15.8	22.1	14.2	12.7	17.4	12.3	12.9	17.3	16.4	23.0	32.1	21.2	20.1	31.1	23.5	10.9	15.6	24.8	17.8	15.6	14.7	21.6	15.5	11.0	18.1	32.7	18.4	12.1	14.7	16.1	95.8	10.4	17.5	15.7	21.4	19.7	18.1	20.3	20.3	17.9	13.2	30.7	18.7	17.2	13.1	36.2	38.8	19.0	37.6	23.4	63.5	33.3	14.7	27.7	19.5	20.5	9.7	19.1	26.7	24.9	18.2	24.0	19.5	40.1	11.0	20.9	23.9	22.2	6.3	21.8	21.3	18.1	31.5	36.7	39.3	25.7	51.6	19.6	55.7	32.1	19.3	17.2	18.3	17.5	26.5	47.2	11.3	34.8	28.6	27.4	57.8	26.9	22.3	27.5	14.9	17.5	31.2	32.5	17.3	24.5	18.0	2.4	18.6	9.0	30.0	28.1	6.0	18.2	43.9	37.7	10.0	20.3	35.8	6.3	33.5	29.8	19.0	26.9	14.9	25.1	37.6	27.9	36.2	31.6	30.9	35.6	26.3	24.8	29.2	4.3	23.4	29.9	38.8	63.5	33.3	26.4	25.3	10.9	17.4	21.2	20.1	24.8	17.8	18.1	20.3
GYG1	GYG	ENSG00000163754	"Glycogenin 1"	P46976	3	148991341-149027668	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 113.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030497	Approved		Supported	Vesicles				Vesicles	Vesicles	"HPA030497: AB_10602326"	"unprognostic (2.68e-2)"	"unprognostic (6.31e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavourable (6.15e-5)"	"unprognostic (2.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.79e-2)"	10.8	7.9	7.0	8.5	8.5	55.7	10.0	9.2	7.5	10.6	31.0	6.0	11.9	4.8	15.6	15.4	18.1	11.1	12.0	32.0	8.0	9.0	8.5	6.3	9.1	14.7	11.6	7.1	13.3	14.3	6.5	7.8	6.5	10.0	16.3	7.6	7.7	11.3	19.4	113.0	4.7	8.4	32.5	8.1	13.6	12.8	47.3	7.4	4.2	9.4	39.6	8.5	28.7	14.6	7.0	26.7	16.8	26.7	17.7	32.5	17.5	18.5	12.0	9.0	10.0	24.9	26.1	12.2	27.4	22.8	40.0	37.4	15.7	19.0	0.0	13.6	31.7	5.7	23.5	12.1	40.4	6.2	10.1	14.2	5.7	17.8	22.5	14.4	21.4	14.3	19.8	13.2	16.7	22.9	8.7	33.8	22.9	32.6	2.8	11.5	10.7	9.8	7.9	13.6	26.6	11.0	17.4	7.4	3.5	14.4	19.9	15.5	19.8	15.4	19.0	20.5	6.1	14.6	20.0	30.7	17.1	13.2	17.3	22.2	6.6	7.2	23.4	16.8	17.4	24.5	32.5	7.0	11.6	18.1	26.7	5.1	6.3	10.7	11.6	17.7	26.7	10.7	15.9	17.5	7.0	8.5	9.2	7.5	8.0	9.0	11.6	7.1	10.0	7.4
GYS1	"GSY, GYS"	ENSG00000104812	"Glycogen synthase 1"	P13807	19	48968125-48993310	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007793, HPA041598"	Enhanced		Approved	Microtubules,Cytosol		10000	10000	"Microtubules, Cytosol"	"Microtubules, Cytosol"	"CAB007793: AB_562291, HPA041598: AB_2677571"	"unprognostic (3.37e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.83e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavourable (3.46e-4)"	"unprognostic (4.04e-2)"	"unprognostic (6.76e-2)"	"unprognostic (5.87e-3)"	"unprognostic (3.81e-2)"	9.7	7.3	5.1	6.1	6.5	16.0	10.6	11.3	6.2	5.3	7.3	6.2	5.8	6.1	6.2	6.9	11.5	5.9	6.1	37.3	6.8	4.0	7.2	4.3	5.0	6.3	5.3	5.5	6.8	4.4	6.4	5.1	5.0	5.9	8.7	6.1	12.4	7.2	7.6	106.1	8.1	6.1	6.8	6.0	5.8	7.3	2.2	5.5	6.4	5.2	42.6	9.0	7.9	6.9	6.7	15.9	8.2	10.5	12.8	10.9	7.3	28.3	11.3	8.4	11.5	19.6	7.7	16.7	19.7	13.9	20.8	24.4	11.0	9.3	11.8	12.0	19.2	20.3	14.0	25.0	18.2	7.3	20.3	9.8	14.5	9.7	11.0	10.7	7.3	19.0	12.0	13.4	11.4	17.4	6.8	15.9	26.0	10.8	13.2	9.3	4.5	13.1	11.2	14.7	11.6	20.6	30.4	5.2	7.3	17.5	22.9	4.6	12.1	11.1	13.4	25.6	9.9	11.5	21.3	13.2	13.6	5.8	26.1	9.4	5.7	8.2	10.5	7.5	8.8	6.3	10.9	6.7	7.6	8.2	15.9	5.5	6.3	5.6	4.4	12.8	8.5	8.6	10.1	7.3	5.1	6.5	11.3	6.2	6.8	4.0	5.3	5.5	5.9	5.5
HADHB	MTPB	ENSG00000138029	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta"	P55084	2	26243170-26290468	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 126.0;skeletal muscle: 155.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037539, HPA037540, HPA066099"	Enhanced		Supported	Mitochondria		1100000	1100000	Mitochondria	Mitochondria	"HPA037539: AB_10671374, HPA037540: AB_2675531, HPA066099: AB_2685618"	"unprognostic (5.15e-2)"	"unprognostic (8.72e-2)"	"unprognostic (8.21e-2)"	"unprognostic (8.67e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.59e-2)"	"unprognostic (7.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.94e-2)"	"prognostic favourable (1.37e-9)"	"unprognostic (2.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.68e-2)"	23.3	45.5	24.8	11.0	24.7	9.9	16.6	16.6	17.4	13.8	21.4	31.1	19.3	43.6	17.1	16.2	20.6	13.9	12.6	126.0	18.0	20.0	45.8	62.4	12.8	16.1	34.8	18.3	16.2	23.7	19.9	13.1	12.6	27.8	15.8	22.8	19.9	27.2	15.9	155.6	13.2	35.0	20.3	29.5	15.3	19.5	15.8	23.8	10.6	22.4	44.9	14.5	18.5	12.8	20.2	45.2	21.5	49.1	23.8	26.8	33.9	22.7	18.0	12.6	22.5	77.7	43.0	12.7	19.2	29.4	19.8	19.4	21.5	22.2	11.4	13.5	31.4	18.0	20.9	27.1	24.3	25.7	18.2	26.2	10.7	42.0	33.3	21.1	20.1	41.6	44.8	20.5	33.5	36.6	21.9	18.5	41.2	16.7	11.8	40.8	8.7	19.6	13.1	41.6	21.7	40.7	32.4	6.0	20.7	32.9	37.5	50.4	23.2	37.8	25.3	18.7	19.5	17.5	13.8	13.9	20.9	20.1	21.5	33.8	18.5	21.0	49.1	18.9	14.2	43.4	18.1	20.2	19.3	17.6	45.2	14.8	18.0	16.3	21.5	23.8	33.2	15.3	26.8	33.9	24.8	24.7	16.6	17.4	18.0	20.0	34.8	18.3	27.8	23.8
HCFC1R1	"FLJ20568, HPIP"	ENSG00000103145	"Host cell factor C1 regulator 1"	Q9NWW0	16	3022620-3024286	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 204.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059647	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA059647: AB_2684094"	"unprognostic (2.24e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.85e-3)"	"unprognostic (6.03e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.43e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.23e-1)"	19.7	28.9	49.3	10.2	61.0	7.8	23.9	25.4	37.5	30.4	17.5	13.5	17.7	14.3	20.5	18.4	20.7	19.4	28.0	27.8	37.2	38.6	24.9	11.1	19.1	10.6	40.9	23.9	24.3	10.4	19.9	19.5	16.5	23.0	22.8	10.0	11.5	15.1	42.4	204.8	25.0	13.9	28.7	23.2	9.1	11.2	11.4	14.7	7.5	13.5	37.0	9.1	24.7	17.2	14.1	26.2	8.4	21.6	13.7	20.2	9.6	13.7	36.5	7.3	8.9	30.1	39.6	7.0	4.4	27.7	13.7	37.6	7.6	16.7	9.6	15.0	25.9	18.2	7.3	27.0	6.3	13.3	17.4	4.2	29.2	12.8	24.7	7.0	8.4	49.0	17.5	14.3	15.5	19.0	5.8	19.3	15.3	12.4	4.3	11.0	16.0	7.7	15.2	6.6	27.0	48.7	2.8	12.7	10.7	10.7	17.2	17.2	11.4	6.5	5.4	22.6	63.2	19.1	11.8	11.7	11.5	8.5	9.6	4.4	5.1	2.7	21.6	8.4	12.3	15.5	11.6	14.1	15.9	13.3	26.2	13.5	11.8	14.2	4.5	13.7	13.5	13.0	20.2	9.6	49.3	61.0	25.4	37.5	37.2	38.6	40.9	23.9	23.0	14.7
HDAC4	"BDMR, HA6116, HD4, HDAC-4, HDAC-A, HDACA, KIAA0288"	ENSG00000068024	"Histone deacetylase 4"	P56524	2	239048168-239401654	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 54.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 10.5;classical monocyte: 7.4;neutrophil: 28.3"	"Group enriched"	"Detected in many"	8	"granulocytes: 28.3;monocytes: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004431, HPA048723"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nuclear speckles"	"CAB004431: AB_627706, HPA048723: AB_2680501"	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-3)"	"unprognostic (3.06e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (6.33e-4)"	"prognostic favourable (1.13e-4)"	"unprognostic (1.40e-1)"	"unprognostic (4.82e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.04e-2)"	7.9	6.8	6.1	6.8	5.2	17.1	4.6	6.4	12.3	11.3	21.4	4.6	4.3	2.5	10.2	6.4	8.8	9.0	24.6	5.2	5.0	6.0	3.2	3.1	4.2	4.3	6.1	5.4	8.5	5.8	4.9	8.3	2.5	5.2	7.5	4.8	8.3	3.7	7.3	54.6	6.9	6.5	15.8	4.2	5.4	7.0	8.1	4.3	6.5	4.8	13.2	5.6	10.2	4.6	0.5	1.7	28.3	7.4	2.1	1.2	0.4	4.3	4.3	5.5	6.6	3.1	5.3	6.5	4.5	3.1	3.6	3.4	2.0	7.8	2.0	1.8	3.9	4.3	3.8	1.8	1.8	12.0	2.0	3.2	5.3	6.3	4.2	4.9	2.9	3.6	4.6	6.6	5.3	3.8	4.5	4.6	1.7	5.3	31.6	6.7	4.3	2.2	8.2	10.4	3.2	4.1	5.5	4.4	7.8	6.3	2.8	11.1	1.5	13.4	6.1	4.2	0.3	7.2	6.1	3.3	3.1	3.9	6.1	6.8	8.3	10.5	7.4	1.1	0.9	2.4	1.1	0.5	0.9	0.8	0.8	0.5	0.5	1.0	28.3	2.1	1.0	1.7	1.2	0.4	6.1	5.2	6.4	7.5	5.0	6.0	6.1	5.4	5.2	4.3
HEXIM2	FLJ32384	ENSG00000168517	"Hexamethylene bisacetamide inducible 2"	Q96MH2	17	45160700-45170040	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 36.4"	"Cell line enhanced"	"Detected in all"		"Hep G2: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023323, HPA028455"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"	"Nucleoplasm, Nuclear speckles"	"HPA023323: AB_1850651, HPA028455: AB_10602603"	"unprognostic (9.03e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.01e-2)"	"prognostic favourable (2.53e-4)"	"unprognostic (2.36e-1)"	"unprognostic (6.35e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-1)"	"prognostic favourable (9.85e-4)"	"unprognostic (2.34e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.32e-3)"	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.90e-2)"	4.0	7.7	8.3	4.2	8.0	3.6	3.4	9.0	11.8	4.3	4.8	5.0	6.5	8.8	4.3	5.6	4.2	5.1	7.9	6.3	6.7	6.2	9.3	9.6	4.1	5.6	7.8	6.7	5.7	9.3	7.5	6.1	3.0	6.6	5.1	2.5	6.9	9.9	5.5	36.4	5.6	6.4	4.3	5.4	5.2	6.9	27.7	6.4	6.4	9.1	6.6	3.0	4.7	4.7	9.7	13.2	10.0	12.2	7.3	8.6	13.3	4.9	17.9	4.0	8.8	4.4	7.3	7.6	2.8	3.4	4.5	5.0	6.7	13.3	3.1	14.5	1.9	8.2	3.9	3.4	1.4	7.1	6.2	2.3	16.7	30.4	3.2	2.0	5.1	6.3	3.2	3.9	1.4	2.2	2.5	7.7	2.0	8.6	3.1	4.2	4.3	7.9	4.2	6.0	9.3	5.7	4.9	4.8	4.1	2.5	5.0	11.5	13.3	3.4	2.1	8.2	4.4	5.4	6.5	12.0	12.6	2.9	6.4	3.6	6.1	8.4	12.2	10.0	5.4	9.7	8.6	9.7	3.8	6.1	10.3	6.5	3.0	5.3	8.3	7.3	3.0	13.2	4.6	13.3	8.3	8.0	9.0	11.8	6.7	6.2	7.8	6.7	6.6	6.4
HFE2	"haemojuvelin, hemojuvelin, HFE2A, HJV, JH, RGMC"	ENSG00000168509	"Hemochromatosis type 2 (juvenile)"	Q6ZVN8	1	146017468-146036746	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 49.4;skeletal muscle: 128.9;tongue: 28.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.1;HSkMC: 4.9;K-562: 4.7;RH-30: 1.7"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 87.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"													42000	42000				"unprognostic (2.30e-1)"			"unprognostic (6.98e-4)"	"unprognostic (7.06e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.55e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.96e-8)"	"unprognostic (6.61e-2)"	"unprognostic (2.72e-1)"		"unprognostic (1.76e-2)"	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	2.5	0.0	0.0	14.0	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.9	0.0	128.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	28.2	2.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	4.9	0.0	0.0	0.0	0.0	4.7	0.1	0.7	0.0	0.0	0.0	0.4	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HINT3	FLJ33126	ENSG00000111911	"Histidine triad nucleotide binding protein 3"	Q9NQE9	6	125956781-125980244	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 65.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA027914	Approved		Approved	Nucleoli,Mitochondria,Cytosol				"Nucleoli, Mitochondria"	"Nucleoli, Mitochondria"	"HPA027914: AB_10602424"	"prognostic unfavourable (4.99e-4)"	"unprognostic (4.75e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.88e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.05e-1)"	"prognostic favourable (1.05e-6)"	"unprognostic (4.09e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.64e-1)"	11.4	16.3	27.4	8.0	23.3	7.2	15.6	19.4	24.3	13.1	13.1	24.8	10.6	10.4	11.5	12.6	15.2	11.4	10.9	19.0	28.1	23.0	15.1	18.5	13.9	7.0	28.7	17.0	10.4	12.8	16.3	13.4	12.1	20.7	20.5	12.1	10.3	16.0	16.2	65.8	11.6	10.5	15.2	40.8	6.8	16.0	21.9	17.0	7.7	15.9	16.8	7.4	16.1	8.8	11.0	11.1	15.0	13.2	7.9	9.9	7.0	6.9	5.5	7.7	15.9	3.0	8.3	9.5	7.5	10.9	5.8	6.0	13.5	3.8	15.1	14.0	5.0	10.4	9.8	6.3	6.8	14.2	12.6	6.3	8.3	11.3	14.2	9.9	10.7	6.5	14.1	5.8	14.8	8.7	19.6	10.2	5.7	10.5	7.9	7.2	2.6	5.3	6.7	5.3	5.0	12.0	12.7	15.4	9.5	6.8	9.8	35.1	9.9	15.3	6.1	4.0	5.6	18.9	10.6	14.8	16.9	9.6	11.2	9.5	5.1	14.4	13.2	11.4	7.2	8.4	7.8	11.0	9.2	7.5	11.1	10.4	9.9	8.7	15.0	7.9	10.8	6.9	9.1	7.0	27.4	23.3	19.4	24.3	28.1	23.0	28.7	17.0	20.7	17.0
HOMER1	"HOMER-1B, SYN47, Ves-1"	ENSG00000152413	"Homer scaffolding protein 1"	Q86YM7	5	79372636-79514217	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.9;skeletal muscle: 28.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004437, HPA036521, HPA036522"	Enhanced	Supported	Approved	Cytosol				Cytosol	Cytosol	"CAB004437: AB_627742, HPA036521: AB_2675170, HPA036522: AB_2675171"	"unprognostic (2.80e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.00e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.83e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.41e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.98e-1)"	"unprognostic (7.35e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.86e-3)"	3.0	1.6	11.3	2.4	19.7	0.6	2.7	8.4	28.9	4.4	1.6	1.2	0.0	1.0	6.8	4.5	4.7	2.5	6.9	19.1	8.5	4.2	5.9	2.0	5.1	1.3	2.9	13.3	4.7	2.4	4.5	3.6	5.3	5.3	2.0	1.3	2.1	1.9	2.1	28.0	2.6	1.2	4.7	2.2	1.1	2.1	5.1	3.5	1.7	14.4	4.8	1.7	5.0	2.2	2.0	0.6	0.2	0.0	0.4	2.3	0.5	8.4	5.9	8.8	14.0	3.4	2.2	20.4	5.4	4.3	5.5	5.9	9.2	6.0	0.1	16.5	4.6	4.6	10.9	14.6	9.5	1.2	8.6	10.2	2.5	9.1	5.5	4.7	3.3	3.6	9.5	4.9	13.8	2.5	12.4	5.6	7.1	11.9	20.0	3.3	14.9	5.0	13.1	14.5	12.9	5.8	13.2	9.0	5.4	10.2	7.3	5.4	10.0	4.2	0.4	4.1	10.3	4.9	9.5	2.7	6.1	5.0	11.6	1.9	7.8	0.0	0.0	0.1	2.3	0.0	1.3	2.0	0.9	0.7	0.0	1.6	0.5	1.7	0.2	0.4	0.0	0.6	0.0	0.5	11.3	19.7	8.4	18.8	8.5	4.2	2.9	13.3	5.3	3.5
HOXA7	"HOX1, HOX1A"	ENSG00000122592	"Homeobox A7"	P31268	7	27153716-27157936	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 27.8"	"Cell line enhanced"	"Detected in many"		"HAP1: 19.4;RPTEC TERT1: 24.0;SCLC-21H: 19.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	14	"pons and medulla: 9.2"	"Cell type enriched"	"Detected in some"	5	"NK-cell: 7.7"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 7.7"	"Region enriched"	"Detected in single"	12	"pons and medulla: 1.4"	"Region enriched"	"Detected in single"	10	"pons and medulla: 2.9"	HPA074048			Supported	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	Nucleoplasm	"HPA074048: AB_2686655"	"unprognostic (5.40e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (7.87e-5)"	"unprognostic (3.30e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.14e-1)"	"prognostic favourable (1.15e-5)"	"unprognostic (9.08e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-1)"	6.5	14.5	0.2	4.8	0.2	0.0	11.2	0.3	0.6	7.3	10.0	0.2	7.9	0.0	5.0	15.4	3.0	12.2	0.5	0.2	0.2	0.0	25.4	0.4	2.6	3.5	0.2	0.2	6.2	0.2	0.3	0.2	1.3	9.2	8.2	7.2	0.2	0.2	8.9	27.8	8.2	6.1	8.1	14.3	3.7	3.2	2.7	0.2	1.6	0.9	0.2	1.1	11.4	6.7	0.2	0.9	0.0	0.0	7.7	1.6	0.2	6.8	2.4	0.0	7.4	0.0	0.0	0.4	2.4	4.2	5.1	5.9	3.6	2.7	4.7	6.8	1.9	4.8	19.4	0.0	3.1	0.0	12.2	0.3	2.7	0.1	0.5	0.4	0.2	4.1	0.2	0.6	6.9	9.7	0.0	0.0	1.9	1.2	0.0	1.0	0.2	0.7	2.4	4.5	0.0	24.0	4.7	19.4	0.0	13.3	0.0	0.0	0.2	1.9	0.8	0.0	4.6	13.8	2.3	0.0	0.1	0.1	0.0	9.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.2	0.9	0.0	0.0	0.1	0.0	7.7	0.0	0.6	0.4	0.2	0.2	0.2	0.3	0.6	0.2	0.0	0.2	0.2	9.2	0.2
HOXC11	HOX3H	ENSG00000123388	"Homeobox C11"	O43248	12	53973126-53977643	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 7.0;skin 1: 9.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 23.0;BJ hTERT+: 11.6;HaCaT: 10.1;T-47d: 18.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038291	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA038291: AB_10674552"	"unprognostic (1.50e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"		"unprognostic (6.90e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.41e-3)"	"unprognostic (4.46e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.06e-1)"		"unprognostic (1.82e-1)"	4.8	0.0	0.1	0.1	0.1	0.0	1.2	0.1	0.1	2.5	0.1	0.1	0.1	0.8	2.0	1.0	0.1	0.7	0.1	0.1	0.1	0.0	2.0	0.1	0.1	0.7	0.1	0.1	0.5	0.1	0.0	0.1	0.6	0.3	0.5	0.0	0.1	0.1	2.0	7.0	9.2	2.7	0.4	0.1	0.1	0.0	1.6	0.1	0.5	0.1	0.1	0.1	1.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.7	0.0	23.0	2.2	3.3	0.0	3.3	11.6	4.9	3.6	0.2	0.9	0.0	0.2	3.1	10.1	4.4	0.0	2.2	0.6	0.1	0.1	7.5	0.0	0.0	0.1	0.1	0.6	0.9	0.0	0.3	0.0	0.9	0.0	3.1	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.8	0.0	0.1	2.1	5.2	2.0	18.1	0.0	0.0	0.0	4.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1
HOXC8	"HOX3, HOX3A"	ENSG00000037965	"Homeobox C8"	P31273	12	54009106-54012362	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 16.7;ovary: 25.2;skeletal muscle: 12.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 23.7;ASC TERT1: 15.5;fHDF/TERT166: 27.6;HSkMC: 18.9;LHCN-M2: 20.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028911, CAB037020"	Uncertain		Supported	Nucleoplasm,Microtubules				Nucleoplasm	Nucleoplasm	"CAB037020: AB_1840935, HPA028911: AB_10602236"	"unprognostic (1.03e-1)"	"unprognostic (5.90e-2)"	"unprognostic (6.26e-6)"	"unprognostic (4.89e-2)"	"unprognostic (5.20e-4)"	"unprognostic (5.34e-3)"		"unprognostic (2.43e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (1.47e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.14e-2)"	5.2	5.4	0.4	0.7	0.2	0.0	7.1	0.2	0.3	0.5	0.5	0.2	0.2	0.0	0.3	16.7	0.4	6.3	0.6	0.6	0.2	0.0	7.0	0.2	0.2	2.2	0.2	0.5	25.2	0.2	0.0	0.2	1.9	0.4	0.3	0.0	0.2	0.2	0.2	12.8	2.6	4.8	7.9	2.5	0.2	0.0	2.6	0.2	0.3	0.7	0.2	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	8.3	23.7	15.5	0.1	1.5	0.0	2.8	1.8	2.5	1.2	0.0	0.2	27.6	1.0	2.2	0.7	3.2	2.8	3.0	0.4	1.0	0.0	2.9	0.0	3.2	18.9	2.1	8.9	5.2	0.2	0.3	0.0	20.6	0.7	0.0	0.2	0.0	0.4	0.0	0.0	0.0	3.1	0.0	0.0	1.1	2.8	0.5	7.2	0.8	0.0	0.0	0.5	4.4	3.8	0.9	0.0	0.0	0.0	0.5	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.3	0.2	0.0	0.2	0.5	0.4	0.2
HOXC9	"HOX3, HOX3B"	ENSG00000180806	"Homeobox C9"	P31274	12	53994895-54003337	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 18.9;skeletal muscle: 28.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.4;HDLM-2: 18.3;HEK 293: 22.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA063965, HPA072160"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA063965: AB_2685162, HPA072160: AB_2686491"	"unprognostic (2.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.19e-5)"	"unprognostic (1.23e-1)"	"unprognostic (4.09e-3)"	"unprognostic (7.12e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.06e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.85e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.53e-1)"	18.9	2.5	0.0	1.2	0.0	0.1	12.8	0.0	0.1	0.5	0.2	0.0	0.4	0.1	1.7	7.8	0.3	6.3	0.1	0.1	0.0	0.0	12.2	0.1	0.1	4.3	0.0	0.0	5.6	1.0	0.1	0.0	2.0	0.0	0.9	0.1	0.0	0.5	0.2	28.3	5.7	4.4	1.2	0.5	0.1	0.1	4.3	0.0	0.1	0.2	0.2	0.3	1.3	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	2.2	0.0	14.4	5.8	4.8	1.0	1.5	1.3	1.9	1.2	0.6	2.2	0.0	1.1	5.7	2.6	0.3	1.5	1.6	18.3	22.3	0.4	3.3	0.5	0.6	0.0	3.3	5.4	2.5	2.8	1.3	1.8	4.5	0.0	3.8	1.6	0.0	1.3	0.0	0.2	0.2	2.8	0.0	4.3	1.4	0.0	4.2	5.2	2.8	5.7	4.3	0.2	0.0	3.4	6.1	1.0	1.7	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HS3ST5	3-OST-5	ENSG00000249853	"Heparan sulfate-glucosamine 3-sulfotransferase 5"	Q8IZT8	6	114055586-114343045	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 13.1;seminal vesicle: 9.4;skeletal muscle: 10.1"	"Cell line enhanced"	"Detected in some"		"PC-3: 4.9;RT4: 9.0;SCLC-21H: 17.5;U-266/70: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021823, HPA064677"	Approved									"HPA021823: AB_1851100, HPA064677: AB_2685318"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.00e-2)"		"unprognostic (7.98e-4)"	"unprognostic (5.39e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.53e-2)"	0.5	1.9	3.3	0.9	13.1	1.3	0.5	0.6	11.9	0.8	1.0	9.1	3.5	0.7	0.8	0.5	0.6	0.6	0.7	0.5	4.2	3.5	0.9	0.5	1.1	0.5	6.1	2.7	0.6	1.3	0.5	0.3	0.6	7.8	0.7	0.9	0.6	0.7	9.4	10.1	1.3	1.2	0.9	7.5	0.5	1.2	0.9	8.0	0.0	0.6	0.0	0.5	2.5	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	4.9	0.0	1.0	0.0	0.0	9.0	17.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.1	4.4	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.3	13.1	0.6	5.7	4.2	3.5	6.1	2.7	7.8	8.0
HSPA2		ENSG00000126803	"Heat shock protein family A (Hsp70) member 2"	P54652	14	64535905-64546173	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 87.0;skeletal muscle: 90.5"	"Cell line enhanced"	"Detected in many"		"A549: 24.6;BEWO: 38.4;BJ hTERT+: 32.8;SCLC-21H: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000798, HPA052504"	Enhanced	Supported	Approved	Nucleoplasm,Vesicles		77000000	77000000	Vesicles	Vesicles	"HPA000798: AB_1079090, HPA052504: AB_2681854"	"prognostic favourable (1.78e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.11e-2)"	"prognostic unfavourable (9.11e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.25e-1)"	5.2	3.3	21.1	5.2	45.3	1.5	5.2	3.7	37.6	3.3	23.3	87.0	0.1	4.4	13.8	12.8	25.2	7.2	4.2	22.8	33.2	18.7	26.6	2.6	4.5	3.2	71.0	20.6	2.4	3.8	7.5	4.3	37.6	37.7	3.8	6.9	3.5	10.2	4.0	90.5	14.8	7.8	17.9	83.8	8.5	5.7	58.8	65.2	0.0	2.3	8.2	3.9	12.4	4.0	0.7	0.3	2.4	0.6	0.9	3.7	0.5	9.6	24.6	3.8	0.0	2.7	0.2	38.4	13.9	32.8	5.6	9.2	0.9	17.4	2.4	5.6	15.1	11.0	0.0	0.7	3.4	1.3	1.9	0.0	1.4	0.0	2.7	0.0	3.3	1.2	0.5	0.8	0.0	0.3	0.0	2.0	2.7	4.3	0.1	0.1	2.8	3.0	1.9	0.0	0.0	8.6	1.5	34.1	1.9	0.6	1.2	0.0	0.9	1.0	0.5	0.1	0.0	1.2	0.0	2.5	0.0	0.0	3.1	0.0	3.7	0.9	0.2	0.1	1.8	0.4	0.1	0.7	1.7	0.8	0.0	0.5	0.6	0.6	2.4	0.9	0.6	0.3	3.7	0.5	21.1	45.3	3.7	28.3	33.2	18.7	71.0	20.6	37.7	65.2
HSPB2	"Hs.78846, MKBP"	ENSG00000170276	"Heat shock protein family B (small) member 2"	Q16082	11	111912242-111914093	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 40.5;heart muscle: 51.6;skeletal muscle: 52.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 15.3;ASC TERT1: 6.1;fHDF/TERT166: 20.3;HSkMC: 7.2;LHCN-M2: 11.7;U-138 MG: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (5.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.69e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.37e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.46e-2)"	11.5	2.5	3.1	2.8	3.6	0.8	40.5	7.8	3.7	8.4	5.8	1.4	3.9	1.7	8.2	10.6	5.4	5.3	6.3	51.6	2.8	2.5	5.0	1.2	4.7	7.5	3.8	2.5	6.0	1.3	0.8	0.8	4.2	4.0	4.8	2.5	5.1	2.5	5.3	52.6	4.4	2.4	8.5	3.0	2.2	2.9	3.6	2.0	0.0	2.7	22.0	1.5	6.7	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	15.3	6.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	9.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.6	7.8	3.7	2.8	2.5	3.8	2.5	4.0	2.0
HSPB3	HSPL27	ENSG00000169271	"Heat shock protein family B (small) member 3"	Q12988	5	54455601-54456384	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 106.0;skeletal muscle: 46.1;tongue: 22.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 37.1;fHDF/TERT166: 16.6;HSkMC: 7.3;LHCN-M2: 5.4"	"Cancer enriched"	"Detected in many"	6	"head and neck cancer: 7.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA062124			Supported	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA062124: AB_2684690"		"unprognostic (1.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.78e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.25e-3)"		"unprognostic (1.13e-1)"	"unprognostic (4.41e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-2)"		"unprognostic (2.73e-1)"	"unprognostic (2.82e-2)"		"unprognostic (7.15e-2)"	0.7	0.1	1.1	0.1	1.0	0.0	0.5	0.0	2.7	0.2	1.0	0.0	0.1	0.1	1.8	4.3	3.7	0.7	0.1	106.0	0.5	0.4	0.0	0.0	0.5	0.0	0.1	1.1	0.3	0.0	0.0	0.9	0.0	0.2	2.0	0.5	0.1	2.1	0.2	46.1	0.5	0.2	2.4	0.0	0.2	0.2	0.3	0.0	0.0	0.1	22.3	0.9	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	37.1	0.0	0.0	0.1	0.0	0.0	0.1	16.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	7.3	2.2	0.0	0.0	0.0	0.1	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	1.0	0.0	2.7	0.5	0.4	0.1	1.1	0.2	0.0
HSPB6	"FLJ32389, Hsp20, PPP1R91"	ENSG00000004776	"Heat shock protein family B (small) member 6"	O14558	19	35754569-35758079	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 356.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 184.7;ASC TERT1: 77.9;HHSteC: 62.6;HSkMC: 72.9"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 93.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB001974, HPA044153, HPA054811"	Enhanced		Supported	"Nucleoli,Golgi apparatus,Cytosol"	"Intracellular and membrane"	86000	86000	Cytosol	Cytosol	"CAB001974: , HPA044153: AB_2678836, HPA054811: "	"unprognostic (3.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.21e-3)"	"unprognostic (7.02e-2)"	"unprognostic (9.67e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.02e-2)"	"prognostic unfavourable (1.93e-5)"	"unprognostic (3.32e-2)"	"unprognostic (6.65e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavourable (1.43e-6)"	95.3	39.5	3.9	18.3	8.1	1.1	40.5	1.1	6.1	49.7	48.4	3.8	18.6	5.7	42.6	57.4	24.6	33.3	80.6	132.0	4.4	2.4	6.2	3.5	8.7	7.2	5.4	2.8	53.4	5.8	1.7	1.2	12.7	8.1	42.1	8.7	18.2	8.6	35.8	356.8	2.5	14.3	128.2	10.2	1.9	32.4	22.6	4.9	0.0	11.0	153.5	16.4	121.6	23.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.2	0.2	184.7	77.9	0.1	8.2	0.1	0.5	0.9	0.1	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	62.6	0.0	0.0	72.9	0.0	1.9	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	1.7	0.0	0.1	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.9	8.1	1.1	6.1	4.4	2.4	5.4	2.8	8.1	4.9
HSPB8	"CMT2L, E2IG1, H11, HSP22, HspB8"	ENSG00000152137	"Heat shock protein family B (small) member 8"	Q9UJY1	12	119178642-119221131	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 152.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 29.1;HeLa: 21.7;MCF7: 38.2;U-87 MG: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015876	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				Cytosol	Cytosol	"HPA015876: AB_1850458"	"unprognostic (1.52e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.99e-3)"	"prognostic unfavourable (2.98e-4)"	"unprognostic (2.47e-1)"	"unprognostic (4.03e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.17e-2)"	12.2	4.4	19.3	8.2	22.7	0.7	6.8	2.0	18.1	15.3	52.7	34.1	13.1	2.8	18.6	7.2	42.9	9.6	12.0	107.9	17.4	17.6	16.3	1.7	13.4	3.3	27.4	14.7	5.7	7.7	73.3	3.0	64.3	24.5	40.1	11.9	21.7	11.4	79.4	152.6	10.0	7.9	65.5	35.0	13.6	20.6	3.6	19.3	5.4	8.0	42.1	26.7	55.6	18.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.4	4.9	0.2	0.0	5.7	4.5	19.1	10.7	9.5	2.2	0.1	12.0	0.2	0.0	29.1	14.8	0.8	0.1	0.0	0.3	0.0	0.4	0.0	21.7	1.0	3.9	0.0	0.0	5.0	1.7	7.2	0.7	4.4	0.0	0.0	5.3	38.2	0.0	0.1	2.2	7.0	0.0	7.9	1.0	15.7	2.0	0.1	0.3	4.1	0.5	2.2	9.9	0.0	6.1	5.3	13.4	6.9	0.5	0.0	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	22.7	2.0	16.0	17.4	17.6	27.4	14.7	24.5	19.3
HYAL4		ENSG00000106302	"Hyaluronoglucosaminidase 4"	Q2M3T9	7	123828983-123877478	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"placenta: 7.1;skeletal muscle: 8.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.4;CAPAN-2: 7.1;RT4: 16.6"	"Cancer enriched"	"Detected in single"	48	"testis cancer: 8.4"					"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA029453	Uncertain									"HPA029453: AB_10601432"	"unprognostic (5.19e-5)"	"unprognostic (4.18e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.20e-1)"		"unprognostic (4.14e-2)"		"unprognostic (2.60e-1)"	"unprognostic (8.24e-2)"	"unprognostic (5.26e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (5.55e-3)"	0.1	0.3	0.0	0.0	0.0	0.7	0.2	0.0	0.5	0.0	0.1			0.0	0.1	0.4	0.4	0.2	0.0	0.4	0.0	0.0	0.6	0.1	0.4	0.0	0.0		0.1	0.6	0.0	0.1	7.1		0.2	0.0		1.2	0.0	8.3	1.4	0.2	0.0	0.1	1.0	0.2	3.4			0.4		1.5	1.0	0.1	1.3	0.6	3.3	0.6	1.0	0.9	0.1	0.3	0.6	0.1	0.4	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	7.1	0.3	0.3	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	16.6	0.2	0.1	0.0	0.9	0.0	0.4	0.2	2.4	0.1	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.5	0.4	0.6	0.5	0.5	0.4	0.5	0.5	0.2	1.3	0.7	0.9	3.3	1.0	0.6	0.6	0.3	0.1										
IDH2		ENSG00000182054	"Isocitrate dehydrogenase (NADP(+)) 2, mitochondrial"	P48735	15	90083045-90102504	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 126.2;skeletal muscle: 190.7"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 68.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007831	Enhanced		Supported	Mitochondria		53000000	53000000	Mitochondria	Mitochondria	"HPA007831: AB_1851397"	"unprognostic (2.45e-2)"	"prognostic favourable (5.15e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.53e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-2)"	5.4	2.0	14.9	10.1	16.6	22.6	8.8	4.9	19.1	6.4	16.2	13.8	12.4	16.1	5.9	15.3	23.7	6.0	9.4	126.2	10.2	9.3	25.0	93.2	6.9	15.8	14.4	12.0	3.0	25.1	8.4	3.3	15.1	11.9	13.3	14.5	6.0	28.0	21.9	190.7	11.0	13.9	15.8	11.0	7.5	27.9	1.2	7.6	28.2	3.4	69.0	13.6	11.0	8.6	16.8	32.8	17.2	56.3	22.2	29.5	31.2	10.2	5.8	30.2	30.0	4.2	5.2	25.7	12.8	19.5	12.1	13.0	2.7	8.9	12.2	3.6	10.6	3.5	4.4	3.9	5.8	23.9	2.9	20.8	2.2	20.3	5.1	14.2	21.1	10.8	2.2	2.9	2.3	24.8	3.1	10.5	9.3	29.8	68.3	22.1	9.0	2.4	57.9	21.7	36.3	18.7	12.3	43.6	22.1	15.9	63.6	5.1	51.3	43.9	5.9	21.7	3.1	2.8	5.9	17.3	3.2	1.4	6.9	30.0	12.5	9.0	26.4	17.2	26.1	48.0	12.4	16.8	18.7	29.5	32.8	9.8	10.2	18.2	5.1	22.2	56.3	17.8	15.9	31.2	14.9	16.6	4.9	19.1	10.2	9.3	14.4	12.0	11.9	7.6
IGDCC4	"LOC57722, NOPE"	ENSG00000103742	"Immunoglobulin superfamily DCC subclass member 4"	Q8TDY8	15	65381464-65423072	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 14.1"	"Cell line enhanced"	"Detected in some"		"A549: 5.0;AF22: 10.2;CAPAN-2: 8.9;EFO-21: 5.1;HSkMC: 5.7;NTERA-2: 7.6"	"Cancer enhanced"	"Detected in many"		"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008510, HPA008576"	Approved	Approved	Approved	Nucleoplasm,Cytosol		34000000	34000000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA008510: , HPA008576: AB_1079496"	"unprognostic (1.16e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.75e-3)"	"unprognostic (9.94e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.83e-8)"	"unprognostic (3.30e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.32e-3)"	1.7	6.2	8.3	3.7	5.0	0.2	1.3	2.0	4.9	6.1	1.4	8.0	0.0	1.0	2.3	7.2	2.6	2.9	6.7	2.2	6.2	4.1	0.6	0.3	0.7	1.1	5.6	3.1	13.3	0.7	0.2	2.4	8.2	6.1	0.9	1.2	1.6	1.5	1.3	14.1	1.5	1.7	3.1	5.0	0.5	1.9	2.5	6.5	0.0	4.6	4.0	1.5	4.7	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	10.2	0.0	0.0	1.1	0.1	0.4	0.0	0.0	0.4	0.6	8.9	0.0	5.1	0.4	0.0	2.5	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.4	0.0	0.0	5.7	0.0	0.5	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.8	7.6	0.0	0.0	2.5	0.0	3.6	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	4.1	2.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	5.0	2.0	3.9	6.2	4.1	5.6	3.1	6.1	6.5
IL6R	CD126	ENSG00000160712	"Interleukin 6 receptor"	P08887	1	154405193-154469450	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 59.6"	"Cell line enhanced"	"Detected in many"		"THP-1: 54.6;U-266/84: 64.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 35.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	22000000	22000000				"unprognostic (1.19e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.42e-2)"	"prognostic favourable (1.65e-4)"	"unprognostic (7.94e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.07e-1)"	8.4	4.0	4.7	14.8	5.1	9.0	6.5	1.4	6.3	6.1	16.9	4.8	1.2	9.6	6.3	4.7	5.2	7.9	6.9	5.0	5.2	2.9	8.9	38.1	20.8	15.4	7.2	2.2	5.7	5.3	0.0	7.7	3.7	7.8	4.5	6.0	3.6	5.4	1.7	59.6	4.7	12.6	5.3	5.0	11.3	6.6	3.7	5.0	4.2	2.5	6.1	13.3	6.3	4.8	0.6	14.3	35.0	11.7	0.5	8.0	5.5	0.8	1.4	0.1	0.1	0.9	1.3	0.1	0.8	0.6	0.5	0.2	0.1	0.9	0.0	1.9	1.0	0.4	0.2	4.4	0.4	14.7	0.4	0.2	0.6	3.3	0.1	2.3	1.3	0.7	2.7	0.4	6.6	0.6	0.1	6.1	0.1	0.3	0.0	3.8	0.4	3.3	0.0	0.0	12.7	2.7	1.1	0.1	0.0	0.2	9.0	14.8	0.8	54.6	0.6	0.9	0.9	0.8	0.5	10.4	64.3	0.1	1.1	14.8	1.4	2.8	11.7	10.4	0.2	7.1	0.6	0.6	6.4	0.7	14.3	0.2	6.4	2.2	35.0	0.5	3.0	5.1	8.0	5.5	4.7	5.1	1.4	6.3	5.2	2.9	7.2	2.2	7.8	5.0
IPO13	"IMP13, KIAA0724, RANBP13"	ENSG00000117408	"Importin 13"	O94829	1	43946939-43968022	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 80.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB070425	Uncertain									"CAB070425: AB_11157631"	"unprognostic (7.15e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.15e-2)"	"unprognostic (7.11e-2)"	"prognostic unfavourable (8.26e-7)"	"unprognostic (1.21e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.56e-1)"	"prognostic favourable (2.21e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.22e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.93e-3)"	8.1	10.7	21.8	7.3	28.5	6.7	6.8	17.6	27.6	8.4	7.4	42.1	4.5	7.2	8.5	11.1	12.2	10.7	7.4	17.4	27.6	16.6	16.0	9.2	7.2	7.0	27.8	18.4	7.6	8.0	21.6	10.8	8.0	18.4	10.4	8.2	7.4	10.5	13.1	80.5	11.1	6.1	12.1	35.8	7.7	7.3	25.1	27.6	6.3	13.8	13.0	7.9	8.1	5.8	2.8	5.5	2.6	3.7	4.5	4.9	2.2	13.3	10.9	11.0	17.4	30.0	15.6	9.2	12.9	12.0	19.3	14.8	8.3	6.8	14.1	13.4	16.8	15.0	19.8	22.7	12.8	14.2	16.9	14.6	19.7	11.4	21.2	9.7	13.7	15.9	23.2	25.0	15.7	12.8	14.6	13.0	15.3	9.3	9.8	12.9	10.1	18.4	13.7	13.9	14.7	14.2	13.0	17.7	8.2	12.1	20.4	16.7	12.8	13.5	10.4	19.4	11.6	16.8	14.5	14.6	17.8	6.8	12.4	21.1	16.8	0.0	3.3	2.6	4.9	3.7	4.4	2.8	3.2	4.9	5.5	2.2	2.9	3.6	1.1	4.5	3.7	5.3	3.8	2.2	21.8	28.5	17.6	27.6	27.6	16.6	27.8	18.4	18.4	27.6
ITGA7		ENSG00000135424	"Integrin subunit alpha 7"	Q13683	12	55684568-55716043	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 66.4;skeletal muscle: 81.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 29.5;hTEC/SVTERT24-B: 27.9;LHCN-M2: 16.9;SK-MEL-30: 20.4;U-87 MG: 25.2"	"Cancer enhanced"	"Detected in all"		"glioma: 35.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008427	Uncertain		Approved	"Nuclear speckles,Vesicles,Plasma membrane"		770000	770000	"Plasma membrane"	"Plasma membrane"	"HPA008427: AB_1851823"	"unprognostic (4.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.02e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.57e-1)"	"prognostic favourable (1.75e-4)"	"unprognostic (2.85e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.10e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavourable (9.59e-5)"	46.2	3.4	6.1	7.2	6.8	0.9	20.6	3.6	7.6	6.3	22.4	5.7	5.9	6.6	15.1	13.5	11.6	12.9	14.8	66.4	7.8	2.6	3.1	4.1	3.4	2.9	3.9	7.6	5.1	1.9	3.4	3.1	1.0	5.7	8.9	3.7	5.6	3.3	14.6	81.3	3.6	7.2	33.3	4.5	2.4	10.3	2.9	5.3	0.2	6.5	10.6	2.2	13.6	14.1	0.5	1.7	0.0	1.0	0.0	0.8	0.3	0.1	1.7	3.2	5.2	29.5	5.9	0.3	2.2	3.7	5.0	5.2	3.5	2.8	0.9	3.2	1.4	0.4	2.2	0.1	4.5	0.1	1.6	0.3	1.1	1.3	0.2	0.1	1.1	8.3	0.0	27.9	0.1	0.0	0.4	0.6	16.9	2.1	0.1	1.2	9.0	0.2	0.0	12.2	0.2	0.1	0.0	0.4	1.2	0.2	0.0	20.4	0.3	5.7	0.0	0.5	5.5	0.3	3.5	1.3	0.9	0.3	25.2	3.4	0.3	0.0	0.7	0.0	0.4	1.0	0.0	0.1	0.0	0.8	1.7	0.5	0.3	0.4	0.0	0.0	1.0	0.6	0.0	0.3	6.1	6.8	3.6	7.6	7.8	2.6	3.9	7.6	5.7	5.3
ITGB1BP2	CHORDC3	ENSG00000147166	"Integrin subunit beta 1 binding protein 2"	Q9UKP3	X	71301734-71305371	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 43.0;skeletal muscle: 21.3;smooth muscle: 18.6;tongue: 19.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 13.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040721			Approved	Cytosol				Cytosol	Cytosol	"HPA040721: "	"unprognostic (1.87e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.91e-5)"	"unprognostic (1.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.02e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.08e-11)"	"unprognostic (4.38e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.64e-1)"	0.7	0.3	0.2	1.0	0.3	0.6	0.3	0.6	0.2	2.7	2.8	0.0	2.3	0.4	12.8	3.4	4.0	1.8	4.8	43.0	0.2	0.2	0.4	0.6	0.5	0.5	0.3	0.0	2.4	0.3	0.0	0.3	0.2	0.2	3.2	0.9	3.5	0.7	5.8	21.3	0.3	1.0	18.6	0.3	0.6	1.1	1.6	0.1	0.0	0.4	19.6	0.7	5.6	0.8	0.2	0.2	1.5	0.2	0.0	0.5	0.0	0.7	2.1	3.1	2.8	0.1	0.1	0.7	1.0	1.4	0.7	0.8	1.6	1.6	3.1	0.3	1.6	1.5	2.8	0.8	1.7	1.0	1.3	1.9	1.9	0.6	0.4	0.6	13.7	1.7	1.2	0.5	0.4	1.2	1.4	0.8	1.6	0.9	1.2	3.4	4.6	1.3	2.0	2.5	1.1	1.5	2.0	1.5	0.5	0.7	0.1	0.8	0.9	0.4	0.0	1.4	2.7	0.3	0.5	2.9	3.7	4.7	0.4	2.4	0.6	0.0	0.2	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.2	0.2	0.2	0.3	0.0	0.2	0.1
ITIH6	"ITIH5L, UNQ6369"	ENSG00000102313	"Inter-alpha-trypsin inhibitor heavy chain family member 6"	Q6UXX5	X	54748899-54798240	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.8;salivary gland: 3.5;skeletal muscle: 5.0"	"Cell line enriched"	"Detected in some"	19	"WM-115: 33.3"	"Cancer enriched"	"Detected in some"	7	"melanoma: 10.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA000506	Uncertain				"Secreted to blood"					"HPA000506: AB_2666007"	"unprognostic (3.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.73e-3)"	"unprognostic (7.24e-2)"		"unprognostic (2.83e-1)"		"unprognostic (5.38e-3)"	"unprognostic (9.81e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.14e-4)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-1)"		"unprognostic (2.35e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	3.5	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
JPH2	JP-2	ENSG00000149596	"Junctophilin 2"	Q9BR39	20	44111695-44187578	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 72.6;smooth muscle: 55.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 12.8;EFO-21: 16.1;fHDF/TERT166: 16.2;HeLa: 10.6;SiHa: 10.8;T-47d: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							HPA052646	Approved									"HPA052646: AB_2681899"	"unprognostic (1.57e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.61e-4)"	"unprognostic (4.71e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.45e-3)"	"unprognostic (6.87e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.73e-2)"	"unprognostic (4.76e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.10e-2)"	3.0	0.8	0.1	5.5	0.3	0.1	2.7	0.1	0.6	13.6	21.6	0.5	10.2	1.4	20.2	6.1	13.5	11.6	14.4	24.3	0.1	0.1	0.9	0.1	1.8	0.3	1.2	0.3	5.0	0.3	0.1	0.3	2.3	1.3	11.6	2.2	5.4	2.1	14.6	72.6	1.2	4.4	55.7	0.5	0.5	7.3	1.5	0.1	0.0	0.9	11.8	1.8	22.1	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.1	0.6	0.2	0.0	0.3	0.3	1.5	2.0	3.7	4.9	2.2	12.8	5.3	0.0	16.1	16.2	9.4	0.0	0.4	2.0	0.0	0.0	0.0	10.6	0.0	0.2	0.0	0.0	0.8	0.9	2.5	3.7	0.0	0.0	0.0	6.7	3.8	0.0	0.1	0.2	1.2	1.7	3.3	0.0	0.3	0.0	0.0	0.0	10.8	3.2	0.0	10.5	0.0	0.2	2.1	2.3	0.3	4.3	0.0	0.0	0.0	0.2	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.6	0.1	0.1	1.2	0.3	1.3	0.1
KBTBD13	"hCG_1645727, NEM6"	ENSG00000234438	"Kelch repeat and BTB domain containing 13"	C9JR72	15	65076816-65078192	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 4.6;skeletal muscle: 19.2;tongue: 9.4"	"Cell line enriched"	"Detected in single"	6	"HMC-1: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062737	Uncertain									"HPA062737: AB_2684856"										"unprognostic (1.18e-1)"		"unprognostic (7.88e-2)"			"unprognostic (6.07e-2)"			0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.6	0.2	0.0	0.0	0.0	0.3	0.2	0.3	0.7	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	1.1	0.2	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	9.4	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
KCNS3	Kv9.3	ENSG00000170745	"Potassium voltage-gated channel modifier subfamily S member 3"	Q9BQ31	2	17877847-18361616	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 54.4"	"Cell line enhanced"	"Detected in many"		"RH-30: 33.1;RPMI-8226: 13.3;RT4: 22.5;U-266/84: 15.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"memory B-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"B-cells: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA014864	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA014864: AB_1852155"	"unprognostic (5.62e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.87e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.30e-1)"	"unprognostic (9.47e-3)"	"unprognostic (9.06e-2)"	"unprognostic (8.45e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (1.53e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.71e-2)"	2.2	1.1	2.7	5.6	3.2	0.4	14.8	0.5	5.1	6.8	7.9	4.8	1.3	3.1	4.5	2.4	7.2	3.3	5.3	4.6	3.9	3.4	4.2	2.6	17.6	1.2	6.8	1.4	1.1	7.7	1.9	0.8	8.3	15.2	4.4	4.1	9.9	7.6	2.8	54.4	3.7	4.3	9.7	4.7	1.1	7.0	3.9	1.4	0.2	2.4	19.0	3.6	5.0	4.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.6	0.3	0.0	0.8	0.4	1.8	1.3	4.0	0.8	1.0	0.0	8.1	0.0	0.4	1.4	1.2	9.8	0.0	0.9	0.0	2.5	0.0	0.1	0.0	4.0	0.1	0.3	0.3	6.2	0.0	0.6	0.2	0.2	0.0	0.5	1.0	0.0	0.0	4.8	0.1	1.1	33.1	13.3	0.8	22.5	9.8	0.3	0.0	2.5	2.7	1.3	0.0	0.0	1.3	0.0	0.1	9.9	0.0	15.4	0.0	7.4	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.2	0.5	5.1	3.9	3.4	6.8	1.4	15.2	1.4
KCNT1	"KCa4.1, KIAA1422, SLACK, Slo2.2"	ENSG00000107147	"Potassium sodium-activated channel subfamily T member 1"	Q5JUK3	9	135702185-135795508	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.7;skeletal muscle: 19.5"	"Cell line enhanced"	"Detected in some"		"RH-30: 2.0;RPMI-8226: 4.5;SCLC-21H: 6.8;SH-SY5Y: 1.4"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059880	Uncertain									"HPA059880: AB_2684149"	"unprognostic (1.50e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.98e-13)"	"unprognostic (9.26e-2)"	"unprognostic (7.73e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.89e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.89e-7)"	"unprognostic (9.15e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.66e-2)"	1.4	0.8	7.3	1.0	12.4	1.0	0.7	29.7	29.3	0.7	0.9	0.2	0.0	1.0	0.8	0.9	1.2	0.9	1.1	1.8	5.3	4.2	0.7	0.7	0.9	0.8	1.8	12.0	7.3	0.8	0.7	4.7	1.2	6.1	0.8	0.8	0.0	0.7	0.8	19.5	0.8	0.8	0.8	2.1	9.6	1.4	1.9	3.1	0.0	0.8	0.0	0.7	1.1	0.1	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	2.0	4.5	0.0	0.0	6.8	1.4	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	7.3	12.4	29.7	29.3	5.3	4.2	1.8	12.0	6.1	3.1
KIAA0408		ENSG00000189367	KIAA0408	Q6ZU52	6	127440343-127459391	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 38.6;smooth muscle: 37.2"	"Cell line enhanced"	"Detected in many"		"AF22: 12.4;SCLC-21H: 31.2;SH-SY5Y: 15.4;U-138 MG: 8.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044035, HPA053341"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA044035: AB_10964274, HPA053341: AB_2732578"	"unprognostic (1.06e-1)"				"unprognostic (4.36e-2)"	"unprognostic (3.06e-1)"		"unprognostic (1.09e-1)"			"unprognostic (8.56e-4)"	"unprognostic (1.00e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.20e-2)"	22.9	3.1	9.1	3.4	6.9	0.0	2.8	12.4	21.0	7.4	12.0	0.6	1.9	1.1	2.6	4.7	16.7	1.1	2.9	2.6	10.2	9.7	0.6	0.7	15.3	0.5	11.5	0.7	3.3	0.5	0.0	6.8	1.1	0.9	20.4	5.0	0.7	1.9	1.7	38.6	0.4	6.7	37.2	13.1	2.0	3.7	3.4	1.2	0.7	1.5	15.4	0.8	25.2	11.3	0.0	0.0	0.0	0.2	0.0	0.9	0.1	0.0	2.8	12.4	0.0	1.1	2.9	0.0	0.3	2.2	1.9	4.4	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	2.9	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.7	0.0	8.1	0.0	0.0	0.0	0.3	2.3	0.0	4.3	0.0	4.2	0.0	0.0	2.1	0.0	0.7	0.0	31.2	15.4	0.0	0.0	0.3	0.0	0.8	0.0	8.5	1.4	0.0	2.0	0.0	0.0	0.0	4.9	0.2	6.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.1	6.9	12.4	11.8	10.2	9.7	11.5	0.7	0.9	1.2
KIAA1217	"DKFZP761L0424, ETL4, SKT"	ENSG00000120549	KIAA1217	Q5T5P2	10	23694746-24547848	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 91.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 33.6;Karpas-707: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.8"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004941	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA004941: AB_2130659"	"unprognostic (3.60e-2)"	"unprognostic (7.55e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.87e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavourable (7.63e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-1)"	24.9	12.7	3.3	6.6	8.7	0.0	21.6	5.5	16.2	10.2	15.1	2.7	18.0	7.5	7.2	16.5	22.6	10.4	11.9	8.6	5.1	3.7	13.5	10.4	8.6	1.4	4.3	8.1	8.4	10.1	34.1	5.5	12.2	8.8	15.1	8.9	16.9	28.8	26.6	91.1	12.0	13.7	4.1	3.8	5.7	10.1	16.8	1.8	3.3	20.5	20.4	8.8	10.1	13.0	0.0	0.0	0.0	0.0	0.9	2.8	0.0	7.5	3.8	1.5	0.0	1.0	2.8	33.6	1.5	2.4	3.5	7.5	6.5	12.1	0.4	7.6	3.0	12.6	1.9	14.4	3.9	2.8	1.4	0.1	8.8	7.6	1.7	0.0	0.1	10.5	9.3	7.7	2.1	0.0	0.0	30.6	1.7	2.6	4.1	0.2	3.4	3.5	0.3	9.0	6.2	8.2	10.0	1.0	0.5	3.7	12.7	0.0	6.1	0.0	8.0	5.4	5.8	21.5	1.9	13.6	11.5	0.0	17.9	0.2	0.2	0.0	0.0	0.0	0.5	0.0	2.8	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	3.3	8.7	5.5	16.2	5.1	3.7	4.3	8.1	8.8	1.8
KIF1B	"CMT2, CMT2A, HMSNII, KIAA0591, KLP"	ENSG00000054523	"Kinesin family member 1B"	O60333	1	10210805-10381603	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015177	Approved									"CAB015177: AB_2296564"	"unprognostic (1.30e-1)"	"unprognostic (6.88e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.82e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.20e-1)"	"prognostic favourable (2.91e-6)"	"unprognostic (1.51e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.33e-3)"	7.8	11.0	32.9	6.2	30.2	10.3	9.0	37.0	43.2	7.4	7.6	31.0	2.0	7.1	10.0	5.7	12.9	7.4	7.8	19.3	28.3	23.7	10.8	7.4	7.4	3.5	29.2	21.5	11.7	8.9	21.2	5.8	7.5	29.9	8.9	7.2	9.5	8.2	7.5	112.9	9.1	7.7	10.9	25.2	5.3	5.4	13.1	25.6	0.3	8.2	13.0	4.2	6.2	5.4	0.8	1.1	8.0	1.8	0.8	1.2	0.7	10.6	7.7	36.1	14.0	10.0	11.3	3.1	10.4	7.3	11.1	11.3	8.4	5.3	1.5	10.6	16.8	7.7	25.9	8.2	15.4	14.9	8.6	6.3	11.4	9.8	8.0	2.2	2.0	8.7	8.4	18.8	12.0	13.6	7.0	6.3	12.2	3.2	2.4	2.2	7.9	5.7	10.5	21.0	2.8	4.6	5.3	24.8	12.1	14.7	7.1	14.5	5.0	3.0	15.8	13.1	8.4	14.6	9.9	3.5	5.8	3.4	11.3	6.8	6.5	2.9	1.4	8.0	1.1	1.4	0.5	0.7	1.1	1.2	1.1	0.8	0.7	0.6	7.5	0.8	1.8	0.8	1.2	0.7	32.9	30.2	37.0	29.5	28.3	23.7	29.2	21.5	29.9	25.6
KIF1C	"SAX2, SPAX2, SPG58"	ENSG00000129250	"Kinesin family member 1C"	O43896	17	4997948-5028401	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 172.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024602, HPA045020"	Approved									"HPA024602: AB_1852480, HPA045020: AB_2679187"	"unprognostic (3.89e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.74e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.28e-1)"	"unprognostic (6.69e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.90e-3)"	"prognostic favourable (2.26e-9)"	"unprognostic (1.10e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.10e-3)"	18.8	6.3	34.1	9.2	33.6	2.9	43.9	8.0	18.9	10.6	16.4	25.2	9.9	19.3	10.3	8.6	27.7	7.8	14.8	60.1	37.3	25.5	14.8	14.8	17.0	7.4	44.4	8.7	7.4	18.7	18.7	2.6	7.4	17.1	12.2	12.7	7.8	12.8	14.8	172.0	13.2	18.3	15.6	53.7	9.5	15.8	6.0	22.0	2.1	15.8	32.0	7.4	11.8	37.8	1.8	1.1	4.6	1.9	1.1	1.2	0.5	27.8	26.8	9.0	19.4	21.4	12.9	14.3	22.3	17.9	17.8	10.9	19.2	6.8	4.5	13.2	34.8	29.0	16.2	29.5	12.7	10.8	19.0	3.2	34.1	15.4	14.6	1.3	9.7	13.2	30.9	23.9	16.5	24.2	12.1	7.9	17.4	16.6	3.9	2.1	7.0	17.6	4.0	15.2	4.6	15.8	19.7	2.2	4.3	31.5	17.6	9.9	17.3	4.0	50.9	24.1	18.3	17.4	26.9	3.0	2.5	2.4	17.8	5.7	11.9	1.7	1.9	2.4	0.9	1.7	0.9	1.4	0.9	1.1	1.1	1.8	0.9	1.0	4.6	1.1	0.9	0.9	1.2	0.5	34.1	33.6	8.0	18.9	37.3	25.5	44.4	8.7	17.1	22.0
KLHDC3	"dJ20C7.3, hPeas, PEAS"	ENSG00000124702	"Kelch domain containing 3"	Q9BQ90	6	43014103-43021298	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 122.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030131, HPA030132, HPA030133, HPA030134"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA030131: AB_10599712, HPA030132: AB_10600880, HPA030133: AB_10611532, HPA030134: AB_10601350"	"unprognostic (3.85e-2)"	"prognostic favourable (9.15e-4)"	"unprognostic (5.31e-2)"	"prognostic unfavourable (4.52e-4)"	"unprognostic (9.97e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.05e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.58e-3)"	"prognostic favourable (9.08e-4)"	"unprognostic (6.34e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.52e-1)"	16.1	19.0	37.2	11.6	41.6	14.7	17.6	38.0	68.2	15.2	16.7	14.6	15.4	14.4	12.8	21.2	16.1	19.9	13.6	34.0	34.2	25.7	14.8	20.2	14.4	14.4	26.7	41.6	20.3	15.2	15.6	17.6	20.9	29.6	16.3	15.0	13.5	21.3	18.5	122.7	15.1	14.7	15.9	14.6	14.1	15.4	47.0	15.3	17.4	19.3	17.6	15.6	13.7	11.2	19.5	39.4	41.6	36.3	21.6	31.5	29.8	27.6	8.5	28.5	47.6	19.6	14.9	20.4	12.5	16.2	24.6	26.9	24.6	14.5	27.5	14.4	18.3	14.7	30.3	16.1	16.9	14.6	41.3	34.2	24.6	25.5	19.3	20.0	24.4	23.9	16.3	18.9	11.1	23.7	41.4	19.6	9.2	34.3	32.8	34.6	37.1	9.2	32.0	20.9	32.9	15.1	16.1	52.9	41.3	13.3	15.3	21.3	26.5	58.2	14.0	11.2	20.9	12.3	12.4	21.5	26.9	39.9	4.9	28.8	9.4	14.9	36.3	41.6	28.5	33.8	24.0	19.2	23.8	25.8	39.4	19.5	31.5	24.5	17.7	21.6	25.8	21.8	25.1	29.8	37.2	41.6	38.0	68.2	34.2	25.7	26.7	41.6	29.6	15.3
KLLN	killin	ENSG00000227268	"Killin, p53 regulated DNA replication inhibitor"	B2CW77	10	87859161-87863437	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 6.3;skeletal muscle: 7.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 8.7"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA074502			Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoplasm	"HPA074502: AB_2686695"	"unprognostic (4.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.71e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.57e-2)"	"unprognostic (4.79e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.02e-4)"	"unprognostic (1.60e-1)"	1.7	1.5	1.2	0.8	1.9	0.6	1.4	2.0	1.4	1.3	1.6			0.7	1.2	2.0	0.6	2.9	0.6	0.7	1.0	1.8	1.7	1.7	0.5	1.3	1.1		0.7	0.6	1.3	1.9	0.9		0.6	1.6		0.4	0.8	7.4	0.4	0.7	0.8	0.9	1.7	0.9	2.4			1.3		1.4	0.9	0.9	1.7	1.4	6.3	1.6	1.7	1.2	0.5	1.4	1.6	2.0	1.4	1.0	0.6	1.5	1.2	1.6	0.9	1.2	1.0	4.4	3.4	0.6	0.5	1.7	1.2	1.3	0.7	0.9	0.5	1.1	2.6	1.1	1.1	2.4	0.9	1.1	1.5	1.2	1.5	0.5	0.8	8.7	0.9	2.9	6.6	2.7	0.8	0.8	4.3	0.3	4.2	0.8	1.4	0.8	1.7	1.5	1.1	0.2	2.8	2.0	0.5	1.0	0.5	1.7	0.6	5.1	5.2	4.9	1.7	4.8	1.0	3.1	1.0	1.5	0.7	1.4	1.1	1.2	0.9	0.9	0.8	1.7	1.2	1.1	6.3	1.7	1.6	1.4	0.7	0.5										
KPNA1	"IPOA5, NPI-1, RCH2, SRP1"	ENSG00000114030	"Karyopherin subunit alpha 1"	P52294	3	122421949-122514945	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053627, HPA063426"	Supported		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA053627: AB_2682211, HPA063426: AB_2685013"	"unprognostic (6.23e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (5.81e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.02e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.77e-3)"	"unprognostic (7.89e-3)"	"unprognostic (5.22e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.43e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.77e-1)"	15.4	16.9	15.1	14.4	15.5	7.6	17.8	14.6	19.3	11.8	13.6	12.0	9.0	9.9	14.4	12.3	17.2	10.8	9.6	18.7	13.9	11.6	13.1	24.6	12.5	11.2	14.4	16.8	10.8	14.5	19.6	13.8	13.6	16.5	12.3	12.3	8.6	13.2	15.1	89.4	13.1	11.3	17.7	15.8	10.9	12.3	15.2	13.5	12.4	14.1	10.9	15.3	14.5	13.6	11.4	17.3	29.3	18.2	13.5	13.9	10.9	29.5	17.6	30.3	15.3	19.7	21.9	9.6	22.9	19.4	25.1	22.8	21.2	14.5	21.6	21.2	25.1	15.6	23.7	19.5	37.2	5.8	9.0	26.5	15.8	11.7	11.6	23.4	12.3	15.1	25.5	18.1	25.5	27.5	18.5	12.5	22.8	13.9	17.0	5.6	13.1	18.9	17.5	25.2	13.8	11.0	20.9	20.9	12.6	24.6	13.4	20.0	17.8	13.9	23.4	15.8	17.4	7.7	17.6	12.1	12.1	40.2	22.1	16.5	16.0	15.7	13.1	12.5	12.6	13.4	13.5	11.4	11.2	13.9	17.3	8.8	11.6	11.8	29.3	13.5	18.2	5.5	11.8	10.9	15.1	15.5	14.6	16.7	13.9	11.6	14.4	16.8	16.5	13.5
KPNA4	"IPOA3, MGC12217, MGC26703, QIP1, SRP3"	ENSG00000186432	"Karyopherin subunit alpha 4"	O00629	3	160494995-160565588	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 66.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034336, HPA043154, HPA045500"	Enhanced		Enhanced	Nucleoplasm		250000	250000	Nucleoplasm	Nucleoplasm	"CAB034336: AB_2281054, HPA043154: AB_2678343, HPA045500: AB_2679351"	"unprognostic (1.58e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavourable (8.59e-4)"	"unprognostic (7.56e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavourable (6.24e-7)"	"unprognostic (7.71e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavourable (1.03e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.48e-1)"	18.0	9.4	12.6	12.9	12.7	15.2	25.1	13.1	14.1	14.8	14.4	8.6	11.1	7.3	13.1	10.8	22.1	8.9	13.9	45.0	12.0	12.1	11.0	12.6	11.4	12.4	11.6	10.8	15.0	10.7	12.5	6.9	17.5	11.1	11.0	9.7	7.1	10.9	13.1	66.1	10.6	9.5	20.4	10.4	12.1	10.8	13.5	6.3	13.8	11.4	22.2	10.2	21.8	25.2	2.9	2.9	6.8	11.5	8.3	5.6	3.2	33.5	11.8	12.2	16.6	14.2	13.1	16.1	20.9	14.9	15.3	13.1	15.1	17.6	17.8	25.0	21.3	15.7	13.7	13.5	23.1	22.0	7.7	15.0	10.6	9.0	18.4	21.0	13.5	13.3	14.3	14.9	30.3	20.2	11.3	14.5	21.7	9.4	18.9	8.7	24.9	11.1	12.6	18.3	18.0	12.3	12.9	10.0	9.7	20.2	20.3	29.0	17.6	11.5	22.5	17.6	15.1	17.5	33.5	26.5	17.5	40.8	16.1	22.0	15.5	6.8	3.6	6.0	3.1	6.7	5.6	2.9	4.5	4.5	2.7	2.5	3.6	4.7	5.4	8.3	11.5	2.9	4.2	3.2	12.6	12.7	13.1	13.3	12.0	12.1	11.6	10.8	11.1	6.3
KY	FLJ33207	ENSG00000174611	"Kyphoscoliosis peptidase"	Q8NBH2	3	134603138-134651636	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 19.5;tongue: 36.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.3;U-2197: 4.5;U-87 MG: 13.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"basophil: 7.4"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036492, HPA036668"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA036492: AB_10672222, HPA036668: AB_2675239"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.82e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.47e-1)"	0.3	5.7	3.5	0.4	2.3	0.5	1.4	2.5	4.6	2.2	1.7	2.1	1.7	0.9	3.9	2.3	3.1	3.7	0.9	4.8	4.9	2.1	0.7	0.2	0.3	0.2	1.7	6.9	1.7	0.2	8.5	6.8	0.2	3.2	3.6	0.6	3.3	1.7	2.8	19.5	12.6	0.5	7.4	2.0	0.3	1.7	0.7	3.6	0.5	5.2	36.2	1.1	1.3	1.4	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	13.6	0.7	0.0	7.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	3.5	2.3	2.5	4.6	4.9	2.1	1.7	6.9	3.2	3.6
LDHD		ENSG00000166816	"Lactate dehydrogenase D"	Q86WU2	16	75111860-75116771	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.3;skeletal muscle: 39.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 8.5;HMC-1: 11.8;T-47d: 22.9;U-266/70: 9.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 8.9;classical monocyte: 2.7;intermediate monocyte: 4.6;non-classical monocyte: 5.7"	"Group enriched"	"Detected in many"	31	"granulocytes: 8.9;monocytes: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041766, HPA048639, HPA066148"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA041766: AB_2677660, HPA048639: AB_2680473, HPA066148: AB_2685626"	"unprognostic (8.75e-2)"	"unprognostic (3.68e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.53e-1)"	"prognostic favourable (5.61e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.01e-1)"	"prognostic favourable (2.95e-14)"	"unprognostic (4.10e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.20e-1)"	15.3	5.5	6.8	1.6	6.7	0.8	3.7	4.9	11.7	4.1	12.5	7.6	4.5	6.1	1.5	3.0	3.8	2.1	3.6	25.3	6.6	5.8	21.5	44.3	2.8	0.9	8.1	9.7	7.9	7.7	8.5	4.4	2.1	9.9	4.4	6.8	5.1	14.2	4.5	39.7	1.8	2.5	1.2	4.5	0.7	11.2	1.0	4.0	0.0	4.3	14.4	2.7	1.1	1.2	0.0	0.2	8.9	5.7	0.1	0.1	0.9	0.5	1.6	0.0	0.3	1.3	1.1	5.0	0.1	0.1	0.1	0.2	2.1	2.1	0.0	1.7	0.7	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.5	8.5	2.1	0.0	11.8	1.6	0.2	0.0	0.0	0.1	0.6	1.9	0.0	3.9	0.0	0.6	1.1	1.0	0.0	0.0	5.9	1.1	0.1	0.0	0.0	0.0	4.0	0.2	22.9	2.5	0.0	0.0	0.2	0.0	0.0	9.1	0.5	0.0	1.5	0.0	0.0	8.9	2.7	0.8	0.0	4.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	5.7	0.0	0.0	0.9	6.8	6.7	4.9	11.7	6.6	5.8	8.1	9.7	9.9	4.0
LGI4		ENSG00000153902	"Leucine rich repeat LGI family member 4"	Q8N135	19	35124513-35142451	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.3;skeletal muscle: 59.4"	"Cell line enriched"	"Detected in single"	30	"WM-115: 25.7"	"Group enriched"	"Detected in many"	6	"glioma: 4.5;melanoma: 11.5;renal cancer: 13.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042116, HPA043556"	Approved		Approved	"Golgi apparatus"	"Secreted in brain"			"Golgi apparatus"	"Golgi apparatus"	"HPA042116: AB_2677855, HPA043556: AB_2678550"	"unprognostic (3.79e-1)"	"unprognostic (6.13e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.26e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.80e-3)"	"prognostic unfavourable (2.84e-7)"	"unprognostic (1.71e-2)"	"unprognostic (4.47e-1)"	"unprognostic (7.73e-2)"	"unprognostic (7.13e-2)"	35.6	10.7	31.7	7.9	18.5	2.0	9.9	16.3	36.5	22.3	26.9	17.1	6.3	7.4	13.2	8.9	9.0	12.2	9.4	12.2	23.3	7.9	3.4	4.7	5.3	4.5	15.4	31.5	5.8	4.5	4.4	1.0	7.6	26.0	10.4	8.1	8.7	8.7	24.7	59.4	5.9	11.7	9.6	50.3	3.5	8.5	3.1	15.1	0.0	5.6	4.8	2.4	9.6	24.4	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	25.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.0	31.7	18.5	16.3	36.5	23.3	7.9	15.4	31.5	26.0	15.1
LGR5	"FEX, GPR49, GPR67, HG38"	ENSG00000139292	"Leucine rich repeat containing G protein-coupled receptor 5"	O75473	12	71439770-71586310	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.3;fallopian tube: 19.9;placenta: 21.6;skeletal muscle: 26.6"	"Group enriched"	"Detected in some"	5	"Hep G2: 15.8;SH-SY5Y: 46.7"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 16.8;endometrial cancer: 26.8;ovarian cancer: 9.8;stomach cancer: 6.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.1"	"Region enriched"	"Detected in some"	8	"olfactory region: 41.8"	"Low region specificity"	"Detected in many"			HPA012530	Approved									"HPA012530: AB_1849329"	"unprognostic (5.19e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-3)"	"unprognostic (1.52e-1)"	"prognostic favourable (5.09e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.01e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.25e-3)"	2.3	2.2	3.5	0.8	18.1	0.4	2.1	0.9	9.5	2.2	4.2	24.5	0.0	6.1	4.9	1.7	0.6	19.9	0.8	0.8	5.0	3.4	0.9	1.4	1.4	0.4	32.3	5.1	1.5	0.6	1.0	2.0	21.6	10.8	1.8	4.6	0.9	3.1	9.0	26.6	4.0	6.5	0.7	15.0	0.6	2.9	0.7	25.7	0.0	0.9	0.9	2.1	0.7	1.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	5.2	0.0	0.4	15.8	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.7	1.0	0.0	0.0	0.0	6.3	0.1	46.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	18.1	0.9	9.5	5.0	3.4	32.3	5.1	10.8	25.7
LIMCH1	"DKFZP686A01247, LIMCH1A, LMO7B"	ENSG00000064042	"LIM and calponin homology domains 1"	Q9UPQ0	4	41359607-41700044	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 87.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 27.9;HeLa: 48.2;RT4: 46.0;SiHa: 26.2;WM-115: 37.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"myeloid DC: 4.4"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004184, HPA063840"	Uncertain		Approved	"Actin filaments"				"Actin filaments"	"Actin filaments"	"HPA004184: AB_1078673, HPA063840: AB_2685133"	"prognostic unfavourable (5.55e-6)"	"unprognostic (3.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.42e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.05e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.94e-1)"	"prognostic favourable (3.82e-7)"	"unprognostic (2.84e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.24e-3)"	19.4	18.7	24.9	3.1	27.6	0.9	11.7	13.8	24.6	6.7	4.3	30.2	8.4	3.0	4.0	6.5	8.8	9.3	11.2	45.0	29.1	21.3	15.0	6.4	58.2	1.9	34.4	18.2	19.1	5.8	59.6	8.6	15.8	23.3	28.7	4.5	13.6	32.5	13.6	87.1	6.6	4.2	7.2	43.3	49.1	5.4	5.1	25.2	0.2	20.6	23.5	2.4	12.4	9.4	0.0	4.4	0.0	0.4	0.0	0.0	0.1	0.6	6.8	10.5	0.7	0.0	0.0	1.0	8.6	4.4	8.7	4.4	1.0	2.7	0.0	27.9	23.0	4.8	5.9	4.0	9.8	0.0	0.8	0.0	48.2	0.0	8.9	0.0	0.0	0.1	11.7	0.0	2.7	0.8	0.0	0.0	2.5	3.7	0.0	0.0	0.7	0.7	0.0	12.9	0.1	7.3	46.0	9.9	20.1	26.2	10.4	0.1	0.8	0.0	0.0	0.1	10.4	2.4	6.6	0.0	0.0	0.0	0.7	0.0	37.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	24.9	27.6	13.8	21.6	29.1	21.3	34.4	18.2	23.3	25.2
LIN7B	"LIN-7B, MALS-2, VELI2"	ENSG00000104863	"Lin-7 homolog B, crumbs cell polarity complex component"	Q9HAP6	19	49114324-49118460	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 51.7"	"Cell line enhanced"	"Detected in many"		"HEK 293: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.01e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.70e-2)"	"prognostic favourable (7.00e-4)"	"unprognostic (4.02e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.15e-2)"	"unprognostic (4.33e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.69e-2)"	3.7	3.4	19.4	2.3	20.4	2.6	3.2	8.3	19.6	3.4	4.7	3.9	4.8	6.0	3.2	3.4	4.5	3.7	3.4	15.9	15.2	19.2	3.1	2.6	3.7	2.8	13.2	10.6	3.1	6.3	1.5	9.6	2.1	10.0	6.9	3.3	3.8	5.6	5.1	51.7	11.3	5.5	2.5	7.6	4.0	4.7	6.3	4.7	1.4	4.2	6.7	3.0	3.8	2.5	4.8	12.5	1.5	5.6	1.5	8.5	4.4	3.0	7.0	3.6	6.7	1.0	1.4	3.1	3.7	1.7	2.3	5.6	3.8	0.6	1.3	3.8	4.7	5.7	4.2	0.4	1.2	7.4	16.1	1.1	7.2	5.1	4.9	1.3	0.9	1.4	2.9	2.1	0.4	0.8	2.1	3.9	3.6	4.2	2.9	4.7	1.8	7.6	4.6	4.6	3.3	2.5	5.4	5.1	4.5	5.3	3.0	3.5	4.1	0.7	2.5	9.2	4.0	4.8	2.2	6.5	12.6	1.9	3.3	2.9	2.8	0.0	5.6	1.5	7.4	2.7	5.8	4.8	6.0	5.2	3.6	4.8	8.5	7.2	0.9	1.5	4.6	12.5	3.2	4.4	19.4	20.4	8.3	19.6	15.2	19.2	13.2	10.6	10.0	4.7
LMCD1		ENSG00000071282	"LIM and cysteine rich domains 1"	Q9NZU5	3	8501707-8574673	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 189.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 29.8;HSkMC: 41.7;hTEC/SVTERT24-B: 30.6;U-2197: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"T-reg: 17.0"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024059	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA024059: AB_1852950"	"unprognostic (2.46e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.21e-3)"	"unprognostic (4.29e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (8.66e-5)"	"unprognostic (3.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.68e-3)"	38.6	3.3	1.6	10.1	1.8	0.0	36.4	3.9	1.9	11.7	4.4	3.8	5.2	1.9	22.3	20.8	8.3	11.9	15.4	15.9	2.3	1.7	5.5	2.2	25.9	3.8	2.4	1.7	17.9	8.5	5.8	2.0	14.1	4.5	16.1	1.6	4.6	19.2	7.0	189.9	5.7	3.3	72.9	3.7	14.3	10.6	9.3	1.3	0.8	4.6	34.3	7.1	29.4	15.7	1.8	2.7	0.0	0.3	0.0	17.0	0.2	2.9	16.6	2.8	2.1	20.7	11.7	2.9	12.1	6.2	6.7	16.5	12.2	3.7	0.0	1.4	14.0	0.2	1.6	3.1	2.7	5.0	1.1	3.6	1.1	2.4	29.8	0.0	0.3	41.7	0.0	30.6	0.2	3.2	0.0	0.0	8.6	2.1	0.0	0.0	5.4	0.7	0.0	9.2	0.0	6.1	1.1	0.1	6.9	2.0	10.1	6.3	13.2	0.0	1.5	6.7	13.5	27.0	8.1	1.6	1.9	0.8	1.3	0.9	8.7	0.0	0.0	0.0	0.0	0.3	0.1	1.8	2.6	0.5	2.7	0.3	0.0	0.0	0.0	0.0	0.0	0.9	17.0	0.2	1.6	1.8	3.9	1.9	2.3	1.7	2.4	1.7	4.5	1.3
LMOD3		ENSG00000163380	"Leiomodin 3"	Q0VAK6	3	69106872-69123032	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 28.3;skeletal muscle: 121.1;tongue: 53.1"	"Cell line enriched"	"Detected in some"	5	"HSkMC: 8.0"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 1.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036034	Uncertain									"HPA036034: AB_10673494"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.63e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.98e-4)"	"unprognostic (3.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.96e-1)"	0.8	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.1	4.8	1.9	0.1	0.0	28.3	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.1	0.0	0.5	0.1	0.0	0.9	0.0	0.0	4.4	0.1	121.1	0.1	0.1	0.3	0.1	0.2	0.2	0.1	0.1	0.0	1.4	53.1	0.7	0.6	0.1	0.9	0.3	4.1	1.1	0.4	1.0	0.2	0.2	0.1	0.9	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.7	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.7	0.6	0.0	0.2	0.7	8.0	0.0	0.1	0.1	0.0	0.1	0.6	1.7	0.1	0.0	0.3	0.1	0.2	0.1	0.6	0.1	0.0	0.8	0.2	0.3	0.2	0.2	0.1	0.1	0.1	1.0	0.3	0.1	0.3	0.1	0.4	0.5	0.2	0.3	0.2	0.3	4.1	0.6	0.8	0.5	0.4	0.6	0.6	0.9	0.7	0.1	0.9	0.6	0.7	0.8	0.4	1.1	0.3	1.0	0.2	0.1	0.2	0.1	0.3	0.1	0.1	0.4	0.0	0.0	0.1
LPIN1	KIAA0188	ENSG00000134324	"Lipin 1"	Q14693	2	11677595-11827409	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024591, HPA038021"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA024591: , HPA038021: AB_10669514"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.02e-1)"	18.1	10.1	13.0	10.7	18.3	6.0	22.1	20.0	16.4	10.5	8.6	10.9	7.3	8.9	11.0	15.0	20.0	7.0	10.4	12.8	11.6	11.9	7.6	13.2	8.0	15.4	13.2	11.2	19.3	7.5	17.2	32.0	9.0	17.9	9.6	7.1	9.0	14.4	11.6	88.4	6.5	9.2	11.0	10.3	8.4	7.6	39.0	13.2	8.3	8.1	14.0	19.2	10.4	21.7	6.5	9.6	11.6	2.8	8.0	11.1	3.2	5.4	6.5	5.4	12.1	25.1	27.9	2.8	7.6	13.2	5.0	8.6	2.3	5.4	2.7	1.0	6.5	5.9	6.1	16.8	4.6	11.2	3.4	6.7	3.6	3.5	8.8	4.6	31.6	25.1	7.5	20.5	7.8	9.5	9.2	24.3	3.6	2.1	4.3	4.0	5.6	6.6	6.0	10.0	17.0	12.5	3.5	15.1	11.9	2.7	6.6	17.3	1.6	2.6	6.7	7.9	7.1	5.0	6.6	38.2	29.5	5.1	11.1	8.3	5.8	9.5	2.8	11.6	10.3	2.1	11.1	6.5	9.6	9.7	2.5	5.0	8.4	7.1	1.1	8.0	2.1	9.6	10.5	3.2	13.0	18.3	20.0	14.4	11.6	11.9	13.2	11.2	17.9	13.2
LRRC38		ENSG00000162494	"Leucine rich repeat containing 38"	Q5VT99	1	13474977-13514048	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 16.0;skeletal muscle: 60.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.8;MOLT-4: 14.2;PC-3: 10.3;U-138 MG: 16.6"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	7	"cerebellum: 4.1;cerebral cortex: 3.0;pons and medulla: 1.1"	"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 1.8"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038778	Approved									"HPA038778: AB_10673294"	"unprognostic (5.13e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.88e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.45e-3)"		"unprognostic (1.72e-1)"		"unprognostic (2.70e-1)"	"unprognostic (9.70e-2)"	"unprognostic (4.23e-1)"		"unprognostic (7.81e-2)"	"unprognostic (4.47e-2)"		"unprognostic (1.05e-1)"	0.4	16.0	0.1	0.1	0.3	0.2	0.7	4.1	3.0	0.2	0.2	0.2	0.0	0.2	0.2	1.4	0.4	0.2	0.2	1.0	0.2	0.1	0.2	0.1	0.2	0.2	0.4	0.3	0.2	0.1	0.2	0.1	0.7	1.1	0.4	0.2	0.8	0.5	0.2	60.8	0.8	0.2	0.2	6.8	0.2	0.2	0.5	0.0	5.7	0.2	10.0	0.3	0.2	0.5	0.1	1.8	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	10.3	0.0	0.1	1.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	16.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.1	0.3	4.1	3.0	0.2	0.1	0.4	0.3	1.1	0.0
LSM10	MGC15749	ENSG00000181817	"LSM10, U7 small nuclear RNA associated"	Q969L4	1	36391238-36397892	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048469			Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA048469: AB_2756307"	"unprognostic (2.15e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (1.83e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.90e-2)"	"prognostic favourable (4.89e-4)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (6.40e-6)"	"unprognostic (1.84e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.59e-2)"	"unprognostic (8.54e-2)"	15.0	11.9	19.8	17.7	20.2	12.6	21.1	11.1	20.9	12.3	20.8	9.5	16.7	11.9	14.2	19.1	15.0	11.4	15.7	28.2	18.6	19.7	17.3	21.3	11.8	27.3	17.7	14.4	14.6	18.6	12.1	16.4	13.2	17.0	16.2	11.0	13.8	16.9	19.5	82.0	10.1	13.0	17.8	12.5	21.1	14.5	12.1	10.3	10.3	18.9	22.0	26.8	19.1	25.0	73.8	45.9	66.7	50.5	19.1	31.0	49.9	18.5	28.4	10.7	28.6	25.3	24.9	11.1	16.8	24.7	27.0	20.7	12.7	17.8	44.1	23.3	22.7	10.3	18.1	21.8	18.0	29.8	21.7	22.1	16.8	29.8	30.8	16.6	32.5	20.8	19.4	24.2	17.2	27.6	20.3	21.6	19.0	33.1	18.5	18.9	27.6	29.6	14.0	10.3	29.7	26.1	11.4	13.7	10.3	13.6	17.5	40.7	9.1	14.3	18.3	12.3	17.1	32.1	26.1	28.6	38.4	34.4	24.8	25.5	27.8	35.7	50.5	61.4	25.6	48.7	27.8	70.6	25.5	26.5	36.0	73.8	23.1	25.0	66.7	19.1	44.9	45.9	31.0	49.9	19.8	20.2	11.1	20.9	18.6	19.7	17.7	14.4	17.0	10.3
MAB21L1	CAGR1	ENSG00000180660	"Mab-21 like 1"	Q13394	13	35474182-35477209	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 24.0;skeletal muscle: 8.5"	"Cell line enhanced"	"Detected in some"		"BJ: 13.5;BJ hTERT+: 11.0;BJ hTERT+ SV40 Large T+: 15.5;BJ hTERT+ SV40 Large T+ RasG12V: 8.8;HBF TERT88: 16.9;SH-SY5Y: 50.0"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"cerebellum: 45.8;midbrain: 22.3;pons and medulla: 12.9"	"Low region specificity"	"Detected in all"			"HPA049324, HPA059864"			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA049324: AB_2680712, HPA059864: AB_2684147"	"unprognostic (4.44e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.79e-3)"	"unprognostic (3.87e-4)"	"unprognostic (5.67e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.86e-1)"	2.9	6.4	0.3	0.5	0.0	0.0	6.3	24.0	0.0	0.0	1.2			0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.8	0.6		1.1	0.0	0.0	0.0	0.0		1.8	0.5		3.7	0.2	8.5	1.2	1.1	0.0	0.8	0.0	0.3	0.0			0.6		0.2	0.2	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	13.5	11.0	15.5	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	16.9	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	1.3	50.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MAMSTR	"FLJ36070, MASTR"	ENSG00000176909	"MEF2 activating motif and SAP domain containing transcriptional regulator"	Q6ZN01	19	48712742-48719721	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 53.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 7.5;RH-30: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049765			Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA049765: AB_2680870"	"unprognostic (6.00e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.50e-3)"	"unprognostic (4.34e-4)"	"unprognostic (2.11e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.39e-2)"	2.4	14.7	1.8	1.0	1.9	0.5	0.9	8.0	4.3	7.9	1.0	2.2	1.1	0.7	13.5	3.5	2.7	4.8	1.0	2.7	1.6	1.0	0.7	0.4	0.9	0.7	1.0	4.3	9.5	1.0	2.7	2.7	1.4	0.7	4.7	0.8	3.3	1.5	1.7	53.9	1.7	0.9	3.6	0.8	2.9	0.7	7.7	1.1	0.0	0.9	9.2	1.1	1.4	2.4	4.1	2.9	1.1	0.9	0.7	4.0	0.6	0.6	1.4	1.5	3.8	2.9	5.1	1.5	5.0	4.0	2.5	3.9	1.4	0.9	0.7	0.3	4.7	1.1	0.2	0.9	1.0	0.5	1.7	0.3	0.5	7.5	1.5	0.1	1.0	3.1	1.0	3.5	0.5	0.9	0.3	0.9	1.6	0.6	1.2	0.6	0.1	1.1	1.4	17.9	0.4	0.3	0.3	1.6	3.0	0.8	0.3	0.3	0.5	0.0	0.3	5.1	0.9	4.1	0.7	1.1	0.7	0.5	1.9	0.6	0.9	0.0	0.5	1.1	3.9	0.9	2.5	3.1	4.0	3.8	1.0	4.1	4.0	3.5	0.4	0.7	0.9	2.9	1.7	0.6	1.8	1.9	8.0	4.3	1.6	1.0	1.0	4.3	0.7	1.1
MAP2K6	"MAPKK6, MEK6, MKK6, PRKMK6, SAPKK3"	ENSG00000108984	"Mitogen-activated protein kinase kinase 6"	P52564	17	69414698-69553861	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.9;skeletal muscle: 55.6"	"Cell line enhanced"	"Detected in many"		"A549: 23.9;HUVEC TERT2: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 9.3;neutrophil: 19.3;plasmacytoid DC: 31.9"	"Group enriched"	"Detected in all"	9	"dendritic cells: 31.9;granulocytes: 19.3;monocytes: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007744, HPA031134"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB007744: AB_562318, HPA031134: AB_10603016"	"prognostic favourable (2.27e-6)"	"unprognostic (2.24e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.61e-3)"	"unprognostic (9.52e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.09e-3)"	"prognostic favourable (7.52e-4)"	"unprognostic (3.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.03e-2)"	4.5	2.0	3.2	8.6	5.9	10.1	14.0	13.7	7.5	19.8	21.5	6.2	4.7	7.2	4.7	3.1	3.4	3.3	5.1	2.5	3.9	3.5	4.1	8.6	2.6	10.3	5.4	4.1	2.7	8.5	0.0	3.2	1.1	5.3	2.8	22.8	5.3	4.0	4.6	55.6	2.3	7.3	2.3	6.2	5.9	5.4	2.1	5.4	13.7	2.8	4.8	5.1	3.0	2.5	2.3	31.9	19.3	9.3	1.8	2.1	2.6	0.1	23.9	10.8	13.0	4.7	2.5	1.6	0.1	3.5	1.0	1.5	0.7	1.1	0.6	8.8	0.5	1.2	3.7	0.5	0.3	0.8	1.9	0.1	6.7	6.7	4.6	1.0	0.9	11.9	0.3	0.3	0.0	17.2	0.0	1.7	0.0	0.1	12.5	0.4	7.6	4.4	4.5	1.1	0.3	4.8	3.3	4.8	7.3	1.0	0.9	2.2	3.3	1.3	3.0	1.3	1.5	1.1	0.4	1.2	1.3	0.3	1.0	1.5	1.0	0.8	9.3	1.6	1.2	1.1	2.1	1.6	1.4	1.5	2.9	2.3	1.6	1.5	19.3	1.8	0.4	31.9	1.9	2.6	3.2	5.9	13.7	7.5	3.9	3.5	5.4	4.1	5.3	5.4
MAP3K20	"MLK7, MLTK, MLTKalpha, MLTKbeta, MRK, ZAK"	ENSG00000091436	"Mitogen-activated protein kinase kinase kinase 20"	Q9NYL2	2	173075435-173268010	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 96.1"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 47.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 13.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 13.7;monocytes: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017205	Approved		Supported	Cytosol				Cytosol	Cytosol	"HPA017205: AB_1858933"	"unprognostic (2.90e-2)"	"unprognostic (9.99e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.63e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.83e-2)"	"unprognostic (9.27e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (3.41e-6)"	"unprognostic (2.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.19e-2)"	21.7	5.0	2.9	7.4	3.3	0.8	9.2	2.8	3.1	25.7	24.8	2.1	10.7	3.1	30.2	15.4	26.2	13.1	14.9	52.5	3.5	3.0	2.4	8.5	7.5	2.5	4.5	3.0	21.7	4.4	22.6	3.1	6.9	4.2	25.6	5.4	11.5	6.7	15.8	96.1	5.8	8.0	68.4	4.7	3.7	15.8	6.6	3.5	2.8	6.7	38.0	4.9	46.7	24.0	2.1	13.7	2.3	8.0	0.4	1.6	2.7	8.7	7.3	5.8	7.6	16.9	25.2	3.6	31.6	24.7	14.8	15.9	5.0	5.8	6.7	8.3	31.6	5.9	8.6	16.7	33.3	13.1	5.8	11.0	8.3	1.0	6.7	9.8	11.6	20.2	7.2	27.8	43.9	9.7	4.9	1.3	9.7	3.7	6.1	4.9	3.2	4.2	9.1	11.9	0.0	3.6	5.0	3.4	3.3	12.2	3.0	5.1	3.4	5.3	9.7	47.2	19.4	14.0	7.1	0.0	0.0	1.4	33.9	2.7	4.9	0.1	8.0	0.0	0.9	7.5	0.9	1.5	0.8	1.6	13.7	2.1	0.0	0.8	2.3	0.4	6.6	0.3	0.7	2.7	2.9	3.3	2.8	3.1	3.5	3.0	4.5	3.0	4.2	3.5
MAP3K7CL	"C21orf7, TAK1L, TAKL, TAKL-1, TAKL-2, TAKL-4"	ENSG00000156265	"MAP3K7 C-terminal like"	P57077	21	29077471-29175889	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 37.9;skeletal muscle: 50.4;tongue: 28.8"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 17.0;LHCN-M2: 18.1;RH-30: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 7.6;granulocytes: 12.0;monocytes: 5.7"									"HPA030079, HPA042439"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA030079: AB_2673299, HPA042439: AB_10794422"	"unprognostic (2.23e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.00e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.39e-3)"	"prognostic unfavourable (8.31e-6)"	"unprognostic (2.68e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.10e-2)"	6.9	5.1	1.6	4.6	2.2	1.4	2.5	1.2	1.7	4.0	4.6	2.4	1.7	0.9	8.6	11.7	3.4	3.0	5.2	16.2	1.4	1.9	4.4	3.2	6.6	5.2	1.8	1.9	4.7	4.3	2.5	2.9	1.7	2.7	4.4	1.8	2.4	1.8	2.6	50.4	2.7	3.1	3.8	3.1	3.9	1.7	3.2	1.4	2.3	2.7	28.8	7.8	3.6	2.1	7.6	0.8	12.0	5.7	0.6	1.5	37.9	0.9	0.2	0.1	0.3	0.1	5.6	0.1	1.3	3.6	3.3	9.1	1.5	0.4	7.8	0.5	5.2	0.0	0.1	4.1	17.0	1.6	0.0	0.8	0.6	0.1	0.8	0.0	0.0	1.9	7.9	11.6	11.0	0.6	0.5	3.2	18.1	0.2	0.1	0.0	0.4	0.3	0.0	72.4	0.2	0.5	0.2	0.5	0.3	0.0	0.0	0.4	0.0	0.4	0.6	7.1	6.1	1.5	0.2	1.4	0.2	0.3	1.1	0.6	1.5	12.0	5.7	1.1	0.6	4.2	1.5	7.6	0.4	0.6	0.7	5.3	0.7	1.1	8.6	0.6	1.9	0.8	1.1	37.9	1.6	2.2	1.2	1.7	1.4	1.9	1.8	1.9	2.7	1.4
MAP4		ENSG00000047849	"Microtubule associated protein 4"	P27816	3	47850690-48089272	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 131.5;skeletal muscle: 197.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038149, HPA038150"	Enhanced		Enhanced	"Plasma membrane,Microtubules,Cytosol"		120000	120000	"Plasma membrane, Microtubules, Cytosol"	"Plasma membrane, Microtubules, Cytosol"	"HPA038149: AB_10672471, HPA038150: AB_10672505"	"unprognostic (2.51e-1)"	"unprognostic (4.48e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.36e-1)"	"unprognostic (4.57e-1)"	"prognostic unfavourable (1.82e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-3)"	39.3	14.8	60.5	18.2	50.9	6.3	16.4	29.3	56.0	26.9	26.4	80.8	15.8	13.6	25.8	27.4	27.0	24.6	20.1	110.2	63.7	57.5	20.8	13.8	22.7	12.4	86.8	26.1	26.8	18.9	14.6	9.3	24.0	59.5	21.8	18.8	25.2	14.0	34.9	197.9	25.1	15.2	35.0	131.5	18.3	16.2	21.2	41.8	7.3	15.4	31.3	14.2	24.3	18.1	9.9	8.9	6.3	19.7	10.7	13.4	6.7	21.9	17.6	22.1	16.7	32.6	58.2	9.3	41.2	45.0	34.9	39.2	14.8	13.8	18.6	9.6	62.1	14.7	28.2	37.3	39.2	26.8	11.9	12.6	19.7	19.1	44.3	8.7	10.2	48.6	46.7	42.3	51.9	45.7	16.2	21.6	27.4	12.4	12.3	10.6	13.3	36.5	6.6	20.8	23.1	22.3	18.4	8.8	13.7	31.6	12.8	21.8	9.4	8.1	61.7	33.0	25.5	34.4	26.3	15.2	11.8	8.8	42.4	10.7	31.2	6.3	5.3	2.8	13.4	9.0	6.5	9.9	9.0	10.9	5.7	9.4	4.3	6.7	2.2	10.7	19.7	8.9	10.2	6.7	60.5	50.9	29.3	51.8	63.7	57.5	86.8	26.1	59.5	41.8
MAP7D1	"FLJ10350, FLJ39022, PARCC1, RPRC1"	ENSG00000116871	"MAP7 domain containing 1"	Q3KQU3	1	36155579-36180849	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 144.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 4.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028075	Approved		Approved	Microtubules,Cytosol				"Microtubules, Cytosol"	"Microtubules, Cytosol"	"HPA028075: AB_10603778"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.32e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (1.49e-6)"	"unprognostic (6.00e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (8.56e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (9.32e-3)"	39.4	12.8	25.4	24.4	27.8	19.4	17.4	26.4	44.7	11.2	24.0	32.4	4.6	12.4	16.6	5.5	25.9	10.6	18.4	51.7	25.1	22.5	7.4	4.9	21.3	14.7	31.2	24.1	10.2	10.0	8.3	12.2	15.4	30.8	18.4	7.1	10.2	11.0	19.5	144.7	20.9	10.9	21.1	40.7	17.8	14.2	6.7	22.8	14.9	10.5	18.6	11.5	22.8	12.4	0.4	0.8	4.7	1.4	0.4	1.9	0.2	28.8	17.0	26.8	16.9	16.4	12.5	19.8	29.0	29.6	30.6	27.1	9.4	29.8	12.1	24.9	26.3	31.8	11.0	39.4	10.1	20.7	9.8	8.2	12.7	3.6	25.9	12.1	21.3	21.7	11.2	41.3	25.7	20.9	7.9	18.8	16.9	5.8	22.3	10.2	24.4	9.6	23.2	19.8	11.5	15.5	10.0	10.4	20.0	16.6	9.3	22.5	6.2	8.6	39.1	36.2	27.6	30.6	39.2	18.7	5.5	14.2	31.0	8.3	21.7	0.5	1.4	1.4	1.1	0.7	1.5	0.1	1.0	0.8	0.6	0.4	1.9	0.6	4.7	0.4	0.5	0.8	0.3	0.2	25.4	27.8	26.4	43.8	25.1	22.5	31.2	24.1	30.8	22.8
MAPKAPK3	"3pK, MAPKAP3"	ENSG00000114738	"Mitogen-activated protein kinase-activated protein kinase 3"	Q16644	3	50611520-50649297	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 86.7;skeletal muscle: 70.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 30.2;eosinophil: 23.0;intermediate monocyte: 50.0;myeloid DC: 27.1;neutrophil: 20.5;non-classical monocyte: 61.4;plasmacytoid DC: 16.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 27.1;granulocytes: 23.0;monocytes: 61.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058275			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA058275: AB_2683663"	"unprognostic (6.46e-3)"	"unprognostic (1.84e-1)"	"prognostic favourable (8.08e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.96e-2)"	"unprognostic (8.77e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.01e-1)"	"prognostic favourable (1.90e-8)"	"unprognostic (2.15e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.69e-1)"	8.9	16.1	5.6	9.3	7.2	30.4	6.3	1.9	6.2	5.5	9.5	7.1	7.5	9.9	5.5	8.6	16.8	5.1	8.5	86.7	4.8	3.7	17.9	11.9	11.0	15.1	7.2	4.1	8.7	24.2	11.2	9.0	9.0	6.0	7.6	6.7	10.9	12.4	9.2	70.1	17.6	12.0	5.2	5.9	12.5	9.0	4.0	5.2	25.9	22.6	40.9	14.3	6.1	7.5	3.0	27.1	23.0	61.4	7.3	6.4	19.5	23.0	7.1	3.0	8.5	4.6	11.5	6.7	5.6	8.0	8.7	7.4	11.1	21.5	9.3	5.7	18.7	8.2	20.5	22.1	7.8	20.4	4.9	48.7	10.2	10.1	9.1	35.0	25.9	9.1	13.8	20.2	27.5	7.6	13.6	6.1	18.2	9.4	14.9	35.3	11.2	29.5	6.6	7.2	13.9	40.3	13.2	5.6	4.0	5.0	14.2	6.4	8.9	21.7	5.5	6.8	15.7	35.3	13.8	4.1	7.6	7.7	36.4	55.1	2.8	6.4	30.2	23.0	5.5	50.0	5.4	3.0	6.2	6.4	27.1	1.8	4.9	5.5	20.5	7.3	61.4	16.9	5.2	19.5	5.6	7.2	1.9	6.2	4.8	3.7	7.2	4.1	6.0	5.2
MAPRE3	"EB3, RP3"	ENSG00000084764	"Microtubule associated protein RP/EB family member 3"	Q9UPY8	2	26970612-27027196	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 77.1;skeletal muscle: 62.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009263	Uncertain		Supported	Cytosol				Cytosol	Cytosol	"HPA009263: AB_1078716"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.77e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.30e-1)"	14.4	17.3	38.5	5.7	46.6	1.7	10.0	39.5	77.1	7.3	9.7	13.4	6.5	5.8	12.0	8.4	7.3	30.2	9.6	22.2	34.6	40.9	9.3	11.3	9.2	4.5	27.7	46.0	22.1	9.6	17.9	25.9	8.2	32.8	12.0	7.8	8.8	7.7	11.8	62.3	17.2	4.5	9.9	15.7	5.7	10.3	25.4	15.9	0.5	9.8	6.3	5.2	6.6	6.0	1.4	1.7	7.0	3.2	1.0	1.5	1.3	10.4	8.1	7.5	13.0	13.7	7.7	2.1	8.2	6.6	7.0	7.2	2.9	13.9	0.0	8.0	10.2	5.4	4.1	8.7	4.1	8.6	10.1	1.5	4.4	0.7	12.6	1.2	20.1	6.3	15.7	3.5	6.6	1.7	10.0	8.2	4.2	4.7	0.0	0.5	3.2	13.0	0.0	0.2	1.1	4.8	6.9	19.0	9.4	5.7	4.2	5.7	4.4	0.7	1.7	6.2	6.3	8.7	7.2	6.3	2.2	0.0	22.2	0.8	12.2	0.2	2.8	0.5	1.5	2.9	1.0	1.4	0.8	0.5	1.7	0.7	1.3	0.3	7.0	1.0	3.2	0.0	0.2	1.3	38.5	46.6	39.5	57.3	34.6	40.9	27.7	46.0	32.8	15.9
MARCOL		ENSG00000248109	"MARCO like"		5	148221650-148243580	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"ductus deferens: 3.8;epididymis: 5.7;seminal vesicle: 3.1;skeletal muscle: 2.9"	"Cell line enriched"	"Detected in some"	8	"HeLa: 124.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.3	0.0	3.8	0.0	0.7	5.7	0.0	0.0	0.0	0.9	0.0		1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.1	2.9	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	124.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0										
MAST2	"KIAA0807, MAST205"	ENSG00000086015	"Microtubule associated serine/threonine kinase 2"	Q6P0Q8	1	45786987-46036124	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 83.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 4.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039722, HPA040155"	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA039722: AB_10795294, HPA040155: AB_10793957"	"unprognostic (7.80e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.17e-2)"	"prognostic unfavourable (4.31e-8)"	"unprognostic (8.86e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (6.85e-13)"	"unprognostic (4.82e-3)"	"unprognostic (2.43e-1)"	"unprognostic (9.73e-2)"	"unprognostic (4.90e-1)"	8.9	4.3	7.0	9.9	8.1	3.7	7.1	7.1	11.8	13.6	15.2	8.4	6.6	11.2	16.7	7.7	8.8	9.5	9.9	25.5	5.0	7.6	4.8	6.1	5.9	4.4	8.9	7.3	19.8	3.6	9.1	10.5	5.5	10.1	13.9	13.9	7.2	8.3	8.6	83.3	5.5	21.3	14.9	5.8	2.5	9.0	24.8	4.8	3.5	5.7	27.4	7.5	16.3	10.6	0.5	1.9	1.4	4.3	1.4	1.4	0.5	15.2	12.4	12.5	9.6	16.4	23.6	13.9	16.3	11.8	15.1	16.9	14.2	5.0	23.9	7.7	19.9	7.6	15.1	9.3	16.0	11.5	8.1	10.8	14.0	13.0	14.3	5.8	13.9	18.1	12.1	25.3	20.3	14.1	8.3	7.3	18.0	10.4	8.4	6.0	10.3	14.2	12.4	21.0	4.5	7.8	8.3	17.5	10.4	19.2	25.1	8.2	11.4	5.7	13.7	29.3	18.9	15.3	16.1	10.0	8.9	8.7	19.6	7.9	12.1	0.0	1.1	1.4	1.4	0.6	1.4	0.2	0.7	1.4	1.9	0.5	0.5	1.0	0.0	1.4	4.3	0.1	0.0	0.5	7.0	8.1	7.1	11.8	5.0	7.6	8.9	7.3	10.1	4.8
MDH2		ENSG00000146701	"Malate dehydrogenase 2"	P40926	7	76048051-76067508	"Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 175.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019714, HPA019716, HPA019848, HPA026720"	Enhanced		Enhanced	Mitochondria		47000000	47000000	Mitochondria	Mitochondria	"HPA019714: AB_1853678, HPA019716: AB_1853680, HPA019848: AB_1853683, HPA026720: AB_1853685"	"unprognostic (3.20e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.55e-3)"	"unprognostic (8.94e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.70e-2)"	"prognostic favourable (1.49e-5)"	"unprognostic (8.57e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.66e-1)"	18.1	39.1	17.4	15.4	20.6	18.3	22.2	15.3	34.4	14.9	27.0	13.5	16.9	32.5	16.6	13.5	31.8	19.4	17.6	103.1	17.1	18.8	29.1	101.9	13.8	26.6	17.4	21.9	17.3	35.5	16.8	16.9	17.5	20.5	17.9	24.3	15.0	26.8	21.5	175.8	24.6	26.7	21.9	12.8	21.1	22.3	17.6	9.5	22.4	20.1	76.2	23.8	19.9	17.8	37.1	52.8	22.1	45.3	30.1	45.6	44.7	28.6	47.0	17.0	42.6	19.5	21.4	29.3	19.3	24.9	27.6	25.0	41.3	34.5	43.4	8.7	25.4	29.3	43.7	28.8	19.8	30.9	63.2	24.1	25.3	38.1	24.0	37.4	24.9	27.0	25.7	26.8	40.1	25.7	75.8	25.4	25.5	64.9	32.4	66.1	37.9	59.3	26.5	21.0	62.4	25.8	37.9	42.7	38.9	19.3	96.8	39.7	55.0	42.3	19.8	27.8	26.3	30.0	38.3	28.5	23.5	48.0	24.1	48.0	42.1	22.1	38.9	18.2	32.7	43.5	34.2	37.1	36.9	35.3	52.8	32.1	36.0	33.1	10.2	30.1	45.3	47.1	45.6	44.7	17.4	20.6	15.3	34.4	17.1	18.8	17.4	21.9	20.5	9.5
MEF2C		ENSG00000081189	"Myocyte enhancer factor 2C"	Q06413	5	88717117-88904257	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 154.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.7;HEL: 52.3;Karpas-707: 28.8;REH: 59.6;WM-115: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 17.2;intermediate monocyte: 19.5;memory B-cell: 32.6;myeloid DC: 22.3;naive B-cell: 48.2;non-classical monocyte: 15.9;plasmacytoid DC: 23.8"	"Group enriched"	"Detected in many"	5	"B-cells: 48.2;dendritic cells: 23.8;monocytes: 19.5"	"Group enriched"	"Detected in many"	7	"amygdala: 209.9;basal ganglia: 138.6;cerebral cortex: 403.6;hippocampal formation: 331.6;olfactory region: 196.3"	"Group enriched"	"Detected in all"	4	"amygdala: 103.2;cerebral cortex: 309.8;hippocampal formation: 290.6;olfactory region: 138.8"	"HPA005533, CAB068196, CAB068197"	Enhanced		Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"CAB068196: AB_2665646, CAB068197: , HPA005533: AB_1079352"	"unprognostic (2.74e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.78e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (1.01e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.42e-2)"	13.9	10.8	17.0	15.0	26.7	3.8	10.7	4.3	52.8	8.2	6.8	6.1	1.5	2.8	10.9	5.4	5.0	6.4	9.8	11.2	11.1	6.8	4.5	4.0	8.3	19.3	6.6	28.0	12.3	2.9	5.2	6.5	14.8	4.8	7.1	5.7	4.6	6.6	6.6	154.8	3.9	7.4	10.8	8.3	16.0	4.5	3.6	4.4	1.6	9.6	3.5	24.0	8.9	5.8	48.2	23.8	5.8	19.5	4.0	0.1	7.2	0.3	0.0	1.7	0.0	1.8	1.1	0.0	0.5	1.0	0.0	0.2	0.0	0.2	23.7	0.1	2.7	0.7	2.2	2.1	0.0	7.2	2.9	52.3	3.1	0.0	0.6	2.3	0.1	5.2	0.0	0.0	0.0	8.2	2.7	28.8	2.1	0.0	0.0	0.0	0.5	1.9	59.6	15.0	11.4	0.0	0.2	0.0	2.0	0.0	0.1	6.9	0.0	13.3	9.4	1.3	0.2	0.1	1.2	21.9	2.5	14.3	0.3	16.2	34.1	0.1	17.2	0.0	0.0	19.5	0.0	32.6	0.0	0.0	22.3	48.2	0.0	0.0	5.8	4.0	15.9	23.8	0.1	7.2	17.0	26.7	4.3	52.8	11.1	6.8	6.6	28.0	4.8	4.4
MEF2D		ENSG00000116604	"Myocyte enhancer factor 2D"	Q14814	1	156463727-156500828	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 97.8"	"Cell line enhanced"	"Detected in all"		"THP-1: 53.9;U-266/70: 47.4;U-266/84: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004807, HPA007114"	Enhanced		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA004807: AB_1079354, HPA007114: AB_1079353"	"unprognostic (3.17e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (7.53e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.45e-1)"	18.1	19.6	14.9	15.7	27.5	47.6	15.5	27.0	40.3	23.8	21.1	12.1	10.5	11.0	28.6	12.9	13.8	19.5	16.6	26.3	11.8	9.6	10.4	10.6	20.0	13.9	8.6	21.1	26.7	22.4	21.4	15.0	16.2	11.6	17.2	10.6	22.3	11.3	18.8	97.8	17.5	14.8	22.0	8.4	17.2	16.1	9.9	9.9	17.2	14.7	19.4	15.6	21.9	19.3	1.7	8.5	8.1	2.0	1.5	2.3	0.8	4.5	8.5	1.8	2.7	4.3	6.0	2.7	6.0	7.8	3.2	3.4	2.7	6.2	10.6	6.9	8.0	4.5	2.1	3.4	1.9	14.4	2.8	2.5	10.4	1.5	5.3	6.2	8.4	6.7	5.8	5.5	7.5	6.0	1.8	18.7	5.0	4.3	4.1	14.3	2.6	4.3	20.4	3.9	12.2	2.7	2.2	2.9	4.6	5.8	12.6	10.0	3.4	53.9	10.0	7.5	7.1	5.5	4.4	47.4	48.8	20.3	6.4	4.9	4.0	1.3	2.0	2.3	1.9	1.1	2.3	1.7	1.4	1.7	1.4	1.7	0.7	1.3	8.1	1.5	1.9	8.5	1.6	0.8	14.9	27.5	27.0	40.3	11.8	9.6	8.6	21.1	11.6	9.9
MFN2	"CMT2A2, CPRP1, KIAA0214, MARF"	ENSG00000116688	"Mitofusin 2"	O95140	1	11980181-12013514	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 100.9;skeletal muscle: 111.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030554	Uncertain									"HPA030554: AB_10603018"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.38e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.55e-1)"	"prognostic favourable (2.36e-8)"	"unprognostic (4.69e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.12e-1)"	12.8	10.1	16.4	8.9	20.3	17.2	10.1	15.9	32.1	8.7	17.0	17.0	11.2	16.5	12.1	8.7	20.1	9.0	9.0	100.9	17.9	16.0	14.8	20.4	10.6	8.0	18.8	19.3	10.2	9.0	22.0	9.3	12.9	20.8	14.1	13.2	16.5	10.7	23.7	111.1	18.8	25.7	22.9	15.7	10.2	14.0	11.3	10.9	7.3	18.7	28.5	12.1	16.3	10.6	7.3	8.9	18.5	16.9	5.8	10.2	13.4	25.8	15.9	18.0	23.6	18.3	13.8	20.9	20.5	19.0	28.2	22.0	26.1	17.3	19.0	22.2	24.8	27.8	29.7	47.6	25.3	68.9	22.6	27.2	25.5	20.3	18.9	27.6	17.1	17.3	36.7	39.6	36.7	19.8	28.1	16.8	20.8	13.0	16.7	12.6	12.4	23.3	19.6	26.2	17.7	16.9	17.3	21.0	13.7	24.0	25.7	23.7	13.9	16.6	19.8	18.9	18.9	28.6	21.4	20.0	21.0	31.1	22.4	31.0	20.4	8.5	10.3	7.1	9.6	13.5	10.2	7.3	7.2	8.6	8.9	6.6	6.3	8.0	18.5	5.8	16.9	4.6	8.0	13.4	16.4	20.3	15.9	32.1	17.9	16.0	18.8	19.3	20.8	10.9
MID1IP1	"FLJ10386, G12-like, MIG12, STRAIT11499, THRSPL"	ENSG00000165175	"MID1 interacting protein 1"	Q9NPA3	X	38801432-38806537	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.2;skeletal muscle: 86.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 3.7;eosinophil: 14.0;neutrophil: 8.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038816	Uncertain									"HPA038816: AB_10670908"	"unprognostic (5.35e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.08e-2)"	"prognostic unfavourable (2.20e-4)"	"unprognostic (2.62e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.31e-3)"	"prognostic favourable (1.15e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-2)"	"prognostic favourable (8.06e-4)"	20.3	9.3	26.9	9.4	59.5	58.4	8.9	5.4	33.3	5.0	9.3	33.7	7.2	11.6	5.5	5.9	7.7	8.7	5.6	6.7	29.1	21.0	8.9	13.9	21.9	7.2	69.2	12.3	13.1	30.6	3.6	3.6	6.5	42.3	8.7	4.3	5.1	7.7	10.3	86.1	6.2	8.7	7.0	31.6	5.8	19.7	9.7	62.9	3.0	4.0	7.1	4.7	9.4	10.5	0.7	1.3	14.0	1.8	0.8	1.5	0.8	18.1	16.8	4.5	3.5	21.4	10.1	4.9	10.3	7.1	2.2	4.2	5.5	13.9	17.7	9.1	3.2	17.1	14.7	12.0	1.4	12.1	5.8	15.1	14.6	4.4	16.3	7.0	11.6	14.8	9.7	8.6	7.5	2.2	13.9	19.3	3.1	15.0	12.2	19.1	15.6	29.9	33.7	5.6	34.8	5.7	9.0	10.9	13.1	5.4	10.6	26.5	8.8	21.5	3.1	6.4	7.2	8.0	7.5	49.5	19.0	16.2	19.5	11.5	7.0	3.7	1.8	14.0	1.0	1.3	1.1	0.5	1.5	1.0	1.3	0.7	1.4	1.3	8.2	0.8	1.8	1.3	0.5	0.8	26.9	59.5	5.4	33.3	29.1	21.0	69.2	12.3	42.3	62.9
MIOS	"FLJ20323, MIO, Sea4"	ENSG00000164654	"Meiosis regulator for oocyte development"	Q9NXC5	7	7566872-7608929	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 67.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042928, HPA052223"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042928: AB_10795610, HPA052223: AB_2681768"	"unprognostic (8.09e-3)"	"unprognostic (1.25e-2)"	"unprognostic (6.93e-2)"	"prognostic favourable (6.51e-4)"	"unprognostic (3.42e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (9.14e-4)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.09e-1)"	"prognostic favourable (3.28e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.10e-2)"	"unprognostic (7.67e-3)"	"unprognostic (2.72e-1)"	9.9	7.8	6.7	14.4	9.5	10.3	9.6	11.7	10.3	9.9	7.0	7.3	10.3	5.5	8.8	8.7	17.1	8.1	6.4	8.0	7.3	5.6	12.0	11.2	7.4	13.9	5.7	7.2	9.0	16.2	24.6	14.9	11.0	16.8	14.7	8.7	10.9	12.3	14.3	67.7	15.3	8.9	8.0	8.8	15.2	10.6	11.9	7.8	14.0	6.8	14.6	19.0	9.3	12.2	10.5	8.3	8.9	11.0	6.4	7.5	4.2	19.1	8.6	10.4	12.4	8.2	17.6	8.7	15.1	12.0	9.6	9.7	10.6	7.5	16.9	4.7	8.9	17.4	10.5	11.0	12.8	6.8	9.2	4.2	10.3	7.0	11.5	18.1	4.8	14.6	13.9	8.5	21.6	8.6	21.1	13.9	40.6	13.3	4.0	8.3	21.0	9.2	12.6	15.9	16.2	8.7	9.8	10.9	17.7	7.9	22.9	8.9	12.5	16.4	7.4	15.0	16.1	8.3	12.7	12.5	13.7	15.2	13.1	10.6	17.4	0.0	5.9	8.9	5.1	11.0	4.3	10.5	5.5	4.7	8.3	9.5	7.5	5.8	0.6	6.4	5.3	5.0	5.4	4.2	6.7	9.5	11.7	10.3	7.3	5.6	5.7	7.2	16.8	7.8
MKNK2	"GPRK7, MNK2"	ENSG00000099875	"MAP kinase interacting serine/threonine kinase 2"	Q9HBH9	19	2037465-2051244	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 207.5"	"Cell line enhanced"	"Detected in all"		"HHSteC: 78.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021875, CAB037253, HPA070499"	Supported		Supported	"Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"CAB037253: AB_1079401, HPA021875: AB_1854050, HPA070499: AB_2732157"	"unprognostic (8.76e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.64e-1)"	"prognostic favourable (4.86e-5)"	"unprognostic (3.08e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.32e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.07e-2)"	"prognostic favourable (4.01e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.59e-1)"	30.3	15.6	7.6	24.2	8.5	31.9	31.1	16.6	9.7	12.5	22.7	6.5	21.4	13.1	9.3	18.4	42.1	11.0	21.7	33.3	7.5	5.7	10.3	22.0	24.5	16.9	10.3	3.3	13.8	53.1	8.3	13.4	16.7	9.2	18.8	8.4	14.2	35.2	32.5	207.5	19.3	15.1	13.0	7.0	27.8	16.7	9.1	9.1	16.0	32.3	47.1	32.8	21.2	63.6	10.7	5.9	26.9	8.0	6.1	7.5	2.2	13.1	14.8	6.3	13.8	46.9	17.0	14.2	7.8	5.6	5.6	5.7	9.5	23.1	18.6	10.8	15.7	16.3	7.9	22.8	2.5	25.3	7.4	7.5	12.5	10.1	78.8	14.7	13.6	18.1	55.5	10.6	22.6	13.2	12.9	33.3	3.8	7.7	8.8	12.3	16.5	16.2	16.9	1.8	23.5	9.9	8.6	8.7	10.4	18.3	27.1	33.4	11.2	18.3	19.8	2.0	8.0	8.2	9.3	54.3	21.0	18.2	16.5	11.1	3.7	2.7	6.1	5.7	5.6	6.3	5.1	10.7	5.8	6.2	4.8	10.2	3.7	4.5	26.9	6.1	8.0	5.9	7.5	2.2	7.6	8.5	16.6	9.7	7.5	5.7	10.3	3.3	9.2	9.1
MLF1		ENSG00000178053	"Myeloid leukemia factor 1"	P58340	3	158571163-158607252	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.4;skeletal muscle: 53.6;testis: 101.1"	"Cell line enhanced"	"Detected in many"		"A-431: 34.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.4"	"Lineage enriched"	"Detected in single"	12	"T-cells: 10.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069479			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA069479: AB_2686140"	"unprognostic (6.49e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (2.15e-5)"	"unprognostic (1.72e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.55e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavourable (5.54e-4)"	"unprognostic (9.34e-3)"	"unprognostic (2.47e-3)"	"unprognostic (3.36e-2)"	3.5	2.6	6.0	1.8	11.9	0.9	5.3	3.4	7.1	3.1	2.7	6.5	0.5	0.8	4.9	5.6	3.5	18.3	4.9	41.4	6.3	6.3	5.7	1.2	5.2	1.0	4.9	6.3	6.2	3.1	5.2	10.4	1.0	20.1	2.0	1.7	2.8	2.2	1.6	53.6	1.8	1.3	4.5	4.7	1.2	1.9	101.1	5.7	0.0	5.3	18.9	1.4	4.2	1.5	0.6	0.3	0.4	0.3	0.8	10.4	2.3	34.1	4.5	11.5	0.0	6.1	7.2	3.4	3.5	3.4	13.0	11.8	0.0	19.5	0.0	13.5	6.1	6.6	0.1	6.0	17.3	0.0	7.5	2.0	3.3	0.3	4.2	0.0	2.6	4.4	8.8	6.2	3.4	3.0	2.5	0.0	8.5	5.0	0.0	0.1	2.7	10.0	0.0	6.4	0.4	9.9	2.4	14.9	8.8	16.1	5.7	16.9	16.4	3.4	1.1	12.1	12.4	14.3	13.7	6.1	3.8	0.0	8.7	0.0	8.7	0.0	0.0	0.0	3.6	0.0	1.6	0.6	8.3	8.7	0.3	0.3	2.1	4.4	0.4	0.8	0.3	0.2	10.4	2.3	6.0	11.9	3.4	7.1	6.3	6.3	4.9	6.3	20.1	5.7
MN1	"MGCR, MGCR1, MGCR1-PEN"	ENSG00000169184	"MN1 proto-oncogene, transcriptional regulator"	Q10571	22	27748277-27801498	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 62.7"	"Cell line enhanced"	"Detected in some"		"AF22: 22.0;HeLa: 8.9;RH-30: 8.9;TIME: 14.0;U-2 OS: 12.0;U-2197: 12.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"non-classical monocyte: 1.7"	"Lineage enriched"	"Detected in single"	8	"monocytes: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003072	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA003072: "	"unprognostic (5.64e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.13e-7)"	"unprognostic (3.84e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.21e-4)"	3.7	2.0	3.4	4.2	17.3	2.4	1.9	1.3	5.6	5.9	4.2	2.6	2.5	2.1	3.0	9.0	7.0	3.4	11.1	5.1	2.5	2.7	1.6	1.4	4.3	1.3	3.3	3.5	12.4	1.5	1.3	2.3	2.6	4.5	3.1	2.2	10.8	2.1	2.7	62.7	2.9	2.1	5.8	1.0	1.5	3.5	2.0	5.4	0.0	1.8	14.8	2.1	5.0	4.7	0.0	0.2	0.0	1.7	0.0	0.1	0.0	0.0	1.0	22.0	0.6	0.4	0.9	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	2.2	3.9	1.8	1.1	1.3	0.0	0.0	0.6	0.0	8.9	0.0	0.5	0.0	0.2	0.0	2.5	0.5	2.2	0.2	0.0	0.1	0.7	0.0	0.0	0.2	2.9	2.0	3.6	8.9	0.0	0.3	0.0	0.0	0.3	1.9	0.0	0.0	0.2	0.0	14.0	0.7	12.0	12.7	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	3.4	17.3	1.3	4.2	2.5	2.7	3.3	3.5	4.5	5.4
MRLN	"Linc-RAM, LINC00948, M1, MLN, MUSER1"	ENSG00000227877	Myoregulin	P0DMT0	10	59736692-59756041	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 14.1;skeletal muscle: 59.2;tongue: 22.0"	"Cell line enriched"	"Detected in some"	10	"RH-30: 22.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.4"					"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in single"	11	"cerebellum: 24.2"	"Low region specificity"	"Detected in many"															"unprognostic (2.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.54e-1)"	"unprognostic (3.17e-3)"		"unprognostic (9.77e-2)"		"unprognostic (1.09e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.46e-1)"	0.8	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	2.2	0.0	0.0	0.0		4.5	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	4.4	0.0	0.9	0.4	0.0	1.2	0.1	0.0	59.2	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.9	22.0	0.7	0.0	0.0	2.5	1.7	4.2	1.4	1.7	2.4	0.4	0.0	0.8	0.4	0.9	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.7	0.5	1.1	0.2	0.0	0.6	0.0	0.0	0.0	0.4	0.7	0.2	1.9	0.3	0.1	0.0	1.0	1.8	0.0	0.6	0.0	0.0	0.1	1.3	0.0	2.1	0.0	0.9	0.2	1.5	0.5	22.2	0.0	0.0	0.1	0.6	0.2	0.3	0.1	0.1	0.4	0.7	0.0	0.3	0.8	0.8	0.6	1.1	0.1	0.1	0.4	0.3	0.0	4.2	1.4	1.6	2.4	1.0	1.7	2.0	1.7	1.5	1.2	2.5	1.2	2.1	4.2	1.7	1.0	1.7	1.5	0.4										
MRPL15	"HSPC145, L15mt, MRP-L15, MRP-L7, RPML7"	ENSG00000137547	"Mitochondrial ribosomal protein L15"	Q9P015	8	54135210-54147901	"Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 77.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044425	Enhanced									"HPA044425: AB_10969629"	"unprognostic (5.67e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (5.37e-4)"	"unprognostic (9.30e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.06e-2)"	13.7	15.2	16.2	10.2	17.7	6.7	16.1	10.7	28.0	11.6	21.8	8.7	7.4	18.4	11.3	10.2	16.9	11.8	10.9	54.2	14.4	16.3	31.2	32.3	9.1	14.5	17.5	15.4	10.1	14.9	16.8	9.0	20.9	18.7	9.9	22.1	12.3	15.2	10.8	77.5	16.2	16.5	13.9	10.2	12.7	14.2	5.4	8.1	11.3	12.4	25.0	16.7	15.8	10.9	28.2	38.5	8.2	32.2	13.6	21.2	21.9	30.9	26.0	19.6	22.7	15.5	23.1	25.1	26.3	18.5	33.3	29.4	27.8	35.8	47.3	33.6	20.5	31.1	38.3	31.1	39.5	22.2	28.7	33.2	13.9	35.8	22.8	17.5	33.1	21.8	34.3	30.7	32.7	67.6	38.4	15.2	48.5	33.5	45.4	39.6	39.8	16.4	31.8	12.6	24.6	43.7	29.4	11.3	17.6	13.3	37.5	30.6	36.8	17.7	25.3	17.8	23.0	27.9	27.9	19.3	24.0	38.8	17.6	27.0	27.9	8.2	25.9	7.4	15.4	32.2	18.6	28.2	19.4	20.1	38.5	21.6	18.4	17.2	1.0	13.6	28.9	24.1	21.2	21.9	16.2	17.7	10.7	28.0	14.4	16.3	17.5	15.4	18.7	8.1
MRPL33	"C2orf1, RPL33L"	ENSG00000243147	"Mitochondrial ribosomal protein L33"	O75394	2	27771717-27988087	"Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 127.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA066872	Approved									"HPA066872: AB_2685739"	"unprognostic (5.13e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-2)"	"unprognostic (7.92e-3)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (4.68e-4)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.54e-1)"	"unprognostic (8.20e-2)"	21.6	96.5	27.3	12.6	36.7	16.7	27.3	18.1	35.4	24.3	29.6	11.3	26.2	15.4	22.4	31.9	14.8	19.1	20.3	75.4	21.7	16.5	37.3	26.9	18.8	14.8	27.1	22.6	19.7	40.0	13.6	32.6	14.7	26.5	26.5	20.2	14.2	20.9	26.0	127.3	10.4	15.3	35.9	24.7	17.5	24.1	20.9	21.7	8.7	18.4	41.0	15.6	19.6	16.3	29.5	62.2	85.8	47.2	25.7	37.5	25.0	60.2	27.3	50.7	20.6	31.9	36.4	23.5	38.4	48.6	38.5	50.6	24.1	46.8	17.4	48.5	40.0	18.5	28.3	30.4	55.3	27.3	54.1	34.0	27.2	43.5	48.5	34.0	20.2	46.3	27.0	34.9	61.6	49.1	26.3	29.7	50.6	19.9	23.3	37.1	28.3	39.8	11.9	57.4	24.2	117.9	24.4	29.0	41.9	26.5	33.9	41.1	15.2	35.2	41.6	24.5	53.0	24.0	60.2	34.5	53.2	51.2	33.8	56.3	22.5	85.8	47.2	44.9	30.2	34.4	32.1	29.5	34.3	31.6	62.2	25.7	29.5	35.2	34.1	25.7	32.9	40.3	37.5	25.0	27.3	36.7	18.1	35.4	21.7	16.5	27.1	22.6	26.5	21.7
MRPL41	"BMRP, MRP-L27, MRPL27, PIG3, RPML27"	ENSG00000182154	"Mitochondrial ribosomal protein L41"	Q8IXM3	9	137551199-137552555	"Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 55.8;skeletal muscle: 60.6"	"Cell line enhanced"	"Detected in many"		"MCF7: 48.3;PC-3: 47.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024550, HPA027160"	Supported		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA024550: AB_1854112, HPA027160: AB_1854113"	"unprognostic (3.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (8.04e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.83e-3)"	"unprognostic (3.24e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.32e-2)"	15.3	8.0	12.8	3.5	14.4	3.1	2.8	4.1	10.7	2.4	8.3			7.1	2.3	1.0	1.7	2.1	1.5	16.4	10.3	7.7	6.8	10.7	2.6	3.3	8.5		4.2	6.3	1.8	2.9	1.6		9.5	2.2		10.8	3.8	60.6	5.3	6.2	1.5	4.0	6.2	10.5	2.1			2.0		1.5	2.7	2.1	38.3	55.8	43.7	42.5	21.8	42.2	42.8	9.8	16.7	2.8	6.7	4.2	3.5	13.0	12.7	3.3	5.8	4.7	11.6	5.6	7.2	16.7	3.1	21.0	3.8	6.0	0.6	10.6	20.8	6.7	9.2	18.1	9.7	10.8	30.9	7.0	8.3	5.3	1.8	5.3	14.5	3.1	3.1	48.3	3.7	35.3	10.8	47.3	4.6	4.9	10.1	5.0	6.6	9.3	10.0	8.4	15.6	20.6	14.7	9.9	10.5	10.2	14.1	18.2	16.4	9.4	13.1	12.9	11.7	10.7	7.7	43.7	42.5	31.5	31.2	34.1	29.5	38.3	33.8	35.9	34.6	28.5	32.2	30.2	5.1	21.8	31.1	55.8	42.2	42.8										
MRPS18A	"FLJ10548, MRPS18-3"	ENSG00000096080	"Mitochondrial ribosomal protein S18A"	Q9NVS2	6	43671303-43687791	"Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 90.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035450, HPA035451"	Approved									"HPA035450: AB_10670701, HPA035451: AB_10602029"	"unprognostic (9.85e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.35e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.86e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.96e-1)"	"prognostic favourable (4.03e-5)"	"unprognostic (9.35e-2)"	16.4	20.9	17.5	14.5	19.1	10.7	16.3	12.1	22.9	15.1	24.6	14.6	12.4	21.8	16.1	13.7	25.8	19.4	17.9	28.1	15.6	14.0	22.8	34.8	12.1	15.1	16.4	15.4	17.1	21.8	14.7	9.7	22.4	14.7	20.8	28.7	17.4	20.7	18.7	90.1	18.6	20.4	17.0	13.4	19.5	24.9	13.6	11.7	20.4	21.0	27.3	20.2	18.2	15.4	55.1	37.7	35.2	30.1	35.3	35.0	32.3	23.4	20.1	15.6	22.0	16.2	11.2	18.0	11.1	17.7	28.1	27.9	40.5	9.9	10.1	19.0	15.8	19.4	22.5	32.4	14.8	15.3	26.7	18.7	15.6	35.4	28.7	25.8	11.4	15.1	26.3	23.5	36.6	21.3	32.5	21.6	16.7	39.3	19.0	21.2	11.2	16.1	16.0	12.2	32.5	21.1	27.5	25.3	13.4	11.4	22.5	39.9	22.7	36.3	10.9	17.4	19.9	13.7	20.2	23.4	19.1	36.5	23.5	18.1	46.1	35.2	30.1	30.6	34.9	25.0	32.9	55.1	32.7	32.9	34.1	38.8	32.9	30.5	13.7	35.3	17.2	37.7	35.0	32.3	17.5	19.1	12.1	22.9	15.6	14.0	16.4	15.4	14.7	11.7
MRPS24	"HSPC335, MRP-S24"	ENSG00000062582	"Mitochondrial ribosomal protein S24"	Q96EL2	7	43866558-43869893	"Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 136.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073947	Approved									"HPA073947: "	"unprognostic (1.35e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.32e-2)"	"unprognostic (8.63e-3)"	"unprognostic (9.42e-2)"	"prognostic unfavourable (1.91e-4)"	"unprognostic (2.03e-1)"	"unprognostic (6.86e-3)"	"unprognostic (9.58e-3)"	"unprognostic (1.71e-2)"	"prognostic favourable (9.89e-4)"	"unprognostic (2.87e-1)"	"unprognostic (9.08e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.95e-1)"	17.9	31.6	23.0	15.1	21.1	26.8	42.8	17.4	34.9	16.6	21.7	8.5	19.3	24.5	16.5	15.5	27.9	19.3	21.3	63.4	18.8	17.1	26.6	38.7	16.6	29.3	19.7	19.1	22.7	50.1	12.7	13.9	17.3	13.0	19.1	16.4	13.3	33.3	18.6	136.5	17.3	21.3	22.9	12.3	15.3	23.1	25.0	11.7	16.9	25.3	54.7	17.4	20.4	19.5	50.2	55.7	20.6	41.9	26.4	47.7	36.8	28.0	45.5	14.2	29.2	14.8	25.5	23.5	27.2	66.7	36.3	36.0	40.5	26.7	24.0	32.8	27.3	35.8	20.0	24.5	28.5	22.4	50.4	14.7	51.0	48.2	22.1	23.6	19.1	24.0	24.9	28.3	34.0	20.8	47.1	18.2	22.6	44.4	28.7	53.2	35.6	45.8	23.5	20.3	91.7	26.1	23.8	28.3	32.3	27.4	68.3	27.3	46.1	43.5	16.8	34.4	47.9	20.6	38.7	55.7	42.1	30.2	41.7	31.8	53.8	8.4	41.9	20.6	28.2	40.0	30.6	50.2	41.3	33.6	55.7	44.8	41.6	35.6	3.4	26.4	38.6	37.5	47.7	36.8	23.0	21.1	17.4	34.9	18.8	17.1	19.7	19.1	13.0	11.7
MSI1		ENSG00000135097	"Musashi RNA binding protein 1"	O43347	12	120341330-120369180	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 27.3;skeletal muscle: 23.2"	"Cell line enhanced"	"Detected in some"		"AF22: 42.9;HAP1: 19.6;NTERA-2: 22.3;SCLC-21H: 31.8;SH-SY5Y: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074923, HPA075573"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA074923: , HPA075573: "	"unprognostic (1.21e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.89e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.75e-2)"	"prognostic favourable (5.99e-4)"	"unprognostic (3.66e-1)"	"unprognostic (1.46e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.19e-1)"	0.8	6.8	8.7	0.6	7.4	0.4	1.2	3.9	14.2	1.9	1.5	8.6	2.2	7.8	4.3	2.7	1.5	3.1	1.4	4.0	11.3	5.9	0.7	1.0	1.0	0.6	4.7	6.1	2.9	7.3	1.3	12.8	1.4	4.6	4.5	1.5	27.3	1.3	2.5	23.2	0.5	5.2	2.2	4.7	0.7	3.1	12.5	5.4	0.0	1.3	0.0	0.4	0.9	0.9	0.1	0.4	0.6	0.2	0.2	0.3	0.0	0.0	0.5	42.9	10.8	0.0	0.0	5.4	0.0	0.0	0.2	0.5	7.5	0.2	0.0	0.6	0.0	0.1	19.6	0.0	0.1	0.2	4.4	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.5	0.0	0.1	22.3	0.2	0.1	0.0	0.1	0.0	0.0	31.8	15.5	0.0	0.3	0.3	6.6	0.0	0.0	0.1	5.9	0.0	0.0	0.5	0.1	0.0	0.1	0.1	0.4	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.1	0.6	0.2	0.2	0.4	0.1	0.0	8.7	7.4	3.9	7.2	11.3	5.9	4.7	6.1	4.6	5.4
MSTN	GDF8	ENSG00000138379	Myostatin	O14793	2	190055697-190062729	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 17.2;tongue: 15.8"	"Group enriched"	"Detected in some"	12	"LHCN-M2: 15.9;RH-30: 32.3"	"Cancer enriched"	"Detected in some"	9	"glioma: 6.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			CAB009963	Approved				"Secreted in other tissues"	4800000	4800000			"CAB009963: AB_2148798"	"unprognostic (8.45e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.54e-1)"	"prognostic favourable (2.86e-4)"	"unprognostic (7.59e-3)"	"unprognostic (2.95e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.24e-3)"	"unprognostic (7.72e-3)"	"unprognostic (1.12e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.94e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.67e-4)"	3.3	1.9	1.7	0.7	1.4	0.2	0.8	4.1	1.8	4.8	1.1	2.2	0.0	0.7	1.8	1.2	2.3	0.5	0.6	0.7	3.5	1.6	1.1	0.3	0.3	0.3	1.3	0.0	0.7	0.4	0.4	1.4	0.2	3.4	1.0	1.1	0.9	1.0	0.5	17.2	1.2	2.1	0.9	1.1	0.3	0.6	0.7	4.0	0.0	0.7	15.8	0.4	0.3	0.9	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	4.1	1.0	3.5	1.6	1.3	0.0	3.4	4.0
MT-ATP6	"ATP6, ATPase-6, MTATP6, RP, Su6m"	ENSG00000198899	"Mitochondrially encoded ATP synthase membrane subunit 6"	P00846	MT	8527-9207	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 419.0;skeletal muscle: 475.3"	"Cell line enhanced"	"Detected in all"		"HeLa: 1161.8"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in all"		"basophil: 419.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"																		"unprognostic (2.97e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.55e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.66e-1)"	"prognostic favourable (3.79e-4)"	"unprognostic (6.47e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.44e-2)"	"prognostic favourable (7.64e-4)"	"unprognostic (6.01e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.52e-3)"	85.2	89.2	126.0	25.1	159.3	20.1	29.6	45.2	81.2	20.1	60.3			75.6	23.5	30.9	42.8	19.8	24.6	309.5	122.3	90.2	154.4	166.8	18.0	19.3	102.8		26.5	54.7	36.2	22.0	34.1		37.6	59.4		66.8	35.6	475.3	62.5	52.6	27.9	61.3	20.7	58.4	27.7			22.4		18.6	23.0	15.7	110.2	58.9	419.0	88.2	72.3	90.5	35.3	98.7	162.9	113.7	178.4	217.2	49.9	74.3	145.5	26.6	19.7	33.3	191.6	108.6	175.9	61.8	78.5	215.2	11.8	113.5	36.6	125.7	103.1	154.0	1161.8	331.5	36.9	91.1	199.6	81.3	100.7	35.3	34.2	34.9	101.3	128.4	76.7	278.0	56.1	242.7	29.9	67.5	70.7	48.5	108.4	204.5	250.6	65.0	83.4	52.1	111.3	105.2	119.0	313.0	184.2	80.3	118.7	132.6	103.9	56.7	74.9	122.0	70.1	194.6	44.9	419.0	88.2	156.1	56.6	66.3	71.6	106.0	64.7	71.1	47.5	110.2	76.5	90.5	100.1	72.3	67.8	58.9	47.6	35.3										
MT-ATP8	"A6L, ATP8, MTATP8"	ENSG00000228253	"Mitochondrially encoded ATP synthase membrane subunit 8"	P03928	MT	8366-8572	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 959.7"	"Cell line enhanced"	"Detected in all"		"HeLa: 796.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in all"		"basophil: 352.9"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 352.9"																				"unprognostic (1.54e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.17e-1)"	"prognostic favourable (7.56e-5)"	"unprognostic (5.17e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.26e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.63e-2)"	257.8	128.5	111.1	33.5	124.1	20.5	31.2	42.1	82.1	14.9	78.9			115.5	23.9	11.6	31.6	14.4	19.9	203.6	108.7	78.8	151.5	165.2	16.9	18.5	88.8		24.3	56.4	22.8	21.1	27.7		44.2	38.7		65.2	25.7	959.7	33.1	91.5	14.2	52.0	19.3	67.4	26.1			23.2		11.8	19.6	15.4	87.7	58.0	352.9	78.1	75.9	79.1	24.2	187.4	69.2	225.8	43.0	246.0	39.3	110.9	394.6	23.3	17.9	31.4	80.3	125.9	480.2	98.5	84.8	322.5	13.9	130.1	28.2	212.2	90.1	363.2	796.3	181.1	44.9	211.5	311.0	84.6	69.0	39.7	34.2	25.5	192.3	152.3	54.9	100.2	123.9	312.0	49.6	49.9	102.3	109.8	101.0	132.1	187.4	71.0	128.4	149.6	138.8	145.8	135.4	444.2	373.1	87.4	193.7	192.5	180.8	103.3	172.9	274.5	86.1	376.2	53.1	352.9	78.1	97.9	49.4	68.6	73.5	87.7	55.9	58.5	47.2	87.3	68.9	79.1	49.0	75.9	68.0	58.0	44.0	24.2										
MT-CO1	"COI, COX1, MTCO1"	ENSG00000198804	"Mitochondrially encoded cytochrome c oxidase I"	P00395	MT	5904-7445	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 396.5;heart muscle: 345.0;skeletal muscle: 380.7"	"Cell line enhanced"	"Detected in all"		"HeLa: 859.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016241, HPA069328"	Enhanced		Supported	Mitochondria				Mitochondria	Mitochondria	"CAB016241: AB_2229888, HPA069328: AB_2686122"	"unprognostic (4.39e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.31e-1)"	"prognostic favourable (2.29e-4)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.20e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.06e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.44e-2)"	57.6	82.5	184.1	22.2	164.2	26.4	37.4	40.6	117.1	31.5	80.8			78.1	25.7	42.7	43.5	24.8	32.4	345.0	161.8	111.7	151.0	150.5	20.9	22.6	126.3		23.7	42.5	62.3	10.1	29.0		35.8	84.4		65.6	54.2	380.7	68.9	60.0	38.2	61.2	28.1	65.5	27.8			23.8		21.9	31.6	15.3	292.2	232.9	177.4	396.5	182.8	192.4	130.5	112.7	170.5	232.0	252.3	531.8	243.6	246.0	257.3	85.7	65.0	108.8	205.2	367.8	298.0	123.7	195.5	428.5	26.5	228.0	93.1	140.8	162.5	178.9	859.1	383.8	73.7	103.2	226.6	284.1	237.4	64.2	142.7	78.2	113.5	213.9	192.4	273.1	84.4	462.1	58.9	139.6	110.6	69.3	178.8	329.5	298.3	110.9	147.9	89.2	345.8	160.5	198.4	347.4	311.5	260.6	177.4	255.7	129.0	101.3	97.0	67.6	128.7	272.4	126.6	177.4	396.5	169.3	156.6	236.0	176.4	255.6	154.9	171.8	163.0	292.2	159.7	192.4	93.5	182.8	260.1	232.9	138.6	130.5										
MT-CO2	"CO2, COX2, MTCO2"	ENSG00000198712	"Mitochondrially encoded cytochrome c oxidase II"	P00403	MT	7586-8269	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 489.9;skeletal muscle: 343.4"	"Cell line enhanced"	"Detected in all"		"HeLa: 1055.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016243, HPA051505, HPA054758"	Enhanced					1300000	1300000			"CAB016243: AB_2066366, HPA051505: AB_2681511, HPA054758: AB_2682595"	"unprognostic (2.67e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.57e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.96e-2)"	"prognostic favourable (2.89e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.72e-3)"	"prognostic favourable (7.10e-4)"	"unprognostic (1.25e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.72e-3)"	54.6	64.8	149.7	21.7	194.8	30.2	45.5	48.9	99.5	27.0	106.9			73.6	23.8	46.3	35.8	25.1	23.7	252.1	151.9	112.4	158.4	173.8	22.7	22.8	154.6		21.2	46.4	50.4	22.5	41.4		38.2	106.4		61.7	56.0	343.4	56.4	51.1	40.0	77.8	25.9	68.5	28.2			23.3		29.5	29.9	16.2	379.8	278.1	489.9	409.1	220.4	273.9	181.4	109.3	176.1	234.4	226.5	479.4	184.8	172.7	142.7	115.8	81.1	122.6	189.3	247.3	228.7	119.5	209.8	415.6	31.0	293.5	109.9	177.1	158.8	164.0	1055.8	364.0	104.4	137.9	184.3	271.0	434.3	41.7	149.8	89.8	153.1	223.1	222.2	236.8	100.8	397.3	61.3	112.1	105.4	71.4	191.6	330.8	305.7	87.7	145.1	117.5	289.9	206.1	201.8	559.1	221.4	196.6	170.7	185.4	100.3	113.3	112.7	129.0	104.6	278.6	129.1	489.9	409.1	476.0	194.9	292.9	236.6	379.8	217.1	218.8	205.5	378.1	227.9	273.9	180.3	220.4	308.7	278.1	170.3	181.4										
MT-CO3	"CO3, COIII, COX3, MTCO3"	ENSG00000198938	"Mitochondrially encoded cytochrome c oxidase III"	P00414	MT	9207-9990	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 319.5"	"Cell line enhanced"	"Detected in all"		"HeLa: 798.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042788	Approved									"HPA042788: AB_10793985"	"unprognostic (2.38e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.93e-1)"	"prognostic favourable (2.01e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.05e-2)"	"prognostic favourable (1.04e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.33e-2)"	56.5	83.7	174.1	20.5	149.4	34.8	55.5	47.4	106.2	30.5	90.9			76.1	27.5	46.0	40.4	26.3	28.7	290.4	159.6	111.4	190.3	143.1	21.0	22.8	120.2		27.9	38.9	60.5	26.7	32.5		37.3	95.5		79.0	64.3	319.5	70.0	55.3	39.0	61.9	21.7	60.5	36.5			31.0		31.0	26.9	18.7	247.1	126.7	244.3	245.3	141.7	181.1	106.8	128.9	153.1	235.3	334.1	468.7	193.4	128.7	168.0	99.6	66.4	102.5	204.9	192.7	288.5	72.8	139.5	354.1	37.0	201.8	117.7	97.8	161.8	153.4	798.5	340.3	94.7	91.2	202.1	185.7	287.1	73.0	108.9	122.8	121.5	292.4	219.2	263.4	92.6	532.0	52.2	110.5	99.1	74.2	207.9	413.9	228.0	105.4	146.4	78.3	85.8	162.3	179.3	402.5	196.6	111.4	190.9	207.8	109.6	120.4	77.5	161.1	111.2	297.5	73.1	132.0	245.3	121.5	110.0	128.3	137.4	198.7	119.5	127.0	126.7	247.1	153.2	181.1	244.3	141.7	122.3	107.8	79.5	106.8										
MT-CYB	"COB, CYTB, MTCYB, UQCR3"	ENSG00000198727	"Mitochondrially encoded cytochrome b"	P00156	MT	14747-15887	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 324.2;skeletal muscle: 302.1"	"Cell line enhanced"	"Detected in all"		"ASC diff: 483.1;HeLa: 486.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032215, HPA068400"	Enhanced		Approved	Mitochondria				Mitochondria	Mitochondria	"CAB032215: AB_2261378, HPA068400: AB_2685982"	"unprognostic (4.50e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.88e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.50e-1)"	"prognostic favourable (5.96e-4)"	"unprognostic (1.63e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.01e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.90e-3)"	"unprognostic (3.07e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.54e-2)"	78.0	52.4	98.5	14.7	143.5	14.4	32.3	38.4	59.6	30.9	54.0			55.6	25.0	43.6	28.0	25.0	21.2	222.5	93.9	68.0	128.7	144.7	19.6	13.7	83.6		25.3	51.4	33.6	23.7	32.6		32.9	57.7		59.2	49.5	302.1	63.5	37.2	37.4	44.3	15.7	55.2	20.2			20.9		20.6	23.6	14.7	183.7	78.7	324.2	155.7	90.0	146.7	57.6	72.3	97.8	121.2	129.4	483.1	77.7	97.7	83.4	34.6	21.9	37.9	96.2	160.1	185.5	40.9	98.8	228.2	17.9	102.5	53.7	90.5	80.3	103.6	486.1	171.4	91.1	58.1	126.7	167.8	153.0	41.4	89.2	55.4	52.9	116.7	111.4	199.8	54.0	119.9	26.9	66.4	63.9	47.6	116.1	173.6	169.1	43.2	76.4	58.1	109.9	82.2	160.2	200.7	173.5	76.7	100.4	139.7	64.0	32.1	42.9	79.4	46.1	90.7	48.2	324.2	155.7	235.1	102.8	94.4	135.3	150.5	118.7	132.0	78.0	183.7	128.3	146.7	148.0	90.0	96.8	78.7	79.8	57.6										
MT-ND1	"MTND1, NAD1, ND1"	ENSG00000198888	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1"	P03886	MT	3307-4262	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 314.4;skeletal muscle: 398.2"	"Cell line enhanced"	"Detected in all"		"HeLa: 660.0"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in all"		"basophil: 314.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 314.4"	"Low region specificity"	"Detected in all"							CAB033779	Approved									"CAB033779: AB_2149736"	"prognostic favourable (3.63e-4)"	"unprognostic (3.55e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.95e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.05e-2)"	"prognostic favourable (3.26e-4)"	"unprognostic (8.67e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.85e-2)"	83.5	48.0	118.0	15.2	136.1	17.7	31.8	45.0	85.9	19.6	58.3			40.2	16.3	43.4	30.7	16.7	17.6	223.1	106.1	74.3	96.0	104.7	20.5	12.1	101.8		14.2	48.2	35.1	14.3	32.2		26.6	58.6		71.2	48.4	398.2	75.4	33.3	24.6	55.2	16.7	45.0	29.8			13.8		17.1	19.9	9.4	60.8	32.2	314.4	54.4	35.8	46.4	19.5	99.9	102.3	83.9	76.4	318.6	58.0	107.9	86.3	25.5	24.0	25.3	177.8	109.1	122.7	54.9	65.0	66.8	9.2	51.9	48.1	87.5	72.1	136.6	660.0	251.9	68.4	64.6	135.0	137.5	142.0	37.1	53.5	25.7	62.8	76.7	71.0	137.5	52.0	267.8	22.5	77.1	54.8	38.1	65.9	132.8	162.3	34.9	55.6	47.8	76.6	83.7	68.3	224.3	135.2	80.2	72.5	102.2	71.6	85.2	52.5	56.8	53.9	114.6	21.9	314.4	54.4	103.0	25.7	31.4	37.3	54.3	30.8	34.0	20.6	60.8	41.1	46.4	157.8	35.8	32.0	32.2	22.0	19.5										
MT-ND3	"MTND3, NAD3, ND3"	ENSG00000198840	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3"	P03897	MT	10059-10404	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 357.8"	"Cell line enhanced"	"Detected in all"		"ASC diff: 639.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063296	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA063296: AB_2684978"	"unprognostic (1.71e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"prognostic favourable (4.63e-5)"	"unprognostic (2.45e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.65e-3)"	102.1	73.9	117.3	17.6	137.2	17.9	59.3	33.7	70.5	31.2	76.3			64.0	25.9	49.2	21.7	24.7	19.7	256.8	110.3	81.7	138.1	145.8	19.7	17.4	92.0		27.5	77.8	14.6	22.2	34.6		39.1	59.1		67.6	50.7	357.8	42.2	48.9	28.4	66.8	19.1	60.6	21.0			25.0		20.3	24.2	15.9	84.8	32.6	159.6	48.5	48.6	75.3	24.4	84.7	138.5	92.5	90.7	639.2	128.1	77.0	71.4	42.0	38.8	43.9	208.4	132.2	88.4	111.0	91.8	176.8	39.7	156.2	66.7	126.6	190.5	86.9	461.1	343.0	99.8	127.8	131.5	221.5	289.5	64.9	73.3	60.3	68.4	103.3	73.1	277.1	67.1	170.7	47.5	128.2	58.2	90.9	81.3	235.9	234.2	38.1	82.9	34.5	69.2	141.3	160.1	206.6	102.3	60.0	91.1	104.2	76.4	40.2	52.6	190.4	48.7	77.7	34.0	159.6	48.5	36.6	36.7	36.4	49.8	73.1	42.6	44.8	32.6	84.8	63.1	75.3	100.7	48.6	32.7	32.3	27.6	24.4										
MT-ND4L	"MTND4L, NAD4L, ND4L"	ENSG00000212907	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L"	P03901	MT	10470-10766	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"blood: 434.4;skeletal muscle: 294.4"	"Cell line enhanced"	"Detected in all"		"HeLa: 879.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA075648			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA075648: AB_2686760"	"unprognostic (5.81e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.91e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.05e-1)"	"prognostic favourable (4.47e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.04e-2)"	"unprognostic (4.63e-3)"	"unprognostic (6.61e-2)"	"unprognostic (7.38e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.97e-2)"	"unprognostic (5.68e-2)"	101.1	71.9	102.4	20.3	114.5	13.2	39.4	41.5	73.3	39.4	83.8			48.0	26.1	34.1	30.7	23.9	23.4	187.5	102.7	79.1	123.5	185.7	20.2	13.1	88.6		26.2	43.4	29.7	18.5	30.9		34.2	80.0		43.2	75.4	294.4	31.8	38.4	38.6	59.2	16.1	62.5	27.5			24.6		24.4	25.8	14.3	200.8	111.2	434.4	139.9	112.1	153.0	66.8	96.4	89.7	161.9	164.8	567.3	119.4	71.4	207.0	51.9	32.5	59.4	149.1	89.1	239.3	84.9	139.8	183.9	25.1	221.6	64.7	94.2	103.6	172.0	879.2	276.9	83.3	176.8	154.7	209.0	227.1	61.9	216.8	65.0	94.8	171.6	119.0	172.3	67.2	226.9	40.8	108.4	39.0	69.8	106.4	172.8	203.7	49.1	66.5	101.6	160.9	69.4	114.4	222.6	207.8	85.3	106.2	124.8	79.2	155.3	72.7	127.4	61.2	240.6	39.8	434.4	139.9	290.0	102.4	110.6	140.6	166.9	110.0	117.5	86.1	200.8	132.4	153.0	78.4	112.1	99.4	111.2	79.0	66.8										
MT-ND5	"MTND5, NAD5, ND5"	ENSG00000198786	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5"	P03915	MT	12337-14148	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 193.9;heart muscle: 190.3;skeletal muscle: 223.2"	"Cell line enhanced"	"Detected in all"		"HeLa: 362.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.87e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.09e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.29e-3)"	"unprognostic (4.78e-2)"	"prognostic favourable (7.31e-5)"	"unprognostic (9.93e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.68e-2)"	47.2	30.4	71.2	14.8	94.5	11.3	16.5	23.2	45.8	13.6	30.3			38.9	16.6	24.9	26.2	21.4	19.1	190.3	65.0	52.8	56.3	66.6	19.3	9.4	56.1		18.6	22.9	23.1	7.9	15.1		27.5	28.0		25.7	21.5	223.2	63.9	29.5	25.3	37.9	12.6	41.4	14.6			12.8		13.2	24.9	8.0	124.1	89.3	193.9	123.4	79.6	99.3	33.7	69.1	73.7	90.2	87.1	272.5	71.4	48.6	142.1	21.8	15.9	26.7	108.2	91.2	168.2	72.1	66.3	148.5	8.4	74.6	26.6	94.1	57.4	123.2	362.2	182.8	31.4	86.1	128.3	106.6	59.7	18.1	43.4	32.1	44.8	80.5	54.4	131.1	32.2	106.4	17.8	40.4	61.9	42.3	72.1	96.6	137.8	27.0	41.2	66.2	118.6	39.5	86.3	129.4	224.8	92.1	64.2	108.4	55.0	30.7	53.1	46.9	49.2	78.7	40.0	193.9	123.4	79.9	81.3	100.2	99.3	99.4	79.3	87.3	73.4	124.1	78.5	86.6	45.3	79.6	95.9	89.3	62.1	33.7										
MT-ND6	"MTND6, NAD6, ND6"	ENSG00000198695	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6"	P03923	MT	14149-14673	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 395.3;skeletal muscle: 593.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 514.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.96e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.03e-3)"	"unprognostic (6.02e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.06e-3)"	"unprognostic (2.91e-1)"	"prognostic favourable (8.91e-6)"	"unprognostic (3.64e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.92e-2)"	79.2	43.1	55.5	34.4	78.5	30.7	9.6	14.7	76.1	5.9	30.2			90.3	19.2	0.0	69.5	23.2	40.2	395.3	50.7	41.2	65.5	42.8	28.5	25.9	41.9		23.2	48.0	0.0	3.5	10.3		28.0	0.3		48.1	0.0	593.2	176.3	63.8	0.0	24.8	19.9	53.2	22.7			17.5		0.0	32.3	5.7	127.3	91.2	164.8	108.2	88.8	104.3	29.7	97.5	79.2	70.1	88.9	11.8	1.1	50.3	131.9	0.2	0.4	0.4	107.6	99.0	210.5	89.8	3.5	146.0	0.7	2.4	0.7	124.3	60.8	126.1	514.1	307.3	0.9	79.8	119.1	2.0	3.2	3.2	2.7	0.7	54.2	82.7	2.9	208.4	24.5	110.1	15.2	38.9	59.6	44.8	90.4	1.9	287.8	28.9	46.4	68.7	121.0	54.5	93.7	155.6	268.3	77.9	65.8	110.3	52.8	28.3	75.5	50.5	52.9	81.4	45.2	164.8	108.2	68.3	89.1	103.5	104.3	118.4	94.5	96.1	66.2	127.3	94.7	102.4	53.7	88.8	103.7	91.2	71.8	29.7										
MT1A	"MT1, MT1S"	ENSG00000205362	"Metallothionein 1A"	P04731	16	56638666-56640087	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 108.5;liver: 146.5;skeletal muscle: 111.3"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 13.7;HHSteC: 9.5;HMC-1: 14.1;hTEC/SVTERT24-B: 38.1;NTERA-2: 18.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 33.3"	"Group enriched"	"Detected in many"	7	"basal ganglia: 35.4;cerebral cortex: 14.5;hippocampal formation: 15.3;pons and medulla: 37.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											"CAB002161, CAB013056"	Approved									"CAB002161: AB_563878, CAB013056: "	"unprognostic (1.36e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.26e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (6.67e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.35e-2)"	108.5	14.2	2.7	8.0	35.4	1.0	35.2	0.6	14.5	11.3	10.2	0.7	0.2	4.8	1.8	4.1	17.4	11.0	16.1	16.2	15.3	1.8	20.7	146.5	16.1	14.2	3.6	0.0	7.1	46.1	1.2	11.0	1.4	37.2	4.4	7.8	3.8	3.0	2.6	111.3	4.4	12.4	9.2	16.9	4.6	6.1	2.0	2.1	0.0	18.6	4.1	1.7	10.7	7.1	0.4	0.6	0.0	0.1	0.3	1.1	0.2	0.0	2.9	0.0	0.0	8.9	13.7	0.1	0.9	3.7	0.6	0.7	1.0	2.2	0.0	1.1	0.5	0.2	0.0	0.1	1.4	0.0	0.0	0.0	1.3	4.5	9.5	0.1	14.1	4.0	0.0	38.1	0.0	3.6	0.3	0.0	2.6	0.0	0.0	0.0	18.9	0.0	0.0	0.0	1.7	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	2.9	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.6	0.0	0.6	0.4	0.8	1.1	0.6	0.0	0.5	0.9	0.0	0.3	0.0	0.3	1.0	0.2	2.7	35.4	0.6	14.5	15.3	1.8	3.6	0.0	37.2	2.1
MT1X	"MT-1l, MT1"	ENSG00000187193	"Metallothionein 1X"	P80297	16	56682424-56684196	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 351.9;skeletal muscle: 474.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 94.7;HBEC3-KT: 166.8;NTERA-2: 60.5;U-87 MG: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"																						"unprognostic (8.15e-2)"	"unprognostic (9.02e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.18e-3)"	"unprognostic (7.05e-3)"	"unprognostic (7.26e-3)"	"unprognostic (9.49e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.40e-2)"	"unprognostic (4.85e-3)"	"unprognostic (3.84e-1)"	"prognostic unfavourable (1.82e-10)"	"unprognostic (1.56e-1)"	"unprognostic (4.25e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.37e-3)"	130.2	18.6	18.1	15.0	86.0	4.3	59.8	14.5	55.7	23.3	39.0	7.3	7.1	15.9	5.4	30.6	120.9	18.3	18.8	72.4	42.3	13.0	98.8	351.9	23.5	43.3	34.6	18.6	10.2	216.6	2.5	20.4	3.2	70.7	20.6	28.2	8.2	49.7	8.3	474.1	78.4	29.3	17.5	78.1	3.2	29.9	4.7	16.8	1.3	130.3	82.5	15.4	10.9	34.1	4.8	17.0	17.0	17.1	6.6	30.3	13.4	4.0	4.0	0.1	8.5	94.7	20.8	3.4	12.6	7.7	3.3	3.7	0.7	3.6	3.0	3.4	2.9	35.4	11.2	166.8	3.9	12.1	6.9	4.0	2.5	1.3	13.5	25.7	9.6	21.1	31.8	8.2	8.6	0.7	0.6	1.1	11.3	10.2	5.2	27.8	60.5	27.0	5.4	0.5	7.8	33.3	0.4	8.7	3.1	38.2	9.7	2.7	1.1	6.7	1.8	7.3	8.9	7.4	8.8	1.3	0.9	1.2	65.6	41.4	4.2	17.0	17.1	5.4	23.2	7.7	26.4	4.8	26.1	28.8	17.0	3.0	24.8	30.3	0.8	6.6	3.1	5.9	25.7	13.4	18.1	86.0	14.5	55.7	42.3	13.0	34.6	18.6	70.7	16.8
MTRNR2L13		ENSG00000270394	"MT-RNR2-like 13"	S4R3P1	4	116298876-116300320	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 11.5"	"Group enriched"	"Detected in some"	5	"HeLa: 8.1;Hep G2: 4.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 4.9"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.9"														"Secreted - unknown location"										"unprognostic (6.40e-2)"					"unprognostic (2.88e-1)"			"unprognostic (2.49e-1)"	"unprognostic (1.99e-1)"				1.7	2.5	0.6	0.2	1.1	0.4	0.6	0.6	1.8	0.6	1.2	0.0	2.9	0.5	0.6	1.0	0.6	0.6	0.4	3.3	0.6	0.6	2.3	1.4	0.9	1.7	0.6	0.5	0.6	0.6	0.0	0.6	0.4	2.7	0.6	1.1	0.2	1.2	0.4	11.5	0.6	1.0	1.1	2.6	0.6	0.6	2.0	1.2	0.0	0.6	1.4	0.2	1.0	0.6	0.4	0.2	4.9	0.4	0.3	0.2	0.3	0.3	1.1	0.1	1.1	0.1	0.1	0.3	0.8	0.0	0.0	0.0	0.1	0.4	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.1	8.1	4.3	0.1	0.1	0.4	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.4	0.0	0.1	0.2	0.1	0.4	0.3	1.2	0.1	0.4	0.2	0.1	0.4	0.2	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.0	0.4	1.0	0.1	0.3	0.1	0.3	0.2	0.1	0.2	0.4	0.2	0.2	4.9	0.3	0.2	0.2	0.0	0.3	0.6	1.1	0.6	1.8	0.6	0.6	0.6	0.5	2.7	1.2
MTRNR2L3		ENSG00000256222	"MT-RNR2-like 3"	P0CJ70	20	57358442-57359980	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 13.3"	"Cell line enhanced"	"Detected in some"		"HeLa: 4.9;Hep G2: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.7"	"Low lineage specificity"	"Detected in many"																"Secreted - unknown location"						"unprognostic (1.55e-4)"	"unprognostic (2.65e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.44e-6)"	"unprognostic (2.56e-1)"	"unprognostic (6.68e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.52e-3)"	"unprognostic (7.52e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.94e-3)"	0.8	1.0	2.9	0.3	2.4	2.4	0.5	1.0	3.6	0.7	0.9	0.0	2.5	0.6	0.5	1.4	0.7	0.5	1.0	1.3	2.5	0.7	1.2	1.1	0.4	0.5	2.1	2.7	0.8	1.2	0.2	0.5	0.3	2.4	0.5	0.9	0.0	2.4	1.1	13.3	1.1	0.5	0.5	1.7	0.4	0.9	1.2	2.7	0.0	0.6	0.0	0.3	0.3	0.6	1.0	0.8	3.7	0.7	0.1	1.3	0.4	0.3	0.0	0.2	0.9	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	4.9	1.5	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.5	0.3	0.6	0.2	0.2	0.4	0.1	0.2	0.0	0.1	0.4	0.1	0.2	0.2	0.6	0.3	0.5	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.1	0.7	0.7	1.1	0.8	0.2	0.6	0.4	0.5	0.5	0.8	1.0	1.3	0.5	3.7	0.1	0.6	0.2	0.7	0.4	2.9	2.4	1.0	3.6	2.5	0.7	2.1	2.7	2.4	2.7
MTRNR2L5		ENSG00000249860	"MT-RNR2-like 5"	P0CJ72	10	55599303-55600041	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"seminal vesicle: 7.0;skeletal muscle: 16.4;tongue: 6.6"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.7;Hep G2: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.8"														"Secreted - unknown location"															"unprognostic (2.11e-2)"				"unprognostic (1.20e-1)"				0.4	1.8	1.5	1.2	2.5	0.2	0.4	0.4	2.3	0.4	0.6	0.4	0.0	0.5	0.4	1.3	0.4	0.4	0.6	0.5	1.0	0.5	0.9	0.4	0.4	0.3	1.4	0.6	0.4	0.7	0.1	0.8	0.1	0.6	0.4	0.3	0.0	4.7	7.0	16.4	0.4	0.8	0.5	0.4	0.4	0.5	0.5	0.9	0.0	0.4	6.6	0.3	1.0	0.4	0.2	0.1	1.8	0.4	0.1	0.1	0.1	0.3	0.0	0.3	0.3	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	1.7	2.4	0.0	0.9	0.4	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.4	0.4	0.0	0.0	0.0	0.2	0.0	0.5	0.0	1.0	0.4	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.1	1.8	0.1	0.1	0.1	0.0	0.1	1.5	2.5	0.4	2.3	1.0	0.5	1.4	0.6	0.6	0.9
MTRNR2L6		ENSG00000270672	"MT-RNR2-like 6"	P0CJ73	7	142666272-142667718	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 81.7;skeletal muscle: 39.1"	"Cell line enhanced"	"Detected in many"		"HeLa: 49.1;Hep G2: 43.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 81.7"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 81.7"														"Secreted to blood"						"unprognostic (5.34e-2)"	"unprognostic (1.34e-3)"	"unprognostic (3.80e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.10e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.69e-1)"	"unprognostic (3.03e-2)"		"unprognostic (2.66e-2)"	"unprognostic (8.07e-3)"	3.4	8.2	1.4	0.8	2.3	0.1	1.1	1.2	5.5	1.1	3.9	1.5	0.8	1.1	1.1	0.8	1.7	1.1	0.8	17.9	6.1	1.4	7.3	4.7	1.1	5.9	2.2	3.9	1.1	2.2	0.0	1.1	0.8	4.5	1.1	2.3	0.8	2.5	0.8	39.1	1.5	2.6	0.8	3.5	1.1	2.2	1.7	1.8	0.8	1.5	0.8	0.8	1.8	1.1	8.4	4.2	81.7	8.2	4.7	3.9	9.5	5.5	9.4	3.2	22.2	3.8	1.9	5.4	5.9	0.5	0.6	1.0	3.1	10.1	4.8	8.1	1.1	19.5	0.1	1.1	0.5	3.0	3.6	6.7	49.1	43.2	1.2	1.4	7.2	3.3	1.4	0.5	1.6	0.5	5.7	7.2	1.7	3.1	2.7	14.9	1.2	1.1	4.4	2.7	3.7	3.8	8.1	2.1	8.0	1.6	3.7	11.3	5.2	9.4	6.8	6.4	6.5	7.7	2.0	2.9	1.3	3.1	3.8	8.5	1.5	20.0	8.2	21.6	2.4	4.9	2.4	8.4	2.9	2.9	4.1	7.7	3.2	3.9	81.7	4.7	4.4	4.2	3.1	9.5	1.4	2.3	1.2	2.9	6.1	1.4	2.2	3.9	4.5	1.8
MTRNR2L7		ENSG00000256892	"MT-RNR2-like 7"	P0CJ74	10	37601440-37602974	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.1;heart muscle: 1.6;skeletal muscle: 1.9"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.1;Hep G2: 1.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.1"														"Secreted - unknown location"															"unprognostic (2.28e-1)"				"unprognostic (5.87e-2)"				0.3	0.6	0.1	0.0	0.1	0.2	0.1	0.1	0.4	0.1	0.3			0.0	0.1	0.2	0.1	0.1	0.0	1.6	0.1	0.1	0.9	0.4	0.1	0.0	0.1		0.1	0.1	0.0	0.3	0.0		0.1	0.5		0.1	0.0	1.9	0.1	0.1	0.0	0.1	0.1	0.2	0.2			0.1		0.0	0.1	0.1	0.3	0.2	2.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.4	0.3	0.0	0.3	0.2	0.0	0.1	0.0	0.7	0.0	0.5	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.8	3.1	1.5	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.6	0.0	0.0	0.1	0.3	0.5	0.4	0.3	0.0	0.2	0.8	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.1	0.8	0.0	1.2	0.2	0.6	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.3	0.2	0.2	2.1	0.2	0.1	0.2	0.1	0.2										
MTRNR2L8		ENSG00000255823	"MT-RNR2-like 8"	P0CJ75	11	10507887-10509189	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"blood: 329.5;skeletal muscle: 107.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 188.8;Hep G2: 138.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 89.7;eosinophil: 97.5;neutrophil: 329.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 329.5"														"Secreted to blood"						"unprognostic (6.19e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.66e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.45e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.59e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.96e-2)"	35.7	33.4	22.5	4.2	22.8	6.6	4.3	7.3	17.5	6.5	15.6	3.6	19.3	10.2	3.8	6.1	12.7	4.6	14.1	73.2	20.1	14.7	30.7	21.7	6.3	4.0	22.0	7.3	7.0	10.9	1.9	6.9	7.0	9.0	7.7	15.5	3.3	12.3	14.8	107.4	12.0	12.9	8.8	16.1	9.7	10.2	28.4	6.5	2.2	4.4	32.3	4.3	10.0	5.8	35.3	24.5	329.5	42.7	16.6	19.0	36.2	30.2	54.5	21.4	96.0	21.5	11.8	29.5	28.6	4.2	4.0	5.1	33.1	46.6	42.5	33.6	6.1	85.7	0.6	6.5	4.4	18.1	47.2	39.6	188.8	138.0	8.3	7.3	38.3	20.9	10.2	3.3	9.8	3.9	33.4	22.1	12.3	19.3	11.1	54.7	7.0	15.2	19.1	18.3	20.4	24.4	30.6	12.1	27.5	14.3	21.0	43.6	24.6	55.0	25.6	28.3	25.1	29.8	11.1	12.4	5.9	22.6	18.5	64.9	6.7	89.7	42.7	97.5	11.6	21.0	14.3	33.7	14.8	13.0	16.3	35.3	19.0	17.5	329.5	16.6	20.1	24.5	14.9	36.2	22.5	22.8	7.3	16.7	20.1	14.7	22.0	7.3	9.0	6.5
MYH14	"DFNA4, FLJ13881, KIAA2034, MHC16, MYH17"	ENSG00000105357	"Myosin heavy chain 14"	Q7Z406	19	50188186-50310544	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 78.6;skeletal muscle: 53.1"	"Cell line enhanced"	"Detected in some"		"A-431: 15.0;CAPAN-2: 19.0;HaCaT: 37.8;MCF7: 18.4;RT4: 46.9;SK-BR-3: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062391, HPA067889, HPA070260"	Enhanced		Approved	Nucleoplasm		59000000	59000000	Nucleoplasm	Nucleoplasm	"HPA062391: AB_2684748, HPA067889: AB_2685917, HPA070260: AB_2686243"	"unprognostic (2.52e-1)"	"unprognostic (5.81e-2)"	"unprognostic (9.63e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"prognostic favourable (3.97e-8)"	"prognostic favourable (7.83e-4)"	"unprognostic (8.50e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.77e-1)"	5.5	0.5	6.1	8.4	6.1	0.1	2.7	4.6	9.4	3.4	63.9	10.5	3.5	38.7	1.1	4.6	14.7	7.5	9.2	16.2	6.4	5.4	4.3	8.7	11.5	0.2	8.5	3.9	1.1	7.5	7.3	4.5	0.7	7.8	3.2	9.4	4.6	12.0	3.1	53.1	20.3	78.6	0.8	11.1	0.2	21.0	0.7	4.2	0.4	16.7	11.4	9.5	4.9	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	1.5	0.0	8.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	10.4	19.0	0.0	9.9	0.0	37.8	0.0	0.0	0.0	0.0	2.7	0.0	0.0	7.9	0.0	0.0	5.6	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	18.4	0.0	0.1	0.2	0.2	0.0	9.6	0.2	0.0	46.9	0.0	0.0	0.9	16.8	0.0	3.1	0.5	0.0	0.0	3.9	0.0	0.0	0.3	3.3	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	6.1	4.6	9.4	6.4	5.4	8.5	3.9	7.8	4.2
MYH3	"HEMHC, MYHC-EMB, MYHSE1, SMHCE"	ENSG00000109063	"Myosin heavy chain 3"	P11055	17	10628526-10657309	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.1;prostate: 25.6;skeletal muscle: 18.5"	"Cell line enriched"	"Detected in some"	28	"HSkMC: 37.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.7"	"Low region specificity"	"Detected in some"			HPA021808	Enhanced					17000000	17000000			"HPA021808: AB_1854242"	"unprognostic (1.70e-2)"	"unprognostic (1.10e-3)"	"unprognostic (4.19e-4)"	"unprognostic (3.35e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.54e-1)"	"unprognostic (7.84e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.24e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.17e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.49e-1)"	1.0	0.5	0.7	0.8	1.0	0.6	0.8	1.9	0.8	2.2	4.1	0.6	3.5	0.9	1.9	13.2	21.1	1.0	0.6	0.6	0.9	0.6	0.8	1.8	0.6	1.0	0.9	0.6	1.4	1.3	0.5	0.7	1.1	0.6	25.6	0.9	0.6	0.7	16.2	18.5	1.5	1.4	16.5	1.2	1.6	0.8	2.8	0.6	1.8	2.3	1.7	2.0	8.5	2.6	1.0	0.1	0.0	0.1	0.9	0.7	0.0	0.1	0.6	0.4	0.6	0.6	0.2	0.6	0.4	0.2	0.3	0.3	0.6	0.1	0.4	0.2	0.2	0.6	0.3	0.1	0.6	0.4	0.5	0.5	0.1	0.9	0.2	0.3	0.8	37.0	0.2	0.4	0.4	0.0	0.2	0.0	0.1	0.4	0.5	1.3	0.5	0.4	0.5	0.5	0.1	0.2	0.1	0.0	0.2	0.2	0.0	0.2	0.2	0.1	0.2	0.0	0.6	0.1	0.0	0.8	0.6	0.1	0.1	0.2	0.3	0.0	0.1	0.0	0.7	0.0	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.9	0.0	0.1	0.6	0.0	0.7	1.0	1.9	0.8	0.9	0.6	0.9	0.6	0.6	0.6
MYL10	"MGC3479, MYLC2PL, PLRLC"	ENSG00000106436	"Myosin light chain 10"	Q9BUA6	7	101613325-101629296	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 4.5;skeletal muscle: 9.1"	"Group enriched"	"Detected in some"	7	"PC-3: 12.2;RH-30: 7.0"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019763	Uncertain		Uncertain	Microtubules				Microtubules	Microtubules	"HPA019763: AB_1854243"		"unprognostic (2.32e-2)"		"unprognostic (3.09e-1)"					"unprognostic (1.11e-1)"		"unprognostic (1.74e-2)"	"unprognostic (2.78e-3)"		"unprognostic (5.04e-3)"	"unprognostic (8.93e-2)"		"unprognostic (1.10e-2)"	0.2	0.1	0.2	0.2	0.2	1.5	0.2	0.2	0.3	1.9	0.2	0.2	0.2	0.1	0.9	0.4	0.2	0.4	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	2.7	2.0	0.2	2.9	0.9	0.2	0.3	0.2	9.1	1.1	0.2	0.2	0.2	0.2	0.1	0.9	0.2	0.2	0.2	2.9	0.6	1.0	0.2	1.4	1.0	4.5	0.9	1.4	1.3	0.2	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.8	0.0	0.3	0.1	0.5	0.1	0.2	0.0	0.2	0.2	0.1	0.2	0.1	0.0	0.1	0.2	0.2	0.8	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.5	0.0	0.2	0.3	12.2	0.0	7.0	0.0	0.1	0.5	0.2	0.0	0.1	0.1	1.2	0.2	0.1	0.2	0.6	1.3	0.0	0.2	0.4	0.2	1.2	0.1	0.3	0.0	4.5	0.9	0.8	0.4	0.5	0.4	0.9	0.6	0.8	0.3	1.4	0.9	0.7	3.4	1.4	0.5	1.0	1.3	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
MYL12A	"MLCB, MRCL3, MRLC3, MYL2B"	ENSG00000101608	"Myosin light chain 12A"	P19105	18	3247481-3256236	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 245.4;heart muscle: 248.0;skeletal muscle: 423.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB004503, HPA039262, HPA045244, HPA059197"	Supported		Approved	"Nucleoplasm,Nucleoli fibrillar center"		70000000	70000000	"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"CAB004503: AB_2282358, HPA039262: AB_2676418, HPA045244: , HPA059197: AB_2683944"	"unprognostic (2.14e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.03e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.49e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.58e-3)"	"unprognostic (7.13e-2)"	60.9	19.9	7.1	31.1	13.1	21.7	63.9	5.1	7.6	25.1	31.2	7.4	22.5	15.6	24.1	29.0	43.6	22.8	32.4	248.0	8.2	6.8	52.7	43.1	58.3	58.4	14.6	5.7	28.6	24.8	24.9	11.1	49.5	18.9	24.3	27.2	14.7	26.5	18.6	423.8	24.2	41.5	27.9	22.1	68.6	22.5	20.4	10.3	40.3	38.6	80.1	42.0	30.6	31.2	103.4	166.8	173.4	91.9	104.2	168.7	245.4	30.7	19.6	44.7	18.7	52.8	55.6	27.4	70.1	92.6	66.7	72.8	29.6	39.0	14.9	18.5	101.7	13.4	25.8	44.0	59.9	21.0	9.2	15.2	23.3	26.0	88.5	43.2	29.7	87.0	62.4	51.8	31.3	104.6	19.0	52.1	136.8	52.6	20.1	43.5	18.3	14.5	11.6	23.4	26.2	146.3	49.8	6.3	15.3	55.4	23.9	48.5	16.8	63.9	111.9	16.5	37.7	45.2	55.4	11.9	17.2	24.1	49.7	17.4	59.1	173.4	74.5	154.6	166.4	77.4	166.7	103.4	156.8	168.7	109.0	80.4	142.5	167.0	122.8	104.2	91.9	166.8	133.2	245.4	7.1	13.1	5.1	7.6	8.2	6.8	14.6	5.7	18.9	10.3
MYL6B	MLC1SA	ENSG00000196465	"Myosin light chain 6B"	P14649	12	56152256-56159647	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 129.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.6"	"Group enriched"	"Detected in all"	5	"B-cells: 5.3;dendritic cells: 15.6;T-cells: 12.0"	"Low region specificity"	"Detected in all"							"HPA038887, HPA046859, HPA063034"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA038887: AB_10674842, HPA046859: AB_2679842, HPA063034: "	"unprognostic (5.25e-2)"	"unprognostic (3.18e-1)"	"unprognostic (6.29e-3)"	"unprognostic (7.39e-2)"	"unprognostic (5.37e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavourable (2.87e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.02e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.56e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.83e-2)"	5.6	10.0	32.0	4.8	33.1	5.4	8.7	11.9	26.7	13.9	4.1	8.0	8.5	3.0	9.8	12.8	8.4	13.2	9.7	13.6	24.1	21.8	9.3	6.2	4.5	6.9	20.7	21.6	20.0	4.8	17.4	14.1	5.1	13.4	12.6	4.0	11.0	7.3	8.3	129.0	5.1	4.1	8.4	10.7	3.9	5.1	24.9	10.2	11.5	9.9	10.7	8.8	5.6	5.0	5.3	15.6	1.8	2.3	2.0	12.0	3.1	8.2	14.1	38.4	36.6	8.1	29.3	26.8	9.6	42.5	38.3	37.4	10.1	13.7	13.7	21.3	20.6	4.7	18.0	23.4	20.7	24.8	26.1	14.4	14.5	17.7	25.8	10.5	10.1	49.0	9.4	35.4	13.8	41.4	15.2	14.2	31.4	10.7	28.7	34.9	32.2	24.4	30.4	23.8	18.1	29.1	5.5	35.4	51.9	10.7	13.0	19.3	10.7	18.0	22.9	22.5	19.4	11.6	20.5	20.2	11.5	11.4	24.1	10.7	24.6	0.7	2.3	0.7	1.8	2.2	1.0	5.3	3.7	3.0	5.4	3.5	2.7	2.2	1.8	2.0	0.9	15.6	12.0	3.1	32.0	33.1	11.9	26.7	24.1	21.8	20.7	21.6	13.4	10.2
MYMK	"TMEM226, TMEM8C"	ENSG00000187616	"Myomaker, myoblast fusion factor"	A6NI61	9	133514586-133528612	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 3.3;epididymis: 3.1;skeletal muscle: 8.0"	"Group enriched"	"Detected in some"	34	"HSkMC: 18.0;RH-30: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051846, HPA055785"	Uncertain									"HPA051846: AB_2681636, HPA055785: AB_2682920"						"unprognostic (9.17e-3)"	"unprognostic (8.63e-2)"	"unprognostic (3.76e-1)"		"unprognostic (1.13e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.37e-1)"	"unprognostic (9.32e-2)"			"unprognostic (1.91e-1)"		0.6	0.2	0.5	0.0	3.3	0.2	0.0	0.7	2.6	0.0	0.0	0.8	0.0	0.0	0.0	3.1	0.6	0.1	0.0	0.3	1.0	0.4	1.7	0.2	0.3	0.0	0.9	2.1	0.0	0.0	0.0	0.1	2.0	1.6	0.6	0.0	0.0	0.2	0.0	8.0	0.2	0.0	0.0	0.4	0.1	0.0	1.5	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.3	0.7	2.6	1.0	0.4	0.9	2.1	1.6	0.4
MYORG	"KIAA1161, NET37"	ENSG00000164976	"Myogenesis regulating glycosidase (putative)"	Q6NSJ0	9	34366670-34376853	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 56.1"	"Cell line enhanced"	"Detected in many"		"Hep G2: 17.4;SK-BR-3: 29.1;T-47d: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060533, HPA067487"	Approved		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA060533: AB_2684311, HPA067487: AB_2685848"	"unprognostic (6.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavourable (6.96e-4)"	"unprognostic (2.44e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.91e-3)"	"unprognostic (3.20e-1)"	"prognostic favourable (1.20e-13)"	"unprognostic (4.08e-3)"	"unprognostic (3.68e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.00e-3)"	6.3	5.6	16.7	4.7	20.5	2.1	3.5	6.9	16.0	2.0	19.9	9.8	1.3	20.9	2.2	2.8	4.8	3.6	11.6	2.9	11.1	8.7	11.7	31.8	3.1	1.7	11.2	12.6	1.6	16.6	2.0	4.0	15.4	10.7	3.2	13.1	0.5	4.7	4.9	56.1	3.6	26.7	4.8	7.0	1.7	9.9	1.7	6.9	0.0	2.2	6.4	2.1	3.5	1.9	1.1	0.8	1.9	0.8	1.9	3.3	0.6	4.0	2.9	4.8	2.9	2.0	0.7	10.3	0.8	0.6	0.4	0.7	7.1	4.3	2.2	8.3	0.7	8.4	3.4	7.8	0.6	0.7	1.9	0.4	12.9	17.4	0.3	0.4	1.4	1.0	3.7	1.3	1.6	1.9	0.5	2.4	1.0	6.7	1.2	0.7	2.9	2.3	2.1	2.5	0.7	2.6	1.5	0.7	6.7	5.8	29.1	0.5	27.0	0.7	1.7	1.1	6.0	0.9	1.8	1.5	3.2	0.9	0.9	1.6	0.9	1.9	0.6	1.2	3.3	0.6	2.6	0.8	2.0	1.9	0.3	1.1	1.3	1.6	1.6	1.9	0.8	0.8	2.6	0.6	16.7	20.5	6.9	16.0	11.1	8.7	11.2	12.6	10.7	6.9
MYPN	MYOP	ENSG00000138347	Myopalladin	Q86TC9	10	68106117-68212017	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 23.6;skeletal muscle: 114.9;tongue: 46.3"	"Cell line enhanced"	"Detected in some"		"BJ: 16.3;fHDF/TERT166: 45.8;HBF TERT88: 10.8;LHCN-M2: 19.7"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 0.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 3.8"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA036299, HPA061494"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA036299: , HPA061494: AB_2684539"	"unprognostic (4.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.14e-3)"	"unprognostic (8.62e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.36e-3)"	"unprognostic (4.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.26e-3)"	"unprognostic (3.94e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.88e-8)"	"unprognostic (4.63e-5)"	"unprognostic (9.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.47e-1)"	4.5	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	2.1	0.0	0.0	23.6	0.4	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.5	0.0	0.1	2.1	0.0	114.9	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.9	46.3	3.4	0.0	0.0	0.3	0.1	3.8	0.1	0.2	0.1	0.0	1.1	0.5	0.0	0.0	0.3	1.7	0.0	16.3	8.2	6.1	2.3	0.0	0.0	0.0	0.0	45.8	0.3	0.0	0.1	10.8	0.1	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.8	0.0	3.3	0.3	0.1	0.0	0.1	19.7	3.4	0.0	0.0	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.3	0.4	0.0	0.0	0.0	0.4	0.3	0.0	1.7	0.0	0.0	0.0	0.0	1.9	0.0	1.7	3.8	0.1	0.5	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.1	0.1	0.9	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.0	0.2	0.0
MYPOP	P42pop	ENSG00000176182	"Myb related transcription factor, partner of profilin"	Q86VE0	19	45890020-45902604	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 36.4"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 18.8;NB-4: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065307			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA065307: AB_2685460"	"unprognostic (5.13e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.87e-3)"	"prognostic unfavourable (1.21e-4)"	"unprognostic (1.94e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (8.67e-5)"	"unprognostic (1.28e-3)"	"unprognostic (1.42e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.19e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-3)"	7.6	9.4	15.7	7.9	14.3	4.2	8.0	15.1	25.9	6.5	7.5	6.8	5.9	11.4	7.2	7.0	6.4	6.1	7.1	8.0	15.9	9.2	9.5	6.1	5.9	8.3	8.5	7.7	6.5	8.5	7.0	12.9	6.1	11.3	7.7	6.0	6.3	9.5	8.2	36.4	10.1	10.1	6.5	9.0	12.3	8.5	6.8	8.7	5.3	5.0	4.3	7.0	6.8	10.7	1.0	1.5	2.7	1.4	0.6	1.1	0.4	4.1	6.7	2.6	5.2	3.3	2.1	5.1	3.1	3.2	3.4	4.5	2.7	2.7	4.0	3.0	1.5	3.5	1.9	1.4	2.4	18.8	10.9	1.9	3.8	4.3	3.6	1.9	6.0	2.0	4.0	1.9	1.8	2.8	2.5	3.6	2.2	1.8	9.9	25.7	2.8	6.8	7.9	1.1	2.3	2.0	2.3	5.3	4.0	3.0	3.3	3.2	2.3	7.0	3.6	3.2	5.3	3.0	4.9	10.7	7.7	2.6	4.7	5.1	3.8	0.0	1.4	2.7	1.1	0.6	0.3	1.0	0.8	0.6	1.5	0.3	0.6	0.7	1.6	0.6	0.7	1.0	0.7	0.4	15.7	14.3	15.1	25.9	15.9	9.2	8.5	7.7	11.3	8.7
NAA50	"FLJ13194, MAK3, NAT13, NAT5, San"	ENSG00000121579	"N(alpha)-acetyltransferase 50, NatE catalytic subunit"	Q9GZZ1	3	113716460-113746300	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 86.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074489	Approved									"HPA074489: "	"unprognostic (9.74e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.19e-2)"	"prognostic unfavourable (2.32e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (1.51e-5)"	"unprognostic (1.62e-3)"	"unprognostic (6.82e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavourable (7.92e-5)"	"unprognostic (2.97e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.59e-2)"	"unprognostic (7.13e-3)"	"unprognostic (2.43e-1)"	23.4	23.6	15.9	18.0	19.8	19.7	25.6	17.1	16.5	14.7	16.2	9.3	12.9	12.7	18.4	13.3	32.6	14.7	13.6	17.0	14.1	10.8	17.6	31.8	17.3	20.7	13.8	13.7	17.8	20.7	18.4	14.1	14.9	15.6	14.5	14.7	10.7	21.6	13.8	86.5	17.7	14.0	16.1	15.7	17.7	16.9	19.0	12.9	22.5	18.3	37.0	23.2	19.9	19.8	32.3	24.7	28.7	22.6	17.4	27.3	26.2	88.9	38.9	21.4	24.9	29.1	23.6	44.7	47.9	27.0	29.6	34.1	55.8	32.1	61.6	29.7	25.4	36.8	37.2	32.8	54.4	12.9	19.0	66.4	29.3	33.5	26.7	69.0	21.6	20.1	25.9	33.1	47.9	26.4	41.7	24.9	30.5	42.1	45.6	15.0	47.9	57.3	47.0	32.8	48.6	22.5	67.9	33.0	19.1	34.7	25.9	34.8	35.9	23.0	24.3	40.9	40.7	17.2	36.0	27.7	45.8	114.3	32.1	38.9	25.1	8.5	22.5	11.9	27.3	22.6	24.3	32.3	20.6	25.5	24.7	20.5	18.2	24.0	28.7	17.4	19.8	14.4	21.9	26.2	15.9	19.8	17.1	16.5	14.1	10.8	13.8	13.7	15.6	12.9
NANOS1	"NOS1, ZC2HC12A"	ENSG00000188613	"Nanos C2HC-type zinc finger 1"	Q8WY41	10	119029716-119033732	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 40.7"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 38.7;SK-BR-3: 22.2;SK-MEL-30: 16.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB012219	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB012219: "	"prognostic unfavourable (1.52e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.59e-3)"	"unprognostic (7.07e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.70e-1)"	"unprognostic (8.22e-3)"	"unprognostic (8.79e-2)"	"unprognostic (2.64e-4)"	"unprognostic (7.89e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.52e-3)"	8.5	10.5	8.1	1.0	7.1	1.0	6.4	6.5	4.8	4.9	2.1	4.5	1.3	1.2	2.1	4.4	2.1	1.5	1.0	16.7	5.0	6.7	3.5	1.0	1.3	1.1	3.4	2.4	0.9	3.3	0.9	2.2	8.2	6.0	3.5	1.2	8.8	1.5	2.5	40.7	1.7	1.4	3.4	6.7	0.9	3.1	2.9	3.0	0.1	9.3	0.3	1.0	3.3	9.8	0.6	0.5	3.2	0.3	0.6	0.3	0.1	7.5	0.6	1.0	0.2	3.6	0.5	4.6	0.1	0.2	0.2	0.1	0.9	2.6	4.0	1.0	0.0	2.7	1.3	1.3	0.3	1.2	3.1	0.1	1.9	0.8	1.7	0.4	0.0	0.7	5.6	0.0	0.7	0.1	0.7	0.5	0.2	1.0	1.0	1.3	3.4	0.6	0.0	1.3	2.7	1.5	0.6	3.0	38.7	2.2	22.2	16.8	3.5	2.1	0.2	0.0	1.7	0.0	0.3	1.1	3.8	1.4	0.3	1.0	0.0	3.2	0.3	0.4	0.2	0.1	0.1	0.2	0.2	0.2	0.0	0.6	0.3	0.2	1.3	0.6	0.2	0.5	0.1	0.1	8.1	7.1	6.5	4.8	5.0	6.7	3.4	2.4	6.0	3.0
NATD1	"C17orf103, Gtlf3b, MGC33894"	ENSG00000274180	"N-acetyltransferase domain containing 1"	Q8N6N6	17	21238870-21253410	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 22.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 19.3;HSkMC: 14.2"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"neutrophil: 9.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.16e-1)"	"unprognostic (9.40e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.17e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.93e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.51e-1)"	"prognostic favourable (3.55e-6)"	"unprognostic (2.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.98e-2)"	8.3	1.9	2.7	1.2	2.2	10.1	4.5	5.0	3.3	3.1	3.2	2.2	3.5	2.3	3.2	5.0	3.8	2.6	5.2	7.7	3.4		3.7	3.5	4.4	1.7	1.7	1.2	2.3	4.0	6.1	1.0	5.4	2.8	5.1	0.9	3.2	4.0	4.6	22.0	4.1	2.4	4.2	0.8	3.2	1.7	4.6	1.5	3.7	12.1	6.6	2.8	4.3	5.6	0.6	0.9	9.0	2.1	0.4	1.3	1.1	1.0	1.8	2.3	2.8	10.1	9.5	19.3	3.0	4.0	2.2	3.5	5.0	0.8	0.0	4.9	4.2	1.5	1.5	1.3	1.0	1.3	5.4	0.4	1.0	0.8	8.7	0.1	1.9	14.2	2.9	2.7	1.9	4.4	2.7	0.0	2.9	0.9	0.2	1.3	5.0	0.5	2.4	1.9	0.7	3.7	1.5	0.7	4.9	2.3	0.3	4.0	1.2	1.4	2.7	1.1	1.5	1.6	0.7	4.0	1.7	1.1	1.3	0.9	1.8	1.1	2.1	2.6	1.3	0.7	0.4	0.3	0.8	1.0	0.4	0.6	0.5	0.5	9.0	0.4	0.6	0.9	1.3	1.1										
NDRG2	"KIAA1248, SYLD"	ENSG00000165795	"NDRG family member 2"	Q9UN36	14	21016763-21070872	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 310.5;skeletal muscle: 253.0"	"Cell line enhanced"	"Detected in many"		"Hep G2: 27.9;HMC-1: 20.0"	"Cancer enhanced"	"Detected in all"		"glioma: 78.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	10	"myeloid DC: 54.5"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 54.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002896, HPA003590, CAB017491"	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		150000	150000	"Centriolar satellite"	"Centriolar satellite"	"CAB017491: AB_2298331, HPA002896: AB_1079459, HPA003590: AB_1079458"	"unprognostic (9.27e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.92e-2)"	"prognostic favourable (6.71e-4)"	"unprognostic (1.85e-3)"	"unprognostic (5.57e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.10e-2)"	"prognostic favourable (1.43e-12)"	"unprognostic (1.46e-1)"	"unprognostic (5.56e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.19e-2)"	19.3	45.3	140.2	4.8	135.1	1.4	50.3	93.5	110.0	35.5	21.0	89.6	23.8	12.2	30.7	44.4	37.3	29.5	21.5	45.2	103.6	86.1	24.3	84.8	13.7	7.7	128.9	73.5	79.7	15.5	35.6	6.0	8.1	95.4	23.7	18.8	8.9	310.5	37.3	253.0	18.9	12.0	22.0	73.0	21.1	11.2	5.2	71.2	0.4	13.6	53.4	16.1	13.9	19.3	1.8	54.5	0.4	1.8	0.7	5.4	4.0	5.3	1.1	3.4	6.4	0.5	0.0	0.5	0.1	2.2	2.0	1.1	7.4	10.0	0.3	2.0	0.1	8.8	15.4	3.1	2.7	0.0	5.5	6.9	1.2	27.9	0.7	0.6	20.0	6.1	6.7	0.4	0.9	0.0	13.9	0.6	0.3	4.6	2.4	1.9	9.1	0.4	7.1	0.3	1.6	3.8	13.6	0.0	9.9	1.5	1.7	7.0	13.5	4.0	0.0	0.6	10.9	0.2	0.2	3.1	2.2	0.1	0.9	0.1	2.3	0.0	1.8	0.2	2.4	0.4	3.2	1.8	3.6	3.3	54.5	1.3	5.4	4.0	0.4	0.7	0.0	1.9	2.4	4.0	140.2	135.1	93.5	110.0	103.6	86.1	128.9	73.5	95.4	71.2
NDUFA1	"CI-MWFE, MWFE"	ENSG00000125356	"NADH:ubiquinone oxidoreductase subunit A1"	O15239	X	119871487-119876662	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 144.8;skeletal muscle: 138.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029768, HPA054359"	Enhanced		Supported	Mitochondria,Cytosol				Mitochondria	Mitochondria	"HPA029768: AB_2673192, HPA054359: AB_2682461"	"unprognostic (1.72e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (4.77e-2)"	"prognostic favourable (3.48e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-3)"	24.5	30.1	37.9	20.1	42.5	25.2	23.8	27.9	37.8	19.7	38.4	8.7	27.3	41.0	13.5	25.8	21.6	15.9	24.8	144.8	30.1	28.5	46.0	40.2	21.1	22.2	34.6	32.8	14.6	40.4	22.7	21.7	15.4	29.5	17.9	31.1	15.5	38.4	29.6	138.8	12.1	34.6	19.3	31.5	17.1	28.1	7.7	21.1	9.2	16.2	67.4	16.7	14.0	14.9	66.3	90.5	96.3	85.7	49.8	75.5	73.8	34.5	37.3	26.7	28.4	32.2	20.4	33.4	27.3	24.9	19.2	23.9	20.8	28.9	28.1	42.1	28.5	33.4	37.4	26.2	22.0	38.9	51.7	29.2	68.1	46.7	25.0	44.6	32.5	33.2	35.7	20.4	15.9	23.8	15.8	43.8	26.3	61.1	31.7	42.3	39.4	66.7	32.1	25.4	84.6	57.8	49.2	19.5	25.7	56.1	69.6	37.4	17.6	52.6	30.6	16.4	16.6	34.0	53.2	40.4	50.0	36.8	29.7	53.0	20.2	96.3	79.0	91.6	60.2	80.4	57.1	66.3	67.1	62.8	84.0	52.7	56.1	65.7	94.6	49.8	85.7	90.5	75.5	73.8	37.9	42.5	27.9	37.8	30.1	28.5	34.6	32.8	29.5	21.1
NDUFA12	"B17.2, DAP13"	ENSG00000184752	"NADH:ubiquinone oxidoreductase subunit A12"	Q9UI09	12	94897055-95003770	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 129.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039903	Supported		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA039903: AB_10795516"	"unprognostic (2.76e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.85e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.27e-2)"	24.0	24.8	36.0	17.9	36.8	19.7	19.7	27.2	36.5	17.9	35.5	12.5	20.0	27.4	17.0	21.9	23.3	19.4	14.4	82.8	31.2	32.0	33.2	34.6	18.1	20.1	37.0	29.9	17.0	18.4	22.3	22.4	21.1	31.3	19.1	35.7	13.1	18.7	20.7	129.0	17.4	26.7	24.0	24.2	23.9	20.9	14.2	23.5	21.0	27.9	40.0	28.1	21.9	21.4	60.8	78.4	69.7	67.9	59.1	93.8	100.6	40.9	44.6	37.3	26.5	30.6	28.5	27.7	19.6	28.8	42.8	38.8	55.0	21.2	47.2	11.6	29.9	31.0	38.3	45.2	48.6	40.6	46.0	39.4	37.2	55.4	31.5	55.9	48.2	30.6	57.1	35.9	44.0	35.0	36.8	21.9	41.4	59.5	38.7	86.5	28.3	77.6	29.6	32.3	53.8	41.9	61.6	35.5	21.5	33.2	48.4	25.4	47.8	36.9	40.0	22.7	23.1	33.0	33.3	35.9	53.2	72.0	13.6	46.8	34.7	69.7	59.5	29.8	52.1	67.9	48.2	60.8	71.6	62.5	78.4	50.7	93.8	68.6	8.6	59.1	63.3	48.0	74.8	100.6	36.0	36.8	27.2	36.5	31.2	32.0	37.0	29.9	31.3	23.5
NDUFA4	"CI-9k, MLRQ"	ENSG00000189043	"NDUFA4, mitochondrial complex associated"	O00483	7	10931951-10940256	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 149.9;skeletal muscle: 151.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA055323			Supported	Mitochondria		18000	18000	Mitochondria	Mitochondria	"HPA055323: "	"unprognostic (1.83e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.74e-1)"	"prognostic favourable (4.61e-8)"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.08e-1)"	21.9	22.0	72.8	13.6	55.3	19.8	27.0	33.1	74.4	20.5	18.3	12.0	16.8	25.1	16.9	29.6	15.8	20.2	16.7	149.9	56.1	32.1	46.2	46.7	15.9	13.5	47.6	48.9	17.1	23.7	18.9	5.6	11.4	33.0	23.1	20.4	14.1	36.0	31.1	151.6	12.1	17.3	21.4	26.3	13.6	23.6	7.4	23.2	6.8	20.4	60.1	15.6	15.8	11.6	29.0	41.1	52.8	39.6	21.7	37.5	48.0	12.6	21.8	37.2	42.7	21.1	19.8	17.1	16.1	15.3	15.1	13.3	27.3	34.8	24.7	15.3	23.1	22.4	24.7	19.1	16.5	12.2	18.0	20.7	25.6	25.4	18.4	28.5	20.4	21.3	19.3	18.5	16.4	21.0	30.7	33.6	31.5	24.4	12.7	25.1	40.7	44.2	17.3	26.5	27.7	38.3	27.5	23.3	24.2	25.5	73.5	14.5	46.4	35.0	18.3	18.1	24.9	25.9	26.5	20.4	26.1	28.3	24.9	30.9	56.0	52.8	32.5	44.4	23.4	38.6	27.4	29.0	32.7	29.3	41.1	22.0	34.1	29.7	7.4	21.7	39.6	38.5	37.5	48.0	72.8	55.3	33.1	74.4	56.1	32.1	47.6	48.9	33.0	23.2
NDUFA7	B14.5a	ENSG00000267855	"NADH:ubiquinone oxidoreductase subunit A7"	O95182	19	8308768-8321396	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 110.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA059251, HPA071866"	Enhanced		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA059251: AB_2683960, HPA071866: AB_2686465"	"unprognostic (6.55e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.85e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.35e-3)"	17.7	30.0	28.0	15.5	30.5	15.3	18.9	15.4	32.0	9.0	17.2	11.3	15.7	12.6	9.9	32.1	18.9	26.2	16.1	69.1	22.1	21.0	26.5	30.9	20.3	22.1	25.9	19.7	10.1	28.5	11.9	30.2	13.0	26.7	20.5	17.6	16.7	23.0	20.7	110.6	16.2	16.0	13.1	18.5	14.7	19.3	13.8	11.1	19.3	22.0	47.5	16.8	14.3	9.1	30.6	65.5	25.1	39.7	24.9	33.5	26.7	15.5	13.3	17.0	8.7	11.6	6.2	9.6	4.4	5.8	16.7	11.2	14.1	13.2	8.8	6.9	10.7	13.6	7.7	23.4	7.9	23.0	48.6	6.5	20.5	33.3	18.1	9.8	9.0	12.5	15.2	9.0	8.3	19.5	11.1	45.9	20.8	17.0	18.7	48.6	13.7	50.9	10.4	3.1	19.1	34.0	9.3	14.3	10.9	6.4	20.0	11.1	7.5	16.2	5.7	9.4	7.6	13.2	12.6	17.9	13.8	10.6	13.4	17.0	14.8	14.2	38.9	25.1	22.6	39.7	24.4	29.9	24.7	22.2	47.9	30.6	24.1	23.4	9.7	24.9	34.4	65.5	33.5	26.7	28.0	30.5	15.4	32.0	22.1	21.0	25.9	19.7	26.7	11.1
NDUFA9	"CI-39k, NDUFS2L, SDR22E1"	ENSG00000139180	"NADH:ubiquinone oxidoreductase subunit A9"	Q16795	12	4649095-4694317	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 66.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042268, HPA073212"	Supported		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA042268: AB_2677922, HPA073212: AB_2686581"	"unprognostic (2.26e-1)"	"unprognostic (7.85e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.64e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.16e-1)"	"prognostic favourable (2.57e-7)"	"unprognostic (7.80e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.93e-2)"	"prognostic favourable (5.75e-4)"	10.7	13.2	11.0	10.1	17.8	21.2	11.7	15.3	20.7	9.2	22.1	12.0	8.6	20.9	10.1	11.0	13.4	8.4	8.5	41.3	11.6	11.0	23.7	22.1	8.5	11.8	12.7	9.9	8.4	10.4	10.4	12.2	9.5	16.2	9.9	22.7	12.1	13.3	10.1	66.6	10.6	18.9	11.7	8.3	11.5	13.6	5.8	9.3	14.4	10.2	30.7	12.8	8.2	8.8	36.8	43.5	14.6	41.5	25.8	35.9	59.6	10.7	19.5	9.6	12.7	7.1	7.1	27.9	8.3	8.4	16.0	12.2	42.2	21.7	12.2	4.4	8.9	18.2	13.9	12.2	10.5	23.6	24.4	11.9	20.7	31.9	15.6	17.4	12.9	9.0	11.9	10.9	14.9	12.0	8.3	23.1	11.8	20.9	17.3	20.0	24.8	16.2	24.5	14.2	12.7	22.0	24.7	7.0	7.8	10.4	28.1	14.5	5.8	16.6	8.4	12.2	24.8	11.1	19.1	4.5	5.3	20.1	12.7	10.8	13.3	14.6	35.8	13.3	27.7	41.5	28.0	36.8	29.0	30.2	42.3	26.2	25.3	26.2	3.1	25.8	32.2	43.5	35.9	59.6	11.0	17.8	15.3	20.7	11.6	11.0	12.7	9.9	16.2	9.3
NDUFAB1	"ACP, ACP1, FASN2A, SDAP"	ENSG00000004779	"NADH:ubiquinone oxidoreductase subunit AB1"	O14561	16	23581002-23596356	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 118.2;skeletal muscle: 112.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA054364	Uncertain		Supported	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"HPA054364: AB_2682463"	"unprognostic (3.33e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.57e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.60e-2)"	"prognostic favourable (1.94e-7)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.16e-1)"	21.6	25.5	29.4	14.8	28.0	15.1	20.4	21.2	37.7	13.4	31.2	11.4	16.2	30.2	13.7	15.5	19.4	16.2	17.4	118.2	24.1	25.6	32.5	38.8	12.0	15.2	27.0	21.6	10.9	29.1	21.9	18.6	15.2	23.3	16.0	26.5	15.3	24.3	19.2	112.0	12.4	25.7	18.1	15.5	14.0	20.1	11.4	11.5	14.5	15.8	54.3	16.7	13.4	12.7	39.3	61.8	17.4	49.3	25.0	39.5	43.1	27.7	20.5	25.7	22.9	18.3	19.9	35.8	21.4	15.9	21.6	17.8	17.8	22.6	46.0	35.2	15.4	23.0	44.7	25.4	17.1	26.0	51.6	24.7	36.8	87.3	19.2	45.7	20.5	18.4	35.4	15.9	17.2	27.4	51.6	23.4	23.3	42.0	35.4	69.6	66.8	47.7	48.7	28.9	62.5	19.8	25.0	35.4	27.6	23.9	43.9	40.0	35.4	38.3	21.5	19.8	20.9	19.2	29.3	29.9	43.4	51.5	22.2	37.1	22.4	15.1	43.1	17.4	31.7	49.3	34.6	39.3	37.7	35.0	55.2	34.6	35.2	36.5	8.9	25.0	38.0	61.8	39.5	43.1	29.4	28.0	21.2	37.7	24.1	25.6	27.0	21.6	23.3	11.5
NDUFAF5	"C20orf7, dJ842G6.1"	ENSG00000101247	"NADH:ubiquinone oxidoreductase complex assembly factor 5"	Q5TEU4	20	13784950-13821582	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 34.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051184	Uncertain									"HPA051184: AB_2681377"	"unprognostic (3.81e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.41e-2)"	"prognostic favourable (2.27e-6)"	"unprognostic (5.38e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.58e-2)"	6.8	6.4	8.3	4.2	11.1	10.4	4.5	10.0	13.8	3.6	6.3	4.4	3.5	7.8	4.8	4.3	5.2	3.7	3.8	15.0	6.1	6.1	8.1	7.8	3.8	3.5	6.0	7.4	3.4	5.8	3.7	5.1	5.0	8.6	5.0	6.0	4.4	4.4	5.0	34.3	5.3	6.7	6.8	5.5	3.8	6.2	6.0	6.8	4.2	3.5	9.4	4.1	5.5	4.1	5.2	7.3	7.5	5.4	6.9	5.6	2.5	6.0	6.0	7.2	4.9	5.7	1.7	3.6	4.5	3.4	5.9	5.0	13.2	4.5	10.1	4.6	4.6	8.2	13.3	8.6	4.8	4.7	7.7	9.1	3.9	16.4	7.3	8.0	4.5	3.4	6.2	7.1	4.7	5.1	7.0	5.0	5.6	7.8	11.3	7.2	2.5	6.4	7.5	8.9	6.3	6.6	8.1	7.2	7.4	4.9	13.2	13.8	6.5	5.6	5.3	7.0	3.6	5.9	6.9	5.6	8.4	8.2	3.1	3.4	7.1	2.3	4.4	7.5	5.6	5.4	3.7	5.2	4.5	3.5	6.0	5.1	5.1	5.0	1.3	6.9	3.9	7.3	4.8	2.5	8.3	11.1	10.0	13.8	6.1	6.1	6.0	7.4	8.6	6.8
NDUFB1	"CI-MNLL, MNLL"	ENSG00000183648	"NADH:ubiquinone oxidoreductase subunit B1"	O75438	14	92116122-92121917	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 161.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA063737	Supported		Supported	"Nuclear speckles,Mitochondria"				Mitochondria	Mitochondria	"HPA063737: AB_2685109"	"unprognostic (1.12e-2)"	"unprognostic (1.31e-3)"	"unprognostic (6.70e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.54e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.74e-3)"	"unprognostic (5.35e-3)"	"unprognostic (4.55e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.15e-2)"	"prognostic favourable (1.31e-5)"	"unprognostic (7.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.05e-3)"	38.3	48.3	47.8	22.4	43.1	30.2	22.1	30.9	53.6	12.4	39.7	13.4	28.1	36.4	14.8	39.2	23.2	15.9	20.0	142.2	38.4	35.7	51.2	64.6	28.1	24.9	40.6	36.0	16.5	48.5	9.9	30.6	13.2	41.8	19.3	26.9	22.9	54.1	35.9	161.6	12.6	32.9	25.9	31.3	19.3	29.4	10.0	26.4	11.9	21.6	48.9	21.3	17.1	16.3	61.7	98.6	116.1	93.9	45.1	70.1	95.0	27.9	56.7	46.1	29.7	30.2	22.6	21.1	34.5	19.4	20.5	19.0	34.1	47.6	25.3	32.1	19.3	35.0	26.3	28.0	18.5	39.7	60.3	48.9	89.0	40.7	24.0	38.6	28.0	27.8	17.0	21.4	19.0	18.2	26.5	52.0	28.0	105.8	38.1	34.6	23.3	69.5	34.1	43.8	37.5	51.0	69.3	30.8	22.4	67.6	41.1	43.8	61.6	60.4	40.7	13.0	24.8	26.1	23.0	41.1	64.2	56.1	39.3	28.6	26.9	58.1	93.9	67.8	43.7	63.5	50.2	61.7	64.7	49.8	82.6	52.0	65.4	60.4	116.1	45.1	58.1	98.6	70.1	95.0	47.8	43.1	30.9	53.6	38.4	35.7	40.6	36.0	41.8	26.4
NDUFB10	PDSW	ENSG00000140990	"NADH:ubiquinone oxidoreductase subunit B10"	O96000	16	1959508-1961975	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 280.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073189	Supported									"HPA073189: AB_2686579"	"unprognostic (3.56e-1)"	"prognostic favourable (7.38e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.44e-1)"	"prognostic favourable (9.43e-6)"	"unprognostic (1.24e-1)"	"unprognostic (5.21e-2)"	"unprognostic (4.43e-1)"	"unprognostic (8.76e-2)"	21.6	20.3	29.0	18.3	30.9	15.6	23.5	21.0	32.2	18.2	31.3	17.0	22.2	32.3	18.8	22.9	22.1	18.9	22.0	97.1	26.9	20.1	28.8	33.9	13.0	22.3	27.7	28.7	15.4	29.8	26.3	13.3	15.1	20.1	18.9	28.2	17.9	32.0	24.2	280.4	16.8	27.8	27.5	18.9	15.7	25.2	19.2	15.6	16.6	20.0	73.7	17.3	20.1	17.7	64.6	84.7	66.6	75.5	51.8	84.8	80.2	17.3	51.0	24.5	29.3	24.7	23.5	25.3	21.6	26.2	25.1	17.3	37.5	23.5	35.4	37.0	27.7	37.0	27.0	33.0	19.0	32.4	100.4	27.3	40.3	42.5	31.7	43.9	26.4	26.4	29.9	24.2	27.2	29.0	25.4	34.7	31.9	72.3	51.8	45.9	31.5	58.2	61.2	26.2	75.7	36.5	17.9	55.6	35.7	40.6	66.2	28.4	40.2	29.9	24.9	23.5	22.1	33.3	23.5	57.5	44.2	46.2	16.5	22.0	24.5	54.8	75.5	66.6	57.7	63.2	55.8	64.6	71.2	72.1	79.0	58.0	56.9	59.5	41.3	51.8	53.2	84.7	84.8	80.2	29.0	30.9	21.0	32.2	26.9	20.1	27.7	28.7	20.1	15.6
NDUFB11	"ESSS, Np15, NP17.3"	ENSG00000147123	"NADH:ubiquinone oxidoreductase subunit B11"	Q9NX14	X	47142216-47145504	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 164.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA030367	Supported		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA030367: AB_10603882"	"unprognostic (2.20e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.80e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.46e-3)"	16.9	33.4	26.1	21.2	24.8	25.2	29.2	18.9	29.7	17.6	23.3	10.5	24.7	24.2	14.3	25.1	23.3	18.8	24.0	64.4	22.4	20.6	24.4	48.8	18.1	36.5	22.5	22.0	14.9	50.9	15.6	24.5	14.2	24.4	18.1	21.2	13.0	37.0	30.2	164.0	17.3	22.8	16.0	18.3	19.2	22.8	9.7	12.3	30.4	38.5	53.6	21.2	14.3	20.5	58.9	69.0	22.2	44.7	27.7	54.6	59.5	19.5	29.1	23.0	26.6	19.9	17.1	24.5	14.3	16.6	23.4	22.7	31.0	24.0	24.1	12.3	15.5	25.1	25.9	15.1	15.6	23.3	69.2	13.8	39.8	25.6	20.0	23.1	21.3	18.7	13.9	20.2	13.4	17.4	16.5	31.8	13.1	44.2	27.2	64.1	36.0	53.6	29.7	22.8	54.8	23.7	20.9	42.5	31.4	27.1	31.2	21.5	44.8	30.4	13.2	16.4	22.3	30.4	16.6	31.4	27.4	27.0	17.8	14.5	21.8	22.2	44.7	19.8	34.0	32.0	42.2	58.9	48.4	39.0	52.8	52.8	54.6	43.6	9.5	27.7	23.7	69.0	51.0	59.5	26.1	24.8	18.9	29.7	22.4	20.6	22.5	22.0	24.4	12.3
NDUFB3	B12	ENSG00000119013	"NADH:ubiquinone oxidoreductase subunit B3"	O43676	2	201071433-201085750	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 113.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA034596	Approved									"HPA034596: AB_10602712"	"unprognostic (5.38e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (7.24e-4)"	"unprognostic (1.41e-3)"	"unprognostic (6.29e-2)"	"unprognostic (8.81e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.27e-2)"	16.9	19.9	23.4	13.9	23.6	10.1	14.7	13.5	33.3	10.4	27.1	8.2	16.8	23.8	8.4	18.9	21.1	8.6	13.0	57.5	24.2	19.9	35.2	25.8	10.4	12.6	25.6	29.7	6.8	13.0	15.3	13.2	10.9	20.8	11.7	23.8	8.8	21.8	11.7	113.9	8.6	21.2	10.8	19.2	13.4	17.5	17.2	17.8	10.8	11.6	39.1	16.9	9.4	12.0	40.5	55.8	66.2	52.9	36.4	47.3	27.2	24.8	20.3	30.7	17.4	26.3	22.6	26.4	29.0	18.3	21.4	23.5	45.5	30.8	17.9	36.0	23.7	23.5	25.0	35.3	32.7	36.8	58.7	41.5	49.2	53.6	16.9	59.8	24.3	22.0	26.7	25.0	14.9	27.5	37.8	35.3	33.8	28.9	42.8	66.4	20.5	67.4	31.3	25.5	55.1	45.6	37.9	30.7	22.3	22.1	23.4	36.3	21.8	53.3	27.6	20.6	27.4	21.7	31.1	27.0	53.5	60.6	37.2	35.1	23.8	43.5	37.7	40.0	32.7	51.7	36.3	40.5	38.5	37.8	45.8	31.4	33.8	41.2	66.2	36.4	52.9	55.8	47.3	27.2	23.4	23.6	13.5	33.3	24.2	19.9	25.6	29.7	20.8	17.8
NDUFB4	B15	ENSG00000065518	"NADH:ubiquinone oxidoreductase subunit B4"	O95168	3	120596309-120602500	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 195.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA051739	Enhanced		Supported	"Nuclear membrane,Mitochondria"				Mitochondria	Mitochondria	"HPA051739: AB_2681585"	"unprognostic (1.75e-1)"	"unprognostic (2.57e-3)"	"unprognostic (6.95e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.35e-3)"	"unprognostic (9.66e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-1)"	"prognostic favourable (1.79e-4)"	25.5	68.2	37.6	20.1	37.7	22.4	59.4	40.7	51.6	25.6	37.2	19.1	25.6	33.6	23.2	32.2	30.2	24.3	27.8	130.2	32.5	30.8	53.3	46.9	25.4	42.0	37.3	29.4	25.8	36.5	34.1	32.8	18.5	36.7	26.8	34.8	24.6	33.9	29.5	195.7	27.3	30.6	37.6	32.4	22.6	28.7	26.6	25.6	31.1	25.9	64.8	25.4	32.3	29.1	64.5	73.4	52.1	60.5	39.1	79.7	49.0	51.9	37.9	45.3	45.4	28.7	34.2	36.9	29.2	38.8	38.0	42.0	36.8	39.9	26.4	59.3	32.7	50.3	34.9	37.2	28.7	40.4	40.3	40.8	39.8	37.0	17.4	35.8	48.3	30.8	49.7	18.5	24.4	47.4	24.1	40.6	40.8	40.7	70.8	51.9	36.1	103.9	41.0	25.9	58.0	61.6	32.5	51.1	52.4	34.2	38.4	62.2	64.7	57.2	36.3	33.7	44.3	14.2	40.7	50.2	45.2	79.8	53.1	50.4	45.5	46.2	46.2	52.1	45.5	60.5	47.4	64.5	63.5	51.3	58.4	47.2	54.8	53.4	28.1	39.1	60.5	73.4	79.7	49.0	37.6	37.7	40.7	51.6	32.5	30.8	37.3	29.4	36.7	25.6
NDUFB7	"B18, CI-B18, MGC2480"	ENSG00000099795	"NADH:ubiquinone oxidoreductase subunit B7"	P17568	19	14566078-14572062	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 182.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002817	Approved									"HPA002817: AB_1079462"	"unprognostic (2.80e-2)"	"prognostic favourable (3.54e-4)"	"unprognostic (2.03e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.45e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.14e-2)"	"prognostic favourable (2.41e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.25e-3)"	35.5	34.0	42.1	24.1	37.3	26.0	34.6	25.1	50.3	24.7	36.2	19.4	28.5	36.6	22.2	31.6	28.3	27.2	31.9	110.4	32.6	32.3	36.2	44.9	22.6	26.8	40.7	29.6	21.3	55.1	20.4	23.9	21.8	29.3	24.5	17.0	24.9	58.1	30.8	182.0	22.6	32.7	28.7	26.4	18.9	30.3	20.9	20.0	20.4	27.6	65.5	19.7	19.3	23.6	64.2	82.6	48.7	77.5	67.3	83.1	90.6	36.8	37.2	15.1	32.1	13.1	13.2	26.8	17.2	19.3	32.2	30.6	49.4	20.5	16.8	51.8	16.0	28.9	9.9	37.7	4.3	25.9	50.7	32.5	61.3	51.0	23.3	21.0	22.6	21.5	31.5	16.9	8.0	25.7	20.0	30.9	14.8	69.8	34.1	46.9	38.4	122.3	26.7	18.0	40.7	22.5	39.5	32.8	34.9	18.0	42.1	45.8	27.7	37.9	19.0	41.0	19.9	51.7	31.6	42.3	43.3	21.0	39.4	41.0	27.4	48.7	77.5	23.8	83.1	68.5	77.1	64.2	56.8	70.0	74.7	56.9	47.6	62.2	21.9	67.3	64.7	82.6	63.8	90.6	42.1	37.3	25.1	50.3	32.6	32.3	40.7	29.6	29.3	20.0
NDUFB9	"B22, LYRM3, UQOR22"	ENSG00000147684	"NADH:ubiquinone oxidoreductase subunit B9"	Q9Y6M9	8	124539103-124568510	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 221.3"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 254.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042768	Approved		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA042768: AB_10797508"	"unprognostic (1.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-3)"	"unprognostic (8.32e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.64e-1)"	"prognostic favourable (3.42e-5)"	"unprognostic (9.54e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.74e-1)"	26.9	20.8	61.0	19.6	45.1	43.7	33.3	26.9	63.7	20.7	40.4	15.0	25.4	35.5	17.4	30.0	27.9	19.4	23.8	125.1	44.2	39.0	50.1	52.9	23.8	38.2	60.0	49.1	16.8	51.7	20.6	16.3	15.8	46.7	20.6	37.5	13.4	39.9	24.0	221.3	18.0	26.1	31.3	44.8	15.3	28.9	44.1	31.1	13.5	27.7	80.7	19.3	16.7	16.5	53.8	52.7	52.1	54.4	37.5	71.2	64.2	28.8	26.7	20.5	27.7	21.4	18.2	17.2	14.2	16.2	25.9	19.6	35.1	27.9	28.6	36.9	16.3	32.9	29.7	22.6	24.5	33.2	40.5	69.6	19.0	42.0	28.5	21.6	19.0	21.2	33.0	23.7	51.4	23.5	43.0	24.1	20.7	90.2	34.0	43.3	20.6	59.4	23.0	15.6	39.0	34.1	24.4	28.6	22.4	30.9	254.7	30.4	35.0	29.3	18.7	15.1	39.4	14.1	33.4	31.1	41.4	32.8	26.3	43.3	19.9	52.1	54.4	27.5	48.3	37.2	47.9	53.8	64.0	53.9	52.7	42.5	63.4	52.2	11.2	37.5	27.2	39.6	71.2	64.2	61.0	45.1	26.9	63.7	44.2	39.0	60.0	49.1	46.7	31.1
NDUFC1	KFYI	ENSG00000109390	"NADH:ubiquinone oxidoreductase subunit C1"	O43677	4	139266880-139302551	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 164.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044556	Approved		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA044556: AB_10794402"	"unprognostic (6.07e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.76e-2)"	"prognostic favourable (8.23e-5)"	"unprognostic (7.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.17e-2)"	"prognostic favourable (9.96e-4)"	"unprognostic (2.33e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"prognostic favourable (7.25e-4)"	7.4	17.0	15.2	6.4	15.8	5.6	8.3	12.2	15.7	8.5	13.1	11.8	7.0	15.2	6.6	12.0	11.7	8.3	7.7	55.5	12.4	14.6	20.3	17.1	8.4	6.7	13.0	12.1	9.7	13.1	11.4	14.3	8.9	10.0	8.1	12.6	11.3	10.9	10.5	164.1	9.1	16.4	7.2	10.4	10.5	11.9	27.1	8.5	6.1	11.6	57.6	9.4	7.0	7.3	32.7	40.0	40.8	24.4	12.8	31.4	26.1	8.6	3.6	10.6	13.1	7.6	8.3	8.4	10.7	7.1	7.9	6.0	6.4	10.8	3.8	3.9	7.5	5.1	20.6	7.0	6.3	5.4	6.6	6.0	7.1	10.2	9.5	5.0	3.3	11.9	10.5	7.5	11.1	7.8	13.8	16.2	5.4	6.1	7.3	12.3	8.1	4.9	6.2	6.5	28.7	12.7	5.6	8.9	6.8	7.6	9.4	4.9	10.3	9.7	3.8	7.8	3.7	5.4	6.0	13.0	22.9	9.5	8.4	13.1	6.2	16.0	24.4	40.8	21.7	17.3	17.3	28.3	24.4	23.2	24.0	32.7	31.4	23.1	15.4	12.8	18.8	40.0	28.3	26.1	15.2	15.8	12.2	15.7	12.4	14.6	13.0	12.1	10.0	8.5
NDUFS1	CI-75k	ENSG00000023228	"NADH:ubiquinone oxidoreductase core subunit S1"	P28331	2	206114817-206159603	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 99.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064605, CAB070844"	Approved		Supported	Mitochondria				Mitochondria	Mitochondria	"CAB070844: , HPA064605: AB_2685297"	"prognostic unfavourable (3.85e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.22e-3)"	"unprognostic (5.01e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.75e-1)"	"unprognostic (3.72e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.28e-1)"	"prognostic favourable (1.47e-12)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.73e-2)"	13.9	29.0	12.1	8.3	22.1	7.6	10.3	11.6	26.4	9.1	17.4	16.4	9.2	18.3	9.1	7.7	15.7	7.7	7.3	62.6	11.3	11.7	29.5	30.7	8.3	7.7	13.3	13.8	8.2	9.3	22.1	11.6	10.8	24.2	10.7	18.9	13.5	12.8	10.9	99.5	11.0	19.9	11.1	10.8	8.4	14.9	8.8	11.1	11.2	10.8	34.7	10.5	11.6	9.4	10.7	15.3	15.7	21.4	12.5	16.1	8.9	12.9	13.0	18.8	13.6	17.6	14.3	21.9	19.1	20.7	31.9	23.2	33.5	15.2	14.7	16.9	23.8	18.2	25.1	18.5	28.4	6.7	11.8	29.4	32.1	30.0	18.3	21.1	13.3	17.4	10.9	25.0	19.7	24.8	31.7	14.9	20.8	16.2	17.4	14.0	17.5	23.1	17.7	26.3	25.4	26.4	23.8	18.4	14.4	22.0	21.6	31.2	19.0	20.5	18.9	17.6	15.7	17.2	18.1	14.4	17.3	21.9	17.7	17.6	18.0	12.0	13.3	15.7	13.6	15.4	10.8	10.7	12.2	13.0	15.3	9.5	10.9	12.4	9.6	12.5	21.4	8.2	16.1	8.9	12.1	22.1	11.6	26.4	11.3	11.7	13.3	13.8	24.2	11.1
NDUFS2	CI-49	ENSG00000158864	"NADH:ubiquinone oxidoreductase core subunit S2"	O75306	1	161197104-161214395	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 104.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055140, HPA061953"	Enhanced		Supported	Mitochondria		16000	16000	Mitochondria	Mitochondria	"HPA055140: AB_2682713, HPA061953: AB_2684646"	"unprognostic (2.13e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.47e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.11e-1)"	"prognostic favourable (2.32e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-1)"	14.6	30.7	16.6	8.0	25.4	10.2	15.5	23.4	25.4	13.0	25.6	17.9	11.7	23.6	12.3	11.2	16.7	14.5	10.6	75.4	17.6	14.8	37.4	52.6	12.8	9.2	28.0	25.0	14.1	14.3	25.6	10.7	11.5	24.1	12.7	27.2	11.4	14.6	14.5	104.9	14.0	22.1	15.7	16.1	13.0	19.4	8.8	25.3	10.4	12.3	37.1	15.1	13.2	10.5	18.9	47.3	26.6	42.2	20.3	29.2	32.4	18.0	29.1	18.4	21.3	27.0	24.0	15.9	16.4	24.1	32.4	25.6	31.8	18.8	22.9	30.9	25.2	24.2	29.3	29.3	28.7	15.2	24.7	22.4	21.8	27.8	28.0	24.2	20.8	34.6	25.9	26.2	30.0	37.1	28.6	12.5	30.4	20.8	15.3	12.9	33.5	26.8	13.3	19.0	32.2	38.5	21.6	19.5	29.0	19.8	48.9	27.9	44.0	63.4	23.7	15.8	13.5	11.0	22.1	17.6	27.9	19.2	24.1	20.5	20.3	26.6	35.9	18.9	20.5	42.2	19.9	18.9	20.9	20.7	47.3	15.7	21.6	21.8	20.2	20.3	37.0	31.8	29.2	32.4	16.6	25.4	23.4	25.4	17.6	14.8	28.0	25.0	24.1	25.3
NDUFS3	CI-30	ENSG00000213619	"NADH:ubiquinone oxidoreductase core subunit S3"	O75489	11	47565336-47584562	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA004484	Approved		Supported	"Nuclear bodies,Mitochondria"				Mitochondria	Mitochondria	"HPA004484: AB_1079464"	"unprognostic (2.18e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.01e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.13e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.75e-3)"	"unprognostic (7.73e-2)"	"prognostic favourable (2.61e-6)"	"unprognostic (2.77e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.17e-3)"	13.4	22.9	29.7	13.2	46.3	25.5	18.1	23.9	35.0	16.6	28.4	16.5	16.1	31.4	12.7	16.0	19.1	17.3	16.3	45.8	26.0	24.8	34.1	32.0	12.0	13.9	29.4	24.9	12.2	23.0	21.4	17.0	12.0	26.0	13.9	30.9	14.4	20.1	17.4	100.9	15.1	28.9	15.9	17.1	14.2	18.9	15.1	15.4	20.5	16.1	51.6	18.8	14.5	11.7	25.0	36.1	18.7	31.2	16.4	23.8	31.5	11.5	21.9	18.6	19.3	16.1	16.6	15.9	11.0	18.8	27.1	25.8	32.2	20.3	25.6	10.9	15.6	21.3	26.2	19.7	22.1	13.7	42.3	15.5	30.8	31.1	16.5	37.9	20.2	16.2	14.3	10.2	17.0	17.0	22.6	17.8	17.5	35.2	25.9	49.2	26.3	31.0	31.7	26.7	21.1	23.2	18.0	20.8	15.0	14.0	24.1	24.8	26.9	36.3	11.9	16.2	18.2	18.8	24.7	20.4	27.0	28.4	16.5	29.2	16.1	12.2	28.6	18.7	18.7	31.2	19.8	25.0	19.7	20.3	33.7	23.1	18.8	20.1	7.5	16.4	25.0	36.1	23.8	31.5	29.7	46.3	23.9	35.0	26.0	24.8	29.4	24.9	26.0	15.4
NDUFS6	CI-13kA	ENSG00000145494	"NADH:ubiquinone oxidoreductase subunit S6"	O75380	5	1801400-1816605	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 146.4"	"Cell line enhanced"	"Detected in all"		"HeLa: 102.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064221	Supported					27000	27000			"HPA064221: AB_2685217"	"unprognostic (2.34e-1)"	"unprognostic (1.43e-3)"	"unprognostic (4.04e-1)"	"unprognostic (9.74e-2)"	"unprognostic (5.91e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.68e-3)"	"unprognostic (8.57e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.46e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.02e-1)"	25.0	20.6	19.8	18.9	20.9	23.7	23.9	13.3	26.8	10.6	26.2	11.5	13.6	34.2	13.6	14.4	20.3	10.9	18.8	59.8	17.6	16.5	28.1	43.1	13.5	26.2	19.9	12.9	13.0	29.7	10.5	13.6	17.1	16.1	15.4	12.6	14.7	22.3	19.0	146.4	13.0	27.1	17.8	16.5	16.4	25.4	13.3	9.3	25.5	14.7	36.6	14.1	15.5	12.7	38.7	55.7	35.8	52.8	32.4	40.2	36.7	20.4	28.2	13.8	20.9	5.0	4.5	37.8	17.5	6.2	9.4	8.2	31.0	20.0	28.3	48.3	7.2	20.4	10.3	13.9	5.1	32.0	34.1	21.8	102.7	26.2	10.2	25.6	19.3	6.4	8.9	9.0	6.4	9.1	26.7	21.7	10.1	34.1	36.6	46.9	18.3	39.7	27.3	18.0	33.2	9.7	22.8	17.1	17.2	56.6	36.4	21.8	24.3	30.5	18.4	15.0	34.8	15.4	28.3	26.3	40.2	36.2	18.9	37.4	16.9	31.4	46.5	35.8	35.1	52.8	34.9	38.7	37.2	35.5	55.7	31.0	31.5	35.2	20.2	32.4	45.7	54.5	40.2	36.7	19.8	20.9	13.3	26.8	17.6	16.5	19.9	12.9	16.1	9.3
NDUFS8	"CI-23k, TYKY"	ENSG00000110717	"NADH:ubiquinone oxidoreductase core subunit S8"	O00217	11	68030617-68036644	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 156.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018524	Approved		Supported	Mitochondria	"Intracellular and membrane"			Mitochondria	Mitochondria	"HPA018524: AB_1854355"	"unprognostic (2.90e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.81e-1)"	"prognostic favourable (3.27e-8)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (9.45e-2)"	26.0	62.0	29.9	16.9	40.5	21.0	19.1	18.4	50.1	18.6	24.7	19.7	24.3	34.7	18.2	15.1	28.3	19.0	22.7	82.4	26.5	27.5	50.3	47.6	16.3	19.1	28.3	22.4	20.8	41.3	25.4	26.7	18.0	25.9	22.9	18.3	30.1	41.3	32.2	156.6	17.3	26.7	19.8	18.2	20.3	25.0	21.1	15.7	29.6	29.2	53.9	24.2	19.1	14.8	37.3	66.6	23.6	46.1	59.0	39.6	42.6	26.8	66.7	18.5	25.1	13.8	12.4	24.3	19.1	16.6	29.6	23.0	62.1	28.7	20.8	34.8	16.5	33.2	21.2	23.2	10.6	24.8	48.8	18.9	42.5	32.6	33.0	17.7	20.9	15.6	24.1	21.7	24.9	19.8	19.4	22.6	19.3	63.7	38.9	37.9	22.7	56.6	27.1	17.9	67.3	37.2	21.8	23.2	18.9	13.9	32.2	67.5	44.2	19.4	15.3	28.7	25.3	41.6	26.3	30.9	32.5	17.6	46.2	21.3	20.0	15.8	46.1	23.6	39.6	45.1	37.0	37.3	34.2	36.0	63.3	30.2	33.0	36.7	4.4	59.0	24.9	66.6	39.6	42.6	29.9	40.5	18.4	50.1	26.5	27.5	28.3	22.4	25.9	15.7
NDUFV1	CI-51K	ENSG00000167792	"NADH:ubiquinone oxidoreductase core subunit V1"	P49821	11	67606852-67612535	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 150.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045211, HPA075051"	Approved		Supported	Mitochondria,Cytosol				Mitochondria	Mitochondria	"HPA045211: AB_10962830, HPA075051: AB_2686732"	"unprognostic (4.57e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.84e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.03e-2)"	"prognostic favourable (7.49e-10)"	"unprognostic (1.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	23.3	28.9	27.3	20.7	33.9	20.3	18.9	32.9	48.8	18.5	33.0	23.1	19.2	40.6	19.4	21.5	25.5	22.5	23.4	93.0	26.5	24.1	39.0	41.5	15.9	20.6	31.5	40.5	24.6	38.3	49.2	18.8	15.7	34.8	16.1	25.1	17.6	27.3	27.0	150.8	28.4	30.3	22.7	23.1	21.5	28.2	30.2	24.3	18.3	23.4	67.9	20.3	18.7	18.6	23.8	41.2	13.5	30.7	36.2	28.2	24.3	26.2	28.2	14.4	28.8	18.0	18.1	26.9	16.4	15.8	25.7	17.2	53.3	31.8	48.5	34.6	14.1	35.4	30.3	25.6	8.1	24.6	23.9	19.9	38.3	26.3	25.5	27.0	22.2	26.8	24.8	20.9	18.7	22.7	36.1	39.7	15.6	39.4	31.5	53.5	14.1	35.5	36.6	27.9	78.7	20.8	19.7	22.9	21.6	20.7	72.5	54.7	36.8	27.5	18.0	24.9	18.6	35.4	17.2	38.8	22.1	24.2	29.0	28.6	23.9	12.6	26.7	13.5	25.9	30.7	28.2	23.2	21.7	24.5	41.2	23.8	20.2	25.1	4.8	36.2	17.4	26.5	27.8	24.3	27.3	33.9	32.9	48.8	26.5	24.1	31.5	40.5	34.8	24.3
NDUFV3	CI-10k	ENSG00000160194	"NADH:ubiquinone oxidoreductase subunit V3"	P56181	21	42879644-42913304	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 129.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019791, HPA020463, HPA030427, CAB034142"	Enhanced		Enhanced	Mitochondria				Mitochondria	Mitochondria	"CAB034142: AB_2298212, HPA019791: AB_1854357, HPA020463: AB_1854358, HPA030427: AB_10603024"	"unprognostic (1.62e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.56e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.94e-1)"	18.1	14.1	16.9	11.1	17.2	15.8	14.6	11.8	23.2	12.0	15.9	11.9	14.6	15.2	15.1	15.7	15.6	12.7	15.4	54.9	14.2	11.0	15.1	24.3	10.8	12.5	14.0	18.6	16.0	17.7	13.2	13.1	11.6	19.2	13.6	11.4	12.2	19.4	21.8	129.5	15.4	13.5	16.9	16.0	13.3	14.3	20.3	13.3	6.6	11.6	18.5	10.6	13.3	11.8	9.9	22.9	16.0	22.8	10.5	8.8	10.3	9.6	11.3	11.0	18.0	13.6	11.8	13.6	19.2	11.0	11.4	9.6	20.7	11.9	10.7	15.2	7.1	10.5	12.8	16.9	7.5	6.1	15.4	35.2	13.3	16.2	21.3	12.0	18.5	13.3	14.7	11.6	18.4	14.4	27.9	13.9	13.1	18.9	8.0	18.2	14.3	22.4	13.8	8.0	33.4	15.4	12.8	8.0	8.4	19.2	22.8	12.7	19.5	15.9	16.9	10.8	7.5	13.8	13.6	20.8	13.7	12.1	14.1	21.6	16.2	3.7	21.4	16.0	8.0	22.8	8.1	8.1	7.6	6.7	22.9	9.9	8.8	7.7	3.8	10.5	19.6	11.3	8.8	10.3	16.9	17.2	11.8	23.2	14.2	11.0	14.0	18.6	19.2	13.3
NECAB3	"APBA2BP, dJ63M2.4, dJ63M2.5, EFCBP3, NIP1, SYTIP2, XB51"	ENSG00000125967	"N-terminal EF-hand calcium binding protein 3"	Q96P71	20	33657087-33674463	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 49.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044785, HPA070595, HPA071786"	Supported		Supported	"Golgi apparatus"	"Intracellular and membrane"			"Golgi apparatus"	"Golgi apparatus"	"HPA044785: AB_2679086, HPA070595: AB_2732158, HPA071786: AB_2732186"	"unprognostic (8.95e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (9.57e-4)"	"unprognostic (1.44e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-1)"	"prognostic favourable (3.19e-5)"	"unprognostic (3.13e-2)"	"prognostic unfavourable (7.81e-4)"	"unprognostic (6.13e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-1)"	7.7	29.1	13.9	5.6	10.5	2.3	6.4	3.8	30.0	5.7	8.1	7.1	9.4	14.6	4.9	8.4	6.5	6.9	5.5	30.5	13.2	10.0	6.4	6.3	11.9	2.9	11.3	15.0	22.4	13.6	10.9	5.5	4.9	15.5	23.8	5.4	6.9	13.7	9.7	49.7	3.3	8.3	7.4	6.8	3.4	13.6	6.5	5.5	0.4	10.6	10.8	3.3	7.7	7.8	1.2	2.6	3.5	6.5	2.4	3.0	1.2	4.4	3.9	2.8	5.8	2.3	4.5	13.9	6.2	2.3	4.0	3.5	18.1	2.9	4.9	14.8	3.6	5.3	2.9	1.8	1.5	1.7	4.3	4.7	16.3	21.0	6.1	1.1	4.5	5.7	2.7	3.7	1.2	2.6	6.7	2.6	5.1	6.8	1.7	4.7	1.2	9.8	5.2	7.4	8.5	3.7	3.3	18.2	5.1	14.3	16.0	6.3	20.3	5.6	2.2	4.9	7.0	6.4	6.9	10.0	4.1	8.9	9.7	2.2	2.1	0.0	2.7	3.5	0.8	2.5	1.9	0.5	1.3	0.7	2.6	1.2	1.0	0.3	0.1	2.4	6.5	0.1	3.0	1.2	13.9	10.5	3.8	30.0	13.2	10.0	11.3	15.0	15.5	5.5
NEDD4	"KIAA0093, MGC176705, NEDD4-1, RPF1"	ENSG00000069869	"Neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase"	P46934	15	55826922-55993746	"Enzymes, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 57.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001991, HPA039883, CAB072833"	Approved		Approved	Cytosol				Cytosol	Cytosol	"CAB001991: , CAB072833: , HPA039883: AB_10795683"	"unprognostic (1.18e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.18e-3)"	"prognostic unfavourable (5.14e-4)"	"unprognostic (1.36e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (3.74e-6)"	"unprognostic (6.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.35e-2)"	14.1	4.1	2.5	3.1	3.3	4.5	8.7	1.5	2.7	9.9	9.4	2.8	3.4	3.4	10.1	4.1	8.2	3.8	4.5	4.1	2.9	2.4	8.6	21.5	7.2	2.1	3.5	1.3	6.6	2.8	6.5	6.7	20.1	3.5	8.4	3.4	5.4	4.0	6.4	57.7	7.1	15.2	10.9	6.0	5.9	4.4	2.6	3.1	9.4	5.7	9.0	3.3	11.9	8.9	0.1	1.6	1.2	2.8	1.2	2.9	0.9	7.3	11.4	3.1	3.0	4.1	6.8	5.1	14.1	22.3	10.4	10.5	5.1	2.2	1.8	3.7	5.3	12.2	3.4	9.3	17.1	4.1	2.1	9.1	2.7	2.6	21.9	4.0	0.9	11.5	23.0	12.5	21.1	8.5	3.9	0.0	30.5	3.8	5.3	0.0	0.8	1.7	3.9	24.7	1.0	4.3	14.6	0.3	2.0	6.3	4.5	5.6	5.6	3.0	29.6	23.2	7.7	4.9	22.9	1.2	2.6	4.8	15.7	8.5	5.5	0.6	1.0	0.0	1.3	2.8	2.9	0.1	1.5	1.2	0.8	0.0	1.4	1.6	1.2	1.2	1.9	1.6	1.3	0.9	2.5	3.3	1.5	2.7	2.9	2.4	3.5	1.3	3.5	3.1
NEURL1	"h-neu, neu-1, NEURL, RNF67"	ENSG00000107954	"Neuralized E3 ubiquitin protein ligase 1"	O76050	10	103493979-103592552	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 37.1;skeletal muscle: 83.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 12.9;HeLa: 7.6;HMC-1: 6.5;SCLC-21H: 16.2;SiHa: 8.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"intermediate monocyte: 16.0;non-classical monocyte: 37.1"	"Lineage enriched"	"Detected in many"	17	"monocytes: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044204	Enhanced									"HPA044204: AB_10959383"	"unprognostic (1.21e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.58e-4)"	"unprognostic (1.31e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.91e-4)"	"unprognostic (3.23e-1)"	1.1	3.9	18.5	3.0	17.5	2.0	1.0	28.2	27.2	6.1	8.6	0.6	1.2	7.7	13.2	11.0	3.6	2.1	2.0	1.1	12.0	7.6	1.3	1.1	1.3	1.3	4.5	18.9	2.1	12.8	2.9	6.5	13.3	6.1	2.8	7.3	7.8	1.5	1.7	83.5	1.9	11.7	11.7	1.2	2.0	4.4	7.5	2.1	0.0	1.2	8.5	1.1	9.2	1.7	0.4	2.1	1.0	37.1	0.2	0.4	1.2	0.8	0.2	1.3	0.0	0.4	0.1	12.9	0.5	0.8	0.2	0.1	0.3	0.3	0.4	0.7	0.1	0.7	0.4	0.2	0.1	0.3	0.7	0.2	7.6	0.6	0.0	0.3	6.5	0.2	0.5	0.1	0.6	0.0	2.1	0.4	0.2	1.1	1.3	0.8	0.0	3.9	0.2	0.6	1.4	0.0	0.5	16.2	5.5	8.1	0.0	0.4	0.7	1.5	0.0	0.1	0.9	0.2	0.2	0.9	0.2	0.3	0.5	0.0	0.3	0.2	1.0	0.2	0.3	16.0	0.4	0.4	0.4	0.4	2.1	0.3	0.4	0.3	1.0	0.2	37.1	1.7	0.1	1.2	18.5	17.5	28.2	27.2	12.0	7.6	4.5	18.9	6.1	2.1
NEXN	"NELIN, nexilin"	ENSG00000162614	"Nexilin F-actin binding protein"	Q0ZGT2	1	77888513-77943895	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 110.8;skeletal muscle: 198.5"	"Cell line enhanced"	"Detected in many"		"BJ: 42.9;LHCN-M2: 39.4;RH-30: 31.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA011185, HPA011904"	Approved		Supported	"Actin filaments"		12000000	12000000	"Actin filaments"	"Actin filaments"	"HPA011185: AB_1854409, HPA011904: "	"unprognostic (9.73e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavourable (5.60e-4)"	"unprognostic (1.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.68e-2)"	8.9	4.3	0.4	10.4	0.8	0.0	5.0	0.5	0.4	14.1	17.0	0.2	12.5	1.9	16.6	12.5	24.1	9.9	8.7	110.8	0.4	0.5	4.0	1.2	6.2	3.8	0.6	0.5	8.2	2.0	0.3	0.5	2.6	0.7	13.1	3.2	0.9	4.1	14.8	198.5	1.4	5.5	45.8	0.8	3.9	10.6	4.2	1.2	0.0	5.1	40.1	1.0	29.7	10.3	1.4	1.7	2.9	3.4	0.6	0.6	7.0	7.0	0.4	1.2	0.0	23.2	22.5	3.5	42.9	19.0	8.7	5.9	1.2	0.0	0.0	2.4	15.5	0.9	0.9	4.0	15.7	0.2	0.9	1.7	2.2	0.4	17.4	0.3	0.0	16.8	0.9	12.1	6.8	6.6	0.0	0.0	39.4	0.0	8.0	0.5	6.8	5.2	6.7	31.2	0.0	10.2	0.3	0.0	0.3	3.7	0.0	0.2	0.0	0.9	6.7	21.0	15.4	8.9	21.3	0.0	0.0	0.0	1.1	0.8	0.0	0.0	3.4	0.0	0.4	2.0	0.1	1.4	0.3	0.4	1.7	1.1	0.6	0.2	2.9	0.6	1.4	1.2	0.0	7.0	0.4	0.8	0.5	0.4	0.4	0.5	0.6	0.5	0.7	1.2
NFE2L1	"FLJ00380, LCR-F1, NRF1, TCF11"	ENSG00000082641	"Nuclear factor, erythroid 2 like 1"	Q14494	17	48048329-48061487	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 194.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063384, HPA065424"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA063384: AB_2684998, HPA065424: AB_2685488"	"unprognostic (3.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (5.44e-2)"	"prognostic favourable (8.20e-5)"	"unprognostic (5.25e-2)"	"prognostic unfavourable (2.73e-4)"	"unprognostic (5.20e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"prognostic favourable (5.79e-6)"	"unprognostic (2.20e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.19e-3)"	"unprognostic (2.01e-2)"	24.2	25.7	15.5	13.1	15.5	4.6	50.3	9.1	19.8	18.8	17.5	17.4	32.3	17.4	31.4	30.5	21.4	22.7	16.3	85.5	18.2	19.2	27.9	18.4	13.9	12.6	21.7	21.2	26.2	11.1	16.6	16.3	16.6	25.0	16.5	13.6	22.6	17.7	26.1	194.7	19.9	18.3	24.3	27.5	17.7	13.9	18.8	16.5	5.8	22.4	58.9	10.7	17.3	24.2	4.1	9.4	19.7	9.4	2.1	2.6	0.9	18.9	42.3	27.7	23.4	58.2	28.4	20.8	31.0	43.1	22.0	24.6	51.5	21.9	21.8	62.9	39.0	39.4	19.6	24.7	23.7	37.4	16.3	12.3	28.6	17.2	69.1	27.3	19.9	38.7	61.7	40.1	45.0	34.4	21.7	60.6	27.0	16.2	17.3	8.5	17.9	16.1	12.3	39.2	20.8	24.3	28.4	17.1	25.9	21.2	14.2	43.6	28.1	18.8	45.9	54.0	23.4	18.2	31.0	101.3	67.8	20.4	51.3	11.6	30.6	7.9	9.4	2.7	2.6	4.8	1.5	3.8	2.5	2.6	1.9	4.1	1.9	2.1	19.7	2.1	5.6	9.4	0.9	0.9	15.5	15.5	9.1	19.8	18.2	19.2	21.7	21.2	25.0	16.5
NFIC	"CTF, CTF5, NF-I, NFI"	ENSG00000141905	"Nuclear factor I C"	P08651	19	3314403-3469217	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 101.7"	"Cell line enhanced"	"Detected in many"		"SiHa: 50.2;U-2197: 49.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004300, CAB004674, HPA052625"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"CAB004300: , CAB004674: AB_425564, HPA052625: AB_2681889"	"unprognostic (2.59e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.11e-1)"	"prognostic favourable (1.52e-6)"	"unprognostic (8.38e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.04e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.81e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.65e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.80e-3)"	25.1	19.8	8.5	11.1	11.1	5.7	14.9	15.3	19.9	23.3	19.7	16.8	27.1	6.4	20.8	14.2	19.6	18.5	21.5	25.7	9.5	6.3	14.4	29.0	12.9	9.1	11.8	8.1	31.8	46.9	22.7	14.6	5.1	11.7	18.8	5.3	20.4	33.9	22.2	101.7	16.8	8.5	26.5	10.9	11.6	16.4	8.6	11.3	2.7	15.6	23.2	10.2	22.4	17.4	2.3	4.0	11.3	5.3	8.4	3.3	3.2	17.8	26.2	0.3	15.9	14.5	12.6	1.7	16.3	9.2	11.1	7.9	0.6	6.3	0.1	5.9	14.9	8.7	4.4	11.0	4.5	12.6	3.8	3.4	21.2	5.2	11.4	5.2	6.7	11.0	7.8	15.2	6.0	10.2	9.0	16.8	8.0	12.8	3.0	1.1	0.8	10.9	7.8	10.1	7.0	4.2	3.6	3.6	9.7	50.2	5.0	4.9	14.7	4.1	15.3	19.0	17.1	49.6	22.2	0.5	0.7	0.1	26.2	11.5	27.5	1.8	5.2	2.4	3.3	5.3	2.8	2.1	3.0	3.0	4.0	2.3	2.1	2.1	11.3	8.4	1.1	1.6	1.1	3.2	8.5	11.1	15.3	19.9	9.5	6.3	11.8	8.1	11.7	11.3
NFIX	NF1A	ENSG00000008441	"Nuclear factor I X"	Q14938	19	12995608-13098796	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 139.7"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 36.8;fHDF/TERT166: 49.4;U-138 MG: 47.1;U-2197: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007533	Supported		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA007533: AB_2667855"	"unprognostic (3.32e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.12e-2)"	"prognostic favourable (4.66e-4)"	"prognostic favourable (2.35e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.38e-2)"	28.6	6.6	21.3	8.0	23.8	5.8	15.5	57.0	60.8	25.1	17.9	41.0	8.9	9.2	29.9	12.4	29.2	29.2	21.8	24.1	27.3	15.0	4.6	8.9	20.3	3.1	21.6	29.8	31.8	10.2	6.8	7.0	5.3	22.1	35.4	8.7	19.5	56.6	26.1	139.7	39.7	10.1	27.6	28.3	5.0	14.6	7.2	23.4	1.2	12.8	29.1	8.1	15.6	17.7	1.1	0.6	0.6	0.8	0.1	2.6	0.5	9.1	3.7	0.2	28.9	27.4	36.8	0.3	11.4	16.2	11.0	7.7	0.3	0.8	0.1	3.3	49.4	4.2	3.0	8.9	4.8	6.0	4.8	4.6	1.8	4.0	13.2	1.9	2.5	24.5	2.6	10.6	5.9	2.9	1.5	1.4	6.9	2.8	3.4	1.4	0.1	31.8	9.9	5.4	5.2	0.1	1.9	4.3	11.6	8.5	0.0	10.6	5.4	4.0	2.9	47.1	6.0	44.9	15.9	1.1	0.4	0.0	12.1	2.9	14.7	0.6	0.4	0.0	2.4	0.8	2.6	0.1	0.1	0.0	0.1	1.1	0.9	0.2	0.5	0.1	0.2	0.6	0.0	0.5	21.3	23.8	57.0	60.8	27.3	15.0	21.6	29.8	22.1	23.4
NIPSNAP2	GBAS	ENSG00000146729	"Nipsnap homolog 2"	O75323	7	55951793-56000181	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 97.3;skeletal muscle: 144.4"	"Cell line enhanced"	"Detected in all"		"A-431: 78.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063084	Enhanced		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA063084: AB_2684938"	"unprognostic (6.88e-2)"	"unprognostic (6.53e-3)"	"unprognostic (8.20e-3)"	"unprognostic (4.95e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"prognostic favourable (3.02e-8)"	"unprognostic (1.79e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.65e-3)"	"unprognostic (3.59e-1)"	14.5	19.3	18.4	8.4	22.9	8.6	16.6	11.8	24.5	12.6	14.6	8.9	11.8	8.1	11.0	11.1	12.9	13.4	8.0	97.3	18.7	15.9	16.6	5.2	13.2	16.6	17.0	16.7	9.5	13.5	11.8	8.6	8.0	17.2	14.3	14.2	6.8	18.9	15.5	144.4	6.3	8.3	21.6	19.3	6.5	11.6	5.8	12.1	7.4	22.6	39.8	7.2	12.4	7.8	14.3	34.1	14.1	33.1	15.2	14.1	24.7	78.8	14.0	18.5	30.7	10.7	18.7	9.1	6.6	15.7	19.2	14.9	9.7	17.5	11.6	11.2	12.4	10.5	13.9	14.0	19.1	7.3	20.5	8.2	8.4	12.3	15.4	17.7	8.3	17.0	21.6	6.5	17.9	20.2	14.5	11.4	14.9	3.5	17.6	18.4	18.1	14.2	17.9	8.6	23.7	25.9	12.5	19.8	22.3	15.1	18.3	20.6	35.4	19.2	11.8	8.8	13.3	3.1	13.7	9.4	7.9	21.4	9.7	11.2	25.9	13.4	33.1	14.1	8.7	31.8	10.6	14.3	11.7	9.3	34.1	12.3	14.1	10.1	5.8	15.2	23.9	14.1	13.6	24.7	18.4	22.9	11.8	24.5	18.7	15.9	17.0	16.7	17.2	12.1
NIPSNAP3B	FLJ11275	ENSG00000165028	"Nipsnap homolog 3B"	Q9BS92	9	104764157-104777457	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 28.6;skeletal muscle: 34.6"	"Cell line enhanced"	"Detected in some"		"REH: 7.5;THP-1: 5.2;U-266/70: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 6.5"	"Group enriched"	"Detected in many"	5	"B-cells: 3.5;dendritic cells: 1.7;granulocytes: 6.5"					"Low region specificity"	"Detected in all"			HPA042491	Uncertain									"HPA042491: AB_2678023"	"unprognostic (1.72e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.25e-5)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.81e-2)"	14.4	8.4	6.1	2.1	11.3	1.2	10.1	3.7	7.8	4.0	1.7	1.5	4.2	1.5	5.0	4.5	3.1	3.5	3.0	28.6	4.4	6.8	2.3	1.3	2.1	2.2	4.4	7.7	5.4	4.7	2.5	8.0	5.1	5.0	5.1	1.7	3.8	2.2	5.9	34.6	1.7	1.9	3.2	3.4	2.5	1.9	2.0	2.8	0.4	3.1	14.1	2.8	2.2	2.5	3.5	1.7	6.5	0.5	0.8	0.6	0.5	0.0	0.3	0.5	0.2	1.9	1.7	1.3	0.4	0.9	1.3	0.6	0.3	0.8	0.8	0.3	0.8	0.0	0.5	0.5	0.5	0.0	0.6	3.4	1.9	0.2	1.6	0.6	0.8	1.4	0.7	0.5	0.1	0.5	3.1	0.2	0.2	0.4	1.5	3.1	0.7	0.5	7.5	0.0	0.2	0.5	0.4	1.2	3.9	4.6	0.0	0.4	3.6	5.2	0.3	0.6	1.6	0.7	0.1	5.7	2.2	0.1	0.0	0.2	0.1	6.5	0.1	2.4	0.2	0.1	0.0	3.5	0.4	0.0	1.7	2.0	0.6	0.3	0.0	0.8	0.5	1.2	0.0	0.5	6.1	11.3	3.7	7.8	4.4	6.8	4.4	7.7	5.0	2.8
NKAIN1	"FAM77C, FLJ12650"	ENSG00000084628	"Sodium/potassium transporting ATPase interacting 1"	Q4KMZ8	1	31179745-31239554	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 15.5;brain: 23.2;skeletal muscle: 26.2"	"Cell line enhanced"	"Detected in some"		"AF22: 10.2;AN3-CA: 16.8;NTERA-2: 43.3;SCLC-21H: 12.9;SH-SY5Y: 20.6"	"Group enriched"	"Detected in many"	5	"breast cancer: 17.2;glioma: 4.6;prostate cancer: 10.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006873	Uncertain									"HPA006873: AB_1848410"	"unprognostic (1.58e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.54e-2)"	"unprognostic (6.11e-5)"	"unprognostic (6.59e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.30e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.07e-2)"	"unprognostic (6.31e-9)"	"unprognostic (1.00e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.62e-4)"	"unprognostic (5.50e-2)"	0.7	15.5	4.2	0.8	13.3	0.5	1.2	23.2	11.8	0.6	0.7	10.7	0.0	0.7	1.5	5.8	1.4	0.8	0.6	0.6	6.3	4.3	0.6	0.5	0.5	0.5	4.7	7.2	0.6	0.7	0.7	0.3	0.9	18.2	2.2	0.7	0.0	0.7	1.1	26.2	1.9	0.7	0.8	3.3	0.5	0.6	0.9	9.0	0.0	0.5	0.1	0.5	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.2	16.8	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.1	0.0	2.3	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	43.3	0.4	0.0	0.1	0.0	0.0	1.5	12.9	20.6	0.4	0.1	1.1	4.5	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	13.3	23.2	9.5	6.3	4.3	4.7	7.2	18.2	9.0
NLRP2B	"CLRX.1, NALP2P, NLRP2P, NOD24, POP4"	ENSG00000215174	"NLR family pyrin domain containing 2B"	P0DMW2	X	57677067-57680260	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"skeletal muscle: 1.8"	"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (3.37e-2)"	"unprognostic (1.07e-1)"		"unprognostic (6.67e-2)"	"unprognostic (3.84e-2)"		"unprognostic (1.80e-1)"	"unprognostic (5.78e-3)"		"unprognostic (3.49e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.39e-2)"	"unprognostic (7.56e-4)"	"unprognostic (7.92e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.75e-3)"	"unprognostic (9.00e-2)"	0.3	0.2		0.1		0.0	0.0		0.3	0.2	0.0			0.0	0.0	0.0	0.2	0.2	0.0	0.0			0.0	0.0	0.1	0.0			0.1	0.0	0.0		0.0		0.2	0.0		0.0	0.1	1.8	0.0	0.0	0.0		0.0	0.0	0.0			0.1		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0										
NNT		ENSG00000112992	"Nicotinamide nucleotide transhydrogenase"	Q13423	5	43602692-43707405	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA004829, CAB004975, HPA066564"	Enhanced		Approved	Mitochondria		1100000	1100000	Mitochondria	Mitochondria	"CAB004975: AB_425908, HPA004829: AB_1079495, HPA066564: "	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.33e-2)"	"prognostic favourable (1.22e-15)"	"unprognostic (8.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.58e-1)"	10.8	10.5	11.7	8.3	14.0	7.3	9.1	8.3	19.0	7.6	11.2	7.3	8.8	9.2	7.1	8.8	7.9	5.4	7.1	62.1	10.8	8.2	26.0	48.5	7.2	9.6	9.2	10.3	5.8	12.2	15.6	6.2	5.8	10.0	8.5	12.1	6.7	14.4	7.8	100.0	6.0	8.9	14.7	6.1	6.5	13.6	4.2	6.1	14.0	14.0	32.6	8.7	10.9	6.2	11.4	25.5	13.1	18.5	18.2	19.1	13.5	8.3	6.1	14.2	26.4	16.5	18.4	4.4	8.3	14.2	10.3	9.3	7.1	13.7	8.5	10.4	15.8	7.9	56.2	2.0	10.9	13.5	15.1	12.3	33.0	8.6	9.6	20.6	18.3	15.8	6.3	5.9	8.4	20.3	8.8	34.1	24.4	5.6	22.1	11.1	2.8	5.5	24.8	33.5	30.5	19.5	7.3	21.0	17.4	30.6	0.4	18.9	21.4	20.7	11.1	15.1	14.6	6.3	4.0	18.4	18.9	13.1	3.1	27.4	9.7	9.3	14.2	13.1	14.4	18.4	14.8	11.4	15.6	14.5	25.5	10.3	14.6	13.3	2.4	18.2	18.5	9.2	19.1	13.5	11.7	14.0	8.3	19.0	10.8	8.2	9.2	10.3	10.0	6.1
NODAL		ENSG00000156574	"Nodal growth differentiation factor"	Q96S42	10	70432315-70447951	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.0;skeletal muscle: 5.1;testis: 5.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.2;SH-SY5Y: 3.9;U-698: 3.3"	"Cancer enriched"	"Detected in some"	10	"testis cancer: 20.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045201	Uncertain				"Secreted to blood"					"HPA045201: AB_2679252"	"unprognostic (3.07e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.66e-3)"	"unprognostic (3.12e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.63e-5)"	"unprognostic (4.37e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.02e-1)"	1.2	0.1	1.1	0.3	2.4	2.0	0.9	2.4	5.0	0.9	0.5	3.8	0.3	0.8	0.7	0.3	1.4	0.4	1.0	0.7	1.2	1.0	0.3	0.3	1.0	0.7	1.5	0.3	0.9	0.3	0.0	0.3	0.9	2.9	0.8	0.0	0.3	0.5	0.3	5.1	3.5	0.6	0.3	0.4	0.9	0.9	5.2	0.3	0.8	0.3	0.3	0.3	0.7	0.7	1.2	0.4	1.1	0.6	0.0	2.2	0.3	1.0	0.6	2.2	2.5	0.0	0.0	0.3	0.1	0.0	0.4	0.0	5.2	0.6	1.7	0.1	0.0	0.2	0.0	1.9	0.0	1.4	0.2	0.0	0.1	0.4	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.7	0.7	0.0	0.7	0.2	0.7	1.4	0.1	0.6	0.7	1.4	0.0	0.3	0.4	3.9	1.1	0.5	0.0	1.1	0.5	0.0	0.0	0.7	0.3	0.3	1.2	2.8	3.3	0.0	0.5	0.3	0.0	0.6	0.0	0.2	0.5	0.7	0.2	1.2	2.2	0.4	1.2	0.8	0.6	1.1	0.0	0.4	0.0	0.2	0.3	1.1	2.4	2.4	5.0	1.2	1.0	1.5	0.3	2.9	0.3
NOL3	"ARC, CARD2, MYP, NOP30"	ENSG00000140939	"Nucleolar protein 3"	O60936	16	67170154-67175735	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.1"	"Cell line enhanced"	"Detected in many"		"T-47d: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 6.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009208	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB009208: AB_634091"	"unprognostic (2.83e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.83e-1)"	"prognostic unfavourable (6.43e-5)"	"unprognostic (5.74e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavourable (2.41e-4)"	"unprognostic (1.39e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.48e-2)"	16.3	22.6	13.0	3.2	19.6	1.3	9.4	7.3	14.1	8.4	7.1	10.8	19.7	5.3	7.5	10.5	15.4	7.8	15.7	29.1	11.1	8.3	10.1	12.8	10.1	2.6	15.9	12.3	6.8	12.3	22.8	14.8	8.6	12.7	19.8	6.1	13.8	18.0	13.3	76.1	39.7	5.2	10.6	11.6	3.7	11.1	2.7	15.8	0.6	9.6	27.7	6.3	9.4	9.2	0.0	2.1	1.5	6.8	0.7	3.4	2.5	6.1	10.1	1.7	9.5	8.5	6.5	9.5	5.0	5.3	5.4	3.2	2.1	16.3	0.1	16.6	5.8	10.3	2.3	7.7	1.3	5.5	3.5	0.2	8.0	3.2	5.3	0.5	1.2	3.9	14.4	4.3	3.0	2.3	2.2	6.6	10.2	16.1	0.1	0.8	1.6	24.9	5.5	3.5	12.3	9.2	1.9	13.5	7.2	21.0	15.2	2.2	32.5	1.7	5.2	7.2	6.2	7.0	4.3	9.6	3.0	1.7	20.4	1.5	2.4	0.0	6.8	0.0	0.3	0.6	0.1	0.0	3.4	0.3	2.1	0.0	0.0	0.5	1.5	0.7	0.2	2.1	0.0	2.5	13.0	19.6	7.3	14.1	11.1	8.3	15.9	12.3	12.7	15.8
NPHP1	"JBTS4, NPH1, SLSN1"	ENSG00000144061	"Nephrocystin 1"	O15259	2	110122311-110205066	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 36.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046093, HPA074071"	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"HPA046093: AB_2679535, HPA074071: "	"unprognostic (2.10e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.66e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.93e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.64e-2)"	3.1	4.3	8.5	1.8	13.7	0.8	5.1	2.1	7.2	5.6	4.7	4.9	8.8	1.7	7.2	11.3	2.1	19.3	4.3	4.4	9.0	7.5	8.7	1.5	5.7	1.5	3.8	6.2	5.4	3.5	17.7	28.1	2.1	20.3	4.4	2.6	4.6	2.8	8.9	36.7	1.7	1.8	7.2	5.4	1.9	3.7	25.0	7.2	0.0	8.9	3.2	1.3	4.1	3.7	3.5	1.0	1.0	0.3	3.2	1.8	0.7	8.6	2.7	5.7	4.2	3.3	6.9	1.2	2.2	7.2	7.8	7.7	2.8	6.5	0.5	5.8	5.1	4.2	2.7	7.0	9.3	1.6	3.5	0.2	1.7	1.9	4.6	1.3	0.0	4.7	4.2	12.1	3.9	4.9	0.1	0.8	4.6	1.7	0.8	2.1	2.6	4.5	0.0	6.0	0.2	13.2	0.7	3.1	3.1	3.2	3.9	7.9	4.7	1.0	3.1	4.5	3.9	5.0	7.0	2.4	2.5	0.6	13.3	0.2	3.2	0.7	0.1	0.1	1.2	0.3	1.8	2.7	0.9	0.6	1.0	3.5	1.8	1.4	1.0	3.2	0.1	0.1	0.1	0.7	8.5	13.7	2.1	7.2	9.0	7.5	3.8	6.2	20.3	7.2
NPLOC4	"FLJ20657, KIAA1499, NPL4"	ENSG00000182446	"NPL4 homolog, ubiquitin recognition factor"	Q8TAT6	17	81556887-81648465	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021560, HPA023295"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA021560: AB_1854586, HPA023295: AB_1854587"	"unprognostic (3.17e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (1.16e-5)"	"unprognostic (1.06e-2)"	"unprognostic (4.42e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (6.95e-7)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.72e-1)"	21.7	23.0	15.3	18.7	16.1	22.0	15.4	14.7	24.1	13.2	15.9	18.6	14.2	14.7	18.9	16.3	25.1	14.7	14.4	35.4	16.2	13.5	20.2	28.2	18.4	18.3	16.4	15.5	13.9	18.2	17.8	17.1	25.6	17.2	16.7	13.3	21.0	16.4	14.9	89.8	24.2	16.4	19.4	14.9	22.0	17.6	31.0	13.4	19.7	14.7	17.1	20.6	15.7	16.6	4.6	5.9	5.7	18.1	2.5	4.6	7.8	28.6	37.8	15.1	23.5	18.7	15.6	18.8	23.8	26.6	39.6	36.8	28.7	26.0	21.3	19.1	27.8	23.3	14.8	20.0	34.5	13.4	19.6	24.7	30.7	25.4	17.9	26.0	31.6	15.3	19.4	36.9	13.2	40.4	26.0	32.5	23.9	18.6	35.0	14.1	17.7	23.9	23.1	24.3	17.4	14.2	27.8	20.3	23.4	29.9	41.8	27.0	32.7	19.2	28.9	52.1	36.2	28.3	38.2	24.8	17.5	26.3	41.5	17.5	33.4	3.0	18.1	3.9	4.6	4.6	2.8	4.6	3.2	3.6	5.9	3.7	2.9	3.8	5.7	2.5	2.8	4.6	3.0	7.8	15.3	16.1	14.7	24.1	16.2	13.5	16.4	15.5	17.2	13.4
NRDC	"hNRD1, hNRD2, NRD1"	ENSG00000078618	"Nardilysin convertase"	O43847	1	51789191-51878937	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 96.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053661			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA053661: AB_2682221"	"unprognostic (1.22e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.25e-2)"	"prognostic unfavourable (5.49e-6)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (2.12e-9)"	"unprognostic (2.75e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.53e-3)"	16.4	15.9	13.4	15.8	17.5	14.5	11.7	14.7	16.9	12.2	13.7	11.0	9.9	11.2	11.8	12.1	14.4	10.9	10.9	25.7	13.1	13.3	12.4	28.5	12.0	13.6	16.2	10.6	11.7	15.9	19.3	21.4	14.2	15.7	13.8	12.1	9.8	11.9	11.3	96.4	19.1	10.3	13.3	14.0	13.6	11.9	32.3	14.5	19.4	11.7	21.5	15.1	13.0	16.0	13.8	18.5	36.3	19.1	15.8	15.1	16.2	47.6	26.8	26.9	38.7	28.3	43.9	31.4	48.1	41.6	35.0	37.2	18.8	18.8	31.4	25.8	36.2	27.8	39.6	37.3	44.4	37.2	19.5	37.5	36.5	16.3	29.1	32.7	28.6	34.9	28.6	51.1	47.5	36.4	49.4	21.1	43.8	17.4	29.6	11.3	47.8	28.9	29.0	32.2	34.6	25.9	27.7	25.9	19.5	43.9	35.3	26.0	23.6	39.9	30.2	30.8	28.6	33.5	40.9	31.5	47.6	29.4	36.4	41.3	35.3	19.3	18.1	26.0	13.7	19.1	13.7	13.8	12.7	15.1	18.5	9.3	12.5	13.4	36.3	15.8	14.5	15.0	14.4	16.2	13.4	17.5	14.7	16.9	13.1	13.3	16.2	10.6	15.7	14.5
NT5C1A	"CN-I, CN-IA, CN1, CN1A, MGC119199, MGC119201"	ENSG00000116981	"5'-nucleotidase, cytosolic IA"	Q9BXI3	1	39659121-39672038	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 51.9;tongue: 13.9"	"Cell line enriched"	"Detected in some"	13	"SH-SY5Y: 19.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050283, HPA054158"	Supported									"HPA050283: AB_2681072, HPA054158: AB_2682402"	"unprognostic (7.85e-2)"				"unprognostic (1.60e-1)"	"unprognostic (6.19e-1)"		"unprognostic (1.51e-3)"	"unprognostic (7.19e-2)"		"unprognostic (2.87e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-2)"		"unprognostic (1.81e-2)"		0.7	2.8	1.2	0.8	3.0	0.5	0.5	5.6	7.6	0.7	0.5	1.0	0.0	0.5	0.6	2.9	3.0	0.7	0.5	9.8	1.7	1.7	0.9	0.5	0.5	0.5	1.8	4.9	0.7	6.0	0.5	0.5	0.5	6.9	0.9	0.5	0.0	0.7	0.7	51.9	0.5	0.6	0.6	5.2	0.5	0.6	0.7	1.0	0.0	0.5	13.9	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	19.9	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.0	5.6	7.6	1.7	1.7	1.8	4.9	6.9	1.0
NT5M	"dNT-2, dNT2, mdN"	ENSG00000205309	"5',3'-nucleotidase, mitochondrial"	Q9NPB1	17	17303335-17347663	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 27.1"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 7.4;SH-SY5Y: 7.1;U-266/70: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043777	Uncertain									"HPA043777: AB_10962842"	"unprognostic (5.70e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.59e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-1)"	"prognostic favourable (8.42e-5)"	"unprognostic (4.28e-5)"	"unprognostic (2.27e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.05e-2)"	2.6	1.8	7.2	2.0	7.4	9.4	2.1	8.8	11.8	3.3	2.8	3.7	3.1	2.1	2.8	1.9	2.7	3.0	1.9	6.6	5.8	5.3	3.3	5.5	1.7	1.7	5.5	3.9	3.8	1.9	2.9	5.0	1.5	5.7	3.3	1.4	3.5	2.7	2.7	27.1	2.1	2.2	2.0	4.1	1.7	1.3	7.0	2.0	4.2	1.7	2.4	1.6	2.6	1.7	0.2	0.6	3.6	0.0	0.0	1.5	3.1	0.4	0.9	0.4	3.6	2.2	2.5	1.6	0.7	0.2	0.3	0.6	0.0	0.2	4.2	2.2	0.0	0.0	0.2	0.1	0.0	3.5	2.3	2.7	0.0	0.3	2.2	0.7	5.4	1.8	1.8	0.4	1.4	0.1	2.3	0.0	0.0	1.1	3.4	3.1	2.3	3.2	2.6	0.3	7.4	1.2	0.0	4.5	7.1	1.2	0.2	3.2	1.3	1.0	0.0	1.2	1.3	0.3	1.0	11.5	1.5	0.6	0.6	0.5	2.9	0.0	0.0	3.6	0.1	0.0	1.4	0.0	0.1	1.5	0.6	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	3.1	7.2	7.4	8.8	11.8	5.8	5.3	5.5	3.9	5.7	2.0
NXPE3	"FAM55C, MGC15606"	ENSG00000144815	"Neurexophilin and PC-esterase domain family member 3"	Q969Y0	3	101779202-101827392	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 44.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 37.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036259	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted - unknown location"	7600	7600	Vesicles	Vesicles	"HPA036259: AB_10671838"	"unprognostic (3.30e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.42e-5)"	"unprognostic (4.98e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.43e-1)"	"prognostic unfavourable (7.76e-6)"	"unprognostic (2.89e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.75e-3)"	6.1	4.7	7.2	7.6	16.6	7.8	5.3	6.1	16.2	6.3	5.2	29.5	6.0	2.4	7.9	2.6	4.5	8.2	4.8	12.6	9.8	5.9	3.0	2.5	6.9	10.7	24.0	8.6	5.5	2.6	15.8	6.9	4.7	22.0	6.2	3.4	3.4	4.2	7.5	44.6	2.5	4.9	7.6	9.4	8.7	4.6	5.1	17.2	6.6	5.3	4.1	9.8	7.3	5.0	8.9	11.6	15.9	13.6	6.7	19.5	11.1	7.7	11.8	10.2	3.7	11.0	11.6	2.2	8.6	10.9	10.3	15.1	2.7	0.8	11.4	25.5	9.7	1.7	11.3	9.2	12.9	14.1	3.6	8.7	7.5	7.3	14.6	7.4	8.2	6.6	1.6	8.6	3.1	11.1	1.8	37.3	17.1	4.0	9.8	1.8	5.8	7.3	4.5	12.4	4.8	7.6	1.9	8.1	9.6	3.7	0.9	6.4	1.7	10.6	9.6	11.5	13.7	1.3	8.9	17.7	17.6	13.4	9.8	32.8	2.2	6.3	13.6	15.9	12.7	10.4	8.8	8.9	14.2	13.2	11.6	5.8	19.5	15.5	6.9	6.7	9.9	7.4	16.3	11.1	7.2	16.6	6.1	16.2	9.8	5.9	24.0	8.6	22.0	17.2
OGDH	E1k	ENSG00000105953	"Oxoglutarate dehydrogenase"	Q02218	7	44606572-44709066	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 99.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019514, HPA020347"	Supported		Enhanced	Mitochondria		53000	53000	Mitochondria	Mitochondria	"HPA019514: AB_1854772, HPA020347: AB_1854773"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.30e-2)"	"prognostic favourable (2.22e-14)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.88e-3)"	18.9	20.8	12.3	14.5	18.5	8.7	11.0	14.3	23.7	10.1	19.4	15.9	13.5	29.0	16.2	11.1	19.5	11.1	11.8	73.9	11.3	12.8	28.8	14.8	13.0	11.1	14.2	11.7	9.8	13.0	25.5	11.0	14.5	22.2	12.3	13.3	22.3	23.7	15.9	99.3	15.6	35.5	16.4	10.1	12.1	14.9	11.3	11.0	11.3	17.8	39.8	15.8	13.0	10.8	7.2	13.4	7.5	20.4	11.2	25.7	11.6	10.8	22.8	13.7	20.8	21.2	23.3	13.4	17.0	16.6	19.4	16.9	20.8	22.5	47.8	20.2	24.7	33.8	27.0	25.4	18.9	27.9	7.1	14.5	46.2	10.2	10.8	17.9	16.3	21.6	19.3	27.4	19.7	26.2	16.7	14.3	20.4	15.3	17.7	10.3	12.6	25.8	17.0	9.6	53.7	22.2	32.4	23.4	11.2	24.6	34.1	10.6	20.2	18.0	20.6	14.0	12.6	24.2	19.6	13.0	24.9	26.4	25.3	20.3	25.3	4.8	12.1	7.3	11.7	17.7	12.8	7.2	13.5	11.7	13.4	5.9	5.8	7.0	7.5	11.2	20.4	6.6	25.7	11.6	12.3	18.5	14.3	23.7	11.3	12.8	14.2	11.7	22.2	11.0
OGFOD1	"FLJ10826, KIAA1612, TPA1"	ENSG00000087263	"2-oxoglutarate and iron dependent oxygenase domain containing 1"	Q8N543	16	56451490-56479100	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003215, HPA003722"	Approved	Approved	Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA003215: AB_1078881, HPA003722: "	"unprognostic (1.13e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.86e-2)"	"unprognostic (2.48e-3)"	"prognostic unfavourable (6.65e-4)"	"prognostic unfavourable (7.02e-4)"	"unprognostic (5.51e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.59e-2)"	"unprognostic (7.49e-2)"	"unprognostic (7.20e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.84e-2)"	8.8	13.4	10.0	8.0	11.6	3.3	9.4	10.3	14.3	10.8	7.0	12.4	6.0	7.4	9.5	8.4	18.1	10.1	7.8	12.9	7.7	11.1	12.9	13.9	7.5	7.5	9.1	10.4	10.2	6.5	13.7	13.1	8.3	15.6	8.0	8.9	8.5	8.4	10.0	56.1	8.8	5.8	15.1	11.1	8.6	7.4	8.2	6.2	10.6	9.3	12.6	13.0	9.6	8.3	7.8	7.5	11.8	8.9	8.7	12.1	6.5	11.1	13.2	13.0	16.1	14.7	17.8	12.2	18.2	14.7	25.9	18.8	16.1	8.2	20.4	9.3	14.5	16.1	27.5	12.4	29.3	6.3	14.8	14.8	11.5	16.5	11.3	16.0	17.5	11.8	14.1	19.2	16.0	21.0	20.6	3.9	21.8	7.2	12.7	9.2	22.0	22.8	23.8	19.9	23.8	11.6	8.0	10.4	11.6	22.5	14.6	12.2	13.3	13.3	13.6	14.4	11.5	11.1	16.0	8.0	15.5	30.1	11.5	11.6	11.4	11.8	4.7	4.8	8.8	6.3	11.9	7.8	11.2	10.4	7.1	6.1	12.1	10.0	1.7	8.7	8.9	7.5	9.3	6.5	10.0	11.6	10.3	14.3	7.7	11.1	9.1	10.4	15.6	6.2
OR13C9		ENSG00000136839	"Olfactory receptor family 13 subfamily C member 9"	Q8NGT0	9	104617248-104618204	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"pituitary gland: 1.2;skeletal muscle: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0			0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	1.2	0.0		0.0	0.0		0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR13J1		ENSG00000168828	"Olfactory receptor family 13 subfamily J member 1"	Q8NGT2	9	35869263-35870601	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 2.2;skeletal muscle: 1.4"	"Cell line enriched"	"Detected in single"	4	"AN3-CA: 2.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (6.58e-2)"			"unprognostic (2.89e-2)"	"unprognostic (1.82e-1)"			"unprognostic (2.49e-1)"		"unprognostic (9.58e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.68e-1)"		"unprognostic (4.07e-1)"		0.1	0.2	1.2	0.2	1.6	0.0	0.0	0.9	2.2	0.0	0.1			0.4	0.1	0.0	0.4	0.1	0.2	0.6	1.7	0.8	0.1	0.1	0.0	0.2	0.6		0.4	0.0	0.0	0.4	0.1		0.3	0.1		1.1	0.0	1.4	0.5	0.0	0.0	0.8	0.0	0.2	0.2			0.2		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR2K2	"HSHTPCRH06, HTPCRH06, OR2AR1P"	ENSG00000171133	"Olfactory receptor family 2 subfamily K member 2"	Q8NGT1	9	111327483-111330183	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 3.2;skeletal muscle: 1.6;testis: 1.7"	"Cell line enhanced"	"Detected in some"		"HSkMC: 1.7;Karpas-707: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA024261	Uncertain									"HPA024261: AB_1854786"					"unprognostic (1.03e-1)"													0.0	0.2	0.3	0.0	0.4	0.4	0.4	0.0	0.4	0.0	0.0			0.0	0.0	0.0	0.2	0.1	0.0	0.9	0.9	0.8	0.0	0.0	0.0	0.1	1.8		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.2	1.6	0.7	0.0	0.2	3.2	0.0	0.0	1.7			0.0		0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.5	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.3	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR2S2		ENSG00000278889	"Olfactory receptor family 2 subfamily S member 2 (gene/pseudogene)"	Q9NQN1	9	35957108-35958154	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"skeletal muscle: 1.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.3;BJ: 1.3;BJ hTERT+: 1.9;fHDF/TERT166: 1.2;HeLa: 1.2;HHSteC: 1.6;U-138 MG: 2.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Region enriched"	"Detected in single"	9	"cerebellum: 0.6"																													0.1	0.0		0.0		0.0	0.4		0.0	0.0	0.3			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.8	0.0			0.0	0.0	0.0		0.0		0.0	0.2		0.0	0.0	1.0	0.0	0.0	0.4		0.0	0.0	0.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR5H2		ENSG00000197938	"Olfactory receptor family 5 subfamily H member 2"	Q8NGV7	3	98282888-98283832	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"skeletal muscle: 1.2"	"Cell line enhanced"	"Detected in single"		"HL-60: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0			0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.5		0.0	0.0		0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.1		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR5K2		ENSG00000231861	"Olfactory receptor family 5 subfamily K member 2"	Q8NHB8	3	98497604-98498663	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"skeletal muscle: 4.3"	"Cell line enhanced"	"Detected in some"		"HEL: 1.3;THP-1: 2.9;U-266/70: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.61e-2)"	"unprognostic (1.21e-2)"			"unprognostic (8.45e-3)"	"unprognostic (1.69e-3)"		"unprognostic (6.47e-3)"			"unprognostic (7.17e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.77e-2)"	"unprognostic (5.93e-2)"	0.4	0.4	0.0	0.6	1.3	0.0	0.4	2.3	0.8	0.9	1.4			0.2	1.2	0.0	0.6	0.1	0.4	0.9	0.0	0.0	0.4	0.0	1.4	1.2	0.0		1.4	0.0	0.0	0.0	0.1		0.5	0.0		0.6	0.0	4.3	1.5	1.3	0.0	0.0	1.4	0.4	0.6			0.4		0.0	1.1	0.6	0.5	0.3	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.6	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.5	0.3	0.9	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0										
ORAI1	"CRACM1, FLJ14466, TMEM142A"	ENSG00000276045	"ORAI calcium release-activated calcium modulator 1"	Q96D31	12	121626550-121642677	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 26.0"	"Cell line enhanced"	"Detected in many"		"NB-4: 34.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016583, HPA061823"	Approved		Enhanced	Cytosol				Cytosol	Cytosol	"HPA016583: AB_1848720, HPA061823: AB_2684619"	"unprognostic (2.22e-2)"	"unprognostic (3.78e-3)"	"unprognostic (7.82e-3)"	"unprognostic (8.83e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.00e-2)"	"prognostic favourable (4.30e-4)"	"unprognostic (1.41e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-2)"	4.3	1.3	0.0	6.2	1.1	3.7	7.1	0.0	1.3	2.1	9.8	1.7	5.0	10.6	2.3	2.2	3.4	1.7	4.8	3.5	0.4		4.9	9.6	7.5	14.1	2.5	0.6	4.8	5.9	1.4	0.0	4.6	5.6	3.3	0.1	10.6	6.8	3.0	26.0	17.0	14.0	4.4	0.9	11.4	3.9	6.8	0.9	8.1	6.5	7.0	9.1	3.8	2.3	6.9	5.6	6.3	4.3	4.9	14.4	5.1	6.1	12.9	1.4	5.9	1.5	1.9	6.6	7.3	1.2	3.4	2.2	11.2	4.9	4.4	12.1	1.3	11.2	1.1	5.1	0.0	14.6	3.0	8.0	2.2	4.9	4.2	4.9	14.9	0.6	2.1	5.1	0.2	5.4	6.4	1.0	1.0	13.4	14.2	34.8	6.1	15.4	6.4	2.3	7.0	2.5	3.3	5.4	0.8	2.7	3.8	5.5	8.6	1.9	6.5	7.7	3.5	9.1	5.6	3.7	2.5	1.8	5.1	8.7	5.8	6.3	4.2	5.7	14.1	4.3	10.9	4.4	11.5	14.4	5.6	6.9	11.2	9.8	5.2	4.9	3.7	1.4	10.0	5.1										
OSBPL11	"FLJ13012, FLJ13164, ORP-11, ORP11"	ENSG00000144909	"Oxysterol binding protein like 11"	Q9BXB4	3	125528858-125595090	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 48.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039144			Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA039144: "	"unprognostic (1.14e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.73e-3)"	"unprognostic (6.38e-2)"	"unprognostic (6.56e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.25e-2)"	"unprognostic (9.84e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.13e-1)"	8.1	5.1	12.6	8.1	16.9	4.7	13.2	5.7	9.7	5.4	7.2	14.1	4.9	5.1	6.1	6.1	6.8	5.0	5.2	5.3	11.0	7.7	6.8	22.4	10.9	11.1	11.2	8.3	4.5	3.8	8.5	5.1	9.0	8.7	4.6	6.6	4.6	5.1	9.7	48.9	6.3	6.0	7.0	10.3	11.4	5.2	7.8	10.9	8.3	5.9	6.0	9.4	6.3	5.3	3.5	11.8	12.8	9.5	1.9	2.2	3.2	12.8	7.0	13.4	7.5	15.2	8.1	17.4	9.7	7.8	12.4	14.2	13.5	4.6	21.3	12.2	8.0	9.7	14.8	8.6	16.6	5.7	6.4	9.8	8.5	8.9	8.5	7.3	13.3	6.6	10.5	10.3	9.1	8.9	10.0	9.7	11.2	7.6	14.4	3.5	18.4	6.3	12.7	7.7	24.8	10.3	8.0	3.0	7.9	12.0	6.9	10.3	7.1	3.8	9.2	9.9	9.0	14.4	7.5	6.1	6.5	26.1	6.9	2.6	9.5	10.8	9.3	2.4	1.8	9.5	1.5	3.5	1.0	1.8	11.8	2.7	1.2	1.4	12.8	1.9	7.8	4.5	2.2	3.2	12.6	16.9	5.7	8.4	11.0	7.7	11.2	8.3	8.7	10.9
OSBPL1A	"ORP-1, ORP1, OSBPL1B"	ENSG00000141447	"Oxysterol binding protein like 1A"	Q9BXW6	18	24162044-24397880	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	18	"basophil: 33.7"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 33.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040959, HPA043401"	Supported		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA040959: AB_10964295, HPA043401: AB_10960208"	"unprognostic (1.75e-2)"	"unprognostic (3.35e-2)"	"unprognostic (9.84e-3)"	"unprognostic (4.92e-3)"	"unprognostic (2.34e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.53e-2)"	"prognostic favourable (4.98e-13)"	"prognostic unfavourable (1.86e-4)"	"unprognostic (2.18e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.56e-1)"	32.3	14.3	33.3	5.9	28.9	7.0	23.8	6.2	43.1	27.7	13.8	33.9	6.2	10.2	24.4	9.0	15.5	15.2	10.6	24.7	37.6	22.6	21.7	6.6	11.9	5.0	40.6	27.7	14.3	8.3	21.0	8.8	4.2	29.9	12.0	11.5	16.6	23.3	13.9	73.2	8.7	9.8	20.4	49.0	4.8	9.7	6.9	29.0	1.0	14.6	9.9	4.1	12.0	29.7	0.2	1.8	33.7	1.8	0.1	0.4	0.6	15.2	4.6	11.0	20.4	25.7	21.1	10.3	5.7	16.7	5.2	4.3	2.9	16.0	0.0	6.8	10.2	15.6	4.3	10.0	4.8	0.0	8.1	4.8	3.3	0.0	12.8	12.0	2.5	27.2	14.4	3.9	16.2	6.5	0.0	0.1	6.4	6.4	2.7	3.6	9.0	15.2	0.0	8.8	1.3	1.4	11.3	7.1	7.0	13.3	15.6	18.2	5.7	8.7	1.4	19.4	4.0	6.2	5.5	0.1	2.1	0.4	9.4	3.5	11.0	33.7	1.8	0.4	0.1	0.9	0.0	0.0	0.4	0.2	1.7	0.2	0.2	0.2	0.7	0.1	0.3	1.8	0.3	0.6	33.3	28.9	6.2	43.1	37.6	22.6	40.6	27.7	29.9	29.0
OSBPL6	ORP6	ENSG00000079156	"Oxysterol binding protein like 6"	Q9BZF3	2	178194481-178402891	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 33.4"	"Cell line enhanced"	"Detected in many"		"HEL: 24.5;hTERT-HME1: 26.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Group enriched"	"Detected in many"	8	"granulocytes: 2.2;T-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032131	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA032131: AB_10670963"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.95e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.15e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.73e-4)"	"unprognostic (4.44e-6)"	2.4	2.8	9.2	1.9	10.5	0.8	3.2	10.2	18.4	1.9	1.7	3.2	0.2	1.6	1.8	1.7	4.1	2.1	2.2	5.9	7.5	6.3	4.5	8.7	6.3	2.0	4.9	8.0	2.8	2.3	1.2	15.1	1.4	11.3	5.3	2.1	2.5	2.9	2.9	33.4	11.6	5.6	2.6	4.3	2.0	1.7	2.4	4.3	0.0	4.1	6.3	1.7	1.5	2.3	0.2	0.1	2.2	0.0	0.2	1.4	0.6	0.0	0.5	4.3	8.7	3.6	4.0	3.3	7.1	3.7	6.3	7.7	0.7	0.1	0.0	0.3	6.5	0.1	10.1	5.8	10.7	0.1	5.2	24.5	1.5	0.0	2.3	4.0	0.1	2.7	9.2	13.8	26.8	3.0	0.4	3.0	8.2	3.5	0.0	0.0	5.2	5.2	0.0	8.8	1.5	0.4	0.0	3.3	1.9	3.2	0.9	7.0	1.2	0.0	5.8	7.2	4.5	4.8	8.2	16.7	6.5	0.0	8.6	0.0	3.3	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.6	0.8	0.0	0.2	1.4	0.1	2.2	0.2	0.0	0.1	0.0	0.6	9.2	10.5	10.2	18.4	7.5	6.3	4.9	8.0	11.3	4.3
OTUD1	"DUBA7, OTDC1"	ENSG00000165312	"OTU deubiquitinase 1"	Q5VV17	10	23439458-23442390	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.8;tongue: 61.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 24.7;HaCaT: 23.3;SiHa: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038503, HPA038504"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"HPA038503: AB_2676049, HPA038504: AB_10672712"	"unprognostic (1.84e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (4.59e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.18e-3)"	"unprognostic (2.41e-1)"	"unprognostic (7.77e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.32e-1)"	"prognostic favourable (6.61e-7)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.43e-2)"	11.6	9.2	5.9	8.5	6.9	39.3	14.7	9.7	9.5	13.8	8.8	9.3	6.9	4.9	9.8	10.0	8.2	9.0	9.9	25.9	6.0	5.9	14.7	7.3	26.6	11.0	6.2	6.7	10.9	6.5	12.8	7.8	11.5	5.4	8.0	5.8	9.8	6.4	6.2	60.8	17.5	7.9	7.3	6.5	13.1	16.9	9.9	5.8	8.1	14.9	61.1	12.3	12.7	10.5	3.5	1.0	5.1	4.0	0.2	3.5	0.5	2.9	1.4	1.6	0.7	6.3	3.2	2.0	1.2	2.7	2.9	2.6	0.6	24.7	1.4	2.6	1.5	23.3	1.7	2.9	1.9	10.5	4.5	0.0	3.6	0.9	5.4	0.2	2.0	3.2	12.9	0.8	4.1	0.9	0.3	9.9	1.6	1.4	0.9	0.9	1.2	0.8	1.5	7.1	1.3	3.8	2.6	0.7	1.7	15.1	2.7	6.8	1.1	2.1	1.7	1.6	2.4	4.5	0.5	4.8	9.0	0.7	2.5	0.9	0.6	5.1	1.6	2.6	0.8	1.7	1.0	1.9	1.5	0.8	1.0	3.5	1.2	1.7	3.6	0.2	4.0	0.6	3.5	0.5	5.9	6.9	9.7	9.5	6.0	5.9	6.2	6.7	5.4	5.8
P2RX6	"MGC129625, P2RXL1, P2X6, P2XM"	ENSG00000099957	"Purinergic receptor P2X 6"	O15547	22	21009808-21028830	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"skeletal muscle: 12.4"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 8.2;RH-30: 5.1;U-87 MG: 14.6"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028776, HPA028777"	Approved		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"	"Nucleoli, Cytosol"	"HPA028776: AB_2672771, HPA028777: AB_2672772"	"unprognostic (1.81e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.79e-5)"	"unprognostic (1.70e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.88e-10)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.39e-3)"	0.2	1.6	0.0	0.2	0.2	0.0	0.0	0.9	3.2	0.0	0.0			0.0	0.1	0.0	0.1	0.3	1.1	1.9	0.2	0.8	0.1	0.0	0.2	0.0	0.6		0.3	0.0	0.0	1.6	1.1		0.2	0.0		0.1	1.1	12.4	0.0	0.0	0.0	0.8	2.3	0.1	1.2			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.8	0.3	0.1	0.0	1.0	0.1	2.0	0.8	1.5	0.0	0.0	0.0	1.4	0.5	1.7	0.0	0.1	0.1	0.3	0.0	2.2	0.8	0.0	3.6	0.0	3.0	0.4	0.0	1.5	0.1	0.0	2.4	0.7	8.2	0.0	0.0	0.4	0.0	0.0	0.0	5.1	0.2	0.0	0.0	0.2	3.8	1.5	0.1	0.7	0.0	0.0	0.0	2.6	0.5	0.0	0.0	0.3	0.0	0.0	14.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0										
P2RY2	P2U	ENSG00000175591	"Purinergic receptor P2Y2"	P41231	11	73218298-73236352	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.1;skeletal muscle: 29.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 16.1;HL-60: 15.2;MCF7: 12.1;NB-4: 12.4;PC-3: 12.6;SK-BR-3: 14.0;THP-1: 35.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 28.1"	"Group enriched"	"Detected in many"	12	"granulocytes: 28.1;monocytes: 10.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB022642	Uncertain		Uncertain	Cytosol				Cytosol	Cytosol	"CAB022642: "	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.97e-3)"	"unprognostic (6.50e-4)"	"unprognostic (2.04e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.93e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavourable (2.19e-5)"	"unprognostic (9.69e-2)"	"unprognostic (4.92e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.57e-3)"	0.4	2.3	0.9	1.4	1.2	10.8	1.3	0.3	1.1	5.5	3.1	1.1	0.3	2.2	1.3	2.3	20.0	1.2	2.8	11.7	0.6	0.3	0.9	2.6	2.9	1.5	1.2	0.6	1.7	1.7	6.1	1.1	10.3	1.0	1.7	2.4	3.3	4.0	1.6	29.5	3.4	10.8	0.4	0.4	6.6	0.6	0.7	0.6	0.6	20.2	20.6	12.8	2.1	10.9	0.0	1.6	28.1	10.4	0.0	0.0	1.2	3.5	3.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	8.2	2.8	0.0	5.5	0.2	16.1	0.4	7.5	0.0	0.0	0.3	1.2	0.2	1.5	0.0	15.2	0.0	0.0	3.5	1.2	0.2	0.7	0.6	0.0	0.0	12.1	0.0	12.4	0.2	12.6	0.0	0.0	0.5	1.2	8.6	0.0	0.0	0.2	14.0	0.0	6.5	35.6	5.2	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	2.7	0.0	0.2	3.4	28.1	0.0	10.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	1.2	0.9	1.2	0.3	1.1	0.6	0.3	1.2	0.6	1.0	0.6
PABPC4	"APP-1, iPABP"	ENSG00000090621	"Poly(A) binding protein cytoplasmic 4"	Q13310	1	39560816-39576790	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 137.3;skeletal muscle: 117.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027301, HPA056496"	Approved		Enhanced	Cytosol				Cytosol	Cytosol	"HPA027301: AB_2672208, HPA056496: AB_2683153"	"unprognostic (6.81e-2)"	"unprognostic (7.01e-3)"	"unprognostic (2.93e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavourable (1.14e-7)"	"unprognostic (2.22e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavourable (3.00e-10)"	"unprognostic (1.87e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.08e-1)"	30.0	19.2	9.0	23.0	7.9	20.8	19.6	7.2	9.6	19.1	26.0	14.0	22.0	12.4	22.2	21.1	20.3	13.7	20.2	32.0	8.6	7.2	12.3	28.8	24.9	38.2	8.3	7.3	28.6	137.3	9.1	8.2	16.2	8.6	20.7	11.5	15.4	16.4	22.9	117.8	12.9	21.1	22.4	16.4	27.5	28.0	29.2	6.4	21.5	18.1	51.1	21.0	25.3	20.3	13.9	13.7	6.7	21.2	8.2	21.4	5.5	56.9	15.5	16.5	27.4	41.3	82.1	54.3	33.7	23.7	26.2	19.5	31.0	29.9	49.2	33.5	42.3	30.5	31.4	37.6	33.9	25.1	25.9	41.5	17.7	30.9	41.5	27.4	27.9	71.2	44.6	31.8	48.5	32.8	43.9	27.3	42.0	22.2	28.4	35.4	51.1	17.8	21.8	52.9	37.3	25.3	56.3	15.6	23.7	23.5	22.5	51.0	23.9	81.3	29.6	25.5	35.4	61.7	42.5	70.4	77.2	38.3	37.8	27.8	14.5	6.7	13.9	3.5	9.9	18.0	10.6	13.8	16.1	10.3	13.7	13.9	21.4	15.1	1.4	8.2	21.2	13.5	11.2	5.5	9.0	7.9	7.2	9.6	8.6	7.2	8.3	7.3	8.6	6.4
PACS2	"KIAA0602, PACS1L"	ENSG00000179364	"Phosphofurin acidic cluster sorting protein 2"	Q86VP3	14	105300563-105398147	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.7;skeletal muscle: 63.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077892			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA077892: AB_2686865"	"unprognostic (4.31e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavourable (3.11e-5)"	"unprognostic (1.18e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.90e-1)"	"prognostic favourable (2.95e-4)"	"unprognostic (1.49e-1)"	"prognostic favourable (1.56e-4)"	"unprognostic (2.08e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.30e-1)"	15.3	10.8	18.8	7.7	25.5	6.1	13.3	20.5	29.8	8.0	7.7	41.7	6.5	8.4	10.0	8.1	8.9	9.6	8.7	15.1	23.9	18.0	6.8	3.7	9.3	6.1	36.8	13.9	11.8	21.3	10.3	8.1	6.9	26.3	7.6	5.5	6.7	11.8	9.8	63.8	7.2	9.1	8.1	65.7	10.9	7.4	13.4	26.8	2.7	7.1	7.0	4.4	8.3	7.3	0.6	5.4	0.3	4.0	2.1	2.0	0.9	9.1	12.7	11.9	11.2	12.0	11.6	14.2	7.0	8.1	6.0	5.3	5.5	17.4	10.0	11.9	10.6	10.6	7.3	10.0	4.3	12.5	6.0	4.5	5.0	8.1	15.8	3.7	8.3	13.5	9.6	4.2	9.8	10.9	2.8	9.3	5.2	28.7	6.3	5.0	4.6	10.5	14.1	7.2	6.3	5.1	21.1	26.9	14.3	6.7	6.0	10.4	15.2	6.9	16.4	8.9	4.1	14.0	6.9	12.4	8.0	3.7	13.6	6.8	8.6	0.0	1.6	0.2	0.9	2.7	1.7	0.2	0.8	1.0	2.7	0.6	0.3	1.0	0.3	2.1	4.0	5.4	2.0	0.9	18.8	25.5	20.5	18.9	23.9	18.0	36.8	13.9	26.3	26.8
PADI2	"KIAA0994, PDI2"	ENSG00000117115	"Peptidyl arginine deiminase 2"	Q9Y2J8	1	17066761-17119435	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 76.7;skeletal muscle: 126.4"	"Cell line enhanced"	"Detected in some"		"A549: 6.8;RPTEC TERT1: 19.9;SK-BR-3: 30.4;T-47d: 8.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 15.1;neutrophil: 37.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 37.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047735	Enhanced									"HPA047735: AB_2680139"	"unprognostic (2.61e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.78e-3)"	"unprognostic (3.28e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.91e-3)"	2.1	1.4	16.2	5.0	25.1	10.9	19.2	3.3	25.6	2.7	41.4	76.7	1.3	1.6	1.4	1.3	3.8	2.3	1.8	1.1	21.9	15.6	5.5	1.3	2.2	1.4	36.8	13.6	1.1	1.7	1.3	1.5	1.6	45.6	2.3	43.4	4.6	21.1	1.8	126.4	2.8	3.6	3.9	69.6	4.2	2.1	1.3	26.0	0.0	1.2	14.8	1.6	2.1	0.7	0.0	4.2	37.2	5.1	0.0	0.0	1.7	0.0	6.8	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.1	2.9	0.1	0.9	0.3	0.9	0.2	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.0	0.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	2.2	0.3	0.8	0.9	0.0	0.0	0.0	0.2	19.9	0.0	1.2	0.1	0.0	30.4	0.0	8.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.4	5.1	15.1	0.0	0.3	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	37.2	0.0	0.1	0.1	0.0	1.7	16.2	25.1	3.3	22.0	21.9	15.6	36.8	13.6	45.6	26.0
PAIP2B	KIAA1155	ENSG00000124374	"Poly(A) binding protein interacting protein 2B"	Q9ULR5	2	71182739-71227083	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.9;pancreas: 47.8;skeletal muscle: 39.4"	"Cell line enhanced"	"Detected in many"		"RH-30: 9.1;RPMI-8226: 13.0;SCLC-21H: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA046784, HPA072371"	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA046784: AB_2679804, HPA072371: AB_2686514"	"unprognostic (8.70e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (8.17e-5)"	"unprognostic (4.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.51e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.76e-1)"	"prognostic favourable (6.96e-12)"	"unprognostic (1.63e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.61e-2)"	2.8	2.4	36.3	2.3	28.8	1.8	4.8	11.9	15.7	3.3	4.2	50.9	5.1	4.0	3.5	2.5	6.2	7.4	1.8	17.8	39.5	25.1	9.9	16.6	3.3	2.5	47.7	9.7	11.6	47.8	6.4	2.1	1.4	21.9	5.2	4.2	2.7	29.9	5.6	39.4	15.1	3.2	3.4	44.9	2.7	6.7	2.7	24.6	0.6	11.1	3.5	4.7	2.7	2.3	5.8	4.5	1.0	0.9	1.5	4.6	1.2	2.1	0.5	0.9	3.1	0.3	0.5	3.9	0.3	0.1	0.3	0.1	0.8	0.9	2.7	0.6	0.0	1.7	5.2	3.1	1.0	1.4	4.3	2.6	0.3	0.1	1.4	0.7	0.2	0.6	2.9	0.1	3.2	0.5	4.5	2.6	0.1	2.6	0.8	1.4	2.3	2.0	0.0	9.1	13.0	1.6	1.4	20.2	1.2	2.2	1.5	0.9	6.5	0.1	0.1	0.2	1.7	1.7	0.9	5.3	4.4	3.3	0.2	1.0	0.5	1.0	0.7	1.0	2.0	0.9	2.6	4.9	2.8	2.0	0.8	5.8	4.6	4.0	0.5	1.5	0.8	4.5	1.1	1.2	36.3	28.8	11.9	15.7	39.5	25.1	47.7	9.7	21.9	24.6
PALMD	"C1orf11, FLJ20271, PALML"	ENSG00000099260	Palmdelphin	Q9NP74	1	99645943-99694541	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 84.9;skeletal muscle: 106.9"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 42.5;LHCN-M2: 13.7;TIME: 59.6;U-87 MG: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017959, HPA030549"	Supported		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"				"Actin filaments"	"Actin filaments"	"HPA017959: AB_1854949, HPA030549: AB_2673518"	"unprognostic (1.48e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.05e-2)"	"prognostic favourable (9.42e-4)"	"unprognostic (7.67e-2)"	"prognostic favourable (5.90e-5)"	"unprognostic (1.54e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.32e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.70e-1)"	"unprognostic (8.08e-2)"	84.9	18.6	8.3	6.2	4.3	0.0	46.4	1.1	3.7	17.1	6.5	3.9	4.0	1.3	18.6	10.1	16.2	8.7	5.3	59.0	5.6	3.4	5.1	20.9	10.6	3.4	3.9	3.8	17.4	2.2	4.4	4.7	16.8	19.0	8.1	2.6	7.9	34.0	4.4	106.9	18.0	3.5	12.2	4.1	2.3	2.8	7.5	2.2	2.1	3.4	48.2	6.2	6.9	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.7	2.9	0.0	0.1	0.0	0.0	0.0	0.0	5.5	7.1	0.0	0.0	0.0	1.1	0.5	0.0	0.0	42.5	6.0	0.0	13.7	0.1	0.0	0.0	0.0	1.8	0.0	10.6	0.0	0.0	2.2	0.2	0.1	0.0	2.7	0.0	0.6	0.0	59.6	0.0	0.1	4.6	0.0	0.0	0.0	0.0	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	4.3	1.1	3.7	5.6	3.4	3.9	3.8	19.0	2.2
PAM16	"Magmas, Tim16, TIMM16"	ENSG00000217930	"Presequence translocase associated motor 16"	Q9Y3D7	16	4331549-4355607	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 54.5"	"Cell line enhanced"	"Detected in all"		"U-2197: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA062721			Approved	Nucleoplasm,Microtubules,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA062721: AB_2684849"	"unprognostic (2.69e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.06e-1)"	"unprognostic (6.81e-2)"	"unprognostic (6.98e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavourable (5.73e-5)"	"unprognostic (7.25e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.56e-1)"	"prognostic favourable (1.33e-4)"	10.9	15.2	12.9	8.4	14.1	17.0	10.0	9.3	15.1	7.0	9.5	5.6	8.2	14.0	7.8	11.8	11.2	7.5	7.5	19.9	11.1	10.7	9.2	33.7	9.8	10.9	9.8	11.3	8.5	26.1	7.1	10.3	8.0	9.2	8.8	8.0	7.8	13.2	11.0	54.5	12.6	10.1	8.2	8.3	9.5	10.1	16.2	7.3	7.3	12.0	17.8	9.6	8.4	9.9	16.0	19.8	11.2	15.3	11.5	14.3	12.3	3.8	7.6	4.1	10.1	2.8	3.9	10.7	9.3	2.3	3.5	2.8	5.3	5.8	11.4	10.5	2.8	8.0	3.8	4.1	1.6	11.0	25.0	11.9	7.1	3.7	4.5	8.3	8.9	5.7	5.4	4.3	4.6	2.8	13.9	5.4	2.9	10.5	7.5	14.5	6.7	17.0	14.3	3.5	10.9	3.7	3.8	15.8	12.2	8.1	6.9	9.5	9.1	10.0	3.5	7.1	9.1	35.9	10.2	8.1	8.7	14.1	2.6	8.1	6.8	0.2	15.3	2.3	12.3	9.5	10.5	16.0	11.2	11.3	10.7	15.5	14.3	13.7	11.2	11.5	10.2	19.8	12.7	12.3	12.9	14.1	9.3	15.1	11.1	10.7	9.8	11.3	9.2	7.3
PANK4	FLJ10782	ENSG00000157881	"Pantothenate kinase 4"	Q9NVE7	1	2508533-2526628	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.1"	"Cell line enhanced"	"Detected in many"		"BJ: 8.9;HDLM-2: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011723, HPA012036, HPA027961"	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA011723: AB_2668522, HPA012036: AB_1854952, HPA027961: AB_10602042"	"unprognostic (1.23e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.92e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.29e-2)"	"prognostic favourable (1.57e-5)"	"unprognostic (1.22e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.15e-2)"	5.3	14.4	10.7	17.8	12.6	4.2	5.4	14.9	12.4	5.5	7.1	6.8	4.9	4.2	7.0	4.2	9.8	5.6	9.2	11.8	8.0	5.2	7.2	7.0	6.7	12.5	9.0	6.8	5.7	5.8	4.2	8.3	6.7	7.4	5.8	6.1	8.9	5.6	5.3	43.1	19.0	7.6	9.1	4.4	8.1	6.3	11.0	9.7	9.4	6.8	6.8	7.2	7.2	5.7	4.5	4.8	11.7	6.9	11.4	8.9	5.3	2.4	6.6	2.3	0.0	0.0	2.7	1.5	8.9	0.0	8.0	7.6	0.0	0.0	1.1	3.0	2.4	3.8	1.9	0.0	1.7	9.2	5.6	0.0	3.8	5.5	2.5	0.0	4.6	0.0	0.0	0.0	0.0	1.9	2.5	0.0	2.1	0.0	1.3	0.2	0.0	2.8	0.0	0.0	1.8	0.0	0.0	2.0	0.0	5.0	1.8	0.0	0.0	3.3	0.0	0.0	1.9	4.6	2.1	1.3	4.5	5.9	3.0	0.9	0.0	11.7	4.9	4.5	6.2	6.6	5.1	4.5	3.9	6.4	4.8	3.0	7.4	8.0	6.4	11.4	6.9	0.9	8.9	5.3	10.7	12.6	14.9	12.4	8.0	5.2	9.0	6.8	7.4	9.7
PARVB	CGI-56	ENSG00000188677	"Parvin beta"	Q9HBI1	22	43999211-44172949	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.1"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 43.7;RPMI-8226: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062601, HPA072217"	Enhanced		Approved	Cytosol		90000000	90000000	Cytosol	Cytosol	"HPA062601: AB_2684803, HPA072217: "	"unprognostic (2.41e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.10e-3)"	"unprognostic (7.65e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.28e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.87e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.19e-2)"	"unprognostic (7.05e-3)"	15.9	10.7	6.4	9.7	7.3	16.8	17.4	3.1	8.3	8.0	7.2	3.5	6.3	3.7	8.6	8.7	7.3	6.8	5.3	28.5	5.6	8.8	7.3	7.3	12.6	19.7	8.0	6.3	13.4	4.8	8.6	9.3	10.2	5.8	7.8	4.4	9.3	5.3	7.2	82.1	5.1	6.3	11.9	8.3	15.2	5.4	5.7	4.5	2.3	4.9	22.4	7.9	11.7	26.0	6.3	14.1	4.8	6.4	0.7	2.2	8.3	6.3	7.5	0.1	5.3	8.0	10.2	0.0	8.9	5.5	5.8	4.4	7.8	3.8	0.0	4.9	23.8	0.2	12.7	0.5	3.2	8.9	7.9	27.1	13.2	0.0	13.4	20.4	24.4	15.9	6.7	4.2	0.0	43.7	9.7	18.6	6.3	4.2	0.1	13.4	2.7	5.2	0.0	0.2	42.7	0.1	0.1	6.9	4.8	2.3	0.4	22.4	4.4	8.3	27.2	5.3	5.7	8.2	0.9	4.6	4.0	0.2	23.4	6.0	29.3	4.5	6.1	1.4	1.0	6.4	1.6	6.0	1.7	1.4	6.8	6.3	0.4	0.9	4.8	0.7	2.6	14.1	2.2	8.3	6.4	7.3	3.1	8.3	5.6	8.8	8.0	6.3	5.8	4.5
PAX7	Hup1	ENSG00000009709	"Paired box 7"	P23759	1	18631006-18748866	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 12.9;tongue: 12.0"	"Group enriched"	"Detected in some"	7	"A549: 3.4;CAPAN-2: 3.7;U-2 OS: 8.0"	"Group enriched"	"Detected in some"	6	"breast cancer: 0.5;cervical cancer: 1.5;lung cancer: 1.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	17	"midbrain: 5.5"	"Low region specificity"	"Detected in some"														"unprognostic (8.41e-4)"	"unprognostic (2.07e-1)"			"unprognostic (5.35e-2)"	"unprognostic (3.96e-2)"		"unprognostic (4.21e-1)"						"unprognostic (1.96e-1)"	"unprognostic (1.34e-1)"			0.4	0.1	0.6	0.0	0.6	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.1	0.0	2.3	0.5	0.1	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	2.4	0.0	3.4	0.3	0.0	0.0	0.1	0.1	12.9	0.0	0.1	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	12.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	3.4	0.8	0.8	2.4	0.0	3.4	0.0
PCBD2	"DCOH2, DCOHM"	ENSG00000132570	"Pterin-4 alpha-carbinolamine dehydratase 2"	Q9H0N5	5	134904906-135007959	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 47.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036428	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA036428: AB_10670103"	"unprognostic (3.70e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.22e-1)"	"unprognostic (6.43e-2)"	"unprognostic (4.49e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (4.57e-2)"	"unprognostic (6.34e-2)"	"unprognostic (9.32e-3)"	"unprognostic (1.50e-1)"	4.9	8.1	5.4	7.0	6.6	6.6	5.3	3.0	4.4	3.9	8.7	6.5	9.4	8.0	6.5	8.4	9.3	4.9	6.9	13.8	5.0	5.3	9.2	9.8	6.5	5.0	5.6	5.2	5.1	12.9	9.6	6.1	4.8	6.8	4.7	6.4	9.6	14.2	7.9	47.0	6.7	12.7	7.6	7.0	5.5	7.1	5.5	5.8	5.3	8.3	13.5	8.1	5.6	5.5	8.2	11.5	7.2	10.1	6.3	6.6	4.3	7.7	7.5	8.0	6.0	5.6	4.7	5.9	6.2	4.8	3.5	3.6	13.9	19.8	9.2	10.4	4.2	5.3	5.4	5.9	3.3	12.9	3.6	5.3	7.9	8.3	5.4	6.0	3.8	2.5	5.8	3.7	8.5	4.1	7.6	13.9	6.2	15.9	6.3	10.2	4.5	7.3	10.0	7.5	8.2	6.5	6.5	6.0	7.9	9.3	4.8	7.7	13.4	7.9	4.5	6.8	5.1	5.9	7.8	10.8	14.8	6.3	6.1	7.3	4.4	2.7	10.1	7.2	5.1	6.3	5.0	8.2	6.3	5.3	8.6	8.2	5.4	5.3	3.3	6.3	6.1	11.5	6.6	4.3	5.4	6.6	3.0	4.1	5.0	5.3	5.6	5.2	6.8	5.8
PCBP4	"LIP4, MCG10"	ENSG00000090097	"Poly(rC) binding protein 4"	P57723	3	51957454-51974016	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 97.5"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 48.5;SK-MEL-30: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	20	"B-cells: 4.6;granulocytes: 4.6;T-cells: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057754			Supported	Cytosol				Cytosol	Cytosol	"HPA057754: AB_2683517"	"unprognostic (7.17e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.94e-2)"	"unprognostic (4.97e-3)"	"unprognostic (4.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.13e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.72e-2)"	19.5	16.6	27.2	9.6	21.9	3.0	10.6	86.0	56.3	12.7	16.7	36.2	16.0	15.1	15.4	12.1	14.5	10.4	18.3	36.5	29.2	29.9	21.2	38.9	13.9	17.0	28.9	13.0	16.3	22.0	22.9	15.8	7.8	16.4	20.1	8.6	47.3	20.3	19.6	97.5	13.6	29.0	14.4	44.4	10.9	13.3	10.6	19.7	11.9	17.3	11.0	15.7	13.3	9.6	4.6	0.3	4.6	0.0	0.1	10.2	2.4	10.0	3.4	13.8	20.1	6.3	11.3	2.3	23.1	11.3	13.9	9.0	12.8	3.6	0.3	3.4	18.3	2.4	12.9	8.1	6.5	15.9	2.0	1.2	11.6	13.2	10.2	1.3	9.8	15.3	15.1	8.9	3.9	6.9	0.6	4.5	22.3	4.7	0.5	1.5	6.7	9.3	7.0	6.7	1.8	4.9	7.2	27.3	48.5	6.3	3.4	41.0	6.4	4.9	13.8	15.0	28.3	4.7	12.3	3.0	1.9	2.0	17.3	2.8	21.7	4.6	0.0	3.1	10.2	0.0	7.1	4.6	9.6	9.8	0.3	2.3	4.6	3.5	0.0	0.1	0.0	0.1	10.0	2.4	27.2	21.9	86.0	24.2	29.2	29.9	28.9	13.0	16.4	19.7
PCDHB1	PCDH-BETA1	ENSG00000171815	"Protocadherin beta 1"	Q9Y5F3	5	141051135-141059344	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"skeletal muscle: 4.9"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA053921	Uncertain									"HPA053921: AB_2682310"	"unprognostic (5.54e-2)"	"unprognostic (1.60e-2)"		"unprognostic (9.01e-4)"	"unprognostic (8.65e-2)"			"unprognostic (8.00e-2)"		"unprognostic (7.82e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.17e-5)"	"unprognostic (3.38e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.77e-4)"	0.1	0.3	0.3	0.1	0.5	1.0	0.1	0.1	0.2	0.5	0.5			0.4	0.1	0.6	0.1	1.8	0.0	0.1	0.4	0.4	0.7	0.1	0.2	0.4	0.2		0.1	1.1	0.7	1.9	0.0		0.1	0.0		0.5	0.0	4.9	0.8	0.5	0.0	0.3	0.3	0.8	1.8			0.3		0.0	0.1	0.1	1.3	0.7	2.5	0.6	1.0	0.6	0.2	0.8	0.4	0.7	1.1	0.2	0.2	1.1	1.1	0.2	0.1	0.1	1.6	1.4	1.1	1.6	0.3	1.5	0.0	0.1	0.2	0.9	1.2	1.1	1.9	0.7	0.1	1.4	1.2	0.2	0.3	0.2	0.2	0.2	0.8	2.6	0.2	1.4	0.7	0.9	1.2	0.4	1.2	1.0	0.8	0.1	1.0	2.2	0.7	0.1	1.8	1.3	0.6	0.5	1.2	1.0	0.7	0.8	0.6	1.5	0.6	1.0	1.1	1.0	1.2	2.3	0.6	0.7	0.5	0.4	0.5	0.7	0.5	0.4	0.2	1.3	0.6	0.5	2.5	1.0	0.4	0.7	0.3	0.2										
PDE4D	DPDE3	ENSG00000113448	"Phosphodiesterase 4D"	Q08499	5	58969038-60522120	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.0"	"Cell line enhanced"	"Detected in many"		"A549: 24.8;AN3-CA: 28.5;HeLa: 41.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 28.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045895	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA045895: AB_10960275"	"unprognostic (1.14e-1)"	"unprognostic (8.73e-3)"	"unprognostic (4.35e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.10e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.65e-1)"	"prognostic favourable (4.00e-5)"	"unprognostic (1.51e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.56e-2)"	8.2	1.9	4.4	6.8	8.6	46.2	5.3	4.2	13.0	13.5	18.6	1.4	14.7	4.1	17.1	14.0	10.3	6.6	12.7	15.5	4.5	5.8	12.8	3.4	11.1	3.7	5.2	6.6	5.3	2.9	7.0	9.0	11.8	2.7	18.2	11.2	8.6	24.4	16.5	60.0	5.1	7.5	35.8	5.0	3.8	10.2	2.6	2.8	4.4	6.2	11.3	9.5	20.0	11.2	6.1	0.7	28.1	1.1	0.1	0.8	0.5	0.0	24.8	5.2	28.5	0.9	1.8	4.1	0.6	0.7	1.4	2.0	9.7	0.8	1.9	0.1	0.2	4.2	0.0	1.1	2.4	1.1	2.8	3.6	41.0	2.1	3.8	1.7	0.2	3.8	0.9	3.9	0.7	2.9	0.0	0.6	2.4	1.7	1.3	4.0	0.9	1.3	0.4	6.5	4.1	6.5	9.3	0.9	3.3	6.5	11.0	5.6	0.8	3.7	3.4	0.3	0.1	4.9	1.3	1.4	0.0	0.2	4.2	6.8	1.1	2.0	1.1	28.1	0.8	0.0	0.8	6.1	0.7	0.3	0.7	6.1	0.5	0.4	1.5	0.1	0.1	0.0	0.4	0.5	4.4	8.6	4.2	13.0	4.5	5.8	5.2	6.6	2.7	2.8
PDE7A	HCP1	ENSG00000205268	"Phosphodiesterase 7A"	Q13946	8	65717510-65842322	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 87.5;skeletal muscle: 48.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 32.1;MOLT-4: 53.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018770, HPA027340"	Approved									"CAB018770: AB_677329, HPA027340: AB_1855127"	"unprognostic (2.76e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.11e-2)"	"prognostic unfavourable (5.64e-4)"	"unprognostic (1.44e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (1.35e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.03e-2)"	6.9	1.4	4.4	22.7	4.6	12.3	10.0	7.3	4.3	7.1	4.1	5.8	5.9	5.6	3.6	8.2	3.6	3.8	6.1	21.0	4.3	3.6	13.4	2.7	10.1	27.7	4.3	2.7	3.4	9.2	1.4	7.5	4.0	4.6	7.3	5.0	3.3	11.7	12.6	48.3	4.3	13.6	4.0	3.4	16.3	6.2	4.8	5.5	87.5	13.0	25.4	22.4	5.4	4.7	7.7	2.2	5.3	0.7	2.1	12.6	1.8	4.0	3.6	15.9	7.4	2.3	2.0	6.7	3.0	2.6	3.9	3.7	4.4	2.7	11.4	0.7	1.9	4.5	5.8	6.4	4.1	13.4	3.0	8.3	5.7	3.1	1.1	6.6	3.3	2.9	10.8	2.5	7.6	3.8	6.1	32.1	2.6	2.3	53.5	8.2	16.9	1.6	20.0	2.4	2.9	2.6	8.1	7.9	9.0	3.2	1.6	1.6	8.7	17.1	2.4	5.4	6.7	3.8	2.4	15.7	6.7	19.8	5.5	13.9	2.9	0.2	0.7	5.3	3.7	0.6	6.0	6.7	5.7	3.7	1.5	7.7	12.6	9.6	2.6	2.1	0.1	2.2	4.5	1.8	4.4	4.6	7.3	4.3	4.3	3.6	4.3	2.7	4.6	5.5
PDGFA	"PDGF-A, PDGF1"	ENSG00000197461	"Platelet derived growth factor subunit A"	P04085	7	497258-520296	"Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 63.1"	"Cell line enriched"	"Detected in many"	4	"WM-115: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005579	Approved		Approved	"Vesicles,Centriolar satellite"	"Secreted to blood"	300000	300000	"Vesicles, Centriolar satellite"	"Vesicles, Centriolar satellite"	"CAB005579: AB_2161916"	"unprognostic (2.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (1.75e-4)"	"prognostic unfavourable (1.78e-4)"	"unprognostic (2.63e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.87e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (8.67e-4)"	9.5	6.1	13.1	6.6	20.4	2.1	16.5	9.0	16.6	11.1	14.8	33.4	5.8	16.3	15.5	11.2	8.5	12.1	10.0	14.0	14.9	14.2	10.4	5.4	16.5	8.1	29.8	12.5	6.6	54.7	5.7	6.1	21.5	21.1	14.4	12.7	7.4	16.6	10.2	63.1	10.6	20.3	10.7	26.4	11.8	20.9	4.5	22.7	1.6	6.0	8.6	2.7	11.0	12.7	3.0	3.3	11.6	4.6	5.3	3.6	2.9	5.7	3.9	0.4	5.6	1.1	0.2	13.3	1.3	0.7	1.7	1.1	6.0	6.5	0.1	2.3	1.1	14.6	0.4	17.7	0.9	3.2	0.6	0.1	3.2	2.1	7.2	0.6	0.7	0.8	7.0	0.8	5.6	3.2	0.5	0.8	4.1	7.2	0.8	1.3	10.4	0.8	2.9	0.4	0.6	2.3	1.3	0.6	0.4	19.7	1.1	3.3	2.8	0.6	9.5	3.6	10.0	2.1	7.8	0.2	0.3	0.2	3.3	1.8	80.7	11.6	2.6	3.5	2.7	2.9	3.6	3.0	2.7	2.5	2.3	3.0	3.3	3.3	7.6	5.3	4.6	3.3	2.8	2.9	13.1	20.4	9.0	14.5	14.9	14.2	29.8	12.5	21.1	22.7
PDHA1	PDHA	ENSG00000131828	"Pyruvate dehydrogenase E1 alpha 1 subunit"	P08559	X	19343893-19361705	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 107.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047487, HPA047864, HPA063053"	Approved		Supported	Mitochondria	"Intracellular and membrane"	15000	15000	Mitochondria	Mitochondria	"HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931"	"unprognostic (5.71e-3)"	"unprognostic (2.46e-3)"	"unprognostic (5.71e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.90e-2)"	"unprognostic (8.68e-2)"	"prognostic favourable (1.13e-7)"	"unprognostic (3.72e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.06e-2)"	22.5	16.1	14.7	11.7	24.3	20.4	14.7	18.6	25.0	12.3	28.6	13.0	27.7	22.7	13.0	21.6	17.2	12.4	11.8	89.3	15.5	12.2	36.6	26.6	10.5	8.9	14.8	19.9	12.2	28.7	25.0	11.6	14.9	19.0	10.8	28.2	12.7	41.8	18.3	107.3	12.7	21.1	21.2	12.7	11.5	24.9	6.3	12.0	11.3	15.0	44.9	14.9	13.1	12.4	39.4	45.1	34.8	46.1	35.5	36.6	31.9	25.7	32.1	23.3	24.5	22.6	17.3	28.6	17.8	15.9	37.0	28.6	45.7	16.6	44.1	13.2	21.4	33.7	71.4	30.9	39.0	14.6	39.8	21.9	55.3	40.2	24.0	34.9	17.9	22.3	28.8	34.1	33.8	22.4	19.2	18.7	25.8	34.1	29.1	35.9	23.7	56.2	30.1	39.0	54.0	63.6	26.4	12.9	13.7	28.4	36.0	32.2	38.0	24.5	13.9	19.1	17.2	52.0	22.5	15.9	16.4	29.2	18.0	24.5	16.5	34.8	35.0	24.2	30.3	46.1	36.6	39.4	29.4	32.8	45.1	29.3	29.0	30.6	6.1	35.5	39.1	29.8	31.1	31.9	14.7	24.3	18.6	25.0	15.5	12.2	14.8	19.9	19.0	12.0
PDHX	"DLDBP, E3BP, OPDX, PDX1, proX"	ENSG00000110435	"Pyruvate dehydrogenase complex component X"	O00330	11	34915829-35020591	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 70.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038484, HPA038485"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"				"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"HPA038484: AB_10669645, HPA038485: AB_10669540"	"unprognostic (1.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.08e-1)"	"prognostic favourable (1.83e-5)"	"unprognostic (2.24e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.82e-1)"	13.5	14.9	13.4	8.6	17.2	4.2	10.4	13.9	23.3	9.2	13.3	10.6	9.3	12.2	8.9	8.6	10.9	6.7	7.7	46.1	14.4	12.8	15.0	25.7	7.8	6.8	14.7	14.1	7.7	13.1	14.6	14.7	15.8	22.1	12.0	12.7	8.9	12.4	14.1	70.5	8.8	12.3	11.5	12.0	6.6	13.7	15.7	9.0	5.9	9.1	19.0	8.7	13.0	10.7	12.8	19.5	12.1	21.7	15.0	14.9	9.8	9.1	23.9	13.8	5.5	10.2	12.0	13.5	17.0	13.9	19.3	18.7	30.8	8.4	12.5	11.2	14.4	17.7	26.7	14.3	19.2	11.2	22.4	11.8	25.2	35.4	22.0	22.2	13.9	12.3	17.8	10.5	14.4	13.9	25.2	11.6	15.1	15.5	13.7	13.7	11.3	14.3	12.1	24.7	10.9	28.8	24.0	14.6	10.6	15.0	22.7	23.3	25.5	13.7	9.6	14.4	16.2	14.7	18.8	11.1	21.9	15.5	11.2	11.0	14.5	8.6	13.6	12.1	11.5	15.0	10.8	12.8	10.9	9.4	19.5	11.7	13.3	9.6	2.8	15.0	21.7	5.2	14.9	9.8	13.4	17.2	13.9	23.3	14.4	12.8	14.7	14.1	22.1	9.0
PDK2	PDHK2	ENSG00000005882	"Pyruvate dehydrogenase kinase 2"	Q15119	17	50094737-50112152	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 101.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008287	Supported		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA008287: AB_1079589"	"unprognostic (2.74e-2)"	"prognostic favourable (5.87e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.63e-3)"	"unprognostic (9.80e-3)"	"unprognostic (8.39e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.21e-1)"	"prognostic favourable (9.59e-5)"	"unprognostic (3.81e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.33e-1)"	"unprognostic (1.55e-1)"	20.6	26.1	17.2	5.2	27.5	3.2	10.8	53.7	34.4	10.1	16.1	16.1	10.1	15.5	13.1	69.8	12.5	14.4	11.5	51.7	18.2	13.0	33.7	27.8	9.0	5.7	14.6	20.9	27.7	24.1	16.9	7.5	8.6	14.2	12.7	12.4	19.5	14.0	16.5	101.0	10.6	16.5	15.1	9.9	7.8	13.6	7.2	11.4	6.2	15.6	31.4	7.4	13.8	9.4	11.3	20.1	8.9	12.9	16.5	17.4	12.2	6.4	9.4	11.3	10.1	11.9	9.0	1.2	7.1	10.5	10.6	10.3	0.9	7.1	8.2	11.9	19.8	3.1	7.5	2.8	10.5	16.5	10.4	7.3	9.2	6.9	6.4	0.0	8.0	18.9	11.0	6.9	0.5	9.2	2.9	8.2	6.0	8.3	6.1	0.0	2.4	9.1	9.2	25.2	11.1	5.8	5.5	7.5	11.4	10.0	3.2	4.7	18.5	7.3	4.7	12.5	10.3	8.5	5.1	16.2	15.3	4.4	18.3	2.6	8.0	8.9	12.9	6.8	14.0	9.8	11.1	11.1	12.5	14.8	14.2	11.3	14.6	15.0	2.2	16.5	10.5	20.1	17.4	12.2	17.2	27.5	53.7	34.4	18.2	13.0	14.6	20.9	14.2	11.4
PDK4		ENSG00000004799	"Pyruvate dehydrogenase kinase 4"	Q16654	7	95583499-95596491	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 351.0;skeletal muscle: 497.0"	"Cell line enriched"	"Detected in some"	7	"ASC diff: 104.7"	"Cancer enhanced"	"Detected in all"		"renal cancer: 107.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"classical monocyte: 14.2;eosinophil: 15.6;intermediate monocyte: 26.1;myeloid DC: 7.1;non-classical monocyte: 15.6"	"Group enriched"	"Detected in many"	11	"dendritic cells: 7.1;granulocytes: 15.6;monocytes: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA056731	Approved									"HPA056731: AB_2683218"	"unprognostic (3.18e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.47e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.87e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavourable (1.80e-4)"	"unprognostic (9.15e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.12e-1)"	90.7	41.9	6.9	5.9	14.6	0.4	49.1	2.5	9.1	12.3	30.9	9.0	150.6	13.6	10.7	13.7	29.0	14.7	15.6	351.0	9.2	3.7	27.7	39.5	14.1	6.1	18.2	2.4	46.6	102.9	0.8	8.1	19.4	26.1	29.3	8.4	4.4	8.4	150.6	497.0	10.2	46.2	20.7	13.9	19.0	21.2	10.8	17.4	1.0	13.4	12.3	2.5	23.8	46.4	0.7	7.1	15.6	26.1	1.4	0.0	4.7	0.0	7.8	0.3	2.0	104.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.3	0.0	1.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.0	0.5	0.1	0.5	0.0	0.6	1.6	0.2	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	14.2	15.6	0.0	26.1	0.0	0.1	0.0	0.0	7.1	0.7	0.0	0.0	1.0	1.4	15.6	0.2	0.0	4.7	6.9	14.6	2.5	9.1	9.2	3.7	18.2	2.4	26.1	17.4
PDLIM5	"Enh, LIM"	ENSG00000163110	"PDZ and LIM domain 5"	Q96HC4	4	94451857-94668227	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 129.6;skeletal muscle: 173.0"	"Low cell line specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	8	"prostate cancer: 132.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"basophil: 51.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 51.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013511, HPA016740, HPA020026"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		2200000	2200000	"Nucleoplasm, Plasma membrane, Focal adhesion sites"	"Nucleoplasm, Plasma membrane, Focal adhesion sites"	"CAB013511: AB_2533388, HPA016740: AB_1855153, HPA020026: AB_1855154"	"unprognostic (6.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	11.6	4.8	6.2	4.2	6.1	8.7	9.8	3.4	5.8	12.7	11.0	3.7	7.1	5.6	37.5	12.9	14.0	10.2	11.0	129.6	5.3	5.2	12.9	13.9	5.6	5.3	5.4	4.5	10.3	8.1	3.4	6.8	18.9	10.2	15.3	5.4	12.6	15.3	12.5	173.0	5.6	15.8	22.1	4.9	7.0	5.6	5.5	3.7	1.0	5.3	52.9	9.5	17.7	7.1	3.2	5.6	51.1	12.2	2.7	3.9	3.8	8.6	25.7	10.0	3.9	22.1	15.2	3.9	21.2	17.6	12.2	9.8	23.7	19.3	3.4	21.7	21.2	9.0	13.6	19.8	20.4	6.1	5.7	12.7	16.8	8.9	31.9	4.1	11.4	20.4	17.5	29.1	22.7	27.3	5.4	3.8	25.8	8.5	4.2	1.4	3.4	10.8	2.0	7.4	3.1	13.6	27.8	5.0	6.7	11.5	26.5	5.9	3.1	1.3	34.2	31.8	5.0	13.7	12.8	2.6	3.4	3.5	17.3	3.0	7.4	51.1	6.8	5.9	3.8	11.8	3.1	3.2	3.7	3.9	5.6	2.5	2.5	3.2	6.8	2.7	12.2	1.9	3.4	3.8	6.2	6.1	3.4	3.9	5.3	5.2	5.4	4.5	10.2	3.7
PDLIM7	ENIGMA	ENSG00000196923	"PDZ and LIM domain 7"	Q9NR12	5	177483394-177497606	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 159.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 27.2;eosinophil: 20.5;neutrophil: 80.6"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 80.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018794, HPA048815"	Approved		Enhanced	"Actin filaments,Focal adhesion sites"		7600000	7600000	"Actin filaments, Focal adhesion sites"	"Actin filaments, Focal adhesion sites"	"HPA018794: AB_1855155, HPA048815: AB_2680530"	"unprognostic (7.70e-3)"	"unprognostic (3.75e-2)"	"unprognostic (9.27e-3)"	"prognostic unfavourable (5.45e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.18e-3)"	"prognostic unfavourable (4.07e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavourable (6.19e-10)"	"unprognostic (6.72e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.68e-2)"	12.4	5.6	3.7	21.1	9.3	12.5	8.3	0.5	5.9	54.6	76.0	3.2	42.6	9.0	85.0	35.8	33.9	35.5	52.3	11.1	3.8	5.0	8.3	2.4	11.6	8.9	3.5	5.8	28.2	3.1	2.1	10.3	11.5	5.6	42.0	7.6	17.6	9.1	61.7	159.6	5.3	16.5	129.5	3.1	12.7	27.0	11.7	2.4	3.7	5.4	24.9	6.5	67.8	19.6	1.8	4.8	80.6	8.4	0.4	1.4	3.9	24.8	4.9	23.7	18.7	6.4	11.8	24.1	47.6	26.0	27.1	19.5	9.6	22.5	4.5	49.2	29.1	12.0	3.9	32.3	6.3	6.2	5.7	14.6	16.3	9.0	17.6	7.8	49.3	25.7	5.4	21.7	10.4	16.2	10.8	3.2	19.6	19.2	1.4	17.2	16.4	21.4	29.0	21.2	2.8	18.1	5.1	3.6	7.8	18.6	3.5	9.1	5.1	7.0	58.3	32.7	35.5	12.4	43.4	0.8	0.9	5.3	15.5	8.4	7.4	27.2	8.4	20.5	0.9	3.9	1.1	1.8	0.6	1.4	4.8	1.0	0.6	0.7	80.6	0.4	4.9	0.3	1.2	3.9	3.7	9.3	0.5	5.9	3.8	5.0	3.5	5.8	5.6	2.4
PEBP4	"CORK1, hPEBP4, MGC22776"	ENSG00000134020	"Phosphatidylethanolamine binding protein 4"	Q96S96	8	22713251-23000000	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 85.8;skeletal muscle: 124.6"	"Cell line enriched"	"Detected in some"	6	"U-266/70: 9.3"	"Group enriched"	"Detected in many"	13	"lung cancer: 11.4;prostate cancer: 23.7;thyroid cancer: 35.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.7;neutrophil: 2.7;NK-cell: 2.6"	"Group enriched"	"Detected in many"	19	"B-cells: 2.7;granulocytes: 2.7;NK-cells: 2.6"									HPA025064	Uncertain				"Secreted in other tissues"	200000000	200000000			"HPA025064: AB_1855174"	"unprognostic (1.34e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.11e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.35e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.66e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.76e-3)"	"unprognostic (9.70e-8)"	"unprognostic (1.13e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.59e-1)"	2.7	0.9	2.2	0.2	4.9	0.2	0.9	1.0	1.9	0.3	0.2	2.4	0.8	0.1	0.3	85.8	1.6	0.5	0.6	43.8	2.2	5.1	0.6	0.7	31.8	0.3	10.8	0.8	0.4	7.4	0.4	4.7	0.2	7.8	10.4	0.2	18.9	12.3	0.8	124.6	0.3	0.2	0.2	1.0	0.2	1.7	1.4	2.5	0.0	22.3	16.6	2.3	0.2	0.0	2.7	0.1	2.7	0.0	2.6	0.1	0.0	0.0	0.0	0.1	0.1	0.5	0.7	0.1	0.0	0.7	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.9	0.1	0.2	0.0	0.0	1.4	0.1	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.3	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.4	0.0	0.0	2.7	2.6	0.0	0.1	0.0	0.0	2.2	4.9	1.0	1.9	2.2	5.1	10.8	0.8	7.8	2.5
PFKFB1	PFRX	ENSG00000158571	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1"	P16118	X	54932961-54998534	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 24.2;liver: 24.4;skeletal muscle: 48.3"	"Group enriched"	"Detected in some"	4	"ASC diff: 13.6;Hep G2: 5.4"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 7.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (2.51e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.33e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.88e-1)"	"unprognostic (5.36e-3)"	"unprognostic (5.06e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.96e-3)"	24.2	0.2	0.1	1.6	0.1	0.1	13.1	0.1	0.2	0.1	1.7	0.1	0.1	0.0	0.1	0.2	0.5	0.0	0.1	0.1	0.1	0.1	0.4	24.4	0.1	1.6	0.1	0.1	0.1	0.6	0.2	0.2	0.1	0.1	0.3	0.2	0.1	1.3	0.1	48.3	0.3	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	8.3	0.6	0.2	2.0	1.5	0.1	0.0	0.7	1.3	2.1	0.3	0.3	0.2	0.4	0.6	13.6	0.3	1.0	0.0	0.1	0.2	0.0	0.8	0.2	0.6	0.2	0.1	0.5	0.1	0.3	0.4	0.4	1.1	0.4	0.1	5.4	0.0	0.1	0.5	0.2	0.6	0.1	0.4	0.0	0.1	2.1	0.2	0.7	0.6	0.3	0.3	0.3	0.5	0.2	0.1	0.0	0.4	0.4	0.2	0.5	1.5	0.2	0.4	0.0	0.1	0.1	0.5	0.4	0.2	1.1	1.7	0.4	0.2	0.4	0.1	0.0	0.0	0.0	0.2	0.7	2.1	1.5	0.2	0.0	0.0	0.8	0.0	0.8	0.0	1.3	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1
PFKFB3		ENSG00000170525	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3"	Q16875	10	6144934-6254644	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 105.6;skeletal muscle: 135.7"	"Cell line enhanced"	"Detected in many"		"A549: 71.1;RPTEC TERT1: 44.9;T-47d: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 20.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008266, CAB020795, HPA043889"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB020795: , HPA008266: AB_1855239, HPA043889: AB_2678717"	"unprognostic (1.61e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.89e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavourable (1.87e-7)"	"unprognostic (1.89e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.74e-1)"	105.6	9.0	16.4	25.7	17.9	77.0	43.4	8.5	29.4	6.6	8.8	29.1	10.6	7.4	9.4	6.3	13.0	14.4	22.4	5.7	16.6	13.2	22.1	11.2	15.1	12.1	19.2	12.9	8.0	8.1	4.0	10.2	7.5	20.7	5.4	3.8	19.3	9.1	20.0	135.7	11.8	6.9	6.5	36.0	12.4	6.7	4.6	16.8	3.3	2.9	4.7	10.3	10.3	10.1	1.5	3.6	20.5	7.1	0.8	4.7	2.9	5.1	71.1	5.6	4.5	21.4	2.7	3.0	7.6	5.4	5.6	8.8	3.3	18.8	8.8	5.0	3.3	16.6	6.0	12.0	6.5	10.4	4.2	5.2	3.6	1.2	1.8	5.0	7.9	1.9	4.0	9.7	2.3	10.9	3.8	3.3	4.5	8.4	3.5	4.7	5.5	5.0	8.0	2.7	3.4	44.9	2.6	5.4	2.2	5.5	6.0	10.8	46.8	6.0	13.7	5.9	5.4	0.7	9.1	6.8	2.3	8.0	16.3	5.9	9.0	2.2	5.6	5.5	1.8	7.1	4.7	1.5	3.4	2.3	3.6	1.4	2.5	2.4	20.5	0.8	4.1	2.2	3.2	2.9	16.4	17.9	8.5	16.9	16.6	13.2	19.2	12.9	20.7	16.8
PGBD4	"FLJ32638, FLJ37497"	ENSG00000182405	"PiggyBac transposable element derived 4"	Q96DM1	15	34102073-34108684	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 18.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA040896, HPA059823"	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Nucleoplasm	"HPA040896: AB_10805831, HPA059823: AB_2684134"	"unprognostic (9.54e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-2)"	"unprognostic (7.43e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-2)"	"unprognostic (6.47e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.32e-3)"	"unprognostic (9.70e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.73e-2)"	2.5	3.6	3.9	4.1	8.5	6.7	3.4	5.3	11.1	2.6	2.8	4.8	4.7	3.2	2.6	3.9	3.8	4.6	2.4	4.0	5.4	3.6	3.4	5.3	2.4	5.2	6.0	6.1	3.0	4.6	4.9	6.7	2.5	12.7	3.0	3.4	3.2	3.3	2.6	18.6	4.4	5.1	2.2	4.0	6.0	4.5	7.9	5.8	4.5	3.3	2.0	4.2	3.2	2.7	2.8	1.7	6.4	1.4	1.6	2.6	0.6	2.0	3.6	2.5	4.1	7.4	4.9	1.6	3.1	3.0	2.0	2.5	2.5	2.7	4.2	2.6	2.4	5.6	1.5	3.6	2.5	4.3	3.8	6.7	6.9	1.8	3.1	2.3	6.1	3.8	4.1	2.6	4.7	2.2	4.6	5.0	4.1	1.4	3.8	5.5	1.0	2.7	5.6	3.5	2.1	2.6	4.3	3.7	3.4	1.6	3.6	1.1	3.5	3.6	2.6	6.1	3.5	3.2	2.1	5.9	3.8	2.3	5.4	5.3	3.6	6.4	1.4	1.5	1.3	1.2	1.1	1.5	1.7	1.3	0.8	2.8	2.6	2.4	3.2	1.6	0.9	1.7	1.3	0.6	3.9	8.5	5.3	11.1	5.4	3.6	6.0	6.1	12.7	5.8
PGP		ENSG00000184207	"Phosphoglycolate phosphatase"	A6NDG6	16	2211997-2214807	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 40.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043096, HPA046739"	Approved		Approved	"Nuclear bodies"		46000	46000	"Nuclear bodies"	"Nuclear bodies"	"HPA043096: AB_2678311, HPA046739: AB_2679779"	"unprognostic (8.33e-2)"	"unprognostic (4.77e-3)"	"unprognostic (2.36e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.76e-1)"	"unprognostic (5.75e-3)"	"unprognostic (5.87e-2)"	"unprognostic (7.90e-2)"	"unprognostic (4.43e-3)"	"unprognostic (6.50e-2)"	"unprognostic (9.04e-2)"	"prognostic favourable (7.05e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"prognostic favourable (6.42e-4)"	5.7	7.2	10.9	7.3	12.5	9.2	3.6	31.4	21.4	3.9	6.7	4.8	7.3	7.9	4.7	6.5	3.6	3.7	4.4	15.6	11.4	9.8	6.1	5.5	6.2	7.5	9.6	12.8	2.5	6.6	8.7	6.1	6.9	17.8	5.3	5.3	4.7	6.2	6.8	40.7	5.6	7.5	4.9	6.0	8.0	6.7	23.0	7.4	5.9	8.8	7.9	5.0	4.2	2.6	1.8	1.9	6.1	3.4	0.3	2.2	0.4	9.1	15.0	10.7	10.1	4.4	3.5	20.5	10.8	5.2	10.0	10.3	23.3	11.6	7.0	10.6	5.0	15.5	7.5	9.2	4.4	9.4	20.8	7.0	22.9	10.5	3.0	12.4	11.6	4.2	4.1	9.3	3.5	6.4	12.7	7.4	5.5	25.0	13.9	20.2	14.1	14.2	22.8	9.3	15.7	8.2	5.8	14.3	8.7	9.6	18.1	7.4	13.4	14.5	6.3	10.3	13.5	9.2	10.7	17.6	7.6	9.9	3.4	11.0	8.0	0.0	2.3	6.1	2.2	3.4	0.3	0.7	1.3	1.6	1.6	1.8	0.8	1.4	1.4	0.3	3.1	1.9	1.3	0.4	10.9	12.5	31.4	21.4	11.4	9.8	9.6	12.8	17.8	7.4
PHKA1	PHKA	ENSG00000067177	"Phosphorylase kinase regulatory subunit alpha 1"	P46020	X	72578814-72714319	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 57.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001081	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA001081: AB_1079607"	"unprognostic (3.68e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (6.84e-4)"	"unprognostic (3.52e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.76e-1)"	"unprognostic (9.45e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	2.7	10.3	3.8	1.9	7.2	0.7	3.4	3.2	3.5	2.2	2.1	2.0	7.8	1.0	2.7	4.7	4.8	2.8	2.6	5.5	3.0	3.0	2.1	1.8	1.6	1.0	4.2	1.6	5.8	4.2	16.9	14.2	1.8	4.7	4.3	2.5	6.5	6.8	5.1	57.4	2.5	1.3	3.4	3.1	2.3	3.7	3.5	2.7	0.8	6.5	12.6	2.8	3.1	3.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	8.6	12.1	0.7	7.2	4.3	4.1	7.6	1.6	1.5	0.3	0.1	3.5	7.7	0.0	4.8	0.2	3.4	14.4	5.9	0.4	22.0	14.6	4.0	9.9	3.2	4.5	0.0	0.0	5.5	6.0	1.4	9.9	8.4	6.1	0.0	7.9	6.2	6.1	0.4	9.6	16.3	0.0	0.0	0.0	2.1	4.1	7.6	9.0	7.7	10.1	0.1	3.6	0.3	4.3	0.0	3.7	1.5	4.1	10.1	9.3	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	7.2	3.2	2.9	3.0	3.0	4.2	1.6	4.7	2.7
PHTF2	DKFZp434D166	ENSG00000006576	"Putative homeodomain transcription factor 2"	Q8N3S3	7	77798792-77957503	"Predicted membrane proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 67.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"non-classical monocyte: 18.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012312	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA012312: AB_2668649"	"unprognostic (1.96e-1)"	"unprognostic (2.60e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.99e-3)"	"unprognostic (5.36e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (3.09e-7)"	"unprognostic (8.28e-3)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (2.78e-4)"	"unprognostic (5.53e-2)"	7.5	4.5	5.6	15.1	8.6	7.7	5.9	8.7	10.3	7.0	5.9	8.9	5.3	3.2	7.3	4.6	6.4	5.7	7.8	9.1	7.0	5.2	5.4	4.7	6.8	13.7	7.0	6.3	7.4	4.7	27.7	8.2	11.4	9.3	5.9	5.1	4.7	5.7	6.9	67.0	5.5	7.8	8.5	8.2	12.1	4.7	9.1	5.8	9.2	5.7	18.2	15.5	7.9	6.3	6.7	2.1	9.2	18.2	3.8	6.2	2.0	15.0	6.9	9.5	19.3	8.3	9.2	7.9	26.7	24.5	16.0	18.2	11.8	12.3	13.6	2.2	20.6	12.5	13.5	6.9	22.8	9.1	10.8	5.5	7.6	3.4	9.0	7.3	15.3	5.4	6.6	9.3	14.1	5.7	9.0	24.1	17.0	9.5	6.0	4.8	8.6	8.2	6.0	19.3	11.0	4.4	20.4	9.2	12.8	14.9	17.0	9.7	18.0	5.7	5.6	27.6	14.9	15.4	15.6	11.4	13.3	16.9	8.7	11.8	23.7	9.2	2.1	3.4	1.5	9.2	3.0	6.7	4.7	1.4	2.1	4.2	1.4	1.5	1.2	3.8	18.2	1.0	6.2	2.0	5.6	8.6	8.7	10.3	7.0	5.2	7.0	6.3	9.3	5.8
PHYH	"PAHX, PHYH1, RD"	ENSG00000107537	"Phytanoyl-CoA 2-hydroxylase"	O14832	10	13277796-13302412	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 128.3;skeletal muscle: 83.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 42.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007598, HPA011796"	Enhanced									"HPA007598: AB_1855334, HPA011796: AB_1855335"	"unprognostic (5.78e-2)"	"unprognostic (3.83e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.09e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.24e-1)"	"prognostic favourable (7.28e-12)"	"unprognostic (2.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.19e-1)"	10.5	16.8	5.3	5.3	6.2	1.4	7.7	5.1	8.7	6.0	10.7	5.4	5.7	11.4	5.4	5.6	6.8	3.6	8.5	38.0	4.0	4.9	36.4	128.3	6.4	3.2	6.5	3.7	7.6	9.9	6.8	6.7	4.5	5.3	6.2	7.4	7.1	6.3	5.4	83.8	3.8	15.5	10.2	4.4	3.0	8.5	4.1	4.1	1.9	13.0	29.5	3.6	7.6	9.4	9.2	13.3	10.7	16.0	3.3	15.4	10.2	6.1	12.8	5.8	8.3	42.1	26.9	4.6	6.3	8.8	7.2	7.2	3.3	11.2	0.3	4.9	10.5	2.9	7.5	7.4	4.5	14.8	4.0	5.3	3.6	13.0	20.9	0.9	10.0	19.1	10.7	7.8	3.1	6.9	3.0	11.9	16.7	5.7	3.2	4.2	5.3	4.7	5.7	9.0	2.0	15.0	7.9	2.0	6.3	23.6	0.5	11.5	24.0	15.9	2.3	11.1	4.1	13.6	4.2	13.7	9.2	1.2	14.4	6.8	4.3	10.7	16.0	6.5	7.2	11.7	15.4	9.2	9.1	9.2	13.3	4.9	11.5	11.7	0.6	3.3	9.0	12.2	8.6	10.2	5.3	6.2	5.1	8.7	4.0	4.9	6.5	3.7	5.3	4.1
PIN4	"EPVH, PAR14, PAR17"	ENSG00000102309	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 4"	Q9Y237	X	72181353-72302926	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 68.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054483, HPA064504"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA054483: AB_2682503, HPA064504: AB_2685274"	"unprognostic (2.47e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.14e-2)"	"prognostic favourable (6.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.92e-1)"	"prognostic favourable (2.58e-4)"	"unprognostic (3.34e-3)"	"prognostic favourable (2.66e-4)"	14.4	11.3	15.0	8.0	14.7	6.1	18.8	10.7	16.2	9.7	9.7	8.4	6.7	9.5	11.6	19.3	8.9	8.7	30.7	11.2	15.2	12.2	15.6	23.2	7.9	7.9	12.9	11.0	12.7	8.1	8.0	9.2	9.8	10.0	10.4	11.1	6.6	30.7	37.1	68.7	7.3	9.6	9.2	12.4	16.7	9.3	4.7	6.9	9.7	12.9	40.1	9.1	7.8	9.2	28.9	26.8	23.4	23.6	22.4	33.4	22.7	15.1	17.8	18.6	12.7	12.8	10.7	9.9	10.4	11.9	12.8	13.1	9.0	11.3	4.6	30.4	10.7	10.8	16.5	18.3	15.8	11.5	37.1	7.8	21.2	23.4	7.1	12.3	6.6	7.2	10.1	13.9	4.8	12.9	13.1	20.2	9.5	18.3	10.7	20.7	13.3	16.1	10.7	14.8	13.4	16.2	10.6	11.9	21.3	12.2	5.7	10.7	8.8	11.2	13.0	5.8	8.9	15.9	7.5	6.9	7.5	7.6	16.7	12.3	6.3	21.9	23.3	23.4	26.8	23.6	26.4	28.9	28.3	25.5	22.8	26.4	29.3	29.4	9.7	22.4	21.8	26.8	33.4	22.7	15.0	14.7	10.7	16.2	15.2	12.2	12.9	11.0	10.0	6.9
PINK1	PARK6	ENSG00000158828	"PTEN induced putative kinase 1"	Q9BXM7	1	20633455-20651511	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 142.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 10.7;monocytes: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001931, CAB026191"	Uncertain									"CAB026191: , HPA001931: AB_1079620"	"unprognostic (3.73e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.06e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.54e-1)"	"prognostic favourable (1.11e-16)"	"unprognostic (2.68e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.08e-1)"	17.9	35.9	38.9	6.7	38.0	6.0	10.1	16.8	45.0	9.8	13.0	17.8	10.0	15.2	9.3	9.8	20.7	10.7	11.4	51.4	31.0	28.7	20.2	26.1	10.0	5.1	39.5	27.1	11.6	24.3	16.3	7.1	13.9	31.0	12.4	7.7	10.6	23.9	15.4	142.0	10.8	12.7	10.8	30.2	8.3	10.5	27.2	16.8	3.3	16.0	21.5	4.6	12.7	9.5	1.2	1.4	10.7	4.4	0.7	1.7	0.8	17.9	8.2	3.8	11.0	13.4	12.7	4.0	25.2	25.4	12.3	21.4	2.8	14.6	4.2	20.0	25.7	8.3	5.6	13.4	6.1	5.0	21.2	2.1	22.9	4.4	10.4	2.2	6.7	11.9	14.5	15.3	5.3	7.9	5.1	5.4	8.8	7.6	3.2	5.1	1.7	27.0	2.8	6.8	3.3	7.6	4.2	14.3	5.6	27.5	9.1	7.6	3.0	7.8	12.0	11.1	5.7	18.5	3.5	6.3	1.2	1.9	24.1	6.5	5.2	4.8	2.2	4.7	1.1	1.4	1.4	0.3	1.0	1.5	0.7	1.2	0.8	1.1	10.7	0.7	4.4	1.4	1.7	0.8	38.9	38.0	16.8	45.0	31.0	28.7	39.5	27.1	31.0	16.8
PIP4K2B	"PIP5K2B, PIP5KIIB, PIP5KIIbeta"	ENSG00000276293	"Phosphatidylinositol-5-phosphate 4-kinase type 2 beta"	P78356	17	38765689-38800126	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 23.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047875, HPA062220"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA047875: AB_2680197, HPA062220: AB_2684715"	"unprognostic (7.77e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (4.54e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.10e-3)"	"unprognostic (3.79e-1)"	"unprognostic (4.82e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.22e-1)"	"prognostic favourable (1.36e-4)"	"unprognostic (2.48e-1)"	5.1	6.5	12.4	3.3	12.9	1.1	5.0	8.8	17.4	6.8	2.7	7.0	4.2	2.2	7.2	5.9	3.5	7.4	3.6	7.1	9.6		4.1	2.2	5.0	4.2	5.4	13.3	13.3	3.0	5.1	2.7	5.4	7.5	5.1	3.2	4.1	3.8	6.5	23.6	5.8	2.3	7.3	4.7	5.1	2.5	2.8	6.5	2.0	4.7	2.2	4.5	3.7	5.9	3.3	3.1	2.4	2.4	3.4	5.0	3.7	5.9	13.1	21.8	22.7	19.1	15.2	4.5	11.1	12.4	14.1	11.5	8.8	5.9	15.2	7.0	19.0	12.8	14.4	9.2	13.6	10.5	9.3	13.2	8.5	13.0	8.7	15.1	8.1	13.3	11.3	11.0	8.1	11.6	11.5	7.2	15.1	4.5	13.8	11.0	12.2	6.1	15.0	21.6	8.3	10.3	7.4	12.2	17.7	11.2	4.6	11.3	14.4	14.3	12.3	11.9	7.9	10.2	9.6	9.5	11.9	6.9	14.1	11.9	10.7	1.6	2.4	0.8	4.8	2.2	5.0	3.1	4.1	4.6	3.1	3.3	4.7	4.2	2.4	3.4	1.8	3.0	3.9	3.7										
PITX2	"ARP1, Brx1, IGDS, IHG2, IRID2, Otlx2, RGS, RIEG, RIEG1, RS"	ENSG00000164093	"Paired like homeodomain 2"	Q99697	4	110617423-110642123	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 30.4;retina: 53.5;skeletal muscle: 28.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 17.7;HEK 293: 7.8;LHCN-M2: 18.2;RH-30: 15.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"hypothalamus: 2.1;midbrain: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 9.8"	"Region enhanced"	"Detected in single"		"hypothalamus: 5.1"	"HPA050074, HPA062728"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA050074: AB_2681005, HPA062728: AB_2684851"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.29e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.61e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.11e-15)"	"unprognostic (6.97e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.98e-2)"	"unprognostic (9.91e-2)"	0.6	0.1	0.0	18.6	0.0	0.1	0.3	0.0	0.1	1.1	3.0	0.0	0.3	0.1	0.1	1.3	2.7	0.2	1.1	3.5	0.0	2.1	0.3	0.1	0.1	0.1	1.1	0.0	0.1	0.5	0.1	12.5	30.4	0.0	8.3	0.3	53.5	9.3	0.2	28.8	0.9	3.4	15.9	0.0	0.1	0.5	0.3	0.0	0.0	0.1	16.8	0.4	19.4	5.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	1.8	0.0	0.7	1.8	1.5	2.9	0.6	0.3	2.0	1.5	17.7	0.0	0.0	3.8	3.6	0.3	0.1	0.0	1.1	0.0	7.8	0.0	1.4	0.0	6.6	0.0	3.7	2.0	0.1	0.3	0.0	0.0	0.4	0.0	18.2	0.5	1.9	0.0	0.3	0.3	0.0	15.3	0.0	0.3	2.4	0.0	0.0	1.4	2.4	0.2	0.1	0.0	0.0	2.4	5.8	0.0	2.9	0.0	0.1	0.7	1.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.1	0.0	0.0	0.0
PITX3	ASMD	ENSG00000107859	"Paired like homeodomain 3"	O75364	10	102230186-102241474	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 19.9;tongue: 13.7"	"Cell line enriched"	"Detected in some"	16	"RH-30: 25.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	18	"midbrain: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 0.3"	"Region enriched"	"Detected in single"	5	"midbrain: 13.2"												"unprognostic (8.13e-2)"	"unprognostic (4.07e-1)"		"unprognostic (5.15e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.06e-1)"		"unprognostic (6.04e-5)"	"unprognostic (6.30e-3)"	"unprognostic (2.02e-1)"	"unprognostic (6.36e-2)"		"unprognostic (2.67e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.76e-2)"	"unprognostic (6.76e-3)"	"unprognostic (4.13e-2)"	1.5	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	0.0	0.0	0.3	0.0	0.1	0.0	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.8	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.4	13.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	25.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	4.8	0.0	0.0	0.0
PLA2G4C	cPLA2-gamma	ENSG00000105499	"Phospholipase A2 group IVC"	Q9UP65	19	48047843-48110817	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.8;skeletal muscle: 45.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 8.0;HHSteC: 13.1;TIME: 18.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 7.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA043083	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA043083: AB_10795714"	"unprognostic (1.27e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.82e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.53e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.87e-1)"	"unprognostic (9.01e-2)"	4.0	11.7	8.9	4.2	23.2	0.4	3.0	12.9	14.5	3.4	3.5	23.4	2.0	5.1	6.8	5.2	3.6	4.3	4.6	18.5	10.0	10.0	4.4	3.8	5.9	7.2	31.8	8.5	2.0	4.1	14.8	4.6	4.1	16.9	5.7	2.9	5.4	3.1	6.7	45.0	4.9	6.7	8.1	18.6	8.1	2.4	2.4	17.1	0.7	3.3	7.5	4.3	4.9	2.1	5.4	2.0	0.0	7.9	1.5	0.8	2.0	0.6	1.1	0.0	0.3	5.1	3.0	0.1	1.3	8.0	1.2	3.4	0.0	2.1	0.0	1.7	3.2	0.2	0.0	0.2	1.9	0.8	0.1	0.0	0.3	1.1	13.1	0.0	1.7	0.6	0.3	0.5	5.3	5.0	0.0	7.2	1.9	2.0	0.0	0.1	0.1	0.1	0.1	1.8	0.6	2.4	0.3	0.7	0.1	1.4	2.5	6.2	0.7	1.8	18.3	2.2	0.7	2.5	0.9	0.4	1.3	0.2	1.6	0.0	4.3	0.0	3.2	0.0	0.2	7.9	0.6	5.4	0.8	0.0	2.0	1.6	0.0	0.0	0.0	1.5	2.0	1.4	0.2	2.0	8.9	23.2	12.9	14.5	10.0	10.0	31.8	8.5	16.9	17.1
PLCD3		ENSG00000161714	"Phospholipase C delta 3"	Q8N3E9	17	45108967-45133354	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 63.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025711, HPA053665"	Approved		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA025711: AB_1855320, HPA053665: AB_2732580"	"unprognostic (3.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.13e-3)"	"prognostic unfavourable (2.89e-6)"	"unprognostic (2.96e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.34e-3)"	"unprognostic (6.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"prognostic favourable (4.28e-4)"	"unprognostic (3.34e-3)"	5.7	12.0	10.1	4.8	16.5	2.4	6.6	12.2	12.9	5.0	24.9	14.0	2.8	2.9	6.3	6.4	8.9	5.8	9.4	13.1	11.6	6.6	3.6	1.2	4.5	1.7	13.9	11.4	9.9	2.7	1.5	3.0	5.7	19.5	5.8	13.7	10.3	4.7	5.7	63.6	9.9	2.8	12.9	15.0	2.0	17.9	5.4	14.6	0.0	2.3	20.1	2.8	17.5	10.5	1.3	0.9	2.9	1.5	1.3	0.9	0.5	9.0	22.8	1.7	3.3	2.5	5.4	11.5	5.0	11.2	4.6	4.4	5.6	16.7	0.3	18.1	11.7	20.9	2.6	21.5	1.8	4.5	8.6	0.3	24.0	7.1	12.9	0.5	1.3	5.8	8.7	4.3	5.7	2.8	1.9	0.7	4.9	14.3	1.4	2.1	2.0	22.5	3.2	3.8	0.6	14.7	18.2	0.4	3.0	5.4	9.1	4.9	19.3	1.0	5.7	2.9	16.0	3.8	5.8	0.8	1.0	0.7	4.7	0.6	2.3	2.3	1.5	2.4	0.9	1.5	0.6	1.0	0.7	0.6	0.5	1.3	0.9	0.8	2.9	1.3	0.3	0.9	0.6	0.5	10.1	16.5	12.2	11.5	11.6	6.6	13.9	11.4	19.5	14.6
PLEC	"EBS1, PCN, PLEC1, PLTN"	ENSG00000178209	Plectin	Q15149	8	143915147-143976734	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 144.9"	"Cell line enhanced"	"Detected in many"		"PC-3: 72.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003847, HPA025967, HPA029906"	Enhanced		Enhanced	"Intermediate filaments,Focal adhesion sites,Cytosol"		7100000	7100000	"Intermediate filaments, Cytosol"	"Intermediate filaments, Cytosol"	"CAB003847: AB_562198, HPA025967: AB_10601671, HPA029906: AB_10602279"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-3)"	"prognostic unfavourable (4.29e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavourable (5.33e-4)"	"unprognostic (1.72e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.85e-3)"	"unprognostic (5.48e-2)"	"prognostic unfavourable (7.98e-6)"	"unprognostic (2.30e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.58e-2)"	"unprognostic (5.58e-3)"	20.9	11.0	15.9	16.5	13.3	27.9	13.1	15.0	20.7	20.7	17.7	14.6	16.7	13.1	20.2	16.8	25.1	18.2	29.0	23.4	18.9	10.7	11.2	10.9	16.6	15.0	9.9	13.0	18.0	14.0	8.8	12.0	24.2	13.2	17.5	9.8	13.0	17.8	14.8	144.9	36.4	24.1	24.7	11.0	16.9	21.4	6.7	12.7	16.3	9.2	44.2	24.5	20.2	19.2	1.5	3.4	0.8	4.1	0.7	2.9	3.2	16.3	51.2	3.3	4.1	6.0	13.4	11.7	24.0	10.7	6.4	3.6	7.1	17.1	1.6	18.7	35.1	19.4	2.2	33.6	2.5	12.2	1.8	6.2	52.0	5.8	9.5	2.0	5.2	15.4	6.6	17.2	33.6	7.4	3.0	5.3	7.4	28.7	1.2	3.4	2.2	72.1	0.3	9.4	4.4	10.7	30.3	3.4	3.4	40.9	8.7	3.9	10.7	2.4	23.8	24.8	44.9	21.8	28.4	0.8	0.6	1.2	23.6	2.6	35.2	0.0	4.1	0.2	1.4	3.8	2.8	1.4	2.7	2.0	3.4	1.5	2.0	1.1	0.8	0.7	2.7	2.8	2.9	3.2	15.9	13.3	15.0	17.3	18.9	10.7	9.9	13.0	13.2	12.7
PLEKHF1	"APPD, MGC4090, PHAFIN1, ZFYVE15"	ENSG00000166289	"Pleckstrin homology and FYVE domain containing 1"	Q96S99	19	29665056-29675457	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 42.3;skeletal muscle: 48.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 22.2;SK-BR-3: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"NK-cells: 16.7;T-cells: 42.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA025925	Uncertain									"HPA025925: AB_1844958"	"unprognostic (5.01e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.43e-3)"	"unprognostic (2.57e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (1.54e-5)"	"unprognostic (1.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.65e-2)"	"prognostic favourable (4.54e-4)"	11.4	2.4	2.6	4.3	4.2	5.2	12.4	1.5	4.9	8.0	5.7	6.6	9.6	4.0	10.0	4.3	7.7	7.7	9.7	13.2	2.9	2.5	2.3	8.3	5.0	7.0	11.3	1.3	4.9	3.8	3.9	1.2	12.4	4.1	10.5	1.6	1.4	20.0	9.7	48.0	4.1	4.6	8.0	3.8	7.2	3.8	5.2	4.9	7.0	3.7	19.3	6.5	9.1	7.4	2.0	0.3	1.4	0.1	16.7	42.3	13.3	7.7	2.9	0.0	1.7	5.7	5.0	22.2	1.9	2.5	2.4	3.8	1.8	3.4	0.0	7.2	2.6	6.8	0.5	1.7	0.3	5.1	3.7	3.9	1.3	3.2	9.8	0.2	10.8	8.7	0.6	2.6	4.8	2.0	4.3	0.0	1.3	1.0	0.5	2.9	0.3	1.3	0.0	2.6	2.1	1.5	12.2	0.0	1.2	1.0	17.8	9.1	6.7	1.1	1.8	3.1	3.4	4.0	3.7	1.4	14.3	0.7	3.4	3.9	1.0	1.4	0.1	0.0	42.3	0.1	29.4	1.2	17.1	33.5	0.3	2.0	10.4	19.5	0.4	16.7	0.1	0.1	15.2	13.3	2.6	4.2	1.5	4.9	2.9	2.5	11.3	1.3	4.1	4.9
PLIN5	"LSDA5, LSDP5, MLDP, OXPAT"	ENSG00000214456	"Perilipin 5"	Q00G26	19	4522531-4535224	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.6;salivary gland: 40.3;skeletal muscle: 40.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.5;RT4: 5.0;SH-SY5Y: 4.7;T-47d: 10.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"neutrophil: 14.7"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 14.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA077050			Supported	"Vesicles,Lipid droplets"				"Vesicles, Lipid droplets"	"Vesicles, Lipid droplets"	"HPA077050: "	"prognostic favourable (7.68e-4)"	"unprognostic (1.01e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavourable (8.56e-4)"	"unprognostic (1.24e-2)"	"unprognostic (6.06e-3)"	"prognostic favourable (2.81e-4)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-1)"	"prognostic favourable (1.97e-4)"	"unprognostic (3.18e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"prognostic favourable (2.16e-4)"	20.9	1.7	8.0	2.9	5.2	3.9	6.5	4.2	5.8	1.8	3.3	2.0	10.5	1.6	1.6	5.5	1.9	3.1	1.9	12.0	7.8	1.4	5.8	44.6	2.8	1.5	3.4	2.6	25.8	30.1	0.5	6.2	0.6	3.7	4.5	0.9	3.4	40.3	4.6	40.8	1.7	1.3	1.5	1.7	1.8	11.5	1.4	4.2	0.0	2.2	6.0	1.1	3.7	5.7	0.6	0.4	14.7	0.5	0.8	0.4	0.1	0.5	0.3	1.1	3.8	2.8	0.1	5.5	0.2	0.2	0.2	0.1	0.4	1.0	0.3	1.2	0.2	0.4	0.0	0.0	0.0	0.5	0.4	0.3	1.4	1.7	0.6	0.4	0.9	0.7	0.0	0.0	0.1	0.3	1.2	0.5	0.3	0.9	0.3	0.9	0.7	0.5	0.3	0.2	3.4	0.3	5.0	0.7	4.7	0.5	0.8	0.0	10.4	0.7	1.0	0.6	0.5	0.5	0.3	0.6	0.2	0.2	0.5	1.1	0.2	1.5	0.5	0.8	0.3	0.4	0.2	0.3	0.2	0.2	0.1	0.6	0.3	0.4	14.7	0.8	0.3	0.4	0.2	0.1	8.0	5.2	4.2	5.8	7.8	1.4	3.4	2.6	3.7	4.2
PLPP7	"C9orf67, FLJ14662, MGC12921, NET39, PPAPDC3"	ENSG00000160539	"Phospholipid phosphatase 7 (inactive)"	Q8NBV4	9	131289459-131359022	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 29.0;skeletal muscle: 107.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 10.7;ASC diff: 11.3;ASC TERT1: 8.7;SCLC-21H: 11.1;SH-SY5Y: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070252	Uncertain		Approved	Nucleoplasm,Vesicles				Vesicles	Vesicles	"HPA070252: AB_2686242"	"unprognostic (2.19e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.71e-1)"	"unprognostic (8.78e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.85e-2)"	"unprognostic (9.72e-3)"	3.6	3.7	3.3	1.7	4.6	1.2	2.8	7.7	8.2	2.3	3.2	4.6	0.0	1.5	2.5	3.1	2.5	2.0	2.3	29.0	3.6	3.9	1.9	1.1	1.5	1.3	3.7	4.2	3.9	1.8	1.1	1.7	1.4	3.7	2.6	1.3	2.0	1.6	2.6	107.3	1.3	1.6	2.9	3.2	1.7	1.4	2.2	3.2	0.0	1.2	22.6	1.2	2.1	1.6	1.3	4.6	0.0	5.2	2.3	0.5	1.9	0.0	0.0	2.2	10.7	11.3	8.7	2.2	1.6	1.1	0.3	0.0	0.0	0.0	0.0	0.3	4.3	0.0	0.2	0.0	0.1	0.0	1.9	0.0	0.1	3.4	2.8	0.0	0.0	2.9	0.0	3.1	0.0	0.0	0.2	0.0	5.1	0.1	0.0	0.1	2.5	0.0	0.0	0.0	0.0	2.4	0.0	11.1	8.5	0.0	0.1	0.0	0.3	2.7	0.1	0.1	0.8	0.5	0.0	0.0	0.4	0.0	1.8	0.0	1.7	0.0	5.2	0.0	0.0	3.3	0.0	1.0	0.0	0.0	4.6	1.3	0.4	0.5	0.0	2.3	2.8	2.0	0.0	1.9	3.3	4.6	7.7	8.2	3.6	3.9	3.7	4.2	3.7	3.2
POLR2J3		ENSG00000285437	"RNA polymerase II subunit J3"		7	102562133-102572583	"Predicted intracellular proteins, RNA polymerase related proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"blood: 29.2;skeletal muscle: 14.6"	"Low cell line specificity"	"Detected in many"											"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA046970			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA046970: AB_2679882"																		0.5	2.3		1.9		5.5	1.3		5.7	0.0	3.9			2.0	2.7	3.7	1.7	0.0	0.5	0.0			2.9	2.7	0.5	1.9			1.3	0.3	0.0		0.5		0.5	2.0		0.0	0.6	14.6	2.0	1.6	0.0		2.1	1.6	1.2			0.5		1.1	0.5		22.4	26.8	29.2	25.2	16.5	23.5	14.4	14.2	1.8	20.3	18.1	1.0	4.2	7.7	20.0	0.7	4.4	1.2	6.7	11.3	6.6	10.0	3.4	8.7	2.7	4.7	13.1	0.8	3.1	15.1	25.6	19.9	2.8	25.3	14.9	4.6	5.9	2.3	1.7	5.8	13.1	38.5	1.8	7.2	35.9	11.2	6.1	0.5	16.9	18.3	19.0	5.7	18.1	9.8	14.5	15.8	15.9	14.0	6.1	14.6	6.3	27.2	12.3	23.8	16.1	17.3	25.5	39.9	15.2	17.8	16.3	26.8	19.9	29.2	17.7	18.0	16.1	22.4	23.5	20.0	17.9	20.2	20.4	19.5	21.1	16.5	25.2	26.8	21.8	14.4										
PPARGC1A	"PGC-1alpha, PGC1, PGC1A, PPARGC1"	ENSG00000109819	"PPARG coactivator 1 alpha"	Q9UBK2	4	23755041-23904089	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 49.5;liver: 49.7;skeletal muscle: 55.6"	"Cell line enriched"	"Detected in some"	7	"A-431: 42.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063136			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA063136: AB_2684948"	"unprognostic (1.08e-1)"	"unprognostic (7.47e-2)"	"unprognostic (6.85e-3)"	"unprognostic (2.28e-6)"	"unprognostic (5.00e-2)"	"unprognostic (1.15e-1)"	"prognostic favourable (3.35e-6)"	"unprognostic (3.04e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.77e-2)"	"unprognostic (4.58e-2)"	"prognostic favourable (1.49e-14)"	"unprognostic (3.62e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (5.80e-4)"	"unprognostic (3.07e-3)"	5.7	2.4	3.1	2.4	4.2	0.3	1.3	4.7	5.5	2.6	9.4	4.2	1.8	5.7	0.9	4.8	3.0	1.2	2.2	24.6	3.3	3.1	49.5	49.7	2.5	0.4	3.1	1.8	1.3	2.8	14.6	7.6	0.3	7.8	2.6	6.6	14.0	30.4	3.0	55.6	5.5	14.2	1.6	3.2	0.8	3.1	3.4	3.4	0.3	17.4	18.2	1.5	1.7	1.0	0.0	0.0	0.2	0.6	0.0	0.0	0.3	42.9	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	2.1	4.9	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	6.2	0.0	2.0	0.1	1.4	0.0	1.7	0.2	0.7	0.0	0.4	0.3	0.0	0.8	3.8	0.0	0.0	0.8	0.7	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.1	4.2	4.7	5.5	3.3	3.1	3.1	1.8	7.8	3.4
PPIAL4E		ENSG00000271567	"Peptidylprolyl isomerase A like 4E"	A0A075B759	1	144372875-144373659	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 3.4;bone marrow: 2.7;skeletal muscle: 1.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.1;HL-60: 1.3;NB-4: 1.4;SK-BR-3: 2.1;TIME: 2.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA058345	Uncertain									"HPA058345: AB_2683685"					"unprognostic (6.97e-2)"					"unprognostic (5.22e-2)"				"unprognostic (2.28e-1)"				0.0	0.4		0.0		2.7	0.0		0.0	0.0	0.0			0.6	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.1	0.0			0.0	0.7	0.0		0.0		0.0	0.0		0.0	0.0	1.8	1.1	0.4	0.0		0.0	0.0	0.0			0.0		0.0	0.0		1.7	0.6	1.9	2.0	3.4	2.9	0.6	0.6	0.5	0.5	0.1	0.0	0.0	0.4	0.2	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.0	2.0	0.1	0.6	0.3	0.0	0.6	0.4	0.2	0.0	0.2	0.0	0.0	2.0	1.0	2.9	0.5	1.9	1.3	1.6	1.3	0.5	1.7	0.5	0.5	1.9	3.4	1.5	0.6	0.8	0.6										
PPIAL4G		ENSG00000236334	"Peptidylprolyl isomerase A like 4G"	P0DN37	1	148479824-148483679	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 6.9;skeletal muscle: 6.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA058345	Uncertain									"HPA058345: AB_2683685"		"unprognostic (2.17e-3)"			"unprognostic (3.63e-1)"	"unprognostic (4.83e-1)"		"unprognostic (2.26e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.11e-1)"		"unprognostic (3.95e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.79e-1)"				0.2	0.1	1.3	0.7	1.8	1.3	0.3	6.9	1.2	0.1	0.2			0.5	0.4	1.0	0.3	0.1	0.3	0.2	0.9	1.1	0.1	0.2	0.2	1.1	0.5		0.4	0.0	0.1	0.3	0.1		0.2	0.3		0.4	0.0	6.8	0.8	0.7	0.0	0.4	2.7	0.5	0.5			0.4		0.3	0.0	0.0	2.2	0.6	2.4	0.8	2.4	3.2	0.2	0.8	1.1	0.5	1.7	0.2	0.3	1.3	0.3	0.3	0.1	0.1	1.3	0.9	1.2	0.8	0.3	1.0	0.1	0.2	0.2	0.5	0.6	1.2	2.4	1.0	0.1	1.5	1.1	0.2	1.8	0.1	0.3	0.2	0.7	1.8	0.0	0.9	0.8	2.5	1.1	0.3	0.6	0.3	0.8	0.3	1.3	0.7	0.9	1.0	0.7	0.4	1.1	1.3	0.8	0.9	0.9	1.4	0.7	1.4	1.2	1.0	0.7	1.0	0.9	2.2	0.4	1.0	3.2	0.4	2.4	0.9	1.5	1.7	0.3	2.2	1.6	2.8	2.4	2.4	0.8	0.6	0.5	0.2										
PPM1J	"DKFZp434P1514, FLJ35951, MGC19531, PP2Czeta, PPP2CZ"	ENSG00000155367	"Protein phosphatase, Mg2+/Mn2+ dependent 1J"	Q5JR12	1	112709994-112715477	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 30.9;skeletal muscle: 45.1;testis: 31.9"	"Cell line enhanced"	"Detected in many"		"T-47d: 20.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	9	"plasmacytoid DC: 30.9"	"Lineage enriched"	"Detected in many"	17	"dendritic cells: 30.9"	"Region enriched"	"Detected in some"	8	"olfactory region: 33.6"	"Low region specificity"	"Detected in all"			HPA046045	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA046045: AB_2679516"	"unprognostic (8.68e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.34e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.30e-3)"	"unprognostic (3.36e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.96e-4)"	0.8	2.3	6.4	0.9	4.8	0.8	1.9	7.8	6.8	0.9	0.7	2.1	1.6	0.7	1.4	14.8	3.0	2.4	1.3	5.4	4.3	4.8	1.2	0.7	0.7	2.4	3.7	4.4	1.3	3.8	2.4	1.1	0.8	3.9	1.4	0.7	1.5	2.3	2.3	45.1	13.3	0.6	1.3	1.6	1.3	0.7	31.9	0.7	1.4	1.6	5.3	1.9	1.6	1.5	0.4	30.9	0.0	1.7	0.0	0.0	0.3	2.7	0.1	1.5	1.7	0.8	1.6	1.2	0.3	0.7	0.3	1.0	1.2	0.8	0.4	0.5	0.8	5.0	1.1	4.6	0.4	0.0	2.7	0.8	0.2	0.1	1.0	0.0	0.2	1.8	3.1	0.9	4.8	2.1	1.0	0.0	1.2	2.8	0.0	0.0	1.7	2.3	0.1	0.2	0.0	2.8	0.1	0.8	0.2	0.6	4.5	1.3	20.0	0.0	1.2	0.3	2.9	0.0	0.2	0.1	0.0	0.0	2.4	0.6	2.7	0.0	0.1	0.0	0.0	0.6	0.0	0.3	0.0	0.0	3.2	0.4	0.0	0.0	0.0	0.0	1.7	30.9	0.0	0.3	6.4	4.8	7.8	6.8	4.3	4.8	3.7	4.4	3.9	0.7
PPM1N	FLJ40125	ENSG00000213889	"Protein phosphatase, Mg2+/Mn2+ dependent 1N (putative)"	Q8N819	19	45488777-45502510	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 43.7;skeletal muscle: 81.9"	"Cell line enhanced"	"Detected in many"		"RT4: 21.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"non-classical monocyte: 43.7"	"Lineage enriched"	"Detected in all"	10	"monocytes: 43.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043577			Supported	Vesicles				Vesicles	Vesicles	"HPA043577: "	"unprognostic (2.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.53e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.71e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.11e-16)"	"unprognostic (3.42e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.86e-3)"	1.7	0.9	5.4	1.2	4.5	1.3	1.9	0.7	4.1	1.3	1.7	0.1	0.7	0.6	1.5	1.0	2.2	0.8	1.0	0.9	3.3	2.3	1.2	1.5	1.5	1.6	2.6	2.2	0.8	0.5	1.3	1.4	2.4	2.7	2.3	1.0	10.6	1.5	1.4	81.9	2.4	1.4	2.6	3.4	15.7	1.7	2.9	3.5	2.5	0.9	0.0	2.4	4.0	1.9	1.9	4.3	2.3	43.7	1.1	2.9	1.9	1.9	5.1	0.9	3.9	4.5	6.1	11.2	1.4	2.3	0.4	1.7	1.3	12.0	8.1	2.4	1.3	5.7	2.3	1.7	0.7	7.9	3.3	6.4	2.0	1.5	1.1	0.5	13.7	2.5	2.6	2.3	1.3	0.7	7.3	7.3	0.8	1.4	2.2	3.5	3.1	1.1	1.4	1.1	2.3	2.5	21.8	4.4	5.2	0.7	8.4	6.3	2.8	1.9	1.1	6.4	3.9	3.1	1.0	1.2	3.2	1.6	4.7	1.7	5.5	1.7	1.6	1.0	2.2	7.2	2.0	1.9	1.4	2.2	4.3	1.3	1.6	2.9	2.3	1.1	43.7	0.8	1.5	1.9	5.4	4.5	0.7	4.1	3.3	2.3	2.6	2.2	2.7	3.5
PPP1R14C	"CPI17-like, KEPI, NY-BR-81"	ENSG00000198729	"Protein phosphatase 1 regulatory inhibitor subunit 14C"	Q8TAE6	6	150143076-150250357	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 50.0;skeletal muscle: 32.0;skin 1: 37.1;thyroid gland: 32.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 15.4;HBEC3-KT: 32.6;hTCEpi: 39.9;hTERT-HME1: 16.0;SK-BR-3: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (1.81e-3)"	"unprognostic (7.65e-2)"	"unprognostic (4.25e-3)"	"unprognostic (6.92e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.63e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.49e-3)"	"unprognostic (6.77e-2)"	0.3	0.4	4.2	1.9	7.7	0.3	3.7	1.3	12.8	4.5	6.8	0.8	0.0	5.7	1.0	0.7	8.0	9.0	0.3	50.0	4.7	3.7	5.3	0.3	6.7	0.4	2.7	7.6	0.2	0.5	4.7	0.8	13.9	7.7	0.9	5.0	0.1	1.5	0.3	32.0	37.1	1.2	0.7	1.3	0.3	0.7	3.5	1.0	0.0	32.4	8.8	3.2	0.4	8.3	0.0	0.0	0.0	0.2	0.0	1.2	0.1	10.2	0.0	4.5	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.5	1.4	0.2	3.1	2.0	15.4	2.3	32.6	0.0	0.0	13.8	0.1	0.0	0.0	0.0	0.0	0.4	0.0	39.9	0.0	16.0	0.0	8.6	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	13.7	0.5	2.4	0.0	0.2	14.5	0.8	0.0	0.7	0.0	0.0	7.9	12.5	3.5	0.0	0.0	0.0	5.5	6.0	0.7	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.9	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	4.2	7.7	1.3	12.8	4.7	3.7	2.7	7.6	7.7	1.0
PPP1R1A		ENSG00000135447	"Protein phosphatase 1 regulatory inhibitor subunit 1A"	Q13522	12	54575387-54588659	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 67.0;skeletal muscle: 227.2"	"Group enriched"	"Detected in some"	4	"ASC diff: 6.4;NTERA-2: 20.8;RPTEC TERT1: 22.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 17.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"memory B-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB007811, HPA041542"	Approved									"CAB007811: AB_598171, HPA041542: AB_2677542"	"unprognostic (6.39e-3)"	"unprognostic (2.61e-1)"	"unprognostic (4.61e-3)"	"prognostic unfavourable (2.36e-5)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.88e-3)"	"unprognostic (7.68e-3)"	"unprognostic (2.17e-1)"	"unprognostic (8.49e-3)"	"unprognostic (7.49e-2)"	67.0	2.1	9.9	1.6	33.2	1.3	51.8	2.2	8.2	1.6	4.0	2.9	0.5	2.2	1.7	1.8	4.3	1.6	1.9	34.6	6.6	3.7	35.4	27.5	1.3	1.4	6.4	4.8	3.3	5.6	3.9	0.1	1.2	4.8	2.9	1.8	0.1	3.1	2.3	227.2	1.3	2.4	2.3	2.7	1.3	4.7	1.7	7.8	0.0	1.4	16.6	1.4	1.4	4.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.8	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.8	0.0	0.0	0.0	0.1	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	33.2	2.2	8.2	6.6	3.7	6.4	4.8	4.8	7.8
PPP2R3A	"PPP2R3, PR130, PR72"	ENSG00000073711	"Protein phosphatase 2 regulatory subunit B''alpha"	Q06190	3	135965673-136147891	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 85.6"	"Cell line enhanced"	"Detected in many"		"A-431: 18.9;BJ hTERT+: 18.5;RPTEC TERT1: 24.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035829, HPA035830, HPA065338"	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA035829: AB_10696513, HPA035830: AB_10670121, HPA065338: AB_2685475"	"unprognostic (3.35e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavourable (4.38e-4)"	"unprognostic (1.71e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.44e-4)"	"unprognostic (9.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.70e-2)"	"prognostic unfavourable (1.14e-5)"	"unprognostic (8.92e-2)"	"prognostic favourable (1.15e-5)"	"unprognostic (4.55e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (3.91e-4)"	6.3	3.3	3.4	1.9	6.4	0.7	4.3	1.5	4.9	5.5	6.7	5.2	5.8	1.7	6.8	5.1	5.0	3.0	3.3	27.4	3.9	2.8	31.7	1.2	2.6	0.9	7.0	4.4	3.7	3.8	7.5	3.7	9.0	5.3	3.8	3.5	1.6	7.7	7.8	85.6	10.4	2.5	11.4	6.1	1.2	5.2	4.2	6.5	0.0	2.3	31.6	1.2	6.5	3.9	1.5	1.8	1.7	1.4	1.8	1.5	0.6	18.9	1.0	5.4	2.6	4.4	5.6	6.3	14.8	18.5	7.0	8.7	1.2	1.2	0.0	5.7	15.1	2.4	2.2	5.2	15.2	0.0	0.7	0.8	0.5	0.0	3.1	0.0	0.7	5.0	4.5	8.9	4.2	6.7	0.5	0.0	10.1	3.1	0.1	0.1	3.7	3.6	0.0	8.0	0.0	24.6	0.7	0.4	3.0	2.4	3.0	5.7	4.7	0.2	4.3	7.3	4.0	9.9	6.5	0.2	0.5	0.0	5.4	0.4	2.5	1.1	1.2	1.5	0.9	1.4	0.5	0.7	1.0	0.8	1.1	1.5	1.5	1.2	1.7	1.8	1.2	1.8	0.7	0.6	3.4	6.4	1.5	4.9	3.9	2.8	7.0	4.4	5.3	6.5
PPP2R3B	"PPP2R3L, PPP2R3LY, PR48, PR70"	ENSG00000167393	"Protein phosphatase 2 regulatory subunit B''beta"	Q9Y5P8	X	333963-386955	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 43.5"	"Cell line enhanced"	"Detected in many"		"PC-3: 15.2;U-698: 23.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.3"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA026606			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA026606: "	"unprognostic (1.25e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.79e-2)"	"prognostic favourable (2.92e-5)"	"unprognostic (4.65e-2)"	"unprognostic (2.29e-8)"	"unprognostic (1.15e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.17e-1)"	"prognostic favourable (1.90e-5)"	1.8	1.3	8.8	1.1	11.7	3.8	4.8	9.1	8.7	7.6	1.2	0.0	0.0	1.4	6.6	0.7	2.4	2.3	1.4	17.7	12.2	2.9	4.1	1.1	1.5	1.7	15.4	6.2	6.9	2.9	1.5	11.0	8.9	13.0	2.4	0.7	0.0	1.6	1.2	43.5	3.9	1.3	1.6	8.3	1.8	1.8	4.1	15.0	0.0	1.0	0.0	0.9	2.9	2.6	0.1	0.6	2.3	0.1	0.0	1.3	0.1	0.5	5.2	0.7	2.2	0.1	0.2	7.0	5.8	1.5	5.2	6.2	5.2	0.0	0.0	3.2	4.4	0.0	0.2	0.0	1.3	3.7	4.2	1.2	1.8	0.2	0.0	1.9	2.2	0.1	0.1	0.0	3.2	0.1	1.0	0.3	1.2	2.6	8.8	7.7	2.3	15.2	4.0	3.4	0.3	1.4	1.5	0.0	9.0	0.0	0.9	4.1	0.0	2.3	0.3	3.1	2.9	0.0	1.9	0.0	0.0	23.8	0.1	2.6	3.9	0.0	0.0	2.3	0.1	0.1	1.3	0.1	0.1	0.0	0.6	0.1	0.3	0.3	0.1	0.0	0.1	0.5	0.0	0.1	8.8	11.7	9.1	8.7	12.2	2.9	15.4	6.2	13.0	15.0
PPP3CB	"CALNA2, CALNB, CNA2, PP2Bbeta"	ENSG00000107758	"Protein phosphatase 3 catalytic subunit beta"	P16298	10	73436428-73496024	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 133.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008233, HPA008823"	Uncertain		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA008233: AB_1855661, HPA008823: AB_2668148"	"unprognostic (3.05e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.28e-2)"	"prognostic unfavourable (9.59e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.12e-2)"	"prognostic favourable (6.96e-5)"	"unprognostic (4.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.68e-2)"	17.3	16.1	40.0	11.7	36.3	7.6	22.5	44.5	42.7	13.4	16.1	7.9	9.5	10.1	17.0	15.0	14.0	12.3	12.0	16.7	39.7	20.5	11.9	9.1	9.8	13.1	18.2	40.7	17.2	10.5	19.3	16.8	10.6	21.1	16.8	12.8	9.5	10.4	17.6	133.0	10.9	9.4	23.0	18.1	10.0	10.7	11.6	11.9	8.4	10.1	10.0	14.3	14.1	14.4	4.2	5.7	4.8	3.8	4.5	10.6	2.7	19.1	10.6	19.0	19.6	27.3	37.9	9.1	17.6	24.2	17.3	17.2	6.7	9.9	17.0	5.7	25.4	10.3	15.3	13.5	24.4	23.8	12.6	7.3	9.6	12.7	16.4	16.0	15.1	26.8	16.3	16.3	22.0	11.9	9.0	20.1	34.8	6.0	14.3	14.9	7.7	31.0	9.6	10.3	8.0	16.8	9.3	10.2	11.8	10.3	25.9	12.9	19.4	15.5	13.0	13.8	12.7	11.0	23.8	13.4	36.6	11.9	17.1	23.1	7.8	3.2	2.9	4.8	6.2	3.8	7.3	4.2	6.7	6.6	3.0	3.0	5.3	7.9	1.7	4.5	2.3	5.7	10.6	2.7	40.0	36.3	44.5	42.7	39.7	20.5	18.2	40.7	21.1	11.9
PPTC7	TA-PP2C	ENSG00000196850	"PTC7 protein phosphatase homolog"	Q8NI37	12	110533245-110583320	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 53.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039335, HPA040614"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA039335: AB_10805474, HPA040614: AB_10795526"	"unprognostic (2.44e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (1.43e-5)"	"prognostic unfavourable (6.76e-4)"	"unprognostic (1.09e-1)"	"prognostic favourable (4.48e-5)"	"unprognostic (5.34e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.83e-1)"	10.4	15.3	6.5	10.3	9.6	26.2	10.3	8.3	12.9	9.7	11.8	5.7	4.9	7.5	9.3	4.6	12.6	7.8	8.8	35.3	9.0	9.0	12.6	11.9	13.1	10.9	10.4	6.8	8.9	7.5	13.0	12.7	6.9	15.3	7.7	9.8	8.0	12.9	8.2	53.8	13.4	11.7	13.1	7.4	9.4	8.4	8.2	6.5	16.1	8.0	15.5	13.1	12.4	12.4	2.1	1.4	6.1	1.7	1.7	2.4	0.6	12.0	6.9	5.9	6.2	14.8	13.1	8.5	5.6	7.4	6.1	6.2	7.8	4.8	21.2	5.8	5.4	11.8	11.9	12.9	12.4	15.4	9.8	18.8	7.4	8.4	14.1	20.7	15.5	11.2	21.3	8.6	25.5	11.6	13.9	6.1	9.9	3.1	18.3	17.8	8.4	12.9	15.3	8.0	12.9	25.4	13.6	9.6	7.5	10.5	14.6	12.3	6.9	11.1	13.2	5.6	6.0	17.1	9.3	17.6	19.4	23.7	9.5	11.5	11.0	0.1	1.7	1.3	2.3	1.5	2.4	1.3	1.9	1.8	1.3	2.1	2.2	1.9	6.1	1.7	1.1	1.4	1.3	0.6	6.5	9.6	8.3	12.9	9.0	9.0	10.4	6.8	15.3	6.5
PRADC1	"C2orf7, hPAP21, MGC13004, PAP21"	ENSG00000135617	"Protease associated domain containing 1"	Q9BSG0	2	73228006-73233238	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051066	Approved				"Secreted to blood"					"HPA051066: AB_2681333"	"unprognostic (2.94e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.93e-2)"	"unprognostic (8.54e-2)"	"unprognostic (9.08e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.09e-3)"	"unprognostic (9.99e-3)"	"unprognostic (3.56e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.23e-2)"	10.3	12.0	11.6	5.6	13.9	4.2	22.5	9.3	13.3	6.2	12.3	6.7	6.6	13.6	4.5	9.5	9.1	4.1	6.4	37.3	10.6	7.7	11.8	23.3	6.4	14.4	10.6	7.3	3.9	39.7	4.8	8.3	4.7	10.9	6.6	12.0	6.9	25.6	8.7	59.4	6.7	16.2	13.1	9.6	8.5	8.7	9.6	7.0	4.1	7.8	22.2	5.8	7.5	5.7	6.2	25.6	11.6	33.8	13.3	10.5	15.0	8.7	7.4	7.5	14.3	23.4	9.2	9.9	14.6	6.9	15.1	8.8	20.8	9.3	9.7	8.5	17.1	8.3	11.8	10.2	10.8	14.6	10.6	14.6	10.6	15.5	7.3	7.6	14.6	11.9	6.3	13.6	7.2	14.0	12.7	21.3	17.3	18.6	21.3	14.6	2.2	30.0	12.3	29.1	30.5	8.4	8.6	15.5	5.1	7.0	19.5	6.9	10.3	7.0	7.3	17.6	7.0	15.0	13.2	22.3	16.8	8.8	11.2	16.9	7.2	4.1	12.3	11.6	9.1	28.9	7.4	6.1	8.9	8.5	12.7	6.2	8.4	7.4	1.6	13.3	33.8	25.6	10.5	15.0	11.6	13.9	9.3	13.3	10.6	7.7	10.6	7.3	10.9	7.0
PRKAA2	"AMPK, AMPKa2, PRKAA"	ENSG00000162409	"Protein kinase AMP-activated catalytic subunit alpha 2"	P54646	1	56645322-56715335	"Enzymes, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 39.1;skeletal muscle: 40.2"	"Cell line enhanced"	"Detected in many"		"HEK 293: 8.5;RPTEC TERT1: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044540	Approved		Supported	"Nuclear speckles,Golgi apparatus"				"Nuclear speckles"	"Nuclear speckles"	"HPA044540: AB_2678977"	"unprognostic (4.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavourable (4.80e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.92e-3)"	"prognostic unfavourable (5.30e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.64e-2)"	"prognostic favourable (4.95e-5)"	"unprognostic (1.30e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.85e-1)"	2.4	2.1	3.7	1.2	6.3	0.7	4.1	7.2	8.1	2.2	5.5	1.2	2.4	1.2	3.0	3.2	6.3	3.5	2.6	39.1	4.2	2.9	14.5	1.4	2.0	0.8	2.4	6.2	2.5	2.6	10.4	2.6	1.2	5.0	4.6	2.2	6.0	4.5	3.5	40.2	1.4	2.1	7.2	1.9	1.9	3.2	1.7	0.8	0.0	4.0	12.3	0.8	4.4	2.1	0.2	0.0	1.0	0.1	0.1	0.1	0.0	0.0	3.7	2.0	0.0	0.7	0.5	2.3	1.8	1.4	2.5	4.3	3.8	4.7	0.0	0.6	0.6	0.0	7.8	0.0	7.1	0.0	8.5	0.0	6.9	5.2	0.0	0.0	0.1	0.6	0.0	3.5	0.3	0.8	0.0	0.0	1.0	0.1	0.0	0.0	5.5	5.4	0.0	0.0	0.0	14.0	1.2	2.0	5.4	5.7	0.1	0.0	3.2	0.0	0.0	1.5	2.3	2.7	6.3	0.0	0.0	0.0	4.5	0.0	1.1	0.5	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	3.7	6.3	7.2	8.1	4.2	2.9	2.4	6.2	5.0	0.8
PRKAB2		ENSG00000131791	"Protein kinase AMP-activated non-catalytic subunit beta 2"	O43741	1	147155106-147172550	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 52.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044342	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA044342: AB_10966508"	"prognostic unfavourable (4.55e-4)"	"unprognostic (2.03e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.03e-2)"	"unprognostic (9.59e-3)"	"prognostic unfavourable (7.32e-4)"	"unprognostic (6.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.78e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.57e-1)"	"prognostic unfavourable (6.78e-7)"	"unprognostic (4.78e-2)"	7.7	7.6	5.6	4.6	7.1	4.7	7.6	13.3	10.9	9.3	24.6	8.9	8.9	19.1	13.0	8.1	10.0	7.4	6.5	15.2	5.6	5.2	6.2	32.6	6.3	3.8	5.9	9.3	8.1	21.0	18.4	6.2	7.5	7.8	10.9	6.9	6.3	5.7	12.6	52.1	9.4	19.1	20.5	8.4	5.7	11.1	6.9	5.5	2.6	5.8	19.9	4.7	19.0	10.3	1.2	1.7	2.9	1.6	5.1	2.5	0.8	4.0	2.2	5.9	4.6	14.1	12.2	21.6	7.6	4.2	5.1	5.6	8.9	8.0	7.2	3.9	6.0	10.7	6.9	8.4	5.0	2.8	4.8	3.2	7.1	14.3	9.7	3.7	1.4	9.6	17.1	5.3	25.0	5.0	4.5	3.0	4.3	4.0	2.8	2.1	12.5	9.9	4.4	8.0	3.5	3.7	3.2	3.8	7.2	5.7	6.5	27.0	6.1	4.7	5.6	5.8	12.8	5.3	12.2	4.8	5.1	3.7	6.0	3.3	7.5	2.9	1.2	1.9	1.5	1.2	2.5	1.2	1.6	0.9	1.7	1.1	1.7	1.1	0.3	5.1	1.6	0.8	0.7	0.8	5.6	7.1	13.3	10.9	5.6	5.2	5.9	9.3	7.8	5.5
PRKN	"AR-JP, PARK2, parkin, PDJ"	ENSG00000185345	"Parkin RBR E3 ubiquitin protein ligase"	O60260	6	161347420-162727771	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 41.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.6;HEL: 9.0;Karpas-707: 5.7;RPMI-8226: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016257, HPA036012"	Enhanced		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nuclear speckles"	"CAB016257: AB_628104, HPA036012: AB_2732471"	"unprognostic (9.23e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.85e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-3)"	"unprognostic (8.16e-2)"	"prognostic favourable (6.75e-12)"	"unprognostic (9.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-1)"	6.8	7.1	7.9	2.3	12.2	1.5	4.2	7.2	13.4	5.3	4.3	6.3	4.6	2.8	7.8	4.4	6.1	3.4	4.3	17.7	9.2	6.2	17.4	3.6	2.6	3.0	5.8	5.2	6.4	3.0	5.6	8.6	2.0	5.5	4.0	2.4	8.3	3.5	4.8	41.8	4.0	3.3	6.6	5.9	2.7	3.5	10.3	6.8	0.6	3.8	4.7	2.7	4.9	2.1	4.6	1.2	4.2	0.8	1.8	4.6	1.3	0.0	0.3	1.2	3.6	0.9	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.2	0.0	0.0	0.2	0.2	0.0	0.4	0.6	9.0	0.2	0.0	0.8	0.2	0.1	3.1	0.1	0.0	0.5	0.0	0.4	5.7	0.9	0.5	0.1	0.1	0.2	0.8	0.0	0.0	5.7	0.6	0.1	0.9	2.5	0.0	0.0	0.3	0.0	0.6	0.0	0.1	0.3	0.1	0.3	0.8	0.1	0.0	0.1	0.1	2.2	2.8	0.8	4.2	2.1	0.5	3.5	1.5	2.0	2.2	1.2	4.6	4.4	4.6	1.5	1.8	0.4	0.3	0.2	1.3	7.9	12.2	7.2	11.7	9.2	6.2	5.8	5.2	5.5	6.8
PRSS45	TESSP5	ENSG00000188086	"Serine protease 45"	Q7RTY3	3	46742092-46744755	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 7.6;skeletal muscle: 6.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.2;HBF TERT88: 1.0;HHSteC: 2.6"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	19	"naive B-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"B-cells: 1.9"									HPA060284	Uncertain									"HPA060284: AB_2684242"	"unprognostic (4.55e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-4)"	"unprognostic (2.33e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.97e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.5	0.2			0.1	0.2	7.6	0.1	0.8	0.0	0.2	0.0	0.0	0.9	0.7	0.2	0.1	0.0		0.3	1.3	2.0	0.5	0.1		0.5	0.0		0.5	0.3	6.7	0.3	0.0	0.0	0.0	0.0	0.2	1.6			3.2		0.0	0.4	0.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PRSS56		ENSG00000237412	"Serine protease 56"	P0CW18	2	232520463-232525716	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.4;retina: 8.6;skeletal muscle: 16.2"	"Cell line enriched"	"Detected in single"	5	"Daudi: 4.6"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 4.7"	"Region enhanced"	"Detected in many"		"hypothalamus: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"basal ganglia: 1.6;olfactory region: 5.2"	"Region enhanced"	"Detected in many"		"olfactory region: 32.6"														"unprognostic (3.26e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.73e-3)"			"unprognostic (2.28e-1)"	"unprognostic (7.15e-2)"				"unprognostic (4.64e-2)"	"unprognostic (1.20e-1)"			0.1	0.1	0.3	0.1	1.8	0.1	0.1	0.1	1.0	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.2	4.4	0.1	0.1	0.1	0.1	2.2	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.2	0.1	8.6	0.1	0.1	16.2	0.1	0.1	0.1	0.8	0.2	0.1	2.6	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.1	1.0	0.2	4.4	2.2	0.1	0.1	0.1
PSMC1	"p56, S4"	ENSG00000100764	"Proteasome 26S subunit, ATPase 1"	P62191	14	90256495-90275429	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 178.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000872	Approved		Enhanced	Nucleoplasm,Cytosol		46000	46000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA000872: AB_1079705"	"unprognostic (4.10e-1)"	"unprognostic (9.70e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (1.78e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-2)"	23.7	21.6	28.2	16.7	26.6	26.9	24.6	17.1	39.1	18.4	21.0	11.8	14.3	12.7	23.7	27.9	23.4	18.0	13.7	34.5	37.8	19.1	22.8	29.7	17.9	16.2	19.8	29.3	16.1	20.4	21.8	15.9	25.3	37.2	19.0	23.0	12.1	18.9	22.8	178.0	22.9	17.2	23.2	31.3	19.3	20.0	42.1	15.6	14.4	18.0	29.2	25.4	23.3	17.2	21.4	37.7	57.0	38.1	28.7	36.4	37.8	31.8	30.2	34.8	36.3	30.6	28.2	36.6	30.9	43.3	68.3	51.6	27.9	36.0	27.2	47.2	37.3	33.1	42.5	36.0	80.0	32.4	18.6	21.3	20.3	23.9	26.4	32.2	28.6	25.2	28.6	44.4	32.7	41.1	30.0	16.4	46.9	60.4	24.0	42.0	30.7	37.5	28.8	45.1	22.2	38.4	33.2	36.6	24.5	25.2	65.6	25.8	41.2	28.5	31.1	26.3	23.6	28.2	44.6	28.4	44.7	40.3	38.1	29.4	40.1	30.9	37.6	57.0	26.6	34.1	26.2	21.4	27.5	27.2	37.7	20.7	25.3	24.8	41.7	28.7	38.1	26.4	36.4	37.8	28.2	26.6	17.1	39.1	37.8	19.1	19.8	29.3	37.2	15.6
PSMC3	"TBP-1, TBP1"	ENSG00000165916	"Proteasome 26S subunit, ATPase 3"	P17980	11	47418769-47426473	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 134.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006065	Approved		Supported	Nucleoplasm,Cytosol		180000	180000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA006065: AB_1079706"	"unprognostic (2.01e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.43e-2)"	"unprognostic (8.12e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.71e-2)"	"unprognostic (8.99e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (4.24e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	27.9	25.9	37.3	24.1	49.3	31.8	26.2	25.6	39.7	25.1	28.2	24.9	21.1	20.3	27.2	26.0	29.4	25.0	21.8	45.7	32.8	28.0	30.7	60.2	21.5	22.8	36.1	27.3	21.0	25.2	31.0	16.8	39.8	28.2	22.6	24.0	21.3	32.1	29.8	134.7	34.8	20.9	30.8	24.3	25.7	24.9	24.0	22.9	33.5	27.1	38.3	28.8	25.5	25.3	39.2	45.1	32.6	54.7	45.0	51.1	61.3	39.0	44.5	42.8	31.5	20.6	22.2	41.7	32.6	48.5	82.1	58.3	39.6	22.9	31.7	20.3	41.0	39.3	37.5	42.7	37.1	47.2	48.4	30.5	54.5	38.2	26.6	35.5	32.6	24.7	23.1	33.3	37.6	46.0	43.1	30.0	50.0	87.1	44.7	45.2	41.9	53.8	47.3	84.2	27.8	38.2	29.5	31.3	27.1	26.7	37.7	20.5	46.5	37.1	32.5	47.1	59.6	66.6	83.5	32.5	37.5	36.7	48.6	35.6	58.8	24.4	43.5	32.6	47.9	53.1	43.7	39.2	40.4	43.8	45.1	32.8	35.6	36.2	9.8	45.0	54.7	45.1	51.1	61.3	37.3	49.3	25.6	39.7	32.8	28.0	36.1	27.3	28.2	22.9
PSMD2	"MGC14274, P97, Rpn1, S2, TRAP2"	ENSG00000175166	"Proteasome 26S subunit, non-ATPase 2"	Q13200	3	184298709-184309054	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 107.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045192	Approved					380000	380000			"HPA045192: AB_10961324"	"unprognostic (1.06e-2)"	"unprognostic (1.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.96e-1)"	"prognostic unfavourable (9.98e-4)"	"prognostic unfavourable (6.63e-7)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (1.69e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.25e-3)"	"unprognostic (1.53e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.74e-3)"	21.6	33.7	31.7	20.8	28.7	23.2	16.3	22.2	31.5	19.4	20.4	17.9	20.6	16.5	22.6	16.8	25.3	18.8	15.7	39.2	27.1	21.2	22.9	28.5	18.3	18.6	23.8	29.7	16.5	16.4	28.2	18.9	25.2	25.0	18.8	22.2	15.7	19.0	22.2	107.0	22.9	16.4	26.2	15.1	19.0	19.2	34.1	17.7	20.1	19.2	28.4	25.2	18.1	24.8	28.3	53.2	37.0	40.4	34.7	35.3	42.7	109.9	29.0	23.3	39.6	28.3	16.0	28.5	62.5	42.8	69.1	40.1	40.3	19.6	29.0	92.4	46.0	31.6	34.7	61.0	87.9	50.5	26.7	31.3	27.5	25.0	15.7	21.2	27.9	18.3	19.1	66.0	41.6	41.6	22.0	27.1	56.9	36.3	22.2	13.0	36.4	48.2	26.1	33.1	30.5	29.7	29.3	20.0	17.3	44.6	38.5	22.3	54.8	19.0	51.9	43.1	54.4	34.4	130.8	30.4	66.3	54.3	55.6	26.8	30.7	20.3	40.4	37.0	31.1	36.1	30.7	28.3	30.6	35.3	53.2	23.4	30.5	30.3	12.3	34.7	37.2	22.7	29.8	42.7	31.7	28.7	22.2	31.5	27.1	21.2	23.8	29.7	25.0	17.7
PSME4	"KIAA0077, PA200"	ENSG00000068878	"Proteasome activator subunit 4"	Q14997	2	53864067-53970840	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 49.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060922	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA060922: AB_2684386"	"unprognostic (2.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavourable (8.99e-4)"	"unprognostic (7.26e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavourable (4.84e-4)"	"unprognostic (4.76e-2)"	"unprognostic (6.67e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.89e-1)"	11.3	8.4	5.2	10.1	7.8	9.9	8.5	4.2	8.3	12.2	8.0	9.1	7.0	3.9	11.2	5.9	8.8	7.5	10.6	30.9	6.2	3.4	4.9	12.2	11.3	7.9	8.7	5.1	6.6	7.0	7.4	8.4	6.1	6.7	6.8	6.2	6.1	14.2	8.6	49.8	7.1	6.8	11.6	4.1	6.4	9.5	23.8	9.4	8.6	9.0	11.7	8.6	11.5	10.1	4.3	2.0	2.4	1.3	2.3	3.3	0.8	15.5	11.0	17.1	4.9	5.8	12.3	10.5	16.4	15.7	18.1	14.8	17.1	6.5	22.5	14.9	17.8	10.8	19.4	14.4	31.7	15.8	9.9	33.7	11.1	22.9	7.5	17.6	10.0	9.3	8.9	20.6	16.8	18.6	27.2	14.6	16.2	6.5	10.7	7.2	15.6	9.2	12.7	23.8	14.7	9.9	16.4	12.1	13.7	10.6	14.7	8.8	11.0	7.5	21.5	16.0	12.9	11.5	15.2	9.1	8.9	14.0	12.5	15.2	9.7	2.2	0.8	2.4	3.3	1.3	1.8	3.2	2.2	2.0	1.2	4.3	2.4	3.0	2.2	2.3	1.1	2.0	1.6	0.8	5.2	7.8	4.2	8.3	6.2	3.4	8.7	5.1	6.7	9.4
PTGES2	"C9orf15, FLJ14038"	ENSG00000148334	"Prostaglandin E synthase 2"	Q9H7Z7	9	128120693-128128462	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020631, HPA020733"	Approved		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA020631: , HPA020733: AB_2670508"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.33e-2)"	"prognostic favourable (5.83e-7)"	"unprognostic (2.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"	9.3	17.0	16.5	9.2	17.8	4.4	7.4	15.3	24.1	7.1	14.8	9.9	7.6	17.7	8.1	9.0	12.6	8.4	10.0	36.4	17.4	14.0	13.2	13.0	5.8	10.2	14.2	11.6	9.2	18.3	11.7	14.3	10.7	10.5	8.0	7.0	13.2	16.2	12.0	73.5	9.3	13.2	5.9	7.0	9.5	14.3	5.8	9.8	9.3	10.5	16.2	13.3	8.5	7.3	5.2	8.2	1.2	6.3	3.7	6.5	2.9	12.6	35.4	3.9	14.7	3.6	3.7	12.1	9.7	5.4	12.3	6.6	26.4	19.8	11.2	15.5	3.9	32.9	5.7	12.0	1.7	8.0	15.4	5.7	26.8	24.6	11.0	11.6	11.5	5.0	8.7	9.9	6.8	8.4	12.6	7.0	4.0	39.1	13.8	22.1	12.6	28.7	10.5	7.9	28.5	8.4	9.5	19.8	11.8	14.0	22.4	9.4	20.0	6.2	11.0	12.6	15.7	17.0	17.6	16.1	7.8	10.9	9.6	9.0	11.7	1.2	6.0	1.0	5.6	6.3	6.5	5.2	3.7	5.9	6.7	4.5	4.3	5.1	1.1	3.7	2.8	8.2	4.2	2.9	16.5	17.8	15.3	24.1	17.4	14.0	14.2	11.6	10.5	9.8
PTGES3L		ENSG00000267060	"Prostaglandin E synthase 3 like"		17	42968088-42980433	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"heart muscle: 18.3;skeletal muscle: 61.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 8.7;RH-30: 8.5;THP-1: 22.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"basal ganglia: 4.2"	"Cell type enriched"	"Detected in some"	7	"plasmacytoid DC: 8.9"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.77e-2)"	"unprognostic (6.61e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.80e-4)"	"unprognostic (9.24e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.25e-2)"	"unprognostic (4.08e-2)"	0.5	0.2	0.7	0.8	4.2	1.1	0.5	0.3	1.2	1.3	5.1	0.2	0.0	0.6	3.5	2.2	2.2	1.1	3.3	18.3	0.5	0.7	0.2	0.1	0.4	0.5	0.6	0.7	0.6	0.2	0.2	0.4	0.2	0.3	1.8	1.5	1.5	1.0	2.2	61.3	0.5	1.2	10.0	0.2	0.3	1.7	0.6	0.1	0.4	0.4	13.6	0.6	4.7	1.3	0.7	8.9	1.3	0.3	0.6	0.3	0.8	0.7	0.6	1.9	3.5	0.1	0.3	1.6	1.2	0.8	1.1	0.6	1.5	0.7	0.6	0.5	0.5	1.4	1.4	1.3	1.7	0.4	0.6	5.1	2.9	3.0	0.1	0.8	8.7	0.7	1.0	2.3	1.6	0.3	1.8	1.5	3.3	0.9	3.1	2.0	2.1	0.5	1.3	8.5	0.6	2.0	1.4	1.7	5.8	1.6	3.2	2.5	1.7	22.2	0.7	1.8	1.7	0.6	1.2	3.9	2.5	0.9	0.3	0.9	0.7	1.3	0.3	0.4	0.3	0.2	0.3	0.3	0.3	0.3	0.3	0.7	0.3	0.3	1.2	0.6	0.2	8.9	0.2	0.8	0.7	4.2	0.3	1.2	0.5	0.7	0.6	0.7	0.3	0.1
PTGES3L-AARSD1		ENSG00000108825	"PTGES3L-AARSD1 readthrough"	Q9BTE6	17	42950526-42980528	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 46.6"	"Cell line enhanced"	"Detected in many"		"RH-30: 6.6;THP-1: 13.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 4.5"	"Cell type enriched"	"Detected in single"	28	"plasmacytoid DC: 5.3"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 5.3"	"Low region specificity"	"Detected in all"							"HPA021408, HPA022869, HPA023714"	Approved		Approved	"Nuclear membrane,Cytosol"				"Nuclear membrane, Cytosol"	"Nuclear membrane, Cytosol"	"HPA021408: AB_1844410, HPA022869: AB_1844411, HPA023714: AB_1844412"	"unprognostic (6.47e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.44e-2)"	"unprognostic (9.34e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.13e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.91e-4)"	"unprognostic (1.83e-1)"	0.7	0.1	0.7	1.2	4.5	1.2	0.5	0.6	1.6	1.5	5.5	0.3	0.1	1.7	4.7	2.4	2.2	1.6	3.6	13.8	0.5	0.7	0.3	0.2	0.6	0.7	0.6	0.8	0.7	0.3	0.4	1.5	0.4	0.4	2.0	3.2	1.6	0.7	3.1	46.6	0.2	1.6	10.6	0.2	0.4	2.4	3.8	0.2	0.5	0.5	14.4	0.8	5.1	1.4	0.1	5.3	0.0	0.0	0.0	0.0	0.4	1.0	0.0	2.7	2.6	0.3	0.0	0.8	2.2	1.9	1.2	1.1	1.7	0.3	0.3	1.7	0.2	0.0	0.4	1.1	1.8	1.0	0.4	5.5	2.2	4.0	0.0	0.5	3.9	0.1	0.7	1.9	0.1	0.6	1.9	0.4	2.2	0.0	1.8	1.4	0.7	0.5	1.5	6.6	0.7	0.3	0.5	1.3	3.4	1.4	0.5	1.4	0.9	13.0	0.0	0.9	1.7	0.0	0.7	3.6	1.1	0.3	0.3	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.4	0.7	4.5	0.6	1.6	0.5	0.7	0.6	0.8	0.4	0.2
PTP4A1	"PRL-1, PRL1, PTPCAAX1"	ENSG00000112245	"Protein tyrosine phosphatase type IVA, member 1"	Q93096	6	63521748-63583587	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 135.1;skeletal muscle: 111.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003281	Approved									"HPA003281: AB_1855903"	"unprognostic (8.63e-2)"	"prognostic unfavourable (5.53e-4)"	"unprognostic (9.05e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.11e-2)"	13.9	42.3	11.3	10.5	14.0	54.3	10.8	7.1	17.0	17.5	30.2	18.9	8.0	17.9	13.1	13.5	16.1	12.3	16.7	10.0	12.0	14.8	14.2	135.1	25.0	9.0	16.1	13.8	24.1	87.4	5.0	12.8	19.8	16.3	17.7	31.2	13.6	20.1	10.0	111.2	17.2	18.3	35.7	24.2	7.1	15.5	19.8	13.3	6.4	11.4	19.9	9.3	31.0	12.6	14.6	18.2	46.9	20.6	15.8	20.1	14.4	18.9	23.6	29.7	28.7	20.3	18.9	59.5	33.4	22.3	12.2	17.0	19.8	11.2	16.2	14.5	19.7	9.4	20.2	42.0	19.6	17.4	13.6	10.1	65.9	89.9	40.2	31.0	16.5	22.9	81.5	26.3	70.5	18.8	23.1	31.5	33.8	25.7	14.8	13.9	12.3	12.8	19.9	12.3	12.8	27.2	22.5	11.2	20.6	73.0	16.0	32.9	15.4	27.6	18.7	30.7	33.7	24.2	32.9	26.3	22.5	29.9	16.4	16.6	36.0	34.6	19.8	15.2	13.7	20.6	20.1	14.6	15.0	14.6	18.2	12.4	14.8	14.2	46.9	15.8	14.2	9.1	18.1	14.4	11.3	14.0	7.1	17.0	12.0	14.8	16.1	13.8	16.3	13.3
PTP4A3	"PRL-3, PRL-R, PRL3"	ENSG00000184489	"Protein tyrosine phosphatase type IVA, member 3"	O75365	8	141391993-141432454	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 166.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 68.7;Karpas-707: 20.9;RPMI-8226: 21.5;U-266/84: 22.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 30.3;non-classical monocyte: 27.8"	"Group enriched"	"Detected in many"	7	"granulocytes: 30.3;monocytes: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003281	Uncertain									"HPA003281: AB_1855903"	"unprognostic (1.09e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.08e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.73e-3)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (1.81e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.77e-1)"	5.9	2.4	2.8	3.9	6.5	1.7	4.1	3.9	10.9	5.5	6.2	2.6	2.5	3.4	7.6	5.4	5.5	6.1	3.0	48.0	2.7	3.0	5.1	1.7	5.5	7.9	2.8	5.0	4.8	13.6	2.4	22.0	4.1	4.6	7.2	2.0	15.7	8.2	3.8	166.4	3.4	3.3	7.6	1.5	5.6	9.9	3.5	0.6	1.7	3.3	15.9	5.1	5.5	3.3	2.8	4.3	30.3	27.8	0.8	3.5	2.5	0.1	0.4	0.7	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	2.0	0.0	6.4	0.1	0.0	0.1	0.0	0.0	68.7	0.5	4.9	0.0	1.0	0.5	0.0	0.2	0.0	0.2	0.0	0.0	0.1	2.7	20.9	0.0	5.2	0.5	0.1	1.3	0.3	11.8	0.0	21.5	0.0	0.1	8.8	2.1	0.4	0.0	1.8	1.0	0.3	0.1	0.0	1.2	0.0	0.0	6.5	22.8	0.2	0.0	2.0	0.2	0.4	1.6	6.6	1.6	14.8	1.1	2.8	3.5	1.6	1.2	0.8	3.4	1.9	30.3	0.8	27.8	4.3	2.5	2.5	2.8	6.5	3.9	10.9	2.7	3.0	2.8	5.0	4.6	0.6
PTPN3	PTPH1	ENSG00000070159	"Protein tyrosine phosphatase, non-receptor type 3"	P26045	9	109375466-109498313	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 38.1"	"Cell line enhanced"	"Detected in many"		"HaCaT: 15.4;RPTEC TERT1: 20.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038343, HPA046728"	Approved									"HPA038343: AB_10671741, HPA046728: AB_2679776"	"prognostic unfavourable (6.71e-4)"	"unprognostic (3.48e-1)"	"unprognostic (3.64e-2)"	"prognostic favourable (1.52e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.71e-2)"	"unprognostic (5.38e-2)"	"unprognostic (6.37e-2)"	"unprognostic (3.57e-2)"	"prognostic favourable (1.22e-15)"	"unprognostic (1.64e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.21e-2)"	2.7	1.9	3.4	4.8	5.0	0.0	4.8	2.1	11.1	4.4	9.4	2.0	10.7	7.6	3.2	13.4	10.3	6.4	6.3	12.1	3.1	2.8	28.8	21.1	4.9	0.5	1.2	3.9	1.5	17.0	10.6	4.9	14.5	4.5	4.7	6.5	3.8	13.1	13.6	38.1	18.8	18.8	0.8	0.9	0.9	5.9	2.1	0.0	1.1	9.4	7.2	9.5	4.1	5.5	0.6	0.3	2.8	0.6	0.3	0.3	0.1	6.4	8.0	0.3	2.1	0.0	0.0	12.7	1.4	0.0	1.7	1.9	4.2	10.5	0.0	1.5	0.1	15.4	2.2	9.0	1.8	3.5	4.9	0.0	3.8	4.3	0.0	0.0	0.1	0.1	9.7	2.2	4.7	0.0	0.0	0.1	0.1	8.1	11.0	1.9	1.0	6.0	0.0	2.6	0.1	20.7	12.4	5.2	1.1	3.5	13.1	0.0	7.5	1.0	0.0	0.6	5.1	0.8	0.0	6.3	10.3	0.0	6.8	0.0	4.6	0.4	0.6	0.8	0.2	0.4	0.2	0.4	0.2	0.2	0.3	0.6	0.3	0.3	2.8	0.3	0.6	0.3	0.1	0.1	3.4	5.0	2.1	11.1	3.1	2.8	1.2	3.9	4.5	0.0
PTX3	"TNFAIP5, TSG-14"	ENSG00000163661	"Pentraxin 3"	P26022	3	157436789-157443628	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 61.7;skeletal muscle: 67.7;urinary bladder: 77.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 84.6;ASC TERT1: 122.6;BJ hTERT+: 80.5;HHSteC: 157.4;HSkMC: 163.9;hTEC/SVTERT24-B: 86.6;TIME: 116.7;U-2197: 108.8"	"Cancer enhanced"	"Detected in many"		"glioma: 22.5"	"Group enriched"	"Detected in some"	6	"hippocampal formation: 1.1;pons and medulla: 3.6"	"Cell type enhanced"	"Detected in some"		"eosinophil: 3.2"	"Group enriched"	"Detected in many"	20	"dendritic cells: 1.3;granulocytes: 3.2;monocytes: 1.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA069320	Approved		Approved	"Plasma membrane"	"Secreted to blood"	310000	310000	"Plasma membrane"	"Plasma membrane"	"HPA069320: AB_2686118"	"unprognostic (1.93e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (8.35e-9)"	"unprognostic (5.79e-3)"	"prognostic unfavourable (6.36e-4)"	"unprognostic (6.03e-3)"	"prognostic unfavourable (8.75e-6)"	"unprognostic (2.45e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.76e-9)"	"unprognostic (6.03e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.92e-3)"	61.7	3.4	0.3	16.7	0.2	31.6	35.3	0.2	0.7	0.8	13.2	0.3	0.6	0.5	0.5	0.8	2.0	6.5	3.5	14.7	1.1	0.0	3.0	0.6	22.5	7.0	0.3	0.1	6.8	18.0	0.3	1.0	4.9	3.6	2.5	1.2	5.2	1.8	0.4	67.7	6.0	1.9	6.4	0.9	9.6	4.9	0.9	0.2	0.3	2.7	0.4	0.4	77.0	2.5	0.0	1.3	3.2	1.2	0.0	0.0	0.1	0.0	0.0	51.0	0.0	84.6	122.6	0.0	8.8	80.5	3.8	4.1	0.0	0.5	0.0	31.4	10.3	0.0	0.0	0.0	7.5	0.0	0.0	0.1	0.0	0.0	157.4	0.1	0.0	163.9	0.0	86.6	29.5	17.8	0.0	0.0	25.4	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.0	0.3	3.5	0.4	0.0	0.5	0.0	0.0	0.0	0.1	116.7	17.3	0.8	108.8	1.5	0.0	0.0	0.0	3.6	0.4	4.9	0.0	1.2	3.2	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.3	0.2	0.2	0.2	1.1	0.0	0.3	0.1	3.6	0.2
RAB12		ENSG00000206418	"RAB12, member RAS oncogene family"	Q6IQ22	18	8609445-8639381	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 96.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040727	Approved		Approved	Vesicles				Vesicles	Vesicles	"HPA040727: AB_10794858"	"unprognostic (7.92e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.67e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.11e-2)"	20.0	16.0	18.0	10.2	18.3	7.2	15.6	23.5	22.1	17.2	16.8	13.8	9.2	7.3	18.5	12.3	17.3	13.4	11.2	45.6	16.2	16.2	18.4	20.7	15.8	12.5	13.7	17.8	19.0	7.5	10.4	12.7	17.6	15.3	15.3	10.5	13.7	10.1	18.6	96.4	18.1	10.3	25.4	12.2	16.3	10.8	8.3	10.6	7.7	12.1	21.2	11.9	19.4	20.2	3.2	4.1	7.7	5.1	3.9	3.1	1.3	12.1	7.2	8.5	8.8	25.2	21.5	4.7	16.6	22.9	19.0	22.3	9.8	11.2	4.2	16.2	19.8	7.7	9.7	17.7	23.0	1.7	7.9	3.6	7.7	10.2	23.4	4.6	3.8	21.2	25.1	13.9	17.8	22.8	5.4	6.0	18.3	13.1	5.3	4.7	5.4	6.8	3.7	20.5	4.0	18.4	16.4	14.0	10.0	12.6	17.2	20.8	5.0	7.2	19.0	22.0	12.8	21.9	25.1	4.1	2.3	3.6	16.4	4.4	14.0	7.7	2.2	2.4	2.1	3.6	3.0	3.2	2.3	2.5	1.8	3.0	3.1	3.0	4.1	3.9	5.1	4.1	2.5	1.3	18.0	18.3	23.5	22.1	16.2	16.2	13.7	17.8	15.3	10.6
RABL6	"bA216L13.9, C9orf86, FLJ10101, FLJ13045, Parf, pp8875, RBEL1"	ENSG00000196642	"RAB, member RAS oncogene family like 6"	Q3YEC7	9	136807943-136841187	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 98.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044037	Uncertain		Approved	Centrosome,Cytosol				Cytosol	Cytosol	"HPA044037: AB_10966437"	"unprognostic (3.10e-3)"	"unprognostic (8.52e-3)"	"unprognostic (1.20e-1)"	"prognostic favourable (4.00e-4)"	"unprognostic (9.23e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.90e-3)"	"unprognostic (7.55e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.92e-2)"	"prognostic favourable (1.46e-4)"	"unprognostic (5.23e-2)"	"unprognostic (1.03e-3)"	"prognostic favourable (9.14e-4)"	"unprognostic (4.08e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.15e-1)"	20.8	17.7	31.0	21.6	42.8	32.9	17.9	43.6	41.4	12.5	25.1	18.0	14.8	29.4	13.7	14.6	17.9	12.8	22.2	29.4	28.2	22.2	17.1	7.3	17.2	18.5	22.7	21.6	13.9	39.6	17.4	23.3	16.0	16.7	24.3	16.6	13.1	24.8	16.9	98.6	21.5	29.4	15.6	20.6	20.0	24.5	16.5	17.2	20.9	13.9	22.6	13.9	13.8	19.9	4.7	4.1	2.9	5.7	6.1	5.2	1.4	19.0	25.3	18.1	21.2	7.4	8.4	47.7	17.3	11.1	16.8	12.3	28.2	20.2	27.0	10.9	13.4	41.7	20.2	15.2	5.8	28.0	26.0	16.5	31.6	32.9	13.4	30.5	21.2	9.3	15.8	10.4	11.6	17.4	35.8	13.2	11.5	38.0	32.6	21.1	34.0	21.8	42.7	21.7	26.3	11.1	16.9	59.8	24.8	30.5	35.9	21.3	30.8	30.8	21.1	21.8	19.0	22.9	27.9	11.3	12.9	21.9	18.3	14.9	20.3	1.2	4.8	2.9	3.7	5.7	3.8	4.5	3.9	3.6	3.3	4.7	3.2	4.1	2.3	6.1	2.0	4.1	5.2	1.4	31.0	42.8	43.6	41.4	28.2	22.2	22.7	21.6	16.7	17.2
RAPGEF1	"C3G, GRF2"	ENSG00000107263	"Rap guanine nucleotide exchange factor 1"	Q13905	9	131576770-131740074	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 83.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006426, HPA075984"	Approved		Supported	Vesicles				Vesicles	Vesicles	"HPA006426: AB_1856070, HPA075984: AB_2686771"	"unprognostic (1.00e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.62e-1)"	"prognostic favourable (1.18e-5)"	"unprognostic (5.66e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.73e-2)"	16.2	10.8	18.4	21.5	28.0	19.7	18.5	21.8	19.5	9.6	11.5	13.7	6.0	10.1	11.1	6.9	10.3	11.4	10.2	21.5	17.4	16.0	9.4	9.7	16.9	21.7	13.1	10.2	7.4	24.1	9.0	7.3	28.5	13.5	9.0	10.3	16.8	8.5	10.0	83.3	9.2	13.7	13.2	13.0	16.7	12.0	6.8	11.6	12.4	9.9	8.8	25.9	11.3	12.0	9.2	2.9	5.3	3.9	2.0	6.5	2.3	10.4	12.2	12.4	12.5	12.7	13.8	47.6	9.0	18.5	10.5	7.6	15.1	6.9	19.0	11.4	18.2	19.2	14.2	12.6	5.3	44.0	5.8	5.6	20.5	7.9	10.7	23.0	25.7	10.5	23.3	13.7	16.4	19.0	14.9	37.7	13.6	10.9	16.2	8.1	12.5	11.1	16.1	29.0	26.4	4.8	12.7	10.5	10.5	13.2	12.6	13.2	12.0	19.4	20.0	28.4	11.9	17.9	13.7	12.7	11.0	37.5	13.5	9.9	6.8	5.3	2.0	2.6	6.5	3.8	3.7	9.2	4.2	4.2	2.4	5.3	1.1	2.9	2.3	2.0	3.9	2.9	3.0	2.3	18.4	28.0	21.8	18.5	17.4	16.0	13.1	10.2	13.5	11.6
RASGRP3	"CalDAG-GEFIII, GRP3, KIAA0846"	ENSG00000152689	"RAS guanyl releasing protein 3"	Q8IV61	2	33436324-33564750	"Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.4;skeletal muscle: 28.7"	"Group enriched"	"Detected in some"	6	"Daudi: 29.3;HEL: 30.9;U-266/70: 48.4;U-266/84: 18.4;U-698: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 11.4;memory B-cell: 10.4;naive B-cell: 13.4"	"Group enriched"	"Detected in many"	16	"B-cells: 13.4;granulocytes: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058937			Approved	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"HPA058937: AB_2683858"	"unprognostic (2.64e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.87e-1)"	"unprognostic (5.82e-2)"	7.8	2.6	9.4	13.6	13.3	3.2	4.9	2.0	9.6	3.1	3.5	35.0	0.0	5.7	2.6	1.3	2.0	2.1	5.0	24.3	13.4	8.8	5.1	4.1	5.8	19.8	25.2	5.5	1.6	3.7	9.3	3.1	8.2	19.9	2.1	5.3	6.7	5.4	1.7	28.7	2.3	4.5	3.7	42.4	10.1	5.4	1.3	26.3	1.9	6.7	5.0	25.0	5.4	2.1	13.4	0.2	11.4	0.1	0.2	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.2	1.5	4.4	0.8	0.2	29.3	0.1	0.2	0.0	0.0	0.0	0.4	3.0	0.3	30.9	0.2	0.0	0.4	0.1	4.2	0.0	0.0	0.0	0.0	1.7	0.1	1.6	0.6	0.0	0.2	2.3	0.1	0.0	0.0	1.4	0.0	0.3	1.8	0.2	0.0	0.0	0.1	1.4	0.0	0.1	0.5	0.1	0.1	0.1	0.2	48.4	18.4	12.9	0.0	0.1	0.1	11.4	0.0	0.0	0.3	0.0	0.4	10.4	0.5	0.5	0.2	13.4	0.7	0.2	0.0	0.2	0.1	0.0	0.7	0.9	9.4	13.3	2.0	9.6	13.4	8.8	25.2	5.5	19.9	26.3
RASL10B	"RRP17, VTS58635"	ENSG00000270885	"RAS like family 10 member B"	Q96S79	17	35731649-35743521	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 24.6;skeletal muscle: 26.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 14.0;HHSteC: 16.0;HSkMC: 11.6;NTERA-2: 23.9;REH: 11.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 14.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046842, HPA057092"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA046842: AB_2679835, HPA057092: AB_2683332"	"unprognostic (5.78e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.36e-2)"	"prognostic unfavourable (6.38e-6)"	"unprognostic (8.60e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.97e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.71e-6)"	"unprognostic (2.41e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.60e-3)"	12.8	0.9	6.3	0.3	9.1	0.2	2.8	0.3	12.3	1.8	0.3	1.0	24.6	0.8	1.3	0.8	0.3	3.9	0.8	10.9	4.7		1.0	1.1	0.4	0.2	0.0	2.8	2.5	4.7	2.5	1.1	2.8	6.3	0.9	0.2	1.1	12.6	15.2	26.7	0.3	0.9	0.9	0.6	0.2	0.3	1.6	2.5	0.0	0.9	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	3.6	0.0	0.6	0.4	1.0	0.6	0.4	2.5	2.1	4.5	0.0	0.0	0.4	0.1	0.0	14.0	0.0	0.8	0.0	4.6	0.0	2.3	5.2	16.0	0.0	0.0	11.6	0.9	0.8	0.0	0.0	3.0	0.0	0.2	0.2	6.3	0.0	23.9	0.0	11.6	6.4	10.4	0.0	0.0	10.7	10.4	0.7	0.2	0.9	1.3	0.7	0.0	1.2	8.6	0.0	0.3	0.0	0.0	2.8	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RBM20		ENSG00000203867	"RNA binding motif protein 20"	Q5T481	10	110644397-110839469	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 45.9;skeletal muscle: 20.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 5.7;HEL: 4.8;K-562: 4.5;RH-30: 15.5;SH-SY5Y: 14.3;T-47d: 8.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"olfactory region: 4.6"	"Low region specificity"	"Detected in many"			"HPA035806, HPA070358"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytokinetic bridge"				"Golgi apparatus"	"Golgi apparatus"	"HPA035806: AB_10672097, HPA070358: "	"unprognostic (2.43e-1)"	"unprognostic (8.24e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.75e-2)"	"unprognostic (5.47e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.78e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-3)"	"unprognostic (3.34e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.46e-2)"	1.7	0.1	0.4	0.6	1.9	0.1	2.2	0.5	1.5	0.9	2.6	1.3	0.0	0.2	2.5	7.5	3.6	1.9	2.3	45.9	0.6	0.2	1.1	0.1	0.5	0.1	0.3	1.3	2.4	13.7	0.9	1.2	1.4	1.4	1.0	0.5	4.3	6.3	0.7	20.9	0.7	1.0	2.1	0.6	0.1	0.6	0.9	1.4	0.0	0.7	3.4	0.5	1.8	3.2	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	1.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.3	5.7	4.8	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	4.5	0.0	0.2	0.0	0.0	0.0	0.4	1.3	0.0	15.5	0.0	0.0	0.0	0.1	14.3	0.1	0.0	0.6	8.7	0.0	0.0	0.2	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	1.9	0.5	1.5	0.6	0.2	0.3	1.3	1.4	1.4
RBM24	"dJ259A10.1, FLJ30829, RNPC6"	ENSG00000112183	"RNA binding motif protein 24"	Q9BX46	6	17281346-17293875	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.0;skeletal muscle: 153.8;tongue: 37.3"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 11.1;LHCN-M2: 28.6;RH-30: 29.5;T-47d: 13.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA066927, HPA067231"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA066927: AB_2685750, HPA067231: AB_2685808"	"unprognostic (9.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.54e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.97e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.33e-4)"	3.4	0.2	1.4	0.9	2.2	0.1	1.1	0.3	1.9	7.0	2.7	0.1	3.0	0.5	9.7	7.3	3.4	7.8	1.7	41.0	1.5	1.7	0.3	0.4	0.4	0.2	0.5	1.1	2.1	0.2	0.1	1.8	0.2	0.3	3.6	2.4	1.6	2.5	2.2	153.8	0.4	1.2	9.3	0.5	0.4	0.8	1.3	0.1	0.1	1.4	37.3	1.9	5.1	2.9	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.7	4.5	5.9	0.0	0.0	0.0	0.0	9.0	3.3	6.1	6.5	0.0	0.5	0.0	2.8	6.4	0.0	5.6	0.2	11.1	0.0	0.2	0.0	0.5	3.0	0.2	0.0	0.5	3.2	0.0	1.2	0.2	0.7	0.0	0.0	28.6	1.3	0.0	0.0	2.0	0.7	0.0	29.5	0.0	0.0	0.0	3.9	0.4	0.0	0.0	0.1	13.8	0.2	0.0	2.1	4.9	0.0	7.7	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	0.3	1.9	1.5	1.7	0.5	1.1	0.3	0.1
RBM38	"dJ800J21.2, HSRNASEB, RNPC1, seb4B, SEB4D"	ENSG00000132819	"RNA binding motif protein 38"	Q9H0Z9	20	57391407-57409333	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 64.3;skeletal muscle: 107.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 38.8;U-698: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			CAB017036	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB017036: "	"unprognostic (1.03e-1)"	"prognostic favourable (3.64e-7)"	"unprognostic (3.71e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.04e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.29e-1)"	"prognostic unfavourable (1.05e-5)"	"unprognostic (2.13e-2)"	"unprognostic (2.29e-1)"	"prognostic favourable (1.63e-4)"	"unprognostic (1.83e-1)"	4.4	3.5	4.5	22.8	4.9	64.3	4.3	10.0	5.2	9.2	28.1	6.4	7.1	5.9	13.0	6.7	16.3	10.4	6.5	24.4	4.2	3.9	5.3	6.7	9.8	23.3	4.7	2.3	17.2	5.9	1.9	4.4	9.9	5.0	12.2	3.4	10.9	11.6	8.3	107.9	2.7	12.9	27.4	3.4	22.0	8.1	16.7	4.1	26.8	4.1	18.9	28.0	25.1	11.4	6.4	2.2	3.5	2.9	5.5	7.6	3.4	5.4	5.6	2.8	7.1	0.0	0.4	16.1	1.8	0.4	3.9	1.0	23.0	5.9	38.8	15.4	0.5	5.0	2.3	2.2	0.6	7.8	9.6	32.9	2.1	14.5	1.7	15.8	15.5	0.5	1.1	1.6	0.3	2.6	26.8	7.1	0.4	23.6	11.4	16.3	10.4	7.1	22.2	7.0	31.5	2.9	2.5	11.7	7.5	4.3	14.3	7.2	7.9	22.3	4.6	1.3	12.4	1.6	7.5	17.0	22.5	40.8	0.3	11.4	1.2	0.0	1.0	3.5	5.4	2.9	3.5	5.6	4.5	3.7	1.8	6.4	5.7	5.0	1.3	5.5	2.7	2.2	7.6	3.4	4.5	4.9	10.0	5.2	4.2	3.9	4.7	2.3	5.0	4.1
RCC1L	WBSCR16	ENSG00000274523	"RCC1 like"	Q96I51	7	75027122-75074228	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 33.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052184, HPA060643"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA052184: AB_2681752, HPA060643: AB_2684335"	"unprognostic (9.73e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.87e-2)"	"prognostic unfavourable (4.88e-4)"	"unprognostic (8.91e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.28e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-1)"	7.4	8.5	4.4	7.0	5.1	4.2	3.3	4.3	5.6	5.8	6.4	7.0	7.2	6.4	5.0	4.8	7.4	4.8	7.7	11.5	3.7		7.9	12.0	3.9	5.5	5.6	4.0	7.1	9.1	4.9	3.3	6.5	3.8	7.2	3.2	7.3	7.8	6.4	33.4	4.3	6.0	9.5	2.3	6.8	4.8	5.4	5.7	3.6	8.7	8.4	6.8	5.8	7.7	6.8	5.5	4.8	4.9	6.7	9.2	2.6	15.1	23.4	12.4	20.9	8.8	7.2	17.0	14.9	10.7	12.8	10.6	23.5	18.8	16.1	6.8	12.0	18.0	10.4	10.0	5.3	17.8	16.6	12.0	15.6	21.9	12.6	19.0	19.4	9.0	8.2	11.1	9.1	11.3	38.1	10.5	9.9	32.4	0.8	28.9	28.8	18.3	9.2	10.0	33.8	11.1	13.8	13.4	20.1	19.9	42.3	18.2	29.8	19.9	12.7	16.9	14.2	15.1	19.3	11.8	9.4	25.5	13.0	20.2	22.3	4.8	3.8	2.2	7.3	4.9	5.7	5.7	7.8	6.4	5.3	6.8	7.5	9.2	1.4	6.7	3.5	5.5	5.9	2.6										
RCSD1	"CapZIP, MGC21854, MK2S4"	ENSG00000198771	"RCSD domain containing 1"	Q6JBY9	1	167630093-167706249	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 56.4;lymphoid tissue: 70.8;skeletal muscle: 52.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 47.6;REH: 47.7;RPMI-8226: 32.6;THP-1: 25.1;U-266/70: 31.9;U-698: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016597, HPA073490"	Enhanced		Approved	"Plasma membrane"		150000	150000	"Plasma membrane"	"Plasma membrane"	"HPA016597: AB_2669397, HPA073490: "	"unprognostic (2.13e-2)"	"unprognostic (7.38e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.08e-1)"	"prognostic favourable (2.97e-4)"	"unprognostic (5.51e-2)"	"unprognostic (8.90e-3)"	"unprognostic (3.65e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.19e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.97e-2)"	8.5	2.9	3.5	33.3	4.8	19.2	7.3	1.2	3.1	3.0	8.4	3.6	1.3	3.6	2.7	5.4	4.1	3.1	8.8	18.4	3.9	3.6	4.2	3.7	9.0	45.6	5.1	2.2	2.5	1.5	0.8	2.0	7.0	3.1	3.7	5.0	3.1	6.5	2.5	52.3	2.3	20.1	7.4	6.9	40.6	4.9	3.7	3.4	70.8	4.8	12.7	29.2	7.4	4.5	51.0	22.1	56.4	38.2	26.6	27.8	26.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.6	0.1	0.0	0.0	0.0	0.0	0.0	20.0	0.0	0.3	0.0	0.0	0.0	8.1	0.9	0.1	0.0	0.1	0.0	0.0	15.2	14.0	6.4	0.0	15.1	11.7	0.4	0.0	47.7	0.2	32.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	25.1	0.1	0.0	0.1	0.0	0.0	31.9	9.5	31.4	0.0	15.6	0.0	48.4	38.2	56.4	15.2	25.1	18.3	45.6	19.8	18.9	22.1	51.0	17.2	15.9	38.5	26.6	24.1	12.8	27.8	26.3	3.5	4.8	1.2	3.1	3.9	3.6	5.1	2.2	3.1	3.4
RETREG1	"FAM134B, FLJ20152, JK1"	ENSG00000154153	"Reticulophagy regulator 1"	Q9H6L5	5	16473038-16617058	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 45.0;skeletal muscle: 78.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 16.4;HSkMC: 18.1;MOLT-4: 11.9;RPTEC TERT1: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 4.0;T-cells: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012077			Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA012077: AB_2668621"	"unprognostic (1.63e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.35e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.48e-1)"	"prognostic favourable (5.25e-10)"	"unprognostic (3.75e-1)"	"unprognostic (9.96e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.58e-1)"	9.8	2.0	8.5	3.7	11.2	1.1	8.7	9.6	19.6	7.4	12.4	14.9	0.3	6.5	2.3	5.4	2.0	4.1	7.1	45.0	11.2	9.4	30.3	21.8	4.9	3.1	13.2	11.4	1.7	19.0	17.7	8.0	6.7	18.5	5.9	16.9	1.5	3.9	3.0	78.5	5.6	12.8	1.5	16.8	1.6	6.1	5.7	15.4	14.1	3.6	12.5	2.3	2.0	4.4	0.9	0.1	4.0	0.4	0.1	4.4	0.6	0.8	0.3	0.1	2.1	16.4	2.0	9.6	0.1	2.1	1.9	2.6	1.4	0.1	0.2	1.5	0.0	2.4	4.8	0.5	0.6	2.4	2.2	0.0	7.2	0.0	0.1	3.1	0.0	18.1	7.4	0.3	2.0	0.0	0.0	0.1	0.7	0.6	11.9	0.0	0.5	0.3	1.9	0.0	0.7	16.6	0.5	10.9	1.3	0.6	0.7	7.8	3.6	1.4	0.0	1.5	0.2	4.0	1.8	0.4	0.0	0.0	9.3	10.8	3.9	4.0	0.4	0.1	0.6	0.0	1.6	0.0	1.5	0.8	0.1	0.9	4.4	2.7	2.3	0.1	0.1	0.0	1.9	0.6	8.5	11.2	9.6	14.4	11.2	9.4	13.2	11.4	18.5	15.4
REX1BD	"C19orf60, FLJ20850, FLJ30108, FLJ34606, FLJ37391"	ENSG00000006015	"Required for excision 1-B domain containing"	Q96EN9	19	18588685-18592336	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 25.2;PC-3: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043414	Approved		Approved	Vesicles				Vesicles	Vesicles	"HPA043414: AB_10797141"	"unprognostic (1.12e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.87e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.60e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.50e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.02e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.48e-1)"	"prognostic favourable (8.47e-4)"	29.8	12.6	21.2	15.2	18.2	13.1	9.9	20.7	21.6	9.8	18.3	10.3	17.5	13.0	10.8	13.9	8.7	8.4	11.5	17.6	18.0	16.6	17.7	25.4	11.5	8.5	16.6	18.0	11.9	15.9	5.0	8.3	8.6	14.4	15.8	4.7	8.5	22.2	14.3	100.1	9.7	17.8	8.7	12.3	25.8	24.1	5.2	11.4	7.4	7.4	14.0	8.8	8.1	9.9	44.5	51.8	50.5	55.2	32.5	57.0	49.0	6.7	8.2	0.7	1.3	1.1	1.0	25.2	7.1	1.1	1.7	2.0	1.5	7.8	7.0	23.7	1.3	4.9	0.3	1.6	0.4	7.6	17.0	4.6	3.1	3.8	1.4	3.9	11.3	2.2	1.6	0.8	0.4	2.1	5.7	2.0	0.8	11.2	7.3	6.4	11.1	35.0	8.0	2.1	17.7	2.4	6.1	3.4	13.1	3.3	3.3	7.9	1.8	3.3	7.0	0.7	7.2	9.8	4.1	20.2	6.3	4.1	6.7	7.1	3.3	28.1	55.2	50.5	55.7	47.3	56.8	44.5	57.0	49.9	51.8	34.3	52.6	49.1	31.6	32.5	43.7	44.8	45.1	49.0	21.2	18.2	20.7	21.6	18.0	16.6	16.6	18.0	14.4	11.4
RGMA	"RGM, RGMa"	ENSG00000182175	"Repulsive guidance molecule BMP co-receptor a"	Q96B86	15	93035273-93089204	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.0;skeletal muscle: 85.5"	"Cell line enhanced"	"Detected in some"		"AF22: 30.4;BEWO: 8.9;MOLT-4: 9.0;NTERA-2: 13.6"	"Cancer enriched"	"Detected in many"	6	"glioma: 26.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012343, HPA039880, HPA044222"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	1400000	1400000	Nucleoplasm	Nucleoplasm	"CAB012343: AB_777667, HPA039880: AB_2676723, HPA044222: "	"unprognostic (3.21e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.96e-3)"	"unprognostic (5.73e-2)"	"unprognostic (4.72e-3)"	"unprognostic (2.53e-2)"	"prognostic favourable (2.78e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"unprognostic (6.25e-2)"	"unprognostic (3.59e-4)"	"unprognostic (8.11e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.98e-5)"	12.2	3.3	17.4	17.6	24.7	1.8	9.3	11.0	59.0	21.0	22.2	22.2	0.9	9.1	21.8	9.4	23.1	12.1	9.5	7.7	19.3	16.2	2.3	1.6	2.8	3.1	23.0	12.8	16.6	9.1	1.9	2.1	2.5	30.9	5.5	6.5	2.3	16.2	7.0	85.5	4.9	12.3	46.9	36.8	2.2	26.6	15.8	23.1	0.2	2.9	12.2	5.6	4.1	8.8	1.3	0.7	1.7	1.0	0.7	0.5	0.2	1.2	0.2	30.4	0.5	6.4	3.6	8.9	0.2	0.0	0.0	0.0	0.3	0.4	0.1	0.1	0.2	2.0	5.0	0.1	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.1	3.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	9.0	0.1	13.6	0.0	7.9	7.0	0.0	0.0	0.3	3.2	1.8	0.3	0.1	0.0	2.4	1.6	0.0	0.0	6.6	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.8	1.4	0.7	0.6	0.4	1.0	0.3	0.6	0.5	0.5	0.1	1.3	0.4	0.5	1.7	0.7	0.4	0.7	0.3	0.2	17.4	24.7	11.0	21.3	19.3	16.2	23.0	12.8	30.9	23.1
RGS9BP	"FLJ45744, PERRS, R9AP, RGS9"	ENSG00000186326	"Regulator of G protein signaling 9 binding protein"	Q6ZS82	19	32675407-32678300	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 38.3;skeletal muscle: 15.8"	"Cell line enhanced"	"Detected in some"		"HEL: 10.4;HMC-1: 2.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"pons and medulla: 6.8"	"Cell type enhanced"	"Detected in some"		"gdTCR: 1.4;memory CD8 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049791	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA049791: AB_2680884"	"unprognostic (2.82e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.20e-7)"	"unprognostic (1.49e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.71e-2)"	"unprognostic (6.74e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.29e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.34e-2)"	0.4	0.5	0.8	0.3	1.1	0.3	0.4	0.2	0.7	0.3	0.4	1.4	0.2	0.4	0.3	0.6	1.1	0.4	0.3	6.7	1.0	0.8	0.9	0.3	0.9	0.3	1.1	0.3	0.3	0.4	0.4	0.6	0.4	6.8	1.3	0.3	38.3	0.5	0.6	15.8	0.6	0.3	7.4	1.3	0.4	0.4	0.9	0.9	0.1	0.4	4.3	0.3	2.3	1.0	0.0	0.3	0.0	0.9	0.5	1.5	0.0	0.2	0.2	0.0	0.9	0.5	0.2	0.5	0.0	0.5	0.3	0.2	0.2	0.3	0.4	0.5	0.1	0.0	1.8	0.1	0.1	0.5	0.2	10.4	0.3	0.0	0.2	0.3	2.8	0.0	0.5	0.0	0.4	0.0	0.9	1.5	0.2	0.4	0.0	1.7	0.0	2.0	0.1	0.4	0.2	0.0	0.1	0.3	0.1	0.0	1.1	0.1	1.0	0.5	0.0	0.5	0.7	0.2	0.3	0.6	0.7	0.1	0.3	0.6	0.8	0.0	0.3	0.0	1.4	0.9	0.0	0.0	0.2	1.5	0.3	0.0	0.0	0.4	0.0	0.5	0.3	0.0	0.0	0.0	0.8	1.1	0.2	0.7	1.0	0.8	1.1	0.3	6.8	0.9
RHOBTB1	KIAA0740	ENSG00000072422	"Rho related BTB domain containing 1"	O94844	10	60869438-61001440	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 50.9;skeletal muscle: 63.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.6;NK-cell: 1.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040205, HPA040226"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA040205: AB_2676883, HPA040226: AB_10795377"	"unprognostic (1.25e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.57e-2)"	7.6	9.8	2.7	2.0	5.8	0.5	4.5	0.8	5.0	8.8	4.7	7.2	16.5	3.4	10.2	4.9	1.9	6.8	6.3	6.6	3.7	2.5	20.5	3.4	5.4	1.4	6.7	2.3	6.9	6.0	7.4	2.2	50.9	4.6	4.9	2.6	13.3	1.4	20.3	63.5	1.9	3.5	7.7	3.8	7.4	11.7	8.5	5.7	0.6	2.3	5.2	0.9	5.0	5.2	0.5	1.6	0.7	0.6	1.3	0.0	1.3	0.1	6.1	9.3	0.0	4.4	3.9	0.0	2.7	2.5	2.2	3.4	0.3	0.1	0.0	11.5	14.3	0.1	2.7	0.8	2.7	0.0	2.5	0.5	4.5	33.9	4.9	0.6	0.2	5.7	1.5	1.4	1.4	10.7	5.0	0.0	9.9	0.2	2.5	0.0	4.0	4.0	2.2	13.1	3.2	7.4	0.3	2.6	10.0	3.2	3.6	3.5	0.7	1.2	9.5	4.4	11.5	0.1	2.9	0.0	0.0	0.0	2.1	2.0	2.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.7	1.3	0.6	0.0	0.0	1.3	2.7	5.8	0.8	5.0	3.7	2.5	6.7	2.3	4.6	5.7
RILP	FLJ31193	ENSG00000167705	"Rab interacting lysosomal protein"	Q96NA2	17	1646145-1650077	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 40.4"	"Cell line enhanced"	"Detected in many"		"HEL: 18.4;HMC-1: 9.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 5.9;intermediate monocyte: 1.9;myeloid DC: 4.0;neutrophil: 5.2;plasmacytoid DC: 2.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 4.0;granulocytes: 5.2;monocytes: 5.9"	"Low region specificity"	"Detected in many"																		"prognostic favourable (7.97e-4)"	"unprognostic (7.93e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.84e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.93e-1)"	"prognostic favourable (8.51e-5)"	"unprognostic (2.26e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (7.12e-4)"	13.6	8.3	3.0	2.6	5.6	9.5	7.7	5.0	10.4	2.4	11.1	2.2	5.8	9.9	3.0	4.4	3.4	3.6	6.9	21.0	2.6	2.9	7.3	16.4	7.6	2.4	3.4	5.4	2.2	6.3	5.4	2.3	3.8	6.2	3.7	3.6	8.6	7.9	3.9	40.4	2.7	16.5	3.0	1.4	7.8	8.6	2.0	2.5	1.5	15.2	7.6	3.0	6.6	3.4	0.4	4.0	5.2	5.9	0.6	0.4	1.1	1.4	1.0	0.2	1.8	1.9	2.7	3.2	0.7	1.1	1.7	0.7	2.1	0.5	0.1	3.5	1.3	2.4	0.2	0.2	0.3	0.2	2.2	18.4	0.5	3.1	1.8	0.1	9.7	2.0	0.7	0.4	0.2	1.4	6.1	0.1	0.5	1.3	0.8	1.3	0.3	5.8	3.7	0.0	0.5	0.1	1.8	0.1	0.3	2.2	1.2	1.1	1.1	0.2	4.9	0.6	0.4	1.6	0.7	0.1	0.3	0.0	1.9	0.8	0.2	0.5	5.9	0.8	0.3	1.9	0.1	0.4	0.3	0.1	4.0	0.0	0.4	0.1	5.2	0.6	0.3	2.4	0.3	1.1	3.0	5.6	5.0	10.4	2.6	2.9	3.4	5.4	6.2	2.5
RNF123	"FLJ12565, KPC1"	ENSG00000164068	"Ring finger protein 123"	Q5XPI4	3	49689499-49721529	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065983, HPA071879"	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA065983: AB_2685592, HPA071879: AB_2686468"	"unprognostic (2.68e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.51e-2)"	"unprognostic (5.03e-3)"	"prognostic favourable (1.33e-8)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.83e-1)"	5.3	8.0	7.7	8.0	10.4	17.5	5.0	13.8	13.6	5.2	6.8	6.2	7.8	12.7	6.4	8.0	7.5	6.4	7.0	12.9	8.5	6.8	8.4	21.8	5.7	6.1	7.3	6.6	5.1	7.7	8.9	8.4	7.3	6.6	7.3	4.8	7.6	6.9	6.7	81.2	7.7	12.5	6.2	6.7	7.6	6.9	8.8	7.8	8.3	6.2	12.0	9.1	6.6	4.8	11.3	12.7	11.8	10.9	7.7	11.4	5.3	6.7	9.5	11.4	11.7	17.3	10.7	12.3	8.8	11.7	11.2	12.5	10.1	11.7	16.4	8.0	12.5	8.5	8.6	13.3	7.9	10.9	11.7	13.4	18.8	22.2	17.3	12.9	14.5	13.5	13.1	10.5	12.3	11.6	14.0	14.3	9.5	10.1	13.6	21.0	6.2	15.4	6.4	6.9	17.0	15.4	11.4	7.8	15.6	12.1	10.8	13.4	11.1	23.3	11.9	9.9	12.1	8.9	10.8	19.4	19.0	6.6	14.0	16.4	14.8	11.8	10.9	7.9	11.4	9.5	6.8	9.8	7.2	6.8	8.6	11.3	8.7	8.2	6.3	7.7	9.7	12.7	5.5	5.3	7.7	10.4	13.8	13.6	8.5	6.8	7.3	6.6	6.6	7.8
RNF157	KIAA1917	ENSG00000141576	"Ring finger protein 157"	Q96PX1	17	76142453-76240373	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.5;skeletal muscle: 52.2;testis: 24.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 41.3;U-266/70: 21.9;U-266/84: 17.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 2.5;T-cells: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021854, HPA021991, HPA023922"	Uncertain		Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus"	"Golgi apparatus"	"HPA021854: AB_10600307, HPA021991: AB_10601112, HPA023922: AB_10602202"	"unprognostic (4.21e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.63e-3)"	"unprognostic (4.93e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.04e-3)"	"unprognostic (4.02e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.69e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.38e-1)"	10.5	3.5	21.0	3.4	19.4	2.3	2.5	10.7	36.5	1.5	7.6	8.0	0.4	8.2	1.9	3.6	1.5	2.4	1.8	3.6	26.4	15.5	5.1	1.4	1.4	4.5	19.7	12.0	1.4	3.6	8.8	2.7	2.1	25.3	1.8	6.6	6.8	1.9	2.0	52.2	1.5	7.3	2.2	11.3	3.0	2.4	24.7	5.9	0.0	3.8	1.5	2.8	1.5	0.5	0.7	0.4	2.5	0.3	1.1	8.5	1.4	0.1	3.4	12.4	4.5	4.0	2.0	5.7	0.1	3.9	0.8	0.4	1.4	1.3	0.0	1.8	0.3	0.1	10.9	0.0	0.7	41.3	3.7	0.0	1.2	1.9	0.6	0.5	4.7	1.1	0.0	1.5	0.0	0.1	6.4	0.1	1.5	3.3	1.8	0.3	2.0	8.8	0.0	0.1	0.0	1.5	1.3	2.2	10.2	2.2	0.0	4.9	0.3	2.1	0.0	0.8	1.0	6.1	3.9	21.9	17.6	0.0	0.3	0.0	6.3	2.5	0.3	0.4	2.3	0.2	4.9	0.3	5.1	4.0	0.2	0.7	8.5	5.5	1.7	1.1	0.3	0.4	2.1	1.4	21.0	19.4	10.7	36.5	26.4	15.5	19.7	12.0	25.3	5.9
RORC	"NR1F3, RORG, RZRG, TOR"	ENSG00000143365	"RAR related orphan receptor C"	P51449	1	151806071-151831872	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 69.8;skeletal muscle: 63.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.1;Karpas-707: 11.0;MOLT-4: 5.6;RPMI-8226: 5.8;SK-BR-3: 5.0;T-47d: 8.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebellum: 7.0;pons and medulla: 2.4"	"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 28.3"	"Lineage enriched"	"Detected in single"	44	"T-cells: 28.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA065620			Supported	"Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA065620: AB_2685521"	"unprognostic (6.51e-2)"	"unprognostic (7.78e-2)"	"prognostic favourable (1.83e-4)"	"unprognostic (9.20e-2)"	"unprognostic (3.05e-4)"	"unprognostic (6.29e-5)"	"unprognostic (1.13e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.42e-1)"	"prognostic favourable (2.94e-5)"	"unprognostic (2.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.80e-2)"	1.3	1.6	0.4	3.4	0.9	0.0	3.3	7.0	0.3	2.7	10.0	0.7	19.8	4.2	1.2	6.7	3.4	8.7	3.5	4.8	0.4	0.5	13.3	30.8	8.7	0.7	0.9	0.3	1.3	30.3	8.5	9.4	0.2	2.4	7.0	4.0	2.8	27.8	33.4	63.8	9.8	10.3	0.8	0.3	0.7	7.7	6.4	1.1	69.8	15.6	11.1	4.0	2.4	1.7	0.0	0.1	0.0	0.0	0.6	28.3	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	21.1	0.0	0.0	2.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.1	5.6	0.0	0.0	0.0	0.0	0.0	5.8	0.3	0.0	0.0	0.2	0.1	5.0	0.0	8.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.9	0.0	28.3	0.0	4.4	4.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	3.0	0.6	0.4	0.9	7.0	0.3	0.4	0.5	0.9	0.3	2.4	1.1
RPL3L		ENSG00000140986	"Ribosomal protein L3 like"	Q92901	16	1943974-1957606	"Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 49.0;skeletal muscle: 148.3;tongue: 36.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 7.6;Karpas-707: 5.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049136	Enhanced		Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA049136: AB_2680648"	"unprognostic (2.53e-1)"	"unprognostic (2.63e-2)"	"unprognostic (9.27e-4)"	"unprognostic (6.38e-4)"	"unprognostic (4.36e-2)"	"unprognostic (3.48e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.32e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.32e-3)"	"unprognostic (4.60e-2)"	1.1	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.5	1.4	0.0	0.1	49.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	2.8	0.0	148.3	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.4	36.7	2.1	0.0	0.0	1.8	1.7	4.9	1.5	0.9	1.4	0.5	2.1	2.4	0.5	2.3	0.1	0.1	1.4	0.9	0.0	0.1	0.0	7.6	4.1	1.3	1.4	0.0	2.1	0.2	0.2	0.0	1.0	1.2	0.8	1.7	2.6	0.0	0.5	0.9	0.2	0.3	0.2	0.2	0.0	0.8	5.6	0.1	1.2	1.6	1.9	1.3	4.9	0.7	0.7	1.7	0.3	0.8	3.3	1.0	1.0	2.7	1.2	1.4	1.1	1.1	1.1	2.8	1.6	0.8	2.5	1.1	1.1	1.6	0.6	0.4	1.6	1.5	1.3	1.4	1.1	0.9	1.4	1.1	1.2	0.5	1.8	1.2	1.4	4.9	0.9	1.0	1.7	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RPP14	P14	ENSG00000163684	"Ribonuclease P/MRP subunit p14"	O95059	3	58306247-58324695	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 53.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036194	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA036194: AB_10672082"	"unprognostic (6.05e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-3)"	"unprognostic (3.76e-2)"	"prognostic favourable (3.07e-10)"	"unprognostic (5.19e-3)"	"unprognostic (2.36e-1)"	"prognostic unfavourable (2.96e-4)"	"unprognostic (5.78e-2)"	7.1	8.5	8.3	5.7	12.9	5.3	7.1	15.8	10.7	6.6	8.6	5.9	6.6	10.2	8.2	7.8	8.5	7.4	6.2	11.8	7.2	6.8	11.2	15.0	5.6	7.6	6.5	9.9	8.4	11.9	10.8	9.4	6.0	7.2	7.4	8.2	9.0	8.5	7.0	53.5	7.4	9.1	11.7	5.5	7.7	7.7	9.1	5.9	6.3	8.1	18.5	8.5	7.2	7.0	4.6	6.6	4.7	9.8	9.8	6.4	3.5	10.1	8.0	9.4	7.4	7.8	8.4	10.3	8.6	9.2	12.3	13.9	12.2	6.7	12.1	2.0	11.5	6.2	14.0	12.7	12.0	8.4	7.4	11.5	9.6	6.6	7.7	19.8	9.6	9.2	12.3	14.6	14.0	9.7	9.9	8.7	11.9	5.5	13.4	7.0	12.3	15.3	5.5	7.4	11.7	9.0	14.5	5.9	10.4	8.0	9.6	11.5	9.2	9.6	8.8	9.3	10.4	9.8	16.2	13.0	22.2	17.5	10.7	13.9	6.6	3.0	5.7	4.7	4.2	4.9	5.6	4.1	5.5	5.8	6.6	4.6	6.4	6.2	2.6	9.8	9.8	6.2	3.0	3.5	8.3	12.9	15.8	10.7	7.2	6.8	6.5	9.9	7.2	5.9
RPP25L	"bA296L22.5, C9orf23, MGC29635"	ENSG00000164967	"Ribonuclease P/MRP subunit p25 like"	Q8N5L8	9	34610486-34612104	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052187, HPA059698"	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA052187: AB_2681755, HPA059698: AB_2684106"	"unprognostic (1.56e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.44e-1)"	"prognostic favourable (3.01e-9)"	"unprognostic (4.63e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.40e-1)"	"prognostic favourable (8.21e-4)"	7.4	10.1	11.1	7.9	13.8	4.9	9.3	8.6	14.0	8.2	18.0	7.2	14.0	15.4	9.9	11.4	13.3	11.8	10.9	19.9	9.8	8.8	11.1	19.9	9.3	10.1	10.1	9.1	11.7	20.4	6.3	7.6	11.0	7.5	14.4	8.2	6.4	15.7	9.5	56.0	9.7	18.4	9.3	7.1	11.4	8.6	10.9	6.1	14.4	14.8	21.9	11.3	11.0	10.4	40.7	30.1	41.5	35.4	32.5	41.7	24.8	18.8	24.6	10.0	9.7	10.3	9.5	10.0	8.1	8.5	13.5	15.5	10.8	12.8	14.5	12.6	4.9	12.7	15.1	20.4	4.8	29.4	20.3	8.7	18.3	15.8	21.9	8.9	13.3	16.9	19.7	11.2	26.1	14.1	13.9	15.6	10.2	20.1	18.5	33.6	9.2	22.3	16.5	10.6	14.6	14.4	9.9	6.7	3.9	14.9	16.8	9.5	15.3	15.8	6.4	4.2	12.4	10.2	6.7	7.6	13.3	16.6	12.8	18.6	20.3	41.5	35.4	33.3	25.6	28.8	31.6	34.9	30.2	26.9	30.1	40.7	35.5	33.5	32.9	32.5	33.6	24.5	41.7	24.8	11.1	13.8	8.6	14.0	9.8	8.8	10.1	9.1	7.5	6.1
RPUSD4	FLJ14494	ENSG00000165526	"RNA pseudouridylate synthase domain containing 4"	Q96CM3	11	126202094-126211692	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 72.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039689	Approved		Approved	Nucleoplasm,Mitochondria				Nucleoplasm	Nucleoplasm	"HPA039689: AB_10673537"	"unprognostic (2.02e-2)"	"unprognostic (3.65e-1)"	"prognostic favourable (6.14e-4)"	"unprognostic (3.16e-3)"	"unprognostic (2.90e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (1.32e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.44e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.47e-2)"	7.5	6.8	5.1	7.7	7.8	6.0	7.8	8.2	9.6	6.3	6.0	4.8	7.6	6.4	7.0	6.8	7.8	7.2	5.2	13.2	5.1	4.9	6.3	10.2	5.0	7.7	6.5	8.1	10.1	16.1	5.7	5.1	4.5	7.2	6.9	6.9	5.2	9.5	8.2	72.0	8.9	5.9	8.3	4.8	7.6	9.3	7.0	7.1	6.2	7.7	18.2	9.3	6.2	12.0	9.8	11.0	1.0	8.5	8.4	15.2	8.7	6.6	6.6	7.9	9.5	12.5	16.3	5.7	7.5	10.4	8.1	7.2	20.4	13.1	15.5	7.3	6.6	11.6	18.2	11.4	8.6	13.0	10.1	36.3	7.1	19.0	8.2	19.0	8.3	15.0	17.3	8.8	11.1	16.2	22.6	11.5	9.6	6.4	11.9	22.0	8.7	11.7	13.9	12.1	14.4	12.4	9.6	13.8	9.4	9.5	14.2	7.0	21.2	10.1	9.8	9.2	6.3	6.8	8.7	4.9	5.1	13.4	4.1	21.7	9.4	1.0	8.5	0.8	10.8	7.7	14.0	9.8	13.3	10.3	11.0	9.5	15.2	12.2	0.7	8.4	8.3	4.7	12.2	8.7	5.1	7.8	8.2	9.6	5.1	4.9	6.5	8.1	7.2	7.1
RRAGD	"bA11D8.2.1, DKFZP761H171"	ENSG00000025039	"Ras related GTP binding D"	Q9NQL2	6	89364636-89412270	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 27.8;SCLC-21H: 14.5;U-266/70: 35.2;U-266/84: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 6.3;monocytes: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068664	Approved		Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"	"Nucleoplasm, Centrosome"	"HPA068664: AB_2686016"	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (7.80e-4)"	"unprognostic (3.75e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (8.47e-8)"	"unprognostic (8.41e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.40e-2)"	8.1	8.4	9.2	2.6	12.8	8.9	8.8	22.4	16.3	8.7	3.3	7.9	3.1	2.2	2.1	6.6	12.8	11.9	3.7	29.9	8.6	7.4	21.8	5.0	6.4	2.8	8.5	7.9	2.2	6.4	16.0	11.5	3.4	10.7	5.9	2.4	12.8	38.7	4.2	60.0	5.5	2.1	7.5	12.6	4.4	2.3	6.1	9.2	4.1	23.3	13.9	5.2	9.2	9.3	0.1	0.7	6.3	3.9	0.1	0.6	0.3	0.0	0.7	1.9	1.4	0.2	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.7	0.0	0.0	10.5	0.0	0.0	0.0	5.2	2.4	0.0	0.0	0.8	7.0	8.3	0.1	0.6	0.0	0.0	0.0	0.2	27.8	0.0	0.7	3.3	3.5	1.5	0.7	7.0	10.1	0.1	2.5	0.2	14.5	0.8	0.2	0.9	11.8	0.3	5.6	0.0	0.8	1.2	5.0	1.3	35.2	16.3	0.0	2.7	5.3	0.8	3.9	1.2	2.6	0.0	1.1	0.1	0.1	0.4	0.0	0.7	0.0	0.3	0.6	6.3	0.1	3.9	0.6	0.0	0.3	9.2	12.8	22.4	9.1	8.6	7.4	8.5	7.9	10.7	9.2
RYR3		ENSG00000198838	"Ryanodine receptor 3"	Q15413	15	33310945-33866121	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 28.8;skeletal muscle: 26.8"	"Cell line enhanced"	"Detected in some"		"A549: 7.0;RH-30: 10.6;RPTEC TERT1: 5.0"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	31	"basophil: 4.0"	"Lineage enriched"	"Detected in single"	31	"granulocytes: 4.0"	"Low region specificity"	"Detected in many"							HPA062004			Approved	Vesicles				Vesicles	Vesicles	"HPA062004: AB_2797267"	"unprognostic (5.85e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.26e-2)"	"unprognostic (8.03e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.10e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.91e-1)"	1.8	2.0	9.9	1.1	15.4	2.5	2.9	4.9	12.4	2.8	4.5	6.0	0.2	1.5	10.2	1.0	2.7	3.9	1.6	1.0	13.3	3.5	1.2	0.9	1.2	0.9	5.6	6.9	1.7	0.8	28.8	1.2	1.0	10.7	1.8	2.9	0.6	1.4	3.9	26.8	1.2	1.3	7.4	5.9	1.4	1.6	1.6	7.9	0.0	1.1	1.5	1.4	2.1	2.6	0.1	0.0	4.0	0.0	0.0	0.1	0.0	0.3	7.0	1.5	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	1.6	0.1	0.4	0.6	0.0	0.2	0.0	0.0	0.0	0.4	0.2	1.4	0.2	0.0	0.0	1.0	0.7	0.0	0.0	0.1	0.0	0.0	0.4	2.6	0.0	0.4	0.2	0.3	1.1	0.1	0.5	10.6	0.2	5.0	0.5	0.1	0.5	0.8	0.0	0.2	0.1	0.3	0.9	0.2	0.1	0.0	0.7	0.3	1.2	0.7	0.5	2.3	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	15.4	4.9	12.4	13.3	3.5	5.6	6.9	10.7	7.9
SAMD4A	"DKFZP434H0350, hSmaug1, KIAA1053, SAMD4, Smaug, SMG, SMGA"	ENSG00000020577	"Sterile alpha motif domain containing 4A"	Q9UPU9	14	54567097-54793315	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 48.7;testis: 44.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.9;non-classical monocyte: 3.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043061, HPA065309"	Approved		Approved	"Cell Junctions,Cytosol"				"Cell Junctions"	"Cell Junctions"	"HPA043061: AB_2678299, HPA065309: AB_2685462"	"unprognostic (1.46e-1)"	"unprognostic (8.10e-3)"	"unprognostic (9.66e-3)"	"unprognostic (1.18e-4)"	"unprognostic (2.79e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.27e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.51e-1)"	7.5	2.9	7.8	9.0	6.0	0.5	4.0	5.6	7.0	8.9	10.1	8.0	3.0	2.3	11.1	5.5	5.4	4.2	6.5	28.2	5.5	7.3	2.5	7.6	6.4	2.9	10.6	5.2	2.1	4.1	4.8	2.0	6.0	10.8	7.7	3.3	3.4	2.4	6.3	48.7	2.6	3.3	23.8	26.5	4.6	3.9	44.6	6.1	0.7	2.4	1.3	4.8	15.9	5.8	0.9	2.6	0.0	3.9	0.0	0.4	0.8	16.7	1.7	3.3	1.7	7.1	11.3	6.2	14.6	21.0	11.6	11.9	17.3	4.0	1.0	7.5	20.2	11.7	3.2	7.3	16.4	9.6	1.6	0.0	2.0	3.5	4.0	0.0	0.1	6.3	2.5	8.3	12.4	9.0	1.3	0.0	5.4	1.1	0.2	0.0	1.6	4.1	0.5	6.7	0.0	5.4	5.4	0.5	5.5	2.3	2.8	7.6	11.1	0.2	18.3	13.8	22.8	3.4	4.5	0.1	0.0	0.0	3.9	0.3	4.4	0.0	2.3	0.0	0.0	3.9	0.0	0.3	0.0	0.0	2.6	0.9	0.0	0.0	0.0	0.0	3.6	0.0	0.4	0.8	7.8	6.0	5.6	5.7	5.5	7.3	10.6	5.2	10.8	6.1
SCN4B	LQT10	ENSG00000177098	"Sodium voltage-gated channel beta subunit 4"	Q8IWT1	11	118133377-118152888	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.4;skeletal muscle: 25.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.8;HBEC3-KT: 2.9;NTERA-2: 4.3;SH-SY5Y: 1.7;U-2 OS: 3.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	11	"basal ganglia: 731.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 122.8"	HPA017293	Approved									"HPA017293: AB_2184174"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.82e-3)"	"unprognostic (9.17e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.31e-4)"	20.5	5.4	1.9	1.2	36.4	0.1	6.1	11.7	21.7	2.4	2.6	2.0	0.5	2.4	3.7	1.8	5.4	5.5	3.2	11.0	3.1	2.9	1.4	0.6	8.7	2.0	5.3	2.1	0.7	5.0	6.4	2.4	1.9	28.7	2.1	2.2	4.3	2.8	2.6	25.6	3.8	4.6	7.0	5.5	0.5	3.0	0.8	8.7	1.5	10.4	9.5	1.1	3.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.8	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.3	2.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	36.4	11.7	21.7	3.1	2.9	5.3	2.1	28.7	8.7
SCX	"bHLHa41, bHLHa48, SCXA, SCXB"	ENSG00000260428	"Scleraxis bHLH transcription factor"	Q7RTU7	8	144266560-144268481	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 18.8;thyroid gland: 33.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 7.9;HaCaT: 8.5"	"Group enriched"	"Detected in all"	6	"endometrial cancer: 12.8;ovarian cancer: 34.4;thyroid cancer: 37.7"					"Cell type enriched"	"Detected in single"	6	"memory B-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"B-cells: 2.4"	"Region enhanced"	"Detected in some"		"cerebellum: 12.0"	"Region enriched"	"Detected in single"	4	"cerebellum: 4.7"	HPA043183	Uncertain									"HPA043183: AB_2678357"	"unprognostic (5.32e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.87e-3)"	"prognostic unfavourable (2.86e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.89e-3)"	0.5	1.1	0.4	1.3	0.0	0.8	0.0	3.0	0.9	4.8	2.8	0.0	0.0	1.4	2.2	4.5	1.7	0.2	3.7	5.5	0.0		0.4	0.1	0.4	0.7	0.0	0.0	0.9	2.8	2.7	2.3	0.3	10.3	1.8	0.3	4.2	3.3	0.5	18.8	1.6	1.8	0.9	0.0	1.3	2.3	4.7	0.0	7.6	33.2	4.5	0.5	1.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.7	0.2	0.9	0.0	0.1	7.9	0.2	0.1	0.2	0.1	0.3	2.4	2.2	2.4	0.4	8.5	0.0	0.0	0.0	1.1	1.5	0.5	2.8	0.3	0.3	0.1	3.6	0.1	0.9	0.0	0.4	0.0	0.4	1.0	0.2	5.0	0.8	1.7	1.9	3.7	2.7	0.4	1.4	0.2	3.4	0.3	1.5	0.9	3.1	3.4	4.0	1.6	0.5	0.7	5.9	2.7	0.4	2.6	0.8	0.5	1.5	2.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SDHA	"FP, SDH2, SDHF"	ENSG00000073578	"Succinate dehydrogenase complex flavoprotein subunit A"	P31040	5	218241-256700	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 100.1;skeletal muscle: 114.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034929, HPA041981, HPA064582"	Enhanced		Supported	Nucleoli,Mitochondria		780000	780000	Mitochondria	Mitochondria	"CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293"	"prognostic unfavourable (6.00e-4)"	"unprognostic (1.93e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (9.53e-8)"	"unprognostic (1.11e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.79e-1)"	17.6	31.4	15.3	11.5	20.3	10.6	12.8	18.8	29.0	10.2	29.4	17.3	10.0	44.3	11.3	12.1	15.3	12.6	14.8	100.1	15.8	14.5	36.5	55.4	10.7	11.7	19.6	19.3	14.5	14.7	23.2	9.5	9.2	29.7	10.7	24.6	14.5	17.3	12.0	114.0	11.5	39.9	16.5	13.2	13.9	21.2	14.6	14.8	15.7	12.5	39.6	12.5	13.2	11.1	28.3	31.9	29.1	29.2	27.1	48.9	32.4	18.4	29.9	12.3	20.1	21.2	15.9	33.4	14.2	18.1	24.5	25.0	32.4	25.1	22.8	45.0	16.2	23.9	21.7	29.0	14.5	48.6	19.9	11.6	82.6	42.0	13.1	14.4	15.1	15.8	18.7	18.3	9.7	26.5	18.6	19.0	11.5	28.2	19.1	39.0	4.2	37.9	24.7	17.9	44.2	52.2	24.5	13.6	7.8	67.0	43.3	17.6	26.3	18.3	19.2	18.2	17.9	10.8	11.7	20.2	8.6	16.8	17.6	20.9	11.5	17.8	24.4	29.1	36.4	29.2	32.1	28.3	34.8	35.1	31.9	24.5	34.5	31.7	5.9	27.1	24.1	20.5	48.9	32.4	15.3	20.3	18.8	29.0	15.8	14.5	19.6	19.3	29.7	14.8
SELENOW	"SELW, SEPW1"	ENSG00000178980	"Selenoprotein W"	P63302	19	47778572-47784686	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 258.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 62.5;HUVEC TERT2: 73.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.03e-1)"	"unprognostic (8.98e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.28e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.46e-3)"	"prognostic favourable (5.44e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.27e-1)"	30.7	18.5	106.3	17.3	78.4	7.0	34.2	39.9	70.6	41.7	56.4	42.9	14.5	22.7	28.1	28.7	41.8	46.7	37.6	151.1	102.1	59.3	17.2	13.2	29.7	16.0	86.3	52.7	27.3	22.6	13.6	17.7	23.7	59.1	37.5	29.2	27.9	34.2	45.2	258.1	45.6	30.4	62.3	63.3	18.3	26.1	11.9	47.6	6.3	28.5	60.2	11.9	42.6	28.3	27.3	25.4	64.4	40.3	27.8	62.2	56.6	10.9	10.2	19.7	19.1	14.3	33.3	6.6	11.6	7.3	9.7	6.8	3.2	7.9	0.0	9.7	16.2	8.2	31.6	49.2	11.1	32.3	7.5	4.5	5.5	3.7	17.5	1.0	19.5	32.1	62.5	14.6	11.5	73.4	6.2	4.1	36.4	13.3	18.9	13.4	9.9	9.2	3.8	2.6	3.0	19.3	9.4	10.2	7.0	11.8	28.8	9.9	16.4	4.9	29.6	10.1	22.6	7.3	20.2	7.0	22.3	2.0	10.9	13.3	23.6	35.5	28.9	64.4	49.4	33.2	41.2	27.3	52.8	48.8	22.6	23.3	53.5	45.9	3.1	27.8	40.3	25.4	62.2	56.6	106.3	78.4	39.9	70.6	102.1	59.3	86.3	52.7	59.1	47.6
SEMA4D	"C9orf164, CD100, coll-4, FLJ39737, SEMAJ"	ENSG00000187764	"Semaphorin 4D"	Q92854	9	89360787-89498130	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 107.1;skeletal muscle: 43.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 42.9;HMC-1: 33.1;MOLT-4: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015662, HPA023277"	Approved		Supported	"Endoplasmic reticulum,Vesicles"		4100000	4100000	Vesicles	Vesicles	"HPA015662: AB_1856671, HPA023277: AB_1856672"	"unprognostic (2.94e-2)"	"prognostic favourable (4.17e-4)"	"unprognostic (1.12e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.43e-1)"	"prognostic favourable (4.06e-5)"	3.9	5.6	18.0	18.6	20.7	14.3	3.6	7.7	20.9	4.0	5.9	54.0	3.1	6.1	3.9	7.4	9.3	6.6	7.2	4.9	28.2	18.8	8.4	2.0	6.7	32.0	42.6	15.0	4.1	4.6	4.9	5.3	3.2	27.5	4.9	5.8	2.9	6.7	4.2	43.3	8.8	9.6	3.3	107.1	19.2	9.4	6.1	23.3	25.3	4.9	3.1	27.6	8.3	5.3	2.6	4.6	21.2	4.1	4.7	14.0	7.8	4.0	3.0	2.8	4.1	0.1	0.2	6.5	0.4	0.2	0.8	0.6	2.0	4.6	15.5	1.7	0.0	2.1	2.5	1.2	0.3	42.9	2.5	6.5	1.0	0.2	0.5	8.6	33.1	0.1	0.9	0.2	0.1	1.6	1.5	10.6	0.0	6.7	38.9	10.8	6.9	0.1	12.4	0.9	4.3	5.5	4.2	6.7	4.4	1.1	3.6	0.1	3.4	4.7	1.0	0.0	2.6	0.3	2.0	11.9	5.1	2.2	2.0	10.5	2.5	7.3	4.1	20.4	13.3	3.8	8.0	2.6	10.6	11.1	1.5	1.6	12.2	14.0	21.2	4.7	4.1	4.6	9.5	7.8	18.0	20.7	7.7	20.9	28.2	18.8	42.6	15.0	27.5	23.3
SGCA	"A2, adhalin, ADL, DMDA2, LGMD2D, SCARMD1"	ENSG00000108823	"Sarcoglycan alpha"	Q16586	17	50164214-50175931	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 144.7"	"Cell line enriched"	"Detected in some"	15	"LHCN-M2: 41.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	7	"cerebellum: 3.0"	"Group enriched"	"Detected in some"	5	"intermediate monocyte: 2.4;memory B-cell: 5.3;myeloid DC: 3.8;naive B-cell: 5.2;non-classical monocyte: 3.1"	"Group enriched"	"Detected in many"	19	"B-cells: 5.3;dendritic cells: 3.8;monocytes: 3.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007537	Uncertain				"Intracellular and membrane"					"HPA007537: AB_1079944"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.43e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.07e-3)"	"unprognostic (4.96e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.15e-2)"	2.8	0.6	0.1	2.5	0.2	0.2	0.8	3.0	0.4	6.8	10.0	0.0	8.6	1.6	7.9	10.5	10.8	3.4	10.7	32.2	0.2	0.1	0.6	0.9	5.7	0.3	0.2	0.3	3.4	0.5	0.2	0.1	1.9	0.4	10.9	1.1	7.1	2.3	8.0	144.7	2.6	3.0	30.3	0.3	0.7	5.7	1.4	0.0	0.0	1.6	39.8	2.3	20.1	4.3	5.3	3.8	0.2	3.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	41.3	0.0	0.0	0.2	0.0	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.2	0.0	2.4	0.0	5.3	0.0	0.0	3.8	5.2	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.7	0.1	0.2	3.0	0.1	0.2	0.1	0.2	0.3	0.4	0.0
SH2B2	APS	ENSG00000160999	"SH2B adaptor protein 2"		7	102285091-102321711	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"skeletal muscle: 37.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.0;Karpas-707: 22.4;RPMI-8226: 16.4;U-266/70: 20.9;U-266/84: 36.5;U-698: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 5.2;neutrophil: 3.9"	"Group enriched"	"Detected in many"	5	"B-cells: 5.2;granulocytes: 3.9;monocytes: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051131	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA051131: AB_2681354"	"unprognostic (2.01e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.32e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.42e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.00e-2)"	"prognostic unfavourable (6.99e-7)"	"unprognostic (1.25e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.02e-3)"	"unprognostic (3.42e-2)"	5.5	1.3	4.2	11.8	5.1	3.9	2.4	6.5	4.3	2.9	2.0	1.3	0.0	3.1	3.3	1.1	2.3	2.9	2.2	1.7	2.7	5.0	3.2	1.1	9.2	12.6	3.6	1.5	2.2	2.6	1.9	1.9	5.7	4.3	2.9	1.1	0.9	2.0	1.5	37.8	2.4	3.5	1.9	5.0	16.7	2.9	2.2	4.1	0.6	2.8	2.6	10.4	3.1	3.9	5.2	0.7	3.9	3.3	0.0	0.2	0.1	1.3	1.0	1.1	2.4	0.2	0.1	10.2	0.4	0.1	0.3	0.2	0.3	0.2	23.0	2.4	0.1	1.3	0.2	0.3	0.1	2.9	1.0	0.0	0.6	0.2	0.2	0.1	0.8	0.2	0.3	0.2	0.0	0.0	0.1	22.4	0.4	2.4	0.1	4.0	2.6	4.2	2.9	1.2	16.4	0.8	0.3	1.1	4.2	0.8	2.0	0.5	0.3	3.0	0.0	0.3	2.3	4.0	0.4	20.9	36.5	31.0	1.4	0.8	0.5	0.0	0.6	0.0	0.2	3.3	0.0	1.4	0.0	0.0	0.7	5.2	0.0	0.0	3.9	0.0	1.3	0.0	0.0	0.1	4.2	5.1	6.5	2.9	2.7	5.0	3.6	1.5	4.3	4.1
SHISA2	"bA398O19.2, C13orf13, hShisa, PRO28631, TMEM46, WGAR9166"	ENSG00000180730	"Shisa family member 2"	Q6UWI4	13	26044597-26051031	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 12.9;skeletal muscle: 10.2;thyroid gland: 20.8"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 13.8;NTERA-2: 10.0;RH-30: 32.0;U-2197: 20.0"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA049752, HPA050172"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"				Nucleoplasm	Nucleoplasm	"HPA049752: , HPA050172: AB_2681041"	"unprognostic (2.08e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.41e-1)"	"unprognostic (9.71e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.20e-1)"	"prognostic favourable (3.30e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.17e-2)"	"prognostic favourable (2.43e-4)"	"unprognostic (5.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.51e-2)"	0.3	0.0	0.7	0.0	2.0	0.0	12.9	0.0	0.5	1.5	0.0			0.4	0.0	7.9	0.0	0.0	0.3	0.0	2.0	0.6	3.0	0.0	3.7	0.1	1.1		0.0	0.0	0.0	1.7	0.0		0.4	0.0		1.9	0.0	10.2	1.0	0.3	0.0	3.5	0.0	1.6	0.9			20.8		0.3	0.0	0.0	0.8	0.6	2.2	1.1	1.0	5.6	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.6	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.2	2.6	1.0	0.0	0.0	1.2	0.7	0.0	0.0	13.8	0.7	1.4	0.3	10.0	5.0	0.0	32.0	0.2	1.2	4.5	0.3	0.0	0.2	0.0	3.5	0.4	0.1	1.1	0.0	0.5	20.0	4.3	0.0	0.0	0.0	0.0	0.0	2.7	2.2	0.4	1.7	0.6	0.7	1.0	0.6	1.7	0.7	0.3	0.8	3.9	5.6	1.6	1.0	1.1	0.6	0.7	0.4										
SIM2	"bHLHe15, MGC119447, SIM"	ENSG00000159263	"Single-minded family bHLH transcription factor 2"	Q14190	21	36699133-36749917	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.3;kidney: 16.1;lymphoid tissue: 28.7;skeletal muscle: 15.7"	"Cell line enhanced"	"Detected in some"		"PC-3: 22.9;RPTEC TERT1: 28.8;RT4: 17.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 0.5"	"Group enriched"	"Detected in some"	4	"hypothalamus: 2.1;midbrain: 0.8"	HPA029295	Approved		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA029295: AB_10610425"	"unprognostic (1.17e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (8.62e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.30e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.16e-3)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-7)"	"unprognostic (2.98e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-2)"	"prognostic favourable (2.88e-4)"	0.5	0.3	0.8	0.1	2.3	0.0	0.1	2.4	2.3	2.8	0.2	0.2	0.0	0.1	0.3	1.5	31.3	0.3	0.2	0.1	2.5	1.1	16.1	0.1	0.1	0.1	1.4	0.7	0.1	0.1	1.2	1.7	0.1	0.3	6.8	0.0	0.2	0.4	0.0	15.7	0.3	0.1	0.0	0.4	0.1	5.5	0.2	1.3	0.0	0.2	11.0	28.7	1.5	0.4	0.3	0.7	0.0	0.0	0.0	0.8	0.0	3.2	5.0	0.2	0.2	0.0	0.0	5.0	0.1	0.0	0.4	0.0	2.6	7.6	0.1	4.6	0.1	1.7	2.5	0.0	0.2	3.9	7.9	0.1	7.2	0.2	0.0	0.0	0.0	0.8	0.7	0.0	1.4	0.0	0.1	0.0	8.3	1.9	0.0	0.0	0.2	22.9	0.0	0.1	0.1	28.8	17.3	0.2	0.3	8.2	0.0	0.7	2.1	0.2	0.3	0.0	1.4	0.5	0.2	0.1	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	2.3	2.4	2.3	2.5	1.1	1.4	0.7	0.3	1.3
SIRT2	SIR2L	ENSG00000068903	"Sirtuin 2"	Q8IXJ6	19	38878555-38899862	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 86.6;skeletal muscle: 108.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004573, HPA011165"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	Nucleoli	"CAB004573: AB_2188600, HPA011165: AB_1856900"	"unprognostic (2.15e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavourable (7.20e-7)"	"unprognostic (3.75e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.70e-1)"	14.1	11.0	30.2	8.1	36.0	10.7	9.1	14.3	38.8	11.0	8.4	78.1	4.0	9.3	9.7	7.8	17.1	12.9	10.7	20.3	36.9	23.5	9.0	12.0	10.8	8.8	52.3	20.5	17.3	9.5	10.1	6.2	7.7	40.8	9.8	7.6	5.8	14.9	11.2	108.7	13.7	9.3	12.8	86.6	9.9	9.0	7.9	46.3	3.2	10.1	23.4	8.9	10.6	7.1	13.2	21.5	28.0	33.0	16.6	23.5	22.1	8.1	5.1	4.4	11.0	25.3	17.4	3.0	6.0	10.7	9.4	12.2	9.2	5.2	2.8	13.1	11.2	4.4	8.0	12.9	5.7	13.0	8.3	5.5	5.8	5.5	17.8	3.8	12.2	18.1	15.6	7.7	9.2	16.4	5.2	22.6	14.3	4.6	7.7	3.0	0.7	7.2	10.2	12.4	7.8	7.5	7.3	11.1	5.0	7.0	9.4	6.6	4.2	9.9	15.6	12.7	2.8	19.6	8.9	9.3	4.5	6.5	10.2	9.6	11.7	19.5	27.3	28.0	23.5	33.0	14.6	12.2	11.4	16.1	21.1	13.2	7.5	12.5	20.7	16.6	25.8	21.5	15.5	22.1	30.2	36.0	14.3	38.8	36.9	23.5	52.3	20.5	40.8	46.3
SIX1	DFNA23	ENSG00000126778	"SIX homeobox 1"	Q15475	14	60643415-60658259	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 39.1;salivary gland: 55.1;skeletal muscle: 59.0"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 52.7;RH-30: 28.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"olfactory region: 1.2;pons and medulla: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001893, CAB058690"	Enhanced		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoplasm	"CAB058690: AB_2665581, HPA001893: AB_1079991"	"unprognostic (3.62e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.09e-2)"	"prognostic unfavourable (8.92e-6)"	"unprognostic (1.33e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.04e-3)"	"prognostic favourable (3.94e-4)"	"unprognostic (1.40e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.06e-8)"	"unprognostic (8.61e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	7.1	0.4	0.3	0.1	0.5	0.1	4.7	0.3	0.6	7.4	0.2	0.2	0.0	0.1	0.2	2.1	1.3	0.5	0.4	0.4	0.3	0.3	0.3	0.2	1.8	0.3	0.4	1.2	0.3	0.3	16.8	39.1	0.1	4.5	8.7	0.1	2.0	55.1	0.2	59.0	0.4	0.2	0.7	0.5	0.2	0.5	1.6	0.0	6.5	2.4	22.5	3.0	1.4	9.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	8.2	1.9	0.2	11.7	6.8	8.0	0.1	2.0	4.5	2.3	2.0	0.0	3.7	0.0	1.1	0.4	2.7	3.9	3.6	0.8	0.0	9.4	0.9	0.8	2.7	0.0	0.0	0.1	6.0	1.7	1.6	0.3	0.1	2.6	0.0	52.7	1.3	0.0	0.2	0.0	4.7	0.0	28.8	0.0	2.2	6.4	1.1	0.1	2.3	0.1	2.4	1.3	0.2	6.7	3.1	3.2	3.6	2.9	0.2	0.0	0.0	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.5	0.3	0.3	0.4	1.2	4.5	0.0
SIX2		ENSG00000170577	"SIX homeobox 2"	Q9NPC8	2	45005161-45009430	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 23.3;skeletal muscle: 21.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 23.4;LHCN-M2: 21.5;RH-30: 14.8;SCLC-21H: 25.3;U-2197: 16.4;U-698: 19.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056958			Supported	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	Nucleoplasm	"HPA056958: AB_2683287"	"unprognostic (1.14e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.09e-6)"	"unprognostic (1.28e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.06e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.53e-9)"	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-5)"	"unprognostic (1.05e-1)"	5.8	0.2	0.2	0.2	0.4	0.1	3.4	0.5	0.4	13.3	0.4	0.2	0.0	0.1	1.1	0.8	0.8	0.1	0.1	0.8	0.1	0.0	0.4	0.1	0.3	0.2	0.9	1.8	0.3	4.6	5.7	13.5	0.3	1.4	5.2	0.1	9.3	23.3	1.3	21.0	0.3	0.1	0.4	0.8	0.1	7.4	1.1	0.0	3.9	0.7	4.0	0.8	1.7	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	6.2	23.4	0.0	0.1	1.0	0.4	0.0	0.1	0.0	0.0	1.0	0.0	0.0	2.1	3.9	0.2	0.0	1.1	0.0	7.5	0.0	0.0	0.0	2.1	1.1	0.0	4.8	0.0	0.7	0.0	0.0	21.5	0.7	0.0	1.2	0.2	4.7	0.0	14.8	0.0	0.0	1.2	25.3	0.2	3.2	0.1	0.0	0.1	1.8	0.3	0.4	1.2	16.4	0.0	0.5	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.4	0.1	0.0	0.9	1.8	1.4	0.0
SIX4	AREC3	ENSG00000100625	"SIX homeobox 4"	Q9UIU6	14	60709528-60724348	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 20.4;salivary gland: 16.4;skeletal muscle: 19.3"	"Cell line enhanced"	"Detected in many"		"A-431: 21.0;RH-30: 21.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA031794	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA031794: AB_10602928"	"unprognostic (2.23e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.63e-4)"	"unprognostic (9.74e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.39e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.08e-1)"	2.0	1.5	0.9	0.6	0.9	0.3	4.8	4.3	4.5	3.3	0.7	0.1	3.3	0.4	1.6	1.3	0.5	3.5	1.1	1.5	1.0	1.0	1.4	0.5	2.1	0.2	1.0	2.2	2.9	3.3	20.4	6.3	2.1	3.6	4.0	0.3	0.8	16.4	2.7	19.3	0.5	0.5	0.9	1.8	0.3	2.0	0.7	1.1	0.8	3.9	2.4	1.4	1.7	14.3	0.2	0.1	1.0	0.1	0.3	0.2	0.0	21.0	1.6	1.3	5.6	5.0	6.3	9.9	4.8	7.2	1.4	2.1	1.0	6.7	0.0	3.2	2.4	8.0	5.7	3.9	3.3	1.7	4.6	0.6	2.1	1.4	1.6	2.1	0.2	2.9	1.8	1.3	6.7	1.2	4.1	0.0	7.3	5.2	0.0	0.2	3.6	9.1	1.3	21.3	0.0	2.5	12.1	3.4	0.3	3.0	4.8	1.3	6.5	0.1	4.1	4.4	9.8	3.0	4.3	1.4	0.0	0.0	1.5	0.0	0.8	0.3	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.1	1.0	0.3	0.1	0.1	0.0	0.0	0.9	0.9	4.3	4.5	1.0	1.0	1.0	2.2	3.6	1.1
SLC16A10	"MCT10, TAT1"	ENSG00000112394	"Solute carrier family 16 member 10"	Q8TF71	6	111087503-111231194	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 25.1;skeletal muscle: 33.4"	"Cell line enhanced"	"Detected in many"		"HAP1: 28.8;HEK 293: 12.4;RPMI-8226: 23.8"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 4.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.7"	"Low region specificity"	"Detected in many"							HPA016860	Approved		Supported	"Vesicles,Cell Junctions"				"Vesicles, Cell Junctions"	"Vesicles, Cell Junctions"	"HPA016860: AB_2189211"	"unprognostic (2.03e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.56e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.86e-3)"	"unprognostic (5.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.91e-1)"	7.6	4.9	1.8	2.4	5.4	0.4	1.1	9.5	2.0	0.8	4.8	1.7	1.7	7.6	0.7	1.6	0.7	1.1	1.0	2.8	1.8	1.0	8.1	9.8	6.1	1.8	0.8	0.5	1.2	25.1	8.9	1.5	17.4	5.6	1.2	1.3	3.6	3.5	6.0	33.4	12.1	6.0	0.8	1.0	2.7	3.9	3.5	0.8	19.6	2.2	1.5	0.9	4.4	1.4	0.5	0.3	0.8	0.2	0.3	4.7	0.3	0.6	0.6	0.2	1.3	0.0	0.0	2.3	0.0	0.1	0.5	0.7	5.0	0.2	4.0	0.9	0.1	0.0	28.8	0.0	0.5	0.0	12.4	4.7	0.3	4.7	0.0	4.9	4.8	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	2.0	6.1	0.6	8.9	1.8	3.5	4.3	23.8	0.0	0.4	6.7	2.1	0.1	0.6	1.1	1.1	0.7	0.0	0.1	1.1	0.3	1.6	1.9	0.0	1.0	0.2	3.7	0.5	0.8	0.2	0.1	0.2	0.2	0.2	0.2	1.1	0.3	0.0	0.5	4.7	4.0	0.8	0.3	0.1	0.3	4.0	0.3	1.8	5.4	9.5	2.0	1.8	1.0	0.8	0.5	5.6	0.8
SLC16A3	"MCT3, MCT4"	ENSG00000141526	"Solute carrier family 16 member 3"	O15427	17	82228397-82261129	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"CAB017490, HPA021451"	Approved		Supported	"Nuclear membrane,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB017490: AB_2189333, HPA021451: AB_1853663"	"unprognostic (2.49e-1)"	"prognostic unfavourable (6.07e-4)"	"unprognostic (4.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-3)"	"unprognostic (4.26e-3)"	"prognostic unfavourable (1.19e-7)"	"prognostic unfavourable (2.02e-5)"	"unprognostic (2.52e-1)"	"unprognostic (2.09e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (3.71e-7)"	"unprognostic (2.27e-1)"	"unprognostic (4.00e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.36e-2)"	10.4	4.8	3.9	16.9	5.2	11.2	8.8	1.0	5.2	8.0	10.5	3.8	1.7	8.0	4.8	4.7	12.4	5.0	10.4	7.4	4.1	3.8	10.9	3.7	19.0	14.2	9.6	0.6	8.3	3.9	1.4	3.6	36.7	8.4	6.9	4.3	42.9	8.1	4.8	81.2	2.1	8.0	4.5	8.0	17.3	13.9	12.7	6.9	3.9	8.7	7.3	11.0	13.0	7.4	3.7	10.3	40.4	12.4	9.9	6.2	5.4	11.4	5.7	0.1	0.1	2.5	8.3	11.4	47.9	29.5	34.0	38.7	2.7	30.0	0.1	37.7	33.7	4.1	4.1	69.4	14.3	20.6	0.2	21.8	42.6	50.0	43.9	32.0	27.0	17.0	10.2	22.9	10.5	18.5	0.1	6.8	29.5	3.1	0.3	31.6	0.4	46.6	0.1	0.5	7.5	18.0	0.5	0.7	0.3	46.0	41.0	0.5	5.9	27.0	31.9	67.9	1.1	1.0	49.9	22.0	0.3	1.0	33.3	20.3	0.5	17.5	12.4	34.6	4.1	11.7	6.2	3.7	3.5	4.6	10.3	2.8	1.8	2.2	40.4	9.9	11.8	6.1	3.0	5.4	3.9	5.2	1.0	5.2	4.1	3.8	9.6	0.6	8.4	6.9
SLC19A2	"THTR1, TRMA"	ENSG00000117479	"Solute carrier family 19 member 2"	O60779	1	169463909-169486003	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 75.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006119, HPA016599"	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA006119: AB_1079996, HPA016599: AB_1857005"	"prognostic favourable (8.41e-4)"	"unprognostic (8.82e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.29e-3)"	"prognostic favourable (2.90e-4)"	"unprognostic (4.45e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"prognostic favourable (2.70e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-2)"	23.1	11.1	1.9	5.3	4.4	4.8	14.2	7.4	6.1	5.9	5.4	2.8	2.7	2.1	5.0	9.0	7.5	10.0	17.5	14.8	2.7	2.1	8.6	23.4	9.2	3.1	2.8	1.7	10.3	14.4	6.8	16.3	22.1	4.7	9.4	2.8	16.4	10.4	4.6	75.7	7.5	6.6	11.3	3.7	1.8	9.4	7.3	1.8	3.6	7.9	21.6	3.9	10.4	9.8	1.4	1.9	3.0	4.6	2.6	3.3	0.7	4.4	3.1	7.2	5.6	22.3	8.2	15.8	3.6	2.6	2.9	4.2	12.8	4.7	4.0	4.1	2.4	4.8	8.6	5.2	3.3	11.3	8.1	3.8	10.2	11.7	12.2	9.4	3.7	9.7	7.7	4.7	12.0	4.3	15.0	2.5	4.9	3.0	4.8	4.2	16.2	4.8	0.0	15.5	4.5	7.7	9.5	6.2	8.4	4.9	8.5	17.4	5.3	6.1	3.6	3.5	4.9	4.3	6.9	3.5	3.3	1.3	5.2	3.7	4.6	0.0	1.7	3.0	0.9	0.7	3.3	1.4	1.1	2.1	1.9	1.2	3.1	3.0	1.1	2.6	4.6	0.7	1.0	0.7	1.9	4.4	7.4	6.1	2.7	2.1	2.8	1.7	4.7	1.8
SLC22A3	"EMT, OCT3"	ENSG00000146477	"Solute carrier family 22 member 3"	O75751	6	160348268-160452581	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 98.6"	"Cell line enhanced"	"Detected in some"		"A549: 17.4;HeLa: 23.4;Hep G2: 14.5;RPTEC TERT1: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"gdTCR: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029750	Approved		Approved	Nucleoplasm,Vesicles,Cytosol				"Vesicles, Cytosol"	"Vesicles, Cytosol"	"HPA029750: AB_10603888"	"unprognostic (8.61e-2)"	"prognostic unfavourable (7.19e-5)"	"unprognostic (4.14e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.36e-4)"	"unprognostic (1.33e-2)"	"unprognostic (2.58e-2)"	"unprognostic (7.28e-2)"	"unprognostic (7.96e-2)"	"unprognostic (5.21e-2)"	"unprognostic (8.13e-4)"	"prognostic unfavourable (7.26e-4)"	4.1	6.9	1.0	2.1	1.3	0.0	5.2	1.8	0.9	7.6	4.1	0.9	4.1	0.2	14.2	11.8	4.1	9.0	9.0	1.1	1.2	1.3	2.4	15.2	12.7	9.7	2.2	0.9	10.3	1.3	0.0	0.9	17.8	1.9	18.9	0.6	0.9	34.5	23.0	98.6	5.1	2.7	10.8	4.4	0.3	2.9	3.4	0.6	0.4	3.4	5.7	2.1	3.2	7.3	0.0	0.0	0.8	0.0	0.1	1.5	0.0	0.0	17.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	4.5	0.0	0.0	0.2	0.0	0.0	0.0	23.4	14.5	0.8	0.0	0.0	0.5	4.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	4.9	0.0	0.0	0.0	8.9	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.0	0.0	0.0	0.0	1.0	1.3	1.8	0.9	1.2	1.3	2.2	0.9	1.9	0.6
SLC22A5	"CDSP, OCTN2, SCD"	ENSG00000197375	"Solute carrier family 22 member 5"	O76082	5	132369752-132395614	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.3;skeletal muscle: 93.6"	"Cell line enhanced"	"Detected in many"		"HeLa: 21.8;SiHa: 22.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA063062			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA063062: AB_2684934"	"unprognostic (3.88e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.19e-2)"	"prognostic favourable (2.87e-5)"	"unprognostic (5.37e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.09e-2)"	"prognostic favourable (7.36e-4)"	"unprognostic (3.53e-2)"	"prognostic favourable (8.36e-4)"	"unprognostic (1.12e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.17e-2)"	3.0	4.7	4.0	1.9	4.9	0.6	4.4	9.0	4.2	4.4	10.6	3.6	15.0	11.8	3.6	12.6	2.5	7.4	5.2	7.2	3.8	3.8	42.3	4.5	2.3	1.5	3.5	3.2	3.9	5.2	17.9	8.5	8.1	3.9	8.2	8.3	5.9	4.2	21.8	93.6	3.5	19.6	2.9	3.8	1.7	4.4	2.5	2.7	1.0	5.0	3.2	2.4	3.9	3.2	1.4	6.4	0.4	4.1	1.5	4.0	2.1	3.5	8.5	0.5	6.9	2.7	1.3	11.8	1.6	1.7	2.7	3.8	6.3	7.3	1.7	3.7	1.5	8.6	5.6	4.2	3.2	2.1	6.9	0.9	21.8	2.8	4.6	1.4	1.5	1.3	7.9	1.8	9.7	0.7	3.9	1.1	2.6	6.0	2.0	1.4	0.6	3.7	0.8	0.0	9.2	8.2	8.9	3.0	2.0	22.5	17.6	4.4	8.2	1.8	0.4	0.4	2.4	5.7	2.0	3.7	7.2	0.1	1.8	3.5	1.6	0.0	4.1	0.0	2.6	2.2	2.8	1.4	2.4	3.1	6.4	1.4	2.6	3.0	0.4	1.5	0.7	0.6	4.0	2.1	4.0	4.9	9.0	4.2	3.8	3.8	3.5	3.2	3.9	2.7
SLC25A11	"OGC, SLC20A4"	ENSG00000108528	"Solute carrier family 25 member 11"	Q02978	17	4937130-4940251	"Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021167	Approved					17000	17000			"HPA021167: AB_1857021"	"unprognostic (8.58e-2)"	"unprognostic (4.06e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.86e-1)"	"unprognostic (9.48e-2)"	"prognostic favourable (6.41e-6)"	"unprognostic (2.84e-1)"	"prognostic favourable (2.84e-9)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.09e-1)"	11.8	17.5	17.8	11.9	20.8	10.3	11.7	18.2	34.3	11.1	15.7	16.3	10.3	17.3	12.4	10.1	18.9	16.1	14.3	82.1	19.8	17.7	24.2	22.6	10.6	13.3	19.5	16.3	12.1	15.3	16.0	12.3	13.3	18.7	12.0	13.7	22.2	16.8	15.6	100.8	16.9	14.6	13.0	13.8	12.8	12.3	5.2	9.6	17.4	14.6	42.4	14.0	15.1	10.5	26.9	50.1	39.3	53.9	42.7	32.4	51.4	16.4	44.5	22.7	22.1	22.3	13.9	16.0	18.6	19.2	32.7	27.2	27.8	8.2	25.5	25.3	18.1	32.9	29.5	33.7	13.0	32.2	37.4	28.0	24.6	24.1	22.9	12.0	34.1	19.9	21.9	28.8	24.5	22.6	12.3	24.9	27.6	29.6	38.6	11.9	11.9	29.8	35.1	14.0	23.1	25.2	17.2	20.3	21.1	23.4	26.5	21.3	24.6	19.1	15.2	14.7	9.6	19.8	35.5	13.3	8.0	9.6	28.9	20.4	36.1	32.7	53.9	39.3	32.4	53.0	30.0	26.9	25.1	28.9	50.1	23.0	25.3	27.5	35.1	42.7	47.8	33.3	29.1	51.4	17.8	20.8	18.2	34.3	19.8	17.7	19.5	16.3	18.7	9.6
SLC25A12	Aralar	ENSG00000115840	"Solute carrier family 25 member 12"	O75746	2	171784370-171999859	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035333, HPA035334"	Enhanced		Uncertain	"Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nuclear speckles"	"HPA035333: AB_10603028, HPA035334: AB_2674577"	"unprognostic (3.24e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavourable (7.86e-4)"	"unprognostic (2.65e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.21e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.13e-1)"	"prognostic favourable (2.91e-8)"	"unprognostic (8.64e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.70e-1)"	6.4	6.7	8.8	6.2	18.2	2.9	9.2	17.9	25.0	10.6	12.2	5.7	5.2	4.2	10.4	7.1	11.5	6.9	5.9	42.4	9.9	13.4	10.7	1.9	5.2	6.5	10.4	12.4	10.0	3.5	16.4	14.7	4.7	15.2	10.6	10.0	11.0	21.7	14.8	84.7	7.6	5.7	14.3	7.1	5.6	9.0	4.3	6.2	5.8	10.1	23.8	8.4	10.0	6.7	6.4	3.6	5.1	4.6	6.6	8.1	2.9	7.1	5.3	5.6	12.8	16.5	18.7	0.1	9.1	15.5	12.4	11.9	2.8	6.7	22.6	6.0	10.6	9.0	11.7	11.4	15.6	13.8	10.9	9.8	7.6	6.6	6.3	19.8	9.8	16.3	11.3	14.4	4.1	12.8	6.8	10.4	7.9	4.3	13.9	8.3	4.5	7.4	14.5	8.0	11.8	13.0	6.3	7.8	2.5	5.7	13.5	7.2	4.9	5.9	8.8	10.3	4.5	11.5	6.2	14.0	9.0	22.9	14.3	10.5	7.0	5.1	3.0	1.6	6.5	3.9	7.3	6.4	4.5	6.8	3.6	3.9	6.3	8.1	0.2	6.6	4.6	0.6	4.5	2.9	8.8	18.2	17.9	25.0	9.9	13.4	10.4	12.4	15.2	6.2
SLC25A30		ENSG00000174032	"Solute carrier family 25 member 30"	Q5SVS4	13	45393316-45418455	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 38.0;skeletal muscle: 43.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA045260			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA045260: "	"unprognostic (9.23e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavourable (3.32e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.58e-1)"	"prognostic favourable (9.91e-8)"	"unprognostic (2.24e-1)"	"unprognostic (5.19e-2)"	"unprognostic (4.12e-1)"	"unprognostic (6.19e-3)"	7.7	6.3	6.2	4.7	5.7	5.3	7.1	3.6	6.3	6.5	4.2	2.1	9.7	2.5	7.7	7.2	5.3	3.9	4.5	38.0	5.8	3.8	24.6	19.5	5.9	9.3	5.4	4.3	10.8	7.5	2.4	5.7	3.4	8.1	8.0	3.5	9.5	6.8	9.1	43.1	4.4	3.5	9.4	7.6	6.1	4.0	5.0	4.9	1.2	6.5	6.7	4.4	6.6	9.0	1.6	5.3	4.3	3.4	1.7	2.7	1.1	2.2	5.0	3.0	12.9	15.1	9.7	1.0	10.8	6.3	9.3	5.6	5.2	6.2	0.0	9.5	11.0	4.4	6.9	10.8	11.1	7.4	5.6	8.5	3.2	13.9	8.9	12.1	11.5	6.3	7.4	13.7	10.2	16.1	5.1	0.0	18.8	2.7	4.4	8.4	4.4	6.4	11.1	5.0	4.5	20.2	1.9	0.6	3.0	6.0	9.2	8.6	7.2	16.4	5.9	8.7	5.0	9.7	7.4	2.2	4.5	0.1	9.5	11.5	13.3	0.0	2.8	4.3	2.2	3.4	1.5	1.6	2.2	2.2	4.0	1.5	2.7	1.2	0.0	1.7	1.5	5.3	0.8	1.1	6.2	5.7	3.6	6.3	5.8	3.8	5.4	4.3	8.1	4.9
SLC25A34	DKFZp781A10161	ENSG00000162461	"Solute carrier family 25 member 34"	Q6PIV7	1	15736405-15741396	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 38.8;skeletal muscle: 22.2"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 7.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 10.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069806			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA069806: AB_2686202"	"unprognostic (2.06e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-4)"	"unprognostic (5.74e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.40e-4)"	2.5	2.4	1.2	0.9	1.9	2.8	0.7	10.4	1.8	1.1	25.9	0.8	0.5	13.5	1.7	1.4	1.6	1.3	3.6	13.3	1.5	1.2	7.3	3.9	1.1	1.1	0.7	1.8	2.4	18.6	0.6	2.1	1.2	1.5	1.1	1.9	3.7	11.1	0.8	22.2	0.8	38.8	1.0	1.1	1.9	1.4	2.3	1.2	0.5	1.9	11.0	1.9	0.7	1.1	0.7	0.5	2.0	0.5	2.2	4.1	1.1	0.7	0.5	3.5	1.6	1.7	0.7	1.5	0.5	0.3	0.9	0.7	1.5	1.9	0.9	0.8	0.7	0.7	0.6	0.6	0.8	1.2	0.7	1.5	1.2	0.5	0.6	0.4	2.2	0.8	2.7	1.1	0.5	0.4	0.6	3.3	0.6	1.8	3.7	2.0	2.9	1.0	2.0	3.1	1.0	0.3	0.1	0.7	2.8	0.8	1.0	7.5	1.9	2.5	1.8	1.7	2.2	2.3	0.6	3.9	3.6	0.7	0.6	2.2	1.4	1.2	0.5	0.4	1.4	0.2	3.1	0.5	3.0	2.0	0.2	0.7	4.1	2.3	2.0	2.2	0.2	0.5	1.3	1.1	1.2	1.9	10.4	1.8	1.5	1.2	0.7	1.8	1.5	1.2
SLC25A48	"FLJ44862, HDMCP"	ENSG00000145832	"Solute carrier family 25 member 48"	Q6ZT89	5	135579202-135889770	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 22.4;kidney: 11.7;skeletal muscle: 12.8"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.9;HEK 293: 4.1;HEL: 4.0;RPMI-8226: 3.6;SCLC-21H: 3.8;U-2 OS: 5.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA014674	Uncertain		Approved	"Intermediate filaments,Actin filaments"				"Intermediate filaments"	"Intermediate filaments"	"HPA014674: AB_1859512"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-7)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	1.0	0.8	10.8	1.0	13.0	0.9	1.6	1.3	18.8	0.9	2.0	10.3	0.0	2.0	1.0	0.7	1.3	0.7	0.9	0.9	11.9	8.1	11.7	1.3	0.7	1.0	22.4	4.1	0.7	3.3	0.8	0.4	1.1	5.6	1.3	1.8	0.0	3.5	0.6	12.8	3.2	4.1	0.7	5.4	0.9	0.8	1.2	15.2	0.0	1.0	0.5	0.7	0.8	0.3	0.6	1.0	2.1	1.0	0.8	0.7	0.2	0.3	0.3	0.1	0.3	0.0	0.0	0.5	0.0	0.1	0.1	0.1	0.4	0.7	0.1	0.4	0.0	0.5	4.9	0.0	0.0	0.7	4.1	4.0	0.6	0.8	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.1	0.0	0.0	1.7	0.8	0.1	0.1	0.0	3.6	0.3	0.6	3.8	0.4	0.6	0.5	1.0	1.8	0.6	0.5	0.4	5.0	0.3	0.2	1.7	0.5	0.2	0.4	0.4	0.3	2.1	0.3	0.7	0.5	0.5	0.6	0.5	0.5	0.4	0.3	0.6	0.6	0.7	1.5	0.8	1.0	1.0	0.5	0.2	10.8	13.0	1.3	9.9	11.9	8.1	22.4	4.1	5.6	15.2
SLC29A2	"DER12, ENT2, HNP36"	ENSG00000174669	"Solute carrier family 29 member 2"	Q14542	11	66362521-66372214	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 68.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 16.4;CAPAN-2: 21.0;T-47d: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"B-cells: 1.6;dendritic cells: 1.6;T-cells: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018168	Approved		Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA018168: AB_1857077"	"unprognostic (3.20e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (3.37e-1)"	"unprognostic (5.08e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.28e-2)"	"prognostic favourable (2.78e-4)"	"unprognostic (2.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.38e-3)"	5.4	1.3	2.5	2.8	3.2	1.2	13.2	10.3	5.1	1.9	4.0	3.1	4.8	5.6	1.2	5.2	2.7	3.0	3.2	9.0	2.9	3.3	6.4	1.5	3.4	2.5	3.3	3.5	1.0	7.8	11.3	5.9	3.3	7.0	4.2	2.3	2.2	6.0	6.3	68.9	1.9	4.3	0.9	1.7	2.0	6.6	0.9	2.0	1.6	4.2	18.0	2.5	1.5	2.2	1.6	1.6	0.2	0.1	0.1	4.1	1.2	5.7	4.3	3.4	0.6	0.3	0.0	16.4	0.2	0.0	0.1	0.2	6.9	21.0	2.6	5.4	0.0	5.8	3.2	4.1	0.0	0.1	9.4	5.6	5.3	0.5	0.7	9.4	0.1	0.3	1.6	0.6	1.9	0.3	15.8	0.0	0.0	11.9	0.7	13.1	9.9	4.5	0.7	0.0	11.9	8.8	4.4	7.0	3.1	0.3	9.0	0.6	25.5	2.0	0.0	0.1	5.7	0.1	0.0	0.1	0.3	0.2	0.4	0.2	0.2	0.0	0.1	0.0	3.5	0.0	1.1	0.6	2.2	4.1	0.8	1.6	4.1	4.1	0.2	0.1	0.1	1.6	0.4	1.2	2.5	3.2	10.3	5.1	2.9	3.3	3.3	3.5	7.0	2.0
SLC2A4	GLUT4	ENSG00000181856	"Solute carrier family 2 member 4"	P14672	17	7281667-7288257	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 37.2;skeletal muscle: 76.8;tongue: 33.5"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 10.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			CAB016544	Enhanced									"CAB016544: AB_629533"	"unprognostic (2.53e-1)"	"unprognostic (7.40e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.12e-4)"	"unprognostic (2.40e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.83e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.23e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.07e-2)"	9.9	1.4	0.6	1.8	0.7	1.1	6.4	0.0	0.6	4.7	13.9	0.2	4.0	1.0	4.2	7.0	11.8	3.2	2.9	37.2	0.3	0.1	0.7	1.2	0.5	0.7	0.8	0.1	1.9	0.4	2.9	1.2	0.8	0.5	6.3	1.4	6.4	4.6	3.8	76.8	0.9	3.3	23.5	0.2	0.2	3.8	1.5	0.0	0.0	1.2	33.5	1.6	18.6	1.6	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.2	0.0	1.8	1.5	0.7	0.0	0.4	0.0	0.1	0.0	0.0	0.6	0.1	1.2	0.2	0.0	0.8	0.3	0.2	0.1	0.0	1.8	0.0	0.3	10.6	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.6	0.2	0.0	0.4	0.0	0.2	0.7	0.1	2.4	0.6	0.8	0.0	0.1	0.0	1.0	0.0	1.3	0.0	0.8	0.1	0.0	0.0	1.5	0.0	0.2	0.6	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.7	0.0	0.6	0.3	0.1	0.8	0.1	0.5	0.0
SLC35E4		ENSG00000100036	"Solute carrier family 35 member E4"	Q6ICL7	22	30635652-30669016	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 20.2;testis: 22.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 14.7;U-2197: 14.2;U-87 MG: 15.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049558	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA049558: AB_2680817"	"unprognostic (2.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.03e-4)"	"unprognostic (5.71e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.45e-7)"	"unprognostic (2.77e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.05e-3)"	4.0	2.5	5.6	3.3	11.8	3.4	2.6	4.0	11.4	2.7	5.9	8.1	2.1	2.7	4.2	3.5	4.5	3.1	2.9	5.6	5.2	4.7	2.0	1.1	2.4	2.1	13.0	6.3	2.8	4.1	3.1	2.8	1.6	6.6	2.9	4.2	2.4	2.6	3.5	20.2	7.3	2.5	3.5	2.6	2.4	3.8	22.5	10.1	0.0	2.0	6.6	2.1	3.6	7.6	0.7	3.6	1.6	2.8	2.1	3.2	0.9	6.4	2.8	1.1	2.1	2.9	7.5	0.6	4.2	3.7	2.9	2.7	0.2	1.8	0.4	2.3	4.3	4.1	1.9	2.4	1.5	14.7	2.1	0.1	2.1	0.2	4.2	0.3	1.8	2.4	1.1	11.7	3.7	9.9	0.6	1.9	4.5	1.8	0.2	1.3	1.3	10.7	1.1	2.2	0.2	1.3	0.5	5.8	2.3	4.4	1.9	2.0	1.3	0.5	13.1	12.5	3.9	14.2	4.0	0.6	0.5	0.2	15.2	0.2	3.2	1.6	2.1	0.3	0.9	2.8	1.4	0.3	2.1	3.2	3.6	0.7	2.1	1.7	0.8	2.1	2.2	1.0	2.3	0.9	5.6	11.8	4.0	11.4	5.2	4.7	13.0	6.3	6.6	10.1
SLC35G3	"AMAC1, FLJ40154, TMEM21A"	ENSG00000164729	"Solute carrier family 35 member G3"	Q8N808	17	35192520-35194523	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.1;skeletal muscle: 1.4;testis: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 3.1"	"Lineage enriched"	"Detected in single"	31	"T-cells: 3.1"																					"unprognostic (1.88e-1)"		"unprognostic (2.67e-1)"		"unprognostic (6.17e-3)"				"unprognostic (3.83e-1)"				"unprognostic (6.24e-2)"	"unprognostic (3.06e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	6.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.9	3.1	0.0	0.0	0.0	0.0	1.1	0.2										
SLC7A2	"ATRC2, CAT-2, HCAT2"	ENSG00000003989	"Solute carrier family 7 member 2"	P52569	8	17497088-17570573	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 68.1;parathyroid gland: 78.2;skeletal muscle: 57.8"	"Cell line enhanced"	"Detected in many"		"HHSteC: 66.3;RT4: 17.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009277			Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane"	"Plasma membrane"	"HPA009277: AB_2668229"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (7.24e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavourable (2.65e-7)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (1.46e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.79e-1)"	10.6	3.8	8.6	1.4	3.4	0.1	18.0	2.5	8.3	11.5	2.5	2.4	2.9	0.8	6.4	11.8	3.7	13.6	5.1	9.7	6.8	0.9	3.8	68.1	3.3	2.8	4.4	3.5	35.1	32.2	78.2	3.0	29.0	9.1	4.9	1.5	13.0	2.4	3.3	57.8	3.3	2.0	4.3	10.9	1.8	3.3	7.7	3.5	0.0	14.3	10.4	1.2	3.4	6.4	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.9	0.3	10.1	0.0	0.1	11.1	0.0	6.8	0.5	0.6	3.3	0.0	0.0	2.3	0.0	0.0	7.3	1.7	2.3	0.0	3.8	0.0	8.0	7.0	66.3	3.0	0.0	8.9	1.4	8.6	8.2	3.1	0.0	0.0	7.7	10.7	0.3	3.5	3.7	0.9	0.0	5.1	5.3	0.8	17.0	0.1	1.3	0.5	0.2	3.1	0.0	0.3	7.1	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.6	3.4	2.5	8.3	6.8	0.9	4.4	3.5	9.1	3.5
SLC7A6	"KIAA0245, LAT-2, LAT3, y+LAT-2"	ENSG00000103064	"Solute carrier family 7 member 6"	Q92536	16	68264516-68301823	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050713	Uncertain		Approved	"Vesicles,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA050713: AB_2681218"	"unprognostic (6.35e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavourable (1.84e-4)"	25.9	7.6	5.4	12.9	6.7	6.9	18.7	9.0	8.0	5.3	7.1	3.4	6.7	3.6	5.5	14.0	4.0	7.1	4.7	13.1	5.3	3.3	5.4	2.3	9.8	16.3	3.3	4.6	3.0	3.2	2.5	11.1	16.3	5.4	6.6	10.8	9.0	5.8	5.1	58.8	8.4	9.4	8.3	3.4	9.4	5.3	5.2	3.7	31.8	15.0	8.0	19.6	5.7	8.0	7.2	16.2	5.9	3.6	6.7	12.6	1.7	9.3	9.5	7.1	7.6	21.1	12.7	20.0	11.0	8.0	16.4	13.8	40.8	7.1	18.6	8.7	14.1	14.3	13.8	13.7	17.9	3.8	9.9	9.9	18.8	12.9	3.9	11.6	9.0	8.5	12.0	12.8	6.4	11.0	14.5	3.3	8.9	5.0	15.2	8.1	5.3	3.5	19.3	4.5	15.6	5.7	8.2	10.5	5.7	31.7	8.9	3.7	13.3	6.3	16.1	10.9	8.3	9.1	13.7	7.1	13.3	21.2	6.9	8.6	7.3	2.5	3.6	3.0	4.9	1.7	6.1	6.6	7.3	4.6	3.4	7.2	12.6	7.4	5.9	6.7	1.4	16.2	3.1	1.7	5.4	6.7	9.0	8.0	5.3	3.3	3.3	4.6	5.4	3.7
SLCO5A1	"OATP-J, OATP5A1, OATPRP4, SLC21A15"	ENSG00000137571	"Solute carrier organic anion transporter family member 5A1"	Q9H2Y9	8	69667047-69835064	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 21.4;lymphoid tissue: 9.5;skeletal muscle: 13.9;tongue: 16.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.8;NTERA-2: 5.9;RPMI-8226: 5.5;SCLC-21H: 6.4;U-266/70: 3.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"basal ganglia: 2.3;olfactory region: 8.2"					HPA025062	Uncertain		Supported	"Vesicles,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA025062: AB_1857220"	"unprognostic (1.30e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.37e-4)"	"unprognostic (1.75e-1)"	"unprognostic (4.48e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.92e-6)"	"unprognostic (2.20e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.50e-2)"	0.7	0.2	0.5	1.5	0.7	1.5	0.2	0.1	0.8	0.3	0.4	0.1	0.0	0.4	0.5	1.5	1.0	0.5	0.4	21.4	0.7	0.7	0.2	0.4	0.3	4.1	0.3	0.3	0.2	0.7	0.0	4.7	0.0	0.5	4.2	0.7	0.6	0.9	0.0	13.9	0.3	0.7	0.2	0.2	0.8	0.3	0.4	0.0	9.5	0.5	16.2	1.7	0.9	0.2	1.7	0.1	0.7	0.0	0.2	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	2.3	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.1	5.9	0.9	1.0	0.9	5.5	0.1	0.0	6.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.5	0.1	1.2	3.4	0.5	0.0	0.3	0.0	1.7	0.7	0.0	0.1	0.3	0.0	0.0	0.5	0.1	0.2	0.0	1.7	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.0	0.5	0.7	0.1	0.7	0.7	0.7	0.3	0.3	0.5	0.0
SMARCD3	"BAF60C, CRACD3, Rsc6p"	ENSG00000082014	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3"	Q6STE5	7	151238764-151277896	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 75.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 8.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.6;granulocytes: 3.1;monocytes: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063955, HPA065517"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA063955: AB_2685159, HPA065517: AB_2685500"	"unprognostic (1.23e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (5.50e-4)"	"unprognostic (4.38e-3)"	"unprognostic (4.67e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.08e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.29e-1)"	9.7	16.0	34.2	4.0	40.3	4.9	9.8	25.4	36.8	12.9	5.6	7.8	7.9	2.9	8.6	11.4	6.7	14.5	10.7	38.5	22.2	24.7	4.9	2.0	8.3	4.0	18.7	18.8	19.2	7.5	6.8	14.7	4.6	13.3	10.8	3.6	7.6	6.6	18.1	75.2	5.7	3.4	10.0	14.1	4.3	4.8	9.0	11.6	0.0	7.4	9.5	2.5	10.1	4.8	0.2	2.6	3.1	8.8	0.0	0.8	2.1	0.3	2.8	9.4	33.2	14.9	6.7	0.7	6.1	6.2	3.6	2.1	2.1	1.9	3.6	2.2	9.6	0.6	7.5	0.6	1.4	1.1	4.6	0.0	1.9	0.6	12.9	0.1	6.0	15.9	0.8	1.2	0.1	0.7	7.1	1.2	18.9	3.8	0.6	4.7	2.9	1.2	0.2	14.7	0.1	3.2	0.0	5.4	10.9	5.7	1.0	4.4	0.8	9.2	1.1	2.3	3.7	7.1	2.0	7.8	0.0	2.9	6.6	8.2	10.3	0.6	8.8	0.0	0.2	1.9	0.1	0.2	0.8	0.0	2.6	0.0	0.5	0.8	3.1	0.0	0.4	0.0	0.7	2.1	34.2	40.3	25.4	27.9	22.2	24.7	18.7	18.8	13.3	11.6
SNAI3	"SMUC, Zfp293, ZNF293"	ENSG00000185669	"Snail family transcriptional repressor 3"	Q3KNW1	16	88677682-88686493	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 25.5;skeletal muscle: 33.9"	"Group enriched"	"Detected in some"	5	"NB-4: 14.4;RPMI-8226: 22.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.3"	"Low region specificity"	"Detected in many"			HPA071127			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA071127: AB_2686346"	"unprognostic (1.03e-2)"	"prognostic favourable (1.39e-4)"	"unprognostic (2.20e-2)"	"unprognostic (6.19e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.98e-3)"	"unprognostic (3.24e-2)"	"unprognostic (7.79e-2)"	"prognostic favourable (3.58e-4)"	"unprognostic (9.09e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.46e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.47e-2)"	0.9	0.8	2.4	6.3	2.3	2.3	0.8	1.9	2.9	1.3	3.4	2.1	0.2	2.2	0.8	1.3	1.3	1.4	2.6	2.4	2.5	1.7	1.3	1.0	5.3	4.5	3.1	0.8	1.5	6.1	2.1	1.0	0.9	2.2	1.6	0.8	1.4	3.6	0.7	33.9	1.1	4.6	1.1	2.4	9.2	3.5	2.1	2.2	2.1	3.0	9.5	13.0	2.7	2.4	4.6	9.2	25.5	7.7	0.5	11.6	5.4	0.2	0.7	0.2	1.1	0.0	0.0	0.5	0.2	0.0	0.0	0.1	2.8	0.2	1.9	0.4	0.0	0.6	0.2	0.2	0.0	0.3	1.1	0.8	0.1	0.9	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	1.6	3.5	0.0	2.6	0.1	14.4	0.3	0.3	3.1	0.2	22.7	0.0	0.3	1.4	0.1	0.6	0.0	0.2	1.0	1.7	0.3	0.1	0.9	0.2	0.0	0.6	3.2	3.2	0.2	3.9	0.4	2.8	7.7	25.5	6.1	2.9	10.9	4.6	9.9	5.7	9.2	3.8	6.1	3.8	17.1	0.5	0.7	6.5	11.6	5.4	2.4	2.3	1.9	2.4	2.5	1.7	3.1	0.8	2.2	2.2
SNRNP25	"C16orf33, U11/U12-25K"	ENSG00000161981	"Small nuclear ribonucleoprotein U11/U12 subunit 25"	Q9BV90	16	53010-57669	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 56.9;skeletal muscle: 63.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 56.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041183, HPA044248"	Uncertain		Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA041183: AB_2677353, HPA044248: AB_2678873"	"unprognostic (7.87e-2)"	"prognostic favourable (1.95e-4)"	"unprognostic (6.04e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-1)"	"prognostic favourable (1.16e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.03e-3)"	7.1	10.1	31.4	11.5	25.4	15.6	7.4	15.7	31.2	7.1	9.7	6.8	5.4	7.2	6.6	9.6	8.8	8.8	6.3	28.7	25.0	22.6	11.7	16.4	5.4	16.4	28.1	20.3	10.9	10.8	7.7	10.8	4.9	24.7	9.8	10.1	7.5	12.6	8.4	63.7	4.3	6.4	8.6	13.5	6.6	10.2	6.4	7.7	9.4	9.4	11.0	16.4	6.8	4.8	18.0	56.9	23.2	9.9	5.2	6.5	5.7	11.4	26.1	14.5	16.8	5.2	6.1	7.1	9.7	6.3	21.8	18.5	35.0	11.2	36.4	11.6	7.9	11.8	26.5	17.9	16.8	13.1	20.6	21.1	36.4	35.0	5.5	38.4	25.0	7.8	6.4	19.4	5.4	11.7	31.4	8.7	12.4	54.3	20.1	16.0	17.3	12.7	32.6	15.5	43.4	11.5	8.1	15.9	10.3	22.0	28.5	4.7	18.4	18.7	9.2	9.7	12.1	12.4	15.5	9.0	21.4	56.4	5.1	20.6	14.7	2.8	6.6	23.2	4.0	9.9	5.0	17.5	4.2	4.9	12.8	18.0	4.5	4.5	4.5	5.2	8.5	56.9	6.5	5.7	31.4	25.4	15.7	31.2	25.0	22.6	28.1	20.3	24.7	7.7
SNTA1	"LQT12, SNT1, TACIP1"	ENSG00000101400	"Syntrophin alpha 1"	Q13424	20	33407955-33443892	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 67.6;skeletal muscle: 130.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 6.7;plasmacytoid DC: 11.1"	"Group enriched"	"Detected in many"	4	"B-cells: 6.7;dendritic cells: 11.1"	"Low region specificity"	"Detected in all"							CAB037059	Approved									"CAB037059: AB_261497"	"unprognostic (2.25e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavourable (9.60e-6)"	"unprognostic (5.68e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-2)"	"prognostic favourable (7.08e-4)"	"unprognostic (2.16e-1)"	"prognostic favourable (3.72e-4)"	"unprognostic (1.99e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.29e-2)"	"unprognostic (7.60e-2)"	13.7	6.5	28.8	3.3	36.2	2.1	4.8	5.9	28.4	6.4	4.3	14.4	2.9	4.4	4.5	5.3	12.2	5.6	4.8	67.6	20.0	15.9	8.5	5.1	3.7	3.8	23.6	19.1	8.5	7.5	7.6	2.5	2.7	11.9	7.3	2.7	10.0	16.0	10.7	130.8	3.8	4.2	9.4	8.8	2.6	4.8	6.7	11.8	0.3	33.0	22.0	3.7	8.6	5.4	6.7	11.1	0.0	0.0	0.0	2.2	0.4	6.0	3.0	1.4	13.4	32.6	6.5	1.3	4.6	6.4	8.8	7.3	7.8	2.0	4.3	5.6	7.8	7.9	4.0	2.5	1.5	0.8	5.1	0.2	7.5	10.9	9.3	0.4	0.7	5.9	3.2	3.8	1.4	1.3	10.3	1.6	4.4	0.7	8.0	1.0	0.8	17.7	5.1	10.0	4.7	1.8	5.4	5.9	5.1	18.1	5.5	9.1	8.5	0.7	2.1	4.4	8.6	17.3	4.2	10.3	5.2	2.5	9.5	0.8	0.6	0.0	0.0	0.0	1.0	0.0	2.2	6.7	1.0	1.0	0.0	2.7	0.3	0.8	0.0	0.0	0.0	11.1	1.2	0.4	28.8	36.2	5.9	28.4	20.0	15.9	23.6	19.1	11.9	11.8
SOD2		ENSG00000112096	"Superoxide dismutase 2"		6	159669057-159745186	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"blood: 254.9;skeletal muscle: 475.1"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 181.9;HSkMC: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	11	"neutrophil: 254.9"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 254.9"									"HPA001814, CAB002013"	Supported		Enhanced	Mitochondria				Mitochondria	Mitochondria	"CAB002013: , HPA001814: AB_1080134"	"unprognostic (2.47e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.14e-2)"	"prognostic unfavourable (1.72e-4)"	"unprognostic (8.12e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.82e-1)"	77.8	28.6	6.2	82.8	13.8	147.9	32.5	3.6	12.5	13.1	25.6	5.7	3.6	9.1	13.3	16.6	20.3	12.6	19.9	42.4	5.8	6.4	157.4	197.5	33.9	52.7	14.3	2.6	31.8	24.9	6.9	7.0	10.0	16.1	27.1	6.1	6.4	39.9	7.4	475.1	9.0	8.1	27.9	25.5	18.4	13.8	13.6	7.3	3.0	36.8	20.8	11.8	43.4	52.8	2.3	5.8	254.9	22.7	0.9	4.5	15.0	3.6	4.6	4.1	9.4	26.6	44.5	2.1	5.3	181.9	6.5	15.1	9.5	2.1	7.5	16.0	5.9	6.3	4.3	4.6	4.9	7.3	8.9	7.9	7.8	16.2	19.7	7.5	3.4	80.3	7.7	20.6	15.4	3.3	10.8	9.0	6.2	3.9	6.2	4.8	6.9	5.8	8.4	5.6	6.9	12.1	6.0	7.8	3.0	11.2	5.7	2.3	3.5	3.5	3.1	19.1	6.9	10.1	9.2	3.8	9.8	9.0	21.1	5.8	2.4	6.2	19.2	9.4	2.2	14.9	2.4	2.3	3.1	2.2	5.8	1.8	2.6	2.1	254.9	0.9	22.7	0.8	4.5	15.0	6.2	13.8	3.6	12.5	5.8	6.4	14.3	2.6	16.1	7.3
SPAG7	"ACRP, FSA-1, MGC20134"	ENSG00000091640	"Sperm associated antigen 7"	O75391	17	4959226-4967872	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA024032, HPA052394"	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA024032: AB_1857410, HPA052394: AB_2681810"	"unprognostic (7.10e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.90e-2)"	"unprognostic (9.83e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.96e-1)"	"prognostic favourable (5.79e-5)"	"unprognostic (4.66e-3)"	"unprognostic (5.51e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.72e-2)"	18.1	19.8	23.5	15.7	24.4	15.5	16.1	14.4	30.9	15.9	19.4	10.5	20.0	14.7	23.2	22.9	18.5	27.6	17.0	53.7	20.5	19.4	25.2	24.4	17.9	15.6	19.8	21.8	14.8	19.4	19.4	13.2	24.8	22.6	17.7	15.5	16.6	18.9	20.1	106.4	14.3	17.6	20.1	21.8	17.4	17.7	15.0	12.8	13.9	22.5	47.9	16.0	15.7	15.4	38.0	42.8	30.8	35.5	24.3	41.9	33.2	12.2	27.0	35.8	19.8	24.8	36.3	20.7	24.4	27.6	23.8	18.4	15.8	16.1	15.6	36.0	29.8	17.6	17.8	37.0	10.8	22.8	15.9	16.9	22.2	21.9	34.8	9.3	25.4	39.8	26.7	20.3	38.1	29.9	11.2	16.2	28.9	19.4	17.0	20.8	20.3	8.7	18.0	22.7	11.1	40.7	15.4	10.1	19.9	20.7	8.3	20.0	17.9	14.8	28.8	16.2	10.6	7.9	19.8	14.3	11.3	9.5	32.0	13.4	20.9	28.1	35.5	30.8	35.4	29.2	38.4	38.0	33.4	33.0	41.7	31.4	41.9	36.6	9.4	24.3	27.8	42.8	37.2	33.2	23.5	24.4	14.4	30.9	20.5	19.4	19.8	21.8	22.6	12.8
SPDYE6		ENSG00000260097	"Speedy/RINGO cell cycle regulator family member E6"		7	102347206-102356444	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"skeletal muscle: 4.5;skin 1: 3.9;testis: 4.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 11.9"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA051750	Approved									"HPA051750: AB_2681590"	"unprognostic (5.47e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.89e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.84e-3)"	"unprognostic (9.81e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.09e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.49e-2)"	"unprognostic (7.81e-6)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.12e-1)"	0.0	0.2		2.0		3.2	0.0		0.0	0.0	0.3			0.7	0.3	0.0	0.8	0.0	0.1	0.2			0.1	0.0	0.0	3.3			0.0	1.1	0.0		0.3		0.0	0.0		1.1	0.0	4.5	3.9	0.8	0.0		1.5	0.9	4.2			1.1		0.0	0.4		3.0	1.1	1.3	1.9	0.4	2.2	1.1	2.8	1.4	1.6	3.1	0.0	0.0	5.2	4.4	0.0	0.0	0.0	1.2	2.5	4.8	1.6	0.0	1.4	0.0	0.0	0.0	1.0	4.1	2.5	7.8	0.8	0.0	2.2	2.3	0.0	0.0	0.0	0.0	0.0	3.4	11.9	0.0	4.4	1.1	2.6	1.6	0.0	3.6	0.5	2.9	0.0	5.5	3.1	1.8	5.8	2.3	1.1	1.2	2.0	1.4	5.2	1.6	3.2	2.5	3.0	2.1	2.8	1.0	4.2	2.3	0.1	0.9	1.3	2.2	1.6	2.1	0.6	1.4	0.9	0.5	3.0	1.4	2.0	0.9	0.4	1.9	1.1	1.7	1.1										
SPEG	"APEG1, BPEG, KIAA1297, MGC12676, SPEGalpha, SPEGbeta"	ENSG00000072195	"SPEG complex locus"	Q15772	2	219434846-219498287	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 88.7"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 14.7;U-2 OS: 15.0;U-251 MG: 13.7;U-87 MG: 16.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA018904	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA018904: AB_1844924"	"unprognostic (3.70e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.45e-4)"	"unprognostic (2.04e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.92e-3)"	"unprognostic (2.29e-2)"	"unprognostic (8.66e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.47e-9)"	"unprognostic (1.14e-1)"	"unprognostic (7.01e-2)"	"unprognostic (5.95e-4)"	"unprognostic (1.28e-3)"	7.7	7.1	10.1	9.1	7.7	1.2	4.2	10.4	9.8	19.2	45.1	4.1	10.5	5.7	31.6	14.1	13.5	19.0	17.4	17.8	8.7	5.3	2.0	1.4	3.0	1.7	4.0	8.0	7.0	2.9	4.7	10.5	4.8	5.5	16.7	4.5	6.7	7.8	23.0	88.7	2.2	9.2	45.2	9.1	1.9	16.1	3.0	3.9	0.0	2.0	16.8	1.6	22.5	12.6	0.0	0.3	0.0	0.0	0.0	0.5	0.7	4.0	0.3	2.1	3.5	1.1	3.2	1.4	8.7	5.8	5.8	4.4	3.1	1.4	0.0	3.2	6.4	5.1	1.7	2.0	2.3	0.5	1.3	0.4	3.7	0.2	1.5	0.0	0.7	9.3	3.1	5.3	1.3	0.0	3.0	0.0	4.2	1.1	0.1	12.4	4.4	1.6	2.1	4.7	0.7	5.7	0.0	2.3	10.9	0.6	0.0	0.1	0.3	0.1	0.1	14.7	15.0	1.7	13.7	0.5	0.0	0.1	16.6	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.7	10.1	7.7	10.4	9.8	8.7	5.3	4.0	8.0	5.5	3.9
SPTB		ENSG00000070182	"Spectrin beta, erythrocytic"	P11277	14	64746283-64879907	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.2;brain: 25.2;skeletal muscle: 67.6"	"Group enriched"	"Detected in some"	5	"HEL: 23.0;K-562: 27.5;U-937: 8.3"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in all"	5	"basal ganglia: 11.6;cerebellum: 25.2;cerebral cortex: 10.4;pons and medulla: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003394, HPA003398, CAB015169, CAB016232"	Enhanced		Approved	Cytosol		43000000	43000000	Cytosol	Cytosol	"CAB015169: AB_2194363, CAB016232: AB_785785, HPA003394: AB_1080076, HPA003398: AB_1080074"	"unprognostic (2.69e-1)"	"unprognostic (4.72e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.18e-2)"	1.9	1.6	3.2	0.7	11.6	32.2	0.7	25.2	10.4	0.8	0.7	0.8	0.3	0.6	0.7	5.2	1.8	0.8	0.8	14.7	3.1	3.2	1.2	0.6	0.9	0.6	2.8	3.5	0.7	2.2	6.5	4.7	4.7	16.4	1.5	0.7	1.1	1.9	1.3	67.6	0.7	0.7	1.0	1.7	1.1	0.7	1.0	1.4	0.0	0.7	17.4	0.6	0.8	0.5	0.0	0.6	0.9	0.0	0.0	0.2	1.5	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	1.4	3.8	0.1	0.0	0.2	2.2	23.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	27.5	0.0	0.0	0.2	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.0	0.1	3.7	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.2	4.2	0.0	0.4	0.9	4.3	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	1.5	3.2	11.6	25.2	10.4	3.1	3.2	2.8	3.5	16.4	1.4
SSH2	KIAA1725	ENSG00000141298	"Slingshot protein phosphatase 2"	Q76I76	17	29625938-29930276	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 37.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017189, HPA057099"	Uncertain									"CAB017189: , HPA057099: AB_2683336"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.00e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.80e-2)"	"unprognostic (9.80e-3)"	"unprognostic (7.52e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.28e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.86e-1)"	12.3	7.7	15.8	19.0	16.0	43.1	7.9	23.9	18.0	6.8	10.6	17.5	8.8	7.4	6.1	8.5	9.4	6.5	7.9	12.0	12.9	8.4	10.8	9.8	15.1	20.9	13.6	12.4	3.7	11.8	6.4	6.5	8.8	10.6	5.1	10.0	7.9	8.6	11.6	59.6	10.5	14.5	6.9	12.6	21.3	10.3	26.1	15.2	22.7	10.7	9.5	19.9	7.8	6.5	7.9	4.0	37.8	4.5	1.4	5.9	1.8	11.9	9.7	6.2	5.3	17.3	11.9	3.6	5.9	6.8	9.8	10.4	5.2	4.5	9.9	9.5	7.0	13.9	7.6	8.6	11.4	3.5	13.6	6.9	9.9	7.7	8.2	7.3	14.9	13.9	5.8	10.4	6.9	22.4	4.9	7.8	6.9	3.3	34.5	7.5	4.6	5.0	16.6	15.8	17.4	17.0	9.4	10.5	11.7	8.6	9.6	17.2	6.4	7.7	12.3	6.7	13.7	11.7	7.1	11.8	7.8	24.8	7.9	5.8	6.1	11.0	3.8	37.8	3.5	4.5	2.9	7.5	4.4	3.5	4.0	7.9	4.1	3.0	9.6	1.4	3.8	2.6	5.9	1.8	15.8	16.0	23.9	18.0	12.9	8.4	13.6	12.4	10.6	15.2
ST3GAL3	"MRT12, SIAT6"	ENSG00000126091	"ST3 beta-galactoside alpha-2,3-sialyltransferase 3"	Q11203	1	43705824-43931165	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 71.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051102	Uncertain				"Intracellular and membrane"					"HPA051102: AB_2681344"	"unprognostic (8.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.01e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.38e-3)"	"unprognostic (7.00e-2)"	"unprognostic (3.68e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.35e-1)"	"unprognostic (6.60e-2)"	11.6	9.0	13.0	8.9	16.5	9.9	12.8	15.5	20.4	9.0	10.3	9.0	8.0	3.2	10.8	10.7	8.7	8.3	7.2	16.9	12.8	13.9	6.7	9.1	7.2	7.6	12.0	10.4	13.3	7.5	6.9	10.9	6.7	11.6	8.8	5.1	9.0	8.0	13.9	71.5	7.4	3.8	15.9	7.7	6.0	5.9	14.5	10.3	3.2	8.1	17.8	4.8	8.1	7.0	7.1	7.0	5.8	4.2	4.7	7.6	6.1	2.4	1.9	14.4	6.8	11.3	14.3	1.8	9.4	19.6	8.8	8.5	1.7	4.0	4.6	4.9	12.1	2.4	1.3	6.2	10.6	5.3	3.2	8.7	6.1	4.6	9.5	3.9	4.4	7.6	4.7	6.4	14.1	6.9	5.1	8.5	16.3	1.6	4.0	7.5	5.7	5.0	6.8	1.9	3.1	7.1	1.6	5.8	8.6	3.7	1.4	8.2	2.2	19.0	6.6	5.3	2.5	8.6	9.5	6.8	3.9	4.3	7.8	9.5	9.8	2.9	4.2	2.5	6.8	2.5	6.1	4.5	4.4	5.1	3.0	7.1	7.6	5.7	5.8	4.7	3.7	7.0	5.2	6.1	13.0	16.5	15.5	20.4	12.8	13.9	12.0	10.4	11.6	10.3
STBD1	"FLJ41801, GENX-3414"	ENSG00000118804	"Starch binding domain 1"	O95210	4	76306026-76311599	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 16.1;liver: 14.3;skeletal muscle: 34.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 14.7;Karpas-707: 30.9;U-266/70: 19.9"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA011952, HPA012849"	Enhanced		Supported	Cytosol				Cytosol	Cytosol	"HPA011952: AB_1847461, HPA012849: AB_1847460"	"unprognostic (1.46e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.74e-2)"	16.1	1.2	0.1	0.7	0.0	1.9	3.7	0.0	0.5	1.2	2.7			1.2	2.3	0.0	1.6	1.2	1.0	7.1	0.0	0.5	0.7	14.3	2.6	0.0	0.3		1.3	1.9	0.4	0.2	1.2		2.1	1.6		1.2	1.1	34.5	0.0	3.9	2.4	0.6	0.0	2.3	0.5			0.1		0.0	3.4	1.4	0.2	3.2	5.9	3.6	3.7	3.6	1.4	3.7	1.8	0.2	2.4	5.2	1.4	3.3	4.1	2.5	1.6	1.9	1.7	4.4	0.0	3.3	2.7	2.3	0.7	0.9	0.6	14.7	1.0	0.2	2.2	2.2	0.7	2.1	2.7	0.8	2.6	1.3	0.6	0.0	0.1	30.9	2.8	2.4	0.2	1.7	0.4	2.0	0.0	0.8	2.5	0.9	1.8	0.8	4.3	3.2	4.1	0.0	1.1	0.7	0.7	3.1	2.0	7.3	2.3	19.9	3.6	0.0	4.3	1.3	1.0	0.3	3.6	5.9	2.7	3.3	1.7	0.2	3.6	3.4	3.2	0.0	0.6	1.1	0.7	3.7	1.6	0.2	0.6	1.4										
STH	MAPTIT	ENSG00000256762	Saitohin	Q8IWL8	17	45999250-45999694	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.2;breast: 1.9;placenta: 1.6;skeletal muscle: 2.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.1;HDLM-2: 3.1;PC-3: 1.0;RT4: 1.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.24e-1)"				"unprognostic (3.22e-1)"													0.0	0.0	0.8	0.0	1.3	0.0	1.9	4.1	4.2	0.0	0.0			0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.2	0.9	0.0	0.0	0.0	0.0	0.7		0.0	0.0	0.0	0.3	1.6		0.2	0.0		0.5	0.0	2.5	0.7	0.0	0.0	0.6	0.0	0.0	0.4			0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.9	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
STRIP2	"FAM40B, FAR11B, KIAA1170"	ENSG00000128578	"Striatin interacting protein 2"	Q9ULQ0	7	129434433-129488399	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.6;retina: 55.6;skeletal muscle: 27.4"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 20.9;U-2197: 23.8;U-87 MG: 21.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 36.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019657	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA019657: AB_1848399"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.80e-3)"	"prognostic unfavourable (6.78e-4)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.87e-6)"	"prognostic favourable (5.41e-4)"	"unprognostic (4.06e-2)"	"unprognostic (5.34e-2)"	"unprognostic (7.50e-2)"	0.7	2.4	1.9	2.0	36.6	3.7	0.8	7.0	10.0	0.4	0.8	3.0	0.0	0.8	0.8	1.6	1.1	0.4	1.2	10.3	1.5	2.1	5.6	0.6	1.0	2.7	2.2	2.9	0.7	1.3	0.4	4.7	1.3	7.6	1.6	1.4	55.6	1.7	0.5	27.4	1.5	1.0	0.8	1.2	1.5	1.0	13.5	9.4	0.2	0.8	2.1	2.1	0.9	0.3	0.6	0.7	2.5	0.6	0.4	0.9	0.4	7.8	3.4	3.1	4.9	1.2	1.1	13.6	3.2	4.1	5.4	5.3	1.8	4.4	3.3	0.4	1.3	8.8	3.3	2.9	8.3	19.1	2.8	2.5	5.6	1.9	0.8	1.6	13.4	1.3	1.0	9.2	5.8	9.3	10.9	2.1	20.9	0.4	4.1	4.0	3.0	7.0	2.8	5.8	0.7	2.0	2.9	0.7	0.7	7.4	0.6	1.6	0.9	3.9	3.3	3.2	3.1	23.8	9.2	1.9	1.3	4.0	21.2	4.1	4.5	2.5	0.6	0.6	0.9	0.4	0.3	0.3	0.6	0.3	0.2	0.6	0.5	0.4	2.0	0.4	0.5	0.7	0.9	0.4	1.9	36.6	7.0	4.8	1.5	2.1	2.2	2.9	7.6	9.4
SUCLA2		ENSG00000136143	"Succinate-CoA ligase ADP-forming beta subunit"	Q9P2R7	13	47745736-48037968	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039435, HPA039536, HPA061528"	Enhanced	Supported	Enhanced	Mitochondria		6600	6600	Mitochondria	Mitochondria	"HPA039435: AB_10673144, HPA039536: AB_2676561, HPA061528: AB_2684553"	"unprognostic (5.66e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"prognostic favourable (7.59e-14)"	"unprognostic (3.53e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavourable (1.22e-4)"	21.6	18.5	19.2	8.6	22.1	5.2	17.5	29.7	32.4	15.3	15.7	11.7	15.6	24.5	12.7	12.1	14.6	11.3	9.4	42.1	20.0	21.6	34.0	12.9	7.9	11.4	22.6	19.1	14.4	10.8	19.8	14.9	12.2	28.7	16.2	16.5	8.9	13.9	14.8	89.0	10.0	22.7	14.7	18.3	9.7	12.3	8.0	15.4	15.6	16.9	25.6	10.2	11.0	12.6	17.1	29.5	12.4	25.0	23.4	25.2	17.2	17.2	20.0	25.4	15.2	29.1	22.0	15.3	26.4	29.6	27.5	18.7	35.5	19.6	24.2	20.2	25.8	24.0	33.5	25.1	34.9	23.1	28.7	27.2	19.0	23.0	20.3	27.5	15.9	20.7	29.6	18.7	22.1	20.2	18.3	8.8	27.3	11.9	28.3	31.5	26.3	25.6	24.1	23.2	18.7	39.7	16.7	14.1	16.8	22.0	20.4	15.5	18.1	24.4	15.4	15.3	9.9	21.7	18.3	9.1	14.2	28.2	9.5	20.1	22.4	5.7	24.5	12.4	17.6	25.0	21.2	17.1	19.7	21.6	29.5	16.3	25.2	24.9	4.5	23.4	20.0	24.3	21.6	17.2	19.2	22.1	29.7	32.4	20.0	21.6	22.6	19.1	28.7	15.4
SVIL		ENSG00000197321	Supervillin	O95425	10	29457338-29736781	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 235.1;tongue: 93.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 40.1;U-2197: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 15.2;monocytes: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010878, HPA020095, HPA020138"	Approved		Supported	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane"	"Plasma membrane"	"CAB010878: AB_476685, HPA020095: AB_1857680, HPA020138: AB_1857681"	"unprognostic (1.11e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.26e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.28e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.11e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (5.70e-5)"	11.9	2.1	0.7	10.5	1.1	3.7	4.5	0.6	0.9	18.7	42.3	0.6	10.7	1.7	34.3	13.3	18.2	8.9	15.5	25.5	0.5	0.6	2.8	2.0	3.8	2.3	0.8	0.7	13.9	2.4	5.1	4.1	2.9	1.7	12.6	5.3	10.0	10.6	15.3	235.1	4.7	9.1	36.4	1.3	1.5	14.2	5.5	0.5	4.6	6.9	93.5	11.6	28.6	9.9	0.1	0.7	15.2	4.2	1.2	1.7	0.6	17.3	7.5	3.4	1.2	9.9	26.6	5.5	2.8	6.7	1.1	1.1	8.8	17.2	0.0	12.3	1.1	40.1	1.9	6.6	1.1	0.2	3.7	0.0	9.5	5.7	6.0	1.5	0.3	24.4	6.5	12.4	4.5	19.9	0.0	0.1	1.7	5.4	1.4	0.8	1.7	2.7	3.2	10.1	0.1	11.8	5.8	4.1	3.4	2.5	0.3	8.8	3.1	1.8	12.8	5.7	5.9	28.1	8.4	0.1	0.0	0.0	22.0	3.4	19.5	2.9	1.1	5.2	1.2	1.9	1.5	0.0	1.1	0.6	0.7	0.1	1.7	1.1	15.2	1.2	4.2	0.2	0.1	0.6	0.7	1.1	0.6	0.9	0.5	0.6	0.8	0.7	1.7	0.5
SYNC	"SYNC1, SYNCOILIN"	ENSG00000162520	"Syncoilin, intermediate filament protein"	Q9H7C4	1	32680360-32703596	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 51.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 26.8;fHDF/TERT166: 38.9;U-138 MG: 34.1;U-2197: 18.1;WM-115: 22.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 1.8"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028311	Approved		Approved	"Golgi apparatus,Vesicles,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA028311: AB_2672554"	"unprognostic (3.99e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.60e-3)"	"unprognostic (1.99e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.32e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.15e-4)"	4.2	3.2	3.7	5.8	3.9	0.1	6.8	1.1	4.2	5.9	7.2	3.7	1.2	1.5	7.7	7.7	15.6	5.3	4.8	7.9	3.5	3.9	1.4	1.1	4.6	0.6	3.6	2.6	7.9	0.9	2.7	2.8	1.1	3.5	6.1	4.8	4.6	4.1	8.4	51.0	1.6	4.0	28.5	4.5	1.9	6.5	5.4	1.9	0.0	1.9	23.6	2.3	7.8	2.5	0.0	0.3	0.0	1.8	0.0	0.3	0.0	0.0	1.3	0.1	0.0	6.5	10.2	0.0	10.5	26.8	9.1	6.6	0.1	0.1	0.0	0.5	38.9	0.4	0.3	0.2	5.5	0.0	0.0	0.2	4.4	0.9	5.2	0.0	0.0	15.7	0.9	10.1	0.3	2.9	0.0	0.0	7.8	0.0	0.0	0.0	0.1	0.9	0.0	2.0	0.0	10.6	0.0	0.1	0.1	10.6	2.2	0.0	0.6	0.0	1.7	34.1	1.5	18.1	2.7	0.0	0.0	0.0	9.6	0.1	22.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	3.7	3.9	1.1	4.2	3.5	3.9	3.6	2.6	3.5	1.9
SYNE2	"DKFZP434H2235, KIAA1011, Nesp2, Nesprin-2, NUA, NUANCE, SYNE-2"	ENSG00000054654	"Spectrin repeat containing nuclear envelope protein 2"	Q8WXH0	14	63852983-64226433	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 111.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 43.5"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"cerebellum: 15.8;pons and medulla: 16.3"	"Cell type enhanced"	"Detected in many"		"eosinophil: 30.3"	"Group enriched"	"Detected in many"	10	"granulocytes: 30.3;T-cells: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003435, HPA050204"	Enhanced		Supported	"Nuclear membrane,Intermediate filaments"				"Nuclear membrane, Intermediate filaments"	"Nuclear membrane, Intermediate filaments"	"HPA003435: AB_1080162, HPA050204: AB_2681051"	"unprognostic (1.93e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-3)"	"unprognostic (9.04e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.24e-1)"	"prognostic favourable (3.56e-9)"	"unprognostic (5.05e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.80e-2)"	30.8	4.5	2.3	18.0	2.8	5.5	29.7	15.8	3.3	16.1	13.4	1.9	7.7	3.6	18.8	13.6	17.2	7.1	8.6	27.3	2.3	2.4	35.6	13.0	15.2	11.0	2.7	2.1	22.8	22.4	60.1	17.6	14.1	16.3	13.7	4.8	13.0	9.8	9.2	111.4	24.1	10.6	10.2	2.3	16.0	6.9	14.3	1.9	16.9	30.9	29.7	15.8	11.1	26.4	2.3	1.1	30.3	0.1	1.5	16.3	1.3	17.3	5.9	8.7	2.8	8.7	2.6	11.5	1.2	1.2	2.0	3.5	1.9	3.6	43.5	1.8	1.1	8.4	5.7	2.2	2.5	6.6	2.2	0.2	4.3	0.5	1.7	0.7	0.2	3.7	8.2	2.5	2.3	4.5	0.2	3.5	1.4	9.7	4.6	0.2	3.9	1.8	5.4	8.2	1.4	13.2	8.3	8.1	6.0	13.8	3.3	3.7	3.8	0.1	3.9	3.2	5.2	1.0	3.6	4.8	2.1	16.5	0.9	0.0	4.6	0.2	0.0	30.3	16.3	0.1	11.0	2.1	10.0	10.8	0.0	2.3	4.9	7.4	13.3	1.5	0.1	1.1	11.1	1.3	2.3	2.8	15.8	2.6	2.3	2.4	2.7	2.1	16.3	1.9
SYNM	"DMN, KIAA0353, SYN"	ENSG00000182253	Synemin	O15061	15	99098217-99135593	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 111.2;smooth muscle: 147.5;urinary bladder: 85.2"	"Cell line enhanced"	"Detected in many"		"A549: 14.6;HeLa: 21.9;WM-115: 49.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	8	"T-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017192, HPA040066, HPA044200, HPA077856"	Enhanced		Supported	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"CAB017192: , HPA040066: AB_2676830, HPA044200: AB_2678854, HPA077856: "	"unprognostic (1.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.27e-2)"	"unprognostic (5.92e-3)"	"unprognostic (3.26e-3)"	6.9	4.2	4.5	5.0	5.4	0.0	11.9	2.5	5.5	2.9	38.4	9.0	27.6	5.4	4.9	7.2	42.1	3.1	9.6	24.8	6.0	5.7	0.8	0.8	2.0	0.7	11.8	4.2	2.9	0.9	1.8	2.0	2.7	8.5	30.1	11.1	10.9	3.2	62.6	111.2	1.5	11.9	147.5	18.2	0.6	16.7	1.5	3.7	0.0	1.4	14.5	1.7	85.2	21.6	0.2	0.1	0.1	0.0	0.2	1.8	0.4	2.5	14.6	3.2	8.7	6.6	0.3	0.2	1.4	2.1	0.8	0.5	2.1	1.9	0.0	2.1	2.1	1.6	2.2	0.0	0.6	0.2	3.6	0.0	21.9	2.1	3.7	0.0	0.4	0.4	0.1	1.4	0.3	1.7	0.0	2.9	2.2	1.4	0.2	0.3	2.9	4.6	0.0	3.0	2.1	0.8	1.4	1.4	1.7	8.6	1.3	5.2	0.0	1.4	1.9	1.6	0.2	1.1	3.4	0.0	0.4	0.0	0.1	0.0	49.6	0.1	0.0	0.0	1.7	0.0	1.4	0.2	1.8	1.1	0.1	0.0	1.6	0.6	0.0	0.2	0.0	0.0	0.0	0.4	4.5	5.4	2.5	4.4	6.0	5.7	11.8	4.2	8.5	3.7
SYNPO2	MYOPODIN	ENSG00000172403	"Synaptopodin 2"	Q9UMS6	4	118850688-119061247	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 185.8"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 25.8;LHCN-M2: 9.2;SH-SY5Y: 39.3"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 27.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"thalamus: 64.1"	"Low region specificity"	"Detected in all"			"HPA030665, CAB037231, HPA049707, HPA068563"	Enhanced		Enhanced	"Vesicles,Actin filaments"				"Vesicles, Actin filaments"	"Vesicles, Actin filaments"	"CAB037231: AB_262098, HPA030665: AB_10696210, HPA049707: AB_2680857, HPA068563: AB_2686006"	"unprognostic (1.50e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.71e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (5.67e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (3.91e-4)"	11.4	2.3	1.8	9.6	3.9	0.0	7.3	1.0	5.6	26.5	56.0	4.4	20.5	6.5	37.5	23.9	37.0	14.2	19.4	29.0	2.6	1.5	2.4	1.7	3.7	5.7	1.9	5.2	27.9	1.4	0.9	2.6	3.8	3.8	35.9	11.1	21.2	4.1	58.8	185.8	3.7	14.5	88.7	4.0	6.1	29.5	9.6	3.1	3.0	3.7	12.8	2.1	50.7	15.5	1.8	0.2	2.0	0.4	1.2	2.3	0.4	0.1	1.8	0.1	0.0	5.5	1.8	0.3	5.7	6.3	0.2	0.2	0.0	0.3	0.6	0.0	25.8	0.1	0.1	0.1	0.3	2.4	0.0	0.3	0.4	0.0	1.3	0.0	0.1	6.6	0.1	1.8	0.1	0.0	0.0	0.3	9.2	0.1	0.3	3.5	0.6	0.0	0.2	0.6	0.1	0.1	0.1	0.2	39.3	0.2	0.1	0.0	0.0	3.3	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.2	0.0	1.9	0.3	2.0	1.2	0.1	1.9	1.3	2.0	1.2	0.1	1.8	2.1	1.3	0.9	1.2	0.4	0.2	2.3	0.4	1.8	3.9	1.0	5.6	2.6	1.5	1.9	5.2	3.8	3.1
TACC2	AZU-1	ENSG00000138162	"Transforming acidic coiled-coil containing protein 2"	O95359	10	121989174-122254545	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 109.4"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA031020, HPA031021, HPA061394"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		110000	110000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA031020: AB_10669988, HPA031021: , HPA061394: AB_2684500"	"unprognostic (3.28e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.15e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.83e-2)"	"prognostic favourable (2.50e-10)"	"unprognostic (7.02e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (8.45e-4)"	"unprognostic (1.61e-1)"	8.2	5.8	9.6	2.4	11.7	0.6	7.8	17.7	16.6	6.9	17.2	2.6	4.0	6.3	8.4	4.3	13.4	9.6	7.7	43.3	8.0	4.8	19.3	3.8	54.1	0.8	3.1	9.0	4.7	6.3	11.9	41.0	45.4	6.8	12.0	8.6	4.8	18.5	6.0	109.4	28.9	8.2	8.9	3.2	1.3	10.2	2.2	3.9	0.1	19.6	4.4	2.5	15.1	8.8	0.1	0.1	0.3	0.0	0.1	0.2	0.0	7.0	22.4	11.0	6.2	3.1	3.2	13.3	3.1	8.5	4.4	3.1	9.1	11.8	0.0	2.9	4.9	23.8	3.5	8.5	4.6	1.1	1.8	0.0	2.8	17.4	4.9	0.0	0.1	1.4	35.9	2.3	15.4	9.1	1.7	0.2	4.2	9.3	0.0	3.9	6.5	10.2	0.1	6.3	3.3	11.8	10.9	7.3	6.0	5.1	21.5	11.4	4.2	0.1	8.4	2.0	1.4	4.9	5.8	1.0	4.4	0.1	3.7	0.0	5.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	9.6	11.7	17.7	16.6	8.0	4.8	3.1	9.0	6.8	3.9
TARSL2	FLJ25005	ENSG00000185418	"Threonyl-tRNA synthetase like 2"	A2RTX5	15	101653598-101724604	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 47.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 9.7;NK-cells: 9.0;T-cells: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066697	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA066697: AB_2685705"	"unprognostic (9.33e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.26e-3)"	"unprognostic (9.76e-3)"	"unprognostic (4.00e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.52e-2)"	"unprognostic (6.48e-3)"	"unprognostic (2.79e-2)"	7.4	6.9	15.1	6.4	20.2	4.8	7.5	15.8	16.2	7.2	7.1	20.2	5.5	6.2	6.5	6.0	6.3	6.5	5.9	21.0	16.9	13.8	8.3	5.9	6.2	6.5	20.0	11.2	11.0	9.8	12.9	10.5	3.7	15.7	9.2	6.2	4.0	7.1	9.7	47.7	4.9	6.5	6.9	19.9	6.2	8.5	5.4	18.9	3.9	9.6	8.0	7.1	7.0	7.8	9.7	2.0	1.6	1.7	9.0	6.1	1.0	2.1	4.1	7.0	3.8	7.5	5.9	3.5	7.5	5.0	5.9	3.7	5.9	2.0	2.8	3.0	9.1	6.3	12.3	4.3	5.4	3.3	19.7	6.9	2.6	4.7	3.5	3.1	1.4	4.1	4.0	2.7	3.4	4.2	6.8	6.1	5.8	3.6	1.7	6.1	8.5	2.9	3.5	10.6	7.3	4.9	2.2	11.2	6.9	10.1	3.9	4.1	2.5	6.4	5.6	2.8	6.7	5.7	2.4	8.6	9.6	3.5	7.3	5.7	5.2	0.9	1.1	1.6	3.4	1.7	3.4	4.8	6.1	5.2	0.8	9.7	5.9	3.2	0.3	9.0	0.7	2.0	1.0	1.0	15.1	20.2	15.8	16.2	16.9	13.8	20.0	11.2	15.7	18.9
TBC1D17	FLJ12168	ENSG00000104946	"TBC1 domain family member 17"	Q9HA65	19	49877425-49888749	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 72.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA068119	Uncertain									"HPA068119: AB_2685958"	"unprognostic (5.88e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.16e-3)"	"unprognostic (4.33e-2)"	"unprognostic (8.39e-2)"	"prognostic favourable (7.18e-4)"	"unprognostic (6.41e-2)"	"unprognostic (8.48e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.49e-1)"	"prognostic favourable (4.02e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.38e-1)"	"unprognostic (9.52e-2)"	17.3	13.9	16.8	8.3	18.4	5.9	11.7	14.3	27.5	16.5	13.2	23.5	10.2	12.1	15.3	11.2	11.6	15.2	11.2	18.5	16.5	14.4	11.2	23.2	12.1	8.2	16.4	13.4	22.7	22.7	14.3	10.6	16.4	18.0	14.0	6.0	13.0	24.0	17.1	72.8	20.3	10.9	11.0	16.6	11.1	12.5	8.3	16.8	10.0	17.8	11.0	8.4	16.5	10.2	11.9	5.6	11.0	4.4	12.1	10.0	6.2	6.3	12.6	4.0	5.3	18.3	13.0	9.3	7.2	23.7	8.3	13.3	6.4	9.0	3.8	7.1	13.5	6.7	3.6	10.1	4.5	9.6	9.9	4.3	10.2	7.6	15.9	2.3	6.4	15.1	10.1	7.8	5.8	7.8	5.0	19.0	6.8	7.2	3.0	4.2	7.4	10.9	4.4	5.9	9.4	10.4	11.0	7.2	8.3	9.8	9.9	6.2	9.4	2.9	9.1	18.2	6.5	6.7	3.7	12.7	15.9	2.6	19.8	2.5	6.7	11.0	4.4	8.8	9.4	4.3	8.6	10.0	8.7	10.0	4.3	11.9	9.0	7.3	6.0	12.1	4.0	5.6	5.0	6.2	16.8	18.4	14.3	27.5	16.5	14.4	16.4	13.4	18.0	16.8
TBC1D3K		ENSG00000273513	"TBC1 domain family member 3K"	A0A087X1G2	17	37924415-37935365	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 1.3;skeletal muscle: 1.1;testis: 4.2"	"Group enriched"	"Detected in some"	5	"SiHa: 2.2;T-47d: 5.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"HPA046969: , HPA047745: AB_2680144, HPA052553: "																		0.0	0.0		0.0		0.5	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.2	1.3			0.6	0.0	0.1		0.0		0.0	0.0		0.0	0.0	1.1	0.0	0.0	0.0		0.0	0.0	4.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0										
TBC1D8	"AD3, GRAMD8, HBLP1, VRP"	ENSG00000204634	"TBC1 domain family member 8"	O95759	2	101007617-101252866	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 76.0;skeletal muscle: 66.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 36.5;ASC TERT1: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 16.6;non-classical monocyte: 20.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015211, HPA037496"	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB015211: , HPA037496: AB_2675507"	"unprognostic (1.82e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (6.73e-4)"	"unprognostic (4.25e-3)"	"unprognostic (3.98e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.73e-2)"	"unprognostic (7.98e-3)"	14.4	4.0	3.0	5.5	4.2	7.3	14.1	10.1	5.1	7.6	19.6	2.2	52.8	4.3	7.8	12.2	8.4	13.2	12.0	24.1	4.8	2.7	8.9	12.8	11.8	6.8	3.0	3.8	5.1	27.5	3.9	8.5	4.4	6.1	25.7	3.8	6.7	15.1	76.0	66.3	15.2	22.7	7.7	5.0	11.3	13.3	11.3	2.8	3.3	5.3	8.3	8.0	8.7	8.6	0.6	4.0	0.2	20.6	0.0	0.3	1.8	2.0	12.8	1.0	3.7	36.5	26.0	10.5	1.2	22.3	0.9	1.1	4.5	3.3	0.9	11.5	0.9	6.4	2.1	9.8	0.6	0.6	1.9	0.6	4.2	15.5	2.5	0.0	11.0	12.0	9.4	1.2	9.3	13.0	0.2	1.1	1.1	5.6	1.1	6.4	2.8	13.7	2.5	3.2	0.2	7.4	13.6	8.0	3.9	1.7	3.1	4.4	0.9	9.4	10.7	0.5	1.9	1.9	0.8	2.1	0.1	0.0	4.7	3.2	3.3	0.0	5.1	0.2	0.1	16.6	0.2	0.2	0.1	0.1	2.8	0.6	0.3	0.2	0.2	0.0	20.6	4.0	0.1	1.8	3.0	4.2	10.1	5.1	4.8	2.7	3.0	3.8	6.1	2.8
TBPL2	"TBP2, TRF3"	ENSG00000182521	"TATA-box binding protein like 2"	Q6SJ96	14	55413541-55456726	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"skeletal muscle: 3.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 8.9;HMC-1: 5.2;U-937: 6.7"	"Cancer enriched"	"Detected in single"	40	"testis cancer: 2.0"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA056241	Uncertain									"HPA056241: AB_2683076"					"unprognostic (3.42e-1)"	"unprognostic (1.16e-1)"				"unprognostic (1.50e-1)"			"unprognostic (3.06e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"		0.4	0.9	0.2	1.7	0.6	0.7	0.4	0.4	0.4	0.8	0.5			2.0	1.3	0.0	0.2	0.2	0.0	0.3	0.3	0.4	0.6	0.3	0.5	0.4	0.5		1.1	0.2	0.2	0.3	0.0		0.3	0.0		1.0	0.0	3.9	3.1	1.2	0.0	0.3	0.8	0.9	1.9			0.5		0.0	0.2	0.3	1.5	1.1	1.5	1.1	1.6	0.9	0.5	3.2	1.0	0.0	1.0	0.0	1.1	2.2	0.0	0.0	0.0	0.4	0.4	0.5	0.6	2.7	0.0	0.8	0.2	0.0	0.0	8.9	0.0	0.6	0.8	0.0	0.0	0.0	5.2	0.0	1.7	0.0	0.4	0.0	0.5	3.2	0.0	2.3	0.5	1.7	0.7	0.9	0.8	0.0	0.6	0.0	1.3	1.8	0.9	0.0	0.2	0.3	1.2	1.1	0.0	0.3	4.2	0.4	0.7	3.1	1.4	0.4	0.5	6.7	0.2	1.5	0.5	0.5	0.9	1.1	0.6	1.0	0.5	0.4	0.6	1.5	0.5	0.2	1.0	1.6	0.3	1.1	0.1	0.5										
TBX15	TBX14	ENSG00000092607	"T-box 15"	Q96SF7	1	118883046-118989556	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.3;skeletal muscle: 84.9;tongue: 37.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 27.7;ASC TERT1: 11.7;BJ hTERT+ SV40 Large T+ RasG12V: 10.6;fHDF/TERT166: 14.1;HSkMC: 19.9;RH-30: 14.9;U-2197: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA052245, HPA053713"	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Nucleoplasm	"HPA052245: AB_2681771, HPA053713: "	"unprognostic (1.94e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.92e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.72e-3)"	"unprognostic (7.79e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.81e-3)"	"unprognostic (5.03e-2)"	"prognostic unfavourable (5.57e-8)"	"unprognostic (2.63e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.31e-1)"	18.1	0.1	0.2	0.1	0.5	0.1	12.5	0.4	0.8	0.1	0.1	0.2	0.0	0.0	0.1	2.1	1.2	0.1	0.3	1.2	0.5	0.0	0.1	23.3	0.2	1.3	0.2	0.2	0.1	0.1	0.2	0.5	0.1	2.1	0.7	0.0	0.2	2.8	0.1	84.9	3.6	0.1	0.2	0.6	0.0	0.1	0.4	0.4	0.0	1.9	37.5	2.4	0.2	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	27.7	11.7	0.0	2.4	3.2	6.3	10.6	0.0	0.0	0.0	1.3	14.1	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.0	19.9	0.1	0.1	0.0	0.0	0.0	0.1	7.2	0.0	0.0	0.1	1.2	0.1	0.0	14.9	0.2	1.5	0.7	0.3	0.0	0.8	0.0	0.3	0.0	0.3	0.0	3.4	2.1	14.0	0.1	0.2	0.1	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.4	0.8	0.5	0.0	0.2	0.2	2.1	0.4
TCEA3	TFIIS.H	ENSG00000204219	"Transcription elongation factor A3"	O75764	1	23381061-23424740	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 114.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.1;Hep G2: 33.5;SiHa: 11.1;T-47d: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 8.5;naive CD4 T-cell: 14.3"	"Lineage enriched"	"Detected in many"	5	"T-cells: 14.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA044960, HPA055811"	Approved		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA044960: AB_10964053, HPA055811: AB_2682932"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-3)"	"unprognostic (9.18e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.77e-3)"	"prognostic favourable (2.56e-4)"	"unprognostic (2.86e-2)"	"unprognostic (4.70e-3)"	"unprognostic (7.37e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.58e-2)"	5.4	17.8	2.5	10.7	1.9	0.1	3.6	1.5	1.5	9.1	12.2	2.2	12.0	4.6	3.8	14.5	12.0	6.2	13.0	20.3	2.4	0.8	12.1	38.0	6.0	1.3	1.2	2.3	19.8	60.4	4.5	3.3	2.5	2.2	16.7	12.5	8.7	32.7	15.9	114.0	8.9	11.9	13.7	2.0	1.6	11.5	2.6	1.3	0.5	8.6	58.3	16.0	8.4	6.9	0.0	2.8	0.0	0.7	0.2	14.3	2.5	0.0	0.1	0.3	0.3	1.7	10.1	5.6	3.9	2.6	2.1	1.2	2.5	0.3	0.1	0.4	4.9	5.5	0.4	0.0	1.8	0.0	0.0	0.0	4.2	33.5	1.2	0.5	0.0	6.6	1.8	1.8	0.0	0.2	0.0	0.0	0.7	0.9	0.2	3.6	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.3	0.1	11.1	0.5	0.4	17.7	1.6	0.2	0.0	0.1	0.4	0.0	0.3	2.9	0.0	0.3	0.3	0.3	0.0	0.1	0.0	0.5	0.7	0.5	0.0	8.5	1.2	2.8	0.0	14.3	6.3	0.0	0.2	0.2	0.9	0.7	2.5	2.5	1.9	1.5	1.5	2.4	0.8	1.2	2.3	2.2	1.3
TCF15	"bHLHa40, EC2, PARAXIS"	ENSG00000125878	"Transcription factor 15"	Q12870	20	603797-610398	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 11.4;heart muscle: 19.4;skeletal muscle: 18.0"	"Cell line enhanced"	"Detected in some"		"HEL: 10.7;HMC-1: 17.6;U-2 OS: 3.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050998, HPA060221"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA050998: AB_2681302, HPA060221: AB_2684225"	"unprognostic (2.12e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavourable (3.25e-4)"	"unprognostic (1.52e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.27e-3)"	"unprognostic (7.21e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.11e-1)"	"unprognostic (6.99e-2)"	8.4	0.3	0.9	0.4	1.0	0.2	11.4	0.1	1.1	0.6	1.3	0.1	0.0	0.4	0.8	0.3	1.7	0.4	0.7	19.4	1.2	0.7	0.5	0.3	0.9	0.3	1.0	0.0	0.2	0.1	0.4	0.3	8.2	0.7	1.0	0.3	0.3	0.8	0.3	18.0	0.2	0.4	1.3	1.1	0.2	0.4	1.6	0.6	0.2	1.3	6.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	1.5	0.0	0.0	0.0	3.0	10.7	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	1.6	0.0	1.4	0.0	0.0	1.4	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.1	1.1	1.2	0.7	1.0	0.0	0.7	0.6
TEAD4	"EFTR-2, RTEF-1, TCF13L1, TEF-3, TEFR-1"	ENSG00000197905	"TEA domain transcription factor 4"	Q15561	12	2959330-3040673	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 60.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 84.7"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 78.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 3.5"	"Low region specificity"	"Detected in all"			HPA056896	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA056896: AB_2683268"	"unprognostic (3.68e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.68e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.21e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (9.78e-9)"	"unprognostic (5.05e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.23e-3)"	7.6	1.9	1.2	4.5	1.8	0.5	11.1	2.0	2.5	3.6	3.1	0.7	7.4	3.2	4.4	5.1	4.2	3.1	4.3	9.7	1.4	1.1	9.2	5.5	10.3	5.3	2.4	0.4	4.4	27.5	1.1	1.5	6.8	3.2	3.8	2.9	3.9	3.5	7.1	60.1	6.2	5.2	5.7	1.9	7.2	3.6	2.2	1.4	0.5	16.4	13.3	2.5	3.1	10.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	8.4	11.9	3.0	8.5	0.9	2.1	32.8	6.8	3.6	11.8	6.6	22.8	9.1	0.0	5.3	5.1	12.2	11.9	84.7	11.0	0.0	9.6	13.4	9.9	19.7	4.6	2.8	2.5	2.9	3.5	10.2	15.8	10.0	8.6	0.1	4.0	12.0	0.1	0.0	23.4	7.1	6.2	17.4	6.5	5.5	3.5	1.7	3.1	8.4	21.2	6.2	14.4	5.0	11.4	6.8	24.0	4.7	3.5	0.0	0.0	0.0	5.5	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.8	2.0	2.5	1.4	1.1	2.4	0.4	3.2	1.4
THBS4		ENSG00000113296	"Thrombospondin 4"	P35443	5	79991311-80083287	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 69.8;heart muscle: 59.0;skeletal muscle: 61.7;smooth muscle: 94.0"	"Cell line enhanced"	"Detected in some"		"AF22: 5.0;THP-1: 10.7;U-2 OS: 4.6;U-266/70: 4.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	51	"eosinophil: 8.0"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 8.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB004597, HPA042426"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	420000000	420000000	Vesicles	Vesicles	"CAB004597: AB_628352, HPA042426: AB_2677992"	"unprognostic (1.41e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.64e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavourable (3.33e-4)"	69.8	1.0	7.6	2.1	8.3	3.7	9.7	0.8	4.6	1.1	21.4	2.6	1.2	1.3	12.2	13.6	6.5	1.4	4.1	59.0	6.4	6.4	0.8	0.6	1.0	0.9	8.5	1.9	2.1	23.0	5.5	7.8	0.6	10.7	3.7	3.7	4.9	19.8	2.6	61.7	1.5	1.4	94.0	11.5	0.6	4.0	5.5	2.6	2.0	9.9	39.3	4.1	3.4	2.7	0.1	0.0	8.0	0.0	0.0	0.1	0.0	0.2	0.0	5.0	0.3	0.4	2.2	0.5	0.1	0.2	1.5	0.5	0.1	0.6	0.2	0.2	0.4	0.2	0.2	0.6	1.3	0.2	0.7	0.5	0.0	0.3	2.7	0.0	0.1	1.5	0.3	0.1	0.3	0.0	0.0	0.3	0.3	0.7	0.1	0.0	3.9	0.1	0.0	1.5	0.0	0.3	0.1	4.0	1.2	0.1	0.0	0.4	0.0	10.7	0.0	0.1	4.6	0.3	0.3	4.1	0.1	0.7	1.8	3.4	0.9	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.6	8.3	0.8	4.6	6.4	6.4	8.5	1.9	10.7	2.6
TM6SF1		ENSG00000136404	"Transmembrane 6 superfamily member 1"	Q9BZW5	15	83107407-83144854	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.3;skeletal muscle: 37.8"	"Cell line enhanced"	"Detected in some"		"HEL: 9.4;HHSteC: 22.3;HUVEC TERT2: 11.7;THP-1: 6.5;TIME: 30.6;U-698: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 44.3;neutrophil: 26.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 44.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016051, HPA056857"	Uncertain									"HPA016051: AB_2203924, HPA056857: AB_2683259"	"unprognostic (8.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.46e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.55e-1)"	"prognostic favourable (6.79e-4)"	"unprognostic (1.15e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.70e-1)"	9.6	3.4	4.9	4.9	6.8	4.7	11.2	4.4	13.9	4.0	3.0	6.8	0.9	2.3	3.2	4.1	2.4	3.4	3.9	9.2	7.2	6.7	2.9	2.5	10.6	9.0	8.0	7.1	2.1	1.5	1.8	1.7	7.2	10.0	2.5	2.9	3.4	3.2	1.9	37.8	1.7	2.6	3.8	12.5	5.2	2.1	4.1	3.7	0.6	9.9	3.5	3.0	4.9	2.4	0.2	4.6	44.3	7.8	1.0	1.2	2.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	1.8	0.0	0.0	0.0	0.2	9.4	0.0	0.0	22.3	0.5	0.0	0.1	0.0	0.0	0.0	11.7	0.4	0.0	0.2	0.0	0.0	0.7	0.2	0.0	0.0	1.6	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.8	0.0	6.5	30.6	0.3	0.4	0.0	0.1	0.9	0.0	7.0	0.0	1.2	0.0	14.1	7.8	44.3	1.2	3.3	0.0	0.0	0.1	0.1	4.6	0.2	0.0	0.1	26.4	1.0	1.4	0.6	0.0	2.8	4.9	6.8	4.4	13.9	7.2	6.7	8.0	7.1	10.0	3.7
TMEM108	"CT124, MGC3040"	ENSG00000144868	"Transmembrane protein 108"	Q6UXF1	3	133038391-133397792	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 25.6"	"Cell line enhanced"	"Detected in some"		"HMC-1: 11.6;LHCN-M2: 6.5;SCLC-21H: 10.0;SH-SY5Y: 44.3"	"Cancer enhanced"	"Detected in many"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063350	Enhanced		Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA063350: AB_2684993"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.06e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.27e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.36e-2)"	2.2	15.1	12.7	2.2	13.8	0.7	2.4	15.6	21.7	3.2	1.8	7.5	0.2	1.1	3.7	1.3	12.7	2.4	1.6	8.4	10.0	8.1	1.0	0.6	12.1	2.5	5.3	13.7	0.8	1.0	6.1	2.8	9.1	4.9	4.0	2.2	16.1	1.8	3.2	25.6	2.2	2.0	10.4	4.4	2.0	2.2	16.8	4.3	0.0	4.1	1.5	3.3	12.0	1.3	0.8	0.4	1.0	0.4	0.6	0.8	0.6	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.3	0.4	0.8	3.9	0.0	0.0	0.0	0.0	11.6	0.1	0.0	0.0	0.0	0.6	0.0	0.0	6.5	0.3	0.0	0.1	1.8	0.0	0.0	2.2	0.0	0.5	0.0	10.0	44.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.3	0.8	0.0	1.7	1.0	0.3	0.2	0.5	0.3	0.3	0.3	0.2	0.5	0.0	0.8	0.3	0.4	0.9	0.6	0.4	0.4	0.8	0.6	12.7	13.8	15.6	21.7	10.0	8.1	5.3	13.7	4.9	4.3
TMEM110-MUSTN1		ENSG00000248592	"TMEM110-MUSTN1 readthrough"		3	52833121-52897562	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.2;Karpas-707: 9.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA051855	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA051855: AB_2681639"	"unprognostic (4.19e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.95e-2)"	"unprognostic (7.28e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.11e-4)"	"unprognostic (4.73e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.01e-6)"	"unprognostic (5.49e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.09e-5)"	13.3	6.7	3.8	5.4	7.6	5.2	5.8	5.2	9.6	4.9	5.5	8.6	3.7	4.1	8.6	3.4	6.4	4.2	3.8	5.8	4.1	3.7	8.0	23.6	5.0	8.6	6.6	3.4	5.2	9.2	2.0	3.8	3.9	6.0	4.1	2.6	6.0	5.5	3.1	58.0	4.2	7.9	7.8	4.8	5.7	5.0	3.9	4.1	8.6	4.4	2.7	6.1	5.8	5.7	0.9	1.6	1.6	1.7	0.0	2.3	0.4	1.5	0.8	1.6	6.1	0.5	0.0	0.0	3.2	1.0	0.2	0.4	0.0	1.0	1.1	0.5	0.0	1.4	1.6	1.6	0.0	8.2	3.2	2.0	0.0	0.0	0.2	1.4	3.1	0.0	0.6	0.6	1.3	0.3	0.9	9.0	0.1	0.9	1.9	1.1	1.1	4.2	0.3	0.0	1.9	0.3	0.0	0.6	0.4	0.8	0.9	1.9	0.7	3.1	0.9	1.1	2.9	1.2	1.8	4.2	3.8	1.2	1.4	4.0	1.7	0.0	0.2	1.6	0.4	1.7	2.3	0.9	0.7	0.9	0.8	0.3	0.0	0.0	0.4	0.0	0.0	1.6	0.6	0.4	3.8	7.6	5.2	7.6	4.1	3.7	6.6	3.4	6.0	4.1
TMEM143	FLJ10922	ENSG00000161558	"Transmembrane protein 143"	Q96AN5	19	48332356-48364237	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 70.1"	"Cell line enhanced"	"Detected in all"		"U-266/70: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014476, HPA058645"	Approved		Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA014476: AB_1858092, HPA058645: "	"unprognostic (1.23e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.50e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.11e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.08e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.82e-2)"	"prognostic favourable (1.53e-7)"	"unprognostic (5.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.04e-1)"	6.2	5.6	3.3	3.5	5.7	2.7	3.2	5.1	6.6	2.6	4.4	4.4	4.1	4.3	4.1	3.8	4.0	3.0	3.2	27.0	3.4	2.7	6.1	9.7	2.9	3.5	4.7	4.5	3.2	4.2	3.1	3.2	3.0	3.9	3.4	3.1	4.7	4.5	4.1	70.1	4.8	4.8	5.3	3.2	4.6	3.7	2.5	4.3	5.4	3.9	16.5	5.1	3.7	2.5	5.0	3.4	3.6	2.3	7.6	5.7	2.7	3.5	5.7	1.9	3.5	3.9	6.3	3.8	3.4	2.0	2.4	3.1	5.0	4.7	6.6	6.5	2.3	4.1	1.9	2.5	1.4	9.0	4.3	4.0	4.6	8.3	3.3	3.2	3.9	5.4	3.1	1.2	3.3	1.9	2.9	9.9	3.0	2.1	4.4	12.3	2.4	2.1	7.1	1.4	11.0	3.2	2.7	7.1	7.0	1.9	2.5	1.5	3.5	2.8	2.3	2.8	3.2	2.0	1.7	20.9	6.2	5.4	2.3	4.2	2.4	3.6	2.3	2.7	4.7	1.5	5.7	5.0	3.7	4.0	3.4	3.4	5.5	3.3	1.7	7.6	2.3	1.3	2.3	2.7	3.3	5.7	5.1	6.6	3.4	2.7	4.7	4.5	3.9	4.3
TMEM201	"Ima1, NET5, RP13-15M17.2, SAMP1"	ENSG00000188807	"Transmembrane protein 201"	Q5SNT2	1	9588922-9614873	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 37.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 4.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB039039	Approved		Supported	"Nucleoplasm,Nuclear membrane"				"Nuclear membrane"	"Nuclear membrane"	"CAB039039: "	"unprognostic (1.75e-2)"	"prognostic favourable (5.36e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.88e-1)"	"unprognostic (1.27e-2)"	"prognostic unfavourable (9.61e-8)"	"unprognostic (2.22e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.45e-1)"	6.2	7.3	9.6	5.7	9.4	10.3	4.0	8.7	11.9	4.4	3.9	10.5	4.4	5.4	6.9	5.1	5.9	5.8	4.0	13.2	9.3	7.9	5.7	2.7	4.5	5.0	9.4	8.3	9.0	9.2	5.5	12.6	4.5	7.9	4.9	2.8	12.6	6.7	5.6	37.0	7.1	3.9	4.9	6.7	5.3	4.0	8.2	7.1	6.9	4.5	13.9	5.4	3.8	4.3	1.4	4.3	0.0	0.8	0.4	1.9	1.0	7.7	10.4	6.6	15.5	2.8	1.8	5.9	9.1	2.8	10.8	7.7	19.2	7.0	13.5	11.6	3.1	16.2	7.3	7.2	3.6	8.8	18.3	9.5	10.0	9.7	5.1	11.5	9.9	3.4	3.3	14.5	2.4	4.3	12.1	3.9	4.3	9.1	9.9	8.4	6.7	9.7	21.1	11.3	11.0	3.8	4.2	15.8	11.9	7.2	17.6	7.8	5.4	7.3	3.9	13.0	11.3	14.2	17.0	6.6	5.4	12.1	9.0	19.0	11.4	0.0	0.8	0.0	1.1	0.6	0.6	1.4	1.4	1.9	1.1	1.1	1.0	0.7	0.0	0.4	0.4	4.3	1.8	1.0	9.6	9.4	8.7	11.9	9.3	7.9	9.4	8.3	7.9	7.1
TMEM38B	"bA219P18.1, C9orf87, D4Ertd89e, FLJ10493, TRIC-B"	ENSG00000095209	"Transmembrane protein 38B"	Q9NVV0	9	105694544-105776612	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018465	Uncertain									"HPA018465: AB_1858116"	"unprognostic (3.34e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.80e-2)"	"prognostic favourable (7.96e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.89e-3)"	"unprognostic (9.98e-2)"	8.8	10.0	6.0	4.0	7.4	10.4	17.4	4.1	5.7	6.8	7.4	10.4	2.8	4.0	5.5	11.0	4.8	4.5	4.2	28.3	6.6	6.1	18.6	11.7	5.7	8.1	12.5	3.4	11.7	4.1	5.3	16.6	2.9	7.9	5.1	7.3	9.2	4.2	4.4	43.9	4.0	6.4	5.2	10.4	3.6	4.3	21.1	9.0	3.3	17.9	15.6	3.0	7.5	8.2	26.3	24.2	24.5	13.3	12.0	20.2	11.3	5.8	9.2	7.1	11.3	41.5	9.2	15.2	8.7	5.5	8.3	8.6	14.2	8.1	13.6	4.3	3.0	4.3	10.2	4.8	9.1	10.2	13.9	5.6	6.4	8.7	5.8	16.8	12.0	8.6	4.3	5.7	8.1	3.3	29.2	12.2	5.1	16.2	11.6	5.1	5.5	10.0	7.8	22.5	6.5	3.8	4.9	12.5	3.0	8.7	14.3	6.2	17.9	11.9	1.7	7.6	7.6	28.8	8.7	14.9	37.0	6.7	14.1	18.5	15.0	5.8	9.7	24.5	6.7	13.3	8.7	26.3	9.2	7.9	10.8	24.7	20.2	12.5	1.4	12.0	11.5	24.2	7.8	11.3	6.0	7.4	4.1	5.7	6.6	6.1	12.5	3.4	7.9	9.0
TMEM70	FLJ20533	ENSG00000175606	"Transmembrane protein 70"	Q9BUB7	8	73972437-73982783	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.1"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023187, CAB034226"	Uncertain		Supported	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"CAB034226: AB_2205189, HPA023187: AB_2671101"	"unprognostic (2.26e-3)"	"unprognostic (4.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.37e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.65e-3)"	"unprognostic (6.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.70e-2)"	9.5	12.3	7.6	7.4	8.0	7.0	9.4	7.1	12.8	6.0	7.4	3.6	3.9	4.8	6.1	9.0	6.2	9.1	7.4	13.3	9.3	7.9	9.7	38.8	6.2	9.6	6.8	7.3	7.3	17.0	5.1	6.3	8.1	10.0	6.3	8.0	3.8	7.1	5.3	81.1	4.8	6.9	7.7	6.3	9.9	10.6	10.9	5.1	8.5	6.5	13.4	7.9	6.7	5.9	18.4	12.3	7.5	11.0	6.2	12.7	12.7	11.0	8.8	7.1	7.4	8.4	7.2	7.3	9.4	8.6	10.6	8.6	8.3	6.4	15.0	8.2	6.4	10.1	13.6	9.1	12.0	9.7	9.3	15.0	5.8	11.0	8.4	8.1	8.0	6.7	8.4	6.7	3.6	8.9	11.2	7.4	11.2	8.2	18.5	15.4	6.6	11.0	13.1	7.0	12.7	11.2	10.5	16.2	7.2	5.8	42.5	11.9	8.8	7.5	5.6	6.2	7.5	11.2	8.9	11.0	9.4	14.7	9.0	6.4	6.8	6.3	10.8	7.0	9.5	11.0	10.9	18.4	10.9	10.8	10.5	10.8	12.7	11.8	7.5	6.2	8.1	12.3	8.6	12.7	7.6	8.0	7.1	12.8	9.3	7.9	6.8	7.3	10.0	5.1
TMOD1	"D9S57E, ETMOD, TMOD"	ENSG00000136842	"Tropomodulin 1"	P28289	9	97501180-97601748	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 71.7;skeletal muscle: 112.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 12.1;HDLM-2: 46.9;K-562: 15.9;SH-SY5Y: 50.2"	"Cancer enhanced"	"Detected in many"		"glioma: 21.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA051202	Enhanced					900000	900000			"HPA051202: AB_2681387"	"unprognostic (8.54e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.88e-5)"	7.9	35.6	10.9	3.4	11.9	11.1	5.9	18.1	17.2	17.3	9.8	6.0	8.9	3.3	27.6	7.1	10.8	16.0	5.3	71.7	7.1	6.1	3.6	21.9	5.2	2.3	4.6	9.3	24.8	7.6	9.5	13.6	2.4	12.8	10.7	4.5	10.4	3.3	6.1	112.7	2.9	3.8	22.6	15.9	1.9	6.0	3.2	5.3	0.0	8.7	36.9	2.3	15.4	19.7	4.6	1.2	2.0	0.9	1.7	5.2	3.1	1.6	0.4	0.0	0.2	2.0	0.2	0.6	0.3	2.8	0.0	0.0	0.3	0.5	0.0	12.1	0.0	0.1	0.5	0.0	0.0	46.9	1.7	2.3	2.9	0.2	0.0	0.0	4.0	0.1	0.0	0.1	0.0	0.2	15.9	0.0	0.0	0.7	0.0	0.3	0.6	0.2	0.0	1.6	0.0	0.0	0.3	0.2	50.2	1.5	0.0	0.8	0.6	2.4	0.2	0.0	1.8	1.4	0.3	6.1	1.2	0.0	2.3	1.6	2.6	2.0	0.7	1.2	3.3	0.7	3.1	3.1	2.6	1.9	1.2	4.6	1.8	2.1	0.2	1.7	0.9	0.4	5.2	3.1	10.9	11.9	18.1	17.2	7.1	6.1	4.6	9.3	12.8	5.3
TNFRSF13B	"CD267, IGAD2, TACI"	ENSG00000240505	"TNF receptor superfamily member 13B"	O14836	17	16929816-16972118	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 45.1;lymphoid tissue: 44.6;skeletal muscle: 30.5"	"Group enriched"	"Detected in some"	8	"Karpas-707: 54.6;RPMI-8226: 34.3;U-266/70: 24.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	42	"memory B-cell: 45.1;naive B-cell: 13.1"	"Lineage enriched"	"Detected in single"	65	"B-cells: 45.1"					"Low region specificity"	"Detected in all"			HPA030453	Uncertain									"HPA030453: AB_10601700"	"unprognostic (3.94e-5)"	"unprognostic (1.11e-3)"	"unprognostic (4.88e-2)"	"unprognostic (4.30e-3)"		"unprognostic (1.23e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.61e-4)"	"unprognostic (2.22e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.59e-5)"	"unprognostic (1.20e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.05e-1)"	0.5	0.3	0.4	17.6	0.3	0.2	0.5	0.2	0.3	0.7	3.0	0.1	0.0	1.9	0.3	0.0	2.7	0.5	0.5	2.5	0.3	0.3	0.6	0.5	1.2	12.5	0.3	0.2	0.3	0.3	0.0	0.3	0.0	0.1	0.9	1.2	0.6	9.0	1.1	30.5	0.3	14.8	0.0	0.4	44.6	2.4	0.3	0.1	0.9	0.6	0.9	37.8	2.3	0.4	45.1	0.0	0.1	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	54.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.0	4.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.1	0.0	0.0	0.0	13.1	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.9	0.4	0.3	0.2	0.3	0.3	0.3	0.3	0.2	0.1	0.1
TOM1		ENSG00000100284	"Target of myb1 membrane trafficking protein"	O60784	22	35299275-35347994	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 83.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000818, HPA001749"	Approved		Approved	"Plasma membrane,Centriolar satellite,Cytosol"		14000	14000	Cytosol	Cytosol	"HPA000818: AB_2666101, HPA001749: AB_1080323"	"unprognostic (3.75e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.18e-2)"	"prognostic favourable (2.20e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.92e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.16e-2)"	"prognostic favourable (3.72e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.54e-3)"	"unprognostic (3.31e-2)"	17.0	21.2	9.5	10.2	13.8	31.1	13.7	10.2	24.6	16.0	14.6	12.0	7.5	17.4	14.1	15.5	31.6	11.7	15.4	19.1	8.8	15.2	16.1	27.4	17.5	8.2	11.6	11.3	12.1	11.8	21.8	16.8	39.0	23.2	10.2	6.4	17.5	37.0	10.1	83.8	29.1	18.6	7.1	8.4	10.6	8.4	13.6	8.7	10.0	14.8	25.9	19.9	12.1	17.6	4.6	15.2	40.9	31.2	4.6	14.7	17.0	6.6	6.7	3.9	6.3	27.9	16.6	18.4	6.5	19.7	12.7	14.3	9.3	6.2	2.6	12.1	20.3	3.1	4.0	6.8	4.6	7.5	9.1	2.2	7.6	19.3	26.3	4.2	10.1	22.4	8.6	17.9	6.1	8.8	4.3	6.6	6.2	6.4	3.4	9.9	3.0	3.9	6.2	5.6	5.6	5.0	5.0	6.7	5.2	14.8	15.4	14.5	7.8	7.0	9.2	15.1	13.1	11.5	3.2	7.7	4.8	6.8	20.3	4.4	4.9	5.9	31.2	13.1	6.4	18.9	5.3	4.6	9.8	6.1	15.2	4.0	7.9	5.3	40.9	4.6	19.4	8.1	14.7	17.0	9.5	13.8	10.2	24.6	8.8	15.2	11.6	11.3	23.2	8.7
TOMM7	Tom7	ENSG00000196683	"Translocase of outer mitochondrial membrane 7"	Q9P0U1	7	22812628-22822852	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 253.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"																		"unprognostic (6.69e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavourable (6.30e-4)"	"unprognostic (2.25e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.01e-2)"	63.5	76.7	66.0	36.7	63.2	48.5	70.1	41.3	58.1	42.7	46.2	19.8	41.4	51.3	41.8	36.0	41.1	40.1	39.1	61.6	50.2	42.6	42.1	43.7	37.0	70.0	58.4	42.5	106.7	96.4	23.0	43.4	22.7	44.0	41.7	30.1	39.5	62.4	42.1	253.0	37.5	41.7	71.5	52.0	45.4	43.6	24.4	47.4	21.1	36.6	81.9	44.2	49.1	70.8	117.8	81.0	47.7	51.3	49.5	151.7	130.5	61.2	18.5	20.7	43.6	51.6	55.0	25.0	52.6	39.5	19.9	16.1	13.0	36.0	37.6	55.2	40.2	42.7	34.1	28.8	18.5	25.0	38.9	20.6	48.3	18.3	48.2	58.0	28.8	79.7	57.6	33.7	48.6	28.6	57.0	40.7	32.7	26.0	27.3	63.0	79.7	47.0	25.2	25.1	59.3	16.9	19.3	18.0	37.1	34.7	78.1	114.2	56.1	94.4	39.5	22.8	45.3	46.4	49.6	104.7	88.6	68.4	34.3	52.4	85.8	20.4	51.3	47.7	65.5	44.0	81.2	117.8	112.6	79.2	51.8	102.3	151.7	106.3	17.8	49.5	44.2	81.0	84.2	130.5	66.0	63.2	41.3	58.1	50.2	42.6	58.4	42.5	44.0	47.4
TP63	"EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L"	ENSG00000073282	"Tumor protein p63"	Q9H3D4	3	189631416-189897279	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 83.2;skin 1: 54.2"	"Group enriched"	"Detected in some"	5	"HaCaT: 23.3;HBEC3-KT: 44.6;hTCEpi: 33.8;hTERT-HME1: 32.3;RT4: 49.0"	"Group enriched"	"Detected in many"	11	"cervical cancer: 37.9;head and neck cancer: 73.3;lung cancer: 37.3;urothelial cancer: 21.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000083, HPA006288, HPA006289, HPA007009, HPA007010"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB000083: AB_2207187, HPA006288: AB_1080334, HPA006289: , HPA007009: , HPA007010: AB_1080336"	"prognostic favourable (1.07e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.74e-3)"	2.9	0.1	0.2	0.7	0.1	0.0	7.2	0.1	0.2	9.5	0.1	0.1	5.7	0.0	0.3	8.0	33.7	0.3	0.0	0.2	0.1	0.1	0.4	0.1	1.2	0.2	0.1	0.2	0.1	0.1	0.0	0.3	7.8	0.8	9.6	0.0	0.3	9.0	7.8	83.2	54.2	0.1	2.7	0.6	0.1	0.1	1.2	0.0	9.0	0.4	36.7	26.1	9.6	19.2	3.7	1.3	3.0	0.9	1.2	1.2	0.2	0.6	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.1	0.0	23.3	0.0	44.6	0.0	0.3	0.0	0.5	0.3	0.1	0.0	0.0	0.1	0.0	33.8	0.0	32.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.1	0.3	0.1	0.0	0.2	2.0	0.4	1.1	0.9	0.5	0.7	3.7	1.2	1.0	0.4	1.7	0.8	0.7	3.0	1.2	0.9	1.3	0.8	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.8	0.0
TPI1		ENSG00000111669	"Triosephosphate isomerase 1"	P60174	12	6867119-6870948	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 234.8;skeletal muscle: 211.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050924, HPA053568"	Uncertain		Approved	Nucleoplasm,Vesicles		270000000	270000000	Nucleoplasm	Nucleoplasm	"HPA050924: AB_2681276, HPA053568: AB_2682193"	"unprognostic (2.85e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavourable (1.04e-5)"	"unprognostic (4.14e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (6.54e-4)"	"unprognostic (7.04e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	20.2	41.2	41.2	24.3	46.9	27.4	83.4	93.2	196.1	27.1	39.1	12.8	18.6	40.1	17.2	22.6	51.0	22.1	33.3	94.9	36.7	33.1	43.1	40.8	48.8	140.2	34.0	34.6	19.9	87.0	32.1	16.8	27.1	70.7	19.0	43.5	21.1	26.0	28.7	211.0	25.8	37.8	29.4	20.8	20.1	21.6	15.7	19.4	14.2	20.2	38.4	38.0	23.0	28.0	55.4	170.3	145.5	148.2	81.2	67.1	234.8	119.2	106.9	56.6	87.6	55.5	58.6	100.1	86.3	95.3	163.1	197.9	110.3	65.6	70.0	17.4	85.1	59.4	134.6	144.2	181.0	92.3	100.3	90.7	78.3	72.7	41.4	103.2	74.5	63.6	60.2	125.8	108.4	99.1	46.9	26.9	125.2	87.8	54.2	87.2	139.7	68.1	31.9	93.2	71.8	102.1	85.1	40.3	67.1	75.3	78.4	41.8	17.9	77.6	61.2	87.5	75.0	56.6	126.5	52.6	21.6	104.6	175.6	64.2	62.7	87.7	146.1	145.5	56.1	148.2	57.0	55.4	56.5	54.5	170.3	44.3	39.9	49.3	61.1	81.2	127.8	30.7	67.1	234.8	41.2	46.9	93.2	196.1	36.7	33.1	34.0	34.6	70.7	19.4
TPM1	"C15orf13, CMH3"	ENSG00000140416	"Tropomyosin 1"	P09493	15	63042632-63071915	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 544.2;skeletal muscle: 589.5"	"Cell line enhanced"	"Detected in many"		"BJ: 123.0;fHDF/TERT166: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 23.8"	"Group enriched"	"Detected in all"	4	"dendritic cells: 8.4;granulocytes: 23.8;monocytes: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, CAB017698, HPA047089, HPA053624"	Supported		Approved	"Actin filaments,Cytosol"		280000000	280000000	"Actin filaments"	"Actin filaments"	"CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.53e-2)"	"prognostic unfavourable (7.30e-4)"	17.9	5.7	5.5	32.4	5.2	1.2	15.2	5.6	5.1	48.1	119.7	2.4	84.2	14.6	72.4	38.3	121.6	36.2	75.3	544.2	4.1	2.6	14.5	4.4	10.5	3.3	3.3	7.0	27.0	29.3	1.9	3.2	17.7	4.1	72.5	28.0	19.1	12.9	81.3	589.5	6.5	39.5	245.2	2.7	6.5	51.7	9.6	2.3	0.4	7.7	121.7	5.9	193.8	38.7	2.7	8.4	23.8	11.6	1.2	3.4	9.9	43.6	28.8	34.8	1.7	12.2	7.7	114.6	123.0	45.3	75.7	56.3	20.2	8.7	0.1	56.5	122.9	24.2	29.5	19.7	50.4	1.1	4.1	6.4	31.0	9.8	34.2	0.2	1.4	10.7	11.4	62.2	16.6	19.8	0.6	1.5	57.8	22.5	1.9	0.5	41.5	5.0	0.7	12.3	1.2	108.1	24.1	8.3	5.7	14.7	23.3	5.2	17.0	1.2	91.2	100.1	49.2	14.9	87.2	0.4	0.3	0.5	28.3	1.7	69.3	23.8	6.1	2.9	2.5	11.6	2.0	2.7	2.4	2.7	8.4	2.6	2.6	2.3	6.7	1.2	7.9	1.7	3.4	9.9	5.5	5.2	5.6	5.1	4.1	2.6	3.3	7.0	4.1	2.3
TPM2	"AMCD1, DA1, NEM4"	ENSG00000198467	"Tropomyosin 2"	P07951	9	35681992-35690121	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 1091.5;tongue: 332.2"	"Cell line enhanced"	"Detected in many"		"BJ: 197.7;fHDF/TERT166: 107.9;HSkMC: 94.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	727	"plasmacytoid DC: 76.4"	"Lineage enriched"	"Detected in single"	727	"dendritic cells: 76.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047089, HPA053624"	Approved					290000000	290000000			"HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (5.56e-2)"	"unprognostic (5.37e-2)"	"prognostic unfavourable (2.64e-4)"	"unprognostic (3.34e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.56e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavourable (8.51e-10)"	"unprognostic (1.43e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.41e-2)"	14.5	8.2	1.8	24.5	1.6	0.7	9.1	3.7	1.7	47.5	101.0	1.4	76.0	8.4	86.6	51.1	166.5	26.8	100.3	34.6	1.9	1.4	9.5	1.1	10.0	5.3	1.5	3.1	29.2	2.2	1.1	2.6	8.6	3.4	72.2	9.6	15.0	21.0	81.0	1091.5	4.2	27.4	231.7	1.6	4.7	48.7	13.4	0.6	0.2	9.3	332.2	22.0	190.7	38.6	0.0	76.4	0.1	0.0	0.0	0.0	0.4	29.9	22.9	16.1	2.6	30.4	81.4	9.9	197.7	80.6	83.7	56.9	0.9	1.9	0.0	17.7	107.9	0.6	0.2	24.4	38.8	55.2	0.7	0.7	81.8	0.9	48.5	0.1	8.1	94.9	3.8	62.7	0.0	19.6	0.3	0.0	84.2	1.1	0.1	2.0	20.4	1.3	1.3	29.8	0.2	2.6	0.5	0.2	1.0	37.6	0.6	1.3	0.5	2.1	2.3	1.2	45.7	0.9	56.3	0.0	0.1	0.2	2.8	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	76.4	0.0	0.4	1.8	1.6	3.7	1.7	1.9	1.4	1.5	3.1	3.4	0.6
TPM3	"NEM1, TRK"	ENSG00000143549	"Tropomyosin 3"	P06753	1	154155304-154194648	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 738.4;tongue: 203.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, HPA047089, HPA053624"	Approved		Approved	"Actin filaments,Cytosol"		410000000	410000000	"Actin filaments"	"Actin filaments"	"HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.64e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.69e-3)"	"prognostic unfavourable (6.73e-6)"	"prognostic unfavourable (4.01e-4)"	"unprognostic (2.80e-1)"	"prognostic favourable (2.39e-5)"	"prognostic unfavourable (3.65e-4)"	"unprognostic (3.31e-2)"	"prognostic unfavourable (3.12e-5)"	"unprognostic (3.52e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.00e-2)"	10.1	7.3	10.8	10.8	10.5	26.5	6.2	6.4	11.2	4.6	9.6	3.9	3.2	7.9	4.1	27.9	18.3	4.4	6.7	29.7	7.7	8.1	7.2	6.8	9.6	12.9	8.9	5.8	4.8	23.2	3.6	3.2	6.7	5.0	5.7	10.7	4.4	20.5	2.5	738.4	5.9	8.2	5.2	7.7	11.7	6.9	5.4	4.4	6.7	9.3	203.6	28.6	6.8	4.9	38.9	72.6	154.8	95.9	35.4	54.4	146.1	67.5	33.7	43.2	28.3	36.6	47.8	43.5	58.1	53.7	77.1	58.2	62.8	63.4	50.9	47.3	65.5	62.6	42.8	61.1	82.2	35.2	23.3	62.6	32.9	42.2	29.1	91.6	83.2	36.0	33.5	67.9	52.3	118.6	47.0	54.7	95.1	40.5	71.3	94.6	97.2	73.3	61.1	30.0	72.1	55.6	51.6	30.3	56.9	44.1	58.8	57.6	82.0	109.5	88.6	67.5	48.9	64.7	91.0	46.6	76.5	68.0	61.0	69.0	106.6	70.8	64.7	154.8	54.4	87.8	48.6	38.9	48.5	51.1	72.6	30.1	36.6	47.3	74.9	35.4	95.9	36.0	52.1	146.1	10.8	10.5	6.4	11.2	7.7	8.1	8.9	5.8	5.0	4.4
TRAK1	"KIAA1042, MILT1, OIP106"	ENSG00000182606	"Trafficking kinesin protein 1"	Q9UPV9	3	42013802-42225889	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 71.9;skeletal muscle: 101.1"	"Cell line enhanced"	"Detected in all"		"RT4: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005853, HPA011367"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA005853: AB_1854778, HPA011367: AB_2668495"	"unprognostic (5.55e-2)"	"unprognostic (1.38e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.56e-3)"	"prognostic favourable (4.84e-8)"	"unprognostic (3.65e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.61e-3)"	11.3	5.9	14.7	8.3	15.7	7.6	8.6	20.5	20.1	7.1	23.5	15.4	4.2	15.5	6.1	8.0	14.9	9.6	21.9	71.9	15.1	12.4	9.5	7.7	11.0	9.8	14.3	15.6	4.1	6.5	16.8	11.0	9.7	16.2	7.8	11.9	23.8	22.9	7.7	101.1	21.6	23.7	7.9	11.7	12.2	26.9	7.0	10.6	4.9	14.4	31.9	14.2	19.1	10.5	7.1	4.8	1.6	4.3	1.7	1.8	1.1	7.4	6.5	12.9	5.6	9.0	8.9	17.0	10.1	11.4	6.6	7.2	4.3	10.6	14.6	5.3	24.9	3.6	8.9	23.1	7.2	13.2	6.4	10.0	6.6	11.9	4.5	11.4	8.0	7.5	10.0	14.5	13.4	13.2	5.1	11.7	8.3	3.1	1.2	6.0	5.6	5.0	5.3	4.8	12.2	9.1	56.2	8.3	9.8	3.8	5.6	5.4	5.0	9.7	13.5	5.7	6.8	34.3	5.8	8.7	7.4	13.2	6.3	10.0	5.5	1.6	2.5	1.0	1.2	4.3	1.1	5.0	1.8	1.5	2.8	7.1	0.8	1.8	1.1	1.7	2.4	4.8	0.8	1.1	14.7	15.7	20.5	20.1	15.1	12.4	14.3	15.6	16.2	10.6
TRDN		ENSG00000186439	Triadin	Q13061	6	123216339-123637093	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 52.8;skeletal muscle: 215.5;tongue: 80.1"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.5;K-562: 1.8;MCF7: 6.0;SCLC-21H: 1.2;SK-BR-3: 1.9"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	30	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 2.9"	"Region enriched"	"Detected in single"	10	"olfactory region: 13.6"					"HPA038226, HPA058226"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA038226: AB_10795574, HPA058226: AB_2683643"	"unprognostic (1.05e-2)"			"unprognostic (1.99e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.06e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.55e-2)"		"unprognostic (3.97e-2)"	3.8	0.4	0.4	0.0	0.5	0.0	0.3	0.2	0.2	0.3	0.1	0.0	0.7	0.1	0.3	9.2	3.0	1.9	0.1	52.8	1.6	1.3	0.1	0.1	0.1	0.1	1.6	0.1	1.5	0.1	0.0	3.2	0.1	1.3	1.9	0.1	1.3	2.0	0.2	215.5	0.1	0.1	0.2	3.4	0.1	0.1	0.7	0.5	0.0	1.2	80.1	1.6	0.1	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.0	6.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.2	1.6	1.3	1.6	0.1	1.3	0.5
TRIM16L	TRIM70	ENSG00000108448	"Tripartite motif containing 16 like"	Q309B1	17	18697998-18736118	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 22.5"	"Cell line enhanced"	"Detected in many"		"A549: 48.6;CAPAN-2: 20.9;HaCaT: 24.8;HeLa: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA066431	Uncertain		Approved	"Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA066431: AB_2685668"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.89e-3)"	"unprognostic (5.66e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavourable (2.87e-4)"	"unprognostic (7.08e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (2.29e-5)"	"unprognostic (1.13e-2)"	2.8	4.4	2.0	1.0	3.1	0.5	7.1	1.0	3.0	2.2	3.6	1.3	1.0	2.0	1.4	3.2	10.5	3.3	8.1	16.8	2.0	2.5	3.5	2.8	2.4	1.0	4.7	1.0	1.3	1.3	0.1	1.0	1.8	3.1	3.6	1.0	2.1	2.6	3.7	22.5	0.8	1.1	6.5	4.7	1.0	3.0	2.9	1.4	1.0	4.5	12.7	3.4	6.7	11.8	1.5	0.8	0.4	1.4	2.7	2.1	1.8	5.2	48.6	0.3	2.0	5.9	2.4	3.8	0.4	4.0	1.8	3.7	0.8	20.9	0.5	3.8	13.9	24.8	0.5	1.1	0.9	0.2	0.7	0.3	38.8	0.5	14.6	0.0	0.5	2.5	1.4	2.7	1.0	0.5	0.0	0.0	4.7	5.1	0.1	0.5	0.5	1.0	0.5	2.5	0.0	3.5	3.0	0.1	1.1	5.5	1.1	2.9	2.5	0.4	10.9	1.2	6.3	1.9	7.0	0.6	0.6	0.0	4.1	0.4	9.2	0.1	0.7	0.4	0.7	1.4	1.0	1.5	1.0	0.6	0.8	1.1	1.6	1.5	0.3	2.7	0.5	0.2	2.1	1.8	2.0	3.1	1.0	1.9	2.0	2.5	4.7	1.0	3.1	1.4
TRIM7	"GNIP, RNF90"	ENSG00000146054	"Tripartite motif containing 7"	Q9C029	5	181193924-181205293	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 81.8;tongue: 34.0"	"Cell line enhanced"	"Detected in many"		"HaCaT: 11.2;HDLM-2: 23.8;PC-3: 13.2;TIME: 10.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	16	"cerebellum: 21.7"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"monocytes: 4.9;T-cells: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039213	Approved		Approved	Nucleoplasm,Vesicles,Cytosol				Vesicles	Vesicles	"HPA039213: AB_10795173"	"unprognostic (6.58e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.89e-4)"	"unprognostic (3.45e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.15e-2)"	1.3	0.9	0.1	0.9	0.5	0.5	3.4	21.7	1.3	2.5	0.8	0.3	1.1	0.5	1.0	6.4	13.0	0.6	1.7	2.2	0.1	0.8	2.2	0.5	0.9	0.6	0.2	0.2	0.6	4.2	1.6	1.9	0.5	0.5	2.0	0.6	0.6	5.9	1.1	81.8	9.5	0.6	0.9	0.3	0.8	1.4	0.9	0.2	0.1	3.3	34.0	13.5	1.6	2.9	0.7	0.8	0.1	4.9	0.5	2.2	1.1	6.1	2.9	0.0	0.3	0.5	0.5	0.1	1.4	0.0	0.5	1.2	0.2	8.0	0.4	4.3	1.7	11.2	3.2	9.2	0.1	23.8	1.3	0.5	7.8	0.1	1.6	0.0	1.3	0.1	7.1	0.2	4.6	2.6	0.3	1.3	0.2	0.8	0.3	0.2	0.0	13.2	0.3	4.2	0.9	3.3	0.0	0.3	0.7	2.9	0.1	4.0	0.7	0.2	10.8	0.1	2.4	0.4	4.2	1.9	0.2	0.7	0.3	0.4	1.0	0.0	4.9	0.1	1.4	1.9	2.2	0.4	1.2	1.4	0.8	0.7	2.2	1.8	0.1	0.5	1.4	0.6	2.2	1.1	0.1	0.5	21.7	1.3	0.1	0.8	0.2	0.2	0.5	0.2
TRIP10	"CIP4, HSTP, STOT, STP"	ENSG00000125733	"Thyroid hormone receptor interactor 10"	Q15642	19	6737925-6751526	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 103.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 19.4"	"Lineage enriched"	"Detected in many"	12	"dendritic cells: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041934, HPA072625, HPA073886"	Approved		Supported	Nucleoplasm,Vesicles		15000	15000	Vesicles	Vesicles	"HPA041934: AB_2677754, HPA072625: AB_2732206, HPA073886: AB_2732244"	"unprognostic (5.75e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (3.61e-4)"	"unprognostic (2.19e-2)"	"unprognostic (6.57e-2)"	"prognostic favourable (1.76e-4)"	"unprognostic (6.73e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.87e-3)"	"unprognostic (3.28e-1)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.93e-2)"	"unprognostic (8.83e-2)"	19.7	10.7	6.0	9.2	7.2	2.3	16.8	3.7	5.4	25.6	19.1	4.5	20.6	9.7	17.8	16.7	44.8	12.0	17.6	18.1	6.5	1.9	14.0	4.5	19.5	5.4	6.7	3.5	22.4	12.9	7.0	4.8	25.4	7.0	19.2	6.6	20.2	16.1	18.3	103.7	10.4	10.1	20.9	6.7	7.1	11.3	8.7	5.4	2.8	31.7	21.6	21.7	24.3	26.5	1.5	19.4	0.1	0.7	1.6	0.9	0.4	26.6	16.2	5.7	8.6	22.4	23.5	20.5	17.2	19.9	19.7	17.3	21.9	15.4	0.5	23.4	14.5	19.9	12.8	25.1	11.8	16.8	5.1	8.7	15.3	16.7	18.4	0.4	2.7	27.1	17.1	17.5	13.5	20.2	12.7	7.3	14.4	9.0	2.3	6.0	12.1	13.8	3.9	11.7	7.8	16.6	13.3	0.0	6.6	22.7	10.2	6.4	10.7	4.7	39.4	13.3	23.9	34.7	18.1	7.7	4.2	2.6	21.5	2.5	8.7	0.0	0.7	0.0	0.5	0.1	0.7	1.2	0.2	0.9	3.8	1.5	0.3	0.2	0.1	1.6	0.1	19.4	0.0	0.4	6.0	7.2	3.7	5.4	6.5	1.9	6.7	3.5	7.0	5.4
TRO	"KIAA1114, MAGE-D3, MAGED3"	ENSG00000067445	Trophinin	Q12816	X	54920462-54931431	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 32.1"	"Cell line enhanced"	"Detected in many"		"AF22: 20.9;HEK 293: 12.9;HSkMC: 13.1;SCLC-21H: 14.0;SH-SY5Y: 18.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 5.2"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA053358			Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA053358: AB_2682125"	"unprognostic (6.18e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavourable (4.41e-5)"	"unprognostic (9.09e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.18e-1)"	"prognostic favourable (1.93e-4)"	"unprognostic (1.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.67e-4)"	"unprognostic (6.33e-2)"	"unprognostic (3.27e-2)"	"unprognostic (6.86e-2)"	4.5	4.2	21.7	2.1	15.5	1.6	3.7	11.3	23.8	8.0	2.5	7.9	1.4	1.7	16.3	8.6	2.4	7.1	5.6	2.9	17.9	15.6	5.3	13.2	2.5	2.3	10.5	13.2	21.7	5.7	7.6	20.2	5.5	22.3	7.4	3.2	5.0	1.5	6.9	32.1	1.5	1.8	10.9	8.9	1.4	2.0	3.6	14.2	4.2	9.2	0.1	2.4	3.6	5.0	0.7	2.6	0.0	0.2	5.2	1.2	0.4	0.0	0.2	20.9	0.0	4.1	5.7	0.0	1.1	7.2	1.1	0.4	0.0	0.0	0.0	3.0	7.5	0.1	0.1	0.3	0.6	0.0	12.9	9.6	0.0	0.8	1.5	0.0	0.1	13.1	0.0	6.7	0.0	0.5	0.0	0.1	7.7	0.0	0.1	0.0	10.7	0.0	6.1	9.1	0.1	2.0	0.1	14.0	18.8	0.0	0.3	1.8	0.0	1.2	0.0	8.8	9.2	0.1	1.1	3.3	0.4	0.0	1.3	0.0	7.6	0.0	0.0	0.0	1.2	0.0	0.7	0.7	0.1	0.4	0.0	0.5	0.3	0.7	0.0	5.2	0.2	2.6	0.0	0.4	21.7	15.5	11.3	23.8	17.9	15.6	10.5	13.2	22.3	14.2
TRPV3	VRL3	ENSG00000167723	"Transient receptor potential cation channel subfamily V member 3"	Q8NET8	17	3510502-3557995	"Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 15.4;skeletal muscle: 29.1"	"Cell line enhanced"	"Detected in some"		"A-431: 3.5;BEWO: 5.3;CACO-2: 4.2;RH-30: 13.0;T-47d: 5.5;U-266/70: 3.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.4"	"Cell type enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in many"	6	"cerebellum: 14.0"	HPA069550			Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA069550: AB_2686149"	"unprognostic (1.84e-4)"	"unprognostic (2.25e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.92e-4)"	"unprognostic (4.87e-3)"	"unprognostic (2.96e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.88e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.64e-2)"	"unprognostic (2.93e-2)"	0.4	0.2	0.4	3.2	2.4	0.9	4.1	0.3	1.2	0.6	10.6	0.1	0.3	3.2	0.2	0.2	2.3	0.3	0.8	0.3	0.4	0.3	0.2	1.1	0.3	0.5	0.4	0.2	0.3	0.9	0.0	0.7	0.4	0.0	0.2	2.9	0.3	0.5	0.4	29.1	8.4	15.4	0.5	0.5	0.4	1.6	0.8	0.0	0.0	0.2	9.7	3.0	0.7	2.1	0.7	0.6	2.9	0.6	0.6	0.7	0.1	3.5	0.0	0.5	0.1	0.2	0.6	5.3	0.2	0.0	0.0	0.0	4.2	0.9	0.2	1.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.6	0.1	0.2	0.8	0.3	0.0	0.7	1.8	0.0	0.1	0.1	0.0	0.7	0.1	0.2	0.1	0.5	0.1	13.0	0.2	0.0	0.2	0.1	0.0	0.2	0.6	0.0	5.5	0.2	0.1	0.1	0.2	0.1	0.1	3.5	2.7	0.0	0.1	0.1	0.0	2.9	0.4	0.4	0.7	0.2	0.5	0.7	0.4	0.7	0.1	0.5	0.4	0.6	1.0	0.6	0.6	0.6	0.2	0.1	0.4	2.4	0.3	1.2	0.4	0.3	0.4	0.2	0.0	0.0
TTN	"CMD1G, CMH9, CMPD4, FLJ32040, LGMD2J, MYLK5, TMD"	ENSG00000155657	Titin	Q8WZ42	2	178525989-178830802	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 136.5;skeletal muscle: 713.8;tongue: 227.0"	"Cell line enhanced"	"Detected in many"		"RH-30: 4.8"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA007042, CAB022682, HPA030048"	Enhanced					25000000	25000000			"CAB022682: , HPA007042: AB_1080292, HPA030048: AB_2732451"	"unprognostic (1.00e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.49e-4)"	"unprognostic (1.99e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.34e-2)"	23.7	0.3	0.2	0.3	0.3	0.9	0.3	0.2	0.4	0.2	0.2	0.0	0.0	0.2	0.2	21.3	8.3	0.2	0.3	136.5	0.2	0.2	0.2	0.2	0.4	0.4	0.2	0.0	0.3	0.4	0.2	0.3	0.3	0.0	0.7	0.2	0.0	11.6	0.2	713.8	0.3	0.2	0.2	0.3	0.3	0.2	0.4	0.0	0.0	5.6	227.0	15.8	0.3	0.2	7.0	0.3	1.9	0.3	5.0	7.3	0.1	0.7	0.3	1.9	1.0	0.0	0.0	3.4	0.6	0.0	0.0	0.0	1.8	0.3	2.4	0.6	0.0	1.7	0.0	0.0	0.0	2.3	2.0	3.7	2.6	1.0	0.0	0.3	0.8	2.4	0.0	0.0	0.0	1.4	2.1	1.2	0.4	0.4	1.6	2.5	0.4	1.8	1.3	4.8	1.3	0.0	0.6	1.0	1.7	0.4	1.3	0.0	0.7	2.4	1.6	0.0	0.0	0.9	0.4	3.5	0.4	3.5	0.1	1.1	0.9	1.9	0.3	0.7	0.5	0.2	0.2	6.9	1.2	0.9	0.2	7.0	2.7	3.5	1.3	5.0	0.2	0.3	7.3	0.1	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
TUBA4A	"FLJ30169, H2-ALPHA, TUBA1"	ENSG00000127824	"Tubulin alpha 4a"	P68366	2	219249711-219278170	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 124.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 78.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004621, CAB005887, HPA039247, HPA043684, HPA063394"	Approved		Enhanced	Microtubules		500000000	500000000	Microtubules	Microtubules	"CAB004621: AB_628411, CAB005887: AB_2288001, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: "	"unprognostic (8.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.18e-3)"	"unprognostic (3.99e-2)"	"prognostic unfavourable (4.54e-6)"	"unprognostic (1.52e-3)"	"unprognostic (4.47e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.38e-3)"	"unprognostic (9.32e-2)"	5.0	9.4	22.4	13.4	30.5	37.7	7.5	23.2	63.3	7.4	13.8	4.5	5.2	8.1	3.4	5.2	27.1	6.1	6.1	23.5	24.9	23.6	13.2	10.5	7.2	20.9	20.4	21.9	6.1	8.0	18.1	6.5	2.9	43.1	7.9	12.4	5.7	15.6	10.7	124.1	63.5	9.5	6.2	6.2	15.7	10.1	8.2	3.3	6.2	3.7	34.8	25.0	9.1	13.9	25.8	4.2	66.8	13.0	14.8	32.0	49.2	19.0	15.9	0.0	0.0	1.7	1.3	0.0	2.9	9.2	0.5	0.3	3.5	20.0	25.1	32.7	2.0	48.3	8.9	78.8	0.7	14.6	0.1	31.5	29.7	2.6	1.4	10.5	11.3	1.2	29.2	4.3	9.3	3.2	3.5	17.2	18.9	0.7	0.0	18.9	6.1	19.0	1.1	25.9	15.3	24.3	1.3	16.1	0.2	37.5	3.3	0.1	1.4	8.9	2.2	9.5	5.1	11.0	10.2	7.0	8.5	30.2	34.8	20.0	0.4	22.1	12.5	32.4	22.5	8.6	23.2	25.8	32.0	30.2	4.2	17.7	30.4	29.5	66.8	14.8	13.0	0.7	27.5	49.2	22.4	30.5	23.2	63.3	24.9	23.6	20.4	21.9	43.1	3.3
TUBA8	TUBAL2	ENSG00000183785	"Tubulin alpha 8"	Q9NY65	22	18110331-18146554	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 50.3;skeletal muscle: 125.4"	"Group enriched"	"Detected in many"	6	"NB-4: 20.4;SCLC-21H: 10.1;TIME: 25.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.2;NK-cell: 5.8"	"Group enriched"	"Detected in many"	14	"granulocytes: 4.2;NK-cells: 5.8"	"Group enriched"	"Detected in many"	4	"cerebellum: 61.3;olfactory region: 66.2"	"Low region specificity"	"Detected in all"			"HPA043684, CAB046031, HPA063394"	Approved		Supported	Microtubules		260000000	260000000	Microtubules	Microtubules	"CAB046031: AB_11124541, HPA043684: AB_2678617, HPA063394: "	"unprognostic (1.07e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.90e-5)"	"unprognostic (9.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.61e-4)"	3.2	1.2	5.3	1.2	10.5	2.4	2.5	20.5	23.4	1.4	1.2	1.5	0.2	1.5	1.2	4.3	2.6	1.6	1.3	50.3	7.5	5.6	1.2	2.0	1.2	2.2	3.9	9.2	1.3	2.2	1.8	4.3	1.0	2.5	1.7	1.1	0.4	2.1	1.2	125.4	1.4	1.4	1.2	1.1	1.6	1.7	19.2	1.0	0.0	3.5	13.3	1.3	1.1	0.3	0.0	0.2	4.2	0.1	5.8	0.3	15.7	0.4	0.9	0.7	0.8	1.3	0.8	0.3	0.7	0.7	1.2	1.1	0.3	0.9	0.6	3.3	0.6	0.3	2.1	0.1	0.3	1.9	1.9	2.3	0.4	0.3	0.7	1.4	1.2	0.7	0.6	0.8	0.1	1.8	0.9	0.7	0.4	2.6	1.7	20.4	0.9	1.0	1.6	0.0	0.2	0.4	0.3	10.1	1.1	0.4	0.5	1.2	0.5	3.3	25.4	0.1	0.2	0.7	0.5	2.3	1.1	0.7	0.8	0.9	0.2	1.2	0.1	2.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	4.2	5.8	0.1	0.2	0.0	15.7	5.3	10.5	20.5	23.4	7.5	5.6	3.9	9.2	2.5	1.0
TWF2	"A6r, A6RP, PTK9L"	ENSG00000247596	"Twinfilin actin binding protein 2"	Q6IBS0	3	52228610-52239260	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053874	Uncertain		Supported	"Plasma membrane"		14000000	14000000	"Plasma membrane"	"Plasma membrane"	"HPA053874: AB_2682287"	"unprognostic (4.24e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.51e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.76e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.58e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.31e-3)"	"unprognostic (4.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.07e-2)"	25.0	13.0	10.4	21.0	10.9	17.0	22.3	17.5	21.1	13.8	15.2	7.7	10.4	12.1	14.3	13.1	17.2	11.4	18.7	38.8	13.2	9.4	13.9	11.7	16.5	39.4	9.2	13.2	14.4	10.9	5.4	7.5	11.0	9.1	13.4	7.1	10.4	18.2	13.5	81.7	11.9	13.5	13.5	8.4	23.3	13.4	7.9	7.3	34.5	9.4	15.4	19.5	18.7	14.3	32.3	46.8	72.5	50.1	26.9	40.9	38.7	6.5	16.9	5.9	10.3	19.3	23.6	10.5	15.5	25.1	18.6	16.7	8.8	18.1	23.6	10.3	18.2	11.6	7.4	21.7	4.2	14.9	9.7	24.2	12.7	21.2	16.7	14.6	40.8	21.9	10.4	22.0	7.5	28.2	5.6	12.3	13.9	5.7	20.1	33.6	9.2	47.9	7.8	6.1	24.7	14.6	10.6	4.6	17.7	5.5	23.4	30.7	5.3	15.9	29.0	18.2	19.9	14.1	13.3	11.1	9.8	11.5	35.9	41.4	21.9	26.8	50.1	39.6	33.7	48.9	30.6	32.3	35.9	35.8	46.8	25.4	28.9	35.6	72.5	26.9	49.5	42.3	40.9	38.7	10.4	10.9	17.5	21.1	13.2	9.4	9.2	13.2	9.1	7.3
UACA	"FLJ10128, KIAA1561"	ENSG00000137831	"Uveal autoantigen with coiled-coil domains and ankyrin repeats"	Q9BZF9	15	70654554-70763593	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 68.0"	"Cell line enhanced"	"Detected in many"		"BJ: 61.3;BJ hTERT+: 37.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 2.2;intermediate monocyte: 4.3;memory B-cell: 1.2;myeloid DC: 2.0;naive B-cell: 3.4;non-classical monocyte: 2.9"	"Group enriched"	"Detected in many"	11	"B-cells: 3.4;dendritic cells: 2.0;monocytes: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041412, HPA043503"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA041412: AB_10966708, HPA043503: AB_2678517"	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavourable (7.01e-5)"	"unprognostic (4.95e-2)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (1.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.42e-2)"	"prognostic unfavourable (1.03e-4)"	21.7	8.9	4.7	8.6	8.1	0.4	25.9	2.9	5.8	15.4	14.1	8.4	22.8	10.6	17.2	22.3	15.6	10.5	15.7	18.0	6.1	4.2	16.4	8.2	23.7	7.5	9.0	4.6	17.5	8.6	8.2	6.5	13.7	9.6	15.5	7.6	26.7	18.8	26.9	68.0	10.1	16.9	11.4	14.9	15.7	8.4	10.1	7.1	1.0	18.6	32.4	5.3	9.9	13.5	3.4	2.0	0.2	4.3	0.1	0.3	0.7	10.4	8.6	3.8	5.1	7.8	33.8	0.0	61.3	37.5	16.1	13.9	14.4	15.5	7.2	16.9	15.2	12.1	8.7	4.8	20.3	0.0	3.8	4.0	6.7	3.0	10.2	0.1	1.5	15.9	2.7	9.5	7.2	17.0	1.0	0.0	19.9	3.4	0.0	0.6	3.2	4.5	0.0	28.0	0.0	7.8	3.5	1.0	1.9	11.6	1.8	12.3	3.4	1.2	32.6	0.9	6.5	5.2	9.7	0.6	2.1	0.0	8.1	1.1	6.9	0.2	2.2	0.0	0.0	4.3	0.0	1.2	0.1	0.0	2.0	3.4	0.3	0.1	0.2	0.1	2.9	0.1	0.0	0.7	4.7	8.1	2.9	5.8	6.1	4.2	9.0	4.6	9.6	7.1
UBE2B	"HHR6B, RAD6B, UBC2"	ENSG00000119048	"Ubiquitin conjugating enzyme E2 B"	P63146	5	134371179-134391992	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 83.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 83.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"HPA003875: AB_2667061, HPA051765: AB_2681597, HPA065898: AB_2685577"	"unprognostic (1.98e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.39e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.64e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.52e-2)"	17.7	27.7	20.4	17.0	16.6	25.9	22.8	16.2	28.3	13.8	18.0	7.9	11.6	14.4	19.4	17.0	25.6	13.6	18.3	59.2	20.3	16.4	17.8	19.8	21.8	18.7	13.8	18.7	16.7	26.4	7.8	16.2	27.8	17.6	15.4	15.1	10.2	16.1	18.5	106.5	15.9	16.2	21.6	15.1	16.6	14.1	21.7	12.7	13.2	18.2	34.0	16.3	19.2	22.8	9.6	8.8	83.3	14.1	9.6	14.6	10.5	36.2	9.6	20.0	19.0	17.5	18.9	32.3	27.3	14.4	17.6	21.0	28.9	24.4	19.8	33.0	17.4	14.5	15.1	20.2	19.2	31.4	16.3	10.9	26.5	31.0	20.5	12.9	22.4	16.2	27.5	15.9	13.5	15.0	19.9	36.0	15.8	21.2	20.4	34.1	8.6	9.1	20.6	22.0	27.6	15.7	28.1	27.0	21.1	21.4	10.1	47.4	21.8	35.6	29.7	20.5	14.3	27.5	29.8	30.1	41.2	27.9	23.1	24.4	20.3	34.7	11.5	31.2	9.4	12.5	8.6	9.6	12.0	9.5	7.9	9.6	14.6	12.3	83.3	9.6	14.1	8.8	14.1	10.5	20.4	16.6	16.2	28.3	20.3	16.4	13.8	18.7	17.6	12.7
UBE2D1	"E2(17)KB1, SFT, UBC4/5, UBCH5, UbcH5A"	ENSG00000072401	"Ubiquitin conjugating enzyme E2 D1"	P51668	10	58334975-58370753	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 74.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 41.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA003920: AB_1858519"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (5.58e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (8.04e-6)"	"unprognostic (9.71e-3)"	"unprognostic (4.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.66e-2)"	8.2	10.6	8.1	10.0	7.9	17.1	7.5	7.7	9.0	6.3	7.3	5.5	4.8	4.7	8.5	5.5	8.2	5.5	6.4	25.6	7.6	7.2	5.5	5.4	7.0	13.7	8.1	6.7	5.9	4.8	5.3	7.4	6.8	7.4	6.5	7.9	3.5	6.4	5.0	74.9	4.6	5.8	8.8	8.4	11.0	5.6	3.2	8.4	5.5	6.0	25.1	7.1	9.5	10.0	3.7	7.2	41.0	13.7	2.8	3.5	7.1	10.6	5.8	10.8	13.9	22.2	17.9	7.0	7.0	12.0	8.1	11.9	11.7	9.2	0.0	11.1	10.5	9.7	20.9	10.2	11.4	11.0	12.3	2.8	2.1	6.7	14.6	8.4	6.8	20.7	11.5	8.4	15.7	16.1	5.5	4.5	10.9	3.3	9.0	9.4	13.2	9.1	7.6	9.8	5.9	12.1	6.2	8.2	11.0	13.8	23.3	11.2	8.5	5.7	12.9	3.1	10.9	10.6	7.7	11.5	8.9	9.4	9.8	17.5	3.5	2.8	13.7	6.2	2.4	9.5	2.8	3.3	2.9	3.0	7.2	3.7	3.0	2.3	41.0	2.8	7.9	3.0	3.5	7.1	8.1	7.9	7.7	9.0	7.6	7.2	8.1	6.7	7.4	8.4
UBE2D4	HBUCE1	ENSG00000078967	"Ubiquitin conjugating enzyme E2 D4 (putative)"	Q9Y2X8	7	43926438-43956136	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 48.6"	"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 24.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA003920: AB_1858519"	"unprognostic (9.95e-3)"	"unprognostic (6.76e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.24e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.58e-3)"	"unprognostic (4.74e-2)"	"unprognostic (5.04e-2)"	"prognostic favourable (4.86e-4)"	"prognostic favourable (5.77e-4)"	"prognostic favourable (6.51e-4)"	"unprognostic (1.11e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.34e-1)"	10.1	13.1	14.7	5.0	13.3	4.5	9.1	13.8	17.4	8.8	7.6	11.4	7.9	5.3	7.5	11.2	8.0	9.0	7.2	23.8	14.2	10.0	12.7	15.3	8.4	5.3	12.1	9.4	7.9	17.4	8.7	6.9	5.9	11.9	8.7	6.2	8.1	10.6	9.1	48.6	9.4	5.3	10.3	12.8	7.3	6.5	5.1	6.1	2.7	9.6	16.1	5.7	7.7	6.5	10.7	11.8	12.9	20.5	7.7	14.0	6.7	3.7	3.2	1.9	8.9	9.2	3.7	1.5	1.9	4.6	2.4	3.1	1.7	4.5	3.7	5.2	4.9	4.3	2.5	2.0	3.6	8.1	4.1	3.9	4.9	4.3	3.4	8.5	8.0	2.9	4.3	2.7	4.1	2.9	4.3	7.6	3.2	2.4	5.0	4.9	4.3	4.1	3.1	2.7	5.6	5.0	4.6	7.3	24.7	3.9	7.9	2.9	3.9	2.6	2.5	1.6	4.9	3.3	5.4	11.0	8.2	1.8	4.7	11.2	8.7	6.3	11.7	12.9	9.3	18.4	9.5	10.3	11.6	10.5	11.8	10.7	14.0	11.5	1.1	7.7	20.5	10.2	9.4	6.7	14.7	13.3	13.8	17.4	14.2	10.0	12.1	9.4	11.9	6.1
UBE2G1	"UBC7, UBE2G"	ENSG00000132388	"Ubiquitin conjugating enzyme E2 G1"	P62253	17	4269259-4366628	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 95.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045681, HPA050551"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA045681: AB_2679417, HPA050551: AB_2681171"	"unprognostic (1.57e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.80e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.67e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.58e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.50e-2)"	10.8	11.1	12.6	17.8	13.5	14.3	11.2	11.6	15.3	13.0	19.4	17.8	8.9	11.9	13.3	8.5	27.4	9.2	9.7	26.9	13.5	11.2	14.6	17.7	8.9	18.7	15.2	9.7	9.1	17.1	12.0	6.0	11.4	14.5	14.0	13.3	8.8	11.9	12.0	95.6	14.1	16.6	14.6	19.4	15.0	11.9	11.8	13.6	21.3	12.5	20.7	23.3	17.7	16.5	23.7	13.1	24.4	11.5	20.5	20.6	13.1	21.2	23.0	21.5	15.7	17.6	18.7	30.7	20.7	16.7	19.8	17.4	15.8	10.9	33.3	21.8	20.3	23.0	26.7	19.2	31.9	17.5	21.8	12.4	12.2	18.0	17.3	18.0	23.6	15.9	28.8	18.7	27.3	26.4	21.8	36.1	16.2	9.5	22.9	16.6	23.7	12.0	29.8	11.4	30.4	23.0	14.0	9.3	17.4	19.5	17.0	16.1	16.7	11.8	19.8	19.9	15.2	23.2	23.1	14.0	16.4	47.1	15.3	16.9	15.2	8.1	10.3	24.4	15.4	10.8	20.6	23.7	20.1	20.1	13.1	15.5	20.2	20.5	18.6	20.5	11.5	9.6	18.3	13.1	12.6	13.5	11.6	15.3	13.5	11.2	15.2	9.7	14.5	13.6
UBR3	"DKFZp434P117, FLJ37422, KIAA2024, ZNF650"	ENSG00000144357	"Ubiquitin protein ligase E3 component n-recognin 3 (putative)"	Q6ZT12	2	169827458-170084131	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035390	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA035390: AB_10670699"	"unprognostic (1.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.18e-1)"	11.9	15.5	10.9	6.1	18.3	5.4	9.6	15.5	18.9	9.9	10.0	9.8	9.1	6.7	11.5	7.1	10.7	8.1	7.8	23.1	10.3	7.2	12.9	16.9	9.2	5.6	11.9	14.0	8.9	9.8	20.9	14.9	7.2	14.7	11.2	7.3	8.0	11.1	9.2	76.3	11.5	8.4	9.6	10.2	6.9	9.2	7.9	11.4	6.3	14.9	10.9	6.0	12.8	8.7	2.0	2.8	1.9	2.1	2.4	4.3	1.2	8.8	7.5	8.0	10.6	16.0	12.7	6.8	16.0	9.3	9.3	7.5	11.5	5.6	10.0	13.9	12.4	11.7	9.5	8.1	11.6	10.4	8.2	36.6	8.0	12.2	8.0	12.1	11.9	7.6	7.6	12.1	8.1	9.1	19.0	10.9	15.7	8.3	7.8	5.9	6.3	6.3	7.5	13.2	10.6	6.7	12.5	15.8	8.6	11.2	10.4	6.5	6.8	6.8	11.5	14.0	5.7	10.9	10.0	8.9	6.9	9.2	11.5	7.1	7.7	0.0	2.1	1.7	3.2	1.8	4.2	2.0	1.9	2.7	2.8	1.2	3.3	4.3	1.9	2.4	1.6	2.4	3.1	1.2	10.9	18.3	15.5	18.6	10.3	7.2	11.9	14.0	14.7	11.4
UCN	"UI, UROC"	ENSG00000163794	Urocortin	P55089	2	27307400-27308445	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 8.5"	"Cell line enhanced"	"Detected in many"		"U-266/70: 19.7"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"NK-cell: 2.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			CAB010911	Approved		Approved	"Endoplasmic reticulum"	"Secreted to blood"			"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB010911: AB_261834"	"unprognostic (7.35e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavourable (8.10e-4)"	"unprognostic (1.42e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavourable (1.84e-7)"	"unprognostic (4.84e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.11e-1)"	1.1	2.8	4.6	1.3	5.5	2.4	1.0	3.1	4.5	0.9	0.7			0.8	1.9	1.4	0.6	1.9	2.0	4.2	4.7	3.8	0.7	3.2	1.6	1.6	3.1		2.3	1.8	0.0	2.2	2.4		1.2	0.0		1.3	0.9	8.5	0.8	1.2	1.0	2.8	3.0	0.5	1.5			1.5		0.4	0.5	0.4	0.0	0.0	0.0	0.7	2.9	0.9	0.2	1.2	2.6	0.4	0.7	1.2	1.1	5.2	0.4	1.0	0.4	0.4	0.2	2.1	1.0	0.6	0.4	0.4	0.5	0.3	0.0	3.3	4.4	2.4	1.6	2.1	3.1	0.2	2.6	1.5	2.0	0.2	2.4	0.0	2.3	1.9	0.1	1.9	1.2	7.0	4.4	2.8	3.4	2.3	1.5	0.1	0.5	0.8	2.3	1.1	0.1	5.7	1.1	3.2	0.2	0.8	4.9	1.5	1.9	19.7	2.1	0.7	3.8	5.6	1.4	0.0	0.7	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	2.9	0.4	0.0	0.6	0.2										
UPK3A	UPK3	ENSG00000100373	"Uroplakin 3A"	O75631	22	45284982-45295874	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.7;skeletal muscle: 24.5;urinary bladder: 45.5"	"Group enriched"	"Detected in some"	5	"Hep G2: 18.3;RT4: 30.6"	"Group enriched"	"Detected in many"	6	"prostate cancer: 35.3;urothelial cancer: 78.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	11	"classical monocyte: 8.5;intermediate monocyte: 9.6;myeloid DC: 33.7;non-classical monocyte: 11.3;plasmacytoid DC: 13.0"	"Group enriched"	"Detected in many"	16	"dendritic cells: 33.7;monocytes: 11.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA018407, HPA018415"	Enhanced		Uncertain	"Nuclear membrane,Nuclear bodies"				"Nuclear membrane"	"Nuclear membrane"	"HPA018407: AB_1858641, HPA018415: AB_1858640"	"unprognostic (1.27e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.98e-5)"	"unprognostic (1.69e-2)"	"unprognostic (4.82e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-5)"	"unprognostic (2.01e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.05e-3)"	0.2	0.1	0.3	1.6	0.4	0.9	0.3	0.2	0.5	0.4	0.7	0.0	0.0	0.0	0.2	2.3	0.2	0.2	0.6	0.2	0.3	0.3	0.2	0.2	0.2	1.0	0.4	0.1	0.2	0.2	6.4	0.5	0.0	0.7	17.9	0.5	0.6	12.9	1.8	24.5	0.2	1.8	13.0	0.3	0.7	0.2	0.2	0.0	1.3	4.6	1.7	0.6	45.5	2.7	0.3	33.7	1.4	11.3	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.1	0.0	0.0	0.0	0.0	0.1	0.0	30.6	0.1	0.0	0.1	0.5	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	9.6	0.0	0.3	0.0	0.0	33.7	0.2	0.0	0.0	1.4	0.1	11.3	13.0	0.0	2.8	0.3	0.4	0.2	0.5	0.3	0.3	0.4	0.1	0.7	0.0
UQCC1	"BFZB, C20orf44, CBP3, FLJ10850, UQCC"	ENSG00000101019	"Ubiquinol-cytochrome c reductase complex assembly factor 1"	Q9NVA1	20	35302566-35412141	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 70.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034875	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"				"Plasma membrane"	"Plasma membrane"	"HPA034875: AB_10603226"	"unprognostic (9.66e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.45e-1)"	"unprognostic (8.72e-3)"	"unprognostic (4.01e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.60e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.34e-2)"	12.6	19.2	13.7	10.6	24.5	2.5	10.1	19.6	23.9	10.9	13.3	15.7	12.1	13.0	14.2	14.2	10.5	11.7	8.4	34.3	13.5	15.9	20.0	17.2	8.7	10.9	16.6	18.2	11.9	10.8	19.8	17.0	10.1	20.1	11.9	17.5	15.8	12.1	12.9	70.2	9.2	11.3	15.5	15.5	11.2	12.2	13.2	13.4	8.9	14.2	17.1	13.8	11.0	9.9	13.5	13.5	16.3	11.9	19.7	15.2	9.6	6.8	9.9	11.2	10.3	11.4	12.5	1.6	13.0	14.1	23.3	16.2	32.1	13.5	21.8	24.6	8.1	18.1	19.7	22.5	17.7	6.5	7.8	29.3	13.2	25.7	7.2	17.5	8.7	12.2	23.0	12.4	15.6	7.9	12.6	7.2	16.2	8.9	20.0	6.3	9.4	20.4	11.0	17.5	12.0	21.4	7.7	15.8	10.6	11.0	53.0	11.4	7.9	11.2	7.4	15.9	10.1	8.3	11.8	11.2	12.1	9.1	28.4	10.2	12.8	16.3	7.7	11.0	12.7	11.9	15.2	10.3	12.1	12.5	13.5	13.5	14.6	13.2	0.3	19.7	7.7	11.5	11.2	9.6	13.7	24.5	19.6	23.9	13.5	15.9	16.6	18.2	20.1	13.4
UQCR10	"HSPC051, QCR9, UCCR7.2, UCRC"	ENSG00000184076	"Ubiquinol-cytochrome c reductase, complex III subunit X"	Q9UDW1	22	29767369-29770413	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 144.4;skeletal muscle: 144.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.09e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.05e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.12e-2)"	"prognostic favourable (5.45e-5)"	"unprognostic (1.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.80e-3)"	23.0	37.0	42.5	18.2	42.9	20.1	23.8	25.2	48.5	17.2	35.5	14.7	24.3	35.9	12.6	24.9	23.7	23.7	19.9	97.9	38.3	30.2	38.3	43.6	22.6	25.2	39.8	25.8	16.1	39.4	19.3	22.5	17.5	25.4	22.2	29.1	21.6	25.2	25.6	144.7	14.7	33.1	17.6	24.2	19.8	29.9	28.5	20.6	20.9	23.6	62.9	20.8	22.8	15.0	132.9	126.0	141.5	118.4	73.9	123.2	144.4	31.3	33.0	31.8	24.7	29.9	19.7	17.7	17.5	21.9	31.3	32.9	42.5	18.1	23.7	19.1	27.6	31.4	37.7	40.9	19.6	29.5	79.3	29.6	40.0	92.9	21.4	38.0	32.4	33.0	25.1	32.6	22.1	23.2	20.1	32.1	30.7	79.2	28.5	44.7	18.2	43.7	31.1	25.5	43.0	53.9	60.0	35.2	17.7	20.3	43.7	27.4	31.0	36.5	18.2	32.4	39.2	19.8	25.7	24.2	24.5	31.6	29.2	29.5	20.3	112.9	118.4	141.5	71.0	115.5	77.6	132.9	98.0	90.9	123.1	107.0	106.8	91.6	82.2	73.9	102.8	126.0	123.2	144.4	42.5	42.9	25.2	48.5	38.3	30.2	39.8	25.8	25.4	20.6
UQCR11	"QCR10, UQCR"	ENSG00000127540	"Ubiquinol-cytochrome c reductase, complex III subunit XI"	O14957	19	1597172-1605490	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 125.4;skeletal muscle: 149.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"																						"unprognostic (1.90e-1)"	"unprognostic (6.67e-3)"	"unprognostic (1.78e-1)"	"prognostic favourable (1.23e-4)"	"unprognostic (5.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.42e-3)"	"unprognostic (9.10e-2)"	"unprognostic (1.14e-1)"	"prognostic favourable (1.86e-4)"	"unprognostic (1.03e-1)"	"prognostic favourable (1.65e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.06e-2)"	24.9	23.6	35.1	15.8	29.5	20.3	18.5	13.2	25.1	12.5	28.5	13.1	20.3	34.4	12.4	18.2	22.9	14.1	21.7	106.4	26.9	21.1	24.4	46.1	11.9	17.2	31.0	19.2	9.8	30.0	8.8	16.7	15.4	18.5	18.3	13.3	14.5	29.6	23.6	149.2	11.5	27.5	16.8	21.5	18.3	27.6	8.8	15.1	10.9	22.0	47.1	12.9	15.8	14.1	63.8	78.6	88.2	75.6	43.8	67.9	125.4	22.5	21.2	10.5	23.8	17.5	12.0	25.5	16.3	12.8	16.1	14.4	34.2	15.2	13.3	16.9	11.5	14.4	15.4	17.3	7.5	21.8	47.1	11.7	26.2	32.1	18.2	19.3	18.3	18.5	17.9	10.1	11.8	14.5	25.8	24.2	10.1	31.0	19.2	23.4	27.4	51.1	11.7	11.0	44.5	20.9	45.6	20.9	22.3	11.2	27.1	28.7	19.2	23.1	20.2	15.6	10.2	41.1	18.9	34.2	28.1	16.4	27.4	20.2	21.1	83.7	75.6	87.0	52.6	61.8	52.9	63.8	64.3	58.2	63.1	54.1	61.7	59.3	88.2	43.8	57.4	78.6	67.9	125.4	35.1	29.5	13.2	25.1	26.9	21.1	31.0	19.2	18.5	15.1
UQCRB	"QCR7, QP-C, UQBP, UQCR6"	ENSG00000156467	"Ubiquinol-cytochrome c reductase binding protein"	P14927	8	96225920-96235634	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 234.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA043060	Approved					380000	380000			"HPA043060: AB_10806376"	"unprognostic (5.48e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.47e-3)"	"unprognostic (2.15e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.92e-1)"	"prognostic favourable (2.90e-4)"	"unprognostic (1.01e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.66e-3)"	37.8	51.7	52.1	27.8	54.3	31.3	27.9	25.5	44.0	31.1	37.7	17.9	28.5	35.2	30.7	41.3	38.6	25.5	27.9	156.1	42.3	39.6	57.3	45.1	22.0	28.1	52.2	35.6	48.7	35.2	25.5	45.5	20.3	41.9	35.6	33.8	19.4	42.0	31.7	234.1	16.8	31.7	57.8	44.3	26.9	30.6	15.5	30.8	22.9	33.0	90.0	31.9	51.2	33.8	50.3	38.5	31.9	65.4	30.3	64.4	46.4	57.3	27.5	35.7	22.7	51.7	52.9	23.3	46.4	35.5	25.8	27.7	24.9	27.7	25.1	70.6	37.2	28.2	32.5	43.3	34.6	37.7	25.9	82.4	52.9	41.3	38.0	45.6	35.2	61.7	38.8	29.0	46.4	37.4	43.3	43.6	39.5	37.2	72.4	69.9	21.0	42.4	32.6	23.6	46.2	50.4	46.1	32.8	32.8	28.1	10.8	70.4	44.4	76.5	45.3	17.0	25.8	29.7	49.5	37.7	28.3	58.0	27.8	61.6	18.4	26.6	34.8	31.9	32.2	56.4	39.5	50.3	52.0	40.2	38.5	38.7	64.4	58.8	24.7	30.3	65.4	33.7	56.8	46.4	52.1	54.3	25.5	44.0	42.3	39.6	52.2	35.6	41.9	30.8
UQCRC1	"D3S3191, QCR1, UQCR1"	ENSG00000010256	"Ubiquinol-cytochrome c reductase core protein 1"	P31930	3	48599002-48610976	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 172.7"	"Cell line enhanced"	"Detected in all"		"PC-3: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002815, HPA003525, CAB033782"	Enhanced		Supported	Mitochondria,Cytosol		1300000	1300000	Mitochondria	Mitochondria	"CAB033782: AB_2213631, HPA002815: AB_1080486, HPA003525: AB_1080484"	"unprognostic (1.29e-1)"	"unprognostic (3.15e-3)"	"unprognostic (6.91e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.91e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.20e-2)"	"prognostic favourable (2.35e-10)"	"unprognostic (5.37e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.72e-2)"	18.1	13.7	11.1	9.8	12.5	9.4	11.8	12.5	20.5	11.0	33.7	6.9	10.4	20.0	9.1	9.7	15.8	12.4	10.8	66.7	10.8	11.2	23.0	30.5	7.7	9.3	13.3	13.5	6.3	14.4	20.4	7.8	11.5	13.3	12.5	12.3	7.8	19.5	21.9	172.7	14.0	20.9	12.0	8.7	8.4	23.0	18.4	7.4	9.4	9.1	39.9	9.8	10.3	9.1	23.3	52.7	28.1	57.8	15.1	22.0	74.3	10.0	16.2	5.9	3.6	8.7	8.0	26.7	18.5	15.0	15.4	14.0	25.2	3.0	25.9	11.7	8.3	9.7	7.4	21.5	2.8	15.4	35.5	26.6	14.1	27.4	17.3	16.7	11.5	11.0	24.4	10.5	17.2	15.2	14.3	1.7	9.3	17.4	12.0	19.1	14.8	64.6	8.2	15.7	21.2	15.9	11.0	6.3	11.2	25.1	3.0	14.8	6.4	2.6	15.3	4.3	16.3	13.4	19.1	15.8	13.9	15.0	9.4	19.3	13.7	17.6	57.8	28.1	18.9	56.9	17.9	23.3	18.9	19.0	52.7	18.6	17.1	16.4	14.1	15.1	48.5	21.0	22.0	74.3	11.1	12.5	12.5	20.5	10.8	11.2	13.3	13.5	13.3	7.4
UQCRFS1	"RIP1, RIS1, RISP, UQCR5"	ENSG00000169021	"Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1"	P47985	19	29205321-29213541	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA041863, HPA050339"	Enhanced		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA041863: AB_10794638, HPA050339: AB_2681095"	"unprognostic (4.00e-2)"	"unprognostic (2.23e-3)"	"prognostic favourable (3.29e-4)"	"unprognostic (7.91e-3)"	"unprognostic (3.93e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavourable (3.84e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-1)"	"prognostic favourable (3.92e-9)"	"unprognostic (6.11e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.92e-2)"	15.2	27.1	20.1	10.8	18.3	25.4	28.2	18.3	33.4	11.9	27.3	9.1	9.8	24.3	10.5	14.3	16.9	11.9	14.2	95.3	19.4	14.8	34.9	33.8	12.0	21.2	18.3	13.1	9.1	26.4	15.9	10.6	10.8	17.6	11.8	30.3	11.5	17.0	13.9	112.3	12.9	27.0	19.6	11.5	11.3	18.8	16.6	6.5	17.7	12.9	55.0	14.5	13.7	10.0	18.5	35.6	14.9	29.9	15.0	22.1	45.1	23.0	38.9	14.5	13.0	23.8	18.2	16.1	18.0	18.9	25.0	27.7	23.5	14.3	21.0	19.0	20.3	24.5	31.6	21.4	30.2	14.2	31.7	29.7	15.4	21.4	20.2	28.2	26.1	21.8	23.2	17.0	26.0	19.9	21.0	13.2	26.7	21.3	19.7	21.1	15.1	15.1	18.0	19.3	15.9	31.0	27.8	17.6	8.6	16.4	32.6	20.6	15.1	23.5	12.5	16.9	25.8	11.6	18.6	6.3	11.9	19.3	14.9	24.6	12.0	14.9	29.9	14.0	17.9	29.3	17.8	18.5	19.2	18.3	35.6	15.7	20.4	19.4	9.1	15.0	24.3	19.7	22.1	45.1	20.1	18.3	18.3	33.4	19.4	14.8	18.3	13.1	17.6	6.5
UQCRQ	"QCR8, QP-C, UQCR7"	ENSG00000164405	"Ubiquinol-cytochrome c reductase complex III subunit VII"	O14949	5	132866560-132868031	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 174.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046693, HPA053323"	Approved		Enhanced	Mitochondria				Mitochondria	Mitochondria	"HPA046693: AB_10968453, HPA053323: AB_2682112"	"unprognostic (3.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.92e-2)"	"prognostic favourable (4.23e-4)"	"unprognostic (1.09e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.72e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.37e-2)"	26.4	38.4	43.2	24.5	34.2	20.9	30.9	18.0	37.5	22.5	49.7	13.8	44.0	42.5	15.4	41.8	32.1	15.3	42.7	111.1	33.2	31.7	48.8	112.5	18.8	21.5	42.0	30.4	12.3	64.6	14.0	23.1	17.0	30.5	32.0	44.8	19.7	44.6	39.6	174.9	16.4	40.5	21.2	25.4	15.2	37.4	16.1	20.8	14.3	24.6	71.5	16.8	22.6	20.5	56.6	95.8	67.9	99.9	53.8	56.7	106.3	45.6	63.9	37.7	91.2	56.6	46.0	32.7	33.1	46.9	53.1	66.3	89.9	53.4	18.8	70.1	43.4	46.3	34.3	80.8	45.7	34.3	72.2	24.9	100.7	70.6	49.1	28.2	42.9	49.0	56.4	37.9	52.3	41.4	31.8	60.6	55.6	86.5	64.8	65.1	26.7	57.7	42.5	41.8	80.7	68.7	89.2	63.3	52.7	41.0	46.3	70.8	69.0	65.0	25.7	48.7	61.5	39.9	67.0	67.0	88.9	33.6	64.8	52.6	48.4	67.9	99.9	61.1	47.0	76.6	48.3	56.6	54.9	53.5	87.4	46.0	53.6	51.5	47.4	53.8	70.2	95.8	56.7	106.3	43.2	34.2	18.0	37.5	33.2	31.7	42.0	30.4	30.5	20.8
USO1	"p115, TAP, VDP"	ENSG00000138768	"USO1 vesicle transport factor"	O60763	4	75724593-75814286	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 94.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010108, HPA038282, HPA038283"	Supported		Supported	"Nucleoli fibrillar center,Golgi apparatus"		43000	43000	"Golgi apparatus"	"Golgi apparatus"	"CAB010108: AB_628059, HPA038282: AB_2675928, HPA038283: AB_2675929"	"unprognostic (9.45e-3)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.56e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.24e-2)"	"unprognostic (9.18e-2)"	"unprognostic (7.95e-3)"	"unprognostic (4.01e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.78e-2)"	18.1	22.1	9.9	14.9	11.5	4.1	14.6	13.8	13.2	18.1	16.5	9.1	24.9	13.0	18.6	25.3	20.1	15.8	12.1	35.4	10.9	10.4	18.7	38.8	13.6	10.8	11.5	11.7	23.2	23.6	16.8	32.1	23.1	16.1	19.4	14.0	11.4	20.8	22.2	94.4	13.2	17.3	19.1	14.7	13.5	14.8	15.3	10.6	15.0	20.7	27.0	14.1	23.8	18.8	10.1	14.6	16.8	21.2	19.1	20.7	11.2	14.2	11.3	15.9	21.3	39.0	51.8	14.6	33.5	41.1	18.5	22.6	11.2	22.1	18.8	20.7	30.7	16.6	23.8	20.8	27.9	20.6	9.2	12.9	10.1	23.5	30.7	17.0	14.9	29.4	25.7	19.2	37.8	27.6	22.3	21.7	27.3	9.3	16.8	9.0	21.7	6.7	11.2	15.2	15.0	27.6	16.6	12.7	12.4	12.3	26.1	21.1	19.1	14.0	21.2	17.0	10.5	30.7	12.6	20.5	11.0	9.1	25.3	10.3	20.0	16.8	11.4	10.1	15.2	16.5	20.7	9.3	12.9	14.5	14.6	10.1	13.6	13.1	7.0	19.1	21.2	11.8	12.9	11.2	9.9	11.5	13.8	13.2	10.9	10.4	11.5	11.7	16.1	10.6
USP13	IsoT-3	ENSG00000058056	"Ubiquitin specific peptidase 13"	Q92995	3	179652755-179789401	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 34.8;skeletal muscle: 90.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"MAIT T-cell: 15.4"	"Lineage enriched"	"Detected in many"	8	"T-cells: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004827	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA004827: AB_1080497"	"unprognostic (1.00e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (2.40e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavourable (3.46e-6)"	"unprognostic (4.93e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavourable (3.06e-4)"	6.4	7.5	2.0	2.3	2.8	0.8	3.5	2.9	4.1	2.7	2.1	4.6	1.5	0.7	3.2	3.8	2.6	2.5	2.5	34.8	2.0	2.3	2.3	3.4	6.0	2.5	2.1	2.1	7.2	3.0	3.3	9.8	1.9	3.0	3.0	1.8	3.1	3.3	2.1	90.3	1.8	1.7	3.7	2.5	1.6	1.6	5.6	1.3	1.7	5.5	17.1	3.2	2.6	1.9	2.0	1.9	0.0	0.4	0.0	15.4	0.7	12.3	5.3	10.1	7.7	4.6	6.4	4.9	7.3	8.4	10.8	9.1	7.8	4.4	15.3	8.2	8.8	0.9	11.3	4.4	12.9	36.2	4.8	4.0	8.0	7.3	3.3	11.2	0.0	6.8	1.6	8.4	10.7	8.6	1.9	19.8	8.9	8.1	6.8	2.0	7.8	4.8	11.7	10.0	12.5	7.3	3.5	5.7	7.4	7.0	9.4	4.2	16.2	8.1	9.3	13.0	10.4	11.1	28.1	9.6	8.0	31.4	6.0	7.6	12.1	0.0	0.2	0.0	1.3	0.4	15.4	2.0	1.3	2.9	1.5	0.6	1.0	1.0	0.0	0.0	0.4	1.9	0.6	0.7	2.0	2.8	2.9	4.1	2.0	2.3	2.1	2.1	3.0	1.3
USP2	UBP41	ENSG00000036672	"Ubiquitin specific peptidase 2"	O75604	11	119355215-119381726	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 79.9"	"Cell line enriched"	"Detected in many"	4	"U-266/70: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006777, HPA007222"	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA006777: AB_1080507, HPA007222: AB_1080505"	"unprognostic (6.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.24e-3)"	"unprognostic (8.02e-3)"	"unprognostic (7.33e-2)"	"prognostic favourable (3.09e-11)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.66e-2)"	3.1	4.8	6.9	1.4	12.2	1.5	1.6	12.6	16.1	2.5	5.9	10.0	0.0	7.9	2.6	6.4	5.9	7.0	2.2	26.8	5.7	3.1	29.7	10.6	2.2	0.7	5.7	6.2	2.9	10.1	18.4	7.6	1.3	6.7	2.3	3.9	19.1	3.2	2.4	79.9	4.6	11.7	4.2	3.8	0.8	2.7	36.1	8.8	0.0	2.2	25.2	1.0	1.9	2.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	3.4	0.3	0.5	1.9	0.1	0.1	0.7	0.4	0.2	0.0	0.3	3.6	0.5	5.9	1.1	0.6	0.6	4.7	1.7	0.1	4.2	0.6	1.7	2.5	7.3	1.6	0.0	1.6	0.6	0.3	0.4	1.2	0.3	8.2	0.5	1.0	2.4	0.0	0.4	0.9	0.7	0.0	1.3	0.8	2.7	0.2	7.2	2.2	2.0	1.6	0.4	5.3	3.6	0.0	0.0	0.9	0.5	0.5	34.4	7.6	0.1	0.0	1.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.7	0.0	0.0	1.3	0.7	0.0	0.0	0.0	0.0	0.3	0.3	6.9	12.2	12.6	16.1	5.7	3.1	5.7	6.2	6.7	8.8
USP24	KIAA1057	ENSG00000162402	"Ubiquitin specific peptidase 24"	Q9UPU5	1	55066359-55215113	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 46.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026723, HPA028428, HPA067124"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA026723: AB_10599851, HPA028428: AB_10600991, HPA067124: AB_2685785"	"unprognostic (2.28e-1)"	"unprognostic (9.81e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.86e-3)"	"unprognostic (9.31e-3)"	"unprognostic (4.84e-3)"	"prognostic unfavourable (1.34e-7)"	"unprognostic (2.04e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.64e-1)"	12.3	7.6	7.5	12.1	8.8	30.1	10.6	20.1	8.5	7.8	10.2	6.8	10.6	5.0	10.1	7.0	7.7	6.9	7.0	14.7	7.9	6.4	10.4	9.3	7.6	12.7	8.0	5.6	10.9	7.3	15.5	16.9	5.8	6.9	7.6	8.5	5.1	9.7	10.7	46.0	8.9	8.7	7.3	6.2	10.9	7.8	4.9	8.7	16.4	7.4	11.5	12.7	9.7	13.7	6.0	10.5	5.9	2.2	3.8	4.5	1.1	17.8	9.8	12.3	6.7	16.1	14.1	14.2	7.9	10.0	11.4	11.9	14.0	6.3	14.3	8.8	14.6	14.5	16.3	13.3	17.9	15.0	9.9	28.7	21.5	16.3	9.6	19.7	22.3	12.3	11.9	17.3	19.7	10.3	26.4	6.0	15.2	4.2	11.9	10.5	18.1	11.9	12.3	15.7	6.2	19.8	12.1	10.9	7.6	13.5	9.7	11.8	6.7	9.8	13.9	10.4	10.1	12.5	12.6	7.6	5.7	18.8	9.9	16.5	9.3	5.9	2.0	2.5	4.5	1.8	2.8	4.8	3.5	3.5	1.8	6.0	3.2	4.2	2.3	3.8	2.2	10.5	1.9	1.1	7.5	8.8	20.1	8.5	7.9	6.4	8.0	5.6	6.9	8.7
USP28	KIAA1515	ENSG00000048028	"Ubiquitin specific peptidase 28"	Q96RU2	11	113797874-113875570	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 40.1;skeletal muscle: 50.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006778, HPA006779"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA006778: AB_1080520, HPA006779: AB_1080517"	"unprognostic (2.54e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.73e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.82e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.35e-3)"	"unprognostic (5.03e-2)"	3.9	3.4	4.8	8.6	5.7	2.4	5.7	26.4	8.6	11.6	5.1	4.9	14.0	4.7	6.0	6.0	5.7	5.0	4.0	40.1	5.0	4.8	5.1	5.6	5.1	7.2	6.8	4.5	7.5	4.1	10.6	9.7	3.9	4.8	8.9	6.0	5.7	5.7	12.2	50.2	3.5	5.1	11.6	6.4	6.9	4.4	5.5	3.8	3.6	5.1	10.1	7.7	7.1	4.6	10.3	4.1	2.1	3.7	17.9	16.2	6.0	10.3	11.6	15.7	20.7	12.8	12.7	11.1	7.6	10.5	10.3	17.7	17.1	14.9	13.7	17.4	10.3	20.3	22.1	14.3	14.4	15.3	10.0	7.3	8.1	9.2	7.9	9.4	7.3	7.6	10.9	11.9	14.2	18.6	12.6	8.9	10.8	5.2	7.1	15.3	18.8	8.4	17.6	21.8	16.6	11.4	10.2	6.9	7.4	18.1	6.2	5.9	15.1	3.3	9.8	11.5	17.2	10.4	7.8	6.1	8.7	11.6	1.1	18.3	7.4	0.1	3.2	2.1	16.2	2.4	8.4	10.3	4.1	11.4	4.1	8.4	2.7	9.4	0.9	17.9	3.7	1.2	5.6	6.0	4.8	5.7	26.4	8.6	5.0	4.8	6.8	4.5	4.8	3.8
USP38	"HP43.8KD, KIAA1891"	ENSG00000170185	"Ubiquitin specific peptidase 38"	Q8NB14	4	143184917-143223830	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 45.3"	"Cell line enhanced"	"Detected in all"		"U-266/84: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036990, HPA047948"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	Nucleoplasm	"HPA036990: AB_2675419, HPA047948: AB_2680220"	"unprognostic (5.01e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.03e-2)"	"unprognostic (7.72e-3)"	"prognostic favourable (1.20e-4)"	"unprognostic (3.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-1)"	7.7	7.8	6.6	6.6	6.5	19.1	8.3	7.4	7.8	7.9	12.1	8.6	8.8	8.8	8.3	7.1	8.6	7.1	7.6	12.5	6.6	5.3	9.3	15.2	12.7	11.1	10.3	5.1	6.3	8.8	10.0	6.2	11.4	5.9	6.6	6.6	7.1	7.2	7.0	45.3	8.9	13.2	6.5	10.8	10.6	7.4	7.5	8.2	22.6	8.6	10.2	8.4	7.8	8.8	6.3	8.1	12.5	5.7	12.3	9.9	5.0	4.7	4.5	4.0	6.8	5.2	5.2	2.9	7.6	7.4	7.0	6.0	12.9	7.0	5.9	5.4	6.4	3.8	9.3	7.5	5.8	14.4	6.0	5.4	5.3	2.7	7.2	10.9	5.4	6.3	6.9	7.2	5.8	7.0	11.7	18.5	4.7	7.5	14.2	2.0	3.6	8.7	9.4	5.9	5.6	4.5	5.5	8.1	7.3	5.9	10.3	6.6	6.3	4.1	8.3	6.5	5.3	5.6	7.9	20.7	35.1	10.7	6.6	8.4	5.4	12.5	5.4	11.7	7.5	5.7	9.6	6.3	6.6	6.5	8.1	5.7	6.7	5.7	5.4	12.3	5.7	3.5	9.9	5.0	6.6	6.5	7.4	7.7	6.6	5.3	10.3	5.1	5.9	8.2
UTP11	"CGI-94, UTP11L"	ENSG00000183520	"UTP11, small subunit processome component"	Q9Y3A2	1	38009258-38024824	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 74.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045830	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA045830: AB_10969917"	"unprognostic (1.95e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (7.44e-8)"	"unprognostic (3.51e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.40e-1)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (1.42e-8)"	"unprognostic (1.39e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-1)"	11.3	12.4	9.1	9.6	8.4	9.3	9.7	7.5	11.3	10.6	12.1	6.0	6.9	7.3	11.4	9.1	13.8	9.8	8.6	11.5	12.9	9.5	9.1	13.1	7.4	8.6	9.3	8.7	10.7	11.5	6.6	10.2	11.4	11.2	12.9	8.7	6.7	10.0	8.8	74.7	9.4	7.6	19.7	10.9	10.2	10.4	9.3	5.7	10.5	8.1	26.1	10.6	22.6	10.9	12.9	18.7	9.6	22.5	21.9	17.7	12.3	14.8	9.0	15.7	15.3	11.8	16.2	14.4	16.9	16.1	22.9	21.0	13.2	18.6	24.8	15.9	13.6	12.9	17.8	14.8	28.6	18.6	16.4	28.9	12.1	11.5	16.0	28.7	19.0	14.9	9.6	25.2	22.0	18.2	32.9	13.5	25.8	10.5	22.2	29.7	38.3	12.0	19.8	33.7	23.0	15.0	14.5	20.8	17.3	14.7	12.8	27.0	11.7	17.7	13.4	15.6	18.9	17.0	31.9	12.8	25.2	20.9	21.0	31.6	19.2	8.4	18.9	9.6	16.9	20.5	17.7	10.5	13.5	14.0	18.7	12.9	12.4	15.0	5.7	21.9	22.5	18.0	15.6	12.3	9.1	8.4	7.5	11.3	12.9	9.5	9.3	8.7	11.2	5.7
VDAC1	"MGC111064, PORIN"	ENSG00000213585	"Voltage dependent anion channel 1"	P21796	5	133971915-134005133	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 189.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005885, HPA030780, CAB072343"	Supported		Uncertain	Vesicles		4800000	4800000	Vesicles	Vesicles	"CAB005885: AB_2214787, CAB072343: , HPA030780: AB_2673608"	"prognostic unfavourable (5.30e-4)"	"unprognostic (7.63e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.01e-1)"	"unprognostic (5.11e-3)"	"prognostic unfavourable (4.90e-4)"	"prognostic unfavourable (8.49e-4)"	"prognostic unfavourable (2.87e-5)"	"unprognostic (1.81e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.19e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	22.4	27.0	32.2	18.9	36.6	9.8	22.6	24.4	46.4	13.8	31.3	15.6	20.4	54.0	12.1	42.8	35.2	13.3	25.8	79.0	31.0	32.3	44.9	52.5	16.3	17.3	30.6	29.5	14.6	27.5	31.6	14.1	22.8	41.8	17.9	35.3	23.3	26.6	17.9	189.4	21.9	39.9	18.9	20.7	18.3	32.5	8.3	14.7	16.3	17.3	66.6	25.5	18.9	21.3	18.9	44.7	9.2	36.5	26.5	23.3	20.0	55.7	49.6	45.5	47.1	45.7	64.0	64.2	62.8	46.5	62.5	64.4	101.4	44.9	77.1	47.3	65.5	44.0	64.1	110.6	78.5	45.5	52.8	44.4	53.1	81.1	46.6	40.7	44.1	58.2	59.4	48.5	54.2	60.5	39.5	31.6	81.5	62.2	49.5	40.6	31.8	42.1	45.7	45.5	73.3	97.1	70.6	50.9	28.8	40.0	48.9	62.6	23.5	40.0	49.0	58.9	39.3	53.9	82.1	42.4	41.9	48.4	87.4	54.7	66.9	6.4	26.2	9.2	18.5	36.5	20.4	18.9	19.1	19.3	44.7	13.4	13.7	15.1	2.2	26.5	31.2	13.1	23.3	20.0	32.2	36.6	24.4	46.4	31.0	32.3	30.6	29.5	41.8	14.7
VDAC3	HD-VDAC3	ENSG00000078668	"Voltage dependent anion channel 3"	Q9Y277	8	42391624-42405897	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 187.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026864	Uncertain		Supported	Mitochondria		9300000	9300000	Mitochondria	Mitochondria	"HPA026864: AB_1858733"	"unprognostic (2.55e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.94e-3)"	19.9	18.8	26.0	13.7	29.8	18.6	17.3	38.3	39.1	16.0	23.7	14.5	12.3	19.1	19.1	17.7	26.8	21.5	13.9	85.8	28.2	35.3	27.9	22.1	12.5	14.6	32.5	24.6	18.1	15.0	17.5	16.5	15.4	44.3	17.6	26.2	16.0	22.2	20.8	187.5	13.0	22.7	22.1	19.6	17.3	16.6	27.4	13.0	20.5	21.6	39.7	18.4	23.1	13.3	34.4	59.4	47.5	44.4	31.4	52.4	81.9	48.2	48.6	38.3	40.7	32.3	28.1	19.0	38.6	33.0	49.7	45.5	37.5	41.3	49.6	37.1	32.7	30.9	51.6	41.4	54.8	25.1	42.6	75.4	32.5	53.3	23.1	36.3	42.1	21.8	31.5	37.6	17.6	60.3	59.1	34.6	50.6	26.7	77.4	41.7	45.4	31.7	41.0	70.5	35.1	53.4	43.0	33.8	29.0	24.4	29.0	24.3	61.3	27.7	32.2	19.4	33.8	48.2	37.4	32.2	53.7	56.5	26.0	51.3	32.6	31.1	44.4	47.5	42.1	43.8	42.4	34.4	45.1	41.7	59.4	24.2	45.1	43.3	22.0	31.4	38.5	43.8	52.4	81.9	26.0	29.8	38.3	39.1	28.2	35.3	32.5	24.6	44.3	13.0
VHLL	"VHLP, VLP"	ENSG00000189030	"VHL like"	Q6RSH7	1	156298624-156299299	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 2.6;pancreas: 1.6;skeletal muscle: 1.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.9;Daudi: 2.4;hTCEpi: 3.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																										"unprognostic (1.61e-1)"									"unprognostic (2.45e-1)"				0.1	0.1	0.1	0.0	0.3	0.0	0.0	2.6	0.2	0.0	0.1			0.0	0.3	0.0	1.2	0.1	0.8	0.1	0.2	0.2	0.0	0.4	0.1	0.1	0.0		0.2	1.6	0.0	0.1	0.1		0.2	0.1		0.0	0.0	1.5	0.3	0.0	0.2	0.1	0.2	0.1	0.6			0.1		0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.5	0.7	0.0	3.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
WBP1L	"C10orf26, FLJ20154, OPAL1"	ENSG00000166272	"WW domain binding protein 1 like"	Q9NX94	10	102743970-102816267	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 77.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037635, HPA038371"	Uncertain		Approved	Nucleoplasm,Microtubules				Microtubules	Microtubules	"HPA037635: AB_10672462, HPA038371: AB_2675980"	"unprognostic (3.28e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.14e-2)"	"prognostic favourable (4.03e-4)"	"unprognostic (5.35e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (1.56e-6)"	"unprognostic (2.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.53e-1)"	23.8	23.0	11.5	12.9	13.7	2.3	14.2	9.5	14.2	19.0	14.5	12.2	13.3	9.0	18.9	14.9	13.1	18.9	15.3	23.6	11.9	8.9	11.6	21.3	13.3	11.5	14.9	8.0	23.6	9.3	12.5	13.5	14.1	17.5	15.2	9.2	20.2	21.8	14.9	77.3	20.1	12.3	16.3	15.0	12.5	15.0	11.0	10.1	23.2	26.1	35.5	11.1	17.6	11.4	6.1	8.2	14.7	16.7	12.4	8.7	8.9	10.1	13.2	7.3	12.2	24.3	19.7	14.9	10.4	28.2	10.4	13.1	8.9	15.9	8.8	14.1	15.9	11.3	5.3	9.0	7.9	8.8	5.6	17.8	6.0	6.4	15.7	8.5	21.2	21.3	16.1	13.3	10.3	20.2	8.6	11.0	17.7	13.3	10.2	9.5	5.5	6.4	20.6	19.1	5.6	9.2	10.0	1.7	7.0	5.7	5.8	11.7	23.6	9.5	15.0	10.0	10.4	11.2	9.2	20.5	10.7	6.5	14.1	16.4	4.4	6.6	11.8	14.7	8.7	13.7	6.9	6.1	7.4	8.4	8.2	6.0	6.8	7.2	14.4	12.4	16.7	5.2	7.5	8.9	11.5	13.7	9.5	14.2	11.9	8.9	14.9	8.0	17.5	10.1
WBP4	"FBP21, MGC117310"	ENSG00000120688	"WW domain binding protein 4"	O75554	13	41061274-41084006	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038965, HPA058738"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"				Nucleoplasm	Nucleoplasm	"HPA038965: AB_10672836, HPA058738: AB_2683803"	"unprognostic (2.56e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.71e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.52e-2)"	"unprognostic (7.65e-3)"	"prognostic favourable (2.89e-4)"	"unprognostic (2.52e-1)"	14.0	14.2	17.2	7.9	22.1	11.4	11.5	15.8	17.2	12.0	10.7	8.6	8.9	9.6	16.6	14.1	10.9	10.1	8.0	18.8	14.7	15.8	10.5	13.4	8.7	9.0	14.7	19.0	11.8	7.5	8.8	11.3	15.9	15.9	12.5	8.0	4.8	7.2	13.2	76.2	9.4	9.6	14.7	15.0	7.9	8.1	10.0	12.8	12.7	9.6	12.6	9.3	13.3	11.1	10.9	15.2	22.7	16.2	9.7	12.9	5.0	8.8	5.9	16.5	10.6	10.8	16.5	10.1	20.2	14.3	15.9	12.3	9.3	9.5	12.7	8.1	14.1	12.6	6.2	10.0	20.5	13.1	8.7	17.9	5.7	9.4	16.6	11.1	11.7	13.5	15.4	11.6	16.5	13.4	9.5	5.6	16.6	7.5	16.0	12.2	10.0	4.9	15.0	10.2	5.0	14.5	8.8	3.8	9.1	6.4	7.0	9.5	5.7	17.5	11.7	10.0	9.2	13.7	11.6	3.7	4.1	8.9	12.3	8.2	13.6	13.0	11.0	9.7	9.3	9.6	8.5	10.9	11.8	9.9	8.9	10.6	12.9	12.6	22.7	9.7	16.2	15.2	11.3	5.0	17.2	22.1	15.8	17.2	14.7	15.8	14.7	19.0	15.9	12.8
WNK2	"KIAA1760, NY-CO-43, PRKWNK2, SDCCAG43"	ENSG00000165238	"WNK lysine deficient protein kinase 2"	Q9Y3S1	9	93184916-93320572	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 21.9;pancreas: 18.3;salivary gland: 19.5;skeletal muscle: 23.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.2;Hep G2: 18.4;SCLC-21H: 23.4"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015555, HPA016519, CAB017813"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"CAB017813: , HPA015555: AB_2669218, HPA016519: AB_2669380"	"unprognostic (5.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.48e-3)"	"unprognostic (6.51e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.38e-4)"	"unprognostic (1.62e-1)"	0.0	0.7	3.9	0.9	3.8	0.0	1.2	9.5	7.2	0.7	7.5			7.4	1.3	1.5	2.1	6.6	0.1	21.9	4.0	4.2	0.0	0.0	0.0	0.0	2.6		0.0	18.3	0.8	7.5	0.9		4.9	4.8		19.5	5.5	23.7	3.0	6.2	1.6	1.1	0.5	3.0	1.5			0.0		0.0	1.0	0.1	0.0	0.0	1.9	0.0	0.0	0.3	0.0	4.4	4.0	2.8	8.1	0.0	0.0	5.4	0.0	0.0	0.0	0.0	1.6	0.1	11.2	1.5	0.0	0.2	6.4	0.0	0.0	0.0	7.4	0.0	3.5	18.4	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	5.8	0.1	0.1	7.1	0.2	0.0	0.0	9.1	0.0	0.6	23.4	9.2	1.4	6.3	0.6	0.8	1.3	0.1	0.0	3.1	0.1	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.0										
XPO4	"FLJ13046, KIAA1721"	ENSG00000132953	"Exportin 4"	Q9C0E2	13	20777329-20903048	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 47.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053768			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA053768: AB_2682254"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.79e-2)"	"prognostic unfavourable (8.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (4.63e-4)"	"unprognostic (1.67e-1)"	"unprognostic (7.24e-3)"	"unprognostic (9.50e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.42e-1)"	8.9	6.6	4.9	6.9	9.6	10.9	7.9	13.6	11.1	7.5	6.7	11.6	7.9	5.0	11.4	5.9	7.5	7.3	4.9	12.8	6.1	5.3	6.9	6.1	7.7	8.6	8.0	5.3	9.0	7.8	8.1	12.9	6.8	10.2	7.3	7.6	10.7	7.4	7.4	47.3	8.2	7.2	8.2	8.3	8.6	6.7	7.9	8.0	14.3	8.4	6.3	12.3	7.8	7.3	3.1	2.7	3.1	6.0	3.1	4.0	1.2	6.6	5.0	8.3	7.9	4.0	7.1	8.6	7.6	5.6	9.0	7.5	10.2	8.4	14.7	4.1	7.3	11.0	19.1	10.3	16.8	10.0	5.5	23.3	6.3	6.9	6.1	20.4	7.6	6.9	6.5	9.1	17.3	10.8	11.0	4.9	8.5	5.5	9.7	9.0	9.4	4.7	10.8	13.7	6.1	6.3	8.1	9.5	6.6	6.5	9.5	7.8	5.6	11.2	8.9	6.4	5.0	7.8	10.8	3.2	4.8	12.2	3.1	13.1	9.5	3.1	2.0	2.1	3.4	2.3	4.0	3.1	2.9	2.9	2.7	2.6	3.6	3.5	0.0	3.1	6.0	2.0	2.7	1.2	4.9	9.6	13.6	11.1	6.1	5.3	8.0	5.3	10.2	8.0
YWHAG	PPP1R170	ENSG00000170027	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma"	P61981	7	76326794-76359031	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 117.8;skeletal muscle: 91.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB013274, CAB018389, HPA026918, HPA061603"	Approved	Approved	Supported	Nucleoplasm,Nucleoli,Cytosol		160000000	160000000	Cytosol	Cytosol	"CAB013274: , CAB018389: AB_2217962, HPA026918: AB_10610566, HPA061603: "	"unprognostic (3.71e-2)"	"prognostic unfavourable (4.53e-4)"	"unprognostic (3.88e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.40e-3)"	"unprognostic (8.98e-3)"	"prognostic unfavourable (5.34e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (7.44e-4)"	"unprognostic (3.03e-2)"	"prognostic unfavourable (4.01e-4)"	"unprognostic (9.31e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.70e-1)"	52.4	31.2	46.3	17.7	54.6	7.3	17.2	36.2	117.8	13.4	14.2	13.3	4.6	14.4	15.0	7.0	18.6	9.0	17.0	33.1	50.2	56.2	15.9	22.0	12.9	12.1	45.9	49.8	13.3	18.0	14.8	7.8	16.6	74.6	14.7	14.0	8.6	10.0	13.3	91.8	11.7	12.5	20.2	22.8	12.7	11.2	8.9	13.5	6.8	8.8	13.8	14.3	14.7	13.2	3.1	5.9	3.2	5.0	1.1	3.3	1.7	37.1	46.7	41.4	52.5	42.4	24.5	18.7	43.2	21.4	26.8	29.2	29.3	40.0	52.4	14.9	38.3	34.8	51.8	47.7	37.8	35.5	22.6	49.6	32.0	32.5	38.7	60.5	48.6	26.8	45.8	31.3	64.9	42.6	68.1	59.3	40.0	35.0	43.2	44.7	45.9	32.8	50.7	41.9	57.9	42.1	25.4	22.2	61.7	47.9	61.4	30.6	42.7	36.7	44.9	52.4	30.5	46.4	57.7	19.7	36.9	80.7	47.1	57.3	55.8	3.2	5.0	1.1	2.1	4.6	3.3	3.1	2.4	2.6	5.2	1.8	1.8	2.0	1.1	1.1	3.8	5.9	2.0	1.7	46.3	54.6	36.2	88.9	50.2	56.2	45.9	49.8	74.6	13.5
ZBTB47	"DKFZp434N0615, KIAA1190, ZNF651"	ENSG00000114853	"Zinc finger and BTB domain containing 47"	Q9UFB7	3	42653684-42665854	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 28.1;skeletal muscle: 33.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 33.5;fHDF/TERT166: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074057	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA074057: AB_2686657"	"unprognostic (1.03e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.99e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.86e-2)"	"unprognostic (8.99e-2)"	"prognostic favourable (7.96e-5)"	"unprognostic (5.77e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.10e-2)"	5.8	3.3	11.4	3.1	18.0	0.5	2.8	3.3	11.3	4.8	4.4	15.7	0.7	1.1	5.4	1.5	4.4	3.1	4.4	28.1	16.1	4.7	1.2	2.0	2.6	2.1	8.6	9.1	5.0	4.5	2.7	3.0	2.1	6.3	4.8	1.0	2.9	7.6	6.2	33.1	2.8	1.4	5.8	12.8	1.7	3.0	3.1	16.7	0.7	5.2	4.2	1.6	3.7	3.3	0.0	0.9	2.8	1.6	0.3	0.3	0.4	3.6	3.2	2.0	1.3	33.5	13.0	0.7	8.7	7.5	3.8	2.8	0.7	1.5	0.0	3.6	17.7	0.9	0.5	3.3	0.8	0.0	4.3	2.2	9.4	0.8	10.3	0.0	3.0	13.9	6.1	4.9	4.2	4.2	2.0	2.6	7.6	0.9	0.1	0.2	1.1	2.1	2.6	3.9	1.0	2.1	0.8	2.2	3.7	4.0	0.7	3.2	4.6	4.8	9.4	8.0	4.6	7.7	3.4	0.1	0.0	0.0	7.3	2.6	2.3	0.0	1.6	0.1	0.3	1.1	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	2.8	0.3	0.9	0.0	0.0	0.4	11.4	18.0	3.3	9.3	16.1	4.7	8.6	9.1	6.3	16.7
ZFAND5	"ZA20D2, ZFAND5A, ZNF216"	ENSG00000107372	"Zinc finger AN1-type containing 5"	O76080	9	72351425-72365235	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 207.5"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018129	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA018129: AB_1859012"	"unprognostic (1.97e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.91e-1)"	"prognostic favourable (4.43e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.39e-3)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.85e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.86e-2)"	"unprognostic (7.03e-2)"	82.5	57.6	26.9	15.5	35.2	36.6	57.1	31.7	34.3	28.6	23.1	20.3	31.4	10.8	25.7	35.5	29.0	27.4	28.7	33.0	24.3	22.6	32.6	56.5	31.6	23.6	24.3	21.1	59.3	20.9	17.0	45.4	22.4	25.1	24.0	15.1	22.4	17.2	52.7	207.5	17.6	15.8	28.4	25.9	24.1	23.2	26.7	21.7	14.6	23.1	29.5	16.5	39.2	29.3	7.0	13.6	15.4	32.1	8.6	6.8	7.8	21.8	22.4	26.4	11.7	34.3	16.3	20.0	25.9	36.1	13.9	10.9	2.7	20.7	12.2	15.7	40.5	24.5	60.9	10.1	20.9	82.5	9.4	9.6	12.9	13.7	25.3	13.8	14.3	21.4	18.8	14.6	16.3	24.7	9.2	16.2	16.4	5.8	18.0	7.8	34.2	15.6	14.1	13.7	12.9	45.5	21.3	19.4	17.3	16.4	18.0	21.1	8.0	12.1	18.8	11.6	14.3	20.5	17.7	23.3	20.3	6.4	15.6	9.4	28.8	15.1	13.6	15.4	5.2	21.6	5.7	7.0	6.8	6.6	13.6	6.2	6.3	5.6	12.2	8.6	32.1	2.9	4.8	7.8	26.9	35.2	31.7	34.3	24.3	22.6	24.3	21.1	25.1	21.7
ZNF106	"SH3BP3, ZFP106, ZNF474"	ENSG00000103994	"Zinc finger protein 106"	Q9H2Y7	15	42412823-42491123	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 64.8;skeletal muscle: 111.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 48.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054267	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	Nucleoli	"HPA054267: AB_2682431"	"unprognostic (2.15e-2)"	"unprognostic (3.31e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-3)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.36e-1)"	"unprognostic (4.09e-3)"	14.9	5.4	8.8	6.6	10.4	9.0	10.3	6.3	9.1	7.1	7.8	4.5	4.5	3.9	7.4	6.3	12.7	5.4	6.1	64.8	9.2	6.3	6.4	3.7	7.8	6.0	7.6	6.4	6.6	4.4	8.4	7.1	5.0	11.9	7.8	5.6	11.3	6.0	5.7	111.1	4.3	5.9	10.9	8.0	6.3	6.0	5.7	7.2	3.4	5.7	46.9	6.8	7.0	17.7	8.3	10.8	48.5	19.6	3.9	5.1	4.5	14.1	8.2	14.4	15.9	36.4	32.1	8.8	11.5	11.0	10.1	10.8	19.3	4.1	9.5	10.3	14.1	16.2	14.9	11.8	15.5	15.4	7.2	18.2	19.2	6.9	10.5	21.8	10.9	24.1	7.9	15.3	17.1	16.2	21.6	1.3	16.4	5.6	8.3	5.3	6.1	8.4	8.0	26.2	5.2	5.3	16.0	9.2	4.9	23.3	11.0	13.0	10.1	14.2	24.4	10.9	16.8	14.4	16.8	7.9	15.2	35.6	9.7	17.4	18.8	19.9	19.6	7.6	5.1	15.9	4.5	6.7	4.2	4.2	10.5	8.3	3.8	3.4	48.5	3.9	18.5	10.8	3.8	4.5	8.8	10.4	6.3	9.1	9.2	6.3	7.6	6.4	11.9	7.2
ZNF593	ZT86	ENSG00000142684	"Zinc finger protein 593"	O00488	1	26169871-26170873	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA054363, HPA059387"	Supported		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoli	"HPA054363: AB_2682462, HPA059387: AB_2684001"	"unprognostic (1.23e-2)"	"unprognostic (8.97e-2)"	"unprognostic (7.13e-2)"	"unprognostic (7.42e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.96e-2)"	"unprognostic (5.06e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.79e-2)"	11.7	11.5	9.4	10.7	9.4	15.7	18.3	7.2	12.1	9.0	11.7	7.0	12.1	11.4	8.7	9.0	10.9	8.4	11.3	14.5	8.9	10.0	13.5	30.8	7.7	16.8	10.0	7.0	11.6	36.2	9.7	9.3	12.7	10.9	10.4	5.8	5.9	15.9	12.0	59.3	9.8	11.0	6.5	7.3	13.0	15.2	9.3	8.3	5.4	15.1	17.2	9.2	10.6	10.1	23.5	26.8	0.7	25.0	16.1	21.7	14.1	20.0	11.0	3.8	13.3	3.7	4.8	20.1	8.9	4.5	10.4	10.0	16.9	12.2	23.4	16.5	5.6	13.1	12.9	11.6	3.8	14.0	41.2	15.9	9.0	25.6	15.9	21.9	14.0	8.8	11.4	11.5	12.1	8.7	23.9	9.1	6.1	15.3	8.9	40.8	15.0	39.3	11.2	6.6	23.6	7.4	8.8	10.1	11.0	10.8	27.2	34.0	11.3	12.4	9.0	10.0	11.9	21.0	16.6	17.9	18.0	25.3	11.8	45.6	12.8	0.1	15.7	0.2	14.2	25.0	13.3	23.5	20.1	14.0	21.7	22.7	15.0	14.3	0.7	16.1	25.0	26.8	21.7	14.1	9.4	9.4	7.2	12.1	8.9	10.0	10.0	7.0	10.9	8.3
ZNF703	"FLJ14299, NLZ1, ZEPPO1, ZNF503L, Zpo1"	ENSG00000183779	"Zinc finger protein 703"	Q9H7S9	8	37695751-37700021	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 64.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 55.4;SK-MEL-30: 20.1;T-47d: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"intermediate monocyte: 5.5;non-classical monocyte: 6.7"	"Lineage enriched"	"Detected in single"	12	"monocytes: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023930, CAB068249"	Supported									"CAB068249: AB_2665667, HPA023930: AB_1859425"	"unprognostic (4.64e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.01e-3)"	"unprognostic (1.71e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.09e-1)"	"unprognostic (9.63e-2)"	"prognostic unfavourable (2.70e-7)"	"unprognostic (5.63e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.23e-1)"	12.7	6.7	9.3	8.2	8.4	2.4	15.4	7.2	10.1	25.1	20.0	4.6	31.3	14.0	13.8	19.5	15.3	18.4	12.1	8.0	8.5	3.6	3.5	2.1	4.9	4.0	5.4	4.7	15.0	4.3	2.0	3.1	54.9	7.8	15.1	12.3	12.0	13.7	17.7	64.6	24.6	15.4	14.9	3.4	13.4	12.6	4.9	5.5	1.9	5.3	24.0	7.2	20.4	13.8	0.0	0.5	0.1	6.7	0.0	0.1	0.2	1.1	2.3	0.3	1.8	5.5	2.9	1.8	10.2	4.8	3.1	2.7	9.4	12.7	0.0	2.6	6.4	6.0	1.0	1.5	2.4	0.3	55.4	0.0	3.3	6.0	5.4	0.0	1.0	9.7	2.9	3.2	1.3	2.7	0.1	0.0	5.0	9.3	0.0	0.3	0.9	4.1	0.9	1.7	1.2	0.9	4.9	1.0	0.1	1.8	1.6	20.1	18.6	1.0	8.0	3.7	8.6	5.7	4.2	0.7	0.0	0.0	3.3	1.1	2.3	0.0	0.7	0.1	0.0	5.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	6.7	0.0	0.0	0.2	9.3	8.4	7.2	10.1	8.5	3.6	5.4	4.7	7.8	5.5
ZNF750	"FLJ13841, Zfp750"	ENSG00000141579	"Zinc finger protein 750"	Q32MQ0	17	82829435-82840578	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 59.3;lymphoid tissue: 54.2;skeletal muscle: 84.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 17.0;hTCEpi: 6.3;MCF7: 4.5;SK-BR-3: 12.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021573, HPA023012"	Enhanced									"HPA021573: AB_1859438, HPA023012: AB_1859439"	"unprognostic (3.46e-3)"	"unprognostic (1.94e-2)"	"unprognostic (7.51e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.33e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.23e-2)"	"unprognostic (5.30e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.25e-2)"	0.4	0.1	0.1	0.1	0.1	0.1	3.0	0.1	0.1	14.0	0.1	0.0	9.0	0.2	0.9	3.8	59.3	0.4	0.2	0.2	0.1	0.1	0.2	0.1	2.3	0.1	0.1	0.0	0.1	0.1	0.6	2.2	19.5	0.0	3.2	0.1	0.0	38.3	13.2	84.2	46.2	0.1	0.4	0.1	0.1	0.1	0.2	0.0	3.4	6.7	44.1	54.2	3.2	16.8	0.2	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.9	1.1	1.0	0.0	12.7	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
ZNF784	MGC75238	ENSG00000179922	"Zinc finger protein 784"	Q8NCA9	19	55620742-55624601	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 39.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059676	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA059676: AB_2684102"	"unprognostic (4.67e-2)"	"unprognostic (8.13e-2)"	"unprognostic (4.03e-1)"	"unprognostic (6.46e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.44e-2)"	"unprognostic (4.74e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.11e-3)"	"unprognostic (4.86e-2)"	"unprognostic (3.48e-3)"	"unprognostic (3.87e-1)"	"unprognostic (7.93e-2)"	"unprognostic (5.10e-2)"	"prognostic favourable (1.02e-4)"	5.9	5.6	2.9	7.4	3.2	5.7	4.9	5.2	5.0	7.5	9.3	3.3	4.1	8.6	7.9	8.0	4.9	6.7	7.0	9.1	2.8	2.3	5.8	7.3	10.4	3.5	2.7	3.2	9.7	15.0	6.0	5.5	4.9	3.9	7.9	3.8	5.8	5.9	5.8	39.1	4.9	11.2	10.4	2.6	6.5	5.8	3.6	2.6	3.2	7.3	16.1	6.1	6.7	4.5	1.4	1.6	2.9	2.0	1.4	1.3	0.6	4.5	6.3	6.0	3.2	2.3	3.1	5.7	4.7	3.0	2.7	3.7	3.2	5.0	5.4	4.2	3.3	2.5	1.7	4.1	1.9	3.0	16.8	5.1	4.9	4.0	4.6	4.1	5.4	4.2	4.5	2.3	2.9	1.8	5.9	5.7	4.1	4.3	3.2	4.7	5.8	14.0	6.1	4.1	6.0	5.0	11.5	6.7	9.0	7.8	3.7	2.1	3.9	7.4	5.4	3.2	3.0	1.9	3.8	6.5	2.7	3.1	4.8	3.1	2.6	0.0	2.0	2.9	0.8	1.8	0.6	1.0	0.8	0.8	1.6	1.4	0.8	1.3	1.1	1.4	1.5	1.2	0.1	0.6	2.9	3.2	5.2	5.0	2.8	2.3	2.7	3.2	3.9	2.6
ZNF853	DKFZp434J1015	ENSG00000236609	"Zinc finger protein 853"	P0CG23	7	6615617-6624290	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 28.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.5;SH-SY5Y: 21.6;U-2 OS: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 3.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.1;NK-cells: 1.1;T-cells: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067690	Approved		Approved	Nucleoli				Nucleoli	Nucleoli	"HPA067690: AB_2685888"	"unprognostic (1.35e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.17e-2)"	"unprognostic (8.77e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.87e-3)"	"unprognostic (9.28e-2)"	"prognostic favourable (2.30e-6)"	"unprognostic (4.41e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.30e-3)"	"unprognostic (4.01e-2)"	3.7	3.9	16.6	2.9	14.4	1.0	4.6	4.5	13.5	7.8	7.7	10.4	2.8	1.8	9.4	5.9	5.6	11.8	5.8	12.3	16.1	15.5	3.3	0.9	4.5	4.3	14.8	9.1	15.6	10.6	7.3	4.5	3.7	11.9	7.6	2.5	6.0	6.7	11.5	28.9	2.4	2.7	8.5	10.1	4.3	3.6	3.0	9.9	2.6	9.9	2.7	2.7	6.5	11.7	0.3	0.4	3.1	0.0	1.1	1.5	0.3	0.0	1.1	3.4	14.5	0.1	0.0	0.1	0.3	0.0	1.5	0.3	2.5	0.5	0.0	5.7	0.0	0.0	5.2	0.1	1.5	0.0	1.9	0.4	0.0	2.6	2.1	0.0	0.1	0.5	0.5	0.2	0.0	0.0	2.2	0.0	0.9	0.1	0.3	1.8	5.4	0.0	1.6	5.7	0.1	1.1	5.4	4.6	21.6	0.0	0.2	0.9	0.8	3.0	0.0	1.1	14.5	0.0	1.3	0.3	0.1	0.0	0.0	0.0	5.6	0.0	0.0	3.1	1.2	0.0	1.5	0.3	0.8	1.4	0.0	0.3	0.2	1.4	0.0	1.1	0.0	0.4	0.0	0.3	16.6	14.4	4.5	12.4	16.1	15.5	14.8	9.1	11.9	9.9
ZNF865		ENSG00000261221	"Zinc finger protein 865"	P0CJ78	19	55605405-55617269	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068079	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoli	"HPA068079: AB_2685947"	"unprognostic (3.98e-3)"	"unprognostic (2.46e-1)"	"unprognostic (4.72e-3)"	"unprognostic (8.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.20e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.41e-3)"	12.1	7.5	8.3	11.0	10.5	11.1	8.2	12.3	15.1	8.0	10.0	9.7	6.6	11.0	11.5	6.8	6.2	8.7	7.0	12.2	7.3	5.8	8.3	6.7	8.7	13.3	7.4	8.5	10.3	11.2	9.9	9.5	6.1	7.4	9.9	4.8	8.1	12.1	7.7	56.2	11.1	10.4	7.4	7.3	16.0	12.2	4.7	7.9	14.0	9.5	8.0	9.1	9.3	9.9	1.2	0.5	1.4	0.1	0.1	0.6	0.1	6.3	5.2	2.3	3.7	2.5	1.9	6.2	4.6	2.6	2.5	2.4	1.7	4.2	7.5	5.4	3.3	5.3	1.4	2.8	1.0	7.3	17.4	4.2	3.2	2.2	3.9	4.8	8.4	2.9	4.4	3.0	1.8	1.7	8.1	5.1	1.6	3.0	7.6	5.2	5.2	9.2	11.9	3.6	4.6	2.9	4.4	5.4	8.8	6.3	3.9	3.8	3.1	7.6	5.0	3.8	9.2	3.5	5.7	10.7	9.3	3.9	4.7	3.8	6.1	0.0	0.0	1.4	0.3	0.1	0.2	1.2	0.2	0.1	0.1	0.2	0.1	0.6	0.8	0.1	0.1	0.5	0.0	0.1	8.3	10.5	12.3	15.1	7.3	5.8	7.4	8.5	7.4	7.9
ZYG11B	"FLJ13456, ZYG11"	ENSG00000162378	"Zyg-11 family member B, cell cycle regulator"	Q9C0D3	1	52726467-52827342	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 63.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028156	Uncertain		Approved	"Golgi apparatus,Intermediate filaments"				"Golgi apparatus, Intermediate filaments"	"Golgi apparatus, Intermediate filaments"	"HPA028156: AB_10602360"	"unprognostic (2.54e-1)"	"unprognostic (2.02e-1)"	"prognostic favourable (5.42e-6)"	"unprognostic (1.58e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.04e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.84e-3)"	"unprognostic (5.06e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.08e-2)"	"prognostic favourable (9.80e-7)"	"unprognostic (2.22e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.57e-2)"	8.9	9.1	10.8	5.6	15.6	7.1	7.7	22.3	21.7	9.9	10.4	9.1	5.6	4.7	11.0	6.5	9.7	7.3	6.8	15.9	10.7	15.4	12.9	17.7	7.7	5.0	10.1	11.6	11.3	6.5	12.7	9.1	7.2	16.4	9.8	7.9	10.1	6.1	9.2	63.9	6.5	5.8	12.3	8.4	5.7	6.3	8.4	7.7	6.9	12.7	11.4	5.7	9.2	7.0	2.2	2.2	5.7	2.4	2.1	3.8	1.0	8.1	7.4	9.4	11.7	17.3	15.1	8.2	9.2	11.8	7.3	6.8	6.3	2.7	7.8	9.3	17.8	4.2	10.7	8.1	11.7	6.5	7.0	10.0	8.5	3.9	9.2	7.5	6.2	10.7	8.8	10.5	7.4	12.7	8.9	1.6	13.2	3.4	2.9	4.7	9.7	7.7	5.1	17.8	7.1	7.5	12.9	4.3	8.8	16.0	10.0	8.5	6.0	5.8	14.6	11.4	6.7	11.2	5.7	6.8	8.2	6.0	7.8	5.1	7.3	1.0	2.4	2.7	2.1	1.3	2.3	2.2	2.6	1.6	2.2	2.1	3.8	2.7	5.7	2.1	2.0	1.7	3.0	1.0	10.8	15.6	22.3	21.7	10.7	15.4	10.1	11.6	16.4	7.7
